data_2ltj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ltj _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo . . . . . 0 C--O 1.23 0.094 0 CA-C-O 120.739 0.224 . . . . 0.0 112.245 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.68 142.17 51.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.786 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.96 111.3 23.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.191 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.66 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 6.1 pt -101.18 -177.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.966 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 0.7 OUTLIER -145.86 162.26 38.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.357 0.598 . . . . 0.0 111.193 -178.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.426 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 26.6 ttt180 -174.01 112.96 0.19 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.051 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 11.1 t -82.19 129.57 34.87 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.817 0.817 . . . . 0.0 111.326 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.451 ' O ' HD13 ' A' ' 44' ' ' ILE . 2.1 mt-10 -98.13 147.72 24.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.002 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -67.08 101.48 0.88 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.028 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 1.9 mp -107.67 87.39 3.5 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.86 160.29 37.44 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.66 2.24 . . . . 0.0 112.688 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.457 ' CD1' ' HA3' ' A' ' 67' ' ' GLY . 33.5 p90 -87.15 -176.92 5.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.985 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.43 115.13 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.841 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 t -67.17 143.83 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.132 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.4 mm -115.84 156.19 16.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -108.74 109.57 20.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -119.82 153.21 36.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -87.91 129.5 35.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.971 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.407 ' ND2' ' CD2' ' A' ' 56' ' ' LEU . 5.8 t-20 -122.17 96.5 46.37 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.09 -23.97 45.45 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.392 2.061 . . . . 0.0 112.333 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -59.69 -28.97 67.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.991 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.407 ' CD2' ' ND2' ' A' ' 53' ' ' ASN . 3.1 mm? -83.18 165.29 41.7 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.742 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -80.84 43.39 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.076 2.518 . . . . 0.0 112.743 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.88 142.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.939 0.399 . . . . 0.0 111.437 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 55.17 25.85 40.93 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.876 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.38 136.84 48.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 0.0 110.979 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -101.2 162.57 12.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -156.32 111.85 2.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.86 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.7 mm -85.65 86.12 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.138 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.9 mm -64.53 -36.07 76.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.953 0.406 . . . . 0.0 110.712 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.449 ' CG2' ' O ' ' A' ' 65' ' ' THR . 9.7 t -166.56 100.35 0.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.554 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.41 135.02 28.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.753 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.457 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -66.0 134.27 34.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.273 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -130.2 132.21 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.907 0.384 . . . . 0.0 111.3 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.435 ' HD3' ' CD2' ' A' ' 46' ' ' PHE . 10.7 mmtt -57.12 125.96 25.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.229 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.449 ' CA ' ' O ' ' A' ' 96' ' ' LYS . . . -105.49 -159.55 23.0 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.051 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.502 ' HA ' HD13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -162.47 154.62 18.88 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.622 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.587 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 14.0 ttt180 -143.67 111.77 6.22 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.572 ' O ' ' HB2' ' A' ' 92' ' ' SER . 64.2 m -72.99 121.46 20.14 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.572 ' O ' ' HA ' ' A' ' 39' ' ' THR . 18.7 m80 -102.26 120.3 40.24 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -86.02 122.27 29.82 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.679 -1.601 . . . . 0.0 110.767 -178.238 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.414 ' HB ' ' CG1' ' A' ' 38' ' ' ILE . 4.2 mp -116.14 141.78 32.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.282 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.24 98.06 7.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.829 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.5 p -81.45 117.9 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.159 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -105.45 124.33 49.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.78 91.24 7.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -123.16 135.96 54.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.2 m120 61.15 30.49 19.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.87 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.54 47.67 81.52 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.597 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.55 142.7 12.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.774 0.321 . . . . 0.0 110.862 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.18 120.79 41.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.889 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 t -105.05 125.86 51.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.866 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.37 107.3 19.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.876 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 97.3 m -133.71 112.75 11.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.923 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.3 m -56.61 162.37 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.966 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 mp -149.18 -56.72 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.343 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.509 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 1.4 t70 -140.65 134.73 30.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.479 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.572 ' HB2' ' O ' ' A' ' 73' ' ' THR . 17.8 p -143.21 133.33 24.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.308 0.575 . . . . 0.0 111.319 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.56 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 3.4 pt20 -89.52 166.58 13.58 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.426 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 5.2 m -85.67 107.3 16.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.564 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 20.0 p -114.22 83.01 1.8 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.192 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.564 ' CB ' ' O ' ' A' ' 95' ' ' THR . 20.2 tptm 107.53 48.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.741 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -33.72 122.24 0.44 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.755 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.414 ' HA ' ' HA3' ' A' ' 70' ' ' GLY . 12.6 p -71.61 109.89 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.212 0.529 . . . . 0.0 111.052 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 34.8 mm -68.72 116.22 8.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.221 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 20.8 m-20 -81.52 129.33 34.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.726 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -62.09 112.36 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.96 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.425 ' CG2' ' CG2' ' A' ' 65' ' ' THR . 58.1 t -95.4 99.73 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.954 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.5 m -122.85 135.72 61.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.133 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -119.8 108.5 14.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.735 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.0 t -91.41 142.0 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.069 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.81 147.1 37.63 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.552 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.655 0.264 . . . . 0.0 111.135 -179.922 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 CA--C 1.529 0.253 0 N-CA-C 112.594 0.19 . . . . 12.88 112.594 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -147.71 112.03 5.24 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.284 -0.416 . . . . 13.36 110.467 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 mp -72.74 111.49 7.94 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.181 -0.463 . . . . 10.75 110.764 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.641 HG13 ' HB ' ' A' ' 76' ' ' ILE . 28.6 pt -99.44 121.0 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-O 121.722 0.772 . . . . 11.89 109.665 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.681 ' HB ' ' CG2' ' A' ' 73' ' ' THR . 6.3 p -87.13 139.39 30.62 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.018 -0.992 . . . . 10.52 111.111 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 7.1 ttt-85 -155.51 117.98 4.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.807 -1.088 . . . . 13.32 108.914 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 68.4 p -79.81 127.49 32.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.503 0.668 . . . . 9.69 110.887 -178.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -96.9 139.41 32.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.639 -1.164 . . . . 8.68 109.83 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.86 97.82 0.37 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.962 -0.563 . . . . 10.74 110.691 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.479 ' CD1' ' CB ' ' A' ' 72' ' ' ARG . 7.5 mt -99.19 103.01 17.59 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 115.43 -0.805 . . . . 6.41 109.585 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.545 ' C ' HG22 ' A' ' 98' ' ' VAL . 90.5 Cg_endo -78.24 145.63 21.74 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.316 2.677 . . . . 7.29 114.363 -177.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.537 ' HB2' ' HA ' ' A' ' 100' ' ' ASN . 39.1 p90 -86.73 -179.82 6.63 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.278 -0.874 . . . . 7.85 111.175 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.07 117.19 6.83 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.397 -0.365 . . . . 6.08 111.678 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' A' ' 101' ' ' GLN . 21.9 t -66.11 134.61 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.039 -0.528 . . . . 7.4 111.536 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.9 mm -123.48 139.76 49.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.278 -0.419 . . . . 9.0 111.49 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -100.19 108.19 20.23 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.881 -0.6 . . . . 10.67 110.394 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.95 106.18 16.57 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.079 -0.509 . . . . 12.54 111.155 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -61.64 105.53 0.55 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.822 0.344 . . . . 14.65 110.524 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 0.8 OUTLIER -108.34 119.82 48.46 Favored Pre-proline 0 C--O 1.232 0.173 0 CA-C-N 116.087 -0.506 . . . . 15.73 111.442 -179.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.56 -24.6 18.64 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.785 2.324 . . . . 18.85 112.371 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -61.76 -39.1 90.45 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.421 -0.354 . . . . 19.41 111.183 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' A' ' 60' ' ' GLN . 1.0 OUTLIER -63.58 164.27 16.49 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.495 -0.32 . . . . 17.22 110.905 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.77 -74.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.769 2.313 . . . . 18.08 113.301 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -178.76 122.51 0.09 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.098 -0.955 . . . . 15.9 111.205 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.21 29.1 62.38 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.189 -0.529 . . . . 13.8 113.025 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.479 ' HB3' HD21 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -106.09 136.69 45.33 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.701 0.25 . . . . 15.58 110.501 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.26 113.4 25.02 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.888 0.375 . . . . 13.22 111.335 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.438 ' HB3' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -106.22 111.99 24.82 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.893 -0.594 . . . . 14.56 109.948 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 24.2 mt -85.58 122.51 38.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.095 0.474 . . . . 13.39 111.851 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.4 mm -100.52 -39.7 7.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.374 -0.83 . . . . 14.36 109.841 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.507 HG22 HG23 ' A' ' 99' ' ' ILE . 0.2 OUTLIER -135.54 99.0 4.08 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.682 -0.69 . . . . 11.92 109.815 179.517 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.4 113.72 1.14 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.02 -0.536 . . . . 11.37 112.074 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 99' ' ' ILE . . . -58.7 109.33 1.95 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.871 -0.604 . . . . 8.47 112.314 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.5 t -135.1 144.56 34.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.91 0.386 . . . . 10.37 111.251 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 45' ' ' PRO . 2.7 mmtt -67.48 116.3 8.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.716 -0.675 . . . . 10.44 111.125 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.444 ' HA2' ' HE3' ' A' ' 96' ' ' LYS . . . -81.96 -171.55 46.18 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.154 -0.546 . . . . 7.86 112.107 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.548 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -158.72 109.18 2.05 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.461 -0.57 . . . . 10.04 109.461 179.499 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.683 ' HG3' ' HA ' ' A' ' 94' ' ' VAL . 36.5 ttm180 -98.18 124.8 42.94 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.554 -0.536 . . . . 6.27 109.554 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.681 ' CG2' ' HB ' ' A' ' 39' ' ' THR . 95.1 m -74.76 125.37 28.62 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 107.719 -1.215 . . . . 9.06 107.719 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.488 ' HA ' ' HB2' ' A' ' 92' ' ' SER . 19.8 m80 -105.66 114.88 29.3 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.927 0.87 . . . . 8.1 112.647 -177.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.694 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -80.09 92.47 5.64 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 113.67 -1.605 . . . . 8.2 109.086 -178.363 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.641 ' HB ' HG13 ' A' ' 38' ' ' ILE . 74.1 mt -88.16 154.86 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 113.411 -1.722 . . . . 11.25 112.474 -177.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.7 t -105.17 121.35 43.63 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.292 -0.413 . . . . 11.99 110.34 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 m -81.76 98.23 4.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.05 0.452 . . . . 13.86 111.351 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.0 mt -103.68 106.85 17.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.967 -0.56 . . . . 15.75 110.209 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 p -73.56 93.88 2.08 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.207 -0.451 . . . . 17.89 111.194 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -90.74 93.99 9.48 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.994 -0.548 . . . . 20.19 110.26 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 58.5 45.6 16.2 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.098 -0.501 . . . . 22.86 110.773 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.76 47.71 6.56 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.108 -0.568 . . . . 21.87 112.713 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -162.13 108.07 1.27 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.657 0.265 . . . . 21.44 111.114 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.4 p -75.72 97.74 3.92 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.239 -0.437 . . . . 18.44 110.653 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 58.9 m -77.37 110.25 11.96 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.092 -0.504 . . . . 16.78 110.751 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.476 ' HB2' HG22 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -80.79 96.34 6.94 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.112 0.482 . . . . 14.81 110.636 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 45.1 m -108.79 126.15 52.72 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.959 -0.564 . . . . 13.35 111.4 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.1 p -59.16 134.89 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.066 -0.516 . . . . 10.64 110.134 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 32.2 mt -137.64 -83.94 0.32 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.147 0.425 . . . . 10.63 112.147 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.81 122.1 44.4 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.563 0.221 . . . . 8.61 111.343 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.644 ' HB2' ' O ' ' A' ' 73' ' ' THR . 1.3 p -145.29 148.94 34.0 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.189 0.519 . . . . 6.55 111.656 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.603 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 19.0 mm-40 -108.65 164.64 12.19 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.032 -1.47 . . . . 9.99 107.032 176.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.683 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 12.3 p -82.22 112.68 20.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.292 -0.563 . . . . 7.93 110.544 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 31.9 p -117.61 72.08 0.83 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.671 0.748 . . . . 9.06 110.612 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 149.37 -43.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.07 -1.423 . . . . 11.79 108.826 178.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.447 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 9.3 tp10 64.55 115.32 0.02 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.327 -0.851 . . . . 8.74 111.571 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.545 HG22 ' C ' ' A' ' 45' ' ' PRO . 11.1 p -71.21 103.24 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.373 0.606 . . . . 6.28 110.107 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.507 HG23 HG22 ' A' ' 65' ' ' THR . 4.5 mp -71.68 118.97 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.424 -0.807 . . . . 9.63 110.962 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.537 ' HA ' ' HB2' ' A' ' 46' ' ' PHE . 4.1 m120 -82.69 133.1 35.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.846 -0.615 . . . . 7.9 110.102 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.526 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -59.64 98.46 0.05 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.422 -0.354 . . . . 9.07 111.032 -179.435 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 76.0 t -90.72 99.11 9.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.862 -0.421 . . . . 10.85 109.862 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.01 125.39 72.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.949 -0.569 . . . . 10.51 111.177 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 53' ' ' ASN . 17.0 mm-40 -96.52 110.29 22.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.822 -0.627 . . . . 13.72 110.248 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.7 t -85.98 115.55 27.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.226 -0.443 . . . . 12.91 110.992 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.8 132.02 46.48 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.015 -0.612 . . . . 14.28 112.721 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.361 0.124 . . . . 15.72 110.933 179.807 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.849 0.27 . . . . 0.0 112.348 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -169.38 128.05 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.88 131.25 35.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.7 OUTLIER -101.12 -177.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.698 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.483 HG21 ' CD1' ' A' ' 75' ' ' TYR . 1.0 OUTLIER -163.31 121.08 1.91 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.113 0.482 . . . . 0.0 110.669 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -142.56 109.72 5.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.774 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 11.3 t -82.52 128.28 34.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.511 0.672 . . . . 0.0 111.407 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.476 ' O ' HD12 ' A' ' 44' ' ' ILE . 1.3 mt-10 -98.31 146.01 26.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.744 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.77 91.67 0.2 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.803 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.577 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.7 mp -89.62 108.23 23.85 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.885 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.422 ' C ' HG23 ' A' ' 98' ' ' VAL . 1.9 Cg_endo -81.95 157.43 18.07 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.941 2.427 . . . . 0.0 112.596 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.43 ' HB3' ' CG2' ' A' ' 98' ' ' VAL . 42.2 p90 -86.57 -174.4 4.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.74 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.99 116.54 3.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.2 t -67.29 148.76 11.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.051 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 37.9 mm -123.82 156.16 30.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.013 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -119.42 100.86 7.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -105.56 141.72 36.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -104.79 124.89 50.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -128.67 133.29 25.03 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.12 -20.77 12.61 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.468 2.112 . . . . 0.0 112.541 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -55.06 -38.49 68.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.06 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.2 mt -62.82 159.64 43.34 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.763 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -80.24 44.98 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.039 2.493 . . . . 0.0 112.724 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.61 125.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.934 0.397 . . . . 0.0 111.424 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.44 53.63 41.92 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.779 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.46 162.91 13.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.746 0.308 . . . . 0.0 110.894 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -145.16 113.92 6.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -143.12 122.54 13.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.422 HG21 HD13 ' A' ' 63' ' ' ILE . 31.2 mt -86.59 131.18 35.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.09 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.5 mm -99.59 -44.24 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.9 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.6 m -144.28 102.25 3.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.659 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.81 153.4 4.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.483 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.59 131.29 10.32 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.19 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -140.62 136.36 35.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.869 0.366 . . . . 0.0 111.132 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -63.12 124.87 22.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 96' ' ' LYS . . . -97.99 -151.98 27.77 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.888 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.478 ' CB ' ' HB3' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -161.03 148.1 15.19 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.577 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 5.2 ttt180 -140.21 111.22 6.98 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.713 ' O ' ' HB2' ' A' ' 92' ' ' SER . 19.1 m -73.58 126.81 31.11 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.458 ' HA ' ' CB ' ' A' ' 92' ' ' SER . 20.3 m80 -107.55 119.72 40.21 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.042 0.925 . . . . 0.0 112.893 -177.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.687 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -91.15 102.72 15.45 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 113.651 -1.613 . . . . 0.0 111.146 -177.529 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.401 ' CD1' ' HG3' ' A' ' 40' ' ' ARG . 4.8 mp -87.86 160.15 2.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.952 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.45 126.8 44.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.685 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.43 109.86 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.254 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.4 mt -115.75 103.53 10.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.841 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.33 123.19 34.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.831 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -129.55 93.09 3.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 61.24 36.24 17.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.964 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.82 46.13 5.22 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.442 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.01 114.64 7.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.812 0.339 . . . . 0.0 110.872 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.85 112.09 23.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.856 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.95 150.73 21.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.96 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -107.77 99.54 9.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 94.1 m -115.37 116.5 28.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.922 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.1 m -50.01 123.67 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.53 -67.87 0.96 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.216 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.51 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -163.13 141.97 8.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.299 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.713 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.6 p -143.56 151.08 39.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.448 0.642 . . . . 0.0 111.394 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.668 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 12.8 mm-40 -110.01 166.96 10.53 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.482 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 8.3 p -84.95 106.93 15.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.007 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.585 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 15.4 p -111.82 82.61 1.65 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.76 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.585 ' CB ' ' O ' ' A' ' 95' ' ' THR . 21.0 tttt 109.92 48.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.585 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 96' ' ' LYS . 1.2 pm0 -32.43 125.47 0.31 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.819 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.43 ' CG2' ' HB3' ' A' ' 46' ' ' PHE . 4.3 p -71.7 119.14 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.03 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.439 HG22 HD13 ' A' ' 99' ' ' ILE . 34.8 mm -70.05 115.96 10.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.919 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -90.36 130.9 36.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.57 127.36 32.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.85 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.5 m -126.5 99.73 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.188 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.9 p -108.25 116.53 51.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.015 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -87.1 108.55 18.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.6 p -98.36 137.73 25.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -72.66 130.85 15.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.511 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 111.063 -179.943 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo . . . . . 0 C--O 1.231 0.14 0 CA-C-O 120.788 0.245 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.01 -179.18 4.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.916 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.1 mt -111.36 115.69 29.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.949 0.404 . . . . 0.0 111.132 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.632 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -101.11 -176.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.525 179.273 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 1.4 p -158.03 140.12 14.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.345 0.593 . . . . 0.0 111.079 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.489 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 33.9 ttp180 -161.23 107.07 1.38 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.02 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 14.8 t -81.93 132.43 35.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.709 0.766 . . . . 0.0 111.706 -178.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.434 ' O ' HD13 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -98.56 144.69 27.6 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.574 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -66.77 91.68 0.2 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.854 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.581 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 3.2 mp -85.19 111.04 33.37 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.783 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -87.46 153.41 7.81 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.667 2.245 . . . . 0.0 112.849 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.454 ' CD2' ' HA3' ' A' ' 67' ' ' GLY . 49.9 p90 -87.07 -176.83 5.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.782 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -149.57 112.46 4.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.098 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.4 t -67.22 149.23 11.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.031 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.0 mm -125.79 156.06 35.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.184 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.03 100.93 7.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.778 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.89 137.59 38.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -93.81 102.73 14.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.899 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -102.57 96.56 7.59 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.838 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.65 -18.06 48.11 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.461 2.108 . . . . 0.0 112.488 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -58.16 -31.5 67.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.977 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.3 mt -76.07 165.4 53.36 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.799 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -83.9 42.34 1.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.13 2.553 . . . . 0.0 112.606 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.06 150.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.843 0.354 . . . . 0.0 111.314 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 55.2 27.15 45.46 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.616 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 -95.49 116.14 28.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -110.91 134.88 52.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -151.13 161.9 41.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.9 mm -126.49 95.9 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.101 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.7 mm -72.88 -31.79 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.98 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.9 m -163.42 96.2 0.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.708 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.87 151.77 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.483 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.454 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -93.4 120.89 6.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.33 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.39 133.75 57.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.823 0.344 . . . . 0.0 111.152 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -59.27 125.74 24.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.156 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -96.05 -141.01 11.46 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.999 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.505 ' N ' ' HB3' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -166.71 141.94 4.31 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.581 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 22.4 ttm180 -136.11 111.11 8.87 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.72 ' O ' ' HB3' ' A' ' 92' ' ' SER . 32.8 m -73.78 124.92 26.98 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.523 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 8.5 m80 -105.08 117.0 32.91 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 122.082 0.944 . . . . 0.0 113.191 -176.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.677 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -89.55 100.72 13.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 113.611 -1.631 . . . . 0.0 110.98 -178.082 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.462 ' HB ' ' CG2' ' A' ' 38' ' ' ILE . 4.5 mp -87.56 161.17 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.281 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.3 t -107.82 112.85 25.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.721 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.8 p -81.54 102.19 7.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.017 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 tp -110.1 108.9 19.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.945 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 t -86.0 107.55 17.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.814 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -104.85 93.22 4.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.847 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 60.4 31.14 20.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.83 43.16 3.4 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.561 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 11.4 ttpt -149.16 112.66 5.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.792 0.33 . . . . 0.0 110.891 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.77 110.42 22.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.855 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.86 132.04 50.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.936 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.76 99.63 11.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.951 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.3 t -113.93 125.47 54.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.927 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.3 m -51.04 115.68 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.094 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.84 -63.42 1.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.533 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -166.04 136.58 3.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.009 -179.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.72 ' HB3' ' O ' ' A' ' 73' ' ' THR . 0.8 OUTLIER -143.59 150.1 38.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.547 0.689 . . . . 0.0 111.576 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.603 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -109.46 166.47 10.86 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.497 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 30.9 m -85.23 106.79 15.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.06 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.568 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 16.9 p -110.95 82.56 1.61 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.714 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 95' ' ' THR . 2.5 tppt? 132.4 -39.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.631 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 59.09 121.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.556 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.2 p -81.71 114.47 22.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.737 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.6 mp -75.32 132.18 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -93.72 140.49 29.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.962 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -77.12 114.4 15.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.94 99.7 9.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.046 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.7 p -121.19 119.56 59.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -93.37 133.16 36.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.839 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.3 m -112.27 123.27 67.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.232 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.77 123.79 19.69 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.449 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 120.767 0.318 . . . . 0.0 111.068 -179.999 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 C--O 1.23 0.097 0 CA-C-O 120.768 0.237 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -168.82 113.73 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.814 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mp -76.95 132.49 39.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.045 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -101.26 -177.06 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.783 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.475 HG21 ' CD1' ' A' ' 75' ' ' TYR . 0.9 OUTLIER -163.67 123.02 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.178 0.513 . . . . 0.0 110.342 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 2.8 mtm180 -149.6 109.36 4.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.29 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 14.9 t -82.41 133.22 35.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.71 0.767 . . . . 0.0 111.872 -178.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.436 ' O ' HD12 ' A' ' 44' ' ' ILE . 3.0 mt-10 -98.35 147.64 24.47 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.453 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.68 98.32 0.51 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.884 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.543 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.9 mp -95.9 105.43 21.28 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.576 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -84.69 150.36 11.37 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.719 2.279 . . . . 0.0 113.171 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.436 ' CA ' HG23 ' A' ' 98' ' ' VAL . 43.0 p90 -86.87 -175.06 5.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.939 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.67 116.53 5.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.239 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.6 t -67.23 149.68 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.122 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -115.65 156.2 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.005 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.92 107.76 12.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -115.25 165.82 12.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.905 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -112.81 138.51 49.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -138.27 96.52 9.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.921 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.02 -20.8 57.15 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.413 2.075 . . . . 0.0 112.438 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -58.3 -29.63 66.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.994 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mt -70.97 165.96 42.4 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.878 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.29 46.79 2.2 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.117 2.545 . . . . 0.0 112.796 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.25 126.48 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.832 0.349 . . . . 0.0 111.641 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 51.67 55.88 18.31 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.928 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.4 144.06 38.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.786 0.327 . . . . 0.0 110.951 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -104.4 130.08 52.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.926 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -146.58 127.86 14.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.982 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 25.0 mm -104.99 90.99 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.034 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.6 mm -65.47 -32.67 59.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.549 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.412 ' CG2' ' CG2' ' A' ' 102' ' ' VAL . 5.3 t -161.38 128.3 3.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.398 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.48 135.37 35.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 111.419 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.429 ' HA3' ' CE2' ' A' ' 46' ' ' PHE . . . -81.98 134.95 13.6 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.308 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 t -145.16 142.95 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 111.088 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.56 119.7 17.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.344 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.84 -139.91 7.79 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.639 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -169.64 146.91 3.4 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.547 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.562 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 2.5 ttt180 -134.91 111.67 10.04 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.693 ' O ' ' HB3' ' A' ' 92' ' ' SER . 37.4 m -73.84 126.65 30.88 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.537 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 9.1 m80 -105.82 117.37 33.84 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 122.148 0.975 . . . . 0.0 112.753 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.67 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -90.37 100.1 13.0 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 113.57 -1.65 . . . . 0.0 111.075 -177.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.407 ' O ' HG13 ' A' ' 38' ' ' ILE . 3.1 mp -87.8 159.9 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.726 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.401 ' N ' ' CG2' ' A' ' 76' ' ' ILE . 40.0 t -102.83 126.71 50.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.828 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.1 m -81.51 106.29 12.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.203 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -112.47 130.99 55.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.943 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.6 135.8 39.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -152.22 115.65 4.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.826 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.8 m120 60.07 34.96 21.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.966 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.98 29.5 66.89 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.509 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -128.3 165.0 21.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.915 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.03 120.32 41.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.97 151.02 22.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.778 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.27 121.97 40.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 98.9 m -144.79 123.07 12.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.967 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 p -58.21 131.99 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.834 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.2 tp -116.04 -55.54 2.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.296 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 3.6 t0 -169.45 136.91 1.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.482 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.693 ' HB3' ' O ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -143.66 145.23 32.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.387 0.613 . . . . 0.0 111.261 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.601 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 34.5 mm-40 -106.89 165.86 11.02 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.53 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 9.0 p -85.88 106.93 15.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.4 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.515 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 9.7 p -111.71 82.11 1.56 Allowed 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.656 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 95' ' ' THR . 0.0 OUTLIER 140.96 -36.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.642 178.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 56.44 115.02 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.821 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.436 HG23 ' CA ' ' A' ' 46' ' ' PHE . 14.9 p -81.49 106.29 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.535 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.1 tt -79.42 133.01 30.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.304 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.418 ' HA ' ' HB2' ' A' ' 46' ' ' PHE . 27.9 m-20 -92.49 161.75 14.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.888 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -96.8 140.54 31.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.412 ' CG2' ' CG2' ' A' ' 65' ' ' THR . 84.2 t -126.1 118.68 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.988 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.4 m -131.25 145.63 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.0 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -116.18 108.38 16.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.26 110.74 20.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.41 133.28 50.3 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.506 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.637 0.256 . . . . 0.0 111.151 179.969 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.813 0.255 . . . . 0.0 112.228 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -93.75 148.89 21.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.657 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.83 117.23 34.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.11 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.686 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 1.1 pp -101.2 -176.72 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.09 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 0.8 OUTLIER -149.66 152.58 35.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.257 0.551 . . . . 0.0 111.025 -179.276 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 74' ' ' HIS . 19.5 ttt-85 -170.05 111.62 0.44 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.003 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 14.9 t -82.16 131.78 35.24 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.828 0.823 . . . . 0.0 111.478 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.481 ' O ' HD13 ' A' ' 44' ' ' ILE . 0.7 OUTLIER -98.15 149.72 22.23 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.871 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -66.95 105.53 1.65 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.059 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.576 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.4 mp -107.73 100.41 34.89 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.867 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -84.99 156.86 11.44 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.038 2.492 . . . . 0.0 112.581 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.423 ' CD1' ' HA3' ' A' ' 67' ' ' GLY . 46.5 p90 -87.13 -174.25 4.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.013 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -153.35 109.05 3.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.986 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.4 p -67.42 154.06 8.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.196 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -124.79 156.15 33.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.045 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.27 100.81 10.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.8 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -90.43 147.7 23.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.965 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -107.95 102.97 12.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -94.16 102.83 9.07 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.61 -26.91 46.06 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.406 2.071 . . . . 0.0 112.271 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -69.41 -31.48 69.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.4 mt -63.59 163.23 21.53 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -86.86 31.0 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.818 2.345 . . . . 0.0 112.948 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 56.85 104.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.266 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 118.25 -25.35 8.29 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.634 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.63 134.9 47.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 0.0 110.868 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -137.96 128.44 26.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -128.14 148.61 50.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.0 mm -97.65 86.33 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.147 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.2 mm -62.24 -35.82 71.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.812 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.3 m -164.28 90.98 0.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.629 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.12 150.97 4.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.52 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.423 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -88.86 134.69 12.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.338 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.41 132.43 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.856 0.36 . . . . 0.0 111.204 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.0 mttp -56.07 126.2 24.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.184 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' A' ' 96' ' ' LYS . . . -99.81 -157.44 28.47 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.129 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.488 ' HA ' HD13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -159.94 151.4 19.79 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.576 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 36.7 ttt180 -141.9 110.91 6.27 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.628 ' O ' ' HB2' ' A' ' 92' ' ' SER . 96.0 m -73.33 121.24 20.11 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.537 ' O ' ' HA ' ' A' ' 39' ' ' THR . 13.7 m80 -102.94 121.55 42.77 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.795 0.807 . . . . 0.0 113.133 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.686 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -89.55 107.78 19.28 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 113.857 -1.52 . . . . 0.0 111.273 -177.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.447 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 2.5 mp -98.69 159.24 3.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.896 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.14 113.47 24.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.867 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.3 p -81.45 113.15 20.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.13 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.33 107.01 15.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.855 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.6 m -76.46 104.05 6.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.992 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -115.3 108.47 16.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.783 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 60.58 35.3 20.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.98 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.84 47.46 25.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.475 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.89 107.41 3.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.785 0.326 . . . . 0.0 110.877 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 p -79.79 125.22 29.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.3 p -123.67 150.98 43.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.95 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -105.59 113.89 27.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.4 t -123.24 123.25 40.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.944 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.3 m -57.66 129.45 19.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.99 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.1 tp -119.12 -58.15 1.96 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.15 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.521 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 1.9 t70 -166.29 140.78 4.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.273 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.628 ' HB2' ' O ' ' A' ' 73' ' ' THR . 17.2 p -143.15 149.26 37.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.33 0.586 . . . . 0.0 111.12 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.567 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 7.0 pt20 -105.46 166.88 10.12 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.493 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 26.0 t -85.31 106.6 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.122 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 21.8 p -113.07 83.05 1.76 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.13 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 95' ' ' THR . 0.0 OUTLIER 105.55 48.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.853 -179.662 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -33.63 126.2 0.4 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.853 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.408 HG22 ' CA ' ' A' ' 46' ' ' PHE . 10.0 p -71.76 112.5 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.98 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.2 mp -72.1 126.79 33.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.021 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -87.32 133.44 33.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.814 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -67.33 150.02 49.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.955 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.24 100.51 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.069 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.0 m -119.08 106.76 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.014 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -94.46 109.86 21.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.5 m -105.27 141.0 21.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.138 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.21 147.7 50.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.535 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 120.712 0.291 . . . . 0.0 111.037 -179.964 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 CA--C 1.526 0.113 0 CA-C-O 120.786 0.244 . . . . 0.0 112.287 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -170.52 128.65 0.82 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.861 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.1 mt -84.09 123.34 29.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.986 0.422 . . . . 0.0 111.069 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.589 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 1.1 pp -101.08 -176.37 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.202 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.475 ' HB ' ' CG2' ' A' ' 73' ' ' THR . 1.8 p -157.34 142.8 17.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.318 0.58 . . . . 0.0 110.901 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.418 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 2.6 ptp85 -162.59 107.33 1.15 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.206 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 15.4 t -82.28 129.86 34.96 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.768 0.794 . . . . 0.0 111.604 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.486 ' O ' HD11 ' A' ' 44' ' ' ILE . 0.6 OUTLIER -98.29 146.3 25.8 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.678 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -66.81 94.83 0.33 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.952 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.595 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 3.2 mp -87.07 109.88 28.53 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.949 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.4 ' C ' HG21 ' A' ' 98' ' ' VAL . 6.3 Cg_exo -78.65 152.91 26.18 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.843 2.362 . . . . 0.0 112.563 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.459 ' HB3' ' CG2' ' A' ' 98' ' ' VAL . 52.6 p90 -86.68 -178.58 6.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -138.83 111.67 7.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.961 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.2 t -67.45 141.95 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.079 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.3 mt -130.42 156.07 42.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.103 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -131.98 100.84 5.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -95.02 171.88 8.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -111.56 139.97 46.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -138.48 110.13 8.15 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.85 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.77 -26.15 38.99 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.409 2.072 . . . . 0.0 112.378 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.74 -32.91 71.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.1 mp -65.17 165.13 18.17 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.877 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -86.95 32.17 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.914 2.409 . . . . 0.0 112.808 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.86 142.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.874 0.368 . . . . 0.0 111.167 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.42 27.82 61.28 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.03 141.91 40.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.747 0.308 . . . . 0.0 110.951 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -136.81 124.73 22.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.904 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -130.55 142.08 50.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.418 HG21 HD11 ' A' ' 63' ' ' ILE . 30.9 mm -94.23 94.34 4.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.097 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.1 mm -73.63 -32.86 37.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.824 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 m -164.62 84.96 0.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.6 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.38 132.63 29.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.505 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.444 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -59.68 131.26 50.77 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.327 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.66 135.52 60.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.389 . . . . 0.0 111.115 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.6 mttp -61.36 116.81 4.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.139 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 98' ' ' VAL . . . -88.46 -149.22 18.44 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.871 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.473 ' CB ' ' HB3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -163.23 146.31 10.45 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.314 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.595 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 19.0 ttp85 -139.67 111.35 7.25 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.735 ' O ' ' HB2' ' A' ' 92' ' ' SER . 91.3 m -73.41 125.16 27.25 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.473 ' HA ' ' HB2' ' A' ' 92' ' ' SER . 13.9 m80 -106.14 119.05 38.22 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 122.185 0.993 . . . . 0.0 113.1 -176.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.676 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -90.34 98.85 12.02 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 113.437 -1.71 . . . . 0.0 111.459 -177.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.5 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.4 mp -87.56 143.45 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.027 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.3 m -89.72 122.26 32.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.708 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.35 98.35 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.111 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.3 tp -112.21 126.51 55.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.863 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 m -89.06 119.58 29.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.93 95.54 4.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.852 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 60.38 36.41 20.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.851 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.82 28.43 26.32 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.426 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.7 127.11 36.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.795 0.331 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.15 102.39 13.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -68.63 135.85 52.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.62 84.9 2.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 88.0 m -132.7 130.23 39.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.884 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 76' ' ' ILE . 12.8 p -85.39 140.37 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.29 2.15 3.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.862 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.464 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.3 OUTLIER 179.96 117.87 0.05 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.9 0.381 . . . . 0.0 111.785 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.735 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.9 p -143.24 134.59 26.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.232 0.539 . . . . 0.0 110.708 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.634 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 5.3 mt-30 -89.72 166.5 13.54 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.424 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 22.9 t -85.5 107.48 16.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.925 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 20.3 p -111.2 82.95 1.68 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.024 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 95' ' ' THR . 7.9 tptm 103.48 41.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.614 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 96' ' ' LYS . 6.6 tm-20 -29.18 130.54 0.07 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.134 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.459 ' CG2' ' HB3' ' A' ' 46' ' ' PHE . 4.9 p -71.76 126.02 31.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.164 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 29.7 mm -88.33 129.68 39.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.055 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -91.95 146.71 23.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.815 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.34 139.39 57.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.4 t -127.67 99.69 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.084 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.22 137.43 53.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -104.56 132.26 51.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.79 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.48 120.43 53.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.133 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.32 119.34 9.32 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.416 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.724 0.297 . . . . 0.0 111.064 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.783 0.243 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -164.14 123.74 2.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.855 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 71.4 mt -95.5 124.36 39.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 111.126 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 5.0 pt -101.01 -177.38 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.654 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 0.7 OUTLIER -156.9 154.6 30.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.538 0.685 . . . . 0.0 111.809 -179.081 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.718 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 54.8 ttp180 -170.97 120.32 0.53 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 5.6 t -81.78 140.53 34.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.999 0.904 . . . . 0.0 112.68 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.443 ' HG2' ' CD2' ' A' ' 74' ' ' HIS . 6.8 mm-40 -98.66 139.27 34.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.123 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.97 91.59 0.21 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.966 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.497 HD12 ' CD ' ' A' ' 72' ' ' ARG . 6.7 mt -96.11 104.7 17.92 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.986 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -84.78 160.5 12.14 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.785 2.323 . . . . 0.0 113.248 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.474 ' CD2' ' HA3' ' A' ' 67' ' ' GLY . 54.1 p90 -87.15 -174.13 4.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.081 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -152.78 110.26 3.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.842 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.3 t -67.01 148.05 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.17 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.5 mt -124.02 156.18 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.152 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -122.96 100.82 7.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.841 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.9 162.97 13.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -94.63 114.51 26.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.906 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -100.91 96.47 5.66 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.2 -26.75 49.25 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.475 2.117 . . . . 0.0 112.288 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -66.86 -31.22 71.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.92 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.3 mt -74.64 163.32 69.07 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -86.83 31.47 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.888 2.392 . . . . 0.0 112.923 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.15 122.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.83 0.348 . . . . 0.0 111.26 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.19 -26.69 19.99 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.582 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -66.78 136.4 55.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 0.0 110.871 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -129.34 114.27 16.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.816 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -109.25 130.06 55.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.417 HG21 HD11 ' A' ' 63' ' ' ILE . 31.2 mm -92.2 86.11 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.3 mp -65.3 -44.06 94.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.956 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.8 m -151.95 93.79 1.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.599 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.18 144.02 10.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.567 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.474 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -77.01 127.6 8.54 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.424 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.46 125.61 37.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.879 0.371 . . . . 0.0 110.985 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.68 113.48 2.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.354 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.8 -146.06 3.17 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.637 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.599 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.1 OUTLIER -177.56 109.88 0.07 Allowed 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.798 ' HB2' ' HA ' ' A' ' 94' ' ' VAL . 0.9 OUTLIER -102.84 138.42 39.75 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.226 -179.621 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.656 ' O ' ' HB3' ' A' ' 92' ' ' SER . 87.7 m -75.6 140.51 42.68 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.525 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.718 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 2.0 m-70 -118.94 118.42 31.47 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.541 0.686 . . . . 0.0 112.082 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.722 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -91.23 118.82 30.79 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.203 -177.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.46 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 2.5 mp -108.69 160.3 7.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.962 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.78 127.37 48.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.895 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.28 98.36 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.3 mt -112.64 111.85 22.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.899 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.62 96.6 6.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -113.72 122.31 46.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.954 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 60.46 34.81 20.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.15 42.34 67.46 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.486 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.87 141.04 17.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.344 . . . . 0.0 110.875 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.37 112.89 25.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.941 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.83 122.98 38.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.839 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -86.66 89.13 7.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.83 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.3 t -103.15 132.75 49.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.934 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.3 m -52.32 124.87 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.121 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.06 -66.83 1.04 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.062 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.515 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -170.87 143.51 2.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.283 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.656 ' HB3' ' O ' ' A' ' 73' ' ' THR . 1.0 OUTLIER -143.4 165.29 27.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.407 0.623 . . . . 0.0 110.846 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.603 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 8.1 pt20 -129.31 166.84 18.69 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.096 -0.957 . . . . 0.0 108.661 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.798 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.1 p -85.69 106.84 15.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.599 ' O ' ' O ' ' A' ' 71' ' ' GLU . 7.2 p -117.12 81.0 1.57 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.35 0.595 . . . . 0.0 110.652 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.485 ' CB ' ' O ' ' A' ' 95' ' ' THR . 3.1 tptm 149.44 -30.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.273 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 58.35 107.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.818 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.419 HG21 ' CA ' ' A' ' 46' ' ' PHE . 6.8 p -71.48 109.76 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.029 0.442 . . . . 0.0 110.085 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.3 mm -63.98 123.69 17.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.853 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -91.93 135.62 33.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.886 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -68.5 99.38 0.96 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.8 t -91.68 99.75 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.009 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.4 m -128.48 127.21 66.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.162 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -108.68 108.49 19.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.811 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.38 142.54 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.134 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.52 142.15 43.61 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.522 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.702 0.287 . . . . 0.0 111.057 179.998 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.927 0.303 . . . . 0.0 112.265 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -81.01 -179.07 7.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.771 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mp -104.4 113.92 27.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.058 0.456 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.679 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -101.3 -176.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.815 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 1.2 p -152.57 139.78 19.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.207 0.527 . . . . 0.0 110.892 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.509 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 17.5 tpt180 -158.65 102.94 1.72 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.085 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 8.0 t -81.96 129.23 34.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.571 0.701 . . . . 0.0 111.496 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.455 ' O ' HD12 ' A' ' 44' ' ' ILE . 0.6 OUTLIER -98.46 144.18 28.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.941 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.97 91.68 0.21 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.638 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.583 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 3.0 mp -87.2 110.17 31.28 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.03 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -86.03 153.68 9.75 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.725 2.283 . . . . 0.0 112.751 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.424 ' HB3' ' CG2' ' A' ' 98' ' ' VAL . 42.7 p90 -87.17 -174.27 4.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.846 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -159.04 118.42 3.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.936 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.49 152.53 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.013 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.66 156.16 42.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.13 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm -128.25 100.86 6.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -101.86 170.35 8.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -109.62 120.34 42.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.954 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -114.16 96.39 42.08 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.843 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.36 60.42 2.59 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.51 2.14 . . . . 0.0 112.408 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.92 27.23 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.026 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mp -130.55 176.53 2.8 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.776 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.27 30.22 0.53 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.176 2.584 . . . . 0.0 112.869 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.2 136.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.91 0.386 . . . . 0.0 111.484 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.9 29.33 67.51 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.734 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -109.39 112.07 23.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.799 0.333 . . . . 0.0 110.762 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.56 143.41 33.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.972 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -135.72 130.05 33.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.0 mm -85.68 86.12 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.164 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.6 mt -71.2 -43.46 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.07 91.93 1.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.613 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.85 154.47 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.522 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.406 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -84.74 129.63 9.33 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.414 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.45 126.96 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.761 0.315 . . . . 0.0 111.075 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -57.37 127.95 34.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.146 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -101.97 -143.44 13.52 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.079 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.533 ' N ' ' HB3' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -166.97 144.05 4.67 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.583 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 42.1 ttt180 -135.98 111.52 9.25 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.686 ' O ' ' HB2' ' A' ' 92' ' ' SER . 62.0 m -73.84 126.82 31.27 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.509 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 13.3 m80 -107.21 119.87 40.56 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 122.068 0.937 . . . . 0.0 112.921 -176.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.683 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -91.36 99.59 12.52 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 113.541 -1.663 . . . . 0.0 111.391 -177.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.482 ' HB ' ' CG2' ' A' ' 38' ' ' ILE . 2.5 mp -87.58 159.71 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.847 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 77.6 p -108.53 105.38 14.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.775 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.8 m -81.43 98.33 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.225 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.6 tt -108.08 116.4 31.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.7 t -81.9 112.17 18.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -116.05 113.27 22.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 60.17 31.83 20.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.894 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.82 44.54 10.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.432 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.77 119.7 4.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.773 0.32 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.84 123.03 32.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.4 150.16 29.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.852 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -97.52 113.8 25.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 94.8 m -133.59 118.05 17.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.931 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.9 p -54.03 125.37 8.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.978 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.83 -53.46 2.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.267 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.521 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -176.68 141.01 0.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.316 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.686 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.6 p -143.67 150.99 39.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.367 0.603 . . . . 0.0 111.32 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.621 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 23.1 mm-40 -110.74 166.53 10.94 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.504 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 6.2 m -85.26 106.64 15.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.054 -178.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.568 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 15.9 p -110.72 82.6 1.62 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.689 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 95' ' ' THR . 26.2 tptp 131.92 -26.96 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.015 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 96' ' ' LYS . 17.9 pt-20 44.56 111.47 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.424 ' CG2' ' HB3' ' A' ' 46' ' ' PHE . 8.2 p -71.88 115.77 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.874 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.5 mm -74.04 128.96 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.068 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -95.14 139.41 31.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.978 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -77.63 100.34 6.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.817 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.4 m -100.59 109.28 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.0 p -123.19 118.38 54.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -87.16 121.01 29.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.832 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.95 128.51 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.209 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.62 130.64 50.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.503 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.626 0.251 . . . . 0.0 111.008 -179.952 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo . . . . . 0 N--CA 1.461 -0.409 0 CA-C-O 120.809 0.254 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.57 129.65 36.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.817 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mt -74.21 114.98 13.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.09 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.654 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -101.38 -176.57 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.095 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.494 ' HB ' ' CG2' ' A' ' 73' ' ' THR . 1.4 p -152.19 136.73 16.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.226 0.536 . . . . 0.0 111.223 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.551 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 10.0 mmm-85 -150.1 103.13 3.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.403 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.402 HG21 ' N ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -82.17 124.8 30.21 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.602 0.715 . . . . 0.0 111.163 -178.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.501 ' O ' HD12 ' A' ' 44' ' ' ILE . 3.4 mt-10 -98.29 147.94 24.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.958 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -66.92 101.42 0.84 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.83 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.563 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.4 mp -106.66 91.42 6.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.847 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.49 161.83 28.05 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.74 2.294 . . . . 0.0 112.799 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.447 ' CD2' ' HA3' ' A' ' 67' ' ' GLY . 49.5 p90 -87.37 176.62 7.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.147 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -147.24 109.38 4.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.971 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.6 t -67.13 153.95 8.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.073 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.94 156.14 33.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.122 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.11 100.81 6.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.831 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.1 mtmt -97.7 171.87 8.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.945 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -109.88 104.77 13.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -110.31 96.51 26.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.78 -18.7 53.26 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.492 2.128 . . . . 0.0 112.593 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -54.78 -29.74 54.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.882 0.372 . . . . 0.0 111.008 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.401 ' HB3' ' CD ' ' A' ' 57' ' ' PRO . 6.2 mp -83.24 175.06 5.12 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.741 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.401 ' CD ' ' HB3' ' A' ' 56' ' ' LEU . 1.8 Cg_endo -82.55 28.33 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.094 2.529 . . . . 0.0 112.979 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.1 123.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.883 0.373 . . . . 0.0 111.55 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.18 -23.28 32.28 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.83 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.47 123.54 22.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.879 0.371 . . . . 0.0 110.956 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -114.44 115.85 27.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -119.04 123.96 45.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.836 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 22.1 mt -85.76 131.42 34.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.019 0.437 . . . . 0.0 111.115 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.8 mm -94.07 -46.78 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.767 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' A' ' 65' ' ' THR . 15.3 t -149.13 97.85 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.516 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.19 126.64 7.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.815 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.447 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -66.25 132.35 33.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.168 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.7 t -131.22 138.83 52.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.954 0.407 . . . . 0.0 111.065 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -66.27 130.8 44.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.406 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -109.42 -148.99 12.83 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.47 ' N ' ' CB ' ' A' ' 96' ' ' LYS . 0.6 OUTLIER -166.69 156.71 11.61 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 4.8 ttt180 -140.14 112.49 7.8 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.674 ' O ' ' HB3' ' A' ' 92' ' ' SER . 86.3 m -73.85 127.32 32.54 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.551 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 20.8 m80 -106.26 117.26 33.59 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.261 1.029 . . . . 0.0 113.055 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.662 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -89.12 102.14 14.8 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 113.433 -1.712 . . . . 0.0 110.921 -177.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.455 ' HB ' ' CD1' ' A' ' 38' ' ' ILE . 2.5 mp -87.66 160.7 2.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.891 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.416 ' N ' ' CG2' ' A' ' 76' ' ' ILE . 74.9 m -110.62 127.89 55.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.834 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.38 103.72 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.196 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mt -125.06 88.66 2.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.818 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.22 146.2 39.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.846 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -153.97 126.89 8.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.908 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 60.4 35.9 20.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.956 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.28 48.69 57.17 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.531 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.7 ttpt -159.69 107.5 1.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.837 0.351 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.81 129.9 37.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.5 m -115.39 151.06 35.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.54 112.75 23.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 96.7 m -133.99 126.65 30.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.901 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.0 p -55.61 148.96 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.991 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.86 -50.89 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.26 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.524 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -158.3 126.63 5.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.321 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.674 ' HB3' ' O ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -143.4 144.25 31.97 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.4 0.619 . . . . 0.0 111.417 179.133 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.568 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 5.4 mt-30 -106.25 165.46 11.23 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.536 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 8.8 p -86.15 106.63 15.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.473 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.476 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 7.2 p -111.71 82.01 1.55 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.568 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' A' ' 95' ' ' THR . 0.0 OUTLIER 148.29 -33.39 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.296 179.087 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 53.33 109.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.892 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.444 HG22 ' HA ' ' A' ' 46' ' ' PHE . 9.4 p -80.7 102.75 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.481 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.2 mp -64.35 123.92 18.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.056 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -89.44 133.85 34.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.673 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 65' ' ' THR . 5.4 tt0 -67.05 125.33 25.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.948 0.404 . . . . 0.0 110.98 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.417 ' CG2' ' CG2' ' A' ' 65' ' ' THR . 60.9 t -113.37 99.71 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.678 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.68 154.71 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -133.22 108.36 8.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.77 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.8 t -101.04 136.56 32.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.172 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.03 148.6 35.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.489 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.721 0.296 . . . . 0.0 111.206 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo . . . . . 0 C--O 1.231 0.161 0 CA-C-O 120.783 0.243 . . . . 0.0 112.399 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -170.65 147.18 2.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.79 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.5 mp -104.36 116.59 32.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.95 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.549 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 5.7 pt -101.27 -177.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.363 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.655 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 0.5 OUTLIER -158.58 154.48 26.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.372 0.606 . . . . 0.0 111.077 -179.209 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.541 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 13.1 ttm180 -169.26 126.08 0.92 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.647 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 16.1 p -81.89 136.08 35.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 122.006 0.908 . . . . 0.0 112.547 -177.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -98.23 142.61 29.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.097 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.78 94.21 0.3 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.671 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.489 ' CD1' ' HG2' ' A' ' 72' ' ' ARG . 6.9 mt -101.66 98.02 8.84 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.777 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.51 157.81 28.83 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.772 2.315 . . . . 0.0 113.176 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.455 ' CE2' ' HA3' ' A' ' 67' ' ' GLY . 45.6 p90 -86.87 -173.93 4.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.105 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.43 102.95 4.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.756 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.421 ' CB ' ' HB3' ' A' ' 101' ' ' GLN . 8.8 p -66.93 146.47 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.148 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.2 mm -125.19 156.19 34.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.179 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -120.42 100.86 7.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.767 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.63 145.13 24.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -114.73 102.61 10.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.44 140.09 26.95 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.913 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -78.13 -19.88 11.81 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.601 2.201 . . . . 0.0 112.538 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -52.34 -30.26 27.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.116 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mp -82.7 169.1 19.09 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.798 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.19 31.23 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.316 2.678 . . . . 0.0 112.874 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 63.18 138.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.899 0.38 . . . . 0.0 111.279 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.02 36.35 80.78 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.603 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -109.51 145.65 35.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.878 0.37 . . . . 0.0 110.935 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.7 113.94 19.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.821 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -118.87 119.12 33.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.928 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.408 HD12 HG21 ' A' ' 63' ' ' ILE . 30.1 mm -85.71 92.76 3.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.7 mt -76.55 -44.9 34.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.88 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.54 91.49 1.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.801 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.9 143.18 3.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.791 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.455 ' HA3' ' CE2' ' A' ' 46' ' ' PHE . . . -91.31 129.63 9.9 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.248 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.0 131.11 41.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.966 0.412 . . . . 0.0 111.156 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.12 112.78 3.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.159 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.55 -144.29 1.24 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.762 -0.733 . . . . 0.0 111.717 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.68 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 7.7 tt0 -177.55 109.29 0.07 Allowed 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.791 ' HB2' ' HA ' ' A' ' 94' ' ' VAL . 0.4 OUTLIER -98.4 138.43 35.65 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.229 0.538 . . . . 0.0 110.448 -179.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.563 ' O ' ' HB2' ' A' ' 92' ' ' SER . 52.0 m -75.55 135.81 40.58 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.729 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.655 ' O ' ' HA ' ' A' ' 39' ' ' THR . 6.5 m80 -116.08 121.83 43.34 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.74 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.708 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -91.93 113.34 25.59 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.772 -178.095 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.474 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 2.1 mp -97.13 143.56 12.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.02 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.9 t -96.01 105.53 17.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.78 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.55 105.27 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.9 tp -97.11 88.66 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.844 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.58 123.66 21.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.965 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -143.65 105.92 4.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 65.16 26.88 12.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.094 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.78 41.44 7.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.819 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.54 122.72 15.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.908 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -101.26 105.5 16.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.8 p -87.11 99.88 12.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -74.8 98.75 3.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 92.1 m -129.66 125.36 35.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 p -51.18 136.84 10.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.022 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.6 -72.66 0.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.343 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.493 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 3.6 t0 -137.96 138.2 38.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.349 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.563 ' HB2' ' O ' ' A' ' 73' ' ' THR . 29.0 p -143.24 165.62 26.95 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.66 0.743 . . . . 0.0 111.395 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.673 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 36.0 mm-40 -130.03 166.45 20.1 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.153 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.791 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 17.2 t -86.2 105.75 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.554 ' O ' ' O ' ' A' ' 71' ' ' GLU . 11.6 p -121.43 80.97 1.73 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.551 0.691 . . . . 0.0 110.889 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.68 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 155.3 -31.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.731 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 62.4 101.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.819 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.424 HG21 ' CA ' ' A' ' 46' ' ' PHE . 6.6 p -71.43 103.75 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.144 0.497 . . . . 0.0 110.12 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.9 mm -63.92 131.05 29.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.222 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -98.86 139.67 34.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.002 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.421 ' HB3' ' CB ' ' A' ' 48' ' ' VAL . 3.0 tp-100 -75.04 103.92 5.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.921 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.29 99.73 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.985 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.1 p -123.12 148.37 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.194 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -111.17 142.02 43.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.816 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.32 136.56 57.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.141 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -73.87 102.05 1.28 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.468 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.75 0.31 . . . . 0.0 111.141 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 N--CA 1.465 -0.195 0 CA-C-O 120.775 0.24 . . . . 0.0 112.301 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -73.86 168.25 19.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.9 mt -92.52 106.37 18.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.963 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.618 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 1.0 OUTLIER -101.3 -176.49 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.445 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.457 HG22 ' CD1' ' A' ' 75' ' ' TYR . 1.0 OUTLIER -152.41 147.85 26.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.281 0.562 . . . . 0.0 110.729 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 74' ' ' HIS . 16.9 ttp180 -164.18 100.62 0.85 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.893 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 15.2 t -81.93 132.19 35.26 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.831 0.824 . . . . 0.0 111.364 -178.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -98.11 145.17 26.83 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.149 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.22 99.11 0.5 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.337 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.52 HD11 ' N ' ' A' ' 72' ' ' ARG . 6.4 mt -105.09 92.6 5.56 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.302 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.32 164.37 26.65 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.818 2.345 . . . . 0.0 112.855 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.458 ' CD1' ' HA3' ' A' ' 67' ' ' GLY . 35.2 p90 -87.28 175.04 8.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.102 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -143.04 108.85 5.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.995 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 101' ' ' GLN . 10.3 t -67.1 154.05 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.22 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -140.71 156.09 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.069 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -110.35 108.62 18.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.98 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.92 118.06 35.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.953 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -77.09 104.69 7.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.985 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -106.12 139.79 20.63 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.11 -29.21 6.75 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.58 2.187 . . . . 0.0 112.406 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -57.54 -44.14 84.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mt -59.76 168.28 2.07 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.93 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -86.31 30.12 0.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.268 2.645 . . . . 0.0 112.69 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 57.73 105.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 0.0 111.315 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.85 -24.18 27.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.784 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.55 144.06 28.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.868 0.366 . . . . 0.0 110.973 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -124.08 173.7 8.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.818 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.8 p30 -154.84 147.75 24.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.9 mm -97.76 86.08 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.106 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.4 mm -74.36 -32.74 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.964 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -161.74 83.83 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.523 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.54 151.64 0.54 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.718 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.458 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -79.43 132.57 11.54 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.192 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.9 t -124.51 131.67 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.844 0.354 . . . . 0.0 111.311 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -64.53 118.88 9.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.347 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -107.14 -151.9 18.09 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.597 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.497 ' N ' ' CB ' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -174.42 156.75 2.55 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.256 0.55 . . . . 0.0 109.992 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.575 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 41.4 ttt180 -133.75 113.95 12.88 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.642 ' O ' ' HB2' ' A' ' 92' ' ' SER . 53.0 m -74.06 123.31 24.13 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.452 ' HA ' ' CB ' ' A' ' 92' ' ' SER . 16.6 m80 -104.81 120.82 42.32 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.146 0.975 . . . . 0.0 113.085 -177.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.655 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -89.41 98.14 11.6 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 113.648 -1.615 . . . . 0.0 111.169 -177.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.481 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.5 mp -87.48 158.55 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.89 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.412 ' N ' ' CG2' ' A' ' 76' ' ' ILE . 0.9 OUTLIER -101.65 108.3 19.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.727 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.2 m -81.6 98.25 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.146 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -117.37 108.9 16.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.975 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.5 m -79.71 124.64 28.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.851 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.21 118.49 21.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 60.36 31.93 20.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.954 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.3 38.96 20.38 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.594 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.62 116.62 4.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.51 119.59 31.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.8 m -101.19 148.4 25.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -109.6 103.44 12.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.852 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.0 t -119.09 116.8 27.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 p -57.19 139.28 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 16.2 mt -130.63 -68.4 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.264 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.45 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 1.3 t70 -137.8 134.34 35.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 111.4 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.642 ' HB2' ' O ' ' A' ' 73' ' ' THR . 18.7 p -143.35 160.62 40.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.027 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.608 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 5.8 pt20 -120.97 165.58 15.04 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.57 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 28.9 m -86.39 106.08 15.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.945 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.497 HG22 ' HB ' ' A' ' 73' ' ' THR . 15.4 p -114.84 81.86 1.64 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.684 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.497 ' CB ' ' N ' ' A' ' 71' ' ' GLU . 6.6 mmmt 146.46 -33.16 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.534 178.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 49.96 106.2 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.858 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.432 HG22 ' HA ' ' A' ' 46' ' ' PHE . 11.8 p -79.92 102.8 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.075 0.465 . . . . 0.0 110.719 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.402 HG22 HD13 ' A' ' 99' ' ' ILE . 27.0 mt -66.55 131.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.185 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -87.7 139.96 30.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.401 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 6.1 tt0 -75.55 103.81 5.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -85.9 99.75 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.012 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.89 110.57 30.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.1 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -96.24 108.55 21.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.8 p -100.7 150.65 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.027 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.48 145.53 31.8 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.486 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.505 0.193 . . . . 0.0 111.161 -179.983 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo . . . . . 0 C--O 1.232 0.187 0 CA-C-O 120.753 0.23 . . . . 0.0 112.274 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -83.84 116.37 22.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.71 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.4 mt -71.0 115.61 10.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.971 0.415 . . . . 0.0 111.123 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.602 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -101.26 -177.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.858 179.091 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.477 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -157.02 133.88 10.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.504 0.669 . . . . 0.0 111.58 -179.014 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.679 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 2.8 tpm_? -155.7 115.63 3.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 1.7 t -81.89 136.08 35.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.895 0.855 . . . . 0.0 112.515 -176.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -98.63 138.74 35.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.014 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -66.73 91.86 0.2 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.445 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.625 ' CD1' ' HB3' ' A' ' 72' ' ' ARG . 6.4 mt -92.68 107.67 25.97 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.907 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -86.03 153.34 9.73 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.832 2.355 . . . . 0.0 113.309 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.435 ' CD2' ' HA3' ' A' ' 67' ' ' GLY . 42.7 p90 -86.99 -174.05 4.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.158 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -154.78 116.34 4.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.922 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' A' ' 101' ' ' GLN . 4.4 t -67.09 151.45 10.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.134 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -129.68 156.15 41.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.086 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp -109.35 100.78 9.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.2 mmtm -98.26 154.48 17.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -106.53 132.13 52.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -134.98 111.85 11.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.64 -26.76 39.26 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.368 2.046 . . . . 0.0 112.333 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -59.96 -32.3 70.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.9 mt -65.56 162.77 39.7 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.75 31.33 0.48 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.875 2.384 . . . . 0.0 112.925 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.98 138.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.913 0.387 . . . . 0.0 111.277 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.14 28.73 61.68 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.665 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.45 144.98 36.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.813 0.339 . . . . 0.0 110.933 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -114.32 118.93 35.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.821 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -128.3 118.37 23.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.425 HD13 HG21 ' A' ' 63' ' ' ILE . 43.5 mt -90.59 132.06 36.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.125 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.5 mt -104.79 -43.63 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.924 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.7 m -144.73 92.24 2.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.724 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.4 126.27 5.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.79 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.435 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -70.73 126.12 14.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.449 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -138.2 138.07 43.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.904 0.383 . . . . 0.0 110.935 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -68.1 116.19 8.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.381 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.11 -147.67 5.61 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.468 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.603 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.4 OUTLIER -177.77 109.27 0.06 Allowed 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.08 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.728 ' HB2' ' HA ' ' A' ' 94' ' ' VAL . 0.4 OUTLIER -104.59 138.08 41.46 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.207 0.527 . . . . 0.0 109.872 -179.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.502 ' O ' ' HB2' ' A' ' 92' ' ' SER . 51.9 m -75.26 136.58 40.93 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.387 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.679 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 2.8 m80 -112.16 116.77 31.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.926 0.869 . . . . 0.0 111.955 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.756 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -91.2 107.93 19.54 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 113.84 -1.527 . . . . 0.0 111.023 -177.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.459 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.4 mp -91.47 156.41 3.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.155 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.41 ' N ' ' CG2' ' A' ' 76' ' ' ILE . 3.8 m -115.85 111.55 20.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.688 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.4 m -81.27 98.38 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.189 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 tp -109.94 148.75 31.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.833 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.24 106.25 12.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -128.91 126.17 39.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 60.33 31.1 20.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.03 28.39 68.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.368 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -149.03 166.64 28.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.878 0.371 . . . . 0.0 110.857 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.3 p -106.29 89.95 3.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.84 150.9 42.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -104.7 109.53 21.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.5 m -140.05 122.21 15.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 76' ' ' ILE . 14.9 p -84.48 150.22 4.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.135 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.07 -41.39 0.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.582 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.441 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 1.6 t70 -117.64 106.92 13.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.837 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.502 ' HB2' ' O ' ' A' ' 73' ' ' THR . 89.3 p -143.14 123.91 14.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.316 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.667 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 5.7 mt-30 -89.38 166.15 13.91 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.728 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 32.1 t -86.1 110.12 19.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.603 ' O ' ' O ' ' A' ' 71' ' ' GLU . 5.9 p -117.69 80.85 1.57 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.361 0.601 . . . . 0.0 110.656 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 71' ' ' GLU . 41.0 tptt 148.52 -32.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.447 -1.252 . . . . 0.0 109.218 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 57.44 108.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.38 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.423 HG21 ' CA ' ' A' ' 46' ' ' PHE . 7.4 p -71.64 104.17 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.109 0.48 . . . . 0.0 110.0 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.1 mp -64.01 129.87 28.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.126 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -99.82 137.7 37.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.013 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.41 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 3.6 tp-100 -72.08 107.13 4.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.833 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.29 99.61 9.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.049 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.2 m -116.78 129.61 73.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.091 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -108.79 117.58 34.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.818 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.6 m -93.7 142.93 12.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.21 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.88 133.84 14.11 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.527 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.78 0.324 . . . . 0.0 111.094 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo . . . . . 0 C--O 1.232 0.199 0 CA-C-O 120.844 0.268 . . . . 0.0 112.324 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.96 155.28 20.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.954 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.13 118.76 36.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.152 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 4.0 pt -101.37 -177.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.421 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 0.5 OUTLIER -159.88 150.42 18.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.209 0.528 . . . . 0.0 110.792 -179.245 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -162.34 133.18 4.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.183 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 1.7 p -82.44 129.16 34.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.762 0.791 . . . . 0.0 112.123 -178.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.471 ' HG3' HG13 ' A' ' 44' ' ' ILE . 3.4 tp10 -98.55 141.68 31.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.66 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.89 97.29 0.47 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.209 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.505 ' CD1' ' HG2' ' A' ' 72' ' ' ARG . 6.9 mt -106.2 94.02 8.9 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.444 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.51 158.29 32.48 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.714 2.276 . . . . 0.0 113.257 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.438 ' CE2' ' HA3' ' A' ' 67' ' ' GLY . 40.9 p90 -86.87 -174.04 4.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.841 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -147.17 103.1 3.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.173 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.425 ' CG2' ' HB3' ' A' ' 101' ' ' GLN . 3.4 p -66.99 132.75 32.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.769 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.8 mm -109.96 156.1 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.177 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -125.83 100.8 6.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.817 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -103.98 171.61 7.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.88 125.63 36.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.868 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -100.51 96.52 5.39 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.35 -18.48 44.27 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.465 2.11 . . . . 0.0 112.482 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.36 29.23 3.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.011 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 mp -124.4 169.43 10.74 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.757 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -87.37 29.09 0.5 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.3 2.667 . . . . 0.0 112.678 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.37 144.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.843 0.354 . . . . 0.0 111.347 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.65 23.22 42.92 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.833 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -109.47 156.67 19.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.757 0.313 . . . . 0.0 110.982 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -140.47 147.26 39.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.913 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.5 129.77 17.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.927 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.419 HG21 HD12 ' A' ' 63' ' ' ILE . 29.8 mm -87.23 92.8 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.136 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.3 mm -72.92 -43.85 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.76 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.83 93.7 1.68 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.544 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.62 152.42 0.47 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.82 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.438 ' HA3' ' CE2' ' A' ' 46' ' ' PHE . . . -99.94 132.76 11.05 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.26 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.93 130.46 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.884 0.374 . . . . 0.0 110.975 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.43 112.72 2.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.28 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.53 -144.91 1.3 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.694 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.672 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 10.3 tt0 -177.58 109.11 0.06 Allowed 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.772 ' HB2' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -98.36 142.79 29.56 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.377 0.608 . . . . 0.0 110.446 -179.695 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.573 ' O ' ' HB3' ' A' ' 92' ' ' SER . 98.3 m -75.68 143.98 41.86 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.248 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.616 ' O ' ' HA ' ' A' ' 39' ' ' THR . 34.5 m-70 -125.92 116.99 22.36 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.592 0.711 . . . . 0.0 111.485 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.735 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -88.02 111.97 22.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.891 -177.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.426 ' HB ' ' CD1' ' A' ' 38' ' ' ILE . 4.3 mp -99.91 160.83 3.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.258 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.8 t -107.47 119.34 39.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.7 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.6 m -81.43 98.36 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.22 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.03 129.92 49.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.55 120.17 36.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.832 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -136.03 100.05 4.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 60.13 35.71 21.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.37 47.39 22.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.469 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.27 123.14 15.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.688 0.28 . . . . 0.0 110.871 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.61 112.43 23.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.954 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.45 118.09 35.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.818 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -94.75 94.81 8.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.4 m -111.5 113.83 26.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.885 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.6 m -52.94 130.07 14.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.205 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.3 mt -120.39 -73.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.069 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.478 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -123.98 131.47 53.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.376 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.598 ' OG ' ' ND1' ' A' ' 74' ' ' HIS . 1.0 OUTLIER -143.14 165.39 27.55 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.459 0.647 . . . . 0.0 111.247 179.441 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.637 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 25.2 mm100 -129.95 166.17 20.59 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.617 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.772 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 46.3 t -86.24 105.92 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.568 ' O ' ' O ' ' A' ' 71' ' ' GLU . 12.5 p -121.12 81.03 1.72 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.501 0.667 . . . . 0.0 110.929 -178.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.672 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 6.6 mmmt 155.37 -30.86 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.751 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 62.82 101.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.8 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.422 HG23 ' CA ' ' A' ' 46' ' ' PHE . 7.6 p -71.45 102.82 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.075 0.465 . . . . 0.0 110.304 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.4 mp -63.99 133.2 29.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.913 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -102.73 142.79 33.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.018 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.425 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 0.2 OUTLIER -76.81 108.3 9.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.927 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.32 109.98 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.055 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.8 p -138.81 125.74 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.154 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -102.31 108.49 19.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.955 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.8 t -92.78 113.75 28.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.129 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.97 142.58 47.42 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.523 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.535 0.207 . . . . 0.0 111.161 -179.912 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.834 0.264 . . . . 0.0 112.228 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -150.44 115.94 5.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.83 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mp -86.18 114.52 23.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.08 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 2.2 pt -101.35 -177.39 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.496 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -161.52 146.24 13.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.436 0.636 . . . . 0.0 111.103 -179.448 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.705 ' O ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -143.36 -159.54 0.99 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.36 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 3.0 p -145.46 126.83 14.92 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.257 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.523 ' CG ' ' ND1' ' A' ' 74' ' ' HIS . 3.7 mm-40 -98.74 135.57 40.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.751 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -67.17 94.87 0.38 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.352 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.484 ' CD1' ' HB3' ' A' ' 72' ' ' ARG . 5.1 mt -102.69 96.43 7.56 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.774 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.87 160.51 30.68 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.803 2.336 . . . . 0.0 113.255 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.506 ' CD2' ' HA3' ' A' ' 67' ' ' GLY . 49.1 p90 -86.94 -174.15 4.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.234 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.63 113.16 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.847 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.408 ' CG2' ' HB3' ' A' ' 101' ' ' GLN . 17.6 t -66.74 146.41 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.103 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.8 mm -124.7 156.18 32.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.092 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.12 100.88 10.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.771 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -96.75 145.55 25.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.029 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -110.5 123.13 49.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -122.97 128.75 25.23 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.16 -24.79 12.23 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.439 2.093 . . . . 0.0 112.495 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -55.17 -50.94 68.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.039 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.4 mt -60.15 167.02 3.22 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.793 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.45 32.36 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.13 2.554 . . . . 0.0 112.697 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.04 119.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.833 0.349 . . . . 0.0 111.398 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.5 -26.27 20.65 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.753 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -70.0 129.92 40.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 110.945 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.404 ' CG ' ' CG1' ' A' ' 103' ' ' VAL . 6.5 tt0 -95.73 158.42 15.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -158.15 118.19 3.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.944 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.448 HG21 HD13 ' A' ' 63' ' ' ILE . 27.6 mt -94.29 132.03 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.186 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.1 mm -105.83 -38.99 4.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.867 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -147.65 96.86 2.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.653 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.33 128.81 17.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.753 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.506 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -67.35 124.42 22.2 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.334 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.63 130.21 59.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.797 0.332 . . . . 0.0 111.065 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.25 113.38 2.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.387 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.1 -146.28 2.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.377 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.691 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 10.7 tt0 -177.52 109.24 0.07 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.77 ' HB2' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -98.47 142.28 30.28 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.457 0.646 . . . . 0.0 110.425 -179.631 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 40' ' ' ARG . 94.7 m -75.62 149.03 38.31 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.92 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.588 ' O ' ' HA ' ' A' ' 39' ' ' THR . 5.2 m80 -128.66 117.9 21.97 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.53 0.681 . . . . 0.0 111.939 -178.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.697 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -90.58 107.27 19.06 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.079 -178.008 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.442 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 2.4 mp -90.08 158.66 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.798 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.7 t -108.15 117.39 34.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.94 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.6 98.51 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.063 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.65 142.3 34.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.5 p -89.96 93.8 9.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -99.12 105.83 17.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.976 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 60.45 33.49 20.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.0 35.78 26.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.516 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.6 147.43 32.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.796 0.331 . . . . 0.0 110.859 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.9 p -101.77 120.0 39.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.849 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.0 m -109.35 151.07 27.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -105.17 103.38 12.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 94.3 m -122.5 121.05 35.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.78 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.3 t -50.11 116.08 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.124 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.66 -70.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.189 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.5 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 7.2 m-20 -140.25 136.88 33.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.212 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.638 ' HB2' ' O ' ' A' ' 73' ' ' THR . 24.0 p -143.24 165.55 27.15 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.582 0.706 . . . . 0.0 111.275 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.695 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 16.5 mm-40 -129.74 166.27 20.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.64 -1.163 . . . . 0.0 109.346 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.77 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.6 p -85.84 105.94 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.555 ' O ' ' O ' ' A' ' 71' ' ' GLU . 13.3 p -120.39 80.94 1.68 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.498 0.666 . . . . 0.0 110.793 -178.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.691 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.1 OUTLIER 154.7 -29.88 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.616 179.028 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 60.17 102.58 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.708 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.409 HG21 ' CA ' ' A' ' 46' ' ' PHE . 6.2 p -71.34 108.36 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.215 0.531 . . . . 0.0 110.073 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.3 mp -63.85 126.87 23.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.965 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -96.02 137.12 35.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.993 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.408 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 2.5 tp60 -69.47 99.4 1.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.833 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.1 99.63 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.053 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.404 ' CG1' ' CG ' ' A' ' 61' ' ' GLU . 21.5 t -119.45 125.9 74.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.177 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -114.45 108.55 17.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.834 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.6 p -96.61 153.39 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.061 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.05 150.69 51.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.442 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.638 0.256 . . . . 0.0 111.145 -179.974 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo . . . . . 0 C--O 1.23 0.088 0 CA-C-O 120.908 0.295 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -147.6 152.9 38.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.819 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.1 mt -109.6 118.12 35.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.1 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.635 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 10.6 pt -101.23 -177.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.187 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.722 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 0.6 OUTLIER -153.84 160.92 42.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.233 0.54 . . . . 0.0 111.041 -179.471 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.523 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 3.6 tpp85 -172.71 131.61 0.55 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.815 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 2.9 p -81.91 129.93 34.91 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.837 0.827 . . . . 0.0 112.35 -177.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.473 ' HG3' HG13 ' A' ' 44' ' ' ILE . 3.5 tp10 -98.53 141.77 30.97 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.689 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -66.8 97.29 0.46 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.048 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.487 ' CD1' ' HG2' ' A' ' 72' ' ' ARG . 7.0 mt -105.22 92.95 6.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.613 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.0 158.04 42.43 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.743 2.296 . . . . 0.0 113.031 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.428 ' CE1' ' HA3' ' A' ' 67' ' ' GLY . 41.6 p90 -86.77 -174.01 4.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.024 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -145.74 105.06 3.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.851 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.4 ' CG2' ' HB3' ' A' ' 101' ' ' GLN . 6.0 p -67.07 138.82 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.001 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.9 mm -122.69 156.17 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.161 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -120.1 100.78 7.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.815 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -98.39 154.34 17.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.985 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -99.29 129.68 45.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.944 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -124.99 127.22 25.14 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.815 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.4 -27.16 11.48 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.411 2.074 . . . . 0.0 112.442 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -58.6 -35.52 72.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.985 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mt -71.03 158.89 87.19 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.825 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -86.33 37.92 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.885 2.39 . . . . 0.0 112.878 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.22 145.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.846 0.355 . . . . 0.0 111.338 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.23 27.74 58.05 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.634 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.01 169.34 8.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.757 0.313 . . . . 0.0 110.963 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -155.32 133.01 11.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.927 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -135.75 125.0 24.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.812 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.431 HD11 HG21 ' A' ' 63' ' ' ILE . 26.1 mm -85.75 92.86 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.087 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.426 HG21 HD12 ' A' ' 64' ' ' ILE . 19.8 mt -74.26 -31.77 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.992 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.4 m -164.21 93.6 0.7 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.666 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.7 145.03 5.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.537 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.428 ' HA3' ' CE1' ' A' ' 46' ' ' PHE . . . -80.79 136.25 16.09 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.341 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.7 t -141.74 120.86 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 0.0 110.957 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.5 mtmt -59.42 112.79 1.89 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.245 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.87 -144.53 1.76 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.758 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.68 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -177.42 109.17 0.07 Allowed 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.219 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.745 ' HB2' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -98.61 139.38 34.42 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.16 0.505 . . . . 0.0 110.47 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.585 ' O ' ' HB2' ' A' ' 92' ' ' SER . 40.5 m -75.39 136.09 40.77 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.451 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.722 ' O ' ' HA ' ' A' ' 39' ' ' THR . 19.8 m-70 -116.17 122.37 44.84 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.416 0.627 . . . . 0.0 111.771 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.74 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -90.69 107.23 19.04 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.054 -177.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.403 ' HB ' ' CD1' ' A' ' 38' ' ' ILE . 3.8 mp -96.22 160.42 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.069 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.76 122.43 47.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.762 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.11 108.97 20.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.31 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.05 137.96 45.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.796 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.53 123.04 29.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -131.48 109.52 10.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.9 p30 44.08 33.98 0.89 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.416 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.28 45.29 5.64 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.473 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -149.23 156.83 42.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 110.825 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.67 116.22 28.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.943 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.28 151.02 20.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -121.41 83.93 2.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.957 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.6 m -108.29 123.2 48.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.792 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.1 m -50.11 130.07 8.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.221 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.48 -64.56 1.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.233 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.488 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -152.82 141.42 20.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.207 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.585 ' HB2' ' O ' ' A' ' 73' ' ' THR . 11.5 p -143.27 165.61 27.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.779 0.8 . . . . 0.0 111.616 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.693 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 41.8 mt-30 -129.18 166.08 20.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.691 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.745 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.5 p -85.96 105.78 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.59 ' O ' ' O ' ' A' ' 71' ' ' GLU . 12.1 p -121.36 80.75 1.7 Allowed 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.579 0.704 . . . . 0.0 110.733 -178.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.68 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 154.46 -31.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.649 178.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 62.94 101.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.777 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.416 HG23 ' CA ' ' A' ' 46' ' ' PHE . 5.8 p -71.48 106.64 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.058 0.456 . . . . 0.0 110.202 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.9 mm -63.87 129.44 27.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.068 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -98.92 134.93 41.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.021 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.4 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 1.5 tm0? -68.47 99.45 0.96 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.25 117.28 32.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.073 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.1 m -143.09 137.58 26.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.095 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -118.4 111.85 19.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.882 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.9 m -88.87 146.94 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.088 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -70.98 146.18 40.97 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.443 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.748 0.308 . . . . 0.0 111.101 179.969 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 N--CA 1.465 -0.172 0 CA-C-O 120.833 0.264 . . . . 0.0 112.298 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -163.6 154.49 16.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.775 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 68.4 mt -95.01 122.79 38.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.072 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 1.2 tt -101.17 -177.32 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.567 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 1.3 p -162.29 142.22 9.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.331 0.586 . . . . 0.0 111.018 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.407 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -163.64 109.88 1.11 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.147 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 12.5 t -82.3 132.71 35.22 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.685 0.755 . . . . 0.0 111.734 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.446 ' O ' HD12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -98.41 148.24 23.89 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.695 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -66.83 100.2 0.69 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.699 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.567 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.0 mp -104.8 91.16 4.01 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.872 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.18 157.38 37.84 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.671 2.247 . . . . 0.0 112.808 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.43 ' CE1' ' HA3' ' A' ' 67' ' ' GLY . 30.0 p90 -86.73 -177.29 6.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.118 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -157.07 120.25 4.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.96 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.0 t -67.26 150.0 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.242 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.8 mt -129.18 156.15 41.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.079 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.4 mtpp -123.59 100.89 7.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.818 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -110.8 147.37 34.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.901 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.87 140.0 32.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -133.71 98.48 14.79 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.51 84.25 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.484 2.122 . . . . 0.0 112.213 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -175.32 -40.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.924 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.7 mt -58.49 167.16 1.87 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.842 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.08 48.84 2.63 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.041 2.494 . . . . 0.0 112.754 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.37 124.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.016 0.436 . . . . 0.0 111.716 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 50.59 55.64 16.39 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.091 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.47 136.5 48.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.742 0.306 . . . . 0.0 110.802 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.9 117.14 27.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -127.08 158.02 38.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.799 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.1 mm -113.91 92.52 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.3 mt -73.24 -32.25 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.921 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.0 m -161.31 92.74 0.91 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.613 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.49 146.45 5.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.582 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' A' ' 46' ' ' PHE . . . -76.45 138.72 22.88 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.262 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.8 t -140.95 135.05 32.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.917 0.389 . . . . 0.0 111.349 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.16 134.87 56.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.335 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.422 ' CA ' ' O ' ' A' ' 96' ' ' LYS . . . -116.25 -159.68 11.91 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.994 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.475 ' HA ' HD12 ' A' ' 44' ' ' ILE . 1.5 tt0 -162.08 153.89 18.84 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.567 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 2.6 ttt180 -141.39 112.2 7.17 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.705 ' O ' ' HB2' ' A' ' 92' ' ' SER . 46.5 m -73.92 125.72 28.85 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.524 ' O ' ' HA ' ' A' ' 39' ' ' THR . 13.8 m80 -106.8 119.7 40.05 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 122.083 0.944 . . . . 0.0 113.137 -177.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.688 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -91.14 93.81 9.3 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.103 -177.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.47 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 2.0 mp -87.35 142.65 12.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.931 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.4 p -77.34 121.42 23.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.762 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.4 105.56 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.203 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -125.55 89.27 3.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.891 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.07 131.4 42.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -137.62 117.24 13.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.909 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 60.67 33.35 20.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.28 32.02 49.55 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.438 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -144.32 113.77 7.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.755 0.312 . . . . 0.0 110.86 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.7 p -75.21 127.8 34.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.6 m -100.01 141.28 33.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.899 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -100.29 101.97 13.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.8 m -118.95 121.0 38.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.8 p -54.26 118.41 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.006 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.0 -59.57 1.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.516 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -177.17 139.95 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.198 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.705 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.8 p -143.64 149.47 37.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.48 0.657 . . . . 0.0 111.362 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.652 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 4.6 mt-30 -107.47 167.11 10.17 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.463 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 8.3 p -84.75 107.16 15.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 119.854 -0.739 . . . . 0.0 109.872 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.549 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 16.8 p -113.22 82.9 1.74 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.686 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 95' ' ' THR . 11.6 mmmt 113.36 52.93 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.097 -1.41 . . . . 0.0 109.385 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -35.21 117.17 0.39 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.544 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' A' ' 46' ' ' PHE . 9.4 p -71.44 106.02 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.206 0.527 . . . . 0.0 110.792 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.0 mm -64.35 121.5 13.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.164 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -98.07 125.95 43.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.931 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.67 128.91 38.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.788 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.8 m -124.01 101.36 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.195 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 m -108.96 118.6 56.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.072 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -87.15 111.58 21.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.783 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.99 143.5 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.225 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.54 109.67 3.03 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.505 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.714 0.292 . . . . 0.0 111.09 179.976 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--O 1.231 0.151 0 CA-C-O 120.796 0.248 . . . . 0.0 112.271 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -78.84 124.84 28.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.641 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 68.4 mt -78.33 116.46 18.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.086 0.469 . . . . 0.0 111.329 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.615 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 1.2 pp -100.89 -176.05 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.288 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 0.6 OUTLIER -156.35 132.94 10.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.499 0.666 . . . . 0.0 112.486 -178.351 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.637 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 4.7 mmm180 -150.72 115.77 5.32 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -82.13 134.37 35.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.897 0.856 . . . . 0.0 112.34 -177.685 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -98.78 138.81 35.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.24 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.415 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 1.7 pt-20 -66.86 91.45 0.2 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.778 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.482 ' CD1' ' HB3' ' A' ' 72' ' ' ARG . 6.5 mt -94.84 105.04 16.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.651 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 43' ' ' GLU . 80.8 Cg_endo -84.19 157.2 13.02 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.769 2.313 . . . . 0.0 113.296 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.439 ' CA ' HG21 ' A' ' 98' ' ' VAL . 42.6 p90 -86.91 -174.02 4.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.965 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -149.42 103.05 3.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.099 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.407 ' CG2' ' HB3' ' A' ' 101' ' ' GLN . 3.9 p -66.82 145.02 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.931 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -128.97 156.1 41.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.039 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -109.44 100.89 9.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.754 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.33 164.6 20.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.035 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -116.35 112.56 21.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.826 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -102.23 96.6 7.26 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.67 -13.21 38.98 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.499 2.132 . . . . 0.0 112.512 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -97.81 27.79 4.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.706 0.289 . . . . 0.0 111.047 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mp -114.97 175.94 1.68 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.85 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -86.78 29.53 0.5 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.281 2.654 . . . . 0.0 112.781 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.7 130.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.978 0.418 . . . . 0.0 111.225 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.78 54.08 40.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.642 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.44 131.7 54.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.765 0.317 . . . . 0.0 110.823 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -115.18 113.85 24.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.937 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -147.25 119.34 8.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.804 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 26.1 mt -85.76 130.96 35.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.251 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.24 -46.18 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.636 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.3 m -141.85 102.17 4.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.497 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.43 162.95 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.545 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.433 ' HA3' ' CE2' ' A' ' 46' ' ' PHE . . . -111.07 127.32 8.18 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.243 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.43 134.7 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.809 0.337 . . . . 0.0 110.97 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -65.37 114.55 4.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.075 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.08 -143.06 0.94 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.802 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.605 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -177.33 109.51 0.07 Allowed 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.194 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.791 ' HB2' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -103.35 134.3 46.97 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.251 0.548 . . . . 0.0 110.127 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.611 ' O ' ' HB2' ' A' ' 92' ' ' SER . 60.6 m -76.15 138.22 40.57 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.532 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.637 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 6.6 m80 -111.79 122.72 48.56 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.687 0.756 . . . . 0.0 112.05 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.726 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -92.99 93.85 8.58 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.241 -177.287 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.439 ' HB ' ' CG1' ' A' ' 38' ' ' ILE . 4.3 mp -87.66 144.69 8.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.221 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.6 p -93.95 115.2 27.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.817 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.8 m -81.44 105.81 11.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -113.98 102.12 9.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.1 m -66.92 91.09 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -62.23 92.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 68.15 -69.86 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.093 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.88 36.99 1.03 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.491 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.88 132.21 6.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.883 0.373 . . . . 0.0 110.859 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.97 130.72 35.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.948 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.61 144.98 43.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -93.84 117.55 30.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.867 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.3 m -144.62 101.1 3.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.7 t -49.74 133.22 8.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.96 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 tp -110.3 -67.23 1.0 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.271 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.49 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 2.1 m-20 -150.79 141.16 22.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.979 0.419 . . . . 0.0 111.539 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.611 ' HB2' ' O ' ' A' ' 73' ' ' THR . 11.8 p -143.7 160.51 40.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.585 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.646 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 3.7 mt-30 -125.18 167.01 15.42 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.791 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.2 p -85.14 106.34 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 119.557 -0.857 . . . . 0.0 108.964 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.528 ' O ' ' O ' ' A' ' 71' ' ' GLU . 6.1 p -115.78 81.02 1.53 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.613 0.721 . . . . 0.0 110.46 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 156.35 -29.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.721 179.081 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 61.78 100.77 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.532 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.439 HG21 ' CA ' ' A' ' 46' ' ' PHE . 5.9 p -71.24 102.7 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 121.213 0.53 . . . . 0.0 109.998 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.8 mp -64.28 133.35 29.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.015 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -105.67 141.53 36.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.143 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.407 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -76.4 108.13 9.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.776 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.92 108.7 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.107 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.1 t -129.32 114.96 33.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.019 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.99 139.94 30.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.763 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.4 109.7 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.082 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.19 128.15 30.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.577 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 120.693 0.282 . . . . 0.0 111.143 179.973 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.464 -0.236 0 CA-C-O 120.876 0.282 . . . . 0.0 112.314 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -139.56 129.13 24.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.5 132.92 42.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.878 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.622 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.7 OUTLIER -101.25 -176.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.444 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 0.1 OUTLIER -163.16 121.93 2.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.03 0.443 . . . . 0.0 109.947 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 74' ' ' HIS . 18.9 ttt180 -145.77 132.49 19.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.328 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 2.2 p -81.85 130.23 35.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.891 0.853 . . . . 0.0 112.235 -177.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.413 ' HG2' HG13 ' A' ' 44' ' ' ILE . 1.1 tt0 -98.36 143.89 28.34 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.806 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.9 94.26 0.31 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.905 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.49 ' CD1' ' HG2' ' A' ' 72' ' ' ARG . 7.3 mt -103.02 95.3 6.38 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.59 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.16 158.6 45.19 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.73 2.287 . . . . 0.0 113.278 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.459 ' CD2' ' HA3' ' A' ' 67' ' ' GLY . 53.9 p90 -86.64 -173.97 4.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.111 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -151.64 111.84 4.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.882 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.407 ' CG2' ' HB3' ' A' ' 101' ' ' GLN . 31.2 t -66.81 151.14 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.249 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -126.92 156.25 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.094 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.6 100.75 7.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.88 150.91 26.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.91 123.51 32.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -117.47 96.55 49.53 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.928 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.63 65.71 1.2 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.448 2.099 . . . . 0.0 112.193 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -149.68 -45.87 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.846 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -55.9 172.93 0.29 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.15 31.72 0.52 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.172 2.582 . . . . 0.0 112.951 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.96 120.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.999 0.428 . . . . 0.0 111.387 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.81 22.17 62.16 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.886 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -109.54 157.68 18.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.826 0.346 . . . . 0.0 110.826 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -136.3 115.17 12.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -117.61 116.68 27.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.406 HD11 HG21 ' A' ' 63' ' ' ILE . 26.1 mt -85.81 132.09 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.108 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.439 HD12 HG21 ' A' ' 64' ' ' ILE . 12.7 mt -103.46 -44.44 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.984 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.55 92.06 2.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.623 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.83 150.92 0.66 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.768 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.459 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -85.71 129.34 9.27 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.229 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.71 125.95 47.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.915 0.388 . . . . 0.0 110.885 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.51 112.71 2.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.281 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.9 -144.15 1.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.509 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.687 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 4.6 tt0 -177.45 109.27 0.07 Allowed 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.77 ' HB2' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -100.39 138.75 37.03 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.24 -179.711 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.581 ' O ' ' HB2' ' A' ' 92' ' ' SER . 94.6 m -75.22 140.12 43.05 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.68 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.543 ' N ' ' O ' ' A' ' 40' ' ' ARG . 20.4 m-70 -119.78 121.75 39.85 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.047 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.725 ' OH ' ' HB2' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -92.22 106.58 18.55 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.24 -177.256 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.0 mp -90.75 160.8 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.874 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.6 t -119.28 129.01 54.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.721 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.4 p -81.41 123.0 37.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.141 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.9 tp -128.91 117.28 20.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.2 p -66.98 98.05 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.818 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.73 92.14 6.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 59.95 31.24 20.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.993 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.24 38.5 7.22 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.541 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -148.12 162.07 40.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.76 0.314 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.97 123.47 48.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.927 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -128.33 110.59 12.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.02 114.66 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.8 t -121.29 121.93 38.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.3 m -52.59 121.15 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.112 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.4 -49.97 3.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.189 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.484 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 5.9 t0 -176.62 143.79 0.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.275 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.581 ' HB2' ' O ' ' A' ' 73' ' ' THR . 11.3 p -143.16 165.61 26.95 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.554 0.692 . . . . 0.0 111.496 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.725 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 5.1 mm-40 -131.85 166.3 21.9 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.947 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.77 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 5.5 m -85.97 105.79 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.591 ' O ' ' O ' ' A' ' 71' ' ' GLU . 10.7 p -121.02 80.68 1.67 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.491 0.663 . . . . 0.0 110.76 -178.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.687 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER 154.47 -30.38 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.846 178.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 62.02 101.58 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.624 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.42 HG22 ' CA ' ' A' ' 46' ' ' PHE . 5.0 p -71.36 108.37 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.163 0.506 . . . . 0.0 110.2 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 43.2 mm -64.2 128.8 27.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.173 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -100.94 134.83 43.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.407 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -64.55 99.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.749 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.82 99.81 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.182 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.6 p -123.71 141.56 43.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.128 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -121.53 120.13 33.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.801 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.8 m -86.99 160.14 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.151 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -98.87 125.84 8.7 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.55 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.762 0.315 . . . . 0.0 111.046 -179.963 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.774 0.239 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.15 121.22 6.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.944 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.71 135.53 33.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.883 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.679 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -100.8 -177.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.452 179.381 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.459 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.7 OUTLIER -157.14 121.82 4.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.344 0.592 . . . . 0.0 111.26 -179.397 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.65 ' O ' ' HA ' ' A' ' 73' ' ' THR . 1.0 OUTLIER -128.06 -151.11 0.46 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.679 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 m -144.96 137.87 26.44 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.115 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.473 ' CB ' ' CE1' ' A' ' 74' ' ' HIS . 0.2 OUTLIER -107.94 131.84 54.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.427 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -66.93 92.83 0.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.058 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.499 ' CD1' ' HG2' ' A' ' 72' ' ' ARG . 4.1 mt -109.1 85.79 3.55 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.152 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.76 163.36 23.72 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.829 2.353 . . . . 0.0 112.93 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.451 ' CE2' ' HA3' ' A' ' 67' ' ' GLY . 40.1 p90 -87.33 -173.98 4.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.225 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -149.31 107.13 3.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.787 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.419 ' CB ' ' HB3' ' A' ' 101' ' ' GLN . 9.4 p -66.85 123.61 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.018 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.8 mm -106.4 156.18 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.228 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -108.74 100.84 10.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.808 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -87.2 159.16 18.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.985 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.87 120.07 39.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -122.94 96.56 44.86 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.918 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.81 -25.19 53.36 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.453 2.102 . . . . 0.0 112.263 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -62.35 -30.97 71.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.18 171.88 2.87 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.748 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -89.06 29.93 0.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.268 2.646 . . . . 0.0 112.598 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.01 146.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.912 0.387 . . . . 0.0 111.292 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.74 21.49 36.51 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.779 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -109.61 148.02 32.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.882 0.372 . . . . 0.0 110.799 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -137.87 141.63 40.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -137.7 162.47 33.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.81 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.499 HD13 HG23 ' A' ' 63' ' ' ILE . 18.2 mm -117.0 86.28 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.113 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.4 mm -62.97 -49.75 82.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.012 0.434 . . . . 0.0 110.94 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.3 m -143.68 91.12 2.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.576 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.06 139.55 4.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.727 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.451 ' HA3' ' CE2' ' A' ' 46' ' ' PHE . . . -82.67 137.01 16.12 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.211 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.48 125.97 33.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.839 0.352 . . . . 0.0 111.075 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -56.48 119.88 6.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.041 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.74 -149.89 6.58 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.528 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.631 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -177.18 109.3 0.07 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.069 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.753 ' HB2' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -101.53 139.0 37.78 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.295 0.569 . . . . 0.0 109.904 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.666 ' O ' ' HB2' ' A' ' 92' ' ' SER . 91.2 m -75.86 138.99 41.45 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.815 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.473 ' CE1' ' CB ' ' A' ' 42' ' ' GLU . 5.0 m80 -111.64 118.97 37.13 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.745 0.784 . . . . 0.0 112.609 -178.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.679 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -92.05 100.05 12.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.066 -1.424 . . . . 0.0 111.508 -177.365 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.41 HG21 ' N ' ' A' ' 77' ' ' SER . 5.0 mp -87.73 141.62 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.79 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.41 ' N ' HG21 ' A' ' 76' ' ' ILE . 5.7 t -98.78 130.26 45.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 0.0 110.753 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.401 ' CG2' ' CG2' ' A' ' 85' ' ' THR . 10.6 p -81.42 119.01 30.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.172 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.4 mp -113.21 116.61 30.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.6 m -88.65 94.34 9.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.94 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -87.35 96.72 10.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 42.88 32.06 0.37 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.401 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.39 43.67 2.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.522 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -147.88 107.38 3.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.82 0.343 . . . . 0.0 110.878 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.401 ' CG2' ' CG2' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -88.91 119.01 29.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.821 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.31 149.96 44.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -97.25 108.62 21.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.974 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 78.0 m -127.5 124.05 37.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.15 121.82 3.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.865 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.9 -71.24 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.381 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.5 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 2.6 t0 -147.06 136.44 22.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.845 0.355 . . . . 0.0 111.576 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.666 ' HB2' ' O ' ' A' ' 73' ' ' THR . 5.8 p -143.56 150.95 39.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.385 0.612 . . . . 0.0 110.938 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.567 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 26.0 mm-40 -113.39 166.93 11.01 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.753 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.6 p -85.27 106.33 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.457 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 71' ' ' GLU . 5.8 p -115.15 81.37 1.56 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.428 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.631 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 157.44 -30.17 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.708 179.159 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 61.73 103.57 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.511 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.441 HG22 ' HA ' ' A' ' 46' ' ' PHE . 7.6 p -71.21 104.26 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.209 0.528 . . . . 0.0 110.081 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.3 mp -63.68 127.17 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.032 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.415 ' HA ' ' HB2' ' A' ' 46' ' ' PHE . 6.2 m120 -92.36 145.74 24.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.017 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.419 ' HB3' ' CB ' ' A' ' 48' ' ' VAL . 3.2 tt0 -84.15 101.56 11.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.867 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.85 99.69 7.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.104 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.402 ' CG1' ' CD1' ' A' ' 63' ' ' ILE . 24.6 m -125.38 120.84 59.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.139 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -100.64 131.94 46.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.4 m -110.53 128.37 66.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.147 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.05 137.74 50.17 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.533 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.817 0.342 . . . . 0.0 111.103 179.961 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo . . . . . 0 C--O 1.23 0.119 0 CA-C-O 120.88 0.283 . . . . 0.0 112.237 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -94.85 145.21 25.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.757 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mp -93.65 114.07 26.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.195 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.696 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 44.0 pt -101.03 -176.4 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.817 178.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 1.1 p -151.39 147.04 26.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.236 0.541 . . . . 0.0 111.47 -178.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 1.4 mtp85 -161.17 104.54 1.3 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.997 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 15.0 t -82.15 131.44 35.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.617 0.722 . . . . 0.0 111.373 -178.526 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.431 ' O ' HD12 ' A' ' 44' ' ' ILE . 2.1 mt-10 -98.39 144.6 27.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.807 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -66.67 91.68 0.19 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.695 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.8 mp -87.72 109.41 26.59 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.978 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -88.26 158.18 6.88 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.837 2.358 . . . . 0.0 112.853 -179.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.416 ' HB3' ' CG2' ' A' ' 98' ' ' VAL . 42.3 p90 -87.27 -174.16 4.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.945 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.42 104.43 2.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.733 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.42 143.5 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.189 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -111.82 156.07 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.094 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.7 pttp -108.29 100.91 10.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.828 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.4 ttmp? -112.5 161.78 16.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.927 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -117.71 139.97 50.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.931 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -137.76 132.96 17.55 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.69 -20.28 13.77 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.454 2.103 . . . . 0.0 112.554 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.98 -30.5 59.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.155 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.5 mt -81.77 162.35 58.03 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.974 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.14 42.15 1.14 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.209 2.606 . . . . 0.0 112.602 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.67 136.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.872 0.368 . . . . 0.0 111.335 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.66 40.54 88.39 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.687 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.47 145.47 36.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -112.05 117.12 31.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.828 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -130.32 126.06 36.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.991 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.3 mm -101.74 96.37 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.044 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.8 mt -66.2 -31.13 52.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.41 ' CG2' ' CG2' ' A' ' 102' ' ' VAL . 6.4 t -163.34 119.26 1.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.71 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.07 125.37 27.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.23 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.0 137.75 48.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.319 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -138.61 124.16 23.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.814 0.34 . . . . 0.0 111.084 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.86 119.1 4.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.183 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.447 ' CA ' ' O ' ' A' ' 96' ' ' LYS . . . -88.28 -152.25 24.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.044 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -161.52 145.94 13.13 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.619 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.591 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 31.1 ttm180 -140.36 110.39 6.52 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.139 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.706 ' O ' ' HB3' ' A' ' 92' ' ' SER . 28.0 m -73.77 125.48 28.2 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.014 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.526 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 10.5 m80 -105.59 117.53 34.25 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 122.098 0.952 . . . . 0.0 113.259 -176.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.696 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -89.44 108.26 19.54 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 113.694 -1.594 . . . . 0.0 111.28 -177.912 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.452 ' HB ' ' CD1' ' A' ' 38' ' ' ILE . 2.4 mp -95.26 160.76 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.814 -179.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.422 ' N ' ' CG2' ' A' ' 76' ' ' ILE . 55.9 p -104.69 118.76 37.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.711 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.45 108.55 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.155 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -113.05 88.68 2.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.6 m -82.16 117.51 22.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -127.8 107.62 10.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.952 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 60.79 31.85 20.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.843 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.75 43.24 7.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.525 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.9 tptp -143.23 107.51 4.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.793 0.33 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.8 m -85.85 120.06 26.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.92 142.8 31.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.925 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -105.85 95.73 6.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.6 m -123.64 125.1 44.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.064 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.9 m -55.11 145.12 5.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.022 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.09 -51.76 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.171 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 1.8 t70 -176.62 137.32 0.26 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.274 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.706 ' HB3' ' O ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -143.66 144.87 32.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.352 0.596 . . . . 0.0 111.306 179.005 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.638 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 3.1 mt-30 -103.47 166.75 10.24 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.582 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.494 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 8.6 p -85.25 107.01 15.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.803 -179.031 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.517 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 19.3 p -110.51 83.2 1.72 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.22 -179.435 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 95' ' ' THR . 0.1 OUTLIER 103.39 44.78 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.746 -179.636 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -31.31 133.32 0.08 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.313 -179.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.416 ' CG2' ' HB3' ' A' ' 46' ' ' PHE . 10.7 p -71.87 118.89 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.002 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.3 mp -75.49 108.79 7.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.962 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -71.22 130.87 42.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -68.53 148.0 51.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.41 ' CG2' ' CG2' ' A' ' 65' ' ' THR . 53.4 t -133.11 100.61 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.007 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.1 t -120.47 133.63 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -110.91 154.89 23.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.78 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.88 138.74 52.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.202 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.7 87.81 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.498 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.706 0.289 . . . . 0.0 111.171 179.962 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.795 0.331 . . . . 0.0 111.254 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -92.8 -30.32 9.72 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.51 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.69 110.08 3.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.776 0.322 . . . . 0.0 110.887 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.8 p -157.53 135.47 10.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.5 m170 -84.6 -177.57 6.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.945 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.9 34.92 0.83 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.971 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -91.88 80.94 5.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.821 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -160.92 31.53 0.15 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -175.65 37.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.927 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.31 -176.57 4.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -60.18 113.22 2.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.955 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.68 37.69 3.43 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.492 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mt -99.5 -68.94 0.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.648 0.261 . . . . 0.0 110.854 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.0 m 42.18 53.95 8.54 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.705 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.57 -71.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.601 2.2 . . . . 0.0 112.269 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 mtt85 59.76 31.33 20.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.874 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -173.93 70.45 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.512 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.5 p -119.81 31.51 6.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 0.0 110.907 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -147.64 -172.88 4.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.856 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 28.4 mtp -137.55 31.67 2.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.859 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.8 p -130.4 123.2 29.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.967 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.56 129.45 37.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -103.28 34.84 2.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -77.3 144.59 37.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.921 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -145.26 32.49 1.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.89 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -107.07 166.57 10.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.0 m -59.95 -41.32 85.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.162 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.29 -75.47 0.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.065 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.15 36.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.6 t30 59.93 175.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 p -68.52 -44.8 82.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.025 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -166.42 -76.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.7 m -164.3 -48.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.2 162.87 42.08 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.55 -165.75 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.587 2.191 . . . . 0.0 112.245 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.68 142.17 51.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.786 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.96 111.3 23.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.191 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.66 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 6.1 pt -101.18 -177.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.966 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 0.7 OUTLIER -145.86 162.26 38.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.357 0.598 . . . . 0.0 111.193 -178.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.426 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 26.6 ttt180 -174.01 112.96 0.19 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.051 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 11.1 t -82.19 129.57 34.87 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.817 0.817 . . . . 0.0 111.326 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.451 ' O ' HD13 ' A' ' 44' ' ' ILE . 2.1 mt-10 -98.13 147.72 24.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.002 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -67.08 101.48 0.88 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.028 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 1.9 mp -107.67 87.39 3.5 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.86 160.29 37.44 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.66 2.24 . . . . 0.0 112.688 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.457 ' CD1' ' HA3' ' A' ' 67' ' ' GLY . 33.5 p90 -87.15 -176.92 5.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.985 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.43 115.13 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.841 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 t -67.17 143.83 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.132 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.4 mm -115.84 156.19 16.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -108.74 109.57 20.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -119.82 153.21 36.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -87.91 129.5 35.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.971 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.407 ' ND2' ' CD2' ' A' ' 56' ' ' LEU . 5.8 t-20 -122.17 96.5 46.37 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.09 -23.97 45.45 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.392 2.061 . . . . 0.0 112.333 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -59.69 -28.97 67.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.991 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.407 ' CD2' ' ND2' ' A' ' 53' ' ' ASN . 3.1 mm? -83.18 165.29 41.7 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.742 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -80.84 43.39 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.076 2.518 . . . . 0.0 112.743 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.88 142.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.939 0.399 . . . . 0.0 111.437 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 55.17 25.85 40.93 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.876 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.38 136.84 48.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 0.0 110.979 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -101.2 162.57 12.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -156.32 111.85 2.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.86 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.7 mm -85.65 86.12 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.138 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.9 mm -64.53 -36.07 76.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.953 0.406 . . . . 0.0 110.712 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.449 ' CG2' ' O ' ' A' ' 65' ' ' THR . 9.7 t -166.56 100.35 0.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.554 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.41 135.02 28.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.753 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.457 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -66.0 134.27 34.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.273 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -130.2 132.21 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.907 0.384 . . . . 0.0 111.3 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.435 ' HD3' ' CD2' ' A' ' 46' ' ' PHE . 10.7 mmtt -57.12 125.96 25.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.229 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.449 ' CA ' ' O ' ' A' ' 96' ' ' LYS . . . -105.49 -159.55 23.0 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.051 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.502 ' HA ' HD13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -162.47 154.62 18.88 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.622 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.587 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 14.0 ttt180 -143.67 111.77 6.22 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.572 ' O ' ' HB2' ' A' ' 92' ' ' SER . 64.2 m -72.99 121.46 20.14 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.572 ' O ' ' HA ' ' A' ' 39' ' ' THR . 18.7 m80 -102.26 120.3 40.24 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -86.02 122.27 29.82 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.679 -1.601 . . . . 0.0 110.767 -178.238 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.414 ' HB ' ' CG1' ' A' ' 38' ' ' ILE . 4.2 mp -116.14 141.78 32.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.282 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.24 98.06 7.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.829 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.5 p -81.45 117.9 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.159 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -105.45 124.33 49.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.78 91.24 7.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -123.16 135.96 54.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.2 m120 61.15 30.49 19.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.87 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.54 47.67 81.52 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.597 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.55 142.7 12.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.774 0.321 . . . . 0.0 110.862 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.18 120.79 41.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.889 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 t -105.05 125.86 51.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.866 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.37 107.3 19.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.876 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 97.3 m -133.71 112.75 11.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.923 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.3 m -56.61 162.37 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.966 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 mp -149.18 -56.72 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.343 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.509 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 1.4 t70 -140.65 134.73 30.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.479 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.572 ' HB2' ' O ' ' A' ' 73' ' ' THR . 17.8 p -143.21 133.33 24.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.308 0.575 . . . . 0.0 111.319 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.56 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 3.4 pt20 -89.52 166.58 13.58 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.426 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 5.2 m -85.67 107.3 16.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.564 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 20.0 p -114.22 83.01 1.8 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.192 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.564 ' CB ' ' O ' ' A' ' 95' ' ' THR . 20.2 tptm 107.53 48.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.741 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -33.72 122.24 0.44 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.755 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.414 ' HA ' ' HA3' ' A' ' 70' ' ' GLY . 12.6 p -71.61 109.89 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.212 0.529 . . . . 0.0 111.052 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 34.8 mm -68.72 116.22 8.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.221 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 20.8 m-20 -81.52 129.33 34.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.726 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -62.09 112.36 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.96 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.425 ' CG2' ' CG2' ' A' ' 65' ' ' THR . 58.1 t -95.4 99.73 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.954 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.5 m -122.85 135.72 61.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.133 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -119.8 108.5 14.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.735 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.0 t -91.41 142.0 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.069 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.81 147.1 37.63 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.552 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.31 144.49 77.49 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.655 0.264 . . . . 0.0 111.135 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.09 -73.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.521 2.147 . . . . 0.0 112.373 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.411 HG12 ' CE1' ' A' ' 111' ' ' HIS . 10.8 p -178.53 -45.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.045 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.9 t -177.83 38.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.912 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.411 ' CE1' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.877 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.741 0.305 . . . . 24.66 111.246 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.27 50.88 1.15 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.981 -0.628 . . . . 22.68 112.563 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.3 t -158.58 87.87 0.9 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.825 0.345 . . . . 22.59 110.895 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.2 m -73.64 -54.22 8.65 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.161 -0.472 . . . . 20.87 110.616 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -127.03 24.51 6.38 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.178 -0.464 . . . . 19.65 111.173 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.2 m80 63.98 175.36 0.18 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.009 0.433 . . . . 20.95 111.581 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 1.303 ' ND1' ' HD1' ' A' ' 7' ' ' HIS . 4.5 p80 -78.64 -150.24 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.897 -0.592 . . . . 18.41 110.289 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -46.92 -53.7 11.65 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.628 0.251 . . . . 19.56 110.81 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 61.56 178.02 0.12 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.079 -0.51 . . . . 18.45 111.889 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.455 ' HB3' HD23 ' A' ' 13' ' ' LEU . 2.2 m -119.46 56.44 0.93 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.865 -0.607 . . . . 16.74 110.382 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.548 ' HA ' ' HG3' ' A' ' 15' ' ' PRO . 52.7 m -67.28 -17.12 64.65 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.157 -0.474 . . . . 16.15 112.111 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.39 -1.88 90.26 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.945 -0.645 . . . . 15.44 114.103 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.545 HD22 HG22 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -155.04 -45.0 0.08 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 117.894 0.847 . . . . 16.9 112.384 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.545 HG22 HD22 ' A' ' 13' ' ' LEU . 74.5 t -150.19 86.89 5.08 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-O 120.788 0.327 . . . . 14.57 110.908 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.548 ' HG3' ' HA ' ' A' ' 11' ' ' SER . 1.7 Cg_endo -80.47 -64.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.043 2.495 . . . . 14.73 111.732 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.3 -41.77 2.6 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.023 -0.535 . . . . 16.19 110.532 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -136.3 -78.04 0.08 OUTLIER Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.873 -0.491 . . . . 12.3 111.873 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.38 -157.39 0.33 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.517 0.199 . . . . 12.26 111.306 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -58.01 -31.52 67.05 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.605 -0.27 . . . . 14.51 111.513 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.425 ' HB2' ' HB3' ' A' ' 23' ' ' ASP . 0.7 OUTLIER 71.34 113.66 0.05 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.587 0.355 . . . . 13.64 111.211 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.1 m -69.51 -23.75 63.65 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.09 -0.504 . . . . 13.86 111.467 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -91.95 -42.56 9.94 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.715 -0.221 . . . . 14.15 111.084 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 4.0 t70 -65.3 -31.67 72.93 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.389 -0.369 . . . . 13.08 111.613 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.67 -22.88 64.36 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.942 0.349 . . . . 13.27 111.942 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 0.0 OUTLIER 73.45 157.56 0.19 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.503 0.321 . . . . 12.6 111.249 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 25' ' ' ASN . 26.4 mm-40 70.98 -92.38 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.929 -0.578 . . . . 13.92 110.848 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 p -176.75 -55.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 111.544 0.202 . . . . 13.47 111.544 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 33.62 -96.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.129 0.572 . . . . 13.8 112.466 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.45 39.3 28.18 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.604 0.24 . . . . 13.6 111.518 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.8 m120 54.68 34.08 20.77 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.251 -0.431 . . . . 13.45 111.544 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 t 51.49 53.19 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 121.013 0.435 . . . . 13.8 111.201 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -105.96 -52.89 2.73 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.992 -0.549 . . . . 13.76 110.907 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.0 m -86.0 115.6 23.7 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.557 -0.292 . . . . 14.21 110.356 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.419 ' HD3' ' HB2' ' A' ' 77' ' ' SER . 1.3 mmt180 58.85 59.39 5.52 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.14 -0.482 . . . . 13.53 110.84 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.34 -43.2 1.1 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.611 2.207 . . . . 12.88 112.594 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -147.71 112.03 5.24 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.284 -0.416 . . . . 13.36 110.467 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 mp -72.74 111.49 7.94 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.181 -0.463 . . . . 10.75 110.764 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.641 HG13 ' HB ' ' A' ' 76' ' ' ILE . 28.6 pt -99.44 121.0 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-O 121.722 0.772 . . . . 11.89 109.665 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.681 ' HB ' ' CG2' ' A' ' 73' ' ' THR . 6.3 p -87.13 139.39 30.62 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.018 -0.992 . . . . 10.52 111.111 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 7.1 ttt-85 -155.51 117.98 4.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.807 -1.088 . . . . 13.32 108.914 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 68.4 p -79.81 127.49 32.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.503 0.668 . . . . 9.69 110.887 -178.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -96.9 139.41 32.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.639 -1.164 . . . . 8.68 109.83 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.86 97.82 0.37 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.962 -0.563 . . . . 10.74 110.691 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.479 ' CD1' ' CB ' ' A' ' 72' ' ' ARG . 7.5 mt -99.19 103.01 17.59 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 115.43 -0.805 . . . . 6.41 109.585 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.545 ' C ' HG22 ' A' ' 98' ' ' VAL . 90.5 Cg_endo -78.24 145.63 21.74 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.316 2.677 . . . . 7.29 114.363 -177.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.537 ' HB2' ' HA ' ' A' ' 100' ' ' ASN . 39.1 p90 -86.73 -179.82 6.63 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.278 -0.874 . . . . 7.85 111.175 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.07 117.19 6.83 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.397 -0.365 . . . . 6.08 111.678 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' A' ' 101' ' ' GLN . 21.9 t -66.11 134.61 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.039 -0.528 . . . . 7.4 111.536 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.9 mm -123.48 139.76 49.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.278 -0.419 . . . . 9.0 111.49 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -100.19 108.19 20.23 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.881 -0.6 . . . . 10.67 110.394 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.95 106.18 16.57 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.079 -0.509 . . . . 12.54 111.155 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -61.64 105.53 0.55 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.822 0.344 . . . . 14.65 110.524 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 0.8 OUTLIER -108.34 119.82 48.46 Favored Pre-proline 0 C--O 1.232 0.173 0 CA-C-N 116.087 -0.506 . . . . 15.73 111.442 -179.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.56 -24.6 18.64 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.785 2.324 . . . . 18.85 112.371 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -61.76 -39.1 90.45 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.421 -0.354 . . . . 19.41 111.183 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' A' ' 60' ' ' GLN . 1.0 OUTLIER -63.58 164.27 16.49 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.495 -0.32 . . . . 17.22 110.905 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.77 -74.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.769 2.313 . . . . 18.08 113.301 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -178.76 122.51 0.09 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.098 -0.955 . . . . 15.9 111.205 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.21 29.1 62.38 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.189 -0.529 . . . . 13.8 113.025 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.479 ' HB3' HD21 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -106.09 136.69 45.33 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.701 0.25 . . . . 15.58 110.501 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.26 113.4 25.02 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.888 0.375 . . . . 13.22 111.335 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.438 ' HB3' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -106.22 111.99 24.82 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.893 -0.594 . . . . 14.56 109.948 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 24.2 mt -85.58 122.51 38.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.095 0.474 . . . . 13.39 111.851 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.4 mm -100.52 -39.7 7.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.374 -0.83 . . . . 14.36 109.841 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.507 HG22 HG23 ' A' ' 99' ' ' ILE . 0.2 OUTLIER -135.54 99.0 4.08 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.682 -0.69 . . . . 11.92 109.815 179.517 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.4 113.72 1.14 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.02 -0.536 . . . . 11.37 112.074 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 99' ' ' ILE . . . -58.7 109.33 1.95 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.871 -0.604 . . . . 8.47 112.314 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.5 t -135.1 144.56 34.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.91 0.386 . . . . 10.37 111.251 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 45' ' ' PRO . 2.7 mmtt -67.48 116.3 8.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.716 -0.675 . . . . 10.44 111.125 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.444 ' HA2' ' HE3' ' A' ' 96' ' ' LYS . . . -81.96 -171.55 46.18 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.154 -0.546 . . . . 7.86 112.107 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.548 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -158.72 109.18 2.05 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.461 -0.57 . . . . 10.04 109.461 179.499 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.683 ' HG3' ' HA ' ' A' ' 94' ' ' VAL . 36.5 ttm180 -98.18 124.8 42.94 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.554 -0.536 . . . . 6.27 109.554 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.681 ' CG2' ' HB ' ' A' ' 39' ' ' THR . 95.1 m -74.76 125.37 28.62 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 107.719 -1.215 . . . . 9.06 107.719 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.488 ' HA ' ' HB2' ' A' ' 92' ' ' SER . 19.8 m80 -105.66 114.88 29.3 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.927 0.87 . . . . 8.1 112.647 -177.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.694 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -80.09 92.47 5.64 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 113.67 -1.605 . . . . 8.2 109.086 -178.363 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.641 ' HB ' HG13 ' A' ' 38' ' ' ILE . 74.1 mt -88.16 154.86 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 113.411 -1.722 . . . . 11.25 112.474 -177.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.419 ' HB2' ' HD3' ' A' ' 34' ' ' ARG . 32.7 t -105.17 121.35 43.63 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.292 -0.413 . . . . 11.99 110.34 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 m -81.76 98.23 4.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.05 0.452 . . . . 13.86 111.351 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.0 mt -103.68 106.85 17.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.967 -0.56 . . . . 15.75 110.209 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 p -73.56 93.88 2.08 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.207 -0.451 . . . . 17.89 111.194 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -90.74 93.99 9.48 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.994 -0.548 . . . . 20.19 110.26 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 58.5 45.6 16.2 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.098 -0.501 . . . . 22.86 110.773 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.76 47.71 6.56 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.108 -0.568 . . . . 21.87 112.713 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -162.13 108.07 1.27 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.657 0.265 . . . . 21.44 111.114 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.4 p -75.72 97.74 3.92 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.239 -0.437 . . . . 18.44 110.653 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 58.9 m -77.37 110.25 11.96 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.092 -0.504 . . . . 16.78 110.751 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.476 ' HB2' HG22 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -80.79 96.34 6.94 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.112 0.482 . . . . 14.81 110.636 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 45.1 m -108.79 126.15 52.72 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.959 -0.564 . . . . 13.35 111.4 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.1 p -59.16 134.89 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.066 -0.516 . . . . 10.64 110.134 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 32.2 mt -137.64 -83.94 0.32 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.147 0.425 . . . . 10.63 112.147 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.81 122.1 44.4 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.563 0.221 . . . . 8.61 111.343 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.644 ' HB2' ' O ' ' A' ' 73' ' ' THR . 1.3 p -145.29 148.94 34.0 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.189 0.519 . . . . 6.55 111.656 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.603 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 19.0 mm-40 -108.65 164.64 12.19 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.032 -1.47 . . . . 9.99 107.032 176.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.683 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 12.3 p -82.22 112.68 20.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.292 -0.563 . . . . 7.93 110.544 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 31.9 p -117.61 72.08 0.83 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.671 0.748 . . . . 9.06 110.612 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 149.37 -43.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.07 -1.423 . . . . 11.79 108.826 178.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.447 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 9.3 tp10 64.55 115.32 0.02 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.327 -0.851 . . . . 8.74 111.571 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.545 HG22 ' C ' ' A' ' 45' ' ' PRO . 11.1 p -71.21 103.24 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.373 0.606 . . . . 6.28 110.107 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.507 HG23 HG22 ' A' ' 65' ' ' THR . 4.5 mp -71.68 118.97 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.424 -0.807 . . . . 9.63 110.962 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.537 ' HA ' ' HB2' ' A' ' 46' ' ' PHE . 4.1 m120 -82.69 133.1 35.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.846 -0.615 . . . . 7.9 110.102 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.526 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -59.64 98.46 0.05 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.422 -0.354 . . . . 9.07 111.032 -179.435 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 76.0 t -90.72 99.11 9.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.862 -0.421 . . . . 10.85 109.862 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.01 125.39 72.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.949 -0.569 . . . . 10.51 111.177 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 53' ' ' ASN . 17.0 mm-40 -96.52 110.29 22.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.822 -0.627 . . . . 13.72 110.248 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.7 t -85.98 115.55 27.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.226 -0.443 . . . . 12.91 110.992 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.8 132.02 46.48 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.015 -0.612 . . . . 14.28 112.721 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.41 111.26 44.49 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-O 120.361 0.124 . . . . 15.72 110.933 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.52 73.08 3.5 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.982 2.454 . . . . 17.27 111.995 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.1 p 50.68 23.8 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 115.888 -0.596 . . . . 18.93 112.24 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.2 t 176.68 123.05 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.439 -0.346 . . . . 19.9 110.526 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 117.999 -1.0 . . . . 21.09 111.091 -179.998 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttp . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.806 0.336 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.71 59.36 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.474 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.0 m -163.45 36.33 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 m -129.93 -46.83 1.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.991 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.411 ' CE1' ' HB2' ' A' ' 10' ' ' SER . 1.0 OUTLIER -100.85 106.67 18.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -110.63 30.61 6.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.955 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.9 m80 59.32 88.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.91 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -161.74 30.43 0.13 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.95 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 52.9 m80 58.96 82.39 0.14 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.975 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.411 ' HB2' ' CE1' ' A' ' 5' ' ' HIS . 2.1 m -88.79 -75.88 0.42 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.7 t -177.59 171.98 1.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.8 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.9 -158.82 24.06 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.527 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 tp -131.55 -56.96 1.01 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.829 0.347 . . . . 0.0 110.861 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.4 m -158.29 155.19 25.31 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.123 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.97 -168.22 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.545 2.163 . . . . 0.0 112.33 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.16 -31.4 14.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.987 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -140.6 -79.89 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.367 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.2 m 60.52 35.91 20.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.352 . . . . 0.0 110.904 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -60.27 -176.94 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 18.1 ttm -98.74 -70.72 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.943 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -177.4 -176.17 0.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.01 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.6 mt 60.28 163.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.95 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -176.62 136.1 0.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -60.65 131.43 50.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -123.08 34.73 5.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.902 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 60.55 -175.14 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.5 t 63.63 158.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.118 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 60.67 156.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.175 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -164.9 -44.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.3 t30 60.65 158.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.1 m -113.15 179.33 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -83.68 -57.6 3.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.5 p 55.79 37.46 28.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.033 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 62.34 149.49 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.48 -45.87 1.08 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.587 2.192 . . . . 0.0 112.348 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -169.38 128.05 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.88 131.25 35.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.7 OUTLIER -101.12 -177.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.698 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.483 HG21 ' CD1' ' A' ' 75' ' ' TYR . 1.0 OUTLIER -163.31 121.08 1.91 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.113 0.482 . . . . 0.0 110.669 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -142.56 109.72 5.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.774 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 11.3 t -82.52 128.28 34.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.511 0.672 . . . . 0.0 111.407 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.476 ' O ' HD12 ' A' ' 44' ' ' ILE . 1.3 mt-10 -98.31 146.01 26.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.744 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.77 91.67 0.2 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.803 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.577 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.7 mp -89.62 108.23 23.85 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.885 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.422 ' C ' HG23 ' A' ' 98' ' ' VAL . 1.9 Cg_endo -81.95 157.43 18.07 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.941 2.427 . . . . 0.0 112.596 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.43 ' HB3' ' CG2' ' A' ' 98' ' ' VAL . 42.2 p90 -86.57 -174.4 4.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.74 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.99 116.54 3.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.2 t -67.29 148.76 11.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.051 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 37.9 mm -123.82 156.16 30.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.013 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -119.42 100.86 7.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -105.56 141.72 36.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.401 ' OE2' ' CD2' ' A' ' 111' ' ' HIS . 3.3 pt-20 -104.79 124.89 50.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -128.67 133.29 25.03 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.12 -20.77 12.61 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.468 2.112 . . . . 0.0 112.541 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -55.06 -38.49 68.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.06 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.2 mt -62.82 159.64 43.34 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.763 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -80.24 44.98 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.039 2.493 . . . . 0.0 112.724 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.61 125.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.934 0.397 . . . . 0.0 111.424 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.44 53.63 41.92 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.779 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.46 162.91 13.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.746 0.308 . . . . 0.0 110.894 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -145.16 113.92 6.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -143.12 122.54 13.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.422 HG21 HD13 ' A' ' 63' ' ' ILE . 31.2 mt -86.59 131.18 35.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.09 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.5 mm -99.59 -44.24 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.9 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.6 m -144.28 102.25 3.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.659 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.81 153.4 4.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.483 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.59 131.29 10.32 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.19 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -140.62 136.36 35.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.869 0.366 . . . . 0.0 111.132 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -63.12 124.87 22.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 96' ' ' LYS . . . -97.99 -151.98 27.77 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.888 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.478 ' CB ' ' HB3' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -161.03 148.1 15.19 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.577 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 5.2 ttt180 -140.21 111.22 6.98 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.713 ' O ' ' HB2' ' A' ' 92' ' ' SER . 19.1 m -73.58 126.81 31.11 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.458 ' HA ' ' CB ' ' A' ' 92' ' ' SER . 20.3 m80 -107.55 119.72 40.21 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.042 0.925 . . . . 0.0 112.893 -177.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.687 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -91.15 102.72 15.45 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 113.651 -1.613 . . . . 0.0 111.146 -177.529 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.401 ' CD1' ' HG3' ' A' ' 40' ' ' ARG . 4.8 mp -87.86 160.15 2.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.952 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.45 126.8 44.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.685 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.43 109.86 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.254 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.4 mt -115.75 103.53 10.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.841 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.33 123.19 34.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.831 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -129.55 93.09 3.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 61.24 36.24 17.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.964 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.82 46.13 5.22 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.442 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.01 114.64 7.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.812 0.339 . . . . 0.0 110.872 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.85 112.09 23.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.856 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.95 150.73 21.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.96 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -107.77 99.54 9.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 94.1 m -115.37 116.5 28.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.922 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.1 m -50.01 123.67 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.53 -67.87 0.96 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.216 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.51 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -163.13 141.97 8.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.299 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.713 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.6 p -143.56 151.08 39.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.448 0.642 . . . . 0.0 111.394 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.668 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 12.8 mm-40 -110.01 166.96 10.53 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.482 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 8.3 p -84.95 106.93 15.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.007 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.585 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 15.4 p -111.82 82.61 1.65 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.76 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.585 ' CB ' ' O ' ' A' ' 95' ' ' THR . 21.0 tttt 109.92 48.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.585 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 96' ' ' LYS . 1.2 pm0 -32.43 125.47 0.31 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.819 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.43 ' CG2' ' HB3' ' A' ' 46' ' ' PHE . 4.3 p -71.7 119.14 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.03 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.439 HG22 HD13 ' A' ' 99' ' ' ILE . 34.8 mm -70.05 115.96 10.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.919 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -90.36 130.9 36.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.57 127.36 32.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.85 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.5 m -126.5 99.73 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.188 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.9 p -108.25 116.53 51.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.015 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -87.1 108.55 18.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.6 p -98.36 137.73 25.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -72.66 130.85 15.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.511 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.32 156.14 80.45 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 111.063 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.24 -168.16 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.572 2.182 . . . . 0.0 112.226 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.5 m -101.92 -37.71 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.124 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.4 m -60.21 -69.15 0.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.401 ' CD2' ' OE2' ' A' ' 52' ' ' GLU . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.917 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.855 0.36 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 105.31 28.47 5.48 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.467 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.3 m 60.34 -169.95 0.15 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.815 0.341 . . . . 0.0 110.885 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.56 159.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.943 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 60.7 80.71 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.886 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -151.59 34.73 0.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -167.73 120.4 0.9 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.828 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -143.44 103.26 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.845 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -169.81 -46.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.3 -171.43 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.48 169.47 8.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.949 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.28 -174.21 44.3 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.5 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mp -95.86 -34.76 11.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.663 0.268 . . . . 0.0 110.832 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.417 ' N ' ' CD ' ' A' ' 15' ' ' PRO . 9.2 p 42.89 52.03 7.44 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.697 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 14' ' ' VAL . 55.7 Cg_endo -69.94 99.09 0.74 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.581 2.187 . . . . 0.0 112.291 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 60.6 31.62 20.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.99 30.28 10.5 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.436 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.3 t 60.43 109.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.803 0.335 . . . . 0.0 111.006 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -91.77 -31.57 15.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.002 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.1 mtm -100.95 134.22 44.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.941 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.5 m -85.75 -31.39 22.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.8 mt -60.19 167.84 2.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -139.26 -169.97 2.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 61.27 113.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.934 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.96 -178.28 4.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.88 177.82 6.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.923 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.64 158.74 4.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.111 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.57 -69.11 0.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.203 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.46 -178.89 0.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.156 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -175.65 153.14 1.39 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.1 m -137.09 179.16 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.069 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -131.31 36.42 3.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.2 m -126.37 -52.09 1.5 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -159.88 141.67 9.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.69 -165.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.552 2.168 . . . . 0.0 112.207 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.01 -179.18 4.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.916 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.1 mt -111.36 115.69 29.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.949 0.404 . . . . 0.0 111.132 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.632 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -101.11 -176.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.525 179.273 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 1.4 p -158.03 140.12 14.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.345 0.593 . . . . 0.0 111.079 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.489 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 33.9 ttp180 -161.23 107.07 1.38 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.02 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 14.8 t -81.93 132.43 35.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.709 0.766 . . . . 0.0 111.706 -178.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.434 ' O ' HD13 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -98.56 144.69 27.6 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.574 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -66.77 91.68 0.2 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.854 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.581 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 3.2 mp -85.19 111.04 33.37 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.783 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -87.46 153.41 7.81 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.667 2.245 . . . . 0.0 112.849 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.454 ' CD2' ' HA3' ' A' ' 67' ' ' GLY . 49.9 p90 -87.07 -176.83 5.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.782 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -149.57 112.46 4.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.098 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.4 t -67.22 149.23 11.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.031 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.0 mm -125.79 156.06 35.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.184 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.03 100.93 7.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.778 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.89 137.59 38.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -93.81 102.73 14.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.899 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -102.57 96.56 7.59 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.838 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.65 -18.06 48.11 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.461 2.108 . . . . 0.0 112.488 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -58.16 -31.5 67.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.977 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.3 mt -76.07 165.4 53.36 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.799 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -83.9 42.34 1.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.13 2.553 . . . . 0.0 112.606 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.06 150.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.843 0.354 . . . . 0.0 111.314 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 55.2 27.15 45.46 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.616 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 -95.49 116.14 28.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -110.91 134.88 52.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -151.13 161.9 41.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.9 mm -126.49 95.9 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.101 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.7 mm -72.88 -31.79 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.98 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.9 m -163.42 96.2 0.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.708 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.87 151.77 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.483 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.454 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -93.4 120.89 6.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.33 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.39 133.75 57.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.823 0.344 . . . . 0.0 111.152 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -59.27 125.74 24.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.156 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -96.05 -141.01 11.46 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.999 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.505 ' N ' ' HB3' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -166.71 141.94 4.31 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.581 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 22.4 ttm180 -136.11 111.11 8.87 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.72 ' O ' ' HB3' ' A' ' 92' ' ' SER . 32.8 m -73.78 124.92 26.98 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.523 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 8.5 m80 -105.08 117.0 32.91 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 122.082 0.944 . . . . 0.0 113.191 -176.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.677 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -89.55 100.72 13.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 113.611 -1.631 . . . . 0.0 110.98 -178.082 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.462 ' HB ' ' CG2' ' A' ' 38' ' ' ILE . 4.5 mp -87.56 161.17 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.281 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.3 t -107.82 112.85 25.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.721 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.8 p -81.54 102.19 7.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.017 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 tp -110.1 108.9 19.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.945 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 t -86.0 107.55 17.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.814 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -104.85 93.22 4.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.847 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 60.4 31.14 20.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.83 43.16 3.4 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.561 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 11.4 ttpt -149.16 112.66 5.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.792 0.33 . . . . 0.0 110.891 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.77 110.42 22.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.855 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.86 132.04 50.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.936 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.76 99.63 11.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.951 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.3 t -113.93 125.47 54.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.927 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.3 m -51.04 115.68 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.094 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.84 -63.42 1.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.533 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -166.04 136.58 3.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.009 -179.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.72 ' HB3' ' O ' ' A' ' 73' ' ' THR . 0.8 OUTLIER -143.59 150.1 38.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.547 0.689 . . . . 0.0 111.576 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.603 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -109.46 166.47 10.86 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.497 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 30.9 m -85.23 106.79 15.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.06 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.568 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 16.9 p -110.95 82.56 1.61 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.714 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 95' ' ' THR . 2.5 tppt? 132.4 -39.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.631 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 59.09 121.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.556 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.2 p -81.71 114.47 22.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.737 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.6 mp -75.32 132.18 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -93.72 140.49 29.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.962 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -77.12 114.4 15.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.94 99.7 9.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.046 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.7 p -121.19 119.56 59.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -93.37 133.16 36.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.839 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.3 m -112.27 123.27 67.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.232 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.77 123.79 19.69 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.449 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -175.24 149.23 1.13 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.767 0.318 . . . . 0.0 111.068 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.85 142.4 43.01 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.585 2.19 . . . . 0.0 112.352 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.2 p -100.6 -32.81 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.062 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.56 -50.76 6.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.822 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 28.9 m170 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.944 179.971 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.82 0.343 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -104.69 -50.23 0.97 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.479 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 t 60.25 82.21 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.868 0.366 . . . . 0.0 110.957 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.1 m -131.17 -46.35 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.837 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -128.57 173.82 9.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -127.92 85.88 2.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.0 m80 64.13 -79.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -171.27 35.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.893 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -176.82 122.33 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.17 93.78 3.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.8 35.91 2.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.944 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.3 163.76 36.08 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.498 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.53 84.13 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.769 0.319 . . . . 0.0 110.861 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.4 m -143.26 154.74 61.25 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.07 -37.52 8.31 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.548 2.165 . . . . 0.0 112.289 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.0 ttp-105 -176.2 90.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -142.7 28.39 2.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.46 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 m -159.41 79.9 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.877 0.37 . . . . 0.0 110.936 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -112.92 -37.59 4.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 tpp -59.71 106.42 0.48 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.86 -31.42 11.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.982 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.3 mt -59.62 -31.48 69.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.017 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -67.29 120.93 14.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -94.81 163.57 13.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.16 -68.08 0.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.952 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.23 170.82 7.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.929 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.38 93.34 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.074 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 58.87 30.51 20.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.168 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.77 -170.43 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.089 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -162.25 -48.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.859 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.2 p -178.13 158.19 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.085 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -119.94 -41.53 2.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.922 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 56.0 m -118.26 142.54 47.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.81 150.88 49.31 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.46 -45.44 1.21 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.624 2.216 . . . . 0.0 112.243 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -168.82 113.73 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.814 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mp -76.95 132.49 39.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.045 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -101.26 -177.06 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.783 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.475 HG21 ' CD1' ' A' ' 75' ' ' TYR . 0.9 OUTLIER -163.67 123.02 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.178 0.513 . . . . 0.0 110.342 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 2.8 mtm180 -149.6 109.36 4.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.29 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 14.9 t -82.41 133.22 35.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.71 0.767 . . . . 0.0 111.872 -178.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.436 ' O ' HD12 ' A' ' 44' ' ' ILE . 3.0 mt-10 -98.35 147.64 24.47 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.453 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.68 98.32 0.51 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.884 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.543 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.9 mp -95.9 105.43 21.28 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.576 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -84.69 150.36 11.37 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.719 2.279 . . . . 0.0 113.171 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.436 ' CA ' HG23 ' A' ' 98' ' ' VAL . 43.0 p90 -86.87 -175.06 5.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.939 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.67 116.53 5.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.239 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.6 t -67.23 149.68 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.122 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -115.65 156.2 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.005 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.92 107.76 12.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -115.25 165.82 12.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.905 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -112.81 138.51 49.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -138.27 96.52 9.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.921 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.02 -20.8 57.15 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.413 2.075 . . . . 0.0 112.438 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -58.3 -29.63 66.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.994 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mt -70.97 165.96 42.4 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.878 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.29 46.79 2.2 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.117 2.545 . . . . 0.0 112.796 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.25 126.48 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.832 0.349 . . . . 0.0 111.641 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 51.67 55.88 18.31 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.928 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.4 144.06 38.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.786 0.327 . . . . 0.0 110.951 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -104.4 130.08 52.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.926 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -146.58 127.86 14.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.982 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 25.0 mm -104.99 90.99 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.034 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.6 mm -65.47 -32.67 59.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.549 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.412 ' CG2' ' CG2' ' A' ' 102' ' ' VAL . 5.3 t -161.38 128.3 3.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.398 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.48 135.37 35.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 111.419 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.429 ' HA3' ' CE2' ' A' ' 46' ' ' PHE . . . -81.98 134.95 13.6 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.308 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 t -145.16 142.95 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 111.088 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.56 119.7 17.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.344 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.84 -139.91 7.79 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.639 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -169.64 146.91 3.4 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.547 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.562 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 2.5 ttt180 -134.91 111.67 10.04 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.693 ' O ' ' HB3' ' A' ' 92' ' ' SER . 37.4 m -73.84 126.65 30.88 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.537 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 9.1 m80 -105.82 117.37 33.84 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 122.148 0.975 . . . . 0.0 112.753 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.67 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -90.37 100.1 13.0 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 113.57 -1.65 . . . . 0.0 111.075 -177.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.407 ' O ' HG13 ' A' ' 38' ' ' ILE . 3.1 mp -87.8 159.9 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.726 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.401 ' N ' ' CG2' ' A' ' 76' ' ' ILE . 40.0 t -102.83 126.71 50.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.828 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.1 m -81.51 106.29 12.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.203 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -112.47 130.99 55.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.943 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.6 135.8 39.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -152.22 115.65 4.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.826 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.8 m120 60.07 34.96 21.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.966 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.98 29.5 66.89 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.509 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -128.3 165.0 21.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.915 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.03 120.32 41.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.97 151.02 22.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.778 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.27 121.97 40.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 98.9 m -144.79 123.07 12.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.967 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 p -58.21 131.99 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.834 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.2 tp -116.04 -55.54 2.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.296 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 3.6 t0 -169.45 136.91 1.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.482 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.693 ' HB3' ' O ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -143.66 145.23 32.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.387 0.613 . . . . 0.0 111.261 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.601 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 34.5 mm-40 -106.89 165.86 11.02 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.53 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 9.0 p -85.88 106.93 15.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.4 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.515 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 9.7 p -111.71 82.11 1.56 Allowed 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.656 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 95' ' ' THR . 0.0 OUTLIER 140.96 -36.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.642 178.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 56.44 115.02 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.821 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.436 HG23 ' CA ' ' A' ' 46' ' ' PHE . 14.9 p -81.49 106.29 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.535 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.1 tt -79.42 133.01 30.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.304 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.418 ' HA ' ' HB2' ' A' ' 46' ' ' PHE . 27.9 m-20 -92.49 161.75 14.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.888 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -96.8 140.54 31.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.412 ' CG2' ' CG2' ' A' ' 65' ' ' THR . 84.2 t -126.1 118.68 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.988 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.4 m -131.25 145.63 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.0 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -116.18 108.38 16.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.26 110.74 20.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.41 133.28 50.3 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.506 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -101.45 148.23 34.91 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.637 0.256 . . . . 0.0 111.151 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.74 -69.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.613 2.209 . . . . 0.0 112.303 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.8 p -178.06 -41.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.115 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.3 t -91.94 157.22 16.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.941 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ptm . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.778 0.323 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -148.51 32.07 1.24 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.484 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.416 ' HB3' ' CD2' ' A' ' 6' ' ' HIS . 3.5 t -100.73 -169.98 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.741 0.305 . . . . 0.0 110.945 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.2 t -61.1 -74.56 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -111.0 135.54 51.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.952 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.416 ' CD2' ' HB3' ' A' ' 3' ' ' SER . 2.0 m-70 -141.29 -74.73 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -176.51 100.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.981 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -176.39 84.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -105.28 -69.29 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.899 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.2 m 60.2 79.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.7 p -126.82 -68.48 0.8 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.961 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 158.69 -161.98 32.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.508 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -108.42 -30.81 8.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 0.0 110.961 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.6 t 64.57 77.55 0.29 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.79 -45.91 0.93 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.643 2.229 . . . . 0.0 112.314 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -156.45 -178.55 7.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.25 -24.97 76.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.599 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.2 t -57.94 124.94 20.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.706 0.289 . . . . 0.0 110.943 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -131.6 -168.06 1.96 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 mmt -58.51 155.53 12.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.937 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.0 m -62.8 -178.09 0.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.952 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -132.37 -74.61 0.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -114.67 81.49 1.57 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -109.57 -31.34 7.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.863 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.9 t30 60.84 157.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.936 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -61.88 142.26 57.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.49 140.17 45.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.18 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.36 88.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.08 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.14 134.44 53.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.072 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -167.7 145.0 4.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.925 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 m -98.92 31.18 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.184 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 60.85 105.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 62.7 m -123.78 -69.37 0.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -163.61 164.2 15.43 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.02 -166.66 0.17 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.567 2.178 . . . . 0.0 112.228 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -93.75 148.89 21.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.657 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.83 117.23 34.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.11 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.686 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 1.1 pp -101.2 -176.72 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.09 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 0.8 OUTLIER -149.66 152.58 35.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.257 0.551 . . . . 0.0 111.025 -179.276 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 74' ' ' HIS . 19.5 ttt-85 -170.05 111.62 0.44 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.003 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 14.9 t -82.16 131.78 35.24 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.828 0.823 . . . . 0.0 111.478 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.481 ' O ' HD13 ' A' ' 44' ' ' ILE . 0.7 OUTLIER -98.15 149.72 22.23 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.871 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -66.95 105.53 1.65 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.059 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.576 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.4 mp -107.73 100.41 34.89 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.867 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -84.99 156.86 11.44 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.038 2.492 . . . . 0.0 112.581 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.423 ' CD1' ' HA3' ' A' ' 67' ' ' GLY . 46.5 p90 -87.13 -174.25 4.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.013 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -153.35 109.05 3.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.986 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.4 p -67.42 154.06 8.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.196 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -124.79 156.15 33.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.045 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.27 100.81 10.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.8 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -90.43 147.7 23.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.965 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -107.95 102.97 12.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -94.16 102.83 9.07 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.61 -26.91 46.06 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.406 2.071 . . . . 0.0 112.271 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -69.41 -31.48 69.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.4 mt -63.59 163.23 21.53 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -86.86 31.0 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.818 2.345 . . . . 0.0 112.948 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 56.85 104.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.266 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 118.25 -25.35 8.29 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.634 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.63 134.9 47.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 0.0 110.868 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -137.96 128.44 26.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -128.14 148.61 50.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.0 mm -97.65 86.33 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.147 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.2 mm -62.24 -35.82 71.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.812 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.3 m -164.28 90.98 0.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.629 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.12 150.97 4.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.52 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.423 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -88.86 134.69 12.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.338 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.41 132.43 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.856 0.36 . . . . 0.0 111.204 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.0 mttp -56.07 126.2 24.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.184 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' A' ' 96' ' ' LYS . . . -99.81 -157.44 28.47 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.129 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.488 ' HA ' HD13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -159.94 151.4 19.79 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.576 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 36.7 ttt180 -141.9 110.91 6.27 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.628 ' O ' ' HB2' ' A' ' 92' ' ' SER . 96.0 m -73.33 121.24 20.11 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.537 ' O ' ' HA ' ' A' ' 39' ' ' THR . 13.7 m80 -102.94 121.55 42.77 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.795 0.807 . . . . 0.0 113.133 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.686 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -89.55 107.78 19.28 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 113.857 -1.52 . . . . 0.0 111.273 -177.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.447 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 2.5 mp -98.69 159.24 3.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.896 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.14 113.47 24.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.867 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.3 p -81.45 113.15 20.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.13 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.33 107.01 15.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.855 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.6 m -76.46 104.05 6.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.992 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -115.3 108.47 16.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.783 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 60.58 35.3 20.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.98 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.84 47.46 25.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.475 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.89 107.41 3.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.785 0.326 . . . . 0.0 110.877 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 p -79.79 125.22 29.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.3 p -123.67 150.98 43.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.95 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -105.59 113.89 27.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.4 t -123.24 123.25 40.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.944 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.3 m -57.66 129.45 19.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.99 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.1 tp -119.12 -58.15 1.96 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.15 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.521 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 1.9 t70 -166.29 140.78 4.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.273 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.628 ' HB2' ' O ' ' A' ' 73' ' ' THR . 17.2 p -143.15 149.26 37.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.33 0.586 . . . . 0.0 111.12 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.567 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 7.0 pt20 -105.46 166.88 10.12 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.493 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 26.0 t -85.31 106.6 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.122 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 21.8 p -113.07 83.05 1.76 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.13 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 95' ' ' THR . 0.0 OUTLIER 105.55 48.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.853 -179.662 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -33.63 126.2 0.4 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.853 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.408 HG22 ' CA ' ' A' ' 46' ' ' PHE . 10.0 p -71.76 112.5 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.98 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.2 mp -72.1 126.79 33.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.021 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -87.32 133.44 33.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.814 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -67.33 150.02 49.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.955 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.24 100.51 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.069 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.0 m -119.08 106.76 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.014 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -94.46 109.86 21.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.5 m -105.27 141.0 21.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.138 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.21 147.7 50.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.535 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -175.23 82.19 0.31 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.712 0.291 . . . . 0.0 111.037 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.1 110.86 2.52 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.557 2.171 . . . . 0.0 112.357 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.1 m -128.65 -46.05 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.068 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.6 t -145.7 171.95 13.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.874 179.884 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.8 mtm . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.844 0.354 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.61 41.21 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.426 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 p -68.96 -32.55 72.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.744 0.307 . . . . 0.0 110.899 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 m -104.79 96.85 6.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -103.95 -31.73 9.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.953 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 60.62 158.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -78.59 128.8 34.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.888 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -89.55 99.87 12.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.407 ' CE1' ' HG3' ' A' ' 26' ' ' GLU . 34.3 m170 -82.72 -74.32 0.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.947 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.05 136.92 32.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.6 p -89.6 94.9 10.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.958 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 141.69 -136.46 7.39 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.487 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.4 mt -143.71 98.71 3.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.838 0.351 . . . . 0.0 110.922 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.0 m -107.31 150.03 39.48 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.195 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.93 130.28 18.86 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.544 2.163 . . . . 0.0 112.267 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -176.43 -46.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.839 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.41 -156.61 24.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.411 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.43 89.91 1.3 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.87 0.367 . . . . 0.0 110.88 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -156.83 107.03 2.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.9 mtm -77.37 98.32 5.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.5 p -132.55 -52.52 0.94 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 pp -94.29 -38.32 11.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.899 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.89 -175.0 0.57 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -101.1 -31.13 11.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.865 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 60.76 105.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.882 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.407 ' HG3' ' CE1' ' A' ' 9' ' ' HIS . 51.2 tt0 -154.08 151.74 29.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.4 m -134.25 83.59 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.102 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -174.2 36.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.122 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -108.94 32.11 5.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.141 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.8 m120 60.67 99.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.838 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.2 t -71.26 138.85 20.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.102 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -131.51 31.51 4.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.0 m -163.91 142.75 7.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.78 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 61.22 155.18 0.11 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.974 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.22 -46.07 1.61 Allowed 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.542 2.162 . . . . 0.0 112.287 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -170.52 128.65 0.82 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.861 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.1 mt -84.09 123.34 29.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.986 0.422 . . . . 0.0 111.069 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.589 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 1.1 pp -101.08 -176.37 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.202 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.475 ' HB ' ' CG2' ' A' ' 73' ' ' THR . 1.8 p -157.34 142.8 17.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.318 0.58 . . . . 0.0 110.901 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.418 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 2.6 ptp85 -162.59 107.33 1.15 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.206 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 15.4 t -82.28 129.86 34.96 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.768 0.794 . . . . 0.0 111.604 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.486 ' O ' HD11 ' A' ' 44' ' ' ILE . 0.6 OUTLIER -98.29 146.3 25.8 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.678 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -66.81 94.83 0.33 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.952 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.595 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 3.2 mp -87.07 109.88 28.53 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.949 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.4 ' C ' HG21 ' A' ' 98' ' ' VAL . 6.3 Cg_exo -78.65 152.91 26.18 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.843 2.362 . . . . 0.0 112.563 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.459 ' HB3' ' CG2' ' A' ' 98' ' ' VAL . 52.6 p90 -86.68 -178.58 6.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -138.83 111.67 7.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.961 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.2 t -67.45 141.95 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.079 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.3 mt -130.42 156.07 42.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.103 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -131.98 100.84 5.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -95.02 171.88 8.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -111.56 139.97 46.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -138.48 110.13 8.15 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.85 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.77 -26.15 38.99 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.409 2.072 . . . . 0.0 112.378 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.74 -32.91 71.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.1 mp -65.17 165.13 18.17 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.877 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -86.95 32.17 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.914 2.409 . . . . 0.0 112.808 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.86 142.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.874 0.368 . . . . 0.0 111.167 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.42 27.82 61.28 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.03 141.91 40.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.747 0.308 . . . . 0.0 110.951 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -136.81 124.73 22.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.904 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -130.55 142.08 50.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.418 HG21 HD11 ' A' ' 63' ' ' ILE . 30.9 mm -94.23 94.34 4.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.097 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.1 mm -73.63 -32.86 37.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.824 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 m -164.62 84.96 0.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.6 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.38 132.63 29.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.505 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.444 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -59.68 131.26 50.77 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.327 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.66 135.52 60.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.389 . . . . 0.0 111.115 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.6 mttp -61.36 116.81 4.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.139 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 98' ' ' VAL . . . -88.46 -149.22 18.44 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.871 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.473 ' CB ' ' HB3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -163.23 146.31 10.45 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.314 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.595 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 19.0 ttp85 -139.67 111.35 7.25 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.735 ' O ' ' HB2' ' A' ' 92' ' ' SER . 91.3 m -73.41 125.16 27.25 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.473 ' HA ' ' HB2' ' A' ' 92' ' ' SER . 13.9 m80 -106.14 119.05 38.22 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 122.185 0.993 . . . . 0.0 113.1 -176.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.676 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -90.34 98.85 12.02 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 113.437 -1.71 . . . . 0.0 111.459 -177.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.5 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.4 mp -87.56 143.45 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.027 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.3 m -89.72 122.26 32.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.708 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.35 98.35 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.111 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.3 tp -112.21 126.51 55.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.863 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 m -89.06 119.58 29.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.93 95.54 4.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.852 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 60.38 36.41 20.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.851 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.82 28.43 26.32 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.426 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.7 127.11 36.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.795 0.331 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.15 102.39 13.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -68.63 135.85 52.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.62 84.9 2.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 88.0 m -132.7 130.23 39.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.884 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 76' ' ' ILE . 12.8 p -85.39 140.37 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.29 2.15 3.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.862 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.464 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.3 OUTLIER 179.96 117.87 0.05 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.9 0.381 . . . . 0.0 111.785 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.735 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.9 p -143.24 134.59 26.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.232 0.539 . . . . 0.0 110.708 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.634 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 5.3 mt-30 -89.72 166.5 13.54 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.424 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 22.9 t -85.5 107.48 16.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.925 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 20.3 p -111.2 82.95 1.68 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.024 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 95' ' ' THR . 7.9 tptm 103.48 41.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.614 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 96' ' ' LYS . 6.6 tm-20 -29.18 130.54 0.07 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.134 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.459 ' CG2' ' HB3' ' A' ' 46' ' ' PHE . 4.9 p -71.76 126.02 31.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.164 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 29.7 mm -88.33 129.68 39.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.055 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -91.95 146.71 23.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.815 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.34 139.39 57.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.4 t -127.67 99.69 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.084 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.22 137.43 53.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -104.56 132.26 51.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.79 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.48 120.43 53.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.133 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.32 119.34 9.32 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.416 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -126.41 153.63 74.92 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.724 0.297 . . . . 0.0 111.064 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.12 -168.37 0.29 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.547 2.164 . . . . 0.0 112.33 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.0 p -61.57 131.15 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.009 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.2 t -141.98 140.36 32.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.824 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.892 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.1 ttm . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.897 0.379 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -170.44 73.65 0.11 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.52 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 p -132.07 116.21 16.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 0.0 110.857 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.8 t -176.65 -40.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.939 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -121.63 99.14 6.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.405 ' O ' ' CG ' ' A' ' 7' ' ' HIS . 18.8 m-70 -107.46 -75.13 0.64 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.405 ' CG ' ' O ' ' A' ' 6' ' ' HIS . 95.0 m-70 -157.19 30.1 0.29 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.943 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 58.87 31.35 21.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.953 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -69.39 83.49 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.8 t 60.28 166.31 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.3 m -124.9 84.92 2.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.03 64.13 0.36 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.475 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.89 81.48 8.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.829 0.347 . . . . 0.0 110.903 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.6 p -59.49 136.35 89.13 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.54 148.35 59.85 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.446 2.097 . . . . 0.0 112.35 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -31.25 68.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.853 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.64 -138.43 4.93 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.562 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.4 m -106.87 162.9 13.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.797 0.332 . . . . 0.0 110.894 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -70.41 -173.66 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.797 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.7 mtp -128.02 -65.54 0.9 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.842 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 m -82.2 -53.44 6.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.35 -70.38 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.956 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.4 t70 61.52 154.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.72 85.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -105.55 79.86 1.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -106.48 169.53 8.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.1 p -66.54 116.19 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.169 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.29 109.06 14.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.064 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.19 89.07 2.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.112 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -134.23 31.56 3.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.5 m -82.27 -30.76 9.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.187 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.73 175.83 12.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.925 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.8 t -116.98 -39.71 3.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.942 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? -147.62 160.27 39.06 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.24 -42.91 26.03 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.544 2.162 . . . . 0.0 112.42 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -164.14 123.74 2.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.855 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 71.4 mt -95.5 124.36 39.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 111.126 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 5.0 pt -101.01 -177.38 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.654 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 0.7 OUTLIER -156.9 154.6 30.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.538 0.685 . . . . 0.0 111.809 -179.081 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.718 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 54.8 ttp180 -170.97 120.32 0.53 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 5.6 t -81.78 140.53 34.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.999 0.904 . . . . 0.0 112.68 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.443 ' HG2' ' CD2' ' A' ' 74' ' ' HIS . 6.8 mm-40 -98.66 139.27 34.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.123 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.97 91.59 0.21 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.966 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.497 HD12 ' CD ' ' A' ' 72' ' ' ARG . 6.7 mt -96.11 104.7 17.92 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.986 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -84.78 160.5 12.14 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.785 2.323 . . . . 0.0 113.248 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.474 ' CD2' ' HA3' ' A' ' 67' ' ' GLY . 54.1 p90 -87.15 -174.13 4.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.081 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -152.78 110.26 3.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.842 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.3 t -67.01 148.05 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.17 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.5 mt -124.02 156.18 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.152 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -122.96 100.82 7.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.841 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.9 162.97 13.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -94.63 114.51 26.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.906 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -100.91 96.47 5.66 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.2 -26.75 49.25 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.475 2.117 . . . . 0.0 112.288 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -66.86 -31.22 71.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.92 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.3 mt -74.64 163.32 69.07 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -86.83 31.47 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.888 2.392 . . . . 0.0 112.923 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.15 122.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.83 0.348 . . . . 0.0 111.26 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.19 -26.69 19.99 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.582 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -66.78 136.4 55.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 0.0 110.871 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -129.34 114.27 16.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.816 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -109.25 130.06 55.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.417 HG21 HD11 ' A' ' 63' ' ' ILE . 31.2 mm -92.2 86.11 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.3 mp -65.3 -44.06 94.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.956 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.8 m -151.95 93.79 1.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.599 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.18 144.02 10.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.567 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.474 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -77.01 127.6 8.54 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.424 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.46 125.61 37.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.879 0.371 . . . . 0.0 110.985 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.68 113.48 2.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.354 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.8 -146.06 3.17 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.637 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.599 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.1 OUTLIER -177.56 109.88 0.07 Allowed 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.798 ' HB2' ' HA ' ' A' ' 94' ' ' VAL . 0.9 OUTLIER -102.84 138.42 39.75 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.226 -179.621 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.656 ' O ' ' HB3' ' A' ' 92' ' ' SER . 87.7 m -75.6 140.51 42.68 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.525 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.718 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 2.0 m-70 -118.94 118.42 31.47 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.541 0.686 . . . . 0.0 112.082 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.722 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -91.23 118.82 30.79 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.203 -177.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.46 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 2.5 mp -108.69 160.3 7.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.962 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.78 127.37 48.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.895 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.28 98.36 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.3 mt -112.64 111.85 22.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.899 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.62 96.6 6.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -113.72 122.31 46.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.954 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 60.46 34.81 20.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.15 42.34 67.46 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.486 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.87 141.04 17.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.344 . . . . 0.0 110.875 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.37 112.89 25.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.941 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.83 122.98 38.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.839 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -86.66 89.13 7.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.83 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.3 t -103.15 132.75 49.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.934 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.3 m -52.32 124.87 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.121 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.06 -66.83 1.04 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.062 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.515 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -170.87 143.51 2.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.283 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.656 ' HB3' ' O ' ' A' ' 73' ' ' THR . 1.0 OUTLIER -143.4 165.29 27.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.407 0.623 . . . . 0.0 110.846 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.603 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 8.1 pt20 -129.31 166.84 18.69 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.096 -0.957 . . . . 0.0 108.661 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.798 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.1 p -85.69 106.84 15.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.599 ' O ' ' O ' ' A' ' 71' ' ' GLU . 7.2 p -117.12 81.0 1.57 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.35 0.595 . . . . 0.0 110.652 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.485 ' CB ' ' O ' ' A' ' 95' ' ' THR . 3.1 tptm 149.44 -30.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.273 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 58.35 107.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.818 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.419 HG21 ' CA ' ' A' ' 46' ' ' PHE . 6.8 p -71.48 109.76 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.029 0.442 . . . . 0.0 110.085 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.3 mm -63.98 123.69 17.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.853 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -91.93 135.62 33.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.886 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -68.5 99.38 0.96 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.8 t -91.68 99.75 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.009 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.4 m -128.48 127.21 66.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.162 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -108.68 108.49 19.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.811 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.38 142.54 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.134 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.52 142.15 43.61 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.522 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -175.82 87.83 0.29 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.702 0.287 . . . . 0.0 111.057 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.22 108.69 2.22 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.622 2.215 . . . . 0.0 112.265 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.2 m -80.9 170.01 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.164 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 t -157.86 80.63 0.86 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.918 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.4 p80 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.864 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 mmt . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.795 0.331 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 150.01 45.34 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.521 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.2 m -169.32 137.26 1.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.855 0.359 . . . . 0.0 110.883 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.1 m -93.41 -75.08 0.51 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.93 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 59.95 44.75 13.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.899 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.0 m170 -59.76 -75.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.966 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 59.85 79.17 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -113.16 35.62 3.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.945 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -107.8 144.53 34.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.907 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.88 86.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.8 t -131.41 123.09 27.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.926 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.79 49.14 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.52 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tp -96.15 -34.22 11.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.798 0.333 . . . . 0.0 110.869 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.3 p -178.68 88.24 0.22 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.055 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.48 141.26 45.89 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.546 2.164 . . . . 0.0 112.302 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 tpp85 68.15 -69.77 0.14 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.993 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 57.84 54.48 37.08 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.542 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.1 m 60.99 41.81 13.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.34 . . . . 0.0 110.835 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.5 t60 61.19 52.42 3.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.0 mpp? 60.73 177.02 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.956 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 p -126.59 151.26 48.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.853 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 60.57 32.01 20.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.935 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -170.52 126.54 0.76 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.79 151.75 7.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.931 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -62.84 -62.77 1.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -176.55 88.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.44 -45.15 79.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.056 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -177.24 -69.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.057 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -171.53 -41.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.122 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 60.2 75.73 0.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.0 m -142.94 -47.17 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 67.26 -72.78 0.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.0 p -146.18 126.68 14.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.997 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.4 ttt85 -143.43 139.84 16.91 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.97 151.01 78.28 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.456 2.104 . . . . 0.0 112.265 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -81.01 -179.07 7.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.771 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mp -104.4 113.92 27.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.058 0.456 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.679 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -101.3 -176.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.815 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 1.2 p -152.57 139.78 19.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.207 0.527 . . . . 0.0 110.892 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.509 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 17.5 tpt180 -158.65 102.94 1.72 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.085 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 8.0 t -81.96 129.23 34.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.571 0.701 . . . . 0.0 111.496 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.455 ' O ' HD12 ' A' ' 44' ' ' ILE . 0.6 OUTLIER -98.46 144.18 28.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.941 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.97 91.68 0.21 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.638 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.583 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 3.0 mp -87.2 110.17 31.28 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.03 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -86.03 153.68 9.75 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.725 2.283 . . . . 0.0 112.751 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.424 ' HB3' ' CG2' ' A' ' 98' ' ' VAL . 42.7 p90 -87.17 -174.27 4.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.846 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -159.04 118.42 3.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.936 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.49 152.53 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.013 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.66 156.16 42.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.13 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm -128.25 100.86 6.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -101.86 170.35 8.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -109.62 120.34 42.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.954 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -114.16 96.39 42.08 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.843 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.36 60.42 2.59 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.51 2.14 . . . . 0.0 112.408 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.92 27.23 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.026 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mp -130.55 176.53 2.8 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.776 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.27 30.22 0.53 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.176 2.584 . . . . 0.0 112.869 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.2 136.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.91 0.386 . . . . 0.0 111.484 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.9 29.33 67.51 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.734 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -109.39 112.07 23.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.799 0.333 . . . . 0.0 110.762 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.56 143.41 33.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.972 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -135.72 130.05 33.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.0 mm -85.68 86.12 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.164 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.6 mt -71.2 -43.46 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.07 91.93 1.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.613 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.85 154.47 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.522 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.406 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -84.74 129.63 9.33 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.414 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.45 126.96 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.761 0.315 . . . . 0.0 111.075 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -57.37 127.95 34.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.146 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -101.97 -143.44 13.52 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.079 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.533 ' N ' ' HB3' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -166.97 144.05 4.67 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.583 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 42.1 ttt180 -135.98 111.52 9.25 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.686 ' O ' ' HB2' ' A' ' 92' ' ' SER . 62.0 m -73.84 126.82 31.27 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.509 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 13.3 m80 -107.21 119.87 40.56 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 122.068 0.937 . . . . 0.0 112.921 -176.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.683 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -91.36 99.59 12.52 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 113.541 -1.663 . . . . 0.0 111.391 -177.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.482 ' HB ' ' CG2' ' A' ' 38' ' ' ILE . 2.5 mp -87.58 159.71 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.847 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 77.6 p -108.53 105.38 14.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.775 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.8 m -81.43 98.33 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.225 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.6 tt -108.08 116.4 31.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.7 t -81.9 112.17 18.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -116.05 113.27 22.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 60.17 31.83 20.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.894 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.82 44.54 10.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.432 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.77 119.7 4.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.773 0.32 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.84 123.03 32.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.4 150.16 29.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.852 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -97.52 113.8 25.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 94.8 m -133.59 118.05 17.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.931 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.9 p -54.03 125.37 8.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.978 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.83 -53.46 2.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.267 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.521 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -176.68 141.01 0.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.316 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.686 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.6 p -143.67 150.99 39.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.367 0.603 . . . . 0.0 111.32 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.621 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 23.1 mm-40 -110.74 166.53 10.94 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.504 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 6.2 m -85.26 106.64 15.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.054 -178.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.568 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 15.9 p -110.72 82.6 1.62 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.689 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 95' ' ' THR . 26.2 tptp 131.92 -26.96 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.015 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 96' ' ' LYS . 17.9 pt-20 44.56 111.47 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.424 ' CG2' ' HB3' ' A' ' 46' ' ' PHE . 8.2 p -71.88 115.77 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.874 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.5 mm -74.04 128.96 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.068 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -95.14 139.41 31.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.978 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -77.63 100.34 6.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.817 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.4 m -100.59 109.28 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.0 p -123.19 118.38 54.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -87.16 121.01 29.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.832 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.95 128.51 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.209 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.62 130.64 50.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.503 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -138.99 91.01 11.74 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.626 0.251 . . . . 0.0 111.008 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.49 -167.79 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.473 2.115 . . . . 0.0 112.308 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.49 131.59 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.249 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.96 -172.58 4.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 13.7 m80 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.888 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 tpp . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.869 0.366 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 106.14 -173.2 19.61 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.479 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 p -138.78 50.64 1.84 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.1 34.25 19.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 60.41 51.67 5.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 60.86 83.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.3 171.83 14.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -126.06 31.28 5.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -176.64 -170.25 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.0 t -129.72 95.67 4.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 p -176.05 165.63 2.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.834 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.95 -73.21 0.85 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.446 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -60.23 -165.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.668 0.271 . . . . 0.0 110.819 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.472 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 42.8 t -56.73 -58.11 19.5 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.635 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 17.9 Cg_endo -58.96 84.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.265 1.976 . . . . 0.0 112.211 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.8 ttt-85 -117.92 135.49 54.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.81 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -165.66 -132.66 1.4 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.44 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 m -130.16 -169.75 2.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.808 0.337 . . . . 0.0 110.885 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -59.93 -31.51 69.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.7 mtm -77.46 -74.4 0.25 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.896 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.3 31.62 20.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.1 mp -74.56 -177.83 3.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -98.38 35.51 1.78 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.869 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -99.1 -33.76 10.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -68.27 121.93 17.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.911 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -68.63 168.48 13.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.941 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.35 -41.37 29.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.193 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.46 124.25 34.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.106 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.15 -75.69 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.108 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -81.83 -74.98 0.31 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.898 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.7 t -151.83 -67.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.051 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 57.39 32.3 21.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.991 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 m -163.92 104.82 0.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.93 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.643 ' N ' ' CD ' ' A' ' 35' ' ' PRO . 2.7 ptm180 -79.43 -30.48 0.64 Allowed Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.014 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 34' ' ' ARG . 90.8 Cg_endo -85.56 -167.45 0.4 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.087 1.858 . . . . 0.0 112.329 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.57 129.65 36.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.817 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mt -74.21 114.98 13.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.09 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.654 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -101.38 -176.57 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.095 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.494 ' HB ' ' CG2' ' A' ' 73' ' ' THR . 1.4 p -152.19 136.73 16.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.226 0.536 . . . . 0.0 111.223 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.551 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 10.0 mmm-85 -150.1 103.13 3.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.403 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.402 HG21 ' N ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -82.17 124.8 30.21 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.602 0.715 . . . . 0.0 111.163 -178.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.501 ' O ' HD12 ' A' ' 44' ' ' ILE . 3.4 mt-10 -98.29 147.94 24.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.958 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -66.92 101.42 0.84 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.83 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.563 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.4 mp -106.66 91.42 6.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.847 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.49 161.83 28.05 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.74 2.294 . . . . 0.0 112.799 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.447 ' CD2' ' HA3' ' A' ' 67' ' ' GLY . 49.5 p90 -87.37 176.62 7.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.147 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -147.24 109.38 4.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.971 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.6 t -67.13 153.95 8.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.073 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.94 156.14 33.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.122 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.11 100.81 6.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.831 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.1 mtmt -97.7 171.87 8.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.945 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -109.88 104.77 13.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -110.31 96.51 26.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.78 -18.7 53.26 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.492 2.128 . . . . 0.0 112.593 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -54.78 -29.74 54.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.882 0.372 . . . . 0.0 111.008 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.401 ' HB3' ' CD ' ' A' ' 57' ' ' PRO . 6.2 mp -83.24 175.06 5.12 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.741 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.401 ' CD ' ' HB3' ' A' ' 56' ' ' LEU . 1.8 Cg_endo -82.55 28.33 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.094 2.529 . . . . 0.0 112.979 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.1 123.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.883 0.373 . . . . 0.0 111.55 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.18 -23.28 32.28 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.83 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.47 123.54 22.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.879 0.371 . . . . 0.0 110.956 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -114.44 115.85 27.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -119.04 123.96 45.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.836 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 22.1 mt -85.76 131.42 34.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.019 0.437 . . . . 0.0 111.115 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.8 mm -94.07 -46.78 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.767 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' A' ' 65' ' ' THR . 15.3 t -149.13 97.85 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.516 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.19 126.64 7.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.815 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.447 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -66.25 132.35 33.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.168 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.7 t -131.22 138.83 52.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.954 0.407 . . . . 0.0 111.065 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -66.27 130.8 44.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.406 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -109.42 -148.99 12.83 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.47 ' N ' ' CB ' ' A' ' 96' ' ' LYS . 0.6 OUTLIER -166.69 156.71 11.61 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 4.8 ttt180 -140.14 112.49 7.8 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.674 ' O ' ' HB3' ' A' ' 92' ' ' SER . 86.3 m -73.85 127.32 32.54 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.551 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 20.8 m80 -106.26 117.26 33.59 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.261 1.029 . . . . 0.0 113.055 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.662 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -89.12 102.14 14.8 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 113.433 -1.712 . . . . 0.0 110.921 -177.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.455 ' HB ' ' CD1' ' A' ' 38' ' ' ILE . 2.5 mp -87.66 160.7 2.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.891 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.416 ' N ' ' CG2' ' A' ' 76' ' ' ILE . 74.9 m -110.62 127.89 55.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.834 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.38 103.72 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.196 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mt -125.06 88.66 2.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.818 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.22 146.2 39.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.846 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -153.97 126.89 8.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.908 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 60.4 35.9 20.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.956 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.28 48.69 57.17 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.531 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.7 ttpt -159.69 107.5 1.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.837 0.351 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.81 129.9 37.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.5 m -115.39 151.06 35.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.54 112.75 23.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 96.7 m -133.99 126.65 30.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.901 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.0 p -55.61 148.96 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.991 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.86 -50.89 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.26 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.524 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -158.3 126.63 5.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.321 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.674 ' HB3' ' O ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -143.4 144.25 31.97 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.4 0.619 . . . . 0.0 111.417 179.133 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.568 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 5.4 mt-30 -106.25 165.46 11.23 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.536 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 8.8 p -86.15 106.63 15.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.473 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.476 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 7.2 p -111.71 82.01 1.55 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.568 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' A' ' 95' ' ' THR . 0.0 OUTLIER 148.29 -33.39 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.296 179.087 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 53.33 109.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.892 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.444 HG22 ' HA ' ' A' ' 46' ' ' PHE . 9.4 p -80.7 102.75 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.481 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.2 mp -64.35 123.92 18.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.056 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -89.44 133.85 34.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.673 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 65' ' ' THR . 5.4 tt0 -67.05 125.33 25.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.948 0.404 . . . . 0.0 110.98 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.417 ' CG2' ' CG2' ' A' ' 65' ' ' THR . 60.9 t -113.37 99.71 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.678 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.68 154.71 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -133.22 108.36 8.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.77 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.8 t -101.04 136.56 32.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.172 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.03 148.6 35.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.489 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.75 148.47 19.36 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.721 0.296 . . . . 0.0 111.206 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.23 171.46 15.97 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.501 2.134 . . . . 0.0 112.313 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.6 t -112.5 -35.17 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.072 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.78 -175.65 4.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.842 179.939 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ttm . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.805 0.336 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 143.03 45.26 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.452 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.37 -78.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 110.969 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.24 31.55 20.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.936 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -176.57 115.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.892 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -74.84 176.48 7.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.964 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -64.31 114.24 4.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.921 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -135.29 -176.49 4.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.919 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -60.21 94.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.7 t -126.87 79.45 1.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.914 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.59 165.42 2.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.825 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 146.39 -165.83 28.22 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.447 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tt -83.87 -31.61 25.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.77 0.319 . . . . 0.0 110.87 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 m -130.36 151.0 77.78 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.116 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.19 -39.52 5.61 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.573 2.182 . . . . 0.0 112.297 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 -130.19 174.18 10.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.866 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.55 53.62 4.09 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.499 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.3 p -107.71 33.54 4.01 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.809 0.338 . . . . 0.0 110.945 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 60.19 -168.78 0.16 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.1 mtt -128.92 89.01 2.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.933 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -176.53 -45.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.5 tp -107.98 120.95 43.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.971 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -161.41 -69.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.931 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 63.9 -79.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.966 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -107.13 -62.12 1.45 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 0.0 110.912 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 61.02 33.32 19.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.905 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.6 m -156.9 177.1 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.077 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.86 93.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.102 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.92 -75.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.08 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 t30 60.44 -175.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.3 t -115.9 32.61 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.074 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -127.92 32.65 4.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.925 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.65 49.08 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.004 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 62.05 151.55 0.1 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.844 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.57 -68.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.496 2.13 . . . . 0.0 112.399 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -170.65 147.18 2.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.79 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.5 mp -104.36 116.59 32.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.95 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.549 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 5.7 pt -101.27 -177.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.363 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.655 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 0.5 OUTLIER -158.58 154.48 26.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.372 0.606 . . . . 0.0 111.077 -179.209 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.541 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 13.1 ttm180 -169.26 126.08 0.92 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.647 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 16.1 p -81.89 136.08 35.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 122.006 0.908 . . . . 0.0 112.547 -177.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -98.23 142.61 29.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.097 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.78 94.21 0.3 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.671 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.489 ' CD1' ' HG2' ' A' ' 72' ' ' ARG . 6.9 mt -101.66 98.02 8.84 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.777 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.51 157.81 28.83 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.772 2.315 . . . . 0.0 113.176 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.455 ' CE2' ' HA3' ' A' ' 67' ' ' GLY . 45.6 p90 -86.87 -173.93 4.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.105 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.43 102.95 4.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.756 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.421 ' CB ' ' HB3' ' A' ' 101' ' ' GLN . 8.8 p -66.93 146.47 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.148 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.2 mm -125.19 156.19 34.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.179 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -120.42 100.86 7.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.767 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.63 145.13 24.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -114.73 102.61 10.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.44 140.09 26.95 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.913 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -78.13 -19.88 11.81 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.601 2.201 . . . . 0.0 112.538 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -52.34 -30.26 27.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.116 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mp -82.7 169.1 19.09 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.798 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.19 31.23 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.316 2.678 . . . . 0.0 112.874 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 63.18 138.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.899 0.38 . . . . 0.0 111.279 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.02 36.35 80.78 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.603 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -109.51 145.65 35.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.878 0.37 . . . . 0.0 110.935 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.7 113.94 19.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.821 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -118.87 119.12 33.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.928 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.408 HD12 HG21 ' A' ' 63' ' ' ILE . 30.1 mm -85.71 92.76 3.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.7 mt -76.55 -44.9 34.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.88 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.54 91.49 1.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.801 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.9 143.18 3.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.791 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.455 ' HA3' ' CE2' ' A' ' 46' ' ' PHE . . . -91.31 129.63 9.9 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.248 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.0 131.11 41.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.966 0.412 . . . . 0.0 111.156 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.12 112.78 3.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.159 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.55 -144.29 1.24 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.762 -0.733 . . . . 0.0 111.717 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.68 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 7.7 tt0 -177.55 109.29 0.07 Allowed 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.791 ' HB2' ' HA ' ' A' ' 94' ' ' VAL . 0.4 OUTLIER -98.4 138.43 35.65 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.229 0.538 . . . . 0.0 110.448 -179.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.563 ' O ' ' HB2' ' A' ' 92' ' ' SER . 52.0 m -75.55 135.81 40.58 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.729 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.655 ' O ' ' HA ' ' A' ' 39' ' ' THR . 6.5 m80 -116.08 121.83 43.34 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.74 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.708 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -91.93 113.34 25.59 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.772 -178.095 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.474 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 2.1 mp -97.13 143.56 12.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.02 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.9 t -96.01 105.53 17.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.78 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.55 105.27 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.9 tp -97.11 88.66 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.844 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.58 123.66 21.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.965 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -143.65 105.92 4.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 65.16 26.88 12.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.094 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.78 41.44 7.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.819 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.54 122.72 15.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.908 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -101.26 105.5 16.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.8 p -87.11 99.88 12.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -74.8 98.75 3.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 92.1 m -129.66 125.36 35.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 p -51.18 136.84 10.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.022 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.6 -72.66 0.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.343 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.493 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 3.6 t0 -137.96 138.2 38.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.349 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.563 ' HB2' ' O ' ' A' ' 73' ' ' THR . 29.0 p -143.24 165.62 26.95 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.66 0.743 . . . . 0.0 111.395 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.673 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 36.0 mm-40 -130.03 166.45 20.1 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.153 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.791 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 17.2 t -86.2 105.75 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.554 ' O ' ' O ' ' A' ' 71' ' ' GLU . 11.6 p -121.43 80.97 1.73 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.551 0.691 . . . . 0.0 110.889 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.68 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 155.3 -31.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.731 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 62.4 101.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.819 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.424 HG21 ' CA ' ' A' ' 46' ' ' PHE . 6.6 p -71.43 103.75 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.144 0.497 . . . . 0.0 110.12 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.9 mm -63.92 131.05 29.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.222 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -98.86 139.67 34.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.002 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.421 ' HB3' ' CB ' ' A' ' 48' ' ' VAL . 3.0 tp-100 -75.04 103.92 5.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.921 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.29 99.73 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.985 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.1 p -123.12 148.37 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.194 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -111.17 142.02 43.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.816 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.32 136.56 57.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.141 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -73.87 102.05 1.28 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.468 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 61.77 151.12 0.1 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.75 0.31 . . . . 0.0 111.141 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.09 -168.42 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.639 2.226 . . . . 0.0 112.329 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.53 -30.89 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.122 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.8 t -92.55 -39.34 11.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.927 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 10.8 m80 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.913 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 mtm . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.744 0.306 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.67 -28.89 11.58 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.496 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.1 p -89.15 -169.82 2.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.902 0.382 . . . . 0.0 110.873 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.3 t 61.3 113.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.852 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -59.96 -176.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.924 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -59.76 149.52 30.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.88 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -60.1 172.85 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.976 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -133.71 -176.2 4.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.958 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -98.15 32.51 2.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.0 m -129.82 106.44 8.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.94 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 p -165.4 163.57 19.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.929 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -145.47 -174.69 17.9 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.559 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.9 tp -142.78 -47.37 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.842 0.353 . . . . 0.0 110.862 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.456 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 11.6 t -58.63 -48.69 96.41 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.492 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 72.8 Cg_endo -77.45 -168.33 0.58 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.242 1.962 . . . . 0.0 112.356 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.11 150.83 28.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.855 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.95 48.5 0.94 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.543 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.7 p -129.33 179.54 5.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.807 0.337 . . . . 0.0 110.92 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -151.44 152.53 33.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.849 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.0 ttt -93.08 141.34 28.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.985 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.3 p -78.81 -37.05 41.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.2 tp -81.24 85.05 6.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -153.61 82.49 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.948 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -103.76 90.63 3.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.888 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -76.13 116.2 16.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.88 125.07 25.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.91 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.07 82.64 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 59.64 -173.1 0.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.079 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.11 -75.55 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.119 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 60.07 -176.36 0.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.937 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 m -73.03 79.45 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.123 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -106.91 179.16 4.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.845 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.1 p -158.92 85.78 0.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.974 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -83.81 165.45 39.48 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.717 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.55 160.53 48.11 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.481 2.12 . . . . 0.0 112.301 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -73.86 168.25 19.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.9 mt -92.52 106.37 18.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.963 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.618 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 1.0 OUTLIER -101.3 -176.49 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.445 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.457 HG22 ' CD1' ' A' ' 75' ' ' TYR . 1.0 OUTLIER -152.41 147.85 26.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.281 0.562 . . . . 0.0 110.729 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 74' ' ' HIS . 16.9 ttp180 -164.18 100.62 0.85 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.893 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 15.2 t -81.93 132.19 35.26 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.831 0.824 . . . . 0.0 111.364 -178.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -98.11 145.17 26.83 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.149 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.22 99.11 0.5 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.337 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.52 HD11 ' N ' ' A' ' 72' ' ' ARG . 6.4 mt -105.09 92.6 5.56 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.302 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.32 164.37 26.65 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.818 2.345 . . . . 0.0 112.855 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.458 ' CD1' ' HA3' ' A' ' 67' ' ' GLY . 35.2 p90 -87.28 175.04 8.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.102 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -143.04 108.85 5.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.995 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 101' ' ' GLN . 10.3 t -67.1 154.05 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.22 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -140.71 156.09 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.069 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -110.35 108.62 18.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.98 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.92 118.06 35.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.953 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -77.09 104.69 7.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.985 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -106.12 139.79 20.63 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.11 -29.21 6.75 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.58 2.187 . . . . 0.0 112.406 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -57.54 -44.14 84.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mt -59.76 168.28 2.07 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.93 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -86.31 30.12 0.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.268 2.645 . . . . 0.0 112.69 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 57.73 105.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 0.0 111.315 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.85 -24.18 27.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.784 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.55 144.06 28.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.868 0.366 . . . . 0.0 110.973 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -124.08 173.7 8.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.818 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.8 p30 -154.84 147.75 24.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.9 mm -97.76 86.08 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.106 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.4 mm -74.36 -32.74 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.964 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -161.74 83.83 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.523 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.54 151.64 0.54 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.718 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.458 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -79.43 132.57 11.54 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.192 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.9 t -124.51 131.67 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.844 0.354 . . . . 0.0 111.311 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -64.53 118.88 9.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.347 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -107.14 -151.9 18.09 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.597 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.497 ' N ' ' CB ' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -174.42 156.75 2.55 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.256 0.55 . . . . 0.0 109.992 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.575 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 41.4 ttt180 -133.75 113.95 12.88 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.642 ' O ' ' HB2' ' A' ' 92' ' ' SER . 53.0 m -74.06 123.31 24.13 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.452 ' HA ' ' CB ' ' A' ' 92' ' ' SER . 16.6 m80 -104.81 120.82 42.32 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.146 0.975 . . . . 0.0 113.085 -177.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.655 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -89.41 98.14 11.6 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 113.648 -1.615 . . . . 0.0 111.169 -177.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.481 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.5 mp -87.48 158.55 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.89 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.412 ' N ' ' CG2' ' A' ' 76' ' ' ILE . 0.9 OUTLIER -101.65 108.3 19.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.727 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.2 m -81.6 98.25 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.146 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -117.37 108.9 16.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.975 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.5 m -79.71 124.64 28.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.851 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.21 118.49 21.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 60.36 31.93 20.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.954 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.3 38.96 20.38 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.594 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.62 116.62 4.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.51 119.59 31.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.8 m -101.19 148.4 25.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -109.6 103.44 12.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.852 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.0 t -119.09 116.8 27.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 p -57.19 139.28 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 16.2 mt -130.63 -68.4 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.264 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.45 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 1.3 t70 -137.8 134.34 35.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 111.4 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.642 ' HB2' ' O ' ' A' ' 73' ' ' THR . 18.7 p -143.35 160.62 40.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.027 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.608 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 5.8 pt20 -120.97 165.58 15.04 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.57 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 28.9 m -86.39 106.08 15.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.945 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.497 HG22 ' HB ' ' A' ' 73' ' ' THR . 15.4 p -114.84 81.86 1.64 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.684 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.497 ' CB ' ' N ' ' A' ' 71' ' ' GLU . 6.6 mmmt 146.46 -33.16 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.534 178.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 49.96 106.2 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.858 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.432 HG22 ' HA ' ' A' ' 46' ' ' PHE . 11.8 p -79.92 102.8 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.075 0.465 . . . . 0.0 110.719 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.402 HG22 HD13 ' A' ' 99' ' ' ILE . 27.0 mt -66.55 131.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.185 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -87.7 139.96 30.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.401 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 6.1 tt0 -75.55 103.81 5.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -85.9 99.75 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.012 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.89 110.57 30.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.1 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -96.24 108.55 21.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.8 p -100.7 150.65 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.027 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.48 145.53 31.8 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.486 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.53 108.36 1.16 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.505 0.193 . . . . 0.0 111.161 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.68 -46.5 1.76 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.44 2.093 . . . . 0.0 112.365 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 m -158.1 178.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.205 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.69 79.34 0.94 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.835 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.9 t60 . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.851 -179.968 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttm . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.818 0.342 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.13 43.88 2.37 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.558 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.0 t -133.45 -52.88 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.981 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.6 m -64.07 -61.82 2.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.861 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -125.92 79.84 1.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -101.58 132.04 47.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.983 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -167.26 -43.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -130.23 106.13 8.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.845 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -176.38 104.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.7 t 60.6 31.56 20.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.67 -175.47 4.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.857 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.99 47.2 2.69 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.537 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.9 mt 60.26 106.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.745 0.307 . . . . 0.0 110.967 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.9 m 41.69 66.19 4.09 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.77 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.37 116.44 4.52 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.495 2.13 . . . . 0.0 112.262 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.2 155.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -173.94 65.6 0.11 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.48 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 m -161.83 177.95 9.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -78.8 -76.66 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.835 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 82.4 mmm -155.89 30.38 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 m 59.53 98.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.954 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -115.91 36.69 3.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -121.14 166.93 13.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -176.9 -173.58 0.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.931 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 62.52 27.01 16.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.05 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 55.69 98.84 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.035 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.5 m -156.58 170.58 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.169 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -159.69 77.4 0.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.034 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.61 171.62 13.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.055 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -110.44 -74.62 0.64 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.6 m -147.82 134.45 13.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -40.05 85.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.6 t 44.53 41.41 4.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.42 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.66 136.83 89.77 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.39 -167.23 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.482 2.121 . . . . 0.0 112.274 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -83.84 116.37 22.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.71 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.4 mt -71.0 115.61 10.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.971 0.415 . . . . 0.0 111.123 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.602 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -101.26 -177.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.858 179.091 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.477 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -157.02 133.88 10.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.504 0.669 . . . . 0.0 111.58 -179.014 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.679 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 2.8 tpm_? -155.7 115.63 3.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 1.7 t -81.89 136.08 35.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.895 0.855 . . . . 0.0 112.515 -176.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -98.63 138.74 35.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.014 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -66.73 91.86 0.2 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.445 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.625 ' CD1' ' HB3' ' A' ' 72' ' ' ARG . 6.4 mt -92.68 107.67 25.97 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.907 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -86.03 153.34 9.73 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.832 2.355 . . . . 0.0 113.309 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.435 ' CD2' ' HA3' ' A' ' 67' ' ' GLY . 42.7 p90 -86.99 -174.05 4.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.158 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -154.78 116.34 4.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.922 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' A' ' 101' ' ' GLN . 4.4 t -67.09 151.45 10.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.134 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -129.68 156.15 41.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.086 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp -109.35 100.78 9.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.2 mmtm -98.26 154.48 17.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -106.53 132.13 52.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -134.98 111.85 11.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.64 -26.76 39.26 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.368 2.046 . . . . 0.0 112.333 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -59.96 -32.3 70.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.9 mt -65.56 162.77 39.7 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.75 31.33 0.48 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.875 2.384 . . . . 0.0 112.925 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.98 138.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.913 0.387 . . . . 0.0 111.277 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.14 28.73 61.68 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.665 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.45 144.98 36.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.813 0.339 . . . . 0.0 110.933 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -114.32 118.93 35.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.821 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -128.3 118.37 23.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.425 HD13 HG21 ' A' ' 63' ' ' ILE . 43.5 mt -90.59 132.06 36.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.125 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.5 mt -104.79 -43.63 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.924 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.7 m -144.73 92.24 2.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.724 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.4 126.27 5.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.79 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.435 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -70.73 126.12 14.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.449 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -138.2 138.07 43.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.904 0.383 . . . . 0.0 110.935 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -68.1 116.19 8.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.381 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.11 -147.67 5.61 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.468 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.603 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.4 OUTLIER -177.77 109.27 0.06 Allowed 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.08 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.728 ' HB2' ' HA ' ' A' ' 94' ' ' VAL . 0.4 OUTLIER -104.59 138.08 41.46 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.207 0.527 . . . . 0.0 109.872 -179.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.502 ' O ' ' HB2' ' A' ' 92' ' ' SER . 51.9 m -75.26 136.58 40.93 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.387 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.679 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 2.8 m80 -112.16 116.77 31.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.926 0.869 . . . . 0.0 111.955 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.756 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -91.2 107.93 19.54 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 113.84 -1.527 . . . . 0.0 111.023 -177.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.459 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.4 mp -91.47 156.41 3.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.155 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.41 ' N ' ' CG2' ' A' ' 76' ' ' ILE . 3.8 m -115.85 111.55 20.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.688 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.4 m -81.27 98.38 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.189 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 tp -109.94 148.75 31.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.833 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.24 106.25 12.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -128.91 126.17 39.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 60.33 31.1 20.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.03 28.39 68.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.368 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -149.03 166.64 28.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.878 0.371 . . . . 0.0 110.857 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.3 p -106.29 89.95 3.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.84 150.9 42.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -104.7 109.53 21.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.5 m -140.05 122.21 15.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 76' ' ' ILE . 14.9 p -84.48 150.22 4.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.135 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.07 -41.39 0.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.582 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.441 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 1.6 t70 -117.64 106.92 13.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.837 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.502 ' HB2' ' O ' ' A' ' 73' ' ' THR . 89.3 p -143.14 123.91 14.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.316 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.667 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 5.7 mt-30 -89.38 166.15 13.91 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.728 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 32.1 t -86.1 110.12 19.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.603 ' O ' ' O ' ' A' ' 71' ' ' GLU . 5.9 p -117.69 80.85 1.57 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.361 0.601 . . . . 0.0 110.656 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 71' ' ' GLU . 41.0 tptt 148.52 -32.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.447 -1.252 . . . . 0.0 109.218 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 57.44 108.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.38 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.423 HG21 ' CA ' ' A' ' 46' ' ' PHE . 7.4 p -71.64 104.17 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.109 0.48 . . . . 0.0 110.0 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.1 mp -64.01 129.87 28.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.126 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -99.82 137.7 37.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.013 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.41 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 3.6 tp-100 -72.08 107.13 4.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.833 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.29 99.61 9.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.049 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.2 m -116.78 129.61 73.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.091 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -108.79 117.58 34.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.818 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.6 m -93.7 142.93 12.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.21 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.88 133.84 14.11 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.527 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -157.89 55.18 0.87 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.78 0.324 . . . . 0.0 111.094 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.31 63.05 2.11 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.598 2.198 . . . . 0.0 112.287 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t 60.06 158.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.135 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.0 m -92.33 -63.64 1.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 14.8 p80 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.895 179.988 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 120.73 0.3 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 106.55 51.97 0.78 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.485 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.9 m 60.37 34.71 20.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.749 0.309 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.2 m -104.95 93.93 4.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -106.16 123.14 47.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.896 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 60.7 111.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.961 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -60.13 156.95 14.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.802 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.33 -71.27 0.68 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -172.08 35.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.967 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.47 -169.8 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.869 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.4 p -90.29 -31.19 17.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.49 26.78 4.97 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.565 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -115.22 131.02 57.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.708 0.29 . . . . 0.0 110.845 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.0 m -58.19 109.33 1.74 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.191 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.53 -46.21 1.41 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.507 2.138 . . . . 0.0 112.27 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -151.92 130.05 11.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.08 75.55 1.57 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.458 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.92 111.47 24.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.757 0.313 . . . . 0.0 110.916 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.6 92.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.921 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.9 mtp -60.35 -178.99 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.842 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 m -113.03 -53.13 2.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.976 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -164.8 146.11 7.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.932 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 t0 61.2 -169.24 0.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 61.21 35.74 18.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -90.69 -52.67 4.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -87.25 -176.93 5.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.847 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.1 p -81.45 131.14 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.045 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -175.28 92.86 0.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.95 91.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.17 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -115.06 -50.14 2.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.4 m -158.25 -48.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.114 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 58.75 80.71 0.18 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -177.09 86.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -177.07 58.77 0.15 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.6 -46.27 1.35 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.596 2.198 . . . . 0.0 112.324 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.96 155.28 20.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.954 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.13 118.76 36.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.152 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 4.0 pt -101.37 -177.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.421 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 0.5 OUTLIER -159.88 150.42 18.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.209 0.528 . . . . 0.0 110.792 -179.245 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -162.34 133.18 4.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.183 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 1.7 p -82.44 129.16 34.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.762 0.791 . . . . 0.0 112.123 -178.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.471 ' HG3' HG13 ' A' ' 44' ' ' ILE . 3.4 tp10 -98.55 141.68 31.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.66 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.89 97.29 0.47 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.209 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.505 ' CD1' ' HG2' ' A' ' 72' ' ' ARG . 6.9 mt -106.2 94.02 8.9 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.444 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.51 158.29 32.48 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.714 2.276 . . . . 0.0 113.257 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.438 ' CE2' ' HA3' ' A' ' 67' ' ' GLY . 40.9 p90 -86.87 -174.04 4.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.841 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -147.17 103.1 3.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.173 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.425 ' CG2' ' HB3' ' A' ' 101' ' ' GLN . 3.4 p -66.99 132.75 32.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.769 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.8 mm -109.96 156.1 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.177 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -125.83 100.8 6.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.817 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -103.98 171.61 7.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.88 125.63 36.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.868 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -100.51 96.52 5.39 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.35 -18.48 44.27 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.465 2.11 . . . . 0.0 112.482 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.36 29.23 3.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.011 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 mp -124.4 169.43 10.74 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.757 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -87.37 29.09 0.5 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.3 2.667 . . . . 0.0 112.678 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.37 144.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.843 0.354 . . . . 0.0 111.347 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.65 23.22 42.92 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.833 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -109.47 156.67 19.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.757 0.313 . . . . 0.0 110.982 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -140.47 147.26 39.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.913 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.5 129.77 17.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.927 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.419 HG21 HD12 ' A' ' 63' ' ' ILE . 29.8 mm -87.23 92.8 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.136 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.3 mm -72.92 -43.85 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.76 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.83 93.7 1.68 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.544 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.62 152.42 0.47 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.82 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.438 ' HA3' ' CE2' ' A' ' 46' ' ' PHE . . . -99.94 132.76 11.05 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.26 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.93 130.46 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.884 0.374 . . . . 0.0 110.975 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.43 112.72 2.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.28 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.53 -144.91 1.3 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.694 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.672 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 10.3 tt0 -177.58 109.11 0.06 Allowed 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.772 ' HB2' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -98.36 142.79 29.56 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.377 0.608 . . . . 0.0 110.446 -179.695 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.573 ' O ' ' HB3' ' A' ' 92' ' ' SER . 98.3 m -75.68 143.98 41.86 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.248 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.616 ' O ' ' HA ' ' A' ' 39' ' ' THR . 34.5 m-70 -125.92 116.99 22.36 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.592 0.711 . . . . 0.0 111.485 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.735 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -88.02 111.97 22.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.891 -177.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.426 ' HB ' ' CD1' ' A' ' 38' ' ' ILE . 4.3 mp -99.91 160.83 3.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.258 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.8 t -107.47 119.34 39.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.7 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.6 m -81.43 98.36 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.22 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.03 129.92 49.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.55 120.17 36.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.832 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -136.03 100.05 4.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 60.13 35.71 21.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.37 47.39 22.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.469 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.27 123.14 15.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.688 0.28 . . . . 0.0 110.871 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.61 112.43 23.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.954 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.45 118.09 35.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.818 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -94.75 94.81 8.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.4 m -111.5 113.83 26.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.885 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.6 m -52.94 130.07 14.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.205 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.3 mt -120.39 -73.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.069 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.478 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -123.98 131.47 53.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.376 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.598 ' OG ' ' ND1' ' A' ' 74' ' ' HIS . 1.0 OUTLIER -143.14 165.39 27.55 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.459 0.647 . . . . 0.0 111.247 179.441 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.637 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 25.2 mm100 -129.95 166.17 20.59 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.617 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.772 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 46.3 t -86.24 105.92 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.568 ' O ' ' O ' ' A' ' 71' ' ' GLU . 12.5 p -121.12 81.03 1.72 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.501 0.667 . . . . 0.0 110.929 -178.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.672 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 6.6 mmmt 155.37 -30.86 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.751 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 62.82 101.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.8 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.422 HG23 ' CA ' ' A' ' 46' ' ' PHE . 7.6 p -71.45 102.82 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.075 0.465 . . . . 0.0 110.304 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.4 mp -63.99 133.2 29.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.913 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -102.73 142.79 33.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.018 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.425 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 0.2 OUTLIER -76.81 108.3 9.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.927 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.32 109.98 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.055 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.8 p -138.81 125.74 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.154 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -102.31 108.49 19.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.955 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.8 t -92.78 113.75 28.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.129 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.97 142.58 47.42 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.523 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.31 108.87 1.39 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.535 0.207 . . . . 0.0 111.161 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.32 -168.01 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.343 2.028 . . . . 0.0 112.365 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.3 p -120.99 150.82 23.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.014 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 m -99.03 35.12 1.95 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 8.8 m80 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.902 -179.932 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.4 mmt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.794 0.331 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -97.04 40.58 2.51 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.456 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.95 80.05 1.61 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.319 . . . . 0.0 110.871 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.3 m -96.46 142.46 28.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.82 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -134.8 -47.18 0.74 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.402 ' O ' ' CG ' ' A' ' 7' ' ' HIS . 80.7 m80 -62.85 -75.2 0.08 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.402 ' CG ' ' O ' ' A' ' 6' ' ' HIS . 12.1 m-70 -173.02 -175.52 1.23 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.916 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -131.71 -50.36 0.98 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.94 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -146.77 -67.88 0.27 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.26 31.76 20.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.7 t -106.78 134.98 49.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.949 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 136.22 -76.64 0.37 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.444 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.4 mt -148.98 -177.78 6.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.841 0.353 . . . . 0.0 110.805 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.6 t 61.99 88.23 0.12 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.074 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.26 -46.35 1.47 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.549 2.166 . . . . 0.0 112.279 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.75 31.15 20.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 19' ' ' HIS . . . 177.03 82.63 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.486 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 p 52.81 -86.62 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.607 0.242 . . . . 0.0 111.319 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.417 ' N ' ' O ' ' A' ' 17' ' ' GLY . 13.3 t-80 68.68 -67.93 0.19 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.821 0.343 . . . . 0.0 111.003 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.33 36.49 2.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.881 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.4 m -142.39 148.4 37.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.952 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.2 -37.89 6.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.946 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -168.62 -176.47 2.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.912 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -135.88 155.54 50.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.964 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -106.41 32.45 4.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.948 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -134.64 153.08 52.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.0 t 69.02 -67.51 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.199 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 59.95 -169.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.13 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.56 106.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.053 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 60.33 167.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.978 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.5 m -142.12 179.32 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -131.57 152.72 50.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.35 -32.17 15.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.775 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 60.57 68.03 1.43 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.42 -45.03 1.35 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.626 2.217 . . . . 0.0 112.228 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -150.44 115.94 5.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.83 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mp -86.18 114.52 23.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.08 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 2.2 pt -101.35 -177.39 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.496 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -161.52 146.24 13.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.436 0.636 . . . . 0.0 111.103 -179.448 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.705 ' O ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -143.36 -159.54 0.99 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.36 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 3.0 p -145.46 126.83 14.92 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.257 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.523 ' CG ' ' ND1' ' A' ' 74' ' ' HIS . 3.7 mm-40 -98.74 135.57 40.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.751 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -67.17 94.87 0.38 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.352 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.484 ' CD1' ' HB3' ' A' ' 72' ' ' ARG . 5.1 mt -102.69 96.43 7.56 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.774 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.87 160.51 30.68 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.803 2.336 . . . . 0.0 113.255 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.506 ' CD2' ' HA3' ' A' ' 67' ' ' GLY . 49.1 p90 -86.94 -174.15 4.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.234 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.63 113.16 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.847 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.408 ' CG2' ' HB3' ' A' ' 101' ' ' GLN . 17.6 t -66.74 146.41 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.103 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.8 mm -124.7 156.18 32.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.092 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.12 100.88 10.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.771 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -96.75 145.55 25.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.029 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -110.5 123.13 49.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -122.97 128.75 25.23 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.16 -24.79 12.23 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.439 2.093 . . . . 0.0 112.495 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -55.17 -50.94 68.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.039 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.4 mt -60.15 167.02 3.22 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.793 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.45 32.36 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.13 2.554 . . . . 0.0 112.697 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.04 119.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.833 0.349 . . . . 0.0 111.398 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.5 -26.27 20.65 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.753 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -70.0 129.92 40.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 110.945 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.404 ' CG ' ' CG1' ' A' ' 103' ' ' VAL . 6.5 tt0 -95.73 158.42 15.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -158.15 118.19 3.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.944 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.448 HG21 HD13 ' A' ' 63' ' ' ILE . 27.6 mt -94.29 132.03 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.186 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.1 mm -105.83 -38.99 4.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.867 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -147.65 96.86 2.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.653 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.33 128.81 17.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.753 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.506 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -67.35 124.42 22.2 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.334 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.63 130.21 59.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.797 0.332 . . . . 0.0 111.065 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.25 113.38 2.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.387 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.1 -146.28 2.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.377 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.691 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 10.7 tt0 -177.52 109.24 0.07 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.77 ' HB2' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -98.47 142.28 30.28 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.457 0.646 . . . . 0.0 110.425 -179.631 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 40' ' ' ARG . 94.7 m -75.62 149.03 38.31 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.92 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.588 ' O ' ' HA ' ' A' ' 39' ' ' THR . 5.2 m80 -128.66 117.9 21.97 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.53 0.681 . . . . 0.0 111.939 -178.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.697 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -90.58 107.27 19.06 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.079 -178.008 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.442 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 2.4 mp -90.08 158.66 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.798 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.7 t -108.15 117.39 34.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.94 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.6 98.51 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.063 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.65 142.3 34.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.5 p -89.96 93.8 9.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -99.12 105.83 17.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.976 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 60.45 33.49 20.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.0 35.78 26.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.516 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.6 147.43 32.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.796 0.331 . . . . 0.0 110.859 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.9 p -101.77 120.0 39.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.849 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.0 m -109.35 151.07 27.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -105.17 103.38 12.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 94.3 m -122.5 121.05 35.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.78 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.3 t -50.11 116.08 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.124 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.66 -70.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.189 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.5 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 7.2 m-20 -140.25 136.88 33.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.212 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.638 ' HB2' ' O ' ' A' ' 73' ' ' THR . 24.0 p -143.24 165.55 27.15 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.582 0.706 . . . . 0.0 111.275 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.695 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 16.5 mm-40 -129.74 166.27 20.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.64 -1.163 . . . . 0.0 109.346 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.77 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.6 p -85.84 105.94 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.555 ' O ' ' O ' ' A' ' 71' ' ' GLU . 13.3 p -120.39 80.94 1.68 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.498 0.666 . . . . 0.0 110.793 -178.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.691 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.1 OUTLIER 154.7 -29.88 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.616 179.028 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 60.17 102.58 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.708 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.409 HG21 ' CA ' ' A' ' 46' ' ' PHE . 6.2 p -71.34 108.36 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.215 0.531 . . . . 0.0 110.073 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.3 mp -63.85 126.87 23.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.965 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -96.02 137.12 35.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.993 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.408 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 2.5 tp60 -69.47 99.4 1.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.833 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.1 99.63 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.053 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.404 ' CG1' ' CG ' ' A' ' 61' ' ' GLU . 21.5 t -119.45 125.9 74.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.177 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -114.45 108.55 17.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.834 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.6 p -96.61 153.39 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.061 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.05 150.69 51.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.442 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.4 99.1 21.62 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.638 0.256 . . . . 0.0 111.145 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.88 -46.14 1.28 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.519 2.146 . . . . 0.0 112.269 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.1 p -177.44 132.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.082 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.27 105.84 1.32 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.855 -179.928 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 mtm . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.799 0.333 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -103.98 -74.45 0.99 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.527 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.1 m -162.67 33.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 0.0 110.923 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.9 m -137.18 31.54 2.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.983 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -176.12 -64.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.891 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -158.87 178.4 10.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -131.79 34.22 3.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 -74.54 126.06 29.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -60.81 -64.33 0.99 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.865 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.4 -78.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.84 120.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.38 . . . . 0.0 110.871 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.39 -56.84 22.86 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.53 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 60.43 -169.39 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.886 0.374 . . . . 0.0 110.85 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.3 p -126.45 136.5 28.74 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.006 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.99 149.44 65.43 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.499 2.133 . . . . 0.0 112.25 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -98.34 35.52 1.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.89 -78.98 0.88 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.495 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 67.98 -70.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.802 0.334 . . . . 0.0 110.95 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -121.05 101.74 7.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.892 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.2 mmt -125.44 -57.67 1.46 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.78 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.73 159.59 41.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.939 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.6 tp -160.46 -49.83 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.848 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.1 p30 -84.02 77.55 9.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -90.4 80.1 6.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -106.92 -177.82 3.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.937 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -106.3 -31.68 8.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.947 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.9 p -153.05 146.49 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.026 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.11 -68.96 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.89 -69.24 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.102 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.9 p-10 -167.73 33.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.884 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.5 m -82.41 148.88 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.097 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -150.42 -178.23 6.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.1 m -63.75 -23.63 67.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.087 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.3 ttm105 -106.06 79.98 0.61 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.893 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.61 -47.03 1.54 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.595 2.197 . . . . 0.0 112.38 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -147.6 152.9 38.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.819 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.1 mt -109.6 118.12 35.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.1 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.635 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 10.6 pt -101.23 -177.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.187 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.722 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 0.6 OUTLIER -153.84 160.92 42.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.233 0.54 . . . . 0.0 111.041 -179.471 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.523 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 3.6 tpp85 -172.71 131.61 0.55 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.815 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 2.9 p -81.91 129.93 34.91 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.837 0.827 . . . . 0.0 112.35 -177.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.473 ' HG3' HG13 ' A' ' 44' ' ' ILE . 3.5 tp10 -98.53 141.77 30.97 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.689 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -66.8 97.29 0.46 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.048 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.487 ' CD1' ' HG2' ' A' ' 72' ' ' ARG . 7.0 mt -105.22 92.95 6.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.613 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.0 158.04 42.43 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.743 2.296 . . . . 0.0 113.031 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.428 ' CE1' ' HA3' ' A' ' 67' ' ' GLY . 41.6 p90 -86.77 -174.01 4.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.024 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -145.74 105.06 3.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.851 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.4 ' CG2' ' HB3' ' A' ' 101' ' ' GLN . 6.0 p -67.07 138.82 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.001 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.9 mm -122.69 156.17 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.161 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -120.1 100.78 7.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.815 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -98.39 154.34 17.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.985 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -99.29 129.68 45.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.944 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -124.99 127.22 25.14 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.815 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.4 -27.16 11.48 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.411 2.074 . . . . 0.0 112.442 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -58.6 -35.52 72.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.985 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mt -71.03 158.89 87.19 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.825 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -86.33 37.92 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.885 2.39 . . . . 0.0 112.878 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.22 145.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.846 0.355 . . . . 0.0 111.338 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.23 27.74 58.05 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.634 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.01 169.34 8.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.757 0.313 . . . . 0.0 110.963 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -155.32 133.01 11.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.927 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -135.75 125.0 24.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.812 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.431 HD11 HG21 ' A' ' 63' ' ' ILE . 26.1 mm -85.75 92.86 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.087 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.426 HG21 HD12 ' A' ' 64' ' ' ILE . 19.8 mt -74.26 -31.77 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.992 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.4 m -164.21 93.6 0.7 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.666 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.7 145.03 5.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.537 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.428 ' HA3' ' CE1' ' A' ' 46' ' ' PHE . . . -80.79 136.25 16.09 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.341 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.7 t -141.74 120.86 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 0.0 110.957 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.5 mtmt -59.42 112.79 1.89 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.245 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.87 -144.53 1.76 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.758 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.68 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -177.42 109.17 0.07 Allowed 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.219 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.745 ' HB2' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -98.61 139.38 34.42 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.16 0.505 . . . . 0.0 110.47 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.585 ' O ' ' HB2' ' A' ' 92' ' ' SER . 40.5 m -75.39 136.09 40.77 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.451 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.722 ' O ' ' HA ' ' A' ' 39' ' ' THR . 19.8 m-70 -116.17 122.37 44.84 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.416 0.627 . . . . 0.0 111.771 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.74 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -90.69 107.23 19.04 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.054 -177.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.403 ' HB ' ' CD1' ' A' ' 38' ' ' ILE . 3.8 mp -96.22 160.42 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.069 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.76 122.43 47.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.762 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.11 108.97 20.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.31 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.05 137.96 45.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.796 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.53 123.04 29.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -131.48 109.52 10.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.9 p30 44.08 33.98 0.89 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.416 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.28 45.29 5.64 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.473 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -149.23 156.83 42.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 110.825 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.67 116.22 28.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.943 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.28 151.02 20.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -121.41 83.93 2.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.957 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.6 m -108.29 123.2 48.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.792 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.1 m -50.11 130.07 8.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.221 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.48 -64.56 1.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.233 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.488 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -152.82 141.42 20.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.207 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.585 ' HB2' ' O ' ' A' ' 73' ' ' THR . 11.5 p -143.27 165.61 27.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.779 0.8 . . . . 0.0 111.616 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.693 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 41.8 mt-30 -129.18 166.08 20.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.691 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.745 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.5 p -85.96 105.78 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.59 ' O ' ' O ' ' A' ' 71' ' ' GLU . 12.1 p -121.36 80.75 1.7 Allowed 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.579 0.704 . . . . 0.0 110.733 -178.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.68 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 154.46 -31.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.649 178.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 62.94 101.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.777 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.416 HG23 ' CA ' ' A' ' 46' ' ' PHE . 5.8 p -71.48 106.64 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.058 0.456 . . . . 0.0 110.202 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.9 mm -63.87 129.44 27.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.068 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -98.92 134.93 41.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.021 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.4 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 1.5 tm0? -68.47 99.45 0.96 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.25 117.28 32.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.073 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.1 m -143.09 137.58 26.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.095 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -118.4 111.85 19.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.882 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.9 m -88.87 146.94 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.088 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -70.98 146.18 40.97 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.443 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -167.35 73.85 1.0 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.748 0.308 . . . . 0.0 111.101 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.06 136.32 29.32 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.615 2.21 . . . . 0.0 112.371 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.3 t 68.87 -67.29 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.204 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m 60.96 80.71 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.954 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.926 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.815 0.341 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 147.12 -92.78 0.15 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.54 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m 60.47 32.31 20.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.801 0.334 . . . . 0.0 110.922 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.4 t -106.15 172.71 6.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.405 ' CE1' ' HB3' ' A' ' 7' ' ' HIS . 0.7 OUTLIER -165.52 -178.71 5.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.7 p-80 -92.67 81.84 4.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.816 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.405 ' HB3' ' CE1' ' A' ' 5' ' ' HIS . 9.7 p80 -106.34 -37.75 6.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -60.36 92.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -161.45 -49.58 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.858 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 m -106.12 161.7 14.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.1 t -83.34 -74.66 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.908 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.53 -39.57 1.68 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.533 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 mt -73.08 69.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.829 0.347 . . . . 0.0 110.891 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.64 ' N ' ' CD ' ' A' ' 15' ' ' PRO . 13.4 p -82.2 -28.64 0.46 Allowed Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 14' ' ' VAL . 89.4 Cg_endo -84.75 -26.67 1.52 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.094 1.863 . . . . 0.0 112.585 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -102.42 -31.3 10.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.11 178.01 52.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.498 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.7 p -176.62 169.63 2.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.844 0.354 . . . . 0.0 110.897 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -105.48 89.79 3.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.845 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.34 -38.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.993 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.82 165.01 4.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.909 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.0 -38.25 5.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -176.86 -178.77 0.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -156.17 -74.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -176.78 104.76 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -176.51 106.65 0.07 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.949 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 p -144.61 39.93 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.013 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -175.78 37.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.043 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.34 -74.93 0.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.021 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.419 ' O ' ' CG2' ' A' ' 31' ' ' VAL . 1.1 t-20 -106.02 -51.58 2.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 30' ' ' ASN . 21.4 m 45.48 -171.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.624 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -144.32 -71.58 0.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.003 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.03 108.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.96 79.86 0.27 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.867 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.69 -35.57 9.7 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.561 2.174 . . . . 0.0 112.298 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -163.6 154.49 16.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.775 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 68.4 mt -95.01 122.79 38.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.072 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 1.2 tt -101.17 -177.32 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.567 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 1.3 p -162.29 142.22 9.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.331 0.586 . . . . 0.0 111.018 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.407 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -163.64 109.88 1.11 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.147 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 12.5 t -82.3 132.71 35.22 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.685 0.755 . . . . 0.0 111.734 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.446 ' O ' HD12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -98.41 148.24 23.89 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.695 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -66.83 100.2 0.69 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.699 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.567 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.0 mp -104.8 91.16 4.01 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.872 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.18 157.38 37.84 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.671 2.247 . . . . 0.0 112.808 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.43 ' CE1' ' HA3' ' A' ' 67' ' ' GLY . 30.0 p90 -86.73 -177.29 6.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.118 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -157.07 120.25 4.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.96 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.0 t -67.26 150.0 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.242 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.8 mt -129.18 156.15 41.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.079 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.4 mtpp -123.59 100.89 7.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.818 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -110.8 147.37 34.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.901 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.87 140.0 32.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -133.71 98.48 14.79 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.51 84.25 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.484 2.122 . . . . 0.0 112.213 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -175.32 -40.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.924 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.7 mt -58.49 167.16 1.87 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.842 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.08 48.84 2.63 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.041 2.494 . . . . 0.0 112.754 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.37 124.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.016 0.436 . . . . 0.0 111.716 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 50.59 55.64 16.39 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.091 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.47 136.5 48.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.742 0.306 . . . . 0.0 110.802 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.9 117.14 27.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -127.08 158.02 38.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.799 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.1 mm -113.91 92.52 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.3 mt -73.24 -32.25 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.921 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.0 m -161.31 92.74 0.91 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.613 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.49 146.45 5.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.582 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' A' ' 46' ' ' PHE . . . -76.45 138.72 22.88 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.262 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.8 t -140.95 135.05 32.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.917 0.389 . . . . 0.0 111.349 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.16 134.87 56.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.335 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.422 ' CA ' ' O ' ' A' ' 96' ' ' LYS . . . -116.25 -159.68 11.91 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.994 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.475 ' HA ' HD12 ' A' ' 44' ' ' ILE . 1.5 tt0 -162.08 153.89 18.84 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.567 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 2.6 ttt180 -141.39 112.2 7.17 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.705 ' O ' ' HB2' ' A' ' 92' ' ' SER . 46.5 m -73.92 125.72 28.85 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.524 ' O ' ' HA ' ' A' ' 39' ' ' THR . 13.8 m80 -106.8 119.7 40.05 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 122.083 0.944 . . . . 0.0 113.137 -177.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.688 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -91.14 93.81 9.3 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.103 -177.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.47 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 2.0 mp -87.35 142.65 12.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.931 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.4 p -77.34 121.42 23.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.762 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.4 105.56 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.203 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -125.55 89.27 3.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.891 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.07 131.4 42.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -137.62 117.24 13.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.909 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 60.67 33.35 20.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.28 32.02 49.55 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.438 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -144.32 113.77 7.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.755 0.312 . . . . 0.0 110.86 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.7 p -75.21 127.8 34.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.6 m -100.01 141.28 33.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.899 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -100.29 101.97 13.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.8 m -118.95 121.0 38.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.8 p -54.26 118.41 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.006 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.0 -59.57 1.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.516 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -177.17 139.95 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.198 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.705 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.8 p -143.64 149.47 37.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.48 0.657 . . . . 0.0 111.362 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.652 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 4.6 mt-30 -107.47 167.11 10.17 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.463 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 8.3 p -84.75 107.16 15.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 119.854 -0.739 . . . . 0.0 109.872 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.549 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 16.8 p -113.22 82.9 1.74 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.686 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 95' ' ' THR . 11.6 mmmt 113.36 52.93 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.097 -1.41 . . . . 0.0 109.385 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -35.21 117.17 0.39 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.544 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' A' ' 46' ' ' PHE . 9.4 p -71.44 106.02 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.206 0.527 . . . . 0.0 110.792 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.0 mm -64.35 121.5 13.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.164 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -98.07 125.95 43.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.931 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.67 128.91 38.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.788 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.8 m -124.01 101.36 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.195 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 m -108.96 118.6 56.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.072 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -87.15 111.58 21.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.783 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.99 143.5 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.225 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.54 109.67 3.03 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.505 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 60.84 155.97 0.11 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.714 0.292 . . . . 0.0 111.09 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.19 -45.41 1.37 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.49 2.127 . . . . 0.0 112.285 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.9 m -157.63 -47.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.15 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 33.1 p -65.55 79.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.873 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 72.1 m80 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.936 179.999 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpp? . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.825 0.345 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.74 162.24 28.68 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.528 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.0 t -160.9 -47.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.829 0.347 . . . . 0.0 110.952 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.82 110.84 4.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -129.4 72.87 1.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -177.49 -40.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.47 ' CG ' ' CE1' ' A' ' 8' ' ' HIS . 1.9 t-80 -59.54 -63.86 1.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.47 ' CE1' ' CG ' ' A' ' 7' ' ' HIS . 0.0 OUTLIER -166.37 -83.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.931 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 61.22 155.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.812 0.339 . . . . 0.0 110.896 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.9 m -60.09 -45.33 93.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.965 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.73 -169.97 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.927 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.81 -179.18 28.17 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.527 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 mp -142.82 -170.3 3.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.858 0.361 . . . . 0.0 110.85 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 m -133.28 87.86 37.23 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.15 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.24 -28.15 23.29 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.476 2.118 . . . . 0.0 112.325 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -60.48 124.96 21.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.97 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -170.91 -146.69 5.3 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.56 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.6 m -146.2 32.24 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 110.925 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -131.59 -46.79 0.97 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.957 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.06 79.51 1.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.82 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.9 p -106.6 117.05 33.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 mt -96.93 79.65 2.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -159.38 31.74 0.2 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.853 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -117.92 51.59 1.05 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 60.94 167.5 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.935 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -98.8 31.62 2.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.5 t -109.08 82.47 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.108 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.74 -56.46 2.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.097 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -170.44 137.13 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.129 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -94.67 47.66 1.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.1 m -59.47 178.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.221 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -169.06 -173.1 1.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.1 -172.37 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.936 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.21 149.78 96.48 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.02 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.26 -166.16 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.636 2.224 . . . . 0.0 112.271 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -78.84 124.84 28.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.641 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 68.4 mt -78.33 116.46 18.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.086 0.469 . . . . 0.0 111.329 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.615 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 1.2 pp -100.89 -176.05 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.288 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 0.6 OUTLIER -156.35 132.94 10.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.499 0.666 . . . . 0.0 112.486 -178.351 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.637 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 4.7 mmm180 -150.72 115.77 5.32 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -82.13 134.37 35.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.897 0.856 . . . . 0.0 112.34 -177.685 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -98.78 138.81 35.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.24 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.415 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 1.7 pt-20 -66.86 91.45 0.2 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.778 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.482 ' CD1' ' HB3' ' A' ' 72' ' ' ARG . 6.5 mt -94.84 105.04 16.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.651 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 43' ' ' GLU . 80.8 Cg_endo -84.19 157.2 13.02 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.769 2.313 . . . . 0.0 113.296 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.439 ' CA ' HG21 ' A' ' 98' ' ' VAL . 42.6 p90 -86.91 -174.02 4.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.965 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -149.42 103.05 3.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.099 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.407 ' CG2' ' HB3' ' A' ' 101' ' ' GLN . 3.9 p -66.82 145.02 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.931 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -128.97 156.1 41.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.039 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -109.44 100.89 9.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.754 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.33 164.6 20.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.035 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -116.35 112.56 21.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.826 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -102.23 96.6 7.26 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.67 -13.21 38.98 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.499 2.132 . . . . 0.0 112.512 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -97.81 27.79 4.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.706 0.289 . . . . 0.0 111.047 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mp -114.97 175.94 1.68 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.85 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -86.78 29.53 0.5 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.281 2.654 . . . . 0.0 112.781 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.7 130.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.978 0.418 . . . . 0.0 111.225 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.78 54.08 40.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.642 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.44 131.7 54.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.765 0.317 . . . . 0.0 110.823 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -115.18 113.85 24.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.937 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -147.25 119.34 8.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.804 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 26.1 mt -85.76 130.96 35.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.251 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.24 -46.18 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.636 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.3 m -141.85 102.17 4.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.497 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.43 162.95 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.545 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.433 ' HA3' ' CE2' ' A' ' 46' ' ' PHE . . . -111.07 127.32 8.18 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.243 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.43 134.7 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.809 0.337 . . . . 0.0 110.97 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -65.37 114.55 4.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.075 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.08 -143.06 0.94 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.802 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.605 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -177.33 109.51 0.07 Allowed 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.194 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.791 ' HB2' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -103.35 134.3 46.97 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.251 0.548 . . . . 0.0 110.127 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.611 ' O ' ' HB2' ' A' ' 92' ' ' SER . 60.6 m -76.15 138.22 40.57 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.532 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.637 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 6.6 m80 -111.79 122.72 48.56 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.687 0.756 . . . . 0.0 112.05 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.726 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -92.99 93.85 8.58 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.241 -177.287 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.439 ' HB ' ' CG1' ' A' ' 38' ' ' ILE . 4.3 mp -87.66 144.69 8.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.221 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.6 p -93.95 115.2 27.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.817 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.8 m -81.44 105.81 11.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -113.98 102.12 9.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.1 m -66.92 91.09 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -62.23 92.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 68.15 -69.86 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.093 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.88 36.99 1.03 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.491 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.88 132.21 6.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.883 0.373 . . . . 0.0 110.859 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.97 130.72 35.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.948 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.61 144.98 43.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -93.84 117.55 30.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.867 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.3 m -144.62 101.1 3.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.7 t -49.74 133.22 8.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.96 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 tp -110.3 -67.23 1.0 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.271 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.49 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 2.1 m-20 -150.79 141.16 22.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.979 0.419 . . . . 0.0 111.539 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.611 ' HB2' ' O ' ' A' ' 73' ' ' THR . 11.8 p -143.7 160.51 40.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.585 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.646 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 3.7 mt-30 -125.18 167.01 15.42 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.791 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.2 p -85.14 106.34 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 119.557 -0.857 . . . . 0.0 108.964 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.528 ' O ' ' O ' ' A' ' 71' ' ' GLU . 6.1 p -115.78 81.02 1.53 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.613 0.721 . . . . 0.0 110.46 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 156.35 -29.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.721 179.081 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 61.78 100.77 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.532 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.439 HG21 ' CA ' ' A' ' 46' ' ' PHE . 5.9 p -71.24 102.7 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 121.213 0.53 . . . . 0.0 109.998 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.8 mp -64.28 133.35 29.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.015 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -105.67 141.53 36.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.143 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.407 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -76.4 108.13 9.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.776 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.92 108.7 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.107 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.1 t -129.32 114.96 33.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.019 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.99 139.94 30.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.763 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.4 109.7 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.082 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.19 128.15 30.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.577 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -84.85 151.83 58.47 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.693 0.282 . . . . 0.0 111.143 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.19 -41.32 3.83 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.612 2.208 . . . . 0.0 112.397 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 31.5 t -63.36 87.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.112 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -176.78 125.93 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.907 -179.973 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.792 0.329 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.59 35.25 88.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.511 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.0 p 58.54 171.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.807 0.337 . . . . 0.0 111.014 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.4 p -87.27 -169.49 2.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.936 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -60.3 -169.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.821 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.48 97.38 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -71.75 -68.05 0.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.002 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.76 -175.22 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.836 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -176.4 37.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.32 164.14 27.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.802 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.3 t -93.08 -170.15 2.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.997 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.18 -133.28 1.85 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.457 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 pp -132.17 133.15 43.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.753 0.311 . . . . 0.0 110.923 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.1 m -150.46 88.15 4.72 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.136 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -176.02 1.33 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.598 2.199 . . . . 0.0 112.293 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.17 -74.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 59.46 -96.39 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.526 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.08 30.68 20.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.739 0.304 . . . . 0.0 110.91 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -177.23 -68.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 77.5 mmm 59.45 -178.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.961 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 p -113.37 152.37 30.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.001 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.87 86.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.885 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -161.93 -175.97 4.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -82.94 -75.27 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 59.82 31.04 20.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.942 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -170.64 161.22 7.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.5 t -104.38 136.81 36.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.7 40.25 1.14 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.99 78.4 0.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.051 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -60.44 134.94 57.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.859 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.73 -67.33 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 62.45 -80.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.959 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 p 55.8 33.26 21.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.896 0.379 . . . . 0.0 111.192 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.408 ' N ' ' CD ' ' A' ' 35' ' ' PRO . 8.1 ttm-85 -164.32 52.73 0.31 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.034 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 34' ' ' ARG . 72.1 Cg_endo -76.78 -43.11 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.511 2.141 . . . . 0.0 112.314 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -139.56 129.13 24.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.5 132.92 42.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.878 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.622 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.7 OUTLIER -101.25 -176.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.444 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 0.1 OUTLIER -163.16 121.93 2.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.03 0.443 . . . . 0.0 109.947 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 74' ' ' HIS . 18.9 ttt180 -145.77 132.49 19.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.328 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 2.2 p -81.85 130.23 35.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.891 0.853 . . . . 0.0 112.235 -177.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.413 ' HG2' HG13 ' A' ' 44' ' ' ILE . 1.1 tt0 -98.36 143.89 28.34 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.806 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.9 94.26 0.31 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.905 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.49 ' CD1' ' HG2' ' A' ' 72' ' ' ARG . 7.3 mt -103.02 95.3 6.38 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.59 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.16 158.6 45.19 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.73 2.287 . . . . 0.0 113.278 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.459 ' CD2' ' HA3' ' A' ' 67' ' ' GLY . 53.9 p90 -86.64 -173.97 4.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.111 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -151.64 111.84 4.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.882 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.407 ' CG2' ' HB3' ' A' ' 101' ' ' GLN . 31.2 t -66.81 151.14 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.249 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -126.92 156.25 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.094 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.6 100.75 7.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.88 150.91 26.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.91 123.51 32.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -117.47 96.55 49.53 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.928 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.63 65.71 1.2 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.448 2.099 . . . . 0.0 112.193 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -149.68 -45.87 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.846 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -55.9 172.93 0.29 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.15 31.72 0.52 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.172 2.582 . . . . 0.0 112.951 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.96 120.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.999 0.428 . . . . 0.0 111.387 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.81 22.17 62.16 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.886 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -109.54 157.68 18.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.826 0.346 . . . . 0.0 110.826 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -136.3 115.17 12.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -117.61 116.68 27.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.406 HD11 HG21 ' A' ' 63' ' ' ILE . 26.1 mt -85.81 132.09 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.108 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.439 HD12 HG21 ' A' ' 64' ' ' ILE . 12.7 mt -103.46 -44.44 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.984 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.55 92.06 2.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.623 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.83 150.92 0.66 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.768 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.459 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -85.71 129.34 9.27 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.229 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.71 125.95 47.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.915 0.388 . . . . 0.0 110.885 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.51 112.71 2.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.281 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.9 -144.15 1.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.509 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.687 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 4.6 tt0 -177.45 109.27 0.07 Allowed 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.77 ' HB2' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -100.39 138.75 37.03 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.24 -179.711 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.581 ' O ' ' HB2' ' A' ' 92' ' ' SER . 94.6 m -75.22 140.12 43.05 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.68 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.543 ' N ' ' O ' ' A' ' 40' ' ' ARG . 20.4 m-70 -119.78 121.75 39.85 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.047 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.725 ' OH ' ' HB2' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -92.22 106.58 18.55 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.24 -177.256 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.0 mp -90.75 160.8 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.874 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.6 t -119.28 129.01 54.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.721 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.4 p -81.41 123.0 37.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.141 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.9 tp -128.91 117.28 20.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.2 p -66.98 98.05 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.818 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.73 92.14 6.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 59.95 31.24 20.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.993 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.24 38.5 7.22 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.541 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -148.12 162.07 40.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.76 0.314 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.97 123.47 48.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.927 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -128.33 110.59 12.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.02 114.66 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.8 t -121.29 121.93 38.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.3 m -52.59 121.15 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.112 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.4 -49.97 3.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.189 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.484 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 5.9 t0 -176.62 143.79 0.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.275 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.581 ' HB2' ' O ' ' A' ' 73' ' ' THR . 11.3 p -143.16 165.61 26.95 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.554 0.692 . . . . 0.0 111.496 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.725 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 5.1 mm-40 -131.85 166.3 21.9 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.947 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.77 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 5.5 m -85.97 105.79 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.591 ' O ' ' O ' ' A' ' 71' ' ' GLU . 10.7 p -121.02 80.68 1.67 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.491 0.663 . . . . 0.0 110.76 -178.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.687 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER 154.47 -30.38 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.846 178.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 62.02 101.58 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.624 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.42 HG22 ' CA ' ' A' ' 46' ' ' PHE . 5.0 p -71.36 108.37 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.163 0.506 . . . . 0.0 110.2 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 43.2 mm -64.2 128.8 27.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.173 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -100.94 134.83 43.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.407 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -64.55 99.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.749 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.82 99.81 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.182 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.6 p -123.71 141.56 43.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.128 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -121.53 120.13 33.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.801 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.8 m -86.99 160.14 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.151 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -98.87 125.84 8.7 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.55 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -177.0 148.5 0.76 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.762 0.315 . . . . 0.0 111.046 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.23 131.34 17.71 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.544 2.162 . . . . 0.0 112.363 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.54 -45.31 95.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.056 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.3 t -179.73 -38.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.884 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.799 0.333 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -147.43 98.12 0.19 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.427 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.17 -56.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.746 0.307 . . . . 0.0 110.865 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.85 92.98 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.6 m170 -161.76 -72.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.897 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -60.9 179.86 0.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.7 t60 60.65 103.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.851 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -149.1 93.7 2.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.83 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -136.92 145.73 44.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 75.3 m -135.31 -55.38 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.801 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.3 m 60.38 100.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.73 -27.84 45.08 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp 60.14 31.56 20.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.714 0.292 . . . . 0.0 110.9 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.482 ' HB ' ' CD ' ' A' ' 15' ' ' PRO . 20.7 t -158.87 -64.6 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.052 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.482 ' CD ' ' HB ' ' A' ' 14' ' ' VAL . 30.9 Cg_endo -63.21 -48.29 6.52 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.271 1.981 . . . . 0.0 112.193 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.19 -40.48 9.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.867 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.89 84.13 1.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.445 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 m -131.52 -65.43 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.865 0.365 . . . . 0.0 110.923 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -105.79 87.94 2.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.9 mtp -61.16 -31.66 71.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.5 p -130.07 177.28 7.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 mp -92.77 -31.49 15.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.944 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -171.96 -43.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 63.88 -79.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.998 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 59.87 62.07 1.76 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 60.08 82.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.785 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.7 m -129.27 164.68 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.134 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -175.16 43.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.054 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.57 -74.54 0.07 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.111 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -146.96 95.21 2.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.932 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.4 m -67.47 -36.89 77.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.086 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -136.43 -177.83 4.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.24 39.69 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.981 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.95 144.62 33.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.864 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.62 -44.64 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.498 2.132 . . . . 0.0 112.366 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.15 121.22 6.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.944 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.71 135.53 33.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.883 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.679 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -100.8 -177.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.452 179.381 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.459 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.7 OUTLIER -157.14 121.82 4.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.344 0.592 . . . . 0.0 111.26 -179.397 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.65 ' O ' ' HA ' ' A' ' 73' ' ' THR . 1.0 OUTLIER -128.06 -151.11 0.46 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.679 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 m -144.96 137.87 26.44 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.115 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.473 ' CB ' ' CE1' ' A' ' 74' ' ' HIS . 0.2 OUTLIER -107.94 131.84 54.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.427 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -66.93 92.83 0.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.058 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.499 ' CD1' ' HG2' ' A' ' 72' ' ' ARG . 4.1 mt -109.1 85.79 3.55 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.152 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.76 163.36 23.72 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.829 2.353 . . . . 0.0 112.93 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.451 ' CE2' ' HA3' ' A' ' 67' ' ' GLY . 40.1 p90 -87.33 -173.98 4.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.225 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -149.31 107.13 3.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.787 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.419 ' CB ' ' HB3' ' A' ' 101' ' ' GLN . 9.4 p -66.85 123.61 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.018 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.8 mm -106.4 156.18 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.228 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -108.74 100.84 10.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.808 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -87.2 159.16 18.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.985 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.87 120.07 39.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -122.94 96.56 44.86 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.918 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.81 -25.19 53.36 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.453 2.102 . . . . 0.0 112.263 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -62.35 -30.97 71.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.18 171.88 2.87 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.748 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -89.06 29.93 0.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.268 2.646 . . . . 0.0 112.598 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.01 146.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.912 0.387 . . . . 0.0 111.292 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.74 21.49 36.51 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.779 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -109.61 148.02 32.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.882 0.372 . . . . 0.0 110.799 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -137.87 141.63 40.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -137.7 162.47 33.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.81 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.499 HD13 HG23 ' A' ' 63' ' ' ILE . 18.2 mm -117.0 86.28 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.113 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.4 mm -62.97 -49.75 82.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.012 0.434 . . . . 0.0 110.94 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.3 m -143.68 91.12 2.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.576 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.06 139.55 4.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.727 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.451 ' HA3' ' CE2' ' A' ' 46' ' ' PHE . . . -82.67 137.01 16.12 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.211 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.48 125.97 33.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.839 0.352 . . . . 0.0 111.075 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -56.48 119.88 6.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.041 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.74 -149.89 6.58 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.528 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.631 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -177.18 109.3 0.07 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.069 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.753 ' HB2' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -101.53 139.0 37.78 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.295 0.569 . . . . 0.0 109.904 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.666 ' O ' ' HB2' ' A' ' 92' ' ' SER . 91.2 m -75.86 138.99 41.45 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.815 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.473 ' CE1' ' CB ' ' A' ' 42' ' ' GLU . 5.0 m80 -111.64 118.97 37.13 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.745 0.784 . . . . 0.0 112.609 -178.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.679 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -92.05 100.05 12.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.066 -1.424 . . . . 0.0 111.508 -177.365 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.41 HG21 ' N ' ' A' ' 77' ' ' SER . 5.0 mp -87.73 141.62 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.79 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.41 ' N ' HG21 ' A' ' 76' ' ' ILE . 5.7 t -98.78 130.26 45.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 0.0 110.753 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.401 ' CG2' ' CG2' ' A' ' 85' ' ' THR . 10.6 p -81.42 119.01 30.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.172 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.4 mp -113.21 116.61 30.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.6 m -88.65 94.34 9.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.94 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -87.35 96.72 10.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 42.88 32.06 0.37 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.401 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.39 43.67 2.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.522 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -147.88 107.38 3.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.82 0.343 . . . . 0.0 110.878 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.401 ' CG2' ' CG2' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -88.91 119.01 29.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.821 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.31 149.96 44.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -97.25 108.62 21.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.974 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 78.0 m -127.5 124.05 37.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.15 121.82 3.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.865 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.9 -71.24 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.381 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.5 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 2.6 t0 -147.06 136.44 22.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.845 0.355 . . . . 0.0 111.576 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.666 ' HB2' ' O ' ' A' ' 73' ' ' THR . 5.8 p -143.56 150.95 39.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.385 0.612 . . . . 0.0 110.938 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.567 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 26.0 mm-40 -113.39 166.93 11.01 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.753 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.6 p -85.27 106.33 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.457 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 71' ' ' GLU . 5.8 p -115.15 81.37 1.56 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.428 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.631 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 157.44 -30.17 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.708 179.159 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 61.73 103.57 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.511 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.441 HG22 ' HA ' ' A' ' 46' ' ' PHE . 7.6 p -71.21 104.26 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.209 0.528 . . . . 0.0 110.081 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.3 mp -63.68 127.17 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.032 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.415 ' HA ' ' HB2' ' A' ' 46' ' ' PHE . 6.2 m120 -92.36 145.74 24.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.017 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.419 ' HB3' ' CB ' ' A' ' 48' ' ' VAL . 3.2 tt0 -84.15 101.56 11.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.867 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.85 99.69 7.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.104 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.402 ' CG1' ' CD1' ' A' ' 63' ' ' ILE . 24.6 m -125.38 120.84 59.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.139 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -100.64 131.94 46.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.4 m -110.53 128.37 66.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.147 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.05 137.74 50.17 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.533 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -173.52 74.92 0.38 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.817 0.342 . . . . 0.0 111.103 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.59 148.5 59.84 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.526 2.15 . . . . 0.0 112.251 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.3 m -149.97 -47.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.133 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.16 -176.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.927 179.988 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mmt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.854 0.359 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.47 122.31 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.475 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.4 p -175.43 -66.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.867 0.365 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 m 60.41 31.46 20.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.951 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.2 m80 60.35 -179.15 0.1 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -151.66 79.52 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -120.39 -42.61 2.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.45 81.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.861 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -117.09 168.66 10.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.4 p -59.85 161.81 6.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.58 -170.01 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.929 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 161.81 -28.51 0.28 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.531 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.5 tp -98.75 31.56 2.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.922 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t 59.92 87.88 0.13 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.129 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.77 140.36 42.45 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.699 2.266 . . . . 0.0 112.275 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -79.82 -178.55 6.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.05 52.62 0.64 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.481 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.03 -59.61 1.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 0.0 110.911 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.0 t60 68.49 -68.04 0.19 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.04 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 18.2 ttm -67.97 93.1 0.4 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.912 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -130.98 79.95 1.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.27 165.11 31.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.93 -52.84 24.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.926 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -68.43 157.02 36.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -133.98 124.7 26.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.928 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.92 -64.2 0.95 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.1 p -110.44 -31.22 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.071 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 60.1 96.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.124 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.83 126.8 8.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.097 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -131.85 -73.37 0.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.923 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t 59.89 85.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.152 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -82.72 78.62 9.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.934 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.35 176.37 6.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -110.79 130.95 22.39 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.39 -167.04 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.494 2.129 . . . . 0.0 112.237 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -94.85 145.21 25.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.757 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mp -93.65 114.07 26.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.195 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.696 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 44.0 pt -101.03 -176.4 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.817 178.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 1.1 p -151.39 147.04 26.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.236 0.541 . . . . 0.0 111.47 -178.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 1.4 mtp85 -161.17 104.54 1.3 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.997 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 15.0 t -82.15 131.44 35.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.617 0.722 . . . . 0.0 111.373 -178.526 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.431 ' O ' HD12 ' A' ' 44' ' ' ILE . 2.1 mt-10 -98.39 144.6 27.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.807 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -66.67 91.68 0.19 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.695 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.8 mp -87.72 109.41 26.59 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.978 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -88.26 158.18 6.88 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.837 2.358 . . . . 0.0 112.853 -179.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.416 ' HB3' ' CG2' ' A' ' 98' ' ' VAL . 42.3 p90 -87.27 -174.16 4.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.945 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.42 104.43 2.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.733 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.42 143.5 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.189 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -111.82 156.07 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.094 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.7 pttp -108.29 100.91 10.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.828 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.4 ttmp? -112.5 161.78 16.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.927 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -117.71 139.97 50.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.931 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -137.76 132.96 17.55 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.69 -20.28 13.77 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.454 2.103 . . . . 0.0 112.554 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.98 -30.5 59.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.155 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.5 mt -81.77 162.35 58.03 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.974 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.14 42.15 1.14 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.209 2.606 . . . . 0.0 112.602 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.67 136.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.872 0.368 . . . . 0.0 111.335 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.66 40.54 88.39 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.687 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.47 145.47 36.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -112.05 117.12 31.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.828 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -130.32 126.06 36.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.991 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.3 mm -101.74 96.37 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.044 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.8 mt -66.2 -31.13 52.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.41 ' CG2' ' CG2' ' A' ' 102' ' ' VAL . 6.4 t -163.34 119.26 1.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.71 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.07 125.37 27.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.23 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.0 137.75 48.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.319 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -138.61 124.16 23.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.814 0.34 . . . . 0.0 111.084 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.86 119.1 4.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.183 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.447 ' CA ' ' O ' ' A' ' 96' ' ' LYS . . . -88.28 -152.25 24.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.044 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -161.52 145.94 13.13 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.619 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.591 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 31.1 ttm180 -140.36 110.39 6.52 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.139 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.706 ' O ' ' HB3' ' A' ' 92' ' ' SER . 28.0 m -73.77 125.48 28.2 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.014 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.526 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 10.5 m80 -105.59 117.53 34.25 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 122.098 0.952 . . . . 0.0 113.259 -176.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.696 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -89.44 108.26 19.54 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 113.694 -1.594 . . . . 0.0 111.28 -177.912 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.452 ' HB ' ' CD1' ' A' ' 38' ' ' ILE . 2.4 mp -95.26 160.76 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.814 -179.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.422 ' N ' ' CG2' ' A' ' 76' ' ' ILE . 55.9 p -104.69 118.76 37.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.711 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.45 108.55 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.155 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -113.05 88.68 2.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.6 m -82.16 117.51 22.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -127.8 107.62 10.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.952 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 60.79 31.85 20.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.843 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.75 43.24 7.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.525 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.9 tptp -143.23 107.51 4.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.793 0.33 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.8 m -85.85 120.06 26.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.92 142.8 31.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.925 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -105.85 95.73 6.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.6 m -123.64 125.1 44.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.064 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.9 m -55.11 145.12 5.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.022 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.09 -51.76 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.171 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 1.8 t70 -176.62 137.32 0.26 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.274 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.706 ' HB3' ' O ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -143.66 144.87 32.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.352 0.596 . . . . 0.0 111.306 179.005 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.638 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 3.1 mt-30 -103.47 166.75 10.24 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.582 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.494 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 8.6 p -85.25 107.01 15.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.803 -179.031 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.517 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 19.3 p -110.51 83.2 1.72 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.22 -179.435 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 95' ' ' THR . 0.1 OUTLIER 103.39 44.78 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.746 -179.636 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -31.31 133.32 0.08 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.313 -179.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.416 ' CG2' ' HB3' ' A' ' 46' ' ' PHE . 10.7 p -71.87 118.89 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.002 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.3 mp -75.49 108.79 7.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.962 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -71.22 130.87 42.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -68.53 148.0 51.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.41 ' CG2' ' CG2' ' A' ' 65' ' ' THR . 53.4 t -133.11 100.61 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.007 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.1 t -120.47 133.63 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -110.91 154.89 23.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.78 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.88 138.74 52.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.202 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.7 87.81 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.498 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 60.92 155.5 0.11 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.706 0.289 . . . . 0.0 111.171 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.14 -168.14 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.64 2.226 . . . . 0.0 112.336 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.4 m -124.03 31.53 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.113 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.97 -40.28 6.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 7.1 m170 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.935 179.967 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo . . . . . 0 C--O 1.23 0.094 0 CA-C-O 120.739 0.224 . . . . 0.0 112.245 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.68 142.17 51.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.786 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.96 111.3 23.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.191 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.682 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 6.1 pt -101.18 -177.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.966 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.772 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.7 OUTLIER -145.86 162.26 38.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.357 0.598 . . . . 0.0 111.193 -178.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 26.6 ttt180 -174.01 112.96 0.19 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.051 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 11.1 t -82.19 129.57 34.87 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.817 0.817 . . . . 0.0 111.326 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.477 ' O ' HD12 ' A' ' 44' ' ' ILE . 2.1 mt-10 -98.13 147.72 24.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.002 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -67.08 101.48 0.88 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.028 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 1.9 mp -107.67 87.39 3.5 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.56 ' C ' HG21 ' A' ' 98' ' ' VAL . 73.2 Cg_endo -75.86 160.29 37.44 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.66 2.24 . . . . 0.0 112.688 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.593 ' HB3' HG22 ' A' ' 98' ' ' VAL . 33.5 p90 -87.15 -176.92 5.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.985 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.5 ' OE1' HD13 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -158.43 115.13 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.841 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.713 HG22 ' CB ' ' A' ' 101' ' ' GLN . 3.1 t -67.17 143.83 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.132 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.5 HD13 ' OE1' ' A' ' 47' ' ' GLU . 33.4 mm -115.84 156.19 16.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.118 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.449 ' N ' HG22 ' A' ' 49' ' ' ILE . 13.1 ptmt -108.74 109.57 20.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -119.82 153.21 36.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -87.91 129.5 35.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.971 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.436 ' ND2' HD23 ' A' ' 56' ' ' LEU . 5.8 t-20 -122.17 96.5 46.37 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.09 -23.97 45.45 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.392 2.061 . . . . 0.0 112.333 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -59.69 -28.97 67.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.991 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.546 HD12 ' CD ' ' A' ' 60' ' ' GLN . 3.1 mm? -83.18 165.29 41.7 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.742 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -80.84 43.39 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.076 2.518 . . . . 0.0 112.743 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.88 142.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.939 0.399 . . . . 0.0 111.437 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 55.17 25.85 40.93 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.876 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.546 ' CD ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -109.38 136.84 48.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 0.0 110.979 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -101.2 162.57 12.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.59 ' ND2' HD11 ' A' ' 64' ' ' ILE . 46.2 t30 -156.32 111.85 2.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.86 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.815 HD13 HG12 ' A' ' 103' ' ' VAL . 36.7 mm -85.65 86.12 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.138 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.59 HD11 ' ND2' ' A' ' 62' ' ' ASN . 36.9 mm -64.53 -36.07 76.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.953 0.406 . . . . 0.0 110.712 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.661 HG22 ' HB ' ' A' ' 102' ' ' VAL . 9.7 t -166.56 100.35 0.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.554 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.41 135.02 28.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.753 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.467 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -66.0 134.27 34.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.273 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -130.2 132.21 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.907 0.384 . . . . 0.0 111.3 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.458 ' HD3' ' CD2' ' A' ' 46' ' ' PHE . 10.7 mmtt -57.12 125.96 25.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.229 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.453 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -105.49 -159.55 23.0 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.051 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.497 ' HA ' HD12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -162.47 154.62 18.88 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.622 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.587 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 14.0 ttt180 -143.67 111.77 6.22 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.576 ' O ' ' HB2' ' A' ' 92' ' ' SER . 64.2 m -72.99 121.46 20.14 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.569 ' O ' ' HA ' ' A' ' 39' ' ' THR . 18.7 m80 -102.26 120.3 40.24 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.772 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -86.02 122.27 29.82 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.679 -1.601 . . . . 0.0 110.767 -178.238 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.802 HG23 ' C ' ' A' ' 88' ' ' THR . 4.2 mp -116.14 141.78 32.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.282 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.678 ' HB2' HD13 ' A' ' 90' ' ' LEU . 0.2 OUTLIER -105.24 98.06 7.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.829 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.522 ' O ' HG13 ' A' ' 78' ' ' VAL . 12.5 p -81.45 117.9 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.159 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.562 HD13 ' N ' ' A' ' 80' ' ' THR . 2.4 tm? -105.45 124.33 49.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.562 ' N ' HD13 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -84.78 91.24 7.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.549 ' HB2' HD12 ' A' ' 79' ' ' LEU . 5.1 tt0 -123.16 135.96 54.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.2 m120 61.15 30.49 19.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.87 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.54 47.67 81.52 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.597 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.55 142.7 12.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.774 0.321 . . . . 0.0 110.862 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.449 HG22 HG22 ' A' ' 78' ' ' VAL . 0.8 OUTLIER -102.18 120.79 41.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.889 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 t -105.05 125.86 51.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.866 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.37 107.3 19.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.876 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.802 ' C ' HG23 ' A' ' 76' ' ' ILE . 97.3 m -133.71 112.75 11.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.923 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.56 HG12 HG13 ' A' ' 76' ' ' ILE . 22.3 m -56.61 162.37 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.966 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.678 HD13 ' HB2' ' A' ' 77' ' ' SER . 1.2 mp -149.18 -56.72 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.343 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.509 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 1.4 t70 -140.65 134.73 30.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.479 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.576 ' HB2' ' O ' ' A' ' 73' ' ' THR . 17.8 p -143.21 133.33 24.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.308 0.575 . . . . 0.0 111.319 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.562 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 3.4 pt20 -89.52 166.58 13.58 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 94' ' ' VAL . 5.2 m -85.67 107.3 16.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.564 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 20.0 p -114.22 83.01 1.8 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.192 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.564 ' CB ' ' O ' ' A' ' 95' ' ' THR . 20.2 tptm 107.53 48.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.741 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -33.72 122.24 0.44 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.755 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.593 HG22 ' HB3' ' A' ' 46' ' ' PHE . 12.6 p -71.61 109.89 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.212 0.529 . . . . 0.0 111.052 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 34.8 mm -68.72 116.22 8.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.221 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 20.8 m-20 -81.52 129.33 34.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.726 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.713 ' CB ' HG22 ' A' ' 48' ' ' VAL . 12.8 tt0 -62.09 112.36 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.96 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.661 ' HB ' HG22 ' A' ' 65' ' ' THR . 58.1 t -95.4 99.73 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.954 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.815 HG12 HD13 ' A' ' 63' ' ' ILE . 25.5 m -122.85 135.72 61.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.133 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -119.8 108.5 14.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.735 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.0 t -91.41 142.0 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.069 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.81 147.1 37.63 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.552 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.655 0.264 . . . . 0.0 111.135 -179.922 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 CA--C 1.529 0.253 0 N-CA-C 112.594 0.19 . . . . 12.38 112.594 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.483 ' O ' HG22 ' A' ' 78' ' ' VAL . 11.1 tp10 -147.71 112.03 5.24 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.284 -0.416 . . . . 13.36 110.467 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 mp -72.74 111.49 7.94 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.181 -0.463 . . . . 10.56 110.764 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.678 HG13 ' HB ' ' A' ' 76' ' ' ILE . 28.6 pt -99.44 121.0 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-O 121.722 0.772 . . . . 11.62 109.665 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.699 ' HB ' ' CG2' ' A' ' 73' ' ' THR . 6.3 p -87.13 139.39 30.62 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.018 -0.992 . . . . 10.51 111.111 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 7.1 ttt-85 -155.51 117.98 4.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.807 -1.088 . . . . 12.83 108.914 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 68.4 p -79.81 127.49 32.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.503 0.668 . . . . 9.41 110.887 -178.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -96.9 139.41 32.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.639 -1.164 . . . . 8.52 109.83 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.86 97.82 0.37 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.962 -0.563 . . . . 10.74 110.691 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.739 HD12 ' H ' ' A' ' 72' ' ' ARG . 7.5 mt -99.19 103.01 17.59 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 115.43 -0.805 . . . . 6.29 109.585 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.627 ' C ' HG21 ' A' ' 98' ' ' VAL . 90.5 Cg_endo -78.24 145.63 21.74 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.316 2.677 . . . . 6.46 114.363 -177.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.548 ' HB2' ' HA ' ' A' ' 100' ' ' ASN . 39.1 p90 -86.73 -179.82 6.63 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.278 -0.874 . . . . 7.25 111.175 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.07 117.19 6.83 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.397 -0.365 . . . . 6.08 111.678 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.823 HG13 ' HB3' ' A' ' 101' ' ' GLN . 21.9 t -66.11 134.61 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.039 -0.528 . . . . 6.99 111.536 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.9 mm -123.48 139.76 49.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.278 -0.419 . . . . 8.71 111.49 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -100.19 108.19 20.23 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.881 -0.6 . . . . 10.39 110.394 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.95 106.18 16.57 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.079 -0.509 . . . . 12.29 111.155 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -61.64 105.53 0.55 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.822 0.344 . . . . 14.65 110.524 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 0.8 OUTLIER -108.34 119.82 48.46 Favored Pre-proline 0 C--O 1.232 0.173 0 CA-C-N 116.087 -0.506 . . . . 15.73 111.442 -179.192 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.56 -24.6 18.64 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.785 2.324 . . . . 18.25 112.371 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -61.76 -39.1 90.45 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.421 -0.354 . . . . 19.33 111.183 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.503 HD21 ' CB ' ' A' ' 62' ' ' ASN . 1.0 OUTLIER -63.58 164.27 16.49 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.495 -0.32 . . . . 17.22 110.905 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.77 -74.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.769 2.313 . . . . 17.35 113.301 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -178.76 122.51 0.09 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.098 -0.955 . . . . 15.79 111.205 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.21 29.1 62.38 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.189 -0.529 . . . . 13.8 113.025 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.436 ' O ' HD22 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -106.09 136.69 45.33 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.701 0.25 . . . . 15.46 110.501 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.26 113.4 25.02 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.888 0.375 . . . . 13.22 111.335 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.503 ' CB ' HD21 ' A' ' 56' ' ' LEU . 1.5 t-20 -106.22 111.99 24.82 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.893 -0.594 . . . . 14.38 109.948 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.416 HG12 HG13 ' A' ' 103' ' ' VAL . 24.2 mt -85.58 122.51 38.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.095 0.474 . . . . 13.39 111.851 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.417 HD11 ' OD1' ' A' ' 62' ' ' ASN . 44.4 mm -100.52 -39.7 7.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.374 -0.83 . . . . 13.85 109.841 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.812 HG22 HG23 ' A' ' 99' ' ' ILE . 0.2 OUTLIER -135.54 99.0 4.08 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.682 -0.69 . . . . 11.74 109.815 179.517 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.4 113.72 1.14 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.02 -0.536 . . . . 10.75 112.074 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.44 ' H ' ' HG2' ' A' ' 101' ' ' GLN . . . -58.7 109.33 1.95 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.871 -0.604 . . . . 8.47 112.314 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.5 t -135.1 144.56 34.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.91 0.386 . . . . 10.08 111.251 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -67.48 116.3 8.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.716 -0.675 . . . . 10.15 111.125 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.491 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -81.96 -171.55 46.18 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.154 -0.546 . . . . 7.45 112.107 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.562 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -158.72 109.18 2.05 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.461 -0.57 . . . . 10.04 109.461 179.499 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.739 ' H ' HD12 ' A' ' 44' ' ' ILE . 36.5 ttm180 -98.18 124.8 42.94 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.554 -0.536 . . . . 6.27 109.554 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.699 ' CG2' ' HB ' ' A' ' 39' ' ' THR . 95.1 m -74.76 125.37 28.62 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 107.719 -1.215 . . . . 8.55 107.719 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.593 ' HD2' HG23 ' A' ' 89' ' ' VAL . 19.8 m80 -105.66 114.88 29.3 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.927 0.87 . . . . 8.1 112.647 -177.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.694 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -80.09 92.47 5.64 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 113.67 -1.605 . . . . 8.08 109.086 -178.363 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.678 ' HB ' HG13 ' A' ' 38' ' ' ILE . 74.1 mt -88.16 154.86 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 113.411 -1.722 . . . . 10.77 112.474 -177.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.7 t -105.17 121.35 43.63 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.292 -0.413 . . . . 11.99 110.34 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.505 ' CG1' HD13 ' A' ' 38' ' ' ILE . 3.9 m -81.76 98.23 4.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.05 0.452 . . . . 13.47 111.351 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.0 mt -103.68 106.85 17.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.967 -0.56 . . . . 15.75 110.209 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 p -73.56 93.88 2.08 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.207 -0.451 . . . . 17.62 111.194 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -90.74 93.99 9.48 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.994 -0.548 . . . . 20.19 110.26 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 58.5 45.6 16.2 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.098 -0.501 . . . . 22.51 110.773 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.76 47.71 6.56 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.108 -0.568 . . . . 21.28 112.713 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -162.13 108.07 1.27 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.657 0.265 . . . . 21.24 111.114 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.4 p -75.72 97.74 3.92 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.239 -0.437 . . . . 17.93 110.653 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 58.9 m -77.37 110.25 11.96 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.092 -0.504 . . . . 16.48 110.751 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.51 ' HB2' HG21 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -80.79 96.34 6.94 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.112 0.482 . . . . 14.73 110.636 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 45.1 m -108.79 126.15 52.72 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.959 -0.564 . . . . 13.13 111.4 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.593 HG23 ' HD2' ' A' ' 74' ' ' HIS . 3.1 p -59.16 134.89 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.066 -0.516 . . . . 10.29 110.134 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 32.2 mt -137.64 -83.94 0.32 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.147 0.425 . . . . 10.3 112.147 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.81 122.1 44.4 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.563 0.221 . . . . 8.61 111.343 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.649 ' HB2' ' O ' ' A' ' 73' ' ' THR . 1.3 p -145.29 148.94 34.0 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.189 0.519 . . . . 6.47 111.656 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.636 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 19.0 mm-40 -108.65 164.64 12.19 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.032 -1.47 . . . . 9.38 107.032 176.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.68 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 12.3 p -82.22 112.68 20.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.292 -0.563 . . . . 7.93 110.544 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 31.9 p -117.61 72.08 0.83 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.671 0.748 . . . . 8.27 110.612 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 149.37 -43.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.07 -1.423 . . . . 11.5 108.826 178.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.445 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 9.3 tp10 64.55 115.32 0.02 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.327 -0.851 . . . . 8.74 111.571 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.627 HG21 ' C ' ' A' ' 45' ' ' PRO . 11.1 p -71.21 103.24 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.373 0.606 . . . . 6.07 110.107 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.812 HG23 HG22 ' A' ' 65' ' ' THR . 4.5 mp -71.68 118.97 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.424 -0.807 . . . . 9.43 110.962 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.548 ' HA ' ' HB2' ' A' ' 46' ' ' PHE . 4.1 m120 -82.69 133.1 35.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.846 -0.615 . . . . 7.9 110.102 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.823 ' HB3' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -59.64 98.46 0.05 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.422 -0.354 . . . . 8.78 111.032 -179.435 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 76.0 t -90.72 99.11 9.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.862 -0.421 . . . . 10.47 109.862 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.495 HG22 ' NE2' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -115.01 125.39 72.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.949 -0.569 . . . . 10.33 111.177 -179.102 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 53' ' ' ASN . 17.0 mm-40 -96.52 110.29 22.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.822 -0.627 . . . . 13.72 110.248 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.7 t -85.98 115.55 27.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.226 -0.443 . . . . 12.91 110.992 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.414 ' HA2' ' HB2' ' A' ' 56' ' ' LEU . . . -61.8 132.02 46.48 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.015 -0.612 . . . . 13.96 112.721 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.361 0.124 . . . . 15.72 110.933 179.807 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.849 0.27 . . . . 0.0 112.348 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -169.38 128.05 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.88 131.25 35.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.824 HD12 ' HB ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER -101.12 -177.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.698 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.748 HG22 ' CD1' ' A' ' 75' ' ' TYR . 1.0 OUTLIER -163.31 121.08 1.91 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.113 0.482 . . . . 0.0 110.669 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.45 ' HG3' HD13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -142.56 109.72 5.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.774 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.563 HG21 ' OE1' ' A' ' 71' ' ' GLU . 11.3 t -82.52 128.28 34.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.511 0.672 . . . . 0.0 111.407 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.574 ' O ' HD12 ' A' ' 44' ' ' ILE . 1.3 mt-10 -98.31 146.01 26.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.744 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.77 91.67 0.2 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.803 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.577 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.7 mp -89.62 108.23 23.85 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.885 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.455 ' C ' HG21 ' A' ' 98' ' ' VAL . 1.9 Cg_endo -81.95 157.43 18.07 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.941 2.427 . . . . 0.0 112.596 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.449 ' HB3' ' CG2' ' A' ' 98' ' ' VAL . 42.2 p90 -86.57 -174.4 4.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.74 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.99 116.54 3.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.874 HG22 ' CB ' ' A' ' 101' ' ' GLN . 43.2 t -67.29 148.76 11.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.051 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 50' ' ' LYS . 37.9 mm -123.82 156.16 30.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.013 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.446 ' N ' HG22 ' A' ' 49' ' ' ILE . 1.9 pttp -119.42 100.86 7.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.414 ' O ' HG12 ' A' ' 105' ' ' VAL . 8.1 mttm -105.56 141.72 36.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 3.3 pt-20 -104.79 124.89 50.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -128.67 133.29 25.03 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.12 -20.77 12.61 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.468 2.112 . . . . 0.0 112.541 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -55.06 -38.49 68.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.06 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.552 HD22 ' NE2' ' A' ' 60' ' ' GLN . 21.2 mt -62.82 159.64 43.34 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.763 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -80.24 44.98 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.039 2.493 . . . . 0.0 112.724 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.61 125.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.934 0.397 . . . . 0.0 111.424 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.44 53.63 41.92 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.779 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.552 ' NE2' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -109.46 162.91 13.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.746 0.308 . . . . 0.0 110.894 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -145.16 113.92 6.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -143.12 122.54 13.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.2 mt -86.59 131.18 35.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.09 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.5 mm -99.59 -44.24 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.9 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.6 m -144.28 102.25 3.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.659 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.417 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -53.81 153.4 4.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.483 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.59 131.29 10.32 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.19 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -140.62 136.36 35.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.869 0.366 . . . . 0.0 111.132 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -63.12 124.87 22.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 98' ' ' VAL . . . -97.99 -151.98 27.77 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.888 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.563 ' OE1' HG21 ' A' ' 41' ' ' THR . 0.3 OUTLIER -161.03 148.1 15.19 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.577 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 5.2 ttt180 -140.21 111.22 6.98 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.724 ' O ' ' HB2' ' A' ' 92' ' ' SER . 19.1 m -73.58 126.81 31.11 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.461 ' HA ' ' CB ' ' A' ' 92' ' ' SER . 20.3 m80 -107.55 119.72 40.21 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.042 0.925 . . . . 0.0 112.893 -177.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.748 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.1 OUTLIER -91.15 102.72 15.45 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 113.651 -1.613 . . . . 0.0 111.146 -177.529 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.824 ' HB ' HD12 ' A' ' 38' ' ' ILE . 4.8 mp -87.86 160.15 2.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.952 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.771 ' HB2' HD23 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -98.45 126.8 44.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.685 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.501 HG22 HD11 ' A' ' 38' ' ' ILE . 21.6 t -81.43 109.86 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.254 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.4 mt -115.75 103.53 10.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.841 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.33 123.19 34.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.831 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -129.55 93.09 3.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 61.24 36.24 17.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.964 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.82 46.13 5.22 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.442 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.01 114.64 7.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.812 0.339 . . . . 0.0 110.872 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.85 112.09 23.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.856 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.95 150.73 21.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.96 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.421 ' HA ' HG21 ' A' ' 76' ' ' ILE . 18.9 mt-10 -107.77 99.54 9.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 94.1 m -115.37 116.5 28.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.922 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.1 m -50.01 123.67 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.771 HD23 ' HB2' ' A' ' 77' ' ' SER . 0.2 OUTLIER -110.53 -67.87 0.96 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.216 -179.667 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.51 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -163.13 141.97 8.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.299 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.724 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.6 p -143.56 151.08 39.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.448 0.642 . . . . 0.0 111.394 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.681 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 12.8 mm-40 -110.01 166.96 10.53 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 94' ' ' VAL . 8.3 p -84.95 106.93 15.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.007 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.585 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 15.4 p -111.82 82.61 1.65 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.76 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.585 ' CB ' ' O ' ' A' ' 95' ' ' THR . 21.0 tttt 109.92 48.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.585 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 96' ' ' LYS . 1.2 pm0 -32.43 125.47 0.31 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.819 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.455 HG21 ' C ' ' A' ' 45' ' ' PRO . 4.3 p -71.7 119.14 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.03 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 66' ' ' ALA . 34.8 mm -70.05 115.96 10.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.919 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -90.36 130.9 36.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.874 ' CB ' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -68.57 127.36 32.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.85 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 102' ' ' VAL . 5.5 m -126.5 99.73 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.188 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 103' ' ' VAL . 11.9 p -108.25 116.53 51.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.015 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -87.1 108.55 18.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 51' ' ' LYS . 12.6 p -98.36 137.73 25.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.5 ' CA ' HD12 ' A' ' 56' ' ' LEU . . . -72.66 130.85 15.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.511 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . . . . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 111.063 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo . . . . . 0 C--O 1.231 0.14 0 CA-C-O 120.788 0.245 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.437 ' HG3' HG12 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -98.01 -179.18 4.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.916 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.1 mt -111.36 115.69 29.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.949 0.404 . . . . 0.0 111.132 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.65 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -101.11 -176.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.525 179.273 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.843 HG22 ' CD1' ' A' ' 75' ' ' TYR . 1.4 p -158.03 140.12 14.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.345 0.593 . . . . 0.0 111.079 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.507 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 33.9 ttp180 -161.23 107.07 1.38 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.02 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.599 HG21 ' CD ' ' A' ' 71' ' ' GLU . 14.8 t -81.93 132.43 35.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.709 0.766 . . . . 0.0 111.706 -178.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.579 ' O ' HD12 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -98.56 144.69 27.6 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.574 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -66.77 91.68 0.2 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.854 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.581 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 3.2 mp -85.19 111.04 33.37 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.783 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.528 ' C ' HG21 ' A' ' 98' ' ' VAL . 81.4 Cg_endo -87.46 153.41 7.81 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.667 2.245 . . . . 0.0 112.849 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.604 ' HB3' HG22 ' A' ' 98' ' ' VAL . 49.9 p90 -87.07 -176.83 5.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.782 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -149.57 112.46 4.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.098 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.718 HG22 ' HB3' ' A' ' 101' ' ' GLN . 16.4 t -67.22 149.23 11.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.031 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.441 HG22 ' N ' ' A' ' 50' ' ' LYS . 33.0 mm -125.79 156.06 35.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.184 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.441 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -119.03 100.93 7.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.778 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.89 137.59 38.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -93.81 102.73 14.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.899 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -102.57 96.56 7.59 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.838 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.65 -18.06 48.11 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.461 2.108 . . . . 0.0 112.488 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -58.16 -31.5 67.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.977 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.729 HD22 ' HG2' ' A' ' 60' ' ' GLN . 11.3 mt -76.07 165.4 53.36 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.799 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -83.9 42.34 1.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.13 2.553 . . . . 0.0 112.606 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.06 150.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.843 0.354 . . . . 0.0 111.314 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 55.2 27.15 45.46 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.616 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.729 ' HG2' HD22 ' A' ' 56' ' ' LEU . 51.7 tp60 -95.49 116.14 28.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 110.907 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -110.91 134.88 52.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.798 ' O ' HG23 ' A' ' 103' ' ' VAL . 25.9 p-10 -151.13 161.9 41.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.9 mm -126.49 95.9 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.101 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.7 mm -72.88 -31.79 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.98 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.9 m -163.42 96.2 0.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.708 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.485 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -53.87 151.77 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.483 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.459 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -93.4 120.89 6.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.33 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.39 133.75 57.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.823 0.344 . . . . 0.0 111.152 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.691 ' HA ' HG23 ' A' ' 98' ' ' VAL . 1.2 mtmp? -59.27 125.74 24.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.156 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.415 ' HA2' ' HG3' ' A' ' 96' ' ' LYS . . . -96.05 -141.01 11.46 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.999 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.599 ' CD ' HG21 ' A' ' 41' ' ' THR . 0.3 OUTLIER -166.71 141.94 4.31 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.815 ' NE ' HG12 ' A' ' 94' ' ' VAL . 22.4 ttm180 -136.11 111.11 8.87 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.736 ' O ' ' HB3' ' A' ' 92' ' ' SER . 32.8 m -73.78 124.92 26.98 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.516 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 3.6 m-70 -105.08 117.0 32.91 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 122.082 0.944 . . . . 0.0 113.191 -176.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.843 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.1 OUTLIER -89.55 100.72 13.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 113.611 -1.631 . . . . 0.0 110.98 -178.082 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.504 HG22 ' N ' ' A' ' 77' ' ' SER . 4.5 mp -87.56 161.17 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.281 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.725 ' HB3' HD23 ' A' ' 90' ' ' LEU . 5.3 t -107.82 112.85 25.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.721 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 78' ' ' VAL . 8.8 p -81.54 102.19 7.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.017 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 tp -110.1 108.9 19.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.945 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 80' ' ' THR . 9.9 t -86.0 107.55 17.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.814 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -104.85 93.22 4.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.847 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 60.4 31.14 20.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.83 43.16 3.4 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.561 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 11.4 ttpt -149.16 112.66 5.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.792 0.33 . . . . 0.0 110.891 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.486 HG22 ' CG2' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -100.77 110.42 22.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.855 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.86 132.04 50.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.936 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.76 99.63 11.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.951 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.3 t -113.93 125.47 54.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.927 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.3 m -51.04 115.68 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.094 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.725 HD23 ' HB3' ' A' ' 77' ' ' SER . 0.1 OUTLIER -100.84 -63.42 1.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.533 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -166.04 136.58 3.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.009 -179.739 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.736 ' HB3' ' O ' ' A' ' 73' ' ' THR . 0.8 OUTLIER -143.59 150.1 38.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.547 0.689 . . . . 0.0 111.576 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.617 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -109.46 166.47 10.86 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.377 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.815 HG12 ' NE ' ' A' ' 72' ' ' ARG . 30.9 m -85.23 106.79 15.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.06 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.568 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 16.9 p -110.95 82.56 1.61 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.714 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 95' ' ' THR . 2.5 tppt? 132.4 -39.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.631 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 59.09 121.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.556 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.691 HG23 ' HA ' ' A' ' 69' ' ' LYS . 8.2 p -81.71 114.47 22.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.737 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.592 ' H ' HD12 ' A' ' 99' ' ' ILE . 4.6 mp -75.32 132.18 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -93.72 140.49 29.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.962 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.718 ' HB3' HG22 ' A' ' 48' ' ' VAL . 1.6 tp60 -77.12 114.4 15.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.94 99.7 9.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.046 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 62' ' ' ASN . 11.7 p -121.19 119.56 59.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -93.37 133.16 36.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.839 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.3 m -112.27 123.27 67.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.232 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.77 123.79 19.69 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.449 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 120.767 0.318 . . . . 0.0 111.068 -179.999 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 C--O 1.23 0.097 0 CA-C-O 120.768 0.237 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -168.82 113.73 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.814 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mp -76.95 132.49 39.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.045 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.708 HD12 ' HB ' ' A' ' 76' ' ' ILE . 0.5 OUTLIER -101.26 -177.06 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.783 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.792 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.9 OUTLIER -163.67 123.02 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.178 0.513 . . . . 0.0 110.342 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.609 ' HG3' HD13 ' A' ' 76' ' ' ILE . 2.8 mtm180 -149.6 109.36 4.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.29 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.536 HG21 ' OE1' ' A' ' 71' ' ' GLU . 14.9 t -82.41 133.22 35.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.71 0.767 . . . . 0.0 111.872 -178.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.583 ' O ' HD12 ' A' ' 44' ' ' ILE . 3.0 mt-10 -98.35 147.64 24.47 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.453 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.403 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -66.68 98.32 0.51 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.884 -179.355 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.583 HD12 ' O ' ' A' ' 42' ' ' GLU . 2.9 mp -95.9 105.43 21.28 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.576 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.522 ' C ' HG21 ' A' ' 98' ' ' VAL . 87.7 Cg_endo -84.69 150.36 11.37 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.719 2.279 . . . . 0.0 113.171 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.669 ' HB3' HG22 ' A' ' 98' ' ' VAL . 43.0 p90 -86.87 -175.06 5.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.939 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.67 116.53 5.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.239 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.709 HG22 ' CB ' ' A' ' 101' ' ' GLN . 61.6 t -67.23 149.68 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.122 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.748 HD12 ' O ' ' A' ' 101' ' ' GLN . 4.0 mp -115.65 156.2 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.005 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.44 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.9 OUTLIER -122.92 107.76 12.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -115.25 165.82 12.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.905 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -112.81 138.51 49.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.402 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 6.3 m-20 -138.27 96.52 9.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.921 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 53' ' ' ASN . 37.3 Cg_endo -66.02 -20.8 57.15 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.413 2.075 . . . . 0.0 112.438 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -58.3 -29.63 66.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.994 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.473 HD22 ' NE2' ' A' ' 60' ' ' GLN . 3.5 mt -70.97 165.96 42.4 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.878 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.29 46.79 2.2 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.117 2.545 . . . . 0.0 112.796 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.25 126.48 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.832 0.349 . . . . 0.0 111.641 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 51.67 55.88 18.31 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.928 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.473 ' NE2' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -109.4 144.06 38.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.786 0.327 . . . . 0.0 110.951 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -104.4 130.08 52.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.926 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.525 ' ND2' HD11 ' A' ' 64' ' ' ILE . 48.9 t30 -146.58 127.86 14.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.982 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.858 HD13 HG12 ' A' ' 103' ' ' VAL . 25.0 mm -104.99 90.99 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.034 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.525 HD11 ' ND2' ' A' ' 62' ' ' ASN . 36.6 mm -65.47 -32.67 59.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.549 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.688 HG22 ' HB ' ' A' ' 102' ' ' VAL . 5.3 t -161.38 128.3 3.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.398 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.48 135.37 35.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 111.419 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.43 ' HA3' ' CE2' ' A' ' 46' ' ' PHE . . . -81.98 134.95 13.6 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.308 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.641 ' H ' HG23 ' A' ' 99' ' ' ILE . 16.5 t -145.16 142.95 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 111.088 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.69 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -72.56 119.7 17.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.344 -179.585 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.436 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -89.84 -139.91 7.79 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.639 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.536 ' OE1' HG21 ' A' ' 41' ' ' THR . 0.9 OUTLIER -169.64 146.91 3.4 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.547 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 2.5 ttt180 -134.91 111.67 10.04 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.699 ' O ' ' HB3' ' A' ' 92' ' ' SER . 37.4 m -73.84 126.65 30.88 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.527 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 3.9 m-70 -105.82 117.37 33.84 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 122.148 0.975 . . . . 0.0 112.753 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.792 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.1 OUTLIER -90.37 100.1 13.0 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 113.57 -1.65 . . . . 0.0 111.075 -177.82 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.708 ' HB ' HD12 ' A' ' 38' ' ' ILE . 3.1 mp -87.8 159.9 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.726 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.695 ' HB2' HD22 ' A' ' 90' ' ' LEU . 40.0 t -102.83 126.71 50.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.828 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 78' ' ' VAL . 29.1 m -81.51 106.29 12.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.203 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.71 HD13 ' N ' ' A' ' 80' ' ' THR . 1.7 tm? -112.47 130.99 55.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.943 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.71 ' N ' HD13 ' A' ' 79' ' ' LEU . 0.8 OUTLIER -98.6 135.8 39.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.898 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -152.22 115.65 4.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.826 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.8 m120 60.07 34.96 21.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.966 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.98 29.5 66.89 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.509 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -128.3 165.0 21.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.915 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.03 120.32 41.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.97 151.02 22.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.778 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.27 121.97 40.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 98.9 m -144.79 123.07 12.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.967 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 p -58.21 131.99 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.834 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.695 HD22 ' HB2' ' A' ' 77' ' ' SER . 2.2 tp -116.04 -55.54 2.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.296 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 3.6 t0 -169.45 136.91 1.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.482 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.699 ' HB3' ' O ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -143.66 145.23 32.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.387 0.613 . . . . 0.0 111.261 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.605 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 34.5 mm-40 -106.89 165.86 11.02 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.608 HG13 ' O ' ' A' ' 94' ' ' VAL . 9.0 p -85.88 106.93 15.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.4 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.515 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 9.7 p -111.71 82.11 1.56 Allowed 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.656 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 95' ' ' THR . 0.0 OUTLIER 140.96 -36.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.642 178.94 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 56.44 115.02 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.821 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.69 HG23 ' HA ' ' A' ' 69' ' ' LYS . 14.9 p -81.49 106.29 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.535 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.641 HG23 ' H ' ' A' ' 68' ' ' VAL . 4.1 tt -79.42 133.01 30.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.304 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.428 ' HA ' ' HB2' ' A' ' 46' ' ' PHE . 27.9 m-20 -92.49 161.75 14.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.888 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.772 ' OE1' HG13 ' A' ' 103' ' ' VAL . 0.8 OUTLIER -96.8 140.54 31.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.688 ' HB ' HG22 ' A' ' 65' ' ' THR . 84.2 t -126.1 118.68 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.988 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.858 HG12 HD13 ' A' ' 63' ' ' ILE . 4.4 m -131.25 145.63 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.0 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -116.18 108.38 16.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.26 110.74 20.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.41 133.28 50.3 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.506 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.637 0.256 . . . . 0.0 111.151 179.969 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.813 0.255 . . . . 0.0 112.228 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -93.75 148.89 21.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.657 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.83 117.23 34.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.11 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.705 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 1.1 pp -101.2 -176.72 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.09 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.857 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -149.66 152.58 35.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.257 0.551 . . . . 0.0 111.025 -179.276 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 74' ' ' HIS . 19.5 ttt-85 -170.05 111.62 0.44 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.003 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 14.9 t -82.16 131.78 35.24 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.828 0.823 . . . . 0.0 111.478 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.505 ' O ' HD12 ' A' ' 44' ' ' ILE . 0.7 OUTLIER -98.15 149.72 22.23 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.871 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -66.95 105.53 1.65 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.059 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.576 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.4 mp -107.73 100.41 34.89 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.867 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.539 ' C ' HG21 ' A' ' 98' ' ' VAL . 2.8 Cg_endo -84.99 156.86 11.44 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.038 2.492 . . . . 0.0 112.581 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.623 ' HB3' HG22 ' A' ' 98' ' ' VAL . 46.5 p90 -87.13 -174.25 4.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.013 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -153.35 109.05 3.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.986 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.572 HG23 ' HG2' ' A' ' 101' ' ' GLN . 10.4 p -67.42 154.06 8.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.196 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.6 mp -124.79 156.15 33.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.045 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -107.27 100.81 10.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.8 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -90.43 147.7 23.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.965 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -107.95 102.97 12.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.538 ' HB2' HD12 ' A' ' 56' ' ' LEU . 2.5 m120 -94.16 102.83 9.07 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.61 -26.91 46.06 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.406 2.071 . . . . 0.0 112.271 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -69.41 -31.48 69.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.572 HD22 ' HB3' ' A' ' 60' ' ' GLN . 21.4 mt -63.59 163.23 21.53 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -86.86 31.0 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.818 2.345 . . . . 0.0 112.948 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 56.85 104.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.266 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 118.25 -25.35 8.29 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.634 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.572 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -70.63 134.9 47.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 0.0 110.868 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -137.96 128.44 26.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.533 ' ND2' HD11 ' A' ' 64' ' ' ILE . 24.6 p-10 -128.14 148.61 50.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.771 HD13 HG12 ' A' ' 103' ' ' VAL . 29.0 mm -97.65 86.33 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.147 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.533 HD11 ' ND2' ' A' ' 62' ' ' ASN . 29.2 mm -62.24 -35.82 71.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.812 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.3 m -164.28 90.98 0.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.629 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.401 ' HB2' HG21 ' A' ' 63' ' ' ILE . . . -52.12 150.97 4.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.52 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.429 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -88.86 134.69 12.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.338 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.405 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.4 t -132.41 132.43 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.856 0.36 . . . . 0.0 111.204 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.0 mttp -56.07 126.2 24.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.184 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' A' ' 96' ' ' LYS . . . -99.81 -157.44 28.47 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.129 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.481 ' HA ' HD12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -159.94 151.4 19.79 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.576 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 36.7 ttt180 -141.9 110.91 6.27 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.633 ' O ' ' HB2' ' A' ' 92' ' ' SER . 96.0 m -73.33 121.24 20.11 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.536 ' O ' ' HA ' ' A' ' 39' ' ' THR . 13.7 m80 -102.94 121.55 42.77 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.795 0.807 . . . . 0.0 113.133 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.857 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -89.55 107.78 19.28 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 113.857 -1.52 . . . . 0.0 111.273 -177.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.675 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.5 mp -98.69 159.24 3.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.896 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.634 ' OG ' HD13 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -115.14 113.47 24.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.867 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.57 ' O ' HG13 ' A' ' 78' ' ' VAL . 11.3 p -81.45 113.15 20.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.13 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.33 107.01 15.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.855 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.6 m -76.46 104.05 6.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.992 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -115.3 108.47 16.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.783 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 60.58 35.3 20.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.98 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.84 47.46 25.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.475 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.89 107.41 3.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.785 0.326 . . . . 0.0 110.877 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 p -79.79 125.22 29.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.3 p -123.67 150.98 43.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.95 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -105.59 113.89 27.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.4 t -123.24 123.25 40.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.944 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.3 m -57.66 129.45 19.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.99 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.634 HD13 ' OG ' ' A' ' 77' ' ' SER . 3.1 tp -119.12 -58.15 1.96 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.15 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.521 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 1.9 t70 -166.29 140.78 4.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.273 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.633 ' HB2' ' O ' ' A' ' 73' ' ' THR . 17.2 p -143.15 149.26 37.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.33 0.586 . . . . 0.0 111.12 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.567 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 7.0 pt20 -105.46 166.88 10.12 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.5 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 26.0 t -85.31 106.6 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.122 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 21.8 p -113.07 83.05 1.76 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.13 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 95' ' ' THR . 0.0 OUTLIER 105.55 48.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.853 -179.662 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -33.63 126.2 0.4 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.853 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.623 HG22 ' HB3' ' A' ' 46' ' ' PHE . 10.0 p -71.76 112.5 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.98 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.599 ' H ' HD12 ' A' ' 99' ' ' ILE . 5.2 mp -72.1 126.79 33.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.021 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -87.32 133.44 33.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.814 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.572 ' HG2' HG23 ' A' ' 48' ' ' VAL . 5.3 tt0 -67.33 150.02 49.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.955 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.24 100.51 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.069 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.771 HG12 HD13 ' A' ' 63' ' ' ILE . 4.0 m -119.08 106.76 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.014 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -94.46 109.86 21.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.5 m -105.27 141.0 21.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.138 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.21 147.7 50.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.535 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 120.712 0.291 . . . . 0.0 111.037 -179.964 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 CA--C 1.526 0.113 0 CA-C-O 120.786 0.244 . . . . 0.0 112.287 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -170.52 128.65 0.82 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.861 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.1 mt -84.09 123.34 29.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.986 0.422 . . . . 0.0 111.069 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.763 HD12 ' N ' ' A' ' 39' ' ' THR . 1.1 pp -101.08 -176.37 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.202 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.852 HG22 ' CD1' ' A' ' 75' ' ' TYR . 1.8 p -157.34 142.8 17.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.318 0.58 . . . . 0.0 110.901 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.589 ' HG2' HD13 ' A' ' 76' ' ' ILE . 2.6 ptp85 -162.59 107.33 1.15 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.206 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.455 ' HB ' ' HA ' ' A' ' 73' ' ' THR . 15.4 t -82.28 129.86 34.96 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.768 0.794 . . . . 0.0 111.604 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.596 ' O ' HD12 ' A' ' 44' ' ' ILE . 0.6 OUTLIER -98.29 146.3 25.8 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.678 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -66.81 94.83 0.33 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.952 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.596 HD12 ' O ' ' A' ' 42' ' ' GLU . 3.2 mp -87.07 109.88 28.53 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.949 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.419 ' C ' HG21 ' A' ' 98' ' ' VAL . 6.3 Cg_exo -78.65 152.91 26.18 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.843 2.362 . . . . 0.0 112.563 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.479 ' HB3' ' CG2' ' A' ' 98' ' ' VAL . 52.6 p90 -86.68 -178.58 6.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -138.83 111.67 7.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.961 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.621 HG13 ' CD ' ' A' ' 101' ' ' GLN . 46.2 t -67.45 141.95 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.079 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.438 HG22 ' N ' ' A' ' 50' ' ' LYS . 27.3 mt -130.42 156.07 42.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.103 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.438 ' N ' HG22 ' A' ' 49' ' ' ILE . 1.6 ptpp? -131.98 100.84 5.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -95.02 171.88 8.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -111.56 139.97 46.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.52 ' ND2' HD13 ' A' ' 56' ' ' LEU . 64.1 t-20 -138.48 110.13 8.15 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.85 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.77 -26.15 38.99 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.409 2.072 . . . . 0.0 112.378 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.74 -32.91 71.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.561 HD23 ' HB3' ' A' ' 60' ' ' GLN . 9.1 mp -65.17 165.13 18.17 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.877 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -86.95 32.17 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.914 2.409 . . . . 0.0 112.808 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.86 142.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.874 0.368 . . . . 0.0 111.167 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.42 27.82 61.28 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.561 ' HB3' HD23 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -109.03 141.91 40.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.747 0.308 . . . . 0.0 110.951 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -136.81 124.73 22.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.904 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.818 ' ND2' HD11 ' A' ' 64' ' ' ILE . 15.7 p-10 -130.55 142.08 50.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.585 HD13 HG22 ' A' ' 103' ' ' VAL . 30.9 mm -94.23 94.34 4.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.097 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.818 HD11 ' ND2' ' A' ' 62' ' ' ASN . 21.1 mm -73.63 -32.86 37.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.824 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 m -164.62 84.96 0.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.6 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.476 ' HB2' HG21 ' A' ' 63' ' ' ILE . . . -51.38 132.63 29.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.505 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.45 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -59.68 131.26 50.77 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.327 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 66' ' ' ALA . 21.5 t -130.66 135.52 60.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.389 . . . . 0.0 111.115 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.6 mttp -61.36 116.81 4.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.139 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.468 ' HA3' ' HA ' ' A' ' 98' ' ' VAL . . . -88.46 -149.22 18.44 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.871 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.49 ' CB ' ' HB3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -163.23 146.31 10.45 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.314 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.595 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 19.0 ttp85 -139.67 111.35 7.25 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.737 ' O ' ' HB2' ' A' ' 92' ' ' SER . 91.3 m -73.41 125.16 27.25 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.695 ' HD2' HG21 ' A' ' 89' ' ' VAL . 13.9 m80 -106.14 119.05 38.22 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 122.185 0.993 . . . . 0.0 113.1 -176.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.852 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.1 OUTLIER -90.34 98.85 12.02 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 113.437 -1.71 . . . . 0.0 111.459 -177.419 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.4 mp -87.56 143.45 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.027 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.813 ' CB ' HD21 ' A' ' 90' ' ' LEU . 25.3 m -89.72 122.26 32.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.708 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.58 HG13 ' CG2' ' A' ' 85' ' ' THR . 21.6 t -81.35 98.35 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.111 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.3 tp -112.21 126.51 55.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.863 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 m -89.06 119.58 29.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.93 95.54 4.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.852 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 60.38 36.41 20.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.851 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.82 28.43 26.32 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.426 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.7 127.11 36.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.795 0.331 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.58 ' CG2' HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -85.15 102.39 13.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -68.63 135.85 52.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.403 ' HA ' HG21 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -115.62 84.9 2.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.548 ' N ' HG23 ' A' ' 76' ' ' ILE . 88.0 m -132.7 130.23 39.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.884 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.695 HG21 ' HD2' ' A' ' 74' ' ' HIS . 12.8 p -85.39 140.37 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.813 HD21 ' CB ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -132.29 2.15 3.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.862 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.464 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.3 OUTLIER 179.96 117.87 0.05 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.9 0.381 . . . . 0.0 111.785 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.737 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.9 p -143.24 134.59 26.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.232 0.539 . . . . 0.0 110.708 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.636 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 5.3 mt-30 -89.72 166.5 13.54 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.43 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 22.9 t -85.5 107.48 16.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.925 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 20.3 p -111.2 82.95 1.68 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.024 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 95' ' ' THR . 7.9 tptm 103.48 41.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.614 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.413 ' CB ' HG11 ' A' ' 94' ' ' VAL . 6.6 tm-20 -29.18 130.54 0.07 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.134 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.479 ' CG2' ' HB3' ' A' ' 46' ' ' PHE . 4.9 p -71.76 126.02 31.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.164 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 29.7 mm -88.33 129.68 39.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.055 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -91.95 146.71 23.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.815 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.621 ' CD ' HG13 ' A' ' 48' ' ' VAL . 0.3 OUTLIER -60.34 139.39 57.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.917 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.4 t -127.67 99.69 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.084 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.796 HG13 ' O ' ' A' ' 62' ' ' ASN . 21.6 t -133.22 137.43 53.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -104.56 132.26 51.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.79 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.48 120.43 53.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.133 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.32 119.34 9.32 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.416 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.724 0.297 . . . . 0.0 111.064 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.783 0.243 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -164.14 123.74 2.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.855 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 71.4 mt -95.5 124.36 39.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 111.126 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.608 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 5.0 pt -101.01 -177.38 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.654 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.759 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.7 OUTLIER -156.9 154.6 30.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.538 0.685 . . . . 0.0 111.809 -179.081 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.75 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 54.8 ttp180 -170.97 120.32 0.53 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 5.6 t -81.78 140.53 34.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.999 0.904 . . . . 0.0 112.68 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.468 ' HG2' ' CD2' ' A' ' 74' ' ' HIS . 6.8 mm-40 -98.66 139.27 34.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.123 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.417 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -66.97 91.59 0.21 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.966 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.844 HD12 ' H ' ' A' ' 72' ' ' ARG . 6.7 mt -96.11 104.7 17.92 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.986 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.546 ' C ' HG21 ' A' ' 98' ' ' VAL . 80.1 Cg_endo -84.78 160.5 12.14 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.785 2.323 . . . . 0.0 113.248 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.598 ' HB3' HG22 ' A' ' 98' ' ' VAL . 54.1 p90 -87.15 -174.13 4.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.081 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -152.78 110.26 3.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.842 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.83 HG22 ' CB ' ' A' ' 101' ' ' GLN . 20.3 t -67.01 148.05 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.17 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 50' ' ' LYS . 5.5 mt -124.02 156.18 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.152 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.44 ' N ' HG22 ' A' ' 49' ' ' ILE . 20.2 tttp -122.96 100.82 7.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.841 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.9 162.97 13.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -94.63 114.51 26.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.906 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.401 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 6.4 t-20 -100.91 96.47 5.66 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 53' ' ' ASN . 37.6 Cg_endo -66.2 -26.75 49.25 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.475 2.117 . . . . 0.0 112.288 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -66.86 -31.22 71.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.92 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 60' ' ' GLN . 18.3 mt -74.64 163.32 69.07 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -86.83 31.47 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.888 2.392 . . . . 0.0 112.923 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.15 122.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.83 0.348 . . . . 0.0 111.26 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.19 -26.69 19.99 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.582 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.455 ' HB3' HD13 ' A' ' 56' ' ' LEU . 1.3 tm0? -66.78 136.4 55.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 0.0 110.871 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -129.34 114.27 16.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.816 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -109.25 130.06 55.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.896 HD13 HG12 ' A' ' 103' ' ' VAL . 31.2 mm -92.2 86.11 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.823 HD13 HG12 ' A' ' 102' ' ' VAL . 3.3 mp -65.3 -44.06 94.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.956 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.429 ' HB ' HG23 ' A' ' 102' ' ' VAL . 25.8 m -151.95 93.79 1.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.599 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -51.18 144.02 10.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.567 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.486 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -77.01 127.6 8.54 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.424 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.46 125.61 37.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.879 0.371 . . . . 0.0 110.985 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.455 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -60.68 113.48 2.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.354 -179.567 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.492 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -78.8 -146.06 3.17 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.637 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.599 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.1 OUTLIER -177.56 109.88 0.07 Allowed 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.844 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.9 OUTLIER -102.84 138.42 39.75 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.226 -179.621 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.668 ' O ' ' HB3' ' A' ' 92' ' ' SER . 87.7 m -75.6 140.51 42.68 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.525 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.75 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 2.0 m-70 -118.94 118.42 31.47 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.541 0.686 . . . . 0.0 112.082 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.759 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -91.23 118.82 30.79 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.203 -177.826 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.691 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.5 mp -108.69 160.3 7.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.962 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.742 ' HB2' HD23 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -101.78 127.37 48.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.895 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.459 HG22 HD13 ' A' ' 38' ' ' ILE . 21.4 t -99.28 98.36 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.3 mt -112.64 111.85 22.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.899 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.62 96.6 6.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -113.72 122.31 46.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.954 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 60.46 34.81 20.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.15 42.34 67.46 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.486 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.87 141.04 17.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.344 . . . . 0.0 110.875 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.37 112.89 25.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.941 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.83 122.98 38.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.839 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -86.66 89.13 7.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.83 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.3 t -103.15 132.75 49.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.934 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.3 m -52.32 124.87 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.121 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.742 HD23 ' HB2' ' A' ' 77' ' ' SER . 0.2 OUTLIER -111.06 -66.83 1.04 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.062 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.515 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -170.87 143.51 2.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.283 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.708 ' HG ' ' CE1' ' A' ' 74' ' ' HIS . 1.0 OUTLIER -143.4 165.29 27.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.407 0.623 . . . . 0.0 110.846 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.603 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 8.1 pt20 -129.31 166.84 18.69 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.096 -0.957 . . . . 0.0 108.661 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.815 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.1 p -85.69 106.84 15.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.599 ' O ' ' O ' ' A' ' 71' ' ' GLU . 7.2 p -117.12 81.0 1.57 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.35 0.595 . . . . 0.0 110.652 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 71' ' ' GLU . 3.1 tptm 149.44 -30.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.273 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 58.35 107.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.818 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.598 HG22 ' HB3' ' A' ' 46' ' ' PHE . 6.8 p -71.48 109.76 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.029 0.442 . . . . 0.0 110.085 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.441 HG22 ' O ' ' A' ' 66' ' ' ALA . 39.3 mm -63.98 123.69 17.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.853 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -91.93 135.62 33.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.886 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.83 ' CB ' HG22 ' A' ' 48' ' ' VAL . 1.8 tt0 -68.5 99.38 0.96 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.823 HG12 HD13 ' A' ' 64' ' ' ILE . 21.8 t -91.68 99.75 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.009 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.896 HG12 HD13 ' A' ' 63' ' ' ILE . 29.4 m -128.48 127.21 66.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.162 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -108.68 108.49 19.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.811 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.38 142.54 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.134 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.52 142.15 43.61 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.522 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.702 0.287 . . . . 0.0 111.057 179.998 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.927 0.303 . . . . 0.0 112.265 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -81.01 -179.07 7.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.771 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mp -104.4 113.92 27.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.058 0.456 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.695 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -101.3 -176.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.815 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.493 HG22 ' CD1' ' A' ' 75' ' ' TYR . 1.2 p -152.57 139.78 19.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.207 0.527 . . . . 0.0 110.892 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 17.5 tpt180 -158.65 102.94 1.72 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.085 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 8.0 t -81.96 129.23 34.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.571 0.701 . . . . 0.0 111.496 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.586 ' O ' HD12 ' A' ' 44' ' ' ILE . 0.6 OUTLIER -98.46 144.18 28.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.941 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.97 91.68 0.21 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.638 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.586 HD12 ' O ' ' A' ' 42' ' ' GLU . 3.0 mp -87.2 110.17 31.28 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.03 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.51 ' C ' HG21 ' A' ' 98' ' ' VAL . 83.8 Cg_endo -86.03 153.68 9.75 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.725 2.283 . . . . 0.0 112.751 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.591 ' HB3' HG22 ' A' ' 98' ' ' VAL . 42.7 p90 -87.17 -174.27 4.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.846 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -159.04 118.42 3.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.936 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.415 HG23 ' CD ' ' A' ' 101' ' ' GLN . 9.0 p -67.49 152.53 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.013 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.1 mp -130.66 156.16 42.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.13 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.44 ' N ' HG22 ' A' ' 49' ' ' ILE . 12.3 mmtm -128.25 100.86 6.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -101.86 170.35 8.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 1.7 mm-40 -109.62 120.34 42.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.954 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.63 HD21 HD22 ' A' ' 56' ' ' LEU . 1.7 p-10 -114.16 96.39 42.08 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.843 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.36 60.42 2.59 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.51 2.14 . . . . 0.0 112.408 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.58 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -160.92 27.23 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.026 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.655 HD23 ' HB3' ' A' ' 60' ' ' GLN . 3.5 mp -130.55 176.53 2.8 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.776 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.27 30.22 0.53 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.176 2.584 . . . . 0.0 112.869 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.2 136.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.91 0.386 . . . . 0.0 111.484 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.9 29.33 67.51 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.734 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.655 ' HB3' HD23 ' A' ' 56' ' ' LEU . 42.9 tp60 -109.39 112.07 23.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.799 0.333 . . . . 0.0 110.762 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.56 143.41 33.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.972 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -135.72 130.05 33.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.0 mm -85.68 86.12 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.164 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.575 HD11 ' HG3' ' A' ' 104' ' ' GLU . 28.6 mt -71.2 -43.46 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.408 ' HB ' HG22 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -149.07 91.93 1.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.613 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.85 154.47 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.522 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.416 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -84.74 129.63 9.33 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.414 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.45 126.96 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.761 0.315 . . . . 0.0 111.075 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.681 ' HA ' HG23 ' A' ' 98' ' ' VAL . 15.0 mtmt -57.37 127.95 34.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.146 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.435 ' HA2' ' HG3' ' A' ' 96' ' ' LYS . . . -101.97 -143.44 13.52 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.079 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.535 ' N ' ' HB3' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -166.97 144.05 4.67 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.593 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 42.1 ttt180 -135.98 111.52 9.25 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.699 ' O ' ' HB2' ' A' ' 92' ' ' SER . 62.0 m -73.84 126.82 31.27 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.524 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 13.3 m80 -107.21 119.87 40.56 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 122.068 0.937 . . . . 0.0 112.921 -176.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.695 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -91.36 99.59 12.52 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 113.541 -1.663 . . . . 0.0 111.391 -177.637 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.666 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.5 mp -87.58 159.71 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.847 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.755 ' OG ' HD23 ' A' ' 90' ' ' LEU . 77.6 p -108.53 105.38 14.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.775 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 78' ' ' VAL . 8.8 m -81.43 98.33 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.225 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.6 tt -108.08 116.4 31.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 80' ' ' THR . 10.7 t -81.9 112.17 18.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.936 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -116.05 113.27 22.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 60.17 31.83 20.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.894 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.82 44.54 10.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.432 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.77 119.7 4.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.773 0.32 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.84 123.03 32.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.4 150.16 29.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.852 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -97.52 113.8 25.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 94.8 m -133.59 118.05 17.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.931 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 89' ' ' VAL . 10.9 p -54.03 125.37 8.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.978 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.755 HD23 ' OG ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -107.83 -53.46 2.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.267 -179.777 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.521 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -176.68 141.01 0.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.316 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.699 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.6 p -143.67 150.99 39.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.367 0.603 . . . . 0.0 111.32 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.635 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 23.1 mm-40 -110.74 166.53 10.94 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.522 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 6.2 m -85.26 106.64 15.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.054 -178.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.568 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 15.9 p -110.72 82.6 1.62 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.689 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 95' ' ' THR . 26.2 tptp 131.92 -26.96 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.015 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 96' ' ' LYS . 17.9 pt-20 44.56 111.47 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.681 HG23 ' HA ' ' A' ' 69' ' ' LYS . 8.2 p -71.88 115.77 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.874 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.5 mm -74.04 128.96 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.068 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -95.14 139.41 31.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.978 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.415 ' CD ' HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -77.63 100.34 6.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.817 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.408 HG22 ' HB ' ' A' ' 65' ' ' THR . 5.4 m -100.59 109.28 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 103' ' ' VAL . 11.0 p -123.19 118.38 54.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.575 ' HG3' HD11 ' A' ' 64' ' ' ILE . 2.4 mm-40 -87.16 121.01 29.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.832 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.95 128.51 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.209 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.62 130.64 50.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.503 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 52' ' ' GLU . . . . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.626 0.251 . . . . 0.0 111.008 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo . . . . . 0 N--CA 1.461 -0.409 0 CA-C-O 120.809 0.254 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.57 129.65 36.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.817 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mt -74.21 114.98 13.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.09 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.677 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -101.38 -176.57 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.095 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.517 ' HB ' ' CG2' ' A' ' 73' ' ' THR . 1.4 p -152.19 136.73 16.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.226 0.536 . . . . 0.0 111.223 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.554 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 10.0 mmm-85 -150.1 103.13 3.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.403 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.652 HG23 ' N ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -82.17 124.8 30.21 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.602 0.715 . . . . 0.0 111.163 -178.771 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.555 ' O ' HD12 ' A' ' 44' ' ' ILE . 3.4 mt-10 -98.29 147.94 24.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.958 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -66.92 101.42 0.84 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.83 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.563 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.4 mp -106.66 91.42 6.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.847 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.687 ' C ' HG21 ' A' ' 98' ' ' VAL . 97.9 Cg_endo -78.49 161.83 28.05 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.74 2.294 . . . . 0.0 112.799 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.546 ' HB3' HG22 ' A' ' 98' ' ' VAL . 49.5 p90 -87.37 176.62 7.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.147 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -147.24 109.38 4.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.971 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.786 HG22 ' CB ' ' A' ' 101' ' ' GLN . 11.6 t -67.13 153.95 8.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.073 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.5 mp -124.94 156.14 33.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.122 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.46 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -125.11 100.81 6.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.831 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.1 mtmt -97.7 171.87 8.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.945 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -109.88 104.77 13.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.578 ' ND2' HD22 ' A' ' 56' ' ' LEU . 2.0 p-10 -110.31 96.51 26.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.78 -18.7 53.26 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.492 2.128 . . . . 0.0 112.593 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.544 ' OD1' HD13 ' A' ' 56' ' ' LEU . 16.1 p30 -54.78 -29.74 54.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.882 0.372 . . . . 0.0 111.008 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.818 HD23 ' HB3' ' A' ' 60' ' ' GLN . 6.2 mp -83.24 175.06 5.12 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.741 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -82.55 28.33 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.094 2.529 . . . . 0.0 112.979 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.1 123.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.883 0.373 . . . . 0.0 111.55 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.18 -23.28 32.28 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.83 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.818 ' HB3' HD23 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -71.47 123.54 22.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.879 0.371 . . . . 0.0 110.956 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.87 ' HG3' HG13 ' A' ' 105' ' ' VAL . 2.5 mp0 -114.44 115.85 27.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.613 ' OD1' HD21 ' A' ' 56' ' ' LEU . 4.8 p-10 -119.04 123.96 45.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.836 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.559 HG23 HG22 ' A' ' 103' ' ' VAL . 22.1 mt -85.76 131.42 34.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.019 0.437 . . . . 0.0 111.115 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.8 mm -94.07 -46.78 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.767 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.772 HG22 ' HB ' ' A' ' 102' ' ' VAL . 15.3 t -149.13 97.85 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.516 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.19 126.64 7.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.815 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.451 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -66.25 132.35 33.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.168 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.421 ' HB ' HD13 ' A' ' 99' ' ' ILE . 22.7 t -131.22 138.83 52.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.954 0.407 . . . . 0.0 111.065 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.612 ' HA ' HG23 ' A' ' 98' ' ' VAL . 8.0 mptt -66.27 130.8 44.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.406 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.403 ' N ' ' HA ' ' A' ' 98' ' ' VAL . . . -109.42 -148.99 12.83 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.47 ' N ' ' CB ' ' A' ' 96' ' ' LYS . 0.6 OUTLIER -166.69 156.71 11.61 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.595 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 4.8 ttt180 -140.14 112.49 7.8 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.693 ' O ' ' HB3' ' A' ' 92' ' ' SER . 86.3 m -73.85 127.32 32.54 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.569 ' HD2' ' O ' ' A' ' 72' ' ' ARG . 13.6 m-70 -106.26 117.26 33.59 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.261 1.029 . . . . 0.0 113.055 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.677 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -89.12 102.14 14.8 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 113.433 -1.712 . . . . 0.0 110.921 -177.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.634 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.5 mp -87.66 160.7 2.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.891 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.642 ' OG ' HD22 ' A' ' 90' ' ' LEU . 74.9 m -110.62 127.89 55.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.834 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.38 103.72 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.196 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mt -125.06 88.66 2.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.818 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.22 146.2 39.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.846 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -153.97 126.89 8.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.908 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 60.4 35.9 20.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.956 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.28 48.69 57.17 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.531 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.7 ttpt -159.69 107.5 1.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.837 0.351 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.81 129.9 37.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.5 m -115.39 151.06 35.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.54 112.75 23.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 96.7 m -133.99 126.65 30.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.901 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.0 p -55.61 148.96 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.991 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.642 HD22 ' OG ' ' A' ' 77' ' ' SER . 0.3 OUTLIER -137.86 -50.89 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.26 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.524 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -158.3 126.63 5.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.321 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.693 ' HB3' ' O ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -143.4 144.25 31.97 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.4 0.619 . . . . 0.0 111.417 179.133 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.595 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 5.4 mt-30 -106.25 165.46 11.23 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 94' ' ' VAL . 8.8 p -86.15 106.63 15.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.473 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.476 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 7.2 p -111.71 82.01 1.55 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.568 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' A' ' 95' ' ' THR . 0.0 OUTLIER 148.29 -33.39 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.296 179.087 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.431 ' H ' HG22 ' A' ' 94' ' ' VAL . 1.5 tt0 53.33 109.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.892 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.687 HG21 ' C ' ' A' ' 45' ' ' PRO . 9.4 p -80.7 102.75 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.481 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.576 ' H ' HD12 ' A' ' 99' ' ' ILE . 5.2 mp -64.35 123.92 18.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.056 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.413 ' HA ' ' HB2' ' A' ' 46' ' ' PHE . 3.2 m-20 -89.44 133.85 34.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.673 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.786 ' CB ' HG22 ' A' ' 48' ' ' VAL . 5.4 tt0 -67.05 125.33 25.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.948 0.404 . . . . 0.0 110.98 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.772 ' HB ' HG22 ' A' ' 65' ' ' THR . 60.9 t -113.37 99.71 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.678 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.559 HG22 HG23 ' A' ' 63' ' ' ILE . 21.8 t -125.68 154.71 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.405 ' N ' HG12 ' A' ' 103' ' ' VAL . 2.5 mt-10 -133.22 108.36 8.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.77 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.87 HG13 ' HG3' ' A' ' 61' ' ' GLU . 21.8 t -101.04 136.56 32.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.172 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.03 148.6 35.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.489 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.721 0.296 . . . . 0.0 111.206 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo . . . . . 0 C--O 1.231 0.161 0 CA-C-O 120.783 0.243 . . . . 0.0 112.399 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -170.65 147.18 2.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.79 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.5 mp -104.36 116.59 32.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.95 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.568 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 5.7 pt -101.27 -177.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.363 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.732 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -158.58 154.48 26.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.372 0.606 . . . . 0.0 111.077 -179.209 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.548 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 13.1 ttm180 -169.26 126.08 0.92 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.646 HG22 ' CA ' ' A' ' 73' ' ' THR . 16.1 p -81.89 136.08 35.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 122.006 0.908 . . . . 0.0 112.547 -177.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HG2' ' ND1' ' A' ' 74' ' ' HIS . 9.3 mm-40 -98.23 142.61 29.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.097 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.405 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -66.78 94.21 0.3 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.671 -179.715 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.91 HD12 ' H ' ' A' ' 72' ' ' ARG . 6.9 mt -101.66 98.02 8.84 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.777 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.484 ' C ' HG21 ' A' ' 98' ' ' VAL . 95.8 Cg_endo -78.51 157.81 28.83 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.772 2.315 . . . . 0.0 113.176 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.682 ' HB3' HG22 ' A' ' 98' ' ' VAL . 45.6 p90 -86.87 -173.93 4.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.105 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.43 102.95 4.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.756 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.71 HG23 ' HG3' ' A' ' 101' ' ' GLN . 8.8 p -66.93 146.47 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.148 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 48' ' ' VAL . 34.2 mm -125.19 156.19 34.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.179 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.445 ' N ' HG22 ' A' ' 49' ' ' ILE . 7.4 mptt -120.42 100.86 7.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.767 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.63 145.13 24.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -114.73 102.61 10.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.781 ' ND2' HD13 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -117.44 140.09 26.95 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.913 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -78.13 -19.88 11.81 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.601 2.201 . . . . 0.0 112.538 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -52.34 -30.26 27.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.116 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.781 HD13 ' ND2' ' A' ' 53' ' ' ASN . 11.2 mp -82.7 169.1 19.09 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.798 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.19 31.23 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.316 2.678 . . . . 0.0 112.874 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 63.18 138.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.899 0.38 . . . . 0.0 111.279 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.02 36.35 80.78 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.603 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.704 ' HB3' HD23 ' A' ' 56' ' ' LEU . 60.1 tp60 -109.51 145.65 35.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.878 0.37 . . . . 0.0 110.935 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.7 113.94 19.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.821 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -118.87 119.12 33.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.928 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.1 mm -85.71 92.76 3.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.722 HD11 ' HG3' ' A' ' 104' ' ' GLU . 21.7 mt -76.55 -44.9 34.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.88 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.54 91.49 1.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.801 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.487 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -46.9 143.18 3.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.791 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.458 ' HA3' ' CE2' ' A' ' 46' ' ' PHE . . . -91.31 129.63 9.9 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.248 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.0 131.11 41.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.966 0.412 . . . . 0.0 111.156 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.522 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -64.12 112.78 3.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.159 -179.647 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.525 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -75.55 -144.29 1.24 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.762 -0.733 . . . . 0.0 111.717 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.68 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 7.7 tt0 -177.55 109.29 0.07 Allowed 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.91 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -98.4 138.43 35.65 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.229 0.538 . . . . 0.0 110.448 -179.726 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.646 ' CA ' HG22 ' A' ' 41' ' ' THR . 52.0 m -75.55 135.81 40.58 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.729 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.659 ' O ' ' HA ' ' A' ' 39' ' ' THR . 6.5 m80 -116.08 121.83 43.34 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.74 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.732 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -91.93 113.34 25.59 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.772 -178.095 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.695 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.1 mp -97.13 143.56 12.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.02 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.9 t -96.01 105.53 17.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.78 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.764 ' CG1' HG22 ' A' ' 85' ' ' THR . 21.4 t -81.55 105.27 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.9 tp -97.11 88.66 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.844 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.58 123.66 21.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.965 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -143.65 105.92 4.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 65.16 26.88 12.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.094 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.78 41.44 7.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.819 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.591 ' HD2' HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -140.54 122.72 15.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.908 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.764 HG22 ' CG1' ' A' ' 78' ' ' VAL . 1.2 p -101.26 105.5 16.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.591 HG23 ' HD2' ' A' ' 84' ' ' LYS . 27.8 p -87.11 99.88 12.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.476 ' HG3' HG21 ' A' ' 76' ' ' ILE . 2.6 tt0 -74.8 98.75 3.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 76' ' ' ILE . 92.1 m -129.66 125.36 35.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 p -51.18 136.84 10.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.022 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -125.6 -72.66 0.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.343 -179.716 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.493 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 3.6 t0 -137.96 138.2 38.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.349 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.565 ' HB2' ' O ' ' A' ' 73' ' ' THR . 29.0 p -143.24 165.62 26.95 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.66 0.743 . . . . 0.0 111.395 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.665 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 36.0 mm-40 -130.03 166.45 20.1 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.153 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.791 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 17.2 t -86.2 105.75 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.554 ' O ' ' O ' ' A' ' 71' ' ' GLU . 11.6 p -121.43 80.97 1.73 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.551 0.691 . . . . 0.0 110.889 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.68 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 155.3 -31.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.731 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 62.4 101.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.819 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.682 HG22 ' HB3' ' A' ' 46' ' ' PHE . 6.6 p -71.43 103.75 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.144 0.497 . . . . 0.0 110.12 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 66' ' ' ALA . 32.9 mm -63.92 131.05 29.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.222 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 46' ' ' PHE . 3.6 m-20 -98.86 139.67 34.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.002 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.71 ' HG3' HG23 ' A' ' 48' ' ' VAL . 3.0 tp-100 -75.04 103.92 5.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.921 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.29 99.73 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.985 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.1 p -123.12 148.37 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.194 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.722 ' HG3' HD11 ' A' ' 64' ' ' ILE . 22.6 mt-10 -111.17 142.02 43.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.816 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.32 136.56 57.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.141 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -73.87 102.05 1.28 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.468 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.75 0.31 . . . . 0.0 111.141 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.568 ' HD3' HD23 ' A' ' 79' ' ' LEU . 57.6 Cg_endo . . . . . 0 N--CA 1.465 -0.195 0 CA-C-O 120.775 0.24 . . . . 0.0 112.301 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -73.86 168.25 19.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.9 mt -92.52 106.37 18.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.963 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.773 HD12 ' N ' ' A' ' 39' ' ' THR . 1.0 OUTLIER -101.3 -176.49 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.445 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.773 ' N ' HD12 ' A' ' 38' ' ' ILE . 1.0 OUTLIER -152.41 147.85 26.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.281 0.562 . . . . 0.0 110.729 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 74' ' ' HIS . 16.9 ttp180 -164.18 100.62 0.85 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.893 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 15.2 t -81.93 132.19 35.26 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.831 0.824 . . . . 0.0 111.364 -178.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -98.11 145.17 26.83 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.149 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.403 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -66.22 99.11 0.5 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.337 -179.561 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.752 HD12 ' N ' ' A' ' 72' ' ' ARG . 6.4 mt -105.09 92.6 5.56 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.302 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.76 ' C ' HG21 ' A' ' 98' ' ' VAL . 94.1 Cg_endo -78.32 164.37 26.65 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.818 2.345 . . . . 0.0 112.855 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.466 ' CD1' ' HA3' ' A' ' 67' ' ' GLY . 35.2 p90 -87.28 175.04 8.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.102 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -143.04 108.85 5.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.995 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.768 HG22 ' CB ' ' A' ' 101' ' ' GLN . 10.3 t -67.1 154.05 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.22 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.1 mp -140.71 156.09 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.069 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' N ' HG22 ' A' ' 49' ' ' ILE . 23.0 mttt -110.35 108.62 18.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.98 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.92 118.06 35.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.953 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -77.09 104.69 7.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.985 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.444 ' HB2' HD12 ' A' ' 56' ' ' LEU . 30.3 m-20 -106.12 139.79 20.63 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.11 -29.21 6.75 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.58 2.187 . . . . 0.0 112.406 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -57.54 -44.14 84.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.565 HD11 ' O ' ' A' ' 104' ' ' GLU . 5.2 mt -59.76 168.28 2.07 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.93 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -86.31 30.12 0.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.268 2.645 . . . . 0.0 112.69 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 57.73 105.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 0.0 111.315 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.85 -24.18 27.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.784 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.55 144.06 28.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.868 0.366 . . . . 0.0 110.973 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.813 ' HG3' HG23 ' A' ' 105' ' ' VAL . 1.5 mp0 -124.08 173.7 8.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.818 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.723 ' ND2' HD11 ' A' ' 64' ' ' ILE . 49.8 p30 -154.84 147.75 24.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.9 mm -97.76 86.08 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.106 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.723 HD11 ' ND2' ' A' ' 62' ' ' ASN . 24.4 mm -74.36 -32.74 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.964 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.479 ' HB ' HG23 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -161.74 83.83 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.523 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.54 151.64 0.54 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.718 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.466 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -79.43 132.57 11.54 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.192 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.9 t -124.51 131.67 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.844 0.354 . . . . 0.0 111.311 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -64.53 118.88 9.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.347 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.459 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -107.14 -151.9 18.09 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.597 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.497 ' N ' ' CB ' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -174.42 156.75 2.55 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.256 0.55 . . . . 0.0 109.992 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.752 ' N ' HD12 ' A' ' 44' ' ' ILE . 41.4 ttt180 -133.75 113.95 12.88 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.652 ' O ' ' HB2' ' A' ' 92' ' ' SER . 53.0 m -74.06 123.31 24.13 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.463 ' CD2' ' HG ' ' A' ' 92' ' ' SER . 16.6 m80 -104.81 120.82 42.32 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.146 0.975 . . . . 0.0 113.085 -177.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.655 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -89.41 98.14 11.6 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 113.648 -1.615 . . . . 0.0 111.169 -177.885 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.668 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.5 mp -87.48 158.55 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.89 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.693 ' OG ' HD12 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -101.65 108.3 19.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.727 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.651 HG13 HG21 ' A' ' 38' ' ' ILE . 11.2 m -81.6 98.25 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.146 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.568 HD23 ' HD3' ' A' ' 35' ' ' PRO . 0.9 OUTLIER -117.37 108.9 16.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.975 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.5 m -79.71 124.64 28.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.851 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.21 118.49 21.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 60.36 31.93 20.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.954 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.3 38.96 20.38 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.594 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.62 116.62 4.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.51 119.59 31.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.8 m -101.19 148.4 25.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -109.6 103.44 12.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.852 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 88' ' ' THR . 13.0 t -119.09 116.8 27.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 p -57.19 139.28 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.693 HD12 ' OG ' ' A' ' 77' ' ' SER . 16.2 mt -130.63 -68.4 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.264 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.45 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 1.3 t70 -137.8 134.34 35.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 111.4 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.652 ' HB2' ' O ' ' A' ' 73' ' ' THR . 18.7 p -143.35 160.62 40.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.027 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.608 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 5.8 pt20 -120.97 165.58 15.04 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 94' ' ' VAL . 28.9 m -86.39 106.08 15.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.945 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.483 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 15.4 p -114.84 81.86 1.64 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.684 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.497 ' CB ' ' N ' ' A' ' 71' ' ' GLU . 6.6 mmmt 146.46 -33.16 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.534 178.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 49.96 106.2 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.858 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.76 HG21 ' C ' ' A' ' 45' ' ' PRO . 11.8 p -79.92 102.8 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.075 0.465 . . . . 0.0 110.719 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 27.0 mt -66.55 131.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.185 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -87.7 139.96 30.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.768 ' CB ' HG22 ' A' ' 48' ' ' VAL . 6.1 tt0 -75.55 103.81 5.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.479 HG23 ' HB ' ' A' ' 65' ' ' THR . 21.7 t -85.9 99.75 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.012 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.414 HG23 ' HG2' ' A' ' 101' ' ' GLN . 21.4 t -118.89 110.57 30.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.1 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.565 ' O ' HD11 ' A' ' 56' ' ' LEU . 3.0 mt-10 -96.24 108.55 21.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.813 HG23 ' HG3' ' A' ' 61' ' ' GLU . 11.8 p -100.7 150.65 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.027 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.52 ' N ' HD13 ' A' ' 56' ' ' LEU . . . -76.48 145.53 31.8 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.486 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.505 0.193 . . . . 0.0 111.161 -179.983 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo . . . . . 0 C--O 1.232 0.187 0 CA-C-O 120.753 0.23 . . . . 0.0 112.274 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -83.84 116.37 22.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.71 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.4 mt -71.0 115.61 10.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.971 0.415 . . . . 0.0 111.123 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -101.26 -177.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.858 179.091 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.566 HG22 HG22 ' A' ' 73' ' ' THR . 0.5 OUTLIER -157.02 133.88 10.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.504 0.669 . . . . 0.0 111.58 -179.014 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.706 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 2.8 tpm_? -155.7 115.63 3.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 1.7 t -81.89 136.08 35.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.895 0.855 . . . . 0.0 112.515 -176.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -98.63 138.74 35.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.014 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.408 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 1.8 mp0 -66.73 91.86 0.2 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.445 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.776 HD12 ' H ' ' A' ' 72' ' ' ARG . 6.4 mt -92.68 107.67 25.97 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.907 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.501 ' C ' HG21 ' A' ' 98' ' ' VAL . 72.3 Cg_endo -86.03 153.34 9.73 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.832 2.355 . . . . 0.0 113.309 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.707 ' HB3' HG22 ' A' ' 98' ' ' VAL . 42.7 p90 -86.99 -174.05 4.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.158 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -154.78 116.34 4.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.922 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.732 HG13 ' CG ' ' A' ' 101' ' ' GLN . 4.4 t -67.09 151.45 10.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.134 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.6 mp -129.68 156.15 41.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.086 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.457 ' N ' HG22 ' A' ' 49' ' ' ILE . 2.9 ttpp -109.35 100.78 9.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.774 ' O ' HG22 ' A' ' 105' ' ' VAL . 9.2 mmtm -98.26 154.48 17.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -106.53 132.13 52.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -134.98 111.85 11.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.64 -26.76 39.26 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.368 2.046 . . . . 0.0 112.333 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -59.96 -32.3 70.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.9 mt -65.56 162.77 39.7 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.75 31.33 0.48 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.875 2.384 . . . . 0.0 112.925 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.98 138.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.913 0.387 . . . . 0.0 111.277 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.14 28.73 61.68 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.665 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.45 144.98 36.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.813 0.339 . . . . 0.0 110.933 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -114.32 118.93 35.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.821 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -128.3 118.37 23.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.507 HG23 ' OE1' ' A' ' 101' ' ' GLN . 43.5 mt -90.59 132.06 36.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.125 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.722 HD11 ' HG3' ' A' ' 104' ' ' GLU . 24.5 mt -104.79 -43.63 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.924 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.456 HG22 ' CG2' ' A' ' 99' ' ' ILE . 24.7 m -144.73 92.24 2.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.724 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.4 126.27 5.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.79 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.444 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -70.73 126.12 14.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.449 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.432 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.8 t -138.2 138.07 43.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.904 0.383 . . . . 0.0 110.935 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.542 ' HA ' HG23 ' A' ' 98' ' ' VAL . 3.7 mttp -68.1 116.19 8.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.381 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.522 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -81.11 -147.67 5.61 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.468 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.603 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.4 OUTLIER -177.77 109.27 0.06 Allowed 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.08 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.776 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -104.59 138.08 41.46 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.207 0.527 . . . . 0.0 109.872 -179.706 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.566 HG22 HG22 ' A' ' 39' ' ' THR . 51.9 m -75.26 136.58 40.93 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.387 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.706 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 2.8 m80 -112.16 116.77 31.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.926 0.869 . . . . 0.0 111.955 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.756 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -91.2 107.93 19.54 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 113.84 -1.527 . . . . 0.0 111.023 -177.245 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.594 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.4 mp -91.47 156.41 3.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.155 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.41 ' N ' ' CG2' ' A' ' 76' ' ' ILE . 3.8 m -115.85 111.55 20.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.688 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 78' ' ' VAL . 25.4 m -81.27 98.38 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.189 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 tp -109.94 148.75 31.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.833 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.24 106.25 12.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -128.91 126.17 39.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 60.33 31.1 20.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.03 28.39 68.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.368 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -149.03 166.64 28.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.878 0.371 . . . . 0.0 110.857 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.3 p -106.29 89.95 3.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.84 150.9 42.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -104.7 109.53 21.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.5 m -140.05 122.21 15.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.658 HG21 ' CD2' ' A' ' 74' ' ' HIS . 14.9 p -84.48 150.22 4.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.135 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -147.07 -41.39 0.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.582 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.441 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 1.6 t70 -117.64 106.92 13.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.837 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.569 ' HG ' ' CD2' ' A' ' 74' ' ' HIS . 89.3 p -143.14 123.91 14.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.316 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.676 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 5.7 mt-30 -89.38 166.15 13.91 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.727 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 32.1 t -86.1 110.12 19.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.603 ' O ' ' O ' ' A' ' 71' ' ' GLU . 5.9 p -117.69 80.85 1.57 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.361 0.601 . . . . 0.0 110.656 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.529 ' HB3' ' H ' ' A' ' 71' ' ' GLU . 41.0 tptt 148.52 -32.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.447 -1.252 . . . . 0.0 109.218 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 57.44 108.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.38 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.707 HG22 ' HB3' ' A' ' 46' ' ' PHE . 7.4 p -71.64 104.17 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.109 0.48 . . . . 0.0 110.0 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.613 ' H ' HD12 ' A' ' 99' ' ' ILE . 5.1 mp -64.01 129.87 28.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.126 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -99.82 137.7 37.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.013 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.732 ' CG ' HG13 ' A' ' 48' ' ' VAL . 3.6 tp-100 -72.08 107.13 4.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.833 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.679 HG12 HD12 ' A' ' 64' ' ' ILE . 21.7 t -98.29 99.61 9.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.049 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.46 HG12 HG12 ' A' ' 63' ' ' ILE . 5.2 m -116.78 129.61 73.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.091 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.722 ' HG3' HD11 ' A' ' 64' ' ' ILE . 1.4 mm-40 -108.79 117.58 34.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.818 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 51' ' ' LYS . 31.6 m -93.7 142.93 12.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.21 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.88 133.84 14.11 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.527 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.78 0.324 . . . . 0.0 111.094 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.433 ' HG2' HG23 ' A' ' 78' ' ' VAL . 52.6 Cg_endo . . . . . 0 C--O 1.232 0.199 0 CA-C-O 120.844 0.268 . . . . 0.0 112.324 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.96 155.28 20.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.954 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.13 118.76 36.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.152 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 4.0 pt -101.37 -177.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.421 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.754 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -159.88 150.42 18.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.209 0.528 . . . . 0.0 110.792 -179.245 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -162.34 133.18 4.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.183 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 1.7 p -82.44 129.16 34.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.762 0.791 . . . . 0.0 112.123 -178.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.493 ' HG3' HG13 ' A' ' 44' ' ' ILE . 3.4 tp10 -98.55 141.68 31.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.66 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.89 97.29 0.47 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.209 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.895 HD12 ' H ' ' A' ' 72' ' ' ARG . 6.9 mt -106.2 94.02 8.9 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.444 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.478 ' C ' HG21 ' A' ' 98' ' ' VAL . 87.7 Cg_endo -77.51 158.29 32.48 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.714 2.276 . . . . 0.0 113.257 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.688 ' HB3' HG22 ' A' ' 98' ' ' VAL . 40.9 p90 -86.87 -174.04 4.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.841 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -147.17 103.1 3.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.173 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.5 HG23 ' HB3' ' A' ' 101' ' ' GLN . 3.4 p -66.99 132.75 32.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.769 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.442 HG22 ' N ' ' A' ' 50' ' ' LYS . 32.8 mm -109.96 156.1 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.177 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.442 ' N ' HG22 ' A' ' 49' ' ' ILE . 8.7 mtpp -125.83 100.8 6.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.817 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -103.98 171.61 7.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.88 125.63 36.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.868 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.863 ' ND2' HD13 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -100.51 96.52 5.39 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.35 -18.48 44.27 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.465 2.11 . . . . 0.0 112.482 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.36 29.23 3.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.011 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.863 HD13 ' ND2' ' A' ' 53' ' ' ASN . 1.3 mp -124.4 169.43 10.74 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.757 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -87.37 29.09 0.5 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.3 2.667 . . . . 0.0 112.678 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.37 144.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.843 0.354 . . . . 0.0 111.347 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.65 23.22 42.92 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.833 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.608 ' HB3' HD23 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -109.47 156.67 19.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.757 0.313 . . . . 0.0 110.982 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.594 ' HG2' HG22 ' A' ' 105' ' ' VAL . 6.4 mt-10 -140.47 147.26 39.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.913 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -145.5 129.77 17.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.927 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.8 mm -87.23 92.8 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.136 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.3 mm -72.92 -43.85 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.76 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.83 93.7 1.68 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.544 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -46.62 152.42 0.47 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.82 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.437 ' HA3' ' CE2' ' A' ' 46' ' ' PHE . . . -99.94 132.76 11.05 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.26 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.428 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.6 t -136.93 130.46 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.884 0.374 . . . . 0.0 110.975 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.49 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -62.43 112.72 2.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.28 -179.665 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.554 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -75.53 -144.91 1.3 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.694 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.672 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 10.3 tt0 -177.58 109.11 0.06 Allowed 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.895 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -98.36 142.79 29.56 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.377 0.608 . . . . 0.0 110.446 -179.695 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.579 ' O ' ' HB3' ' A' ' 92' ' ' SER . 98.3 m -75.68 143.98 41.86 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.248 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.622 ' O ' ' HA ' ' A' ' 39' ' ' THR . 34.5 m-70 -125.92 116.99 22.36 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.592 0.711 . . . . 0.0 111.485 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.754 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -88.02 111.97 22.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.891 -177.609 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.501 HG22 ' N ' ' A' ' 77' ' ' SER . 4.3 mp -99.91 160.83 3.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.258 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.63 ' HB2' HD12 ' A' ' 90' ' ' LEU . 9.8 t -107.47 119.34 39.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.7 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 78' ' ' VAL . 8.6 m -81.43 98.36 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.22 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.612 HD13 ' N ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -103.03 129.92 49.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.612 ' N ' HD13 ' A' ' 79' ' ' LEU . 0.5 OUTLIER -96.55 120.17 36.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.832 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -136.03 100.05 4.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 60.13 35.71 21.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.37 47.39 22.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.469 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.27 123.14 15.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.688 0.28 . . . . 0.0 110.871 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.61 112.43 23.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.954 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.45 118.09 35.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.818 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.411 ' CA ' HG21 ' A' ' 76' ' ' ILE . 20.8 mt-10 -94.75 94.81 8.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.918 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.4 m -111.5 113.83 26.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.885 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.6 m -52.94 130.07 14.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.205 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.63 HD12 ' HB2' ' A' ' 77' ' ' SER . 14.3 mt -120.39 -73.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.069 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.478 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -123.98 131.47 53.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.376 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.579 ' HB3' ' O ' ' A' ' 73' ' ' THR . 1.0 OUTLIER -143.14 165.39 27.55 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.459 0.647 . . . . 0.0 111.247 179.441 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.627 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 25.2 mm100 -129.95 166.17 20.59 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.617 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.778 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 46.3 t -86.24 105.92 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.568 ' O ' ' O ' ' A' ' 71' ' ' GLU . 12.5 p -121.12 81.03 1.72 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.501 0.667 . . . . 0.0 110.929 -178.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.672 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 6.6 mmmt 155.37 -30.86 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.751 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 62.82 101.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.8 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.688 HG22 ' HB3' ' A' ' 46' ' ' PHE . 7.6 p -71.45 102.82 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.075 0.465 . . . . 0.0 110.304 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.615 ' H ' HD12 ' A' ' 99' ' ' ILE . 4.4 mp -63.99 133.2 29.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.913 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -102.73 142.79 33.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.018 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.5 ' HB3' HG23 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -76.81 108.3 9.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.927 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.32 109.98 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.055 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 103' ' ' VAL . 10.8 p -138.81 125.74 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.154 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -102.31 108.49 19.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.955 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.594 HG22 ' HG2' ' A' ' 61' ' ' GLU . 27.8 t -92.78 113.75 28.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.129 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.97 142.58 47.42 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.523 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.535 0.207 . . . . 0.0 111.161 -179.912 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.834 0.264 . . . . 0.0 112.228 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -150.44 115.94 5.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.83 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mp -86.18 114.52 23.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.08 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 2.2 pt -101.35 -177.39 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.496 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.768 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -161.52 146.24 13.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.436 0.636 . . . . 0.0 111.103 -179.448 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.726 ' O ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -143.36 -159.54 0.99 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.36 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 3.0 p -145.46 126.83 14.92 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.257 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.534 ' HG3' ' CE1' ' A' ' 74' ' ' HIS . 3.7 mm-40 -98.74 135.57 40.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.751 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.416 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 2.6 mm-40 -67.17 94.87 0.38 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.352 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.841 HD12 ' H ' ' A' ' 72' ' ' ARG . 5.1 mt -102.69 96.43 7.56 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.774 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.516 ' C ' HG21 ' A' ' 98' ' ' VAL . 98.8 Cg_endo -77.87 160.51 30.68 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.803 2.336 . . . . 0.0 113.255 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.629 ' HB3' HG22 ' A' ' 98' ' ' VAL . 49.1 p90 -86.94 -174.15 4.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.234 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.456 ' OE1' HD13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -152.63 113.16 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.847 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.769 HG22 ' CB ' ' A' ' 101' ' ' GLN . 17.6 t -66.74 146.41 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.103 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.456 HD13 ' OE1' ' A' ' 47' ' ' GLU . 36.8 mm -124.7 156.18 32.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.092 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.443 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -105.12 100.88 10.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.771 179.821 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.567 ' O ' HG12 ' A' ' 105' ' ' VAL . 4.7 tptt -96.75 145.55 25.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.029 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -110.5 123.13 49.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -122.97 128.75 25.23 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.16 -24.79 12.23 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.439 2.093 . . . . 0.0 112.495 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -55.17 -50.94 68.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.039 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.773 HD22 ' OE1' ' A' ' 60' ' ' GLN . 9.4 mt -60.15 167.02 3.22 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.793 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.407 ' HD2' ' CB ' ' A' ' 60' ' ' GLN . 1.2 Cg_endo -83.45 32.36 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.13 2.554 . . . . 0.0 112.697 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.04 119.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.833 0.349 . . . . 0.0 111.398 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.5 -26.27 20.65 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.753 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.773 ' OE1' HD22 ' A' ' 56' ' ' LEU . 2.3 tm0? -70.0 129.92 40.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 110.945 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.404 ' CG ' ' CG1' ' A' ' 103' ' ' VAL . 6.5 tt0 -95.73 158.42 15.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -158.15 118.19 3.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.944 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.6 mt -94.29 132.03 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.186 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.1 mm -105.83 -38.99 4.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.867 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.442 HG22 ' CG2' ' A' ' 99' ' ' ILE . 7.4 m -147.65 96.86 2.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.653 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.33 128.81 17.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.753 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.515 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -67.35 124.42 22.2 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.334 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.45 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.9 t -132.63 130.21 59.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.797 0.332 . . . . 0.0 111.065 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.4 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -62.25 113.38 2.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.387 -179.32 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.524 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -78.1 -146.28 2.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.377 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.694 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 10.7 tt0 -177.52 109.24 0.07 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.841 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -98.47 142.28 30.28 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.457 0.646 . . . . 0.0 110.425 -179.631 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.726 ' HA ' ' O ' ' A' ' 40' ' ' ARG . 94.7 m -75.62 149.03 38.31 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.92 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.589 ' O ' ' HA ' ' A' ' 39' ' ' THR . 5.2 m80 -128.66 117.9 21.97 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.53 0.681 . . . . 0.0 111.939 -178.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.768 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -90.58 107.27 19.06 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.079 -178.008 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.659 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.4 mp -90.08 158.66 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.798 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.499 ' OG ' HD23 ' A' ' 79' ' ' LEU . 11.7 t -108.15 117.39 34.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.449 HG13 ' HB ' ' A' ' 85' ' ' THR . 21.6 t -84.6 98.51 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.063 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.499 HD23 ' OG ' ' A' ' 77' ' ' SER . 2.8 mm? -103.65 142.3 34.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.5 p -89.96 93.8 9.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -99.12 105.83 17.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.976 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 60.45 33.49 20.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.0 35.78 26.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.516 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.6 147.43 32.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.796 0.331 . . . . 0.0 110.859 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.449 ' HB ' HG13 ' A' ' 78' ' ' VAL . 39.9 p -101.77 120.0 39.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.849 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.0 m -109.35 151.07 27.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -105.17 103.38 12.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.409 ' N ' HG23 ' A' ' 76' ' ' ILE . 94.3 m -122.5 121.05 35.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.78 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.3 t -50.11 116.08 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.124 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.43 ' HA ' HD22 ' A' ' 90' ' ' LEU . 0.2 OUTLIER -105.66 -70.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.189 -179.637 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.5 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 7.2 m-20 -140.25 136.88 33.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.212 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.649 ' HB2' ' O ' ' A' ' 73' ' ' THR . 24.0 p -143.24 165.55 27.15 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.582 0.706 . . . . 0.0 111.275 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.686 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 16.5 mm-40 -129.74 166.27 20.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.64 -1.163 . . . . 0.0 109.346 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.798 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.6 p -85.84 105.94 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.555 ' O ' ' O ' ' A' ' 71' ' ' GLU . 13.3 p -120.39 80.94 1.68 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.498 0.666 . . . . 0.0 110.793 -178.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.694 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.1 OUTLIER 154.7 -29.88 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.616 179.028 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 60.17 102.58 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.708 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.629 HG22 ' HB3' ' A' ' 46' ' ' PHE . 6.2 p -71.34 108.36 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.215 0.531 . . . . 0.0 110.073 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.574 ' H ' HD12 ' A' ' 99' ' ' ILE . 5.3 mp -63.85 126.87 23.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.965 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -96.02 137.12 35.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.993 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.769 ' CB ' HG22 ' A' ' 48' ' ' VAL . 2.5 tp60 -69.47 99.4 1.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.833 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.414 HG23 ' HB ' ' A' ' 65' ' ' THR . 21.5 t -86.1 99.63 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.053 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.404 ' CG1' ' CG ' ' A' ' 61' ' ' GLU . 21.5 t -119.45 125.9 74.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.177 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -114.45 108.55 17.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.834 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 51' ' ' LYS . 10.6 p -96.61 153.39 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.061 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.05 150.69 51.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.442 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.638 0.256 . . . . 0.0 111.145 -179.974 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo . . . . . 0 C--O 1.23 0.088 0 CA-C-O 120.908 0.295 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.53 ' HG3' HG22 ' A' ' 78' ' ' VAL . 5.1 pt-20 -147.6 152.9 38.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.819 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.1 mt -109.6 118.12 35.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.1 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.653 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 10.6 pt -101.23 -177.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.187 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.724 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 0.6 OUTLIER -153.84 160.92 42.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.233 0.54 . . . . 0.0 111.041 -179.471 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.527 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 3.6 tpp85 -172.71 131.61 0.55 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.815 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 2.9 p -81.91 129.93 34.91 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.837 0.827 . . . . 0.0 112.35 -177.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.496 ' HG3' HG13 ' A' ' 44' ' ' ILE . 3.5 tp10 -98.53 141.77 30.97 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.689 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -66.8 97.29 0.46 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.048 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.888 HD12 ' H ' ' A' ' 72' ' ' ARG . 7.0 mt -105.22 92.95 6.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.613 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.463 ' C ' HG21 ' A' ' 98' ' ' VAL . 73.7 Cg_endo -75.0 158.04 42.43 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.743 2.296 . . . . 0.0 113.031 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.658 ' HB3' HG22 ' A' ' 98' ' ' VAL . 41.6 p90 -86.77 -174.01 4.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.024 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -145.74 105.06 3.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.851 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.548 HG23 ' HB3' ' A' ' 101' ' ' GLN . 6.0 p -67.07 138.82 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.001 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.472 HD13 ' O ' ' A' ' 48' ' ' VAL . 27.9 mm -122.69 156.17 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.161 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.444 ' N ' HG22 ' A' ' 49' ' ' ILE . 16.8 mtmt -120.1 100.78 7.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.815 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.709 ' O ' HG22 ' A' ' 105' ' ' VAL . 2.5 tppt? -98.39 154.34 17.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.985 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.654 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 2.3 mm-40 -99.29 129.68 45.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.944 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -124.99 127.22 25.14 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.815 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.4 -27.16 11.48 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.411 2.074 . . . . 0.0 112.442 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -58.6 -35.52 72.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.985 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.453 HD22 ' NE2' ' A' ' 60' ' ' GLN . 8.3 mt -71.03 158.89 87.19 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.825 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -86.33 37.92 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.885 2.39 . . . . 0.0 112.878 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.22 145.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.846 0.355 . . . . 0.0 111.338 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.23 27.74 58.05 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.634 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.453 ' NE2' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -106.01 169.34 8.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.757 0.313 . . . . 0.0 110.963 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -155.32 133.01 11.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.927 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -135.75 125.0 24.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.812 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.791 HD13 ' CG1' ' A' ' 103' ' ' VAL . 26.1 mm -85.75 92.86 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.087 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.408 HD11 ' HG3' ' A' ' 104' ' ' GLU . 19.8 mt -74.26 -31.77 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.992 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.4 m -164.21 93.6 0.7 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.666 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.7 145.03 5.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.537 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.432 ' HA3' ' CE1' ' A' ' 46' ' ' PHE . . . -80.79 136.25 16.09 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.341 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.7 t -141.74 120.86 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 0.0 110.957 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.519 ' HA ' HG23 ' A' ' 98' ' ' VAL . 28.5 mtmt -59.42 112.79 1.89 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.245 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.504 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -76.87 -144.53 1.76 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.758 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.679 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -177.42 109.17 0.07 Allowed 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.219 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.888 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -98.61 139.38 34.42 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.16 0.505 . . . . 0.0 110.47 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.586 ' O ' ' HB2' ' A' ' 92' ' ' SER . 40.5 m -75.39 136.09 40.77 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.451 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.724 ' O ' ' HA ' ' A' ' 39' ' ' THR . 25.7 m80 -116.17 122.37 44.84 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.416 0.627 . . . . 0.0 111.771 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.74 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -90.69 107.23 19.04 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.054 -177.873 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 77' ' ' SER . 3.8 mp -96.22 160.42 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.069 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.51 ' HB2' HD23 ' A' ' 90' ' ' LEU . 0.7 OUTLIER -112.76 122.43 47.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.762 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 78' ' ' VAL . 35.8 m -90.11 108.97 20.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.31 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.05 137.96 45.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.796 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.53 123.04 29.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -131.48 109.52 10.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.9 p30 44.08 33.98 0.89 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.416 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.28 45.29 5.64 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.473 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -149.23 156.83 42.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 110.825 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.67 116.22 28.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.943 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.28 151.02 20.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -121.41 83.93 2.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.957 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.6 m -108.29 123.2 48.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.792 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.1 m -50.11 130.07 8.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.221 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.51 HD23 ' HB2' ' A' ' 77' ' ' SER . 0.5 OUTLIER -114.48 -64.56 1.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.233 -179.703 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.488 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -152.82 141.42 20.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.207 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.594 ' HB3' ' CD2' ' A' ' 74' ' ' HIS . 11.5 p -143.27 165.61 27.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.779 0.8 . . . . 0.0 111.616 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.686 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 41.8 mt-30 -129.18 166.08 20.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.691 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.755 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.5 p -85.96 105.78 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.59 ' O ' ' O ' ' A' ' 71' ' ' GLU . 12.1 p -121.36 80.75 1.7 Allowed 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.579 0.704 . . . . 0.0 110.733 -178.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.679 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 154.46 -31.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.649 178.719 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 62.94 101.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.777 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.658 HG22 ' HB3' ' A' ' 46' ' ' PHE . 5.8 p -71.48 106.64 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.058 0.456 . . . . 0.0 110.202 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.9 mm -63.87 129.44 27.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.068 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -98.92 134.93 41.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.021 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.548 ' HB3' HG23 ' A' ' 48' ' ' VAL . 1.5 tm0? -68.47 99.45 0.96 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.25 117.28 32.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.073 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.791 ' CG1' HD13 ' A' ' 63' ' ' ILE . 5.1 m -143.09 137.58 26.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.095 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.408 ' HG3' HD11 ' A' ' 64' ' ' ILE . 19.7 mt-10 -118.4 111.85 19.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.882 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 51' ' ' LYS . 29.9 m -88.87 146.94 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.088 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -70.98 146.18 40.97 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.443 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.654 ' HB3' ' HB3' ' A' ' 52' ' ' GLU . . . . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.748 0.308 . . . . 0.0 111.101 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 N--CA 1.465 -0.172 0 CA-C-O 120.833 0.264 . . . . 0.0 112.298 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -163.6 154.49 16.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.775 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 68.4 mt -95.01 122.79 38.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.072 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 76' ' ' ILE . 1.2 tt -101.17 -177.32 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.567 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.852 HG22 ' CD1' ' A' ' 75' ' ' TYR . 1.3 p -162.29 142.22 9.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.331 0.586 . . . . 0.0 111.018 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.688 ' CG ' HD13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -163.64 109.88 1.11 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.147 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 12.5 t -82.3 132.71 35.22 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.685 0.755 . . . . 0.0 111.734 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.469 ' O ' HD12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -98.41 148.24 23.89 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.695 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.407 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 4.8 mt-10 -66.83 100.2 0.69 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.699 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.567 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.0 mp -104.8 91.16 4.01 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.872 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.512 ' C ' HG21 ' A' ' 98' ' ' VAL . 72.0 Cg_endo -76.18 157.38 37.84 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.671 2.247 . . . . 0.0 112.808 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.618 ' HB3' HG22 ' A' ' 98' ' ' VAL . 30.0 p90 -86.73 -177.29 6.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.118 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -157.07 120.25 4.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.96 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.778 HG22 ' CB ' ' A' ' 101' ' ' GLN . 40.0 t -67.26 150.0 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.242 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 50' ' ' LYS . 7.8 mt -129.18 156.15 41.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.079 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' N ' HG22 ' A' ' 49' ' ' ILE . 4.4 mtpp -123.59 100.89 7.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.818 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -110.8 147.37 34.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.901 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.87 140.0 32.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -133.71 98.48 14.79 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.51 84.25 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.484 2.122 . . . . 0.0 112.213 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -175.32 -40.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.924 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.739 HD13 ' HB3' ' A' ' 60' ' ' GLN . 41.7 mt -58.49 167.16 1.87 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.842 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.08 48.84 2.63 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.041 2.494 . . . . 0.0 112.754 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.37 124.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.016 0.436 . . . . 0.0 111.716 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 50.59 55.64 16.39 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.091 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.739 ' HB3' HD13 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -109.47 136.5 48.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.742 0.306 . . . . 0.0 110.802 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.9 117.14 27.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.628 ' O ' HG12 ' A' ' 103' ' ' VAL . 8.5 p-10 -127.08 158.02 38.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.799 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.751 HD13 HG12 ' A' ' 103' ' ' VAL . 31.1 mm -113.91 92.52 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.463 HD11 ' HG3' ' A' ' 104' ' ' GLU . 24.3 mt -73.24 -32.25 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.921 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.0 m -161.31 92.74 0.91 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.613 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.49 146.45 5.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.582 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.429 ' HA3' ' CE1' ' A' ' 46' ' ' PHE . . . -76.45 138.72 22.88 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.262 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.8 t -140.95 135.05 32.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.917 0.389 . . . . 0.0 111.349 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.16 134.87 56.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.335 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 96' ' ' LYS . . . -116.25 -159.68 11.91 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.994 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.475 ' HA ' HD12 ' A' ' 44' ' ' ILE . 1.5 tt0 -162.08 153.89 18.84 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 2.6 ttt180 -141.39 112.2 7.17 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.717 ' O ' ' HB2' ' A' ' 92' ' ' SER . 46.5 m -73.92 125.72 28.85 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.526 ' O ' ' HA ' ' A' ' 39' ' ' THR . 13.8 m80 -106.8 119.7 40.05 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 122.083 0.944 . . . . 0.0 113.137 -177.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.852 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -91.14 93.81 9.3 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.103 -177.899 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.688 HD13 ' CG ' ' A' ' 40' ' ' ARG . 2.0 mp -87.35 142.65 12.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.931 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.724 ' OG ' HD23 ' A' ' 90' ' ' LEU . 2.4 p -77.34 121.42 23.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.762 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.489 ' C ' HD22 ' A' ' 79' ' ' LEU . 21.4 t -81.4 105.56 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.203 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.489 HD22 ' C ' ' A' ' 78' ' ' VAL . 3.9 mm? -125.55 89.27 3.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.891 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.07 131.4 42.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -137.62 117.24 13.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.909 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 60.67 33.35 20.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.28 32.02 49.55 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.438 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -144.32 113.77 7.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.755 0.312 . . . . 0.0 110.86 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.7 p -75.21 127.8 34.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.6 m -100.01 141.28 33.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.899 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -100.29 101.97 13.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.8 m -118.95 121.0 38.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 89' ' ' VAL . 10.8 p -54.26 118.41 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.006 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.724 HD23 ' OG ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -106.0 -59.57 1.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.516 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -177.17 139.95 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.198 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.717 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.8 p -143.64 149.47 37.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.48 0.657 . . . . 0.0 111.362 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.668 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 4.6 mt-30 -107.47 167.11 10.17 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 94' ' ' VAL . 8.3 p -84.75 107.16 15.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 119.854 -0.739 . . . . 0.0 109.872 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.549 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 16.8 p -113.22 82.9 1.74 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.686 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 95' ' ' THR . 11.6 mmmt 113.36 52.93 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.097 -1.41 . . . . 0.0 109.385 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -35.21 117.17 0.39 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.544 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.618 HG22 ' HB3' ' A' ' 46' ' ' PHE . 9.4 p -71.44 106.02 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.206 0.527 . . . . 0.0 110.792 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.0 mm -64.35 121.5 13.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.164 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -98.07 125.95 43.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.931 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.804 ' OE1' HG13 ' A' ' 103' ' ' VAL . 0.5 OUTLIER -62.67 128.91 38.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.788 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.8 m -124.01 101.36 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.195 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.804 HG13 ' OE1' ' A' ' 101' ' ' GLN . 2.4 m -108.96 118.6 56.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.072 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.463 ' HG3' HD11 ' A' ' 64' ' ' ILE . 18.0 mt-10 -87.15 111.58 21.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.783 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.99 143.5 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.225 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.54 109.67 3.03 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.505 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.714 0.292 . . . . 0.0 111.09 179.976 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--O 1.231 0.151 0 CA-C-O 120.796 0.248 . . . . 0.0 112.271 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -78.84 124.84 28.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.641 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 68.4 mt -78.33 116.46 18.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.086 0.469 . . . . 0.0 111.329 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.763 HD11 ' CD1' ' A' ' 76' ' ' ILE . 1.2 pp -100.89 -176.05 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.288 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.67 ' N ' HD12 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -156.35 132.94 10.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.499 0.666 . . . . 0.0 112.486 -178.351 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.653 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 4.7 mmm180 -150.72 115.77 5.32 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -82.13 134.37 35.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.897 0.856 . . . . 0.0 112.34 -177.685 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.417 ' HG2' ' ND1' ' A' ' 74' ' ' HIS . 1.2 mm-40 -98.78 138.81 35.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.24 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.434 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 1.7 pt-20 -66.86 91.45 0.2 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.778 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.866 HD12 ' H ' ' A' ' 72' ' ' ARG . 6.5 mt -94.84 105.04 16.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.651 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.493 ' C ' HG21 ' A' ' 98' ' ' VAL . 80.8 Cg_endo -84.19 157.2 13.02 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.769 2.313 . . . . 0.0 113.296 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.713 ' HB3' HG22 ' A' ' 98' ' ' VAL . 42.6 p90 -86.91 -174.02 4.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.965 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -149.42 103.05 3.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.099 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 101' ' ' GLN . 3.9 p -66.82 145.02 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.931 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.453 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.6 mp -128.97 156.1 41.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.039 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.453 ' N ' HG22 ' A' ' 49' ' ' ILE . 3.4 mptt -109.44 100.89 9.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.754 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.33 164.6 20.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.035 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -116.35 112.56 21.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.826 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.46 ' HB3' HD13 ' A' ' 56' ' ' LEU . 1.4 t-20 -102.23 96.6 7.26 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.67 -13.21 38.98 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.499 2.132 . . . . 0.0 112.512 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -97.81 27.79 4.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.706 0.289 . . . . 0.0 111.047 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.763 HD23 ' HB3' ' A' ' 60' ' ' GLN . 3.5 mp -114.97 175.94 1.68 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.85 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -86.78 29.53 0.5 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.281 2.654 . . . . 0.0 112.781 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.7 130.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.978 0.418 . . . . 0.0 111.225 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.78 54.08 40.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.642 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.763 ' HB3' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -109.44 131.7 54.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.765 0.317 . . . . 0.0 110.823 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -115.18 113.85 24.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.937 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -147.25 119.34 8.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.804 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.418 HG12 HG22 ' A' ' 103' ' ' VAL . 26.1 mt -85.76 130.96 35.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.251 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.752 HD11 ' HG3' ' A' ' 104' ' ' GLU . 2.4 mp -100.24 -46.18 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.636 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.3 m -141.85 102.17 4.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.497 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.68 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -49.43 162.95 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.545 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.436 ' HA3' ' CE2' ' A' ' 46' ' ' PHE . . . -111.07 127.32 8.18 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.243 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.43 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.6 t -139.43 134.7 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.809 0.337 . . . . 0.0 110.97 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.506 ' HA ' HG23 ' A' ' 98' ' ' VAL . 10.0 mttt -65.37 114.55 4.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.075 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.485 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -75.08 -143.06 0.94 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.802 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.608 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -177.33 109.51 0.07 Allowed 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.194 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.866 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -103.35 134.3 46.97 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.251 0.548 . . . . 0.0 110.127 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 92' ' ' SER . 60.6 m -76.15 138.22 40.57 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.532 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.653 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 6.6 m80 -111.79 122.72 48.56 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.687 0.756 . . . . 0.0 112.05 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.726 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -92.99 93.85 8.58 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.241 -177.287 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.763 ' CD1' HD11 ' A' ' 38' ' ' ILE . 4.3 mp -87.66 144.69 8.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.221 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.619 ' HB3' HD22 ' A' ' 90' ' ' LEU . 21.6 p -93.95 115.2 27.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.817 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.452 HG13 HG21 ' A' ' 38' ' ' ILE . 6.8 m -81.44 105.81 11.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' A' ' 79' ' ' LEU . 1.1 tm? -113.98 102.12 9.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.1 m -66.92 91.09 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -62.23 92.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 68.15 -69.86 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.093 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.88 36.99 1.03 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.491 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.88 132.21 6.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.883 0.373 . . . . 0.0 110.859 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.97 130.72 35.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.948 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.61 144.98 43.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -93.84 117.55 30.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.867 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.591 ' C ' HG23 ' A' ' 76' ' ' ILE . 91.3 m -144.62 101.1 3.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.7 t -49.74 133.22 8.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.96 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.619 HD22 ' HB3' ' A' ' 77' ' ' SER . 3.0 tp -110.3 -67.23 1.0 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.271 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.49 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 2.1 m-20 -150.79 141.16 22.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.979 0.419 . . . . 0.0 111.539 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.621 ' HB2' ' O ' ' A' ' 73' ' ' THR . 11.8 p -143.7 160.51 40.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.585 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.66 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 3.7 mt-30 -125.18 167.01 15.42 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.813 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.2 p -85.14 106.34 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 119.557 -0.857 . . . . 0.0 108.964 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.528 ' O ' ' O ' ' A' ' 71' ' ' GLU . 6.1 p -115.78 81.02 1.53 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.613 0.721 . . . . 0.0 110.46 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 156.35 -29.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.721 179.081 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 61.78 100.77 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.532 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.713 HG22 ' HB3' ' A' ' 46' ' ' PHE . 5.9 p -71.24 102.7 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 121.213 0.53 . . . . 0.0 109.998 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.68 HG22 ' O ' ' A' ' 66' ' ' ALA . 3.8 mp -64.28 133.35 29.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.015 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -105.67 141.53 36.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.143 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.531 ' O ' HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -76.4 108.13 9.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.776 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.741 HG12 HD13 ' A' ' 64' ' ' ILE . 21.3 t -95.92 108.7 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.107 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.418 HG22 HG12 ' A' ' 63' ' ' ILE . 22.1 t -129.32 114.96 33.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.019 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.752 ' HG3' HD11 ' A' ' 64' ' ' ILE . 0.7 OUTLIER -89.99 139.94 30.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.763 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.4 109.7 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.082 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.19 128.15 30.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.577 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 120.693 0.282 . . . . 0.0 111.143 179.973 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.464 -0.236 0 CA-C-O 120.876 0.282 . . . . 0.0 112.314 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -139.56 129.13 24.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.5 132.92 42.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.878 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.868 HD12 ' HB ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER -101.25 -176.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.444 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.591 ' H ' HG22 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -163.16 121.93 2.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.03 0.443 . . . . 0.0 109.947 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 74' ' ' HIS . 18.9 ttt180 -145.77 132.49 19.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.328 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.612 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 2.2 p -81.85 130.23 35.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.891 0.853 . . . . 0.0 112.235 -177.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.443 ' HG2' HG13 ' A' ' 44' ' ' ILE . 1.1 tt0 -98.36 143.89 28.34 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.806 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.9 94.26 0.31 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.905 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.897 HD12 ' H ' ' A' ' 72' ' ' ARG . 7.3 mt -103.02 95.3 6.38 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.59 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.473 ' C ' HG21 ' A' ' 98' ' ' VAL . 74.4 Cg_endo -74.16 158.6 45.19 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.73 2.287 . . . . 0.0 113.278 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.644 ' HB3' HG22 ' A' ' 98' ' ' VAL . 53.9 p90 -86.64 -173.97 4.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.111 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -151.64 111.84 4.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.882 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.874 HG22 ' CB ' ' A' ' 101' ' ' GLN . 31.2 t -66.81 151.14 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.249 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.5 mp -126.92 156.25 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.094 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.459 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -121.6 100.75 7.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.807 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -107.88 150.91 26.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.499 ' HG3' ' HB3' ' A' ' 107' ' ' ALA . 0.6 OUTLIER -87.91 123.51 32.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -117.47 96.55 49.53 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.928 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.63 65.71 1.2 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.448 2.099 . . . . 0.0 112.193 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -149.68 -45.87 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.846 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.697 HD23 ' HB3' ' A' ' 60' ' ' GLN . 7.1 mp -55.9 172.93 0.29 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 60' ' ' GLN . 2.0 Cg_endo -82.15 31.72 0.52 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.172 2.582 . . . . 0.0 112.951 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.96 120.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.999 0.428 . . . . 0.0 111.387 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.81 22.17 62.16 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.886 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.697 ' HB3' HD23 ' A' ' 56' ' ' LEU . 69.5 tp60 -109.54 157.68 18.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.826 0.346 . . . . 0.0 110.826 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -136.3 115.17 12.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.48 ' OD1' HD21 ' A' ' 56' ' ' LEU . 7.2 p-10 -117.61 116.68 27.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 26.1 mt -85.81 132.09 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.108 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.444 HD11 ' HG3' ' A' ' 104' ' ' GLU . 12.7 mt -103.46 -44.44 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.984 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.55 92.06 2.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.623 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.501 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -46.83 150.92 0.66 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.768 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.466 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -85.71 129.34 9.27 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.229 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.71 125.95 47.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.915 0.388 . . . . 0.0 110.885 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -60.51 112.71 2.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.281 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.492 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -76.9 -144.15 1.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.509 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.692 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 4.6 tt0 -177.45 109.27 0.07 Allowed 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.897 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -100.39 138.75 37.03 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.24 -179.711 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 92' ' ' SER . 94.6 m -75.22 140.12 43.05 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.68 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.577 ' CD2' ' HB3' ' A' ' 92' ' ' SER . 29.0 m80 -119.78 121.75 39.85 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.047 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.722 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -92.22 106.58 18.55 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.24 -177.256 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.868 ' HB ' HD12 ' A' ' 38' ' ' ILE . 5.0 mp -90.75 160.8 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.874 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.822 ' HB3' HD23 ' A' ' 90' ' ' LEU . 5.6 t -119.28 129.01 54.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.721 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.468 HG23 ' CG2' ' A' ' 85' ' ' THR . 11.4 p -81.41 123.0 37.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.141 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.9 tp -128.91 117.28 20.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.2 p -66.98 98.05 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.818 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.73 92.14 6.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 59.95 31.24 20.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.993 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.24 38.5 7.22 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.541 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -148.12 162.07 40.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.76 0.314 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.468 ' CG2' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -106.97 123.47 48.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.927 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -128.33 110.59 12.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.02 114.66 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 77' ' ' SER . 11.8 t -121.29 121.93 38.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.3 m -52.59 121.15 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.112 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.822 HD23 ' HB3' ' A' ' 77' ' ' SER . 0.2 OUTLIER -110.4 -49.97 3.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.189 -179.736 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.484 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 5.9 t0 -176.62 143.79 0.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.275 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.582 ' HB2' ' O ' ' A' ' 73' ' ' THR . 11.3 p -143.16 165.61 26.95 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.554 0.692 . . . . 0.0 111.496 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.717 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 5.1 mm-40 -131.85 166.3 21.9 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.947 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.798 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 5.5 m -85.97 105.79 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.591 ' O ' ' O ' ' A' ' 71' ' ' GLU . 10.7 p -121.02 80.68 1.67 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.491 0.663 . . . . 0.0 110.76 -178.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.692 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER 154.47 -30.38 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.846 178.837 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 62.02 101.58 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.624 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.644 HG22 ' HB3' ' A' ' 46' ' ' PHE . 5.0 p -71.36 108.37 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.163 0.506 . . . . 0.0 110.2 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 66' ' ' ALA . 43.2 mm -64.2 128.8 27.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.173 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -100.94 134.83 43.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.874 ' CB ' HG22 ' A' ' 48' ' ' VAL . 0.3 OUTLIER -64.55 99.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.749 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.82 99.81 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.182 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.6 p -123.71 141.56 43.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.128 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.444 ' HG3' HD11 ' A' ' 64' ' ' ILE . 2.6 mt-10 -121.53 120.13 33.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.801 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.807 HG22 ' O ' ' A' ' 51' ' ' LYS . 27.8 m -86.99 160.14 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.151 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -98.87 125.84 8.7 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.55 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.499 ' HB3' ' HG3' ' A' ' 52' ' ' GLU . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.762 0.315 . . . . 0.0 111.046 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.774 0.239 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.15 121.22 6.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.944 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.71 135.53 33.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.883 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.804 HD12 ' HB ' ' A' ' 76' ' ' ILE . 0.5 OUTLIER -100.8 -177.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.452 179.381 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.704 ' H ' HG22 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -157.14 121.82 4.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.344 0.592 . . . . 0.0 111.26 -179.397 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.668 ' O ' ' HA ' ' A' ' 73' ' ' THR . 1.0 OUTLIER -128.06 -151.11 0.46 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.679 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 m -144.96 137.87 26.44 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.115 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.473 ' CB ' ' CE1' ' A' ' 74' ' ' HIS . 0.2 OUTLIER -107.94 131.84 54.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.427 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -66.93 92.83 0.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.058 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.775 HD11 ' HG2' ' A' ' 72' ' ' ARG . 4.1 mt -109.1 85.79 3.55 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.152 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.591 ' C ' HG21 ' A' ' 98' ' ' VAL . 86.1 Cg_endo -79.76 163.36 23.72 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.829 2.353 . . . . 0.0 112.93 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.629 ' HB3' HG22 ' A' ' 98' ' ' VAL . 40.1 p90 -87.33 -173.98 4.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.225 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -149.31 107.13 3.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.787 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.527 HG23 ' HG2' ' A' ' 101' ' ' GLN . 9.4 p -66.85 123.61 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.018 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 50' ' ' LYS . 22.8 mm -106.4 156.18 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.228 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.431 ' N ' HG22 ' A' ' 49' ' ' ILE . 8.5 ptmt -108.74 100.84 10.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.808 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.531 ' O ' HG22 ' A' ' 105' ' ' VAL . 32.6 ttmt -87.2 159.16 18.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.985 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.637 ' HG3' ' HB3' ' A' ' 107' ' ' ALA . 0.1 OUTLIER -100.87 120.07 39.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.653 ' HB3' HD13 ' A' ' 56' ' ' LEU . 7.9 t-20 -122.94 96.56 44.86 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.918 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.81 -25.19 53.36 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.453 2.102 . . . . 0.0 112.263 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -62.35 -30.97 71.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.705 HD23 ' HB3' ' A' ' 60' ' ' GLN . 8.5 mp -65.18 171.88 2.87 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.748 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -89.06 29.93 0.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.268 2.646 . . . . 0.0 112.598 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.01 146.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.912 0.387 . . . . 0.0 111.292 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.74 21.49 36.51 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.779 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.705 ' HB3' HD23 ' A' ' 56' ' ' LEU . 1.8 tt0 -109.61 148.02 32.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.882 0.372 . . . . 0.0 110.799 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -137.87 141.63 40.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -137.7 162.47 33.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.81 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.913 HD13 HG12 ' A' ' 103' ' ' VAL . 18.2 mm -117.0 86.28 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.113 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.4 mm -62.97 -49.75 82.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.012 0.434 . . . . 0.0 110.94 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.3 m -143.68 91.12 2.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.576 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.06 139.55 4.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.727 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.445 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -82.67 137.01 16.12 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.211 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.482 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.9 t -137.48 125.97 33.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.839 0.352 . . . . 0.0 111.075 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -56.48 119.88 6.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.041 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.583 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -80.74 -149.89 6.58 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.528 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.632 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -177.18 109.3 0.07 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.069 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.793 ' HB2' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -101.53 139.0 37.78 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.295 0.569 . . . . 0.0 109.904 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.671 ' O ' ' HB2' ' A' ' 92' ' ' SER . 91.2 m -75.86 138.99 41.45 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.815 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.473 ' CE1' ' CB ' ' A' ' 42' ' ' GLU . 5.0 m80 -111.64 118.97 37.13 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.745 0.784 . . . . 0.0 112.609 -178.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.698 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -92.05 100.05 12.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.066 -1.424 . . . . 0.0 111.508 -177.365 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.804 ' HB ' HD12 ' A' ' 38' ' ' ILE . 5.0 mp -87.73 141.62 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.79 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.601 ' O ' HD12 ' A' ' 79' ' ' LEU . 5.7 t -98.78 130.26 45.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 0.0 110.753 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.607 HG23 HG22 ' A' ' 85' ' ' THR . 10.6 p -81.42 119.01 30.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.172 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 77' ' ' SER . 5.4 mp -113.21 116.61 30.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.6 m -88.65 94.34 9.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.94 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -87.35 96.72 10.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 42.88 32.06 0.37 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.401 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.39 43.67 2.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.522 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -147.88 107.38 3.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.82 0.343 . . . . 0.0 110.878 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.607 HG22 HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -88.91 119.01 29.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.821 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.31 149.96 44.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -97.25 108.62 21.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.974 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.767 ' O ' HG23 ' A' ' 76' ' ' ILE . 78.0 m -127.5 124.05 37.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 89' ' ' VAL . 9.9 p -55.15 121.82 3.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.865 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.526 HD23 ' HB3' ' A' ' 77' ' ' SER . 0.2 OUTLIER -104.9 -71.24 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.381 -179.523 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.5 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 2.6 t0 -147.06 136.44 22.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.845 0.355 . . . . 0.0 111.576 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.671 ' HB2' ' O ' ' A' ' 73' ' ' THR . 5.8 p -143.56 150.95 39.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.385 0.612 . . . . 0.0 110.938 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.576 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 26.0 mm-40 -113.39 166.93 11.01 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.793 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.6 p -85.27 106.33 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.457 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 71' ' ' GLU . 5.8 p -115.15 81.37 1.56 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.428 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.632 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 157.44 -30.17 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.708 179.159 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 61.73 103.57 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.511 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.629 HG22 ' HB3' ' A' ' 46' ' ' PHE . 7.6 p -71.21 104.26 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.209 0.528 . . . . 0.0 110.081 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.611 ' H ' HD12 ' A' ' 99' ' ' ILE . 5.3 mp -63.68 127.17 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.032 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.435 ' HA ' ' HB2' ' A' ' 46' ' ' PHE . 6.2 m120 -92.36 145.74 24.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.017 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.527 ' HG2' HG23 ' A' ' 48' ' ' VAL . 3.2 tt0 -84.15 101.56 11.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.867 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.85 99.69 7.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.104 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.913 HG12 HD13 ' A' ' 63' ' ' ILE . 24.6 m -125.38 120.84 59.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.139 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -100.64 131.94 46.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 51' ' ' LYS . 6.4 m -110.53 128.37 66.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.147 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.05 137.74 50.17 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.533 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.637 ' HB3' ' HG3' ' A' ' 52' ' ' GLU . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.817 0.342 . . . . 0.0 111.103 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo . . . . . 0 C--O 1.23 0.119 0 CA-C-O 120.88 0.283 . . . . 0.0 112.237 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -94.85 145.21 25.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.757 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mp -93.65 114.07 26.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.195 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.719 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 44.0 pt -101.03 -176.4 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.817 178.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.908 HG22 ' CD1' ' A' ' 75' ' ' TYR . 1.1 p -151.39 147.04 26.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.236 0.541 . . . . 0.0 111.47 -178.564 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.698 ' HG3' HD13 ' A' ' 76' ' ' ILE . 1.4 mtp85 -161.17 104.54 1.3 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.997 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.552 HG21 ' CD ' ' A' ' 71' ' ' GLU . 15.0 t -82.15 131.44 35.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.617 0.722 . . . . 0.0 111.373 -178.526 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.542 ' O ' HD12 ' A' ' 44' ' ' ILE . 2.1 mt-10 -98.39 144.6 27.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.807 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.408 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 28.8 tt0 -66.67 91.68 0.19 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.695 -179.47 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.8 mp -87.72 109.41 26.59 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.978 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.506 ' C ' HG21 ' A' ' 98' ' ' VAL . 69.6 Cg_endo -88.26 158.18 6.88 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.837 2.358 . . . . 0.0 112.853 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.577 ' HB3' HG22 ' A' ' 98' ' ' VAL . 42.3 p90 -87.27 -174.16 4.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.945 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.42 104.43 2.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.733 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.533 HG23 ' HG2' ' A' ' 101' ' ' GLN . 11.9 p -67.42 143.5 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.189 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 49' ' ' ILE . 4.2 mp -111.82 156.07 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.094 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.453 ' N ' HG22 ' A' ' 49' ' ' ILE . 9.7 pttp -108.29 100.91 10.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.828 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.4 ttmp? -112.5 161.78 16.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.927 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -117.71 139.97 50.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.931 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -137.76 132.96 17.55 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.69 -20.28 13.77 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.454 2.103 . . . . 0.0 112.554 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.98 -30.5 59.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.155 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.506 HD22 ' NE2' ' A' ' 60' ' ' GLN . 10.5 mt -81.77 162.35 58.03 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.974 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.14 42.15 1.14 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.209 2.606 . . . . 0.0 112.602 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.67 136.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.872 0.368 . . . . 0.0 111.335 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.66 40.54 88.39 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.687 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.506 ' NE2' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -109.47 145.47 36.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 0.0 110.905 -179.993 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -112.05 117.12 31.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.828 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -130.32 126.06 36.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.991 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.688 HD13 HG22 ' A' ' 103' ' ' VAL . 27.3 mm -101.74 96.37 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.044 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.539 HD12 HG12 ' A' ' 102' ' ' VAL . 35.8 mt -66.2 -31.13 52.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.794 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.644 ' CG2' HG23 ' A' ' 102' ' ' VAL . 6.4 t -163.34 119.26 1.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.71 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.07 125.37 27.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.23 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.0 137.75 48.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.319 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.449 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.8 t -138.61 124.16 23.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.814 0.34 . . . . 0.0 111.084 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.86 119.1 4.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.183 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.447 ' CA ' ' O ' ' A' ' 96' ' ' LYS . . . -88.28 -152.25 24.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.044 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.552 ' CD ' HG21 ' A' ' 41' ' ' THR . 0.2 OUTLIER -161.52 145.94 13.13 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.619 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.591 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 31.1 ttm180 -140.36 110.39 6.52 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.139 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.724 ' O ' ' HB3' ' A' ' 92' ' ' SER . 28.0 m -73.77 125.48 28.2 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.014 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.513 ' HD2' ' O ' ' A' ' 72' ' ' ARG . 4.7 m-70 -105.59 117.53 34.25 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 122.098 0.952 . . . . 0.0 113.259 -176.783 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.908 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -89.44 108.26 19.54 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 113.694 -1.594 . . . . 0.0 111.28 -177.912 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.698 HD13 ' HG3' ' A' ' 40' ' ' ARG . 2.4 mp -95.26 160.76 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.814 -179.625 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.731 ' OG ' HD23 ' A' ' 90' ' ' LEU . 55.9 p -104.69 118.76 37.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.711 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.731 HG23 HG23 ' A' ' 85' ' ' THR . 9.9 p -81.45 108.55 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.155 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -113.05 88.68 2.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.6 m -82.16 117.51 22.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -127.8 107.62 10.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.952 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 60.79 31.85 20.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.843 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.75 43.24 7.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.525 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.9 tptp -143.23 107.51 4.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.793 0.33 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.731 HG23 HG23 ' A' ' 78' ' ' VAL . 24.8 m -85.85 120.06 26.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.92 142.8 31.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.925 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -105.85 95.73 6.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.6 m -123.64 125.1 44.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.064 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.9 m -55.11 145.12 5.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.022 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.731 HD23 ' OG ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -130.09 -51.76 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.171 -179.851 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 1.8 t70 -176.62 137.32 0.26 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.274 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.724 ' HB3' ' O ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -143.66 144.87 32.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.352 0.596 . . . . 0.0 111.306 179.005 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.645 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 3.1 mt-30 -103.47 166.75 10.24 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.582 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 94' ' ' VAL . 8.6 p -85.25 107.01 15.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.803 -179.031 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.517 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 19.3 p -110.51 83.2 1.72 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.22 -179.435 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 95' ' ' THR . 0.1 OUTLIER 103.39 44.78 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.746 -179.636 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.46 ' HB2' HG21 ' A' ' 94' ' ' VAL . 6.1 tp10 -31.31 133.32 0.08 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.313 -179.604 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.577 HG22 ' HB3' ' A' ' 46' ' ' PHE . 10.7 p -71.87 118.89 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.002 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.564 ' H ' HD12 ' A' ' 99' ' ' ILE . 5.3 mp -75.49 108.79 7.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.962 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -71.22 130.87 42.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.533 ' HG2' HG23 ' A' ' 48' ' ' VAL . 29.2 tt0 -68.53 148.0 51.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.644 HG23 ' CG2' ' A' ' 65' ' ' THR . 53.4 t -133.11 100.61 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.007 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.688 HG22 HD13 ' A' ' 63' ' ' ILE . 20.1 t -120.47 133.63 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -110.91 154.89 23.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.78 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.88 138.74 52.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.202 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.7 87.81 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.498 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.706 0.289 . . . . 0.0 111.171 179.962 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.795 0.331 . . . . 0.0 111.254 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -92.8 -30.32 9.72 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.51 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.69 110.08 3.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.776 0.322 . . . . 0.0 110.887 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.8 p -157.53 135.47 10.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.5 m170 -84.6 -177.57 6.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.945 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.9 34.92 0.83 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.971 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -91.88 80.94 5.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.821 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -160.92 31.53 0.15 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -175.65 37.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.927 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.31 -176.57 4.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -60.18 113.22 2.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.955 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.68 37.69 3.43 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.492 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mt -99.5 -68.94 0.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.648 0.261 . . . . 0.0 110.854 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.0 m 42.18 53.95 8.54 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.705 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.57 -71.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.601 2.2 . . . . 0.0 112.269 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 mtt85 59.76 31.33 20.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.874 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -173.93 70.45 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.512 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.5 p -119.81 31.51 6.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 0.0 110.907 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -147.64 -172.88 4.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.856 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 28.4 mtp -137.55 31.67 2.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.859 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.8 p -130.4 123.2 29.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.967 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.56 129.45 37.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -103.28 34.84 2.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -77.3 144.59 37.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.921 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -145.26 32.49 1.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.89 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -107.07 166.57 10.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.419 HG23 ' N ' ' A' ' 28' ' ' ALA . 31.0 m -59.95 -41.32 85.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.162 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.419 ' N ' HG23 ' A' ' 27' ' ' VAL . . . -130.29 -75.47 0.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.065 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.15 36.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.6 t30 59.93 175.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.48 HG13 ' N ' ' A' ' 32' ' ' GLU . 12.2 p -68.52 -44.8 82.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.025 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.48 ' N ' HG13 ' A' ' 31' ' ' VAL . 4.8 mt-10 -166.42 -76.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.905 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.7 m -164.3 -48.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.2 162.87 42.08 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.55 -165.75 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.587 2.191 . . . . 0.0 112.245 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.68 142.17 51.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.786 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.96 111.3 23.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.191 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.682 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 6.1 pt -101.18 -177.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.966 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.772 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.7 OUTLIER -145.86 162.26 38.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.357 0.598 . . . . 0.0 111.193 -178.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 26.6 ttt180 -174.01 112.96 0.19 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.051 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 11.1 t -82.19 129.57 34.87 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.817 0.817 . . . . 0.0 111.326 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.477 ' O ' HD12 ' A' ' 44' ' ' ILE . 2.1 mt-10 -98.13 147.72 24.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.002 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -67.08 101.48 0.88 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.028 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 1.9 mp -107.67 87.39 3.5 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.56 ' C ' HG21 ' A' ' 98' ' ' VAL . 73.2 Cg_endo -75.86 160.29 37.44 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.66 2.24 . . . . 0.0 112.688 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.593 ' HB3' HG22 ' A' ' 98' ' ' VAL . 33.5 p90 -87.15 -176.92 5.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.985 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.5 ' OE1' HD13 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -158.43 115.13 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.841 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.713 HG22 ' CB ' ' A' ' 101' ' ' GLN . 3.1 t -67.17 143.83 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.132 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.5 HD13 ' OE1' ' A' ' 47' ' ' GLU . 33.4 mm -115.84 156.19 16.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.118 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.449 ' N ' HG22 ' A' ' 49' ' ' ILE . 13.1 ptmt -108.74 109.57 20.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -119.82 153.21 36.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -87.91 129.5 35.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.971 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.436 ' ND2' HD23 ' A' ' 56' ' ' LEU . 5.8 t-20 -122.17 96.5 46.37 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.09 -23.97 45.45 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.392 2.061 . . . . 0.0 112.333 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -59.69 -28.97 67.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.991 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.546 HD12 ' CD ' ' A' ' 60' ' ' GLN . 3.1 mm? -83.18 165.29 41.7 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.742 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -80.84 43.39 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.076 2.518 . . . . 0.0 112.743 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.88 142.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.939 0.399 . . . . 0.0 111.437 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 55.17 25.85 40.93 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.876 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.546 ' CD ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -109.38 136.84 48.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 0.0 110.979 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -101.2 162.57 12.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.59 ' ND2' HD11 ' A' ' 64' ' ' ILE . 46.2 t30 -156.32 111.85 2.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.86 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.815 HD13 HG12 ' A' ' 103' ' ' VAL . 36.7 mm -85.65 86.12 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.138 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.59 HD11 ' ND2' ' A' ' 62' ' ' ASN . 36.9 mm -64.53 -36.07 76.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.953 0.406 . . . . 0.0 110.712 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.661 HG22 ' HB ' ' A' ' 102' ' ' VAL . 9.7 t -166.56 100.35 0.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.554 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.41 135.02 28.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.753 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.467 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -66.0 134.27 34.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.273 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -130.2 132.21 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.907 0.384 . . . . 0.0 111.3 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.458 ' HD3' ' CD2' ' A' ' 46' ' ' PHE . 10.7 mmtt -57.12 125.96 25.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.229 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.453 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -105.49 -159.55 23.0 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.051 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.497 ' HA ' HD12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -162.47 154.62 18.88 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.622 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.587 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 14.0 ttt180 -143.67 111.77 6.22 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.576 ' O ' ' HB2' ' A' ' 92' ' ' SER . 64.2 m -72.99 121.46 20.14 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.569 ' O ' ' HA ' ' A' ' 39' ' ' THR . 18.7 m80 -102.26 120.3 40.24 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.772 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -86.02 122.27 29.82 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.679 -1.601 . . . . 0.0 110.767 -178.238 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.802 HG23 ' C ' ' A' ' 88' ' ' THR . 4.2 mp -116.14 141.78 32.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.282 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.678 ' HB2' HD13 ' A' ' 90' ' ' LEU . 0.2 OUTLIER -105.24 98.06 7.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.829 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.522 ' O ' HG13 ' A' ' 78' ' ' VAL . 12.5 p -81.45 117.9 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.159 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.562 HD13 ' N ' ' A' ' 80' ' ' THR . 2.4 tm? -105.45 124.33 49.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.562 ' N ' HD13 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -84.78 91.24 7.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.549 ' HB2' HD12 ' A' ' 79' ' ' LEU . 5.1 tt0 -123.16 135.96 54.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.2 m120 61.15 30.49 19.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.87 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.54 47.67 81.52 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.597 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.55 142.7 12.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.774 0.321 . . . . 0.0 110.862 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.449 HG22 HG22 ' A' ' 78' ' ' VAL . 0.8 OUTLIER -102.18 120.79 41.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.889 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 t -105.05 125.86 51.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.866 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.37 107.3 19.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.876 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.802 ' C ' HG23 ' A' ' 76' ' ' ILE . 97.3 m -133.71 112.75 11.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.923 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.56 HG12 HG13 ' A' ' 76' ' ' ILE . 22.3 m -56.61 162.37 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.966 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.678 HD13 ' HB2' ' A' ' 77' ' ' SER . 1.2 mp -149.18 -56.72 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.343 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.509 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 1.4 t70 -140.65 134.73 30.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.479 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.576 ' HB2' ' O ' ' A' ' 73' ' ' THR . 17.8 p -143.21 133.33 24.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.308 0.575 . . . . 0.0 111.319 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.562 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 3.4 pt20 -89.52 166.58 13.58 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 94' ' ' VAL . 5.2 m -85.67 107.3 16.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.564 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 20.0 p -114.22 83.01 1.8 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.192 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.564 ' CB ' ' O ' ' A' ' 95' ' ' THR . 20.2 tptm 107.53 48.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.741 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -33.72 122.24 0.44 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.755 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.593 HG22 ' HB3' ' A' ' 46' ' ' PHE . 12.6 p -71.61 109.89 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.212 0.529 . . . . 0.0 111.052 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 34.8 mm -68.72 116.22 8.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.221 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 20.8 m-20 -81.52 129.33 34.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.726 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.713 ' CB ' HG22 ' A' ' 48' ' ' VAL . 12.8 tt0 -62.09 112.36 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.96 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.661 ' HB ' HG22 ' A' ' 65' ' ' THR . 58.1 t -95.4 99.73 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.954 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.815 HG12 HD13 ' A' ' 63' ' ' ILE . 25.5 m -122.85 135.72 61.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.133 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -119.8 108.5 14.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.735 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.0 t -91.41 142.0 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.069 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.81 147.1 37.63 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.552 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.31 144.49 77.49 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.655 0.264 . . . . 0.0 111.135 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.09 -73.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.521 2.147 . . . . 0.0 112.373 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.549 HG13 HG22 ' A' ' 110' ' ' THR . 10.8 p -178.53 -45.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.045 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.549 HG22 HG13 ' A' ' 109' ' ' VAL . 9.9 t -177.83 38.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.912 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.429 ' CE1' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.877 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.741 0.305 . . . . 24.44 111.246 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.27 50.88 1.15 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.981 -0.628 . . . . 22.38 112.563 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.3 t -158.58 87.87 0.9 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.825 0.345 . . . . 22.39 110.895 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.2 m -73.64 -54.22 8.65 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.161 -0.472 . . . . 20.83 110.616 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -127.03 24.51 6.38 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.178 -0.464 . . . . 19.5 111.173 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.2 m80 63.98 175.36 0.18 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.009 0.433 . . . . 20.52 111.581 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -78.64 -150.24 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.897 -0.592 . . . . 18.21 110.289 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -46.92 -53.7 11.65 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.628 0.251 . . . . 19.2 110.81 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 61.56 178.02 0.12 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.079 -0.51 . . . . 18.15 111.889 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.2 m -119.46 56.44 0.93 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.865 -0.607 . . . . 16.59 110.382 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.546 ' HA ' ' HG3' ' A' ' 15' ' ' PRO . 52.7 m -67.28 -17.12 64.65 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.157 -0.474 . . . . 16.02 112.111 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.39 -1.88 90.26 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.945 -0.645 . . . . 15.34 114.103 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.854 HD22 ' N ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -155.04 -45.0 0.08 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 117.894 0.847 . . . . 16.67 112.384 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.854 ' N ' HD22 ' A' ' 13' ' ' LEU . 74.5 t -150.19 86.89 5.08 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-O 120.788 0.327 . . . . 14.4 110.908 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.546 ' HG3' ' HA ' ' A' ' 11' ' ' SER . 1.7 Cg_endo -80.47 -64.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.043 2.495 . . . . 14.22 111.732 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.3 -41.77 2.6 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.023 -0.535 . . . . 15.75 110.532 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -136.3 -78.04 0.08 OUTLIER Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.873 -0.491 . . . . 12.26 111.873 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.38 -157.39 0.33 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.517 0.199 . . . . 12.26 111.306 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -58.01 -31.52 67.05 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.605 -0.27 . . . . 13.96 111.513 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.466 ' HB2' ' HB3' ' A' ' 23' ' ' ASP . 0.7 OUTLIER 71.34 113.66 0.05 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.587 0.355 . . . . 13.44 111.211 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.1 m -69.51 -23.75 63.65 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.09 -0.504 . . . . 13.72 111.467 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -91.95 -42.56 9.94 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.715 -0.221 . . . . 13.88 111.084 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 4.0 t70 -65.3 -31.67 72.93 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.389 -0.369 . . . . 13.08 111.613 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.67 -22.88 64.36 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.942 0.349 . . . . 13.27 111.942 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 0.0 OUTLIER 73.45 157.56 0.19 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.503 0.321 . . . . 12.35 111.249 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 25' ' ' ASN . 26.4 mm-40 70.98 -92.38 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.929 -0.578 . . . . 13.92 110.848 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.468 HG13 ' H ' ' A' ' 28' ' ' ALA . 2.6 p -176.75 -55.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 111.544 0.202 . . . . 13.31 111.544 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.468 ' H ' HG13 ' A' ' 27' ' ' VAL . . . 33.62 -96.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.129 0.572 . . . . 13.44 112.466 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.45 39.3 28.18 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.604 0.24 . . . . 13.29 111.518 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.8 m120 54.68 34.08 20.77 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.251 -0.431 . . . . 13.27 111.544 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.512 HG12 ' HB3' ' A' ' 35' ' ' PRO . 3.3 t 51.49 53.19 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 121.013 0.435 . . . . 13.59 111.201 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -105.96 -52.89 2.73 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.992 -0.549 . . . . 13.76 110.907 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.0 m -86.0 115.6 23.7 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.557 -0.292 . . . . 13.77 110.356 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.445 ' HD3' ' HB2' ' A' ' 77' ' ' SER . 1.3 mmt180 58.85 59.39 5.52 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.14 -0.482 . . . . 13.11 110.84 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.512 ' HB3' HG12 ' A' ' 31' ' ' VAL . 56.6 Cg_endo -72.34 -43.2 1.1 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.611 2.207 . . . . 12.38 112.594 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.483 ' O ' HG22 ' A' ' 78' ' ' VAL . 11.1 tp10 -147.71 112.03 5.24 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.284 -0.416 . . . . 13.36 110.467 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 mp -72.74 111.49 7.94 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.181 -0.463 . . . . 10.56 110.764 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.678 HG13 ' HB ' ' A' ' 76' ' ' ILE . 28.6 pt -99.44 121.0 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-O 121.722 0.772 . . . . 11.62 109.665 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.699 ' HB ' ' CG2' ' A' ' 73' ' ' THR . 6.3 p -87.13 139.39 30.62 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.018 -0.992 . . . . 10.51 111.111 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 7.1 ttt-85 -155.51 117.98 4.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.807 -1.088 . . . . 12.83 108.914 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 68.4 p -79.81 127.49 32.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.503 0.668 . . . . 9.41 110.887 -178.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -96.9 139.41 32.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.639 -1.164 . . . . 8.52 109.83 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.86 97.82 0.37 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.962 -0.563 . . . . 10.74 110.691 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.739 HD12 ' H ' ' A' ' 72' ' ' ARG . 7.5 mt -99.19 103.01 17.59 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 115.43 -0.805 . . . . 6.29 109.585 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.627 ' C ' HG21 ' A' ' 98' ' ' VAL . 90.5 Cg_endo -78.24 145.63 21.74 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.316 2.677 . . . . 6.46 114.363 -177.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.548 ' HB2' ' HA ' ' A' ' 100' ' ' ASN . 39.1 p90 -86.73 -179.82 6.63 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.278 -0.874 . . . . 7.25 111.175 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.07 117.19 6.83 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.397 -0.365 . . . . 6.08 111.678 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.823 HG13 ' HB3' ' A' ' 101' ' ' GLN . 21.9 t -66.11 134.61 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.039 -0.528 . . . . 6.99 111.536 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.9 mm -123.48 139.76 49.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.278 -0.419 . . . . 8.71 111.49 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -100.19 108.19 20.23 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.881 -0.6 . . . . 10.39 110.394 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.95 106.18 16.57 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.079 -0.509 . . . . 12.29 111.155 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -61.64 105.53 0.55 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.822 0.344 . . . . 14.65 110.524 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 0.8 OUTLIER -108.34 119.82 48.46 Favored Pre-proline 0 C--O 1.232 0.173 0 CA-C-N 116.087 -0.506 . . . . 15.73 111.442 -179.192 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.56 -24.6 18.64 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.785 2.324 . . . . 18.25 112.371 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -61.76 -39.1 90.45 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.421 -0.354 . . . . 19.33 111.183 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.503 HD21 ' CB ' ' A' ' 62' ' ' ASN . 1.0 OUTLIER -63.58 164.27 16.49 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.495 -0.32 . . . . 17.22 110.905 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.77 -74.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.769 2.313 . . . . 17.35 113.301 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.514 ' HB1' ' HB3' ' A' ' 108' ' ' PRO . . . -178.76 122.51 0.09 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.098 -0.955 . . . . 15.79 111.205 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.21 29.1 62.38 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.189 -0.529 . . . . 13.8 113.025 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.436 ' O ' HD22 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -106.09 136.69 45.33 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.701 0.25 . . . . 15.46 110.501 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.26 113.4 25.02 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.888 0.375 . . . . 13.22 111.335 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.503 ' CB ' HD21 ' A' ' 56' ' ' LEU . 1.5 t-20 -106.22 111.99 24.82 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.893 -0.594 . . . . 14.38 109.948 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.416 HG12 HG13 ' A' ' 103' ' ' VAL . 24.2 mt -85.58 122.51 38.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.095 0.474 . . . . 13.39 111.851 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.417 HD11 ' OD1' ' A' ' 62' ' ' ASN . 44.4 mm -100.52 -39.7 7.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.374 -0.83 . . . . 13.85 109.841 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.812 HG22 HG23 ' A' ' 99' ' ' ILE . 0.2 OUTLIER -135.54 99.0 4.08 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.682 -0.69 . . . . 11.74 109.815 179.517 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.4 113.72 1.14 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.02 -0.536 . . . . 10.75 112.074 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.44 ' H ' ' HG2' ' A' ' 101' ' ' GLN . . . -58.7 109.33 1.95 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.871 -0.604 . . . . 8.47 112.314 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.5 t -135.1 144.56 34.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.91 0.386 . . . . 10.08 111.251 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -67.48 116.3 8.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.716 -0.675 . . . . 10.15 111.125 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.491 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -81.96 -171.55 46.18 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.154 -0.546 . . . . 7.45 112.107 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.562 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -158.72 109.18 2.05 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.461 -0.57 . . . . 10.04 109.461 179.499 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.739 ' H ' HD12 ' A' ' 44' ' ' ILE . 36.5 ttm180 -98.18 124.8 42.94 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.554 -0.536 . . . . 6.27 109.554 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.699 ' CG2' ' HB ' ' A' ' 39' ' ' THR . 95.1 m -74.76 125.37 28.62 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 107.719 -1.215 . . . . 8.55 107.719 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.593 ' HD2' HG23 ' A' ' 89' ' ' VAL . 19.8 m80 -105.66 114.88 29.3 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.927 0.87 . . . . 8.1 112.647 -177.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.694 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -80.09 92.47 5.64 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 113.67 -1.605 . . . . 8.08 109.086 -178.363 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.678 ' HB ' HG13 ' A' ' 38' ' ' ILE . 74.1 mt -88.16 154.86 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 113.411 -1.722 . . . . 10.77 112.474 -177.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.445 ' HB2' ' HD3' ' A' ' 34' ' ' ARG . 32.7 t -105.17 121.35 43.63 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.292 -0.413 . . . . 11.99 110.34 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.505 ' CG1' HD13 ' A' ' 38' ' ' ILE . 3.9 m -81.76 98.23 4.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.05 0.452 . . . . 13.47 111.351 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.0 mt -103.68 106.85 17.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.967 -0.56 . . . . 15.75 110.209 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 p -73.56 93.88 2.08 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.207 -0.451 . . . . 17.62 111.194 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -90.74 93.99 9.48 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.994 -0.548 . . . . 20.19 110.26 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 58.5 45.6 16.2 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.098 -0.501 . . . . 22.51 110.773 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.76 47.71 6.56 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.108 -0.568 . . . . 21.28 112.713 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -162.13 108.07 1.27 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.657 0.265 . . . . 21.24 111.114 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.4 p -75.72 97.74 3.92 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.239 -0.437 . . . . 17.93 110.653 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 58.9 m -77.37 110.25 11.96 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.092 -0.504 . . . . 16.48 110.751 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.51 ' HB2' HG21 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -80.79 96.34 6.94 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.112 0.482 . . . . 14.73 110.636 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 45.1 m -108.79 126.15 52.72 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.959 -0.564 . . . . 13.13 111.4 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.593 HG23 ' HD2' ' A' ' 74' ' ' HIS . 3.1 p -59.16 134.89 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.066 -0.516 . . . . 10.29 110.134 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 32.2 mt -137.64 -83.94 0.32 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.147 0.425 . . . . 10.3 112.147 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.81 122.1 44.4 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.563 0.221 . . . . 8.61 111.343 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.649 ' HB2' ' O ' ' A' ' 73' ' ' THR . 1.3 p -145.29 148.94 34.0 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.189 0.519 . . . . 6.47 111.656 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.636 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 19.0 mm-40 -108.65 164.64 12.19 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.032 -1.47 . . . . 9.38 107.032 176.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.68 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 12.3 p -82.22 112.68 20.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.292 -0.563 . . . . 7.93 110.544 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 31.9 p -117.61 72.08 0.83 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.671 0.748 . . . . 8.27 110.612 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 149.37 -43.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.07 -1.423 . . . . 11.5 108.826 178.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.445 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 9.3 tp10 64.55 115.32 0.02 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.327 -0.851 . . . . 8.74 111.571 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.627 HG21 ' C ' ' A' ' 45' ' ' PRO . 11.1 p -71.21 103.24 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.373 0.606 . . . . 6.07 110.107 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.812 HG23 HG22 ' A' ' 65' ' ' THR . 4.5 mp -71.68 118.97 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.424 -0.807 . . . . 9.43 110.962 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.548 ' HA ' ' HB2' ' A' ' 46' ' ' PHE . 4.1 m120 -82.69 133.1 35.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.846 -0.615 . . . . 7.9 110.102 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.823 ' HB3' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -59.64 98.46 0.05 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.422 -0.354 . . . . 8.78 111.032 -179.435 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 76.0 t -90.72 99.11 9.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.862 -0.421 . . . . 10.47 109.862 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.495 HG22 ' NE2' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -115.01 125.39 72.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.949 -0.569 . . . . 10.33 111.177 -179.102 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 53' ' ' ASN . 17.0 mm-40 -96.52 110.29 22.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.822 -0.627 . . . . 13.72 110.248 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.7 t -85.98 115.55 27.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.226 -0.443 . . . . 12.91 110.992 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.414 ' HA2' ' HB2' ' A' ' 56' ' ' LEU . . . -61.8 132.02 46.48 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.015 -0.612 . . . . 13.96 112.721 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . . . -89.41 111.26 44.49 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-O 120.361 0.124 . . . . 15.72 110.933 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.604 ' O ' HG12 ' A' ' 109' ' ' VAL . 7.2 Cg_exo -73.52 73.08 3.5 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.982 2.454 . . . . 17.07 111.995 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.604 HG12 ' O ' ' A' ' 108' ' ' PRO . 4.1 p 50.68 23.8 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 115.888 -0.596 . . . . 18.7 112.24 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 108' ' ' PRO . 6.2 t 176.68 123.05 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.439 -0.346 . . . . 19.9 110.526 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 117.999 -1.0 . . . . 21.09 111.091 -179.998 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttp . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.806 0.336 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.71 59.36 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.474 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.0 m -163.45 36.33 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 m -129.93 -46.83 1.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.991 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.418 ' CE1' ' HB2' ' A' ' 10' ' ' SER . 1.0 OUTLIER -100.85 106.67 18.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -110.63 30.61 6.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.955 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.9 m80 59.32 88.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.91 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -161.74 30.43 0.13 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.95 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 52.9 m80 58.96 82.39 0.14 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.975 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.418 ' HB2' ' CE1' ' A' ' 5' ' ' HIS . 2.1 m -88.79 -75.88 0.42 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.7 t -177.59 171.98 1.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.8 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.9 -158.82 24.06 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.527 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.517 ' O ' HG13 ' A' ' 14' ' ' VAL . 3.6 tp -131.55 -56.96 1.01 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.829 0.347 . . . . 0.0 110.861 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 13' ' ' LEU . 6.4 m -158.29 155.19 25.31 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.123 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.97 -168.22 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.545 2.163 . . . . 0.0 112.33 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.16 -31.4 14.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.987 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -140.6 -79.89 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.367 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.2 m 60.52 35.91 20.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.352 . . . . 0.0 110.904 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -60.27 -176.94 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 18.1 ttm -98.74 -70.72 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.943 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -177.4 -176.17 0.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.01 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.6 mt 60.28 163.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.95 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -176.62 136.1 0.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -60.65 131.43 50.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -123.08 34.73 5.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.902 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 60.55 -175.14 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 28' ' ' ALA . 21.5 t 63.63 158.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.118 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.483 ' N ' HG12 ' A' ' 27' ' ' VAL . . . 60.67 156.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.175 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -164.9 -44.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.3 t30 60.65 158.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.82 HG23 HG23 ' A' ' 33' ' ' THR . 6.1 m -113.15 179.33 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -83.68 -57.6 3.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.82 HG23 HG23 ' A' ' 31' ' ' VAL . 9.5 p 55.79 37.46 28.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.033 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 62.34 149.49 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.48 -45.87 1.08 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.587 2.192 . . . . 0.0 112.348 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -169.38 128.05 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.88 131.25 35.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.824 HD12 ' HB ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER -101.12 -177.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.698 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.748 HG22 ' CD1' ' A' ' 75' ' ' TYR . 1.0 OUTLIER -163.31 121.08 1.91 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.113 0.482 . . . . 0.0 110.669 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.45 ' HG3' HD13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -142.56 109.72 5.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.774 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.563 HG21 ' OE1' ' A' ' 71' ' ' GLU . 11.3 t -82.52 128.28 34.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.511 0.672 . . . . 0.0 111.407 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.574 ' O ' HD12 ' A' ' 44' ' ' ILE . 1.3 mt-10 -98.31 146.01 26.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.744 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.77 91.67 0.2 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.803 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.577 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.7 mp -89.62 108.23 23.85 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.885 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.455 ' C ' HG21 ' A' ' 98' ' ' VAL . 1.9 Cg_endo -81.95 157.43 18.07 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.941 2.427 . . . . 0.0 112.596 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.449 ' HB3' ' CG2' ' A' ' 98' ' ' VAL . 42.2 p90 -86.57 -174.4 4.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.74 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.99 116.54 3.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.874 HG22 ' CB ' ' A' ' 101' ' ' GLN . 43.2 t -67.29 148.76 11.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.051 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 50' ' ' LYS . 37.9 mm -123.82 156.16 30.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.013 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.446 ' N ' HG22 ' A' ' 49' ' ' ILE . 1.9 pttp -119.42 100.86 7.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.414 ' O ' HG12 ' A' ' 105' ' ' VAL . 8.1 mttm -105.56 141.72 36.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 3.3 pt-20 -104.79 124.89 50.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -128.67 133.29 25.03 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.12 -20.77 12.61 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.468 2.112 . . . . 0.0 112.541 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -55.06 -38.49 68.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.06 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.552 HD22 ' NE2' ' A' ' 60' ' ' GLN . 21.2 mt -62.82 159.64 43.34 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.763 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -80.24 44.98 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.039 2.493 . . . . 0.0 112.724 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.61 125.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.934 0.397 . . . . 0.0 111.424 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.44 53.63 41.92 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.779 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.552 ' NE2' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -109.46 162.91 13.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.746 0.308 . . . . 0.0 110.894 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -145.16 113.92 6.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -143.12 122.54 13.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.2 mt -86.59 131.18 35.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.09 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.5 mm -99.59 -44.24 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.9 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.6 m -144.28 102.25 3.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.659 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.417 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -53.81 153.4 4.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.483 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.59 131.29 10.32 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.19 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -140.62 136.36 35.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.869 0.366 . . . . 0.0 111.132 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -63.12 124.87 22.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 98' ' ' VAL . . . -97.99 -151.98 27.77 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.888 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.563 ' OE1' HG21 ' A' ' 41' ' ' THR . 0.3 OUTLIER -161.03 148.1 15.19 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.577 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 5.2 ttt180 -140.21 111.22 6.98 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.724 ' O ' ' HB2' ' A' ' 92' ' ' SER . 19.1 m -73.58 126.81 31.11 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.461 ' HA ' ' CB ' ' A' ' 92' ' ' SER . 20.3 m80 -107.55 119.72 40.21 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.042 0.925 . . . . 0.0 112.893 -177.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.748 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.1 OUTLIER -91.15 102.72 15.45 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 113.651 -1.613 . . . . 0.0 111.146 -177.529 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.824 ' HB ' HD12 ' A' ' 38' ' ' ILE . 4.8 mp -87.86 160.15 2.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.952 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.771 ' HB2' HD23 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -98.45 126.8 44.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.685 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.501 HG22 HD11 ' A' ' 38' ' ' ILE . 21.6 t -81.43 109.86 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.254 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.4 mt -115.75 103.53 10.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.841 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.33 123.19 34.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.831 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -129.55 93.09 3.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 61.24 36.24 17.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.964 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.82 46.13 5.22 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.442 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.01 114.64 7.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.812 0.339 . . . . 0.0 110.872 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.85 112.09 23.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.856 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.95 150.73 21.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.96 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.421 ' HA ' HG21 ' A' ' 76' ' ' ILE . 18.9 mt-10 -107.77 99.54 9.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 94.1 m -115.37 116.5 28.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.922 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.1 m -50.01 123.67 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.771 HD23 ' HB2' ' A' ' 77' ' ' SER . 0.2 OUTLIER -110.53 -67.87 0.96 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.216 -179.667 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.51 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -163.13 141.97 8.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.299 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.724 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.6 p -143.56 151.08 39.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.448 0.642 . . . . 0.0 111.394 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.681 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 12.8 mm-40 -110.01 166.96 10.53 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 94' ' ' VAL . 8.3 p -84.95 106.93 15.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.007 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.585 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 15.4 p -111.82 82.61 1.65 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.76 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.585 ' CB ' ' O ' ' A' ' 95' ' ' THR . 21.0 tttt 109.92 48.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.585 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 96' ' ' LYS . 1.2 pm0 -32.43 125.47 0.31 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.819 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.455 HG21 ' C ' ' A' ' 45' ' ' PRO . 4.3 p -71.7 119.14 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.03 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 66' ' ' ALA . 34.8 mm -70.05 115.96 10.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.919 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -90.36 130.9 36.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.874 ' CB ' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -68.57 127.36 32.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.85 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 102' ' ' VAL . 5.5 m -126.5 99.73 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.188 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 103' ' ' VAL . 11.9 p -108.25 116.53 51.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.015 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -87.1 108.55 18.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 51' ' ' LYS . 12.6 p -98.36 137.73 25.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.5 ' CA ' HD12 ' A' ' 56' ' ' LEU . . . -72.66 130.85 15.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.511 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . . . -132.32 156.14 80.45 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 111.063 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.24 -168.16 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.572 2.182 . . . . 0.0 112.226 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.5 m -101.92 -37.71 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.124 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.4 m -60.21 -69.15 0.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.401 ' CD2' ' OE2' ' A' ' 52' ' ' GLU . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.917 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.855 0.36 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 105.31 28.47 5.48 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.467 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.3 m 60.34 -169.95 0.15 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.815 0.341 . . . . 0.0 110.885 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.56 159.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.943 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 60.7 80.71 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.886 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -151.59 34.73 0.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -167.73 120.4 0.9 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.828 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -143.44 103.26 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.845 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -169.81 -46.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.3 -171.43 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.48 169.47 8.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.949 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.28 -174.21 44.3 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.5 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mp -95.86 -34.76 11.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.663 0.268 . . . . 0.0 110.832 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 14' ' ' VAL . 9.2 p 42.89 52.03 7.44 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.697 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 14' ' ' VAL . 55.7 Cg_endo -69.94 99.09 0.74 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.581 2.187 . . . . 0.0 112.291 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 60.6 31.62 20.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.99 30.28 10.5 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.436 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.3 t 60.43 109.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.803 0.335 . . . . 0.0 111.006 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -91.77 -31.57 15.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.002 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.1 mtm -100.95 134.22 44.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.941 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.5 m -85.75 -31.39 22.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.8 mt -60.19 167.84 2.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -139.26 -169.97 2.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 61.27 113.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.934 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.96 -178.28 4.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.88 177.82 6.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.923 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 28' ' ' ALA . 21.3 t -78.64 158.74 4.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.111 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.483 ' N ' HG12 ' A' ' 27' ' ' VAL . . . -79.57 -69.11 0.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.203 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.46 -178.89 0.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.156 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -175.65 153.14 1.39 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.1 m -137.09 179.16 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.069 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -131.31 36.42 3.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.2 m -126.37 -52.09 1.5 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -159.88 141.67 9.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.69 -165.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.552 2.168 . . . . 0.0 112.207 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.437 ' HG3' HG12 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -98.01 -179.18 4.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.916 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.1 mt -111.36 115.69 29.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.949 0.404 . . . . 0.0 111.132 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.65 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -101.11 -176.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.525 179.273 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.843 HG22 ' CD1' ' A' ' 75' ' ' TYR . 1.4 p -158.03 140.12 14.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.345 0.593 . . . . 0.0 111.079 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.507 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 33.9 ttp180 -161.23 107.07 1.38 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.02 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.599 HG21 ' CD ' ' A' ' 71' ' ' GLU . 14.8 t -81.93 132.43 35.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.709 0.766 . . . . 0.0 111.706 -178.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.579 ' O ' HD12 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -98.56 144.69 27.6 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.574 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -66.77 91.68 0.2 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.854 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.581 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 3.2 mp -85.19 111.04 33.37 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.783 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.528 ' C ' HG21 ' A' ' 98' ' ' VAL . 81.4 Cg_endo -87.46 153.41 7.81 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.667 2.245 . . . . 0.0 112.849 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.604 ' HB3' HG22 ' A' ' 98' ' ' VAL . 49.9 p90 -87.07 -176.83 5.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.782 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -149.57 112.46 4.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.098 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.718 HG22 ' HB3' ' A' ' 101' ' ' GLN . 16.4 t -67.22 149.23 11.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.031 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.441 HG22 ' N ' ' A' ' 50' ' ' LYS . 33.0 mm -125.79 156.06 35.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.184 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.441 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -119.03 100.93 7.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.778 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.89 137.59 38.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -93.81 102.73 14.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.899 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -102.57 96.56 7.59 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.838 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.65 -18.06 48.11 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.461 2.108 . . . . 0.0 112.488 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -58.16 -31.5 67.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.977 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.729 HD22 ' HG2' ' A' ' 60' ' ' GLN . 11.3 mt -76.07 165.4 53.36 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.799 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -83.9 42.34 1.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.13 2.553 . . . . 0.0 112.606 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.06 150.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.843 0.354 . . . . 0.0 111.314 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 55.2 27.15 45.46 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.616 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.729 ' HG2' HD22 ' A' ' 56' ' ' LEU . 51.7 tp60 -95.49 116.14 28.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 110.907 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -110.91 134.88 52.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.798 ' O ' HG23 ' A' ' 103' ' ' VAL . 25.9 p-10 -151.13 161.9 41.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.9 mm -126.49 95.9 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.101 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.7 mm -72.88 -31.79 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.98 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.9 m -163.42 96.2 0.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.708 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.485 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -53.87 151.77 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.483 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.459 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -93.4 120.89 6.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.33 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.39 133.75 57.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.823 0.344 . . . . 0.0 111.152 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.691 ' HA ' HG23 ' A' ' 98' ' ' VAL . 1.2 mtmp? -59.27 125.74 24.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.156 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.415 ' HA2' ' HG3' ' A' ' 96' ' ' LYS . . . -96.05 -141.01 11.46 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.999 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.599 ' CD ' HG21 ' A' ' 41' ' ' THR . 0.3 OUTLIER -166.71 141.94 4.31 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.815 ' NE ' HG12 ' A' ' 94' ' ' VAL . 22.4 ttm180 -136.11 111.11 8.87 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.736 ' O ' ' HB3' ' A' ' 92' ' ' SER . 32.8 m -73.78 124.92 26.98 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.516 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 3.6 m-70 -105.08 117.0 32.91 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 122.082 0.944 . . . . 0.0 113.191 -176.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.843 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.1 OUTLIER -89.55 100.72 13.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 113.611 -1.631 . . . . 0.0 110.98 -178.082 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.504 HG22 ' N ' ' A' ' 77' ' ' SER . 4.5 mp -87.56 161.17 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.281 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.725 ' HB3' HD23 ' A' ' 90' ' ' LEU . 5.3 t -107.82 112.85 25.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.721 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 78' ' ' VAL . 8.8 p -81.54 102.19 7.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.017 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 tp -110.1 108.9 19.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.945 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 80' ' ' THR . 9.9 t -86.0 107.55 17.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.814 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -104.85 93.22 4.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.847 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 60.4 31.14 20.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.83 43.16 3.4 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.561 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 11.4 ttpt -149.16 112.66 5.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.792 0.33 . . . . 0.0 110.891 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.486 HG22 ' CG2' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -100.77 110.42 22.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.855 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.86 132.04 50.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.936 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.76 99.63 11.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.951 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.3 t -113.93 125.47 54.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.927 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.3 m -51.04 115.68 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.094 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.725 HD23 ' HB3' ' A' ' 77' ' ' SER . 0.1 OUTLIER -100.84 -63.42 1.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.533 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -166.04 136.58 3.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.009 -179.739 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.736 ' HB3' ' O ' ' A' ' 73' ' ' THR . 0.8 OUTLIER -143.59 150.1 38.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.547 0.689 . . . . 0.0 111.576 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.617 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -109.46 166.47 10.86 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.377 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.815 HG12 ' NE ' ' A' ' 72' ' ' ARG . 30.9 m -85.23 106.79 15.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.06 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.568 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 16.9 p -110.95 82.56 1.61 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.714 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 95' ' ' THR . 2.5 tppt? 132.4 -39.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.631 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 59.09 121.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.556 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.691 HG23 ' HA ' ' A' ' 69' ' ' LYS . 8.2 p -81.71 114.47 22.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.737 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.592 ' H ' HD12 ' A' ' 99' ' ' ILE . 4.6 mp -75.32 132.18 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -93.72 140.49 29.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.962 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.718 ' HB3' HG22 ' A' ' 48' ' ' VAL . 1.6 tp60 -77.12 114.4 15.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.94 99.7 9.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.046 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 62' ' ' ASN . 11.7 p -121.19 119.56 59.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -93.37 133.16 36.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.839 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.3 m -112.27 123.27 67.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.232 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.77 123.79 19.69 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.449 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -175.24 149.23 1.13 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.767 0.318 . . . . 0.0 111.068 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.85 142.4 43.01 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.585 2.19 . . . . 0.0 112.352 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.2 p -100.6 -32.81 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.062 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.56 -50.76 6.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.822 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 28.9 m170 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.944 179.971 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.82 0.343 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -104.69 -50.23 0.97 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.479 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 t 60.25 82.21 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.868 0.366 . . . . 0.0 110.957 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.1 m -131.17 -46.35 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.837 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -128.57 173.82 9.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -127.92 85.88 2.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.0 m80 64.13 -79.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -171.27 35.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.893 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -176.82 122.33 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.17 93.78 3.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.8 35.91 2.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.944 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.3 163.76 36.08 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.498 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.53 84.13 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.769 0.319 . . . . 0.0 110.861 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.4 m -143.26 154.74 61.25 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.07 -37.52 8.31 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.548 2.165 . . . . 0.0 112.289 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.0 ttp-105 -176.2 90.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -142.7 28.39 2.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.46 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 m -159.41 79.9 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.877 0.37 . . . . 0.0 110.936 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -112.92 -37.59 4.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 tpp -59.71 106.42 0.48 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.86 -31.42 11.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.982 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.3 mt -59.62 -31.48 69.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.017 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -67.29 120.93 14.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -94.81 163.57 13.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.16 -68.08 0.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.952 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.23 170.82 7.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.929 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 27' ' ' VAL . 7.2 p -139.38 93.34 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.074 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 58.87 30.51 20.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.168 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.77 -170.43 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.089 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -162.25 -48.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.859 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.848 HG11 ' NE ' ' A' ' 34' ' ' ARG . 11.2 p -178.13 158.19 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.085 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.466 ' N ' HG22 ' A' ' 31' ' ' VAL . 46.4 mm-40 -119.94 -41.53 2.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 56.0 m -118.26 142.54 47.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.848 ' NE ' HG11 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -118.81 150.88 49.31 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.46 -45.44 1.21 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.624 2.216 . . . . 0.0 112.243 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -168.82 113.73 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.814 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mp -76.95 132.49 39.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.045 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.708 HD12 ' HB ' ' A' ' 76' ' ' ILE . 0.5 OUTLIER -101.26 -177.06 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.783 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.792 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.9 OUTLIER -163.67 123.02 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.178 0.513 . . . . 0.0 110.342 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.609 ' HG3' HD13 ' A' ' 76' ' ' ILE . 2.8 mtm180 -149.6 109.36 4.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.29 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.536 HG21 ' OE1' ' A' ' 71' ' ' GLU . 14.9 t -82.41 133.22 35.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.71 0.767 . . . . 0.0 111.872 -178.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.583 ' O ' HD12 ' A' ' 44' ' ' ILE . 3.0 mt-10 -98.35 147.64 24.47 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.453 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.403 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -66.68 98.32 0.51 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.884 -179.355 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.583 HD12 ' O ' ' A' ' 42' ' ' GLU . 2.9 mp -95.9 105.43 21.28 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.576 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.522 ' C ' HG21 ' A' ' 98' ' ' VAL . 87.7 Cg_endo -84.69 150.36 11.37 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.719 2.279 . . . . 0.0 113.171 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.669 ' HB3' HG22 ' A' ' 98' ' ' VAL . 43.0 p90 -86.87 -175.06 5.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.939 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.67 116.53 5.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.239 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.709 HG22 ' CB ' ' A' ' 101' ' ' GLN . 61.6 t -67.23 149.68 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.122 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.748 HD12 ' O ' ' A' ' 101' ' ' GLN . 4.0 mp -115.65 156.2 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.005 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.44 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.9 OUTLIER -122.92 107.76 12.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -115.25 165.82 12.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.905 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -112.81 138.51 49.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.402 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 6.3 m-20 -138.27 96.52 9.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.921 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 53' ' ' ASN . 37.3 Cg_endo -66.02 -20.8 57.15 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.413 2.075 . . . . 0.0 112.438 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -58.3 -29.63 66.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.994 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.473 HD22 ' NE2' ' A' ' 60' ' ' GLN . 3.5 mt -70.97 165.96 42.4 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.878 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.29 46.79 2.2 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.117 2.545 . . . . 0.0 112.796 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.25 126.48 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.832 0.349 . . . . 0.0 111.641 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 51.67 55.88 18.31 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.928 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.473 ' NE2' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -109.4 144.06 38.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.786 0.327 . . . . 0.0 110.951 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -104.4 130.08 52.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.926 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.525 ' ND2' HD11 ' A' ' 64' ' ' ILE . 48.9 t30 -146.58 127.86 14.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.982 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.858 HD13 HG12 ' A' ' 103' ' ' VAL . 25.0 mm -104.99 90.99 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.034 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.525 HD11 ' ND2' ' A' ' 62' ' ' ASN . 36.6 mm -65.47 -32.67 59.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.549 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.688 HG22 ' HB ' ' A' ' 102' ' ' VAL . 5.3 t -161.38 128.3 3.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.398 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.48 135.37 35.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 111.419 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.43 ' HA3' ' CE2' ' A' ' 46' ' ' PHE . . . -81.98 134.95 13.6 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.308 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.641 ' H ' HG23 ' A' ' 99' ' ' ILE . 16.5 t -145.16 142.95 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 111.088 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.69 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -72.56 119.7 17.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.344 -179.585 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.436 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -89.84 -139.91 7.79 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.639 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.536 ' OE1' HG21 ' A' ' 41' ' ' THR . 0.9 OUTLIER -169.64 146.91 3.4 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.547 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 2.5 ttt180 -134.91 111.67 10.04 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.699 ' O ' ' HB3' ' A' ' 92' ' ' SER . 37.4 m -73.84 126.65 30.88 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.527 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 3.9 m-70 -105.82 117.37 33.84 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 122.148 0.975 . . . . 0.0 112.753 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.792 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.1 OUTLIER -90.37 100.1 13.0 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 113.57 -1.65 . . . . 0.0 111.075 -177.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.708 ' HB ' HD12 ' A' ' 38' ' ' ILE . 3.1 mp -87.8 159.9 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.726 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.695 ' HB2' HD22 ' A' ' 90' ' ' LEU . 40.0 t -102.83 126.71 50.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.828 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 78' ' ' VAL . 29.1 m -81.51 106.29 12.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.203 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.71 HD13 ' N ' ' A' ' 80' ' ' THR . 1.7 tm? -112.47 130.99 55.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.943 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.71 ' N ' HD13 ' A' ' 79' ' ' LEU . 0.8 OUTLIER -98.6 135.8 39.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.898 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -152.22 115.65 4.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.826 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.8 m120 60.07 34.96 21.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.966 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.98 29.5 66.89 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.509 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -128.3 165.0 21.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.915 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.03 120.32 41.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.97 151.02 22.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.778 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.27 121.97 40.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 98.9 m -144.79 123.07 12.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.967 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 p -58.21 131.99 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.834 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.695 HD22 ' HB2' ' A' ' 77' ' ' SER . 2.2 tp -116.04 -55.54 2.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.296 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 3.6 t0 -169.45 136.91 1.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.482 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.699 ' HB3' ' O ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -143.66 145.23 32.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.387 0.613 . . . . 0.0 111.261 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.605 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 34.5 mm-40 -106.89 165.86 11.02 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.608 HG13 ' O ' ' A' ' 94' ' ' VAL . 9.0 p -85.88 106.93 15.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.4 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.515 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 9.7 p -111.71 82.11 1.56 Allowed 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.656 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 95' ' ' THR . 0.0 OUTLIER 140.96 -36.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.642 178.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 56.44 115.02 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.821 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.69 HG23 ' HA ' ' A' ' 69' ' ' LYS . 14.9 p -81.49 106.29 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.535 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.641 HG23 ' H ' ' A' ' 68' ' ' VAL . 4.1 tt -79.42 133.01 30.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.304 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.428 ' HA ' ' HB2' ' A' ' 46' ' ' PHE . 27.9 m-20 -92.49 161.75 14.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.888 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.772 ' OE1' HG13 ' A' ' 103' ' ' VAL . 0.8 OUTLIER -96.8 140.54 31.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.688 ' HB ' HG22 ' A' ' 65' ' ' THR . 84.2 t -126.1 118.68 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.988 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.858 HG12 HD13 ' A' ' 63' ' ' ILE . 4.4 m -131.25 145.63 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.0 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -116.18 108.38 16.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.26 110.74 20.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.41 133.28 50.3 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.506 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -101.45 148.23 34.91 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.637 0.256 . . . . 0.0 111.151 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.74 -69.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.613 2.209 . . . . 0.0 112.303 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.429 HG13 ' N ' ' A' ' 110' ' ' THR . 10.8 p -178.06 -41.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.115 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.429 ' N ' HG13 ' A' ' 109' ' ' VAL . 8.3 t -91.94 157.22 16.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.941 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ptm . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.778 0.323 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -148.51 32.07 1.24 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.484 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.438 ' HB3' ' CD2' ' A' ' 6' ' ' HIS . 3.5 t -100.73 -169.98 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.741 0.305 . . . . 0.0 110.945 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.2 t -61.1 -74.56 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -111.0 135.54 51.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.952 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.438 ' CD2' ' HB3' ' A' ' 3' ' ' SER . 2.0 m-70 -141.29 -74.73 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -176.51 100.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.981 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -176.39 84.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -105.28 -69.29 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.899 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.2 m 60.2 79.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.7 p -126.82 -68.48 0.8 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.961 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 158.69 -161.98 32.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.508 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -108.42 -30.81 8.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 0.0 110.961 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.6 t 64.57 77.55 0.29 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.79 -45.91 0.93 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.643 2.229 . . . . 0.0 112.314 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -156.45 -178.55 7.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.25 -24.97 76.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.599 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.2 t -57.94 124.94 20.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.706 0.289 . . . . 0.0 110.943 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -131.6 -168.06 1.96 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 mmt -58.51 155.53 12.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.937 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.525 ' C ' HD12 ' A' ' 22' ' ' LEU . 43.0 m -62.8 -178.09 0.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.952 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 21' ' ' SER . 6.9 mp -132.37 -74.61 0.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.899 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -114.67 81.49 1.57 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -109.57 -31.34 7.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.863 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.9 t30 60.84 157.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.936 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -61.88 142.26 57.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.463 HG12 ' H ' ' A' ' 29' ' ' ALA . 21.4 t -135.49 140.17 45.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.18 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.36 88.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.08 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.463 ' H ' HG12 ' A' ' 27' ' ' VAL . . . -65.14 134.44 53.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.072 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -167.7 145.0 4.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.925 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 m -98.92 31.18 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.184 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 60.85 105.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 62.7 m -123.78 -69.37 0.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -163.61 164.2 15.43 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.02 -166.66 0.17 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.567 2.178 . . . . 0.0 112.228 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -93.75 148.89 21.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.657 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.83 117.23 34.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.11 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.705 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 1.1 pp -101.2 -176.72 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.09 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.857 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -149.66 152.58 35.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.257 0.551 . . . . 0.0 111.025 -179.276 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 74' ' ' HIS . 19.5 ttt-85 -170.05 111.62 0.44 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.003 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 14.9 t -82.16 131.78 35.24 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.828 0.823 . . . . 0.0 111.478 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.505 ' O ' HD12 ' A' ' 44' ' ' ILE . 0.7 OUTLIER -98.15 149.72 22.23 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.871 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -66.95 105.53 1.65 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.059 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.576 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.4 mp -107.73 100.41 34.89 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.867 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.539 ' C ' HG21 ' A' ' 98' ' ' VAL . 2.8 Cg_endo -84.99 156.86 11.44 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.038 2.492 . . . . 0.0 112.581 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.623 ' HB3' HG22 ' A' ' 98' ' ' VAL . 46.5 p90 -87.13 -174.25 4.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.013 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -153.35 109.05 3.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.986 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.572 HG23 ' HG2' ' A' ' 101' ' ' GLN . 10.4 p -67.42 154.06 8.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.196 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.6 mp -124.79 156.15 33.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.045 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -107.27 100.81 10.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.8 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -90.43 147.7 23.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.965 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -107.95 102.97 12.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.538 ' HB2' HD12 ' A' ' 56' ' ' LEU . 2.5 m120 -94.16 102.83 9.07 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.61 -26.91 46.06 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.406 2.071 . . . . 0.0 112.271 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -69.41 -31.48 69.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.572 HD22 ' HB3' ' A' ' 60' ' ' GLN . 21.4 mt -63.59 163.23 21.53 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -86.86 31.0 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.818 2.345 . . . . 0.0 112.948 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 56.85 104.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.266 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 118.25 -25.35 8.29 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.634 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.572 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -70.63 134.9 47.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 0.0 110.868 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -137.96 128.44 26.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.533 ' ND2' HD11 ' A' ' 64' ' ' ILE . 24.6 p-10 -128.14 148.61 50.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.771 HD13 HG12 ' A' ' 103' ' ' VAL . 29.0 mm -97.65 86.33 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.147 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.533 HD11 ' ND2' ' A' ' 62' ' ' ASN . 29.2 mm -62.24 -35.82 71.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.812 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.3 m -164.28 90.98 0.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.629 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.401 ' HB2' HG21 ' A' ' 63' ' ' ILE . . . -52.12 150.97 4.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.52 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.429 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -88.86 134.69 12.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.338 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.405 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.4 t -132.41 132.43 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.856 0.36 . . . . 0.0 111.204 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.0 mttp -56.07 126.2 24.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.184 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' A' ' 96' ' ' LYS . . . -99.81 -157.44 28.47 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.129 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.481 ' HA ' HD12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -159.94 151.4 19.79 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.576 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 36.7 ttt180 -141.9 110.91 6.27 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.633 ' O ' ' HB2' ' A' ' 92' ' ' SER . 96.0 m -73.33 121.24 20.11 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.536 ' O ' ' HA ' ' A' ' 39' ' ' THR . 13.7 m80 -102.94 121.55 42.77 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.795 0.807 . . . . 0.0 113.133 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.857 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -89.55 107.78 19.28 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 113.857 -1.52 . . . . 0.0 111.273 -177.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.675 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.5 mp -98.69 159.24 3.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.896 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.634 ' OG ' HD13 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -115.14 113.47 24.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.867 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.57 ' O ' HG13 ' A' ' 78' ' ' VAL . 11.3 p -81.45 113.15 20.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.13 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.33 107.01 15.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.855 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.6 m -76.46 104.05 6.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.992 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -115.3 108.47 16.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.783 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 60.58 35.3 20.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.98 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.84 47.46 25.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.475 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.89 107.41 3.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.785 0.326 . . . . 0.0 110.877 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 p -79.79 125.22 29.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.3 p -123.67 150.98 43.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.95 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -105.59 113.89 27.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.4 t -123.24 123.25 40.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.944 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.3 m -57.66 129.45 19.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.99 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.634 HD13 ' OG ' ' A' ' 77' ' ' SER . 3.1 tp -119.12 -58.15 1.96 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.15 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.521 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 1.9 t70 -166.29 140.78 4.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.273 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.633 ' HB2' ' O ' ' A' ' 73' ' ' THR . 17.2 p -143.15 149.26 37.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.33 0.586 . . . . 0.0 111.12 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.567 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 7.0 pt20 -105.46 166.88 10.12 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.5 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 26.0 t -85.31 106.6 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.122 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 21.8 p -113.07 83.05 1.76 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.13 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 95' ' ' THR . 0.0 OUTLIER 105.55 48.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.853 -179.662 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -33.63 126.2 0.4 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.853 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.623 HG22 ' HB3' ' A' ' 46' ' ' PHE . 10.0 p -71.76 112.5 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.98 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.599 ' H ' HD12 ' A' ' 99' ' ' ILE . 5.2 mp -72.1 126.79 33.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.021 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -87.32 133.44 33.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.814 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.572 ' HG2' HG23 ' A' ' 48' ' ' VAL . 5.3 tt0 -67.33 150.02 49.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.955 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.24 100.51 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.069 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.771 HG12 HD13 ' A' ' 63' ' ' ILE . 4.0 m -119.08 106.76 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.014 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -94.46 109.86 21.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.5 m -105.27 141.0 21.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.138 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.21 147.7 50.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.535 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -175.23 82.19 0.31 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.712 0.291 . . . . 0.0 111.037 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.1 110.86 2.52 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.557 2.171 . . . . 0.0 112.357 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.728 HG23 HG22 ' A' ' 110' ' ' THR . 14.1 m -128.65 -46.05 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.068 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.728 HG22 HG23 ' A' ' 109' ' ' VAL . 2.6 t -145.7 171.95 13.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.874 179.884 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.8 mtm . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.844 0.354 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.61 41.21 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.426 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 p -68.96 -32.55 72.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.744 0.307 . . . . 0.0 110.899 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 m -104.79 96.85 6.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -103.95 -31.73 9.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.953 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 60.62 158.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -78.59 128.8 34.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.888 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -89.55 99.87 12.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -82.72 -74.32 0.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.947 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.05 136.92 32.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.6 p -89.6 94.9 10.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.958 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 141.69 -136.46 7.39 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.487 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.4 mt -143.71 98.71 3.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.838 0.351 . . . . 0.0 110.922 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.478 HG23 ' HD3' ' A' ' 16' ' ' ARG . 7.0 m -107.31 150.03 39.48 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.195 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.93 130.28 18.86 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.544 2.163 . . . . 0.0 112.267 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.478 ' HD3' HG23 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -176.43 -46.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.839 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.41 -156.61 24.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.411 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.43 89.91 1.3 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.87 0.367 . . . . 0.0 110.88 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -156.83 107.03 2.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.9 mtm -77.37 98.32 5.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.5 p -132.55 -52.52 0.94 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' A' ' 23' ' ' ASP . 3.7 pp -94.29 -38.32 11.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.899 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.463 ' HB2' HD12 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -176.89 -175.0 0.57 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -101.1 -31.13 11.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.865 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 60.76 105.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.882 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -154.08 151.74 29.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 27' ' ' VAL . 6.4 m -134.25 83.59 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.102 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -174.2 36.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.122 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -108.94 32.11 5.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.141 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.8 m120 60.67 99.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.838 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.533 HG12 ' H ' ' A' ' 33' ' ' THR . 28.2 t -71.26 138.85 20.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.102 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -131.51 31.51 4.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.533 ' H ' HG12 ' A' ' 31' ' ' VAL . 7.0 m -163.91 142.75 7.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.78 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 61.22 155.18 0.11 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.974 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.22 -46.07 1.61 Allowed 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.542 2.162 . . . . 0.0 112.287 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -170.52 128.65 0.82 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.861 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.1 mt -84.09 123.34 29.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.986 0.422 . . . . 0.0 111.069 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.763 HD12 ' N ' ' A' ' 39' ' ' THR . 1.1 pp -101.08 -176.37 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.202 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.852 HG22 ' CD1' ' A' ' 75' ' ' TYR . 1.8 p -157.34 142.8 17.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.318 0.58 . . . . 0.0 110.901 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.589 ' HG2' HD13 ' A' ' 76' ' ' ILE . 2.6 ptp85 -162.59 107.33 1.15 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.206 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.455 ' HB ' ' HA ' ' A' ' 73' ' ' THR . 15.4 t -82.28 129.86 34.96 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.768 0.794 . . . . 0.0 111.604 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.596 ' O ' HD12 ' A' ' 44' ' ' ILE . 0.6 OUTLIER -98.29 146.3 25.8 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.678 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -66.81 94.83 0.33 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.952 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.596 HD12 ' O ' ' A' ' 42' ' ' GLU . 3.2 mp -87.07 109.88 28.53 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.949 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.419 ' C ' HG21 ' A' ' 98' ' ' VAL . 6.3 Cg_exo -78.65 152.91 26.18 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.843 2.362 . . . . 0.0 112.563 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.479 ' HB3' ' CG2' ' A' ' 98' ' ' VAL . 52.6 p90 -86.68 -178.58 6.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -138.83 111.67 7.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.961 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.621 HG13 ' CD ' ' A' ' 101' ' ' GLN . 46.2 t -67.45 141.95 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.079 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.438 HG22 ' N ' ' A' ' 50' ' ' LYS . 27.3 mt -130.42 156.07 42.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.103 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.438 ' N ' HG22 ' A' ' 49' ' ' ILE . 1.6 ptpp? -131.98 100.84 5.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -95.02 171.88 8.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -111.56 139.97 46.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.52 ' ND2' HD13 ' A' ' 56' ' ' LEU . 64.1 t-20 -138.48 110.13 8.15 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.85 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.77 -26.15 38.99 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.409 2.072 . . . . 0.0 112.378 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.74 -32.91 71.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.561 HD23 ' HB3' ' A' ' 60' ' ' GLN . 9.1 mp -65.17 165.13 18.17 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.877 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -86.95 32.17 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.914 2.409 . . . . 0.0 112.808 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.86 142.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.874 0.368 . . . . 0.0 111.167 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.42 27.82 61.28 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.561 ' HB3' HD23 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -109.03 141.91 40.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.747 0.308 . . . . 0.0 110.951 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -136.81 124.73 22.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.904 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.818 ' ND2' HD11 ' A' ' 64' ' ' ILE . 15.7 p-10 -130.55 142.08 50.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.585 HD13 HG22 ' A' ' 103' ' ' VAL . 30.9 mm -94.23 94.34 4.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.097 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.818 HD11 ' ND2' ' A' ' 62' ' ' ASN . 21.1 mm -73.63 -32.86 37.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.824 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 m -164.62 84.96 0.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.6 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.476 ' HB2' HG21 ' A' ' 63' ' ' ILE . . . -51.38 132.63 29.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.505 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.45 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -59.68 131.26 50.77 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.327 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 66' ' ' ALA . 21.5 t -130.66 135.52 60.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.389 . . . . 0.0 111.115 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.6 mttp -61.36 116.81 4.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.139 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.468 ' HA3' ' HA ' ' A' ' 98' ' ' VAL . . . -88.46 -149.22 18.44 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.871 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.49 ' CB ' ' HB3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -163.23 146.31 10.45 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.314 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.595 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 19.0 ttp85 -139.67 111.35 7.25 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.737 ' O ' ' HB2' ' A' ' 92' ' ' SER . 91.3 m -73.41 125.16 27.25 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.695 ' HD2' HG21 ' A' ' 89' ' ' VAL . 13.9 m80 -106.14 119.05 38.22 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 122.185 0.993 . . . . 0.0 113.1 -176.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.852 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.1 OUTLIER -90.34 98.85 12.02 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 113.437 -1.71 . . . . 0.0 111.459 -177.419 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.4 mp -87.56 143.45 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.027 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.813 ' CB ' HD21 ' A' ' 90' ' ' LEU . 25.3 m -89.72 122.26 32.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.708 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.58 HG13 ' CG2' ' A' ' 85' ' ' THR . 21.6 t -81.35 98.35 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.111 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.3 tp -112.21 126.51 55.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.863 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 m -89.06 119.58 29.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.93 95.54 4.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.852 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 60.38 36.41 20.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.851 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.82 28.43 26.32 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.426 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.7 127.11 36.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.795 0.331 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.58 ' CG2' HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -85.15 102.39 13.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -68.63 135.85 52.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.403 ' HA ' HG21 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -115.62 84.9 2.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.548 ' N ' HG23 ' A' ' 76' ' ' ILE . 88.0 m -132.7 130.23 39.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.884 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.695 HG21 ' HD2' ' A' ' 74' ' ' HIS . 12.8 p -85.39 140.37 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.813 HD21 ' CB ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -132.29 2.15 3.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.862 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.464 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.3 OUTLIER 179.96 117.87 0.05 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.9 0.381 . . . . 0.0 111.785 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.737 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.9 p -143.24 134.59 26.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.232 0.539 . . . . 0.0 110.708 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.636 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 5.3 mt-30 -89.72 166.5 13.54 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.43 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 22.9 t -85.5 107.48 16.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.925 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 20.3 p -111.2 82.95 1.68 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.024 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 95' ' ' THR . 7.9 tptm 103.48 41.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.614 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.413 ' CB ' HG11 ' A' ' 94' ' ' VAL . 6.6 tm-20 -29.18 130.54 0.07 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.134 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.479 ' CG2' ' HB3' ' A' ' 46' ' ' PHE . 4.9 p -71.76 126.02 31.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.164 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 29.7 mm -88.33 129.68 39.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.055 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -91.95 146.71 23.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.815 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.621 ' CD ' HG13 ' A' ' 48' ' ' VAL . 0.3 OUTLIER -60.34 139.39 57.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.917 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.4 t -127.67 99.69 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.084 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.796 HG13 ' O ' ' A' ' 62' ' ' ASN . 21.6 t -133.22 137.43 53.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -104.56 132.26 51.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.79 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.48 120.43 53.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.133 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.32 119.34 9.32 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.416 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -126.41 153.63 74.92 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.724 0.297 . . . . 0.0 111.064 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.12 -168.37 0.29 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.547 2.164 . . . . 0.0 112.33 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.0 p -61.57 131.15 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.009 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.2 t -141.98 140.36 32.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.824 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.892 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.1 ttm . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.897 0.379 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -170.44 73.65 0.11 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.52 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 p -132.07 116.21 16.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 0.0 110.857 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.8 t -176.65 -40.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.939 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -121.63 99.14 6.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.405 ' O ' ' CG ' ' A' ' 7' ' ' HIS . 18.8 m-70 -107.46 -75.13 0.64 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.405 ' CG ' ' O ' ' A' ' 6' ' ' HIS . 95.0 m-70 -157.19 30.1 0.29 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.943 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 58.87 31.35 21.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.953 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -69.39 83.49 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.8 t 60.28 166.31 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.3 m -124.9 84.92 2.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.03 64.13 0.36 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.475 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.89 81.48 8.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.829 0.347 . . . . 0.0 110.903 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.453 HG23 ' HD2' ' A' ' 15' ' ' PRO . 10.6 p -59.49 136.35 89.13 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.453 ' HD2' HG23 ' A' ' 14' ' ' VAL . 56.9 Cg_endo -70.54 148.35 59.85 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.446 2.097 . . . . 0.0 112.35 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -31.25 68.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.853 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.64 -138.43 4.93 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.562 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.4 m -106.87 162.9 13.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.797 0.332 . . . . 0.0 110.894 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -70.41 -173.66 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.797 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.7 mtp -128.02 -65.54 0.9 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.842 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 m -82.2 -53.44 6.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.35 -70.38 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.956 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.4 t70 61.52 154.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.72 85.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -105.55 79.86 1.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -106.48 169.53 8.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.527 ' O ' HG13 ' A' ' 27' ' ' VAL . 11.1 p -66.54 116.19 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.169 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.29 109.06 14.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.064 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.19 89.07 2.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.112 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -134.23 31.56 3.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.618 HG23 ' CD ' ' A' ' 32' ' ' GLU . 12.5 m -82.27 -30.76 9.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.187 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.618 ' CD ' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -152.73 175.83 12.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.925 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.8 t -116.98 -39.71 3.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.942 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? -147.62 160.27 39.06 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.24 -42.91 26.03 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.544 2.162 . . . . 0.0 112.42 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -164.14 123.74 2.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.855 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 71.4 mt -95.5 124.36 39.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 111.126 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.608 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 5.0 pt -101.01 -177.38 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.654 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.759 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.7 OUTLIER -156.9 154.6 30.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.538 0.685 . . . . 0.0 111.809 -179.081 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.75 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 54.8 ttp180 -170.97 120.32 0.53 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 5.6 t -81.78 140.53 34.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.999 0.904 . . . . 0.0 112.68 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.468 ' HG2' ' CD2' ' A' ' 74' ' ' HIS . 6.8 mm-40 -98.66 139.27 34.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.123 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.417 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -66.97 91.59 0.21 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.966 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.844 HD12 ' H ' ' A' ' 72' ' ' ARG . 6.7 mt -96.11 104.7 17.92 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.986 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.546 ' C ' HG21 ' A' ' 98' ' ' VAL . 80.1 Cg_endo -84.78 160.5 12.14 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.785 2.323 . . . . 0.0 113.248 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.598 ' HB3' HG22 ' A' ' 98' ' ' VAL . 54.1 p90 -87.15 -174.13 4.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.081 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -152.78 110.26 3.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.842 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.83 HG22 ' CB ' ' A' ' 101' ' ' GLN . 20.3 t -67.01 148.05 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.17 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 50' ' ' LYS . 5.5 mt -124.02 156.18 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.152 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.44 ' N ' HG22 ' A' ' 49' ' ' ILE . 20.2 tttp -122.96 100.82 7.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.841 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.9 162.97 13.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -94.63 114.51 26.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.906 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.401 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 6.4 t-20 -100.91 96.47 5.66 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 53' ' ' ASN . 37.6 Cg_endo -66.2 -26.75 49.25 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.475 2.117 . . . . 0.0 112.288 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -66.86 -31.22 71.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.92 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 60' ' ' GLN . 18.3 mt -74.64 163.32 69.07 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -86.83 31.47 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.888 2.392 . . . . 0.0 112.923 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.15 122.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.83 0.348 . . . . 0.0 111.26 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.19 -26.69 19.99 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.582 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.455 ' HB3' HD13 ' A' ' 56' ' ' LEU . 1.3 tm0? -66.78 136.4 55.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 0.0 110.871 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -129.34 114.27 16.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.816 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -109.25 130.06 55.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.896 HD13 HG12 ' A' ' 103' ' ' VAL . 31.2 mm -92.2 86.11 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.823 HD13 HG12 ' A' ' 102' ' ' VAL . 3.3 mp -65.3 -44.06 94.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.956 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.429 ' HB ' HG23 ' A' ' 102' ' ' VAL . 25.8 m -151.95 93.79 1.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.599 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -51.18 144.02 10.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.567 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.486 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -77.01 127.6 8.54 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.424 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.46 125.61 37.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.879 0.371 . . . . 0.0 110.985 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.455 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -60.68 113.48 2.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.354 -179.567 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.492 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -78.8 -146.06 3.17 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.637 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.599 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.1 OUTLIER -177.56 109.88 0.07 Allowed 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.844 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.9 OUTLIER -102.84 138.42 39.75 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.226 -179.621 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.668 ' O ' ' HB3' ' A' ' 92' ' ' SER . 87.7 m -75.6 140.51 42.68 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.525 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.75 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 2.0 m-70 -118.94 118.42 31.47 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.541 0.686 . . . . 0.0 112.082 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.759 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -91.23 118.82 30.79 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.203 -177.826 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.691 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.5 mp -108.69 160.3 7.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.962 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.742 ' HB2' HD23 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -101.78 127.37 48.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.895 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.459 HG22 HD13 ' A' ' 38' ' ' ILE . 21.4 t -99.28 98.36 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.3 mt -112.64 111.85 22.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.899 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.62 96.6 6.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -113.72 122.31 46.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.954 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 60.46 34.81 20.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.15 42.34 67.46 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.486 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.87 141.04 17.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.344 . . . . 0.0 110.875 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.37 112.89 25.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.941 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.83 122.98 38.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.839 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -86.66 89.13 7.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.83 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.3 t -103.15 132.75 49.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.934 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.3 m -52.32 124.87 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.121 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.742 HD23 ' HB2' ' A' ' 77' ' ' SER . 0.2 OUTLIER -111.06 -66.83 1.04 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.062 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.515 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -170.87 143.51 2.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.283 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.708 ' HG ' ' CE1' ' A' ' 74' ' ' HIS . 1.0 OUTLIER -143.4 165.29 27.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.407 0.623 . . . . 0.0 110.846 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.603 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 8.1 pt20 -129.31 166.84 18.69 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.096 -0.957 . . . . 0.0 108.661 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.815 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.1 p -85.69 106.84 15.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.599 ' O ' ' O ' ' A' ' 71' ' ' GLU . 7.2 p -117.12 81.0 1.57 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.35 0.595 . . . . 0.0 110.652 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 71' ' ' GLU . 3.1 tptm 149.44 -30.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.273 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 58.35 107.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.818 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.598 HG22 ' HB3' ' A' ' 46' ' ' PHE . 6.8 p -71.48 109.76 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.029 0.442 . . . . 0.0 110.085 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.441 HG22 ' O ' ' A' ' 66' ' ' ALA . 39.3 mm -63.98 123.69 17.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.853 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -91.93 135.62 33.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.886 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.83 ' CB ' HG22 ' A' ' 48' ' ' VAL . 1.8 tt0 -68.5 99.38 0.96 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.823 HG12 HD13 ' A' ' 64' ' ' ILE . 21.8 t -91.68 99.75 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.009 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.896 HG12 HD13 ' A' ' 63' ' ' ILE . 29.4 m -128.48 127.21 66.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.162 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -108.68 108.49 19.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.811 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.38 142.54 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.134 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.52 142.15 43.61 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.522 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -175.82 87.83 0.29 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.702 0.287 . . . . 0.0 111.057 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.22 108.69 2.22 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.622 2.215 . . . . 0.0 112.265 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.2 m -80.9 170.01 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.164 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 t -157.86 80.63 0.86 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.918 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.864 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 mmt . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.795 0.331 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 150.01 45.34 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.521 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.2 m -169.32 137.26 1.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.855 0.359 . . . . 0.0 110.883 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.1 m -93.41 -75.08 0.51 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.93 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 59.95 44.75 13.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.899 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.0 m170 -59.76 -75.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.966 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 59.85 79.17 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -113.16 35.62 3.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.945 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -107.8 144.53 34.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.907 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.88 86.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.8 t -131.41 123.09 27.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.926 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.79 49.14 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.52 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tp -96.15 -34.22 11.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.798 0.333 . . . . 0.0 110.869 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.639 ' O ' HG13 ' A' ' 14' ' ' VAL . 7.3 p -178.68 88.24 0.22 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.055 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.48 141.26 45.89 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.546 2.164 . . . . 0.0 112.302 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 tpp85 68.15 -69.77 0.14 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.993 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 57.84 54.48 37.08 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.542 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.1 m 60.99 41.81 13.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.34 . . . . 0.0 110.835 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.5 t60 61.19 52.42 3.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.0 mpp? 60.73 177.02 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.956 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 p -126.59 151.26 48.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.853 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.534 ' O ' HD23 ' A' ' 22' ' ' LEU . 0.8 OUTLIER 60.57 32.01 20.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.935 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -170.52 126.54 0.76 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.79 151.75 7.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.931 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -62.84 -62.77 1.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -176.55 88.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 28' ' ' ALA . 11.3 p -69.44 -45.15 79.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.056 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.491 ' N ' HG13 ' A' ' 27' ' ' VAL . . . -177.24 -69.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.057 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -171.53 -41.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.122 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 m120 60.2 75.73 0.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.452 HG23 ' N ' ' A' ' 32' ' ' GLU . 11.0 m -142.94 -47.17 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.452 ' N ' HG23 ' A' ' 31' ' ' VAL . 1.1 tp10 67.26 -72.78 0.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.0 p -146.18 126.68 14.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.997 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.4 ttt85 -143.43 139.84 16.91 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.97 151.01 78.28 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.456 2.104 . . . . 0.0 112.265 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -81.01 -179.07 7.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.771 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mp -104.4 113.92 27.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.058 0.456 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.695 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -101.3 -176.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.815 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.493 HG22 ' CD1' ' A' ' 75' ' ' TYR . 1.2 p -152.57 139.78 19.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.207 0.527 . . . . 0.0 110.892 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 17.5 tpt180 -158.65 102.94 1.72 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.085 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 8.0 t -81.96 129.23 34.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.571 0.701 . . . . 0.0 111.496 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.586 ' O ' HD12 ' A' ' 44' ' ' ILE . 0.6 OUTLIER -98.46 144.18 28.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.941 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.97 91.68 0.21 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.638 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.586 HD12 ' O ' ' A' ' 42' ' ' GLU . 3.0 mp -87.2 110.17 31.28 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.03 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.51 ' C ' HG21 ' A' ' 98' ' ' VAL . 83.8 Cg_endo -86.03 153.68 9.75 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.725 2.283 . . . . 0.0 112.751 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.591 ' HB3' HG22 ' A' ' 98' ' ' VAL . 42.7 p90 -87.17 -174.27 4.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.846 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -159.04 118.42 3.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.936 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.415 HG23 ' CD ' ' A' ' 101' ' ' GLN . 9.0 p -67.49 152.53 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.013 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.1 mp -130.66 156.16 42.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.13 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.44 ' N ' HG22 ' A' ' 49' ' ' ILE . 12.3 mmtm -128.25 100.86 6.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -101.86 170.35 8.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 1.7 mm-40 -109.62 120.34 42.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.954 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.63 HD21 HD22 ' A' ' 56' ' ' LEU . 1.7 p-10 -114.16 96.39 42.08 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.843 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.36 60.42 2.59 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.51 2.14 . . . . 0.0 112.408 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.58 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -160.92 27.23 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.026 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.655 HD23 ' HB3' ' A' ' 60' ' ' GLN . 3.5 mp -130.55 176.53 2.8 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.776 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.27 30.22 0.53 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.176 2.584 . . . . 0.0 112.869 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.2 136.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.91 0.386 . . . . 0.0 111.484 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.9 29.33 67.51 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.734 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.655 ' HB3' HD23 ' A' ' 56' ' ' LEU . 42.9 tp60 -109.39 112.07 23.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.799 0.333 . . . . 0.0 110.762 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.56 143.41 33.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.972 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -135.72 130.05 33.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.0 mm -85.68 86.12 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.164 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.575 HD11 ' HG3' ' A' ' 104' ' ' GLU . 28.6 mt -71.2 -43.46 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.408 ' HB ' HG22 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -149.07 91.93 1.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.613 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.85 154.47 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.522 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.416 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -84.74 129.63 9.33 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.414 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.45 126.96 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.761 0.315 . . . . 0.0 111.075 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.681 ' HA ' HG23 ' A' ' 98' ' ' VAL . 15.0 mtmt -57.37 127.95 34.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.146 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.435 ' HA2' ' HG3' ' A' ' 96' ' ' LYS . . . -101.97 -143.44 13.52 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.079 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.535 ' N ' ' HB3' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -166.97 144.05 4.67 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.593 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 42.1 ttt180 -135.98 111.52 9.25 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.699 ' O ' ' HB2' ' A' ' 92' ' ' SER . 62.0 m -73.84 126.82 31.27 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.524 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 13.3 m80 -107.21 119.87 40.56 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 122.068 0.937 . . . . 0.0 112.921 -176.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.695 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -91.36 99.59 12.52 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 113.541 -1.663 . . . . 0.0 111.391 -177.637 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.666 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.5 mp -87.58 159.71 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.847 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.755 ' OG ' HD23 ' A' ' 90' ' ' LEU . 77.6 p -108.53 105.38 14.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.775 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 78' ' ' VAL . 8.8 m -81.43 98.33 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.225 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.6 tt -108.08 116.4 31.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 80' ' ' THR . 10.7 t -81.9 112.17 18.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.936 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -116.05 113.27 22.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 60.17 31.83 20.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.894 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.82 44.54 10.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.432 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.77 119.7 4.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.773 0.32 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.84 123.03 32.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.4 150.16 29.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.852 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -97.52 113.8 25.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 94.8 m -133.59 118.05 17.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.931 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 89' ' ' VAL . 10.9 p -54.03 125.37 8.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.978 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.755 HD23 ' OG ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -107.83 -53.46 2.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.267 -179.777 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.521 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -176.68 141.01 0.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.316 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.699 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.6 p -143.67 150.99 39.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.367 0.603 . . . . 0.0 111.32 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.635 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 23.1 mm-40 -110.74 166.53 10.94 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.522 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 6.2 m -85.26 106.64 15.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.054 -178.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.568 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 15.9 p -110.72 82.6 1.62 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.689 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 95' ' ' THR . 26.2 tptp 131.92 -26.96 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.015 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 96' ' ' LYS . 17.9 pt-20 44.56 111.47 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.681 HG23 ' HA ' ' A' ' 69' ' ' LYS . 8.2 p -71.88 115.77 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.874 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.5 mm -74.04 128.96 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.068 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -95.14 139.41 31.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.978 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.415 ' CD ' HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -77.63 100.34 6.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.817 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.408 HG22 ' HB ' ' A' ' 65' ' ' THR . 5.4 m -100.59 109.28 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 103' ' ' VAL . 11.0 p -123.19 118.38 54.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.575 ' HG3' HD11 ' A' ' 64' ' ' ILE . 2.4 mm-40 -87.16 121.01 29.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.832 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.95 128.51 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.209 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.62 130.64 50.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.503 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 52' ' ' GLU . . . -138.99 91.01 11.74 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.626 0.251 . . . . 0.0 111.008 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.49 -167.79 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.473 2.115 . . . . 0.0 112.308 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.49 131.59 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.249 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.445 HG22 ' H ' ' A' ' 111' ' ' HIS . 0.2 OUTLIER -150.96 -172.58 4.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.445 ' H ' HG22 ' A' ' 110' ' ' THR . 13.7 m80 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.888 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 tpp . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.869 0.366 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 106.14 -173.2 19.61 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.479 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 p -138.78 50.64 1.84 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.1 34.25 19.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 60.41 51.67 5.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 60.86 83.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.3 171.83 14.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -126.06 31.28 5.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -176.64 -170.25 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.0 t -129.72 95.67 4.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 p -176.05 165.63 2.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.834 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.95 -73.21 0.85 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.464 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -60.23 -165.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.668 0.271 . . . . 0.0 110.819 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.483 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 42.8 t -56.73 -58.11 19.5 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.635 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 17.9 Cg_endo -58.96 84.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.265 1.976 . . . . 0.0 112.211 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.8 ttt-85 -117.92 135.49 54.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.81 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -165.66 -132.66 1.4 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.44 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 m -130.16 -169.75 2.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.808 0.337 . . . . 0.0 110.885 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -59.93 -31.51 69.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.7 mtm -77.46 -74.4 0.25 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.896 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.3 31.62 20.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.1 mp -74.56 -177.83 3.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -98.38 35.51 1.78 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.869 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -99.1 -33.76 10.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -68.27 121.93 17.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.911 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -68.63 168.48 13.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.941 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.35 -41.37 29.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.193 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.46 124.25 34.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.106 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.15 -75.69 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.108 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -81.83 -74.98 0.31 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.898 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.7 t -151.83 -67.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.051 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 57.39 32.3 21.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.991 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.505 HG22 ' HD2' ' A' ' 35' ' ' PRO . 3.7 m -163.92 104.82 0.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.93 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.643 ' N ' ' CD ' ' A' ' 35' ' ' PRO . 2.7 ptm180 -79.43 -30.48 0.64 Allowed Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.014 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 34' ' ' ARG . 90.8 Cg_endo -85.56 -167.45 0.4 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.087 1.858 . . . . 0.0 112.329 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.57 129.65 36.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.817 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mt -74.21 114.98 13.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.09 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.677 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -101.38 -176.57 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.095 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.517 ' HB ' ' CG2' ' A' ' 73' ' ' THR . 1.4 p -152.19 136.73 16.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.226 0.536 . . . . 0.0 111.223 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.554 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 10.0 mmm-85 -150.1 103.13 3.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.403 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.652 HG23 ' N ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -82.17 124.8 30.21 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.602 0.715 . . . . 0.0 111.163 -178.771 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.555 ' O ' HD12 ' A' ' 44' ' ' ILE . 3.4 mt-10 -98.29 147.94 24.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.958 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -66.92 101.42 0.84 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.83 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.563 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.4 mp -106.66 91.42 6.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.847 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.687 ' C ' HG21 ' A' ' 98' ' ' VAL . 97.9 Cg_endo -78.49 161.83 28.05 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.74 2.294 . . . . 0.0 112.799 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.546 ' HB3' HG22 ' A' ' 98' ' ' VAL . 49.5 p90 -87.37 176.62 7.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.147 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -147.24 109.38 4.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.971 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.786 HG22 ' CB ' ' A' ' 101' ' ' GLN . 11.6 t -67.13 153.95 8.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.073 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.5 mp -124.94 156.14 33.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.122 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.46 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -125.11 100.81 6.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.831 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.1 mtmt -97.7 171.87 8.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.945 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -109.88 104.77 13.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.578 ' ND2' HD22 ' A' ' 56' ' ' LEU . 2.0 p-10 -110.31 96.51 26.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.78 -18.7 53.26 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.492 2.128 . . . . 0.0 112.593 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.544 ' OD1' HD13 ' A' ' 56' ' ' LEU . 16.1 p30 -54.78 -29.74 54.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.882 0.372 . . . . 0.0 111.008 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.818 HD23 ' HB3' ' A' ' 60' ' ' GLN . 6.2 mp -83.24 175.06 5.12 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.741 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -82.55 28.33 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.094 2.529 . . . . 0.0 112.979 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.1 123.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.883 0.373 . . . . 0.0 111.55 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.18 -23.28 32.28 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.83 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.818 ' HB3' HD23 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -71.47 123.54 22.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.879 0.371 . . . . 0.0 110.956 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.87 ' HG3' HG13 ' A' ' 105' ' ' VAL . 2.5 mp0 -114.44 115.85 27.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.613 ' OD1' HD21 ' A' ' 56' ' ' LEU . 4.8 p-10 -119.04 123.96 45.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.836 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.559 HG23 HG22 ' A' ' 103' ' ' VAL . 22.1 mt -85.76 131.42 34.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.019 0.437 . . . . 0.0 111.115 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.8 mm -94.07 -46.78 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.767 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.772 HG22 ' HB ' ' A' ' 102' ' ' VAL . 15.3 t -149.13 97.85 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.516 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.19 126.64 7.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.815 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.451 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -66.25 132.35 33.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.168 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.421 ' HB ' HD13 ' A' ' 99' ' ' ILE . 22.7 t -131.22 138.83 52.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.954 0.407 . . . . 0.0 111.065 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.612 ' HA ' HG23 ' A' ' 98' ' ' VAL . 8.0 mptt -66.27 130.8 44.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.406 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.403 ' N ' ' HA ' ' A' ' 98' ' ' VAL . . . -109.42 -148.99 12.83 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.47 ' N ' ' CB ' ' A' ' 96' ' ' LYS . 0.6 OUTLIER -166.69 156.71 11.61 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.595 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 4.8 ttt180 -140.14 112.49 7.8 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.693 ' O ' ' HB3' ' A' ' 92' ' ' SER . 86.3 m -73.85 127.32 32.54 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.569 ' HD2' ' O ' ' A' ' 72' ' ' ARG . 13.6 m-70 -106.26 117.26 33.59 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.261 1.029 . . . . 0.0 113.055 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.677 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -89.12 102.14 14.8 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 113.433 -1.712 . . . . 0.0 110.921 -177.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.634 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.5 mp -87.66 160.7 2.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.891 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.642 ' OG ' HD22 ' A' ' 90' ' ' LEU . 74.9 m -110.62 127.89 55.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.834 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.38 103.72 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.196 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mt -125.06 88.66 2.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.818 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.22 146.2 39.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.846 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -153.97 126.89 8.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.908 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 60.4 35.9 20.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.956 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.28 48.69 57.17 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.531 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.7 ttpt -159.69 107.5 1.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.837 0.351 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.81 129.9 37.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.5 m -115.39 151.06 35.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.54 112.75 23.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 96.7 m -133.99 126.65 30.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.901 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.0 p -55.61 148.96 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.991 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.642 HD22 ' OG ' ' A' ' 77' ' ' SER . 0.3 OUTLIER -137.86 -50.89 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.26 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.524 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -158.3 126.63 5.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.321 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.693 ' HB3' ' O ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -143.4 144.25 31.97 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.4 0.619 . . . . 0.0 111.417 179.133 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.595 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 5.4 mt-30 -106.25 165.46 11.23 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 94' ' ' VAL . 8.8 p -86.15 106.63 15.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.473 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.476 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 7.2 p -111.71 82.01 1.55 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.568 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' A' ' 95' ' ' THR . 0.0 OUTLIER 148.29 -33.39 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.296 179.087 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.431 ' H ' HG22 ' A' ' 94' ' ' VAL . 1.5 tt0 53.33 109.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.892 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.687 HG21 ' C ' ' A' ' 45' ' ' PRO . 9.4 p -80.7 102.75 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.481 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.576 ' H ' HD12 ' A' ' 99' ' ' ILE . 5.2 mp -64.35 123.92 18.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.056 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.413 ' HA ' ' HB2' ' A' ' 46' ' ' PHE . 3.2 m-20 -89.44 133.85 34.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.673 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.786 ' CB ' HG22 ' A' ' 48' ' ' VAL . 5.4 tt0 -67.05 125.33 25.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.948 0.404 . . . . 0.0 110.98 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.772 ' HB ' HG22 ' A' ' 65' ' ' THR . 60.9 t -113.37 99.71 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.678 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.559 HG22 HG23 ' A' ' 63' ' ' ILE . 21.8 t -125.68 154.71 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.405 ' N ' HG12 ' A' ' 103' ' ' VAL . 2.5 mt-10 -133.22 108.36 8.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.77 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.87 HG13 ' HG3' ' A' ' 61' ' ' GLU . 21.8 t -101.04 136.56 32.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.172 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.03 148.6 35.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.489 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.75 148.47 19.36 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.721 0.296 . . . . 0.0 111.206 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.23 171.46 15.97 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.501 2.134 . . . . 0.0 112.313 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.6 t -112.5 -35.17 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.072 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 111' ' ' HIS . 0.2 OUTLIER -78.78 -175.65 4.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.478 ' H ' HG22 ' A' ' 110' ' ' THR . 8.7 m-70 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.842 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ttm . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.805 0.336 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 143.03 45.26 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.452 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.37 -78.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 110.969 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.24 31.55 20.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.936 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -176.57 115.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.892 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -74.84 176.48 7.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.964 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -64.31 114.24 4.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.921 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -135.29 -176.49 4.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.919 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -60.21 94.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.7 t -126.87 79.45 1.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.914 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.59 165.42 2.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.825 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 146.39 -165.83 28.22 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.447 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tt -83.87 -31.61 25.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.77 0.319 . . . . 0.0 110.87 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 m -130.36 151.0 77.78 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.116 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.19 -39.52 5.61 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.573 2.182 . . . . 0.0 112.297 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 -130.19 174.18 10.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.866 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.55 53.62 4.09 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.499 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.3 p -107.71 33.54 4.01 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.809 0.338 . . . . 0.0 110.945 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 60.19 -168.78 0.16 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.1 mtt -128.92 89.01 2.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.933 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -176.53 -45.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.5 tp -107.98 120.95 43.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.971 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -161.41 -69.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.931 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 63.9 -79.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.966 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -107.13 -62.12 1.45 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 0.0 110.912 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 27' ' ' VAL . 2.6 tm-20 61.02 33.32 19.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.905 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 26' ' ' GLU . 6.6 m -156.9 177.1 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.077 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.86 93.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.102 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.92 -75.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.08 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 t30 60.44 -175.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.586 ' O ' HG12 ' A' ' 31' ' ' VAL . 16.3 t -115.9 32.61 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.074 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -127.92 32.65 4.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.925 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.65 49.08 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.004 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 62.05 151.55 0.1 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.844 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.57 -68.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.496 2.13 . . . . 0.0 112.399 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -170.65 147.18 2.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.79 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.5 mp -104.36 116.59 32.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.95 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.568 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 5.7 pt -101.27 -177.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.363 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.732 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -158.58 154.48 26.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.372 0.606 . . . . 0.0 111.077 -179.209 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.548 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 13.1 ttm180 -169.26 126.08 0.92 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.646 HG22 ' CA ' ' A' ' 73' ' ' THR . 16.1 p -81.89 136.08 35.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 122.006 0.908 . . . . 0.0 112.547 -177.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HG2' ' ND1' ' A' ' 74' ' ' HIS . 9.3 mm-40 -98.23 142.61 29.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.097 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.405 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -66.78 94.21 0.3 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.671 -179.715 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.91 HD12 ' H ' ' A' ' 72' ' ' ARG . 6.9 mt -101.66 98.02 8.84 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.777 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.484 ' C ' HG21 ' A' ' 98' ' ' VAL . 95.8 Cg_endo -78.51 157.81 28.83 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.772 2.315 . . . . 0.0 113.176 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.682 ' HB3' HG22 ' A' ' 98' ' ' VAL . 45.6 p90 -86.87 -173.93 4.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.105 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.43 102.95 4.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.756 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.71 HG23 ' HG3' ' A' ' 101' ' ' GLN . 8.8 p -66.93 146.47 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.148 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 48' ' ' VAL . 34.2 mm -125.19 156.19 34.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.179 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.445 ' N ' HG22 ' A' ' 49' ' ' ILE . 7.4 mptt -120.42 100.86 7.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.767 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.63 145.13 24.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -114.73 102.61 10.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.781 ' ND2' HD13 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -117.44 140.09 26.95 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.913 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -78.13 -19.88 11.81 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.601 2.201 . . . . 0.0 112.538 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -52.34 -30.26 27.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.116 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.781 HD13 ' ND2' ' A' ' 53' ' ' ASN . 11.2 mp -82.7 169.1 19.09 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.798 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.19 31.23 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.316 2.678 . . . . 0.0 112.874 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 63.18 138.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.899 0.38 . . . . 0.0 111.279 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.02 36.35 80.78 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.603 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.704 ' HB3' HD23 ' A' ' 56' ' ' LEU . 60.1 tp60 -109.51 145.65 35.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.878 0.37 . . . . 0.0 110.935 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.7 113.94 19.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.821 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -118.87 119.12 33.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.928 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.1 mm -85.71 92.76 3.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.722 HD11 ' HG3' ' A' ' 104' ' ' GLU . 21.7 mt -76.55 -44.9 34.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.88 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.54 91.49 1.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.801 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.487 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -46.9 143.18 3.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.791 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.458 ' HA3' ' CE2' ' A' ' 46' ' ' PHE . . . -91.31 129.63 9.9 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.248 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.0 131.11 41.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.966 0.412 . . . . 0.0 111.156 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.522 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -64.12 112.78 3.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.159 -179.647 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.525 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -75.55 -144.29 1.24 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.762 -0.733 . . . . 0.0 111.717 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.68 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 7.7 tt0 -177.55 109.29 0.07 Allowed 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.91 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -98.4 138.43 35.65 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.229 0.538 . . . . 0.0 110.448 -179.726 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.646 ' CA ' HG22 ' A' ' 41' ' ' THR . 52.0 m -75.55 135.81 40.58 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.729 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.659 ' O ' ' HA ' ' A' ' 39' ' ' THR . 6.5 m80 -116.08 121.83 43.34 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.74 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.732 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -91.93 113.34 25.59 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.772 -178.095 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.695 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.1 mp -97.13 143.56 12.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.02 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.9 t -96.01 105.53 17.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.78 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.764 ' CG1' HG22 ' A' ' 85' ' ' THR . 21.4 t -81.55 105.27 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.9 tp -97.11 88.66 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.844 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.58 123.66 21.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.965 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -143.65 105.92 4.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 65.16 26.88 12.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.094 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.78 41.44 7.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.819 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.591 ' HD2' HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -140.54 122.72 15.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.908 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.764 HG22 ' CG1' ' A' ' 78' ' ' VAL . 1.2 p -101.26 105.5 16.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.591 HG23 ' HD2' ' A' ' 84' ' ' LYS . 27.8 p -87.11 99.88 12.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.476 ' HG3' HG21 ' A' ' 76' ' ' ILE . 2.6 tt0 -74.8 98.75 3.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 76' ' ' ILE . 92.1 m -129.66 125.36 35.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 p -51.18 136.84 10.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.022 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -125.6 -72.66 0.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.343 -179.716 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.493 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 3.6 t0 -137.96 138.2 38.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.349 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.565 ' HB2' ' O ' ' A' ' 73' ' ' THR . 29.0 p -143.24 165.62 26.95 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.66 0.743 . . . . 0.0 111.395 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.665 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 36.0 mm-40 -130.03 166.45 20.1 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.153 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.791 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 17.2 t -86.2 105.75 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.554 ' O ' ' O ' ' A' ' 71' ' ' GLU . 11.6 p -121.43 80.97 1.73 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.551 0.691 . . . . 0.0 110.889 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.68 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 155.3 -31.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.731 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 62.4 101.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.819 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.682 HG22 ' HB3' ' A' ' 46' ' ' PHE . 6.6 p -71.43 103.75 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.144 0.497 . . . . 0.0 110.12 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 66' ' ' ALA . 32.9 mm -63.92 131.05 29.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.222 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 46' ' ' PHE . 3.6 m-20 -98.86 139.67 34.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.002 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.71 ' HG3' HG23 ' A' ' 48' ' ' VAL . 3.0 tp-100 -75.04 103.92 5.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.921 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.29 99.73 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.985 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.1 p -123.12 148.37 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.194 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.722 ' HG3' HD11 ' A' ' 64' ' ' ILE . 22.6 mt-10 -111.17 142.02 43.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.816 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.32 136.56 57.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.141 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -73.87 102.05 1.28 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.468 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 61.77 151.12 0.1 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.75 0.31 . . . . 0.0 111.141 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.09 -168.42 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.639 2.226 . . . . 0.0 112.329 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.53 -30.89 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.122 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.8 t -92.55 -39.34 11.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.927 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 10.8 m80 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.913 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 mtm . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.744 0.306 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.67 -28.89 11.58 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.496 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.1 p -89.15 -169.82 2.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.902 0.382 . . . . 0.0 110.873 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.3 t 61.3 113.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.852 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -59.96 -176.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.924 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -59.76 149.52 30.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.88 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -60.1 172.85 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.976 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -133.71 -176.2 4.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.958 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -98.15 32.51 2.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.0 m -129.82 106.44 8.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.94 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 p -165.4 163.57 19.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.929 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -145.47 -174.69 17.9 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.559 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.9 tp -142.78 -47.37 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.842 0.353 . . . . 0.0 110.862 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.481 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 11.6 t -58.63 -48.69 96.41 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.492 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 72.8 Cg_endo -77.45 -168.33 0.58 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.242 1.962 . . . . 0.0 112.356 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.11 150.83 28.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.855 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.95 48.5 0.94 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.543 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.7 p -129.33 179.54 5.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.807 0.337 . . . . 0.0 110.92 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -151.44 152.53 33.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.849 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.0 ttt -93.08 141.34 28.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.985 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.3 p -78.81 -37.05 41.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.2 tp -81.24 85.05 6.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -153.61 82.49 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.948 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -103.76 90.63 3.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.888 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -76.13 116.2 16.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.88 125.07 25.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.91 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.07 82.64 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 59.64 -173.1 0.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.079 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.11 -75.55 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.119 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 60.07 -176.36 0.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.937 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 31' ' ' VAL . 9.6 m -73.03 79.45 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.123 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.485 ' O ' HG23 ' A' ' 33' ' ' THR . 18.9 mt-10 -106.91 179.16 4.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.845 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 32' ' ' GLU . 23.1 p -158.92 85.78 0.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.974 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.425 ' CG ' ' HD2' ' A' ' 35' ' ' PRO . 2.4 mpt_? -83.81 165.45 39.48 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.717 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.568 ' HD3' HD23 ' A' ' 79' ' ' LEU . 57.6 Cg_endo -71.55 160.53 48.11 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.481 2.12 . . . . 0.0 112.301 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -73.86 168.25 19.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.9 mt -92.52 106.37 18.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.963 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.773 HD12 ' N ' ' A' ' 39' ' ' THR . 1.0 OUTLIER -101.3 -176.49 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.445 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.773 ' N ' HD12 ' A' ' 38' ' ' ILE . 1.0 OUTLIER -152.41 147.85 26.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.281 0.562 . . . . 0.0 110.729 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 74' ' ' HIS . 16.9 ttp180 -164.18 100.62 0.85 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.893 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 15.2 t -81.93 132.19 35.26 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.831 0.824 . . . . 0.0 111.364 -178.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -98.11 145.17 26.83 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.149 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.403 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -66.22 99.11 0.5 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.337 -179.561 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.752 HD12 ' N ' ' A' ' 72' ' ' ARG . 6.4 mt -105.09 92.6 5.56 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.302 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.76 ' C ' HG21 ' A' ' 98' ' ' VAL . 94.1 Cg_endo -78.32 164.37 26.65 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.818 2.345 . . . . 0.0 112.855 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.466 ' CD1' ' HA3' ' A' ' 67' ' ' GLY . 35.2 p90 -87.28 175.04 8.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.102 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -143.04 108.85 5.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.995 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.768 HG22 ' CB ' ' A' ' 101' ' ' GLN . 10.3 t -67.1 154.05 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.22 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.1 mp -140.71 156.09 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.069 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' N ' HG22 ' A' ' 49' ' ' ILE . 23.0 mttt -110.35 108.62 18.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.98 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.92 118.06 35.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.953 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -77.09 104.69 7.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.985 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.444 ' HB2' HD12 ' A' ' 56' ' ' LEU . 30.3 m-20 -106.12 139.79 20.63 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.11 -29.21 6.75 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.58 2.187 . . . . 0.0 112.406 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -57.54 -44.14 84.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.565 HD11 ' O ' ' A' ' 104' ' ' GLU . 5.2 mt -59.76 168.28 2.07 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.93 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -86.31 30.12 0.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.268 2.645 . . . . 0.0 112.69 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 57.73 105.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 0.0 111.315 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.85 -24.18 27.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.784 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.55 144.06 28.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.868 0.366 . . . . 0.0 110.973 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.813 ' HG3' HG23 ' A' ' 105' ' ' VAL . 1.5 mp0 -124.08 173.7 8.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.818 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.723 ' ND2' HD11 ' A' ' 64' ' ' ILE . 49.8 p30 -154.84 147.75 24.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.9 mm -97.76 86.08 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.106 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.723 HD11 ' ND2' ' A' ' 62' ' ' ASN . 24.4 mm -74.36 -32.74 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.964 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.479 ' HB ' HG23 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -161.74 83.83 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.523 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.54 151.64 0.54 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.718 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.466 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -79.43 132.57 11.54 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.192 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.9 t -124.51 131.67 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.844 0.354 . . . . 0.0 111.311 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -64.53 118.88 9.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.347 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.459 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -107.14 -151.9 18.09 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.597 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.497 ' N ' ' CB ' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -174.42 156.75 2.55 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.256 0.55 . . . . 0.0 109.992 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.752 ' N ' HD12 ' A' ' 44' ' ' ILE . 41.4 ttt180 -133.75 113.95 12.88 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.652 ' O ' ' HB2' ' A' ' 92' ' ' SER . 53.0 m -74.06 123.31 24.13 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.463 ' CD2' ' HG ' ' A' ' 92' ' ' SER . 16.6 m80 -104.81 120.82 42.32 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.146 0.975 . . . . 0.0 113.085 -177.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.655 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -89.41 98.14 11.6 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 113.648 -1.615 . . . . 0.0 111.169 -177.885 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.668 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.5 mp -87.48 158.55 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.89 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.693 ' OG ' HD12 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -101.65 108.3 19.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.727 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.651 HG13 HG21 ' A' ' 38' ' ' ILE . 11.2 m -81.6 98.25 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.146 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.568 HD23 ' HD3' ' A' ' 35' ' ' PRO . 0.9 OUTLIER -117.37 108.9 16.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.975 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.5 m -79.71 124.64 28.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.851 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.21 118.49 21.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 60.36 31.93 20.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.954 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.3 38.96 20.38 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.594 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.62 116.62 4.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.51 119.59 31.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.8 m -101.19 148.4 25.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -109.6 103.44 12.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.852 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 88' ' ' THR . 13.0 t -119.09 116.8 27.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 p -57.19 139.28 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.693 HD12 ' OG ' ' A' ' 77' ' ' SER . 16.2 mt -130.63 -68.4 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.264 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.45 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 1.3 t70 -137.8 134.34 35.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 111.4 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.652 ' HB2' ' O ' ' A' ' 73' ' ' THR . 18.7 p -143.35 160.62 40.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.027 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.608 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 5.8 pt20 -120.97 165.58 15.04 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 94' ' ' VAL . 28.9 m -86.39 106.08 15.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.945 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.483 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 15.4 p -114.84 81.86 1.64 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.684 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.497 ' CB ' ' N ' ' A' ' 71' ' ' GLU . 6.6 mmmt 146.46 -33.16 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.534 178.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 49.96 106.2 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.858 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.76 HG21 ' C ' ' A' ' 45' ' ' PRO . 11.8 p -79.92 102.8 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.075 0.465 . . . . 0.0 110.719 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 27.0 mt -66.55 131.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.185 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -87.7 139.96 30.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.768 ' CB ' HG22 ' A' ' 48' ' ' VAL . 6.1 tt0 -75.55 103.81 5.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.479 HG23 ' HB ' ' A' ' 65' ' ' THR . 21.7 t -85.9 99.75 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.012 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.414 HG23 ' HG2' ' A' ' 101' ' ' GLN . 21.4 t -118.89 110.57 30.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.1 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.565 ' O ' HD11 ' A' ' 56' ' ' LEU . 3.0 mt-10 -96.24 108.55 21.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.813 HG23 ' HG3' ' A' ' 61' ' ' GLU . 11.8 p -100.7 150.65 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.027 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.52 ' N ' HD13 ' A' ' 56' ' ' LEU . . . -76.48 145.53 31.8 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.486 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.53 108.36 1.16 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.505 0.193 . . . . 0.0 111.161 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.495 ' O ' HG13 ' A' ' 109' ' ' VAL . 48.5 Cg_endo -68.68 -46.5 1.76 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.44 2.093 . . . . 0.0 112.365 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 108' ' ' PRO . 9.9 m -158.1 178.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.205 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.69 79.34 0.94 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.835 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.9 t60 . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.851 -179.968 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttm . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.818 0.342 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.13 43.88 2.37 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.558 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.0 t -133.45 -52.88 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.981 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.6 m -64.07 -61.82 2.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.861 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -125.92 79.84 1.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -101.58 132.04 47.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.983 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -167.26 -43.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -130.23 106.13 8.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.845 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -176.38 104.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.7 t 60.6 31.56 20.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.67 -175.47 4.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.857 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.99 47.2 2.69 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.537 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.9 mt 60.26 106.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.745 0.307 . . . . 0.0 110.967 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.9 m 41.69 66.19 4.09 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.77 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.37 116.44 4.52 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.495 2.13 . . . . 0.0 112.262 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.2 155.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -173.94 65.6 0.11 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.48 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 m -161.83 177.95 9.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -78.8 -76.66 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.835 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 82.4 mmm -155.89 30.38 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 m 59.53 98.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.954 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -115.91 36.69 3.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.436 ' OD1' HG21 ' A' ' 27' ' ' VAL . 3.2 t0 -121.14 166.93 13.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -176.9 -173.58 0.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.931 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 62.52 27.01 16.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.05 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 55.69 98.84 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.035 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.436 HG21 ' OD1' ' A' ' 23' ' ' ASP . 29.5 m -156.58 170.58 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.169 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -159.69 77.4 0.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.034 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.61 171.62 13.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.055 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -110.44 -74.62 0.64 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.6 m -147.82 134.45 13.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.457 ' O ' HG22 ' A' ' 33' ' ' THR . 0.0 OUTLIER -59.4 -40.05 85.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 32' ' ' GLU . 14.6 t 44.53 41.41 4.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.42 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.66 136.83 89.77 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.39 -167.23 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.482 2.121 . . . . 0.0 112.274 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -83.84 116.37 22.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.71 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.4 mt -71.0 115.61 10.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.971 0.415 . . . . 0.0 111.123 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -101.26 -177.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.858 179.091 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.566 HG22 HG22 ' A' ' 73' ' ' THR . 0.5 OUTLIER -157.02 133.88 10.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.504 0.669 . . . . 0.0 111.58 -179.014 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.706 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 2.8 tpm_? -155.7 115.63 3.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 1.7 t -81.89 136.08 35.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.895 0.855 . . . . 0.0 112.515 -176.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -98.63 138.74 35.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.014 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.408 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 1.8 mp0 -66.73 91.86 0.2 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.445 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.776 HD12 ' H ' ' A' ' 72' ' ' ARG . 6.4 mt -92.68 107.67 25.97 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.907 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.501 ' C ' HG21 ' A' ' 98' ' ' VAL . 72.3 Cg_endo -86.03 153.34 9.73 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.832 2.355 . . . . 0.0 113.309 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.707 ' HB3' HG22 ' A' ' 98' ' ' VAL . 42.7 p90 -86.99 -174.05 4.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.158 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -154.78 116.34 4.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.922 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.732 HG13 ' CG ' ' A' ' 101' ' ' GLN . 4.4 t -67.09 151.45 10.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.134 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.6 mp -129.68 156.15 41.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.086 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.457 ' N ' HG22 ' A' ' 49' ' ' ILE . 2.9 ttpp -109.35 100.78 9.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.774 ' O ' HG22 ' A' ' 105' ' ' VAL . 9.2 mmtm -98.26 154.48 17.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -106.53 132.13 52.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -134.98 111.85 11.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.64 -26.76 39.26 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.368 2.046 . . . . 0.0 112.333 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -59.96 -32.3 70.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.9 mt -65.56 162.77 39.7 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.75 31.33 0.48 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.875 2.384 . . . . 0.0 112.925 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.98 138.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.913 0.387 . . . . 0.0 111.277 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.14 28.73 61.68 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.665 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.45 144.98 36.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.813 0.339 . . . . 0.0 110.933 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -114.32 118.93 35.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.821 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -128.3 118.37 23.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.507 HG23 ' OE1' ' A' ' 101' ' ' GLN . 43.5 mt -90.59 132.06 36.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.125 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.722 HD11 ' HG3' ' A' ' 104' ' ' GLU . 24.5 mt -104.79 -43.63 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.924 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.456 HG22 ' CG2' ' A' ' 99' ' ' ILE . 24.7 m -144.73 92.24 2.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.724 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.4 126.27 5.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.79 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.444 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -70.73 126.12 14.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.449 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.432 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.8 t -138.2 138.07 43.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.904 0.383 . . . . 0.0 110.935 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.542 ' HA ' HG23 ' A' ' 98' ' ' VAL . 3.7 mttp -68.1 116.19 8.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.381 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.522 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -81.11 -147.67 5.61 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.468 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.603 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.4 OUTLIER -177.77 109.27 0.06 Allowed 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.08 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.776 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -104.59 138.08 41.46 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.207 0.527 . . . . 0.0 109.872 -179.706 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.566 HG22 HG22 ' A' ' 39' ' ' THR . 51.9 m -75.26 136.58 40.93 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.387 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.706 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 2.8 m80 -112.16 116.77 31.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.926 0.869 . . . . 0.0 111.955 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.756 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -91.2 107.93 19.54 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 113.84 -1.527 . . . . 0.0 111.023 -177.245 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.594 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.4 mp -91.47 156.41 3.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.155 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.41 ' N ' ' CG2' ' A' ' 76' ' ' ILE . 3.8 m -115.85 111.55 20.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.688 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 78' ' ' VAL . 25.4 m -81.27 98.38 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.189 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 tp -109.94 148.75 31.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.833 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.24 106.25 12.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -128.91 126.17 39.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 60.33 31.1 20.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.03 28.39 68.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.368 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -149.03 166.64 28.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.878 0.371 . . . . 0.0 110.857 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.3 p -106.29 89.95 3.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.84 150.9 42.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -104.7 109.53 21.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.5 m -140.05 122.21 15.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.658 HG21 ' CD2' ' A' ' 74' ' ' HIS . 14.9 p -84.48 150.22 4.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.135 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -147.07 -41.39 0.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.582 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.441 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 1.6 t70 -117.64 106.92 13.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.837 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.569 ' HG ' ' CD2' ' A' ' 74' ' ' HIS . 89.3 p -143.14 123.91 14.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.316 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.676 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 5.7 mt-30 -89.38 166.15 13.91 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.727 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 32.1 t -86.1 110.12 19.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.603 ' O ' ' O ' ' A' ' 71' ' ' GLU . 5.9 p -117.69 80.85 1.57 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.361 0.601 . . . . 0.0 110.656 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.529 ' HB3' ' H ' ' A' ' 71' ' ' GLU . 41.0 tptt 148.52 -32.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.447 -1.252 . . . . 0.0 109.218 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 57.44 108.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.38 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.707 HG22 ' HB3' ' A' ' 46' ' ' PHE . 7.4 p -71.64 104.17 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.109 0.48 . . . . 0.0 110.0 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.613 ' H ' HD12 ' A' ' 99' ' ' ILE . 5.1 mp -64.01 129.87 28.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.126 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -99.82 137.7 37.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.013 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.732 ' CG ' HG13 ' A' ' 48' ' ' VAL . 3.6 tp-100 -72.08 107.13 4.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.833 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.679 HG12 HD12 ' A' ' 64' ' ' ILE . 21.7 t -98.29 99.61 9.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.049 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.46 HG12 HG12 ' A' ' 63' ' ' ILE . 5.2 m -116.78 129.61 73.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.091 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.722 ' HG3' HD11 ' A' ' 64' ' ' ILE . 1.4 mm-40 -108.79 117.58 34.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.818 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 51' ' ' LYS . 31.6 m -93.7 142.93 12.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.21 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.88 133.84 14.11 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.527 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -157.89 55.18 0.87 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.78 0.324 . . . . 0.0 111.094 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.31 63.05 2.11 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.598 2.198 . . . . 0.0 112.287 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 110' ' ' THR . 21.5 t 60.06 158.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.135 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.482 ' N ' HG12 ' A' ' 109' ' ' VAL . 3.0 m -92.33 -63.64 1.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 14.8 p80 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.895 179.988 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 120.73 0.3 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 106.55 51.97 0.78 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.485 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.9 m 60.37 34.71 20.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.749 0.309 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.2 m -104.95 93.93 4.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -106.16 123.14 47.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.896 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 60.7 111.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.961 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -60.13 156.95 14.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.802 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -127.33 -71.27 0.68 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -172.08 35.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.967 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.47 -169.8 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.869 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.4 p -90.29 -31.19 17.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.49 26.78 4.97 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.565 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 13' ' ' LEU . 3.3 mm? -115.22 131.02 57.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.708 0.29 . . . . 0.0 110.845 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.0 m -58.19 109.33 1.74 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.191 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.53 -46.21 1.41 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.507 2.138 . . . . 0.0 112.27 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -151.92 130.05 11.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.08 75.55 1.57 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.458 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.92 111.47 24.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.757 0.313 . . . . 0.0 110.916 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.6 92.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.921 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.9 mtp -60.35 -178.99 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.842 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 m -113.03 -53.13 2.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.976 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.649 HD13 ' H ' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -164.8 146.11 7.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.932 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.649 ' H ' HD13 ' A' ' 22' ' ' LEU . 1.4 t0 61.2 -169.24 0.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 61.21 35.74 18.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -90.69 -52.67 4.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -87.25 -176.93 5.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.847 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.1 p -81.45 131.14 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.045 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -175.28 92.86 0.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.95 91.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.17 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.518 ' O ' HG13 ' A' ' 31' ' ' VAL . 11.6 p30 -115.06 -50.14 2.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 30' ' ' ASN . 5.4 m -158.25 -48.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.114 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.434 ' N ' HG23 ' A' ' 31' ' ' VAL . 19.5 mt-10 58.75 80.71 0.18 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -177.09 86.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.497 ' CZ ' HD11 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -177.07 58.77 0.15 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.433 ' HG2' HG23 ' A' ' 78' ' ' VAL . 52.6 Cg_endo -69.6 -46.27 1.35 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.596 2.198 . . . . 0.0 112.324 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.96 155.28 20.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.954 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.497 HD11 ' CZ ' ' A' ' 34' ' ' ARG . 5.4 mp -111.13 118.76 36.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.152 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 4.0 pt -101.37 -177.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.421 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.754 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -159.88 150.42 18.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.209 0.528 . . . . 0.0 110.792 -179.245 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -162.34 133.18 4.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.183 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 1.7 p -82.44 129.16 34.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.762 0.791 . . . . 0.0 112.123 -178.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.493 ' HG3' HG13 ' A' ' 44' ' ' ILE . 3.4 tp10 -98.55 141.68 31.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.66 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.89 97.29 0.47 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.209 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.895 HD12 ' H ' ' A' ' 72' ' ' ARG . 6.9 mt -106.2 94.02 8.9 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.444 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.478 ' C ' HG21 ' A' ' 98' ' ' VAL . 87.7 Cg_endo -77.51 158.29 32.48 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.714 2.276 . . . . 0.0 113.257 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.688 ' HB3' HG22 ' A' ' 98' ' ' VAL . 40.9 p90 -86.87 -174.04 4.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.841 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -147.17 103.1 3.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.173 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.5 HG23 ' HB3' ' A' ' 101' ' ' GLN . 3.4 p -66.99 132.75 32.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.769 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.442 HG22 ' N ' ' A' ' 50' ' ' LYS . 32.8 mm -109.96 156.1 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.177 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.442 ' N ' HG22 ' A' ' 49' ' ' ILE . 8.7 mtpp -125.83 100.8 6.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.817 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -103.98 171.61 7.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.88 125.63 36.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.868 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.863 ' ND2' HD13 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -100.51 96.52 5.39 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.35 -18.48 44.27 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.465 2.11 . . . . 0.0 112.482 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.36 29.23 3.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.011 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.863 HD13 ' ND2' ' A' ' 53' ' ' ASN . 1.3 mp -124.4 169.43 10.74 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.757 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -87.37 29.09 0.5 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.3 2.667 . . . . 0.0 112.678 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.449 ' HB1' ' HA ' ' A' ' 108' ' ' PRO . . . 62.37 144.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.843 0.354 . . . . 0.0 111.347 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.65 23.22 42.92 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.833 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.608 ' HB3' HD23 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -109.47 156.67 19.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.757 0.313 . . . . 0.0 110.982 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.594 ' HG2' HG22 ' A' ' 105' ' ' VAL . 6.4 mt-10 -140.47 147.26 39.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.913 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -145.5 129.77 17.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.927 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.8 mm -87.23 92.8 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.136 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.3 mm -72.92 -43.85 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.76 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.83 93.7 1.68 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.544 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -46.62 152.42 0.47 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.82 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.437 ' HA3' ' CE2' ' A' ' 46' ' ' PHE . . . -99.94 132.76 11.05 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.26 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.428 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.6 t -136.93 130.46 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.884 0.374 . . . . 0.0 110.975 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.49 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -62.43 112.72 2.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.28 -179.665 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.554 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -75.53 -144.91 1.3 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.694 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.672 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 10.3 tt0 -177.58 109.11 0.06 Allowed 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.895 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -98.36 142.79 29.56 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.377 0.608 . . . . 0.0 110.446 -179.695 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.579 ' O ' ' HB3' ' A' ' 92' ' ' SER . 98.3 m -75.68 143.98 41.86 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.248 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.622 ' O ' ' HA ' ' A' ' 39' ' ' THR . 34.5 m-70 -125.92 116.99 22.36 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.592 0.711 . . . . 0.0 111.485 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.754 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -88.02 111.97 22.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.891 -177.609 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.501 HG22 ' N ' ' A' ' 77' ' ' SER . 4.3 mp -99.91 160.83 3.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.258 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.63 ' HB2' HD12 ' A' ' 90' ' ' LEU . 9.8 t -107.47 119.34 39.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.7 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 78' ' ' VAL . 8.6 m -81.43 98.36 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.22 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.612 HD13 ' N ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -103.03 129.92 49.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.612 ' N ' HD13 ' A' ' 79' ' ' LEU . 0.5 OUTLIER -96.55 120.17 36.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.832 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -136.03 100.05 4.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 60.13 35.71 21.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.37 47.39 22.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.469 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.27 123.14 15.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.688 0.28 . . . . 0.0 110.871 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.61 112.43 23.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.954 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.45 118.09 35.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.818 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.411 ' CA ' HG21 ' A' ' 76' ' ' ILE . 20.8 mt-10 -94.75 94.81 8.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.918 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.4 m -111.5 113.83 26.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.885 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.6 m -52.94 130.07 14.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.205 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.63 HD12 ' HB2' ' A' ' 77' ' ' SER . 14.3 mt -120.39 -73.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.069 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.478 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -123.98 131.47 53.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.376 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.579 ' HB3' ' O ' ' A' ' 73' ' ' THR . 1.0 OUTLIER -143.14 165.39 27.55 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.459 0.647 . . . . 0.0 111.247 179.441 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.627 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 25.2 mm100 -129.95 166.17 20.59 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.617 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.778 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 46.3 t -86.24 105.92 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.568 ' O ' ' O ' ' A' ' 71' ' ' GLU . 12.5 p -121.12 81.03 1.72 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.501 0.667 . . . . 0.0 110.929 -178.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.672 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 6.6 mmmt 155.37 -30.86 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.751 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 62.82 101.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.8 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.688 HG22 ' HB3' ' A' ' 46' ' ' PHE . 7.6 p -71.45 102.82 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.075 0.465 . . . . 0.0 110.304 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.615 ' H ' HD12 ' A' ' 99' ' ' ILE . 4.4 mp -63.99 133.2 29.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.913 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -102.73 142.79 33.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.018 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.5 ' HB3' HG23 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -76.81 108.3 9.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.927 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.32 109.98 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.055 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 103' ' ' VAL . 10.8 p -138.81 125.74 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.154 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -102.31 108.49 19.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.955 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.594 HG22 ' HG2' ' A' ' 61' ' ' GLU . 27.8 t -92.78 113.75 28.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.129 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.97 142.58 47.42 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.523 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.31 108.87 1.39 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.535 0.207 . . . . 0.0 111.161 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.449 ' HA ' ' HB1' ' A' ' 58' ' ' ALA . 54.2 Cg_endo -69.32 -168.01 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.343 2.028 . . . . 0.0 112.365 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.3 p -120.99 150.82 23.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.014 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 m -99.03 35.12 1.95 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 8.8 m80 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.902 -179.932 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.4 mmt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.794 0.331 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -97.04 40.58 2.51 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.456 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.95 80.05 1.61 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.319 . . . . 0.0 110.871 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.3 m -96.46 142.46 28.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.82 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -134.8 -47.18 0.74 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.402 ' O ' ' CG ' ' A' ' 7' ' ' HIS . 80.7 m80 -62.85 -75.2 0.08 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.402 ' CG ' ' O ' ' A' ' 6' ' ' HIS . 2.9 m80 -173.02 -175.52 1.23 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.916 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -131.71 -50.36 0.98 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.94 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -146.77 -67.88 0.27 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.26 31.76 20.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.7 t -106.78 134.98 49.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.949 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 136.22 -76.64 0.37 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.444 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.4 mt -148.98 -177.78 6.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.841 0.353 . . . . 0.0 110.805 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.6 t 61.99 88.23 0.12 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.074 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.26 -46.35 1.47 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.549 2.166 . . . . 0.0 112.279 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.574 ' CD ' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER 59.75 31.15 20.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 19' ' ' HIS . . . 177.03 82.63 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.486 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 p 52.81 -86.62 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.607 0.242 . . . . 0.0 111.319 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.417 ' N ' ' O ' ' A' ' 17' ' ' GLY . 13.3 t-80 68.68 -67.93 0.19 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.821 0.343 . . . . 0.0 111.003 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.33 36.49 2.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.881 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.4 m -142.39 148.4 37.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.952 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.2 -37.89 6.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.946 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -168.62 -176.47 2.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.912 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -135.88 155.54 50.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.964 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -106.41 32.45 4.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.948 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -134.64 153.08 52.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.0 t 69.02 -67.51 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.199 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 59.95 -169.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.13 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.56 106.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.053 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 60.33 167.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.978 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.5 m -142.12 179.32 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -131.57 152.72 50.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.35 -32.17 15.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.775 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 60.57 68.03 1.43 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.42 -45.03 1.35 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.626 2.217 . . . . 0.0 112.228 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -150.44 115.94 5.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.83 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.574 HD13 ' CD ' ' A' ' 16' ' ' ARG . 5.0 mp -86.18 114.52 23.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.08 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 2.2 pt -101.35 -177.39 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.496 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.768 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -161.52 146.24 13.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.436 0.636 . . . . 0.0 111.103 -179.448 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.726 ' O ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -143.36 -159.54 0.99 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.36 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 3.0 p -145.46 126.83 14.92 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.257 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.534 ' HG3' ' CE1' ' A' ' 74' ' ' HIS . 3.7 mm-40 -98.74 135.57 40.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.751 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.416 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 2.6 mm-40 -67.17 94.87 0.38 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.352 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.841 HD12 ' H ' ' A' ' 72' ' ' ARG . 5.1 mt -102.69 96.43 7.56 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.774 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.516 ' C ' HG21 ' A' ' 98' ' ' VAL . 98.8 Cg_endo -77.87 160.51 30.68 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.803 2.336 . . . . 0.0 113.255 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.629 ' HB3' HG22 ' A' ' 98' ' ' VAL . 49.1 p90 -86.94 -174.15 4.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.234 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.456 ' OE1' HD13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -152.63 113.16 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.847 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.769 HG22 ' CB ' ' A' ' 101' ' ' GLN . 17.6 t -66.74 146.41 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.103 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.456 HD13 ' OE1' ' A' ' 47' ' ' GLU . 36.8 mm -124.7 156.18 32.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.092 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.443 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -105.12 100.88 10.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.771 179.821 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.567 ' O ' HG12 ' A' ' 105' ' ' VAL . 4.7 tptt -96.75 145.55 25.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.029 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -110.5 123.13 49.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -122.97 128.75 25.23 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.16 -24.79 12.23 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.439 2.093 . . . . 0.0 112.495 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -55.17 -50.94 68.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.039 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.773 HD22 ' OE1' ' A' ' 60' ' ' GLN . 9.4 mt -60.15 167.02 3.22 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.793 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.407 ' HD2' ' CB ' ' A' ' 60' ' ' GLN . 1.2 Cg_endo -83.45 32.36 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.13 2.554 . . . . 0.0 112.697 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.634 ' HB1' ' HD3' ' A' ' 108' ' ' PRO . . . 62.04 119.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.833 0.349 . . . . 0.0 111.398 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.5 -26.27 20.65 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.753 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.773 ' OE1' HD22 ' A' ' 56' ' ' LEU . 2.3 tm0? -70.0 129.92 40.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 110.945 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.404 ' CG ' ' CG1' ' A' ' 103' ' ' VAL . 6.5 tt0 -95.73 158.42 15.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -158.15 118.19 3.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.944 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.6 mt -94.29 132.03 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.186 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.1 mm -105.83 -38.99 4.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.867 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.442 HG22 ' CG2' ' A' ' 99' ' ' ILE . 7.4 m -147.65 96.86 2.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.653 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.33 128.81 17.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.753 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.515 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -67.35 124.42 22.2 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.334 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.45 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.9 t -132.63 130.21 59.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.797 0.332 . . . . 0.0 111.065 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.4 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -62.25 113.38 2.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.387 -179.32 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.524 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -78.1 -146.28 2.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.377 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.694 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 10.7 tt0 -177.52 109.24 0.07 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.841 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -98.47 142.28 30.28 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.457 0.646 . . . . 0.0 110.425 -179.631 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.726 ' HA ' ' O ' ' A' ' 40' ' ' ARG . 94.7 m -75.62 149.03 38.31 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.92 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.589 ' O ' ' HA ' ' A' ' 39' ' ' THR . 5.2 m80 -128.66 117.9 21.97 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.53 0.681 . . . . 0.0 111.939 -178.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.768 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -90.58 107.27 19.06 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.079 -178.008 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.659 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.4 mp -90.08 158.66 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.798 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.499 ' OG ' HD23 ' A' ' 79' ' ' LEU . 11.7 t -108.15 117.39 34.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.449 HG13 ' HB ' ' A' ' 85' ' ' THR . 21.6 t -84.6 98.51 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.063 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.499 HD23 ' OG ' ' A' ' 77' ' ' SER . 2.8 mm? -103.65 142.3 34.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.5 p -89.96 93.8 9.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -99.12 105.83 17.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.976 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 60.45 33.49 20.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.0 35.78 26.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.516 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.6 147.43 32.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.796 0.331 . . . . 0.0 110.859 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.449 ' HB ' HG13 ' A' ' 78' ' ' VAL . 39.9 p -101.77 120.0 39.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.849 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.0 m -109.35 151.07 27.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -105.17 103.38 12.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.409 ' N ' HG23 ' A' ' 76' ' ' ILE . 94.3 m -122.5 121.05 35.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.78 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.3 t -50.11 116.08 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.124 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.43 ' HA ' HD22 ' A' ' 90' ' ' LEU . 0.2 OUTLIER -105.66 -70.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.189 -179.637 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.5 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 7.2 m-20 -140.25 136.88 33.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.212 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.649 ' HB2' ' O ' ' A' ' 73' ' ' THR . 24.0 p -143.24 165.55 27.15 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.582 0.706 . . . . 0.0 111.275 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.686 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 16.5 mm-40 -129.74 166.27 20.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.64 -1.163 . . . . 0.0 109.346 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.798 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.6 p -85.84 105.94 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.555 ' O ' ' O ' ' A' ' 71' ' ' GLU . 13.3 p -120.39 80.94 1.68 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.498 0.666 . . . . 0.0 110.793 -178.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.694 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.1 OUTLIER 154.7 -29.88 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.616 179.028 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 60.17 102.58 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.708 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.629 HG22 ' HB3' ' A' ' 46' ' ' PHE . 6.2 p -71.34 108.36 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.215 0.531 . . . . 0.0 110.073 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.574 ' H ' HD12 ' A' ' 99' ' ' ILE . 5.3 mp -63.85 126.87 23.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.965 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -96.02 137.12 35.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.993 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.769 ' CB ' HG22 ' A' ' 48' ' ' VAL . 2.5 tp60 -69.47 99.4 1.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.833 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.414 HG23 ' HB ' ' A' ' 65' ' ' THR . 21.5 t -86.1 99.63 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.053 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.404 ' CG1' ' CG ' ' A' ' 61' ' ' GLU . 21.5 t -119.45 125.9 74.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.177 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -114.45 108.55 17.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.834 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 51' ' ' LYS . 10.6 p -96.61 153.39 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.061 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.05 150.69 51.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.442 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.4 99.1 21.62 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.638 0.256 . . . . 0.0 111.145 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.634 ' HD3' ' HB1' ' A' ' 58' ' ' ALA . 54.1 Cg_endo -69.88 -46.14 1.28 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.519 2.146 . . . . 0.0 112.269 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.1 p -177.44 132.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.082 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.27 105.84 1.32 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.855 -179.928 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.407 ' HG2' ' CE1' ' A' ' 8' ' ' HIS . 7.6 mtm . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.799 0.333 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -103.98 -74.45 0.99 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.527 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.1 m -162.67 33.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 0.0 110.923 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.9 m -137.18 31.54 2.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.983 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -176.12 -64.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.891 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -158.87 178.4 10.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -131.79 34.22 3.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.407 ' CE1' ' HG2' ' A' ' 1' ' ' MET . 55.4 p-80 -74.54 126.06 29.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -60.81 -64.33 0.99 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.865 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.4 -78.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.84 120.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.38 . . . . 0.0 110.871 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.39 -56.84 22.86 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.53 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 60.43 -169.39 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.886 0.374 . . . . 0.0 110.85 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.442 HG23 ' HD2' ' A' ' 15' ' ' PRO . 10.3 p -126.45 136.5 28.74 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.006 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 14' ' ' VAL . 55.5 Cg_endo -69.99 149.44 65.43 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.499 2.133 . . . . 0.0 112.25 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -98.34 35.52 1.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.89 -78.98 0.88 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.495 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 67.98 -70.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.802 0.334 . . . . 0.0 110.95 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -121.05 101.74 7.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.892 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.2 mmt -125.44 -57.67 1.46 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.78 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.73 159.59 41.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.939 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.6 tp -160.46 -49.83 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.848 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.1 p30 -84.02 77.55 9.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -90.4 80.1 6.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -106.92 -177.82 3.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.937 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -106.3 -31.68 8.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.947 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.9 p -153.05 146.49 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.026 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.11 -68.96 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.89 -69.24 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.102 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.9 p-10 -167.73 33.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.884 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.5 m -82.41 148.88 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.097 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -150.42 -178.23 6.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.99 HG23 HD21 ' A' ' 79' ' ' LEU . 35.1 m -63.75 -23.63 67.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.087 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.41 ' HD3' HD21 ' A' ' 37' ' ' LEU . 20.3 ttm105 -106.06 79.98 0.61 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.893 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.61 -47.03 1.54 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.595 2.197 . . . . 0.0 112.38 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.53 ' HG3' HG22 ' A' ' 78' ' ' VAL . 5.1 pt-20 -147.6 152.9 38.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.819 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.41 HD21 ' HD3' ' A' ' 34' ' ' ARG . 7.1 mt -109.6 118.12 35.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.1 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.653 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 10.6 pt -101.23 -177.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.187 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.724 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 0.6 OUTLIER -153.84 160.92 42.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.233 0.54 . . . . 0.0 111.041 -179.471 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.527 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 3.6 tpp85 -172.71 131.61 0.55 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.815 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 2.9 p -81.91 129.93 34.91 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.837 0.827 . . . . 0.0 112.35 -177.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.496 ' HG3' HG13 ' A' ' 44' ' ' ILE . 3.5 tp10 -98.53 141.77 30.97 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.689 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -66.8 97.29 0.46 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.048 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.888 HD12 ' H ' ' A' ' 72' ' ' ARG . 7.0 mt -105.22 92.95 6.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.613 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.463 ' C ' HG21 ' A' ' 98' ' ' VAL . 73.7 Cg_endo -75.0 158.04 42.43 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.743 2.296 . . . . 0.0 113.031 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.658 ' HB3' HG22 ' A' ' 98' ' ' VAL . 41.6 p90 -86.77 -174.01 4.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.024 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -145.74 105.06 3.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.851 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.548 HG23 ' HB3' ' A' ' 101' ' ' GLN . 6.0 p -67.07 138.82 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.001 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.472 HD13 ' O ' ' A' ' 48' ' ' VAL . 27.9 mm -122.69 156.17 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.161 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.444 ' N ' HG22 ' A' ' 49' ' ' ILE . 16.8 mtmt -120.1 100.78 7.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.815 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.709 ' O ' HG22 ' A' ' 105' ' ' VAL . 2.5 tppt? -98.39 154.34 17.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.985 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.654 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 2.3 mm-40 -99.29 129.68 45.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.944 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -124.99 127.22 25.14 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.815 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.4 -27.16 11.48 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.411 2.074 . . . . 0.0 112.442 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -58.6 -35.52 72.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.985 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.453 HD22 ' NE2' ' A' ' 60' ' ' GLN . 8.3 mt -71.03 158.89 87.19 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.825 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -86.33 37.92 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.885 2.39 . . . . 0.0 112.878 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.526 ' HB2' ' CD ' ' A' ' 108' ' ' PRO . . . 62.22 145.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.846 0.355 . . . . 0.0 111.338 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.23 27.74 58.05 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.634 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.453 ' NE2' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -106.01 169.34 8.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.757 0.313 . . . . 0.0 110.963 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -155.32 133.01 11.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.927 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -135.75 125.0 24.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.812 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.791 HD13 ' CG1' ' A' ' 103' ' ' VAL . 26.1 mm -85.75 92.86 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.087 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.408 HD11 ' HG3' ' A' ' 104' ' ' GLU . 19.8 mt -74.26 -31.77 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.992 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.4 m -164.21 93.6 0.7 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.666 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.7 145.03 5.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.537 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.432 ' HA3' ' CE1' ' A' ' 46' ' ' PHE . . . -80.79 136.25 16.09 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.341 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.7 t -141.74 120.86 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 0.0 110.957 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.519 ' HA ' HG23 ' A' ' 98' ' ' VAL . 28.5 mtmt -59.42 112.79 1.89 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.245 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.504 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -76.87 -144.53 1.76 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.758 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.679 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -177.42 109.17 0.07 Allowed 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.219 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.888 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -98.61 139.38 34.42 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.16 0.505 . . . . 0.0 110.47 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.586 ' O ' ' HB2' ' A' ' 92' ' ' SER . 40.5 m -75.39 136.09 40.77 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.451 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.724 ' O ' ' HA ' ' A' ' 39' ' ' THR . 25.7 m80 -116.17 122.37 44.84 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.416 0.627 . . . . 0.0 111.771 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.74 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -90.69 107.23 19.04 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.054 -177.873 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 77' ' ' SER . 3.8 mp -96.22 160.42 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.069 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.51 ' HB2' HD23 ' A' ' 90' ' ' LEU . 0.7 OUTLIER -112.76 122.43 47.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.762 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 78' ' ' VAL . 35.8 m -90.11 108.97 20.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.31 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.99 HD21 HG23 ' A' ' 33' ' ' THR . 1.0 OUTLIER -108.05 137.96 45.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.796 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.53 123.04 29.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -131.48 109.52 10.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.9 p30 44.08 33.98 0.89 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.416 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.28 45.29 5.64 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.473 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -149.23 156.83 42.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 110.825 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.67 116.22 28.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.943 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.28 151.02 20.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -121.41 83.93 2.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.957 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.6 m -108.29 123.2 48.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.792 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.1 m -50.11 130.07 8.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.221 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.51 HD23 ' HB2' ' A' ' 77' ' ' SER . 0.5 OUTLIER -114.48 -64.56 1.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.233 -179.703 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.488 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -152.82 141.42 20.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.207 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.594 ' HB3' ' CD2' ' A' ' 74' ' ' HIS . 11.5 p -143.27 165.61 27.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.779 0.8 . . . . 0.0 111.616 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.686 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 41.8 mt-30 -129.18 166.08 20.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.691 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.755 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.5 p -85.96 105.78 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.59 ' O ' ' O ' ' A' ' 71' ' ' GLU . 12.1 p -121.36 80.75 1.7 Allowed 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.579 0.704 . . . . 0.0 110.733 -178.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.679 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 154.46 -31.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.649 178.719 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 62.94 101.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.777 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.658 HG22 ' HB3' ' A' ' 46' ' ' PHE . 5.8 p -71.48 106.64 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.058 0.456 . . . . 0.0 110.202 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.9 mm -63.87 129.44 27.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.068 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -98.92 134.93 41.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.021 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.548 ' HB3' HG23 ' A' ' 48' ' ' VAL . 1.5 tm0? -68.47 99.45 0.96 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.25 117.28 32.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.073 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.791 ' CG1' HD13 ' A' ' 63' ' ' ILE . 5.1 m -143.09 137.58 26.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.095 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.408 ' HG3' HD11 ' A' ' 64' ' ' ILE . 19.7 mt-10 -118.4 111.85 19.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.882 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 51' ' ' LYS . 29.9 m -88.87 146.94 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.088 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -70.98 146.18 40.97 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.443 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.654 ' HB3' ' HB3' ' A' ' 52' ' ' GLU . . . -167.35 73.85 1.0 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.748 0.308 . . . . 0.0 111.101 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.526 ' CD ' ' HB2' ' A' ' 58' ' ' ALA . 57.8 Cg_endo -71.06 136.32 29.32 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.615 2.21 . . . . 0.0 112.371 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.3 t 68.87 -67.29 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.204 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m 60.96 80.71 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.954 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.926 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.815 0.341 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 147.12 -92.78 0.15 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.54 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m 60.47 32.31 20.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.801 0.334 . . . . 0.0 110.922 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.4 t -106.15 172.71 6.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -165.52 -178.71 5.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.7 p-80 -92.67 81.84 4.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.816 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -106.34 -37.75 6.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -60.36 92.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -161.45 -49.58 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.858 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 m -106.12 161.7 14.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.1 t -83.34 -74.66 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.908 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.53 -39.57 1.68 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.533 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 mt -73.08 69.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.829 0.347 . . . . 0.0 110.891 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.64 ' N ' ' CD ' ' A' ' 15' ' ' PRO . 13.4 p -82.2 -28.64 0.46 Allowed Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 14' ' ' VAL . 89.4 Cg_endo -84.75 -26.67 1.52 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.094 1.863 . . . . 0.0 112.585 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -102.42 -31.3 10.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.11 178.01 52.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.498 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.7 p -176.62 169.63 2.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.844 0.354 . . . . 0.0 110.897 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -105.48 89.79 3.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.845 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.34 -38.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.993 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.82 165.01 4.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.909 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.0 -38.25 5.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -176.86 -178.77 0.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -156.17 -74.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -176.78 104.76 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -176.51 106.65 0.07 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.949 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 27' ' ' VAL . 14.9 p -144.61 39.93 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.013 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -175.78 37.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.043 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.34 -74.93 0.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.021 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.514 ' O ' HG22 ' A' ' 31' ' ' VAL . 1.1 t-20 -106.02 -51.58 2.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 30' ' ' ASN . 21.4 m 45.48 -171.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.624 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -144.32 -71.58 0.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.003 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.03 108.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.96 79.86 0.27 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.867 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.69 -35.57 9.7 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.561 2.174 . . . . 0.0 112.298 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -163.6 154.49 16.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.775 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 68.4 mt -95.01 122.79 38.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.072 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 76' ' ' ILE . 1.2 tt -101.17 -177.32 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.567 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.852 HG22 ' CD1' ' A' ' 75' ' ' TYR . 1.3 p -162.29 142.22 9.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.331 0.586 . . . . 0.0 111.018 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.688 ' CG ' HD13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -163.64 109.88 1.11 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.147 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 12.5 t -82.3 132.71 35.22 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.685 0.755 . . . . 0.0 111.734 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.469 ' O ' HD12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -98.41 148.24 23.89 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.695 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.407 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 4.8 mt-10 -66.83 100.2 0.69 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.699 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.567 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.0 mp -104.8 91.16 4.01 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.872 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.512 ' C ' HG21 ' A' ' 98' ' ' VAL . 72.0 Cg_endo -76.18 157.38 37.84 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.671 2.247 . . . . 0.0 112.808 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.618 ' HB3' HG22 ' A' ' 98' ' ' VAL . 30.0 p90 -86.73 -177.29 6.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.118 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -157.07 120.25 4.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.96 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.778 HG22 ' CB ' ' A' ' 101' ' ' GLN . 40.0 t -67.26 150.0 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.242 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 50' ' ' LYS . 7.8 mt -129.18 156.15 41.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.079 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' N ' HG22 ' A' ' 49' ' ' ILE . 4.4 mtpp -123.59 100.89 7.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.818 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -110.8 147.37 34.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.901 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.87 140.0 32.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -133.71 98.48 14.79 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.51 84.25 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.484 2.122 . . . . 0.0 112.213 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -175.32 -40.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.924 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.739 HD13 ' HB3' ' A' ' 60' ' ' GLN . 41.7 mt -58.49 167.16 1.87 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.842 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.08 48.84 2.63 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.041 2.494 . . . . 0.0 112.754 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.37 124.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.016 0.436 . . . . 0.0 111.716 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 50.59 55.64 16.39 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.091 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.739 ' HB3' HD13 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -109.47 136.5 48.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.742 0.306 . . . . 0.0 110.802 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.9 117.14 27.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.628 ' O ' HG12 ' A' ' 103' ' ' VAL . 8.5 p-10 -127.08 158.02 38.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.799 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.751 HD13 HG12 ' A' ' 103' ' ' VAL . 31.1 mm -113.91 92.52 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.463 HD11 ' HG3' ' A' ' 104' ' ' GLU . 24.3 mt -73.24 -32.25 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.921 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.0 m -161.31 92.74 0.91 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.613 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.49 146.45 5.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.582 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.429 ' HA3' ' CE1' ' A' ' 46' ' ' PHE . . . -76.45 138.72 22.88 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.262 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.8 t -140.95 135.05 32.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.917 0.389 . . . . 0.0 111.349 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.16 134.87 56.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.335 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 96' ' ' LYS . . . -116.25 -159.68 11.91 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.994 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.475 ' HA ' HD12 ' A' ' 44' ' ' ILE . 1.5 tt0 -162.08 153.89 18.84 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 2.6 ttt180 -141.39 112.2 7.17 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.717 ' O ' ' HB2' ' A' ' 92' ' ' SER . 46.5 m -73.92 125.72 28.85 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.526 ' O ' ' HA ' ' A' ' 39' ' ' THR . 13.8 m80 -106.8 119.7 40.05 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 122.083 0.944 . . . . 0.0 113.137 -177.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.852 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -91.14 93.81 9.3 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.103 -177.899 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.688 HD13 ' CG ' ' A' ' 40' ' ' ARG . 2.0 mp -87.35 142.65 12.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.931 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.724 ' OG ' HD23 ' A' ' 90' ' ' LEU . 2.4 p -77.34 121.42 23.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.762 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.489 ' C ' HD22 ' A' ' 79' ' ' LEU . 21.4 t -81.4 105.56 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.203 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.489 HD22 ' C ' ' A' ' 78' ' ' VAL . 3.9 mm? -125.55 89.27 3.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.891 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.07 131.4 42.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -137.62 117.24 13.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.909 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 60.67 33.35 20.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.28 32.02 49.55 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.438 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -144.32 113.77 7.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.755 0.312 . . . . 0.0 110.86 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.7 p -75.21 127.8 34.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.6 m -100.01 141.28 33.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.899 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -100.29 101.97 13.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.8 m -118.95 121.0 38.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 89' ' ' VAL . 10.8 p -54.26 118.41 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.006 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.724 HD23 ' OG ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -106.0 -59.57 1.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.516 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -177.17 139.95 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.198 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.717 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.8 p -143.64 149.47 37.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.48 0.657 . . . . 0.0 111.362 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.668 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 4.6 mt-30 -107.47 167.11 10.17 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 94' ' ' VAL . 8.3 p -84.75 107.16 15.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 119.854 -0.739 . . . . 0.0 109.872 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.549 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 16.8 p -113.22 82.9 1.74 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.686 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 95' ' ' THR . 11.6 mmmt 113.36 52.93 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.097 -1.41 . . . . 0.0 109.385 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -35.21 117.17 0.39 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.544 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.618 HG22 ' HB3' ' A' ' 46' ' ' PHE . 9.4 p -71.44 106.02 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.206 0.527 . . . . 0.0 110.792 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.0 mm -64.35 121.5 13.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.164 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -98.07 125.95 43.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.931 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.804 ' OE1' HG13 ' A' ' 103' ' ' VAL . 0.5 OUTLIER -62.67 128.91 38.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.788 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.8 m -124.01 101.36 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.195 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.804 HG13 ' OE1' ' A' ' 101' ' ' GLN . 2.4 m -108.96 118.6 56.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.072 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.463 ' HG3' HD11 ' A' ' 64' ' ' ILE . 18.0 mt-10 -87.15 111.58 21.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.783 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.99 143.5 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.225 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.54 109.67 3.03 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.505 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 60.84 155.97 0.11 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.714 0.292 . . . . 0.0 111.09 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.493 ' O ' HG13 ' A' ' 109' ' ' VAL . 55.3 Cg_endo -70.19 -45.41 1.37 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.49 2.127 . . . . 0.0 112.285 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 108' ' ' PRO . 6.9 m -157.63 -47.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.15 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.435 ' N ' HG23 ' A' ' 109' ' ' VAL . 33.1 p -65.55 79.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.873 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 72.1 m80 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.936 179.999 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpp? . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.825 0.345 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.74 162.24 28.68 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.528 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.0 t -160.9 -47.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.829 0.347 . . . . 0.0 110.952 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.82 110.84 4.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -129.4 72.87 1.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -177.49 -40.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.47 ' CG ' ' CE1' ' A' ' 8' ' ' HIS . 1.9 t-80 -59.54 -63.86 1.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.47 ' CE1' ' CG ' ' A' ' 7' ' ' HIS . 0.0 OUTLIER -166.37 -83.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.931 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.9 m170 61.22 155.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.812 0.339 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.9 m -60.09 -45.33 93.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.965 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.73 -169.97 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.927 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.81 -179.18 28.17 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.527 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 mp -142.82 -170.3 3.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.858 0.361 . . . . 0.0 110.85 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.45 ' O ' HG23 ' A' ' 14' ' ' VAL . 6.7 m -133.28 87.86 37.23 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.15 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.24 -28.15 23.29 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.476 2.118 . . . . 0.0 112.325 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -60.48 124.96 21.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.97 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -170.91 -146.69 5.3 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.56 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.6 m -146.2 32.24 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 110.925 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -131.59 -46.79 0.97 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.957 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.06 79.51 1.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.82 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.9 p -106.6 117.05 33.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 mt -96.93 79.65 2.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -159.38 31.74 0.2 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.853 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -117.92 51.59 1.05 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 60.94 167.5 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.935 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -98.8 31.62 2.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.5 t -109.08 82.47 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.108 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.74 -56.46 2.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.097 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -170.44 137.13 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.129 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -94.67 47.66 1.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.1 m -59.47 178.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.221 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -169.06 -173.1 1.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 34' ' ' ARG . 0.2 OUTLIER 62.1 -172.37 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.936 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.462 ' H ' HG22 ' A' ' 33' ' ' THR . 0.0 OUTLIER -65.21 149.78 96.48 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.02 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.26 -166.16 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.636 2.224 . . . . 0.0 112.271 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -78.84 124.84 28.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.641 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 68.4 mt -78.33 116.46 18.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.086 0.469 . . . . 0.0 111.329 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.763 HD11 ' CD1' ' A' ' 76' ' ' ILE . 1.2 pp -100.89 -176.05 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.288 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.67 ' N ' HD12 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -156.35 132.94 10.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.499 0.666 . . . . 0.0 112.486 -178.351 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.653 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 4.7 mmm180 -150.72 115.77 5.32 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -82.13 134.37 35.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.897 0.856 . . . . 0.0 112.34 -177.685 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.417 ' HG2' ' ND1' ' A' ' 74' ' ' HIS . 1.2 mm-40 -98.78 138.81 35.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.24 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.434 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 1.7 pt-20 -66.86 91.45 0.2 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.778 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.866 HD12 ' H ' ' A' ' 72' ' ' ARG . 6.5 mt -94.84 105.04 16.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.651 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.493 ' C ' HG21 ' A' ' 98' ' ' VAL . 80.8 Cg_endo -84.19 157.2 13.02 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.769 2.313 . . . . 0.0 113.296 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.713 ' HB3' HG22 ' A' ' 98' ' ' VAL . 42.6 p90 -86.91 -174.02 4.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.965 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -149.42 103.05 3.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.099 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 101' ' ' GLN . 3.9 p -66.82 145.02 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.931 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.453 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.6 mp -128.97 156.1 41.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.039 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' N ' HG22 ' A' ' 49' ' ' ILE . 3.4 mptt -109.44 100.89 9.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.754 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.33 164.6 20.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.035 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -116.35 112.56 21.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.826 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.46 ' HB3' HD13 ' A' ' 56' ' ' LEU . 1.4 t-20 -102.23 96.6 7.26 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.67 -13.21 38.98 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.499 2.132 . . . . 0.0 112.512 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -97.81 27.79 4.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.706 0.289 . . . . 0.0 111.047 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.763 HD23 ' HB3' ' A' ' 60' ' ' GLN . 3.5 mp -114.97 175.94 1.68 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.85 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -86.78 29.53 0.5 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.281 2.654 . . . . 0.0 112.781 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.7 130.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.978 0.418 . . . . 0.0 111.225 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.78 54.08 40.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.642 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.763 ' HB3' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -109.44 131.7 54.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.765 0.317 . . . . 0.0 110.823 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -115.18 113.85 24.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.937 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -147.25 119.34 8.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.804 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.418 HG12 HG22 ' A' ' 103' ' ' VAL . 26.1 mt -85.76 130.96 35.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.251 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.752 HD11 ' HG3' ' A' ' 104' ' ' GLU . 2.4 mp -100.24 -46.18 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.636 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.3 m -141.85 102.17 4.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.497 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.68 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -49.43 162.95 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.545 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.436 ' HA3' ' CE2' ' A' ' 46' ' ' PHE . . . -111.07 127.32 8.18 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.243 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.43 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.6 t -139.43 134.7 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.809 0.337 . . . . 0.0 110.97 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.506 ' HA ' HG23 ' A' ' 98' ' ' VAL . 10.0 mttt -65.37 114.55 4.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.075 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.485 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -75.08 -143.06 0.94 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.802 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.608 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -177.33 109.51 0.07 Allowed 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.194 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.866 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -103.35 134.3 46.97 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.251 0.548 . . . . 0.0 110.127 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 92' ' ' SER . 60.6 m -76.15 138.22 40.57 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.532 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.653 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 6.6 m80 -111.79 122.72 48.56 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.687 0.756 . . . . 0.0 112.05 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.726 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -92.99 93.85 8.58 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.241 -177.287 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.763 ' CD1' HD11 ' A' ' 38' ' ' ILE . 4.3 mp -87.66 144.69 8.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.221 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.619 ' HB3' HD22 ' A' ' 90' ' ' LEU . 21.6 p -93.95 115.2 27.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.817 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.452 HG13 HG21 ' A' ' 38' ' ' ILE . 6.8 m -81.44 105.81 11.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' A' ' 79' ' ' LEU . 1.1 tm? -113.98 102.12 9.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.1 m -66.92 91.09 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -62.23 92.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 68.15 -69.86 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.093 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.88 36.99 1.03 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.491 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.88 132.21 6.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.883 0.373 . . . . 0.0 110.859 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.97 130.72 35.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.948 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.61 144.98 43.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -93.84 117.55 30.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.867 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.591 ' C ' HG23 ' A' ' 76' ' ' ILE . 91.3 m -144.62 101.1 3.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.7 t -49.74 133.22 8.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.96 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.619 HD22 ' HB3' ' A' ' 77' ' ' SER . 3.0 tp -110.3 -67.23 1.0 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.271 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.49 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 2.1 m-20 -150.79 141.16 22.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.979 0.419 . . . . 0.0 111.539 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.621 ' HB2' ' O ' ' A' ' 73' ' ' THR . 11.8 p -143.7 160.51 40.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.585 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.66 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 3.7 mt-30 -125.18 167.01 15.42 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.813 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.2 p -85.14 106.34 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 119.557 -0.857 . . . . 0.0 108.964 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.528 ' O ' ' O ' ' A' ' 71' ' ' GLU . 6.1 p -115.78 81.02 1.53 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.613 0.721 . . . . 0.0 110.46 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 156.35 -29.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.721 179.081 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 61.78 100.77 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.532 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.713 HG22 ' HB3' ' A' ' 46' ' ' PHE . 5.9 p -71.24 102.7 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 121.213 0.53 . . . . 0.0 109.998 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.68 HG22 ' O ' ' A' ' 66' ' ' ALA . 3.8 mp -64.28 133.35 29.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.015 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -105.67 141.53 36.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.143 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.531 ' O ' HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -76.4 108.13 9.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.776 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.741 HG12 HD13 ' A' ' 64' ' ' ILE . 21.3 t -95.92 108.7 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.107 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.418 HG22 HG12 ' A' ' 63' ' ' ILE . 22.1 t -129.32 114.96 33.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.019 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.752 ' HG3' HD11 ' A' ' 64' ' ' ILE . 0.7 OUTLIER -89.99 139.94 30.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.763 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.4 109.7 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.082 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.19 128.15 30.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.577 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -84.85 151.83 58.47 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.693 0.282 . . . . 0.0 111.143 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.19 -41.32 3.83 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.612 2.208 . . . . 0.0 112.397 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 31.5 t -63.36 87.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.112 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -176.78 125.93 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 22.3 p80 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.907 -179.973 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.792 0.329 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.59 35.25 88.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.511 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.0 p 58.54 171.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.807 0.337 . . . . 0.0 111.014 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.4 p -87.27 -169.49 2.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.936 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -60.3 -169.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.821 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.48 97.38 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -71.75 -68.05 0.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.002 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.76 -175.22 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.836 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -176.4 37.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.32 164.14 27.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.802 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.3 t -93.08 -170.15 2.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.997 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.18 -133.28 1.85 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.457 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.613 ' O ' HD12 ' A' ' 13' ' ' LEU . 1.7 pp -132.17 133.15 43.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.753 0.311 . . . . 0.0 110.923 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 14' ' ' VAL . 6.1 m -150.46 88.15 4.72 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.136 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -176.02 1.33 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.598 2.199 . . . . 0.0 112.293 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.17 -74.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 59.46 -96.39 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.526 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.08 30.68 20.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.739 0.304 . . . . 0.0 110.91 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -177.23 -68.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 77.5 mmm 59.45 -178.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.961 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 p -113.37 152.37 30.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.001 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.87 86.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.885 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -161.93 -175.97 4.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -82.94 -75.27 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 59.82 31.04 20.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.942 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -170.64 161.22 7.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.5 t -104.38 136.81 36.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.7 40.25 1.14 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.99 78.4 0.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.051 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -60.44 134.94 57.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.859 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.913 HG12 HG23 ' A' ' 33' ' ' THR . 21.7 t -112.73 -67.33 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 62.45 -80.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.959 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.913 HG23 HG12 ' A' ' 31' ' ' VAL . 10.2 p 55.8 33.26 21.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.896 0.379 . . . . 0.0 111.192 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.408 ' N ' ' CD ' ' A' ' 35' ' ' PRO . 8.1 ttm-85 -164.32 52.73 0.31 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.034 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 34' ' ' ARG . 72.1 Cg_endo -76.78 -43.11 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.511 2.141 . . . . 0.0 112.314 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -139.56 129.13 24.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.5 132.92 42.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.878 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.868 HD12 ' HB ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER -101.25 -176.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.444 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.591 ' H ' HG22 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -163.16 121.93 2.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.03 0.443 . . . . 0.0 109.947 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 74' ' ' HIS . 18.9 ttt180 -145.77 132.49 19.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.328 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.612 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 2.2 p -81.85 130.23 35.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.891 0.853 . . . . 0.0 112.235 -177.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.443 ' HG2' HG13 ' A' ' 44' ' ' ILE . 1.1 tt0 -98.36 143.89 28.34 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.806 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.9 94.26 0.31 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.905 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.897 HD12 ' H ' ' A' ' 72' ' ' ARG . 7.3 mt -103.02 95.3 6.38 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.59 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.473 ' C ' HG21 ' A' ' 98' ' ' VAL . 74.4 Cg_endo -74.16 158.6 45.19 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.73 2.287 . . . . 0.0 113.278 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.644 ' HB3' HG22 ' A' ' 98' ' ' VAL . 53.9 p90 -86.64 -173.97 4.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.111 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -151.64 111.84 4.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.882 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.874 HG22 ' CB ' ' A' ' 101' ' ' GLN . 31.2 t -66.81 151.14 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.249 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.5 mp -126.92 156.25 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.094 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.459 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -121.6 100.75 7.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.807 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -107.88 150.91 26.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.499 ' HG3' ' HB3' ' A' ' 107' ' ' ALA . 0.6 OUTLIER -87.91 123.51 32.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -117.47 96.55 49.53 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.928 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.63 65.71 1.2 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.448 2.099 . . . . 0.0 112.193 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -149.68 -45.87 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.846 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.697 HD23 ' HB3' ' A' ' 60' ' ' GLN . 7.1 mp -55.9 172.93 0.29 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 60' ' ' GLN . 2.0 Cg_endo -82.15 31.72 0.52 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.172 2.582 . . . . 0.0 112.951 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.96 120.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.999 0.428 . . . . 0.0 111.387 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.81 22.17 62.16 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.886 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.697 ' HB3' HD23 ' A' ' 56' ' ' LEU . 69.5 tp60 -109.54 157.68 18.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.826 0.346 . . . . 0.0 110.826 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -136.3 115.17 12.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.48 ' OD1' HD21 ' A' ' 56' ' ' LEU . 7.2 p-10 -117.61 116.68 27.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 26.1 mt -85.81 132.09 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.108 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.444 HD11 ' HG3' ' A' ' 104' ' ' GLU . 12.7 mt -103.46 -44.44 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.984 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.55 92.06 2.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.623 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.501 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -46.83 150.92 0.66 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.768 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.466 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -85.71 129.34 9.27 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.229 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.71 125.95 47.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.915 0.388 . . . . 0.0 110.885 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -60.51 112.71 2.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.281 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.492 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -76.9 -144.15 1.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.509 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.692 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 4.6 tt0 -177.45 109.27 0.07 Allowed 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.897 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -100.39 138.75 37.03 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.24 -179.711 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 92' ' ' SER . 94.6 m -75.22 140.12 43.05 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.68 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.577 ' CD2' ' HB3' ' A' ' 92' ' ' SER . 29.0 m80 -119.78 121.75 39.85 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.047 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.722 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -92.22 106.58 18.55 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.24 -177.256 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.868 ' HB ' HD12 ' A' ' 38' ' ' ILE . 5.0 mp -90.75 160.8 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.874 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.822 ' HB3' HD23 ' A' ' 90' ' ' LEU . 5.6 t -119.28 129.01 54.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.721 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.468 HG23 ' CG2' ' A' ' 85' ' ' THR . 11.4 p -81.41 123.0 37.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.141 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.9 tp -128.91 117.28 20.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.2 p -66.98 98.05 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.818 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.73 92.14 6.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 59.95 31.24 20.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.993 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.24 38.5 7.22 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.541 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -148.12 162.07 40.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.76 0.314 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.468 ' CG2' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -106.97 123.47 48.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.927 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -128.33 110.59 12.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.02 114.66 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 77' ' ' SER . 11.8 t -121.29 121.93 38.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.3 m -52.59 121.15 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.112 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.822 HD23 ' HB3' ' A' ' 77' ' ' SER . 0.2 OUTLIER -110.4 -49.97 3.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.189 -179.736 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.484 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 5.9 t0 -176.62 143.79 0.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.275 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.582 ' HB2' ' O ' ' A' ' 73' ' ' THR . 11.3 p -143.16 165.61 26.95 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.554 0.692 . . . . 0.0 111.496 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.717 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 5.1 mm-40 -131.85 166.3 21.9 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.947 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.798 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 5.5 m -85.97 105.79 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.591 ' O ' ' O ' ' A' ' 71' ' ' GLU . 10.7 p -121.02 80.68 1.67 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.491 0.663 . . . . 0.0 110.76 -178.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.692 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER 154.47 -30.38 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.846 178.837 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 62.02 101.58 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.624 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.644 HG22 ' HB3' ' A' ' 46' ' ' PHE . 5.0 p -71.36 108.37 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.163 0.506 . . . . 0.0 110.2 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 66' ' ' ALA . 43.2 mm -64.2 128.8 27.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.173 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -100.94 134.83 43.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.874 ' CB ' HG22 ' A' ' 48' ' ' VAL . 0.3 OUTLIER -64.55 99.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.749 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.82 99.81 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.182 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.6 p -123.71 141.56 43.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.128 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.444 ' HG3' HD11 ' A' ' 64' ' ' ILE . 2.6 mt-10 -121.53 120.13 33.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.801 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.807 HG22 ' O ' ' A' ' 51' ' ' LYS . 27.8 m -86.99 160.14 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.151 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -98.87 125.84 8.7 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.55 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.499 ' HB3' ' HG3' ' A' ' 52' ' ' GLU . . . -177.0 148.5 0.76 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.762 0.315 . . . . 0.0 111.046 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.23 131.34 17.71 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.544 2.162 . . . . 0.0 112.363 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.501 HG13 HG22 ' A' ' 110' ' ' THR . 9.9 p -64.54 -45.31 95.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.056 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.501 HG22 HG13 ' A' ' 109' ' ' VAL . 2.3 t -179.73 -38.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.884 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.799 0.333 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -147.43 98.12 0.19 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.427 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.17 -56.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.746 0.307 . . . . 0.0 110.865 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.85 92.98 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -161.76 -72.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.897 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -60.9 179.86 0.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.7 t60 60.65 103.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.851 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -149.1 93.7 2.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.83 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -136.92 145.73 44.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 75.3 m -135.31 -55.38 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.801 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.3 m 60.38 100.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.73 -27.84 45.08 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.582 ' O ' HG23 ' A' ' 14' ' ' VAL . 5.7 mp 60.14 31.56 20.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.714 0.292 . . . . 0.0 110.9 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 13' ' ' LEU . 20.7 t -158.87 -64.6 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.052 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.501 ' CD ' ' HB ' ' A' ' 14' ' ' VAL . 30.9 Cg_endo -63.21 -48.29 6.52 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.271 1.981 . . . . 0.0 112.193 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.19 -40.48 9.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.867 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.89 84.13 1.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.445 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 m -131.52 -65.43 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.865 0.365 . . . . 0.0 110.923 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -105.79 87.94 2.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.9 mtp -61.16 -31.66 71.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.5 p -130.07 177.28 7.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 22' ' ' LEU . 3.6 mp -92.77 -31.49 15.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.944 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -171.96 -43.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.528 ' O ' HG13 ' A' ' 27' ' ' VAL . 9.9 mt-10 63.88 -79.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.998 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 59.87 62.07 1.76 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 60.08 82.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.785 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 24' ' ' GLU . 12.7 m -129.27 164.68 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.134 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -175.16 43.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.054 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.57 -74.54 0.07 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.111 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -146.96 95.21 2.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.932 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.4 m -67.47 -36.89 77.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.086 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -136.43 -177.83 4.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.24 39.69 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.981 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.95 144.62 33.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.864 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.62 -44.64 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.498 2.132 . . . . 0.0 112.366 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.15 121.22 6.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.944 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.71 135.53 33.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.883 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.804 HD12 ' HB ' ' A' ' 76' ' ' ILE . 0.5 OUTLIER -100.8 -177.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.452 179.381 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.704 ' H ' HG22 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -157.14 121.82 4.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.344 0.592 . . . . 0.0 111.26 -179.397 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.668 ' O ' ' HA ' ' A' ' 73' ' ' THR . 1.0 OUTLIER -128.06 -151.11 0.46 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.679 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 m -144.96 137.87 26.44 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.115 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.473 ' CB ' ' CE1' ' A' ' 74' ' ' HIS . 0.2 OUTLIER -107.94 131.84 54.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.427 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -66.93 92.83 0.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.058 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.775 HD11 ' HG2' ' A' ' 72' ' ' ARG . 4.1 mt -109.1 85.79 3.55 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.152 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.591 ' C ' HG21 ' A' ' 98' ' ' VAL . 86.1 Cg_endo -79.76 163.36 23.72 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.829 2.353 . . . . 0.0 112.93 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.629 ' HB3' HG22 ' A' ' 98' ' ' VAL . 40.1 p90 -87.33 -173.98 4.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.225 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -149.31 107.13 3.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.787 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.527 HG23 ' HG2' ' A' ' 101' ' ' GLN . 9.4 p -66.85 123.61 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.018 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 50' ' ' LYS . 22.8 mm -106.4 156.18 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.228 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.431 ' N ' HG22 ' A' ' 49' ' ' ILE . 8.5 ptmt -108.74 100.84 10.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.808 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.531 ' O ' HG22 ' A' ' 105' ' ' VAL . 32.6 ttmt -87.2 159.16 18.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.985 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.637 ' HG3' ' HB3' ' A' ' 107' ' ' ALA . 0.1 OUTLIER -100.87 120.07 39.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.653 ' HB3' HD13 ' A' ' 56' ' ' LEU . 7.9 t-20 -122.94 96.56 44.86 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.918 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.81 -25.19 53.36 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.453 2.102 . . . . 0.0 112.263 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -62.35 -30.97 71.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.705 HD23 ' HB3' ' A' ' 60' ' ' GLN . 8.5 mp -65.18 171.88 2.87 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.748 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -89.06 29.93 0.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.268 2.646 . . . . 0.0 112.598 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.01 146.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.912 0.387 . . . . 0.0 111.292 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.74 21.49 36.51 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.779 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.705 ' HB3' HD23 ' A' ' 56' ' ' LEU . 1.8 tt0 -109.61 148.02 32.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.882 0.372 . . . . 0.0 110.799 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -137.87 141.63 40.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -137.7 162.47 33.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.81 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.913 HD13 HG12 ' A' ' 103' ' ' VAL . 18.2 mm -117.0 86.28 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.113 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.4 mm -62.97 -49.75 82.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.012 0.434 . . . . 0.0 110.94 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.3 m -143.68 91.12 2.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.576 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.06 139.55 4.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.727 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.445 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -82.67 137.01 16.12 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.211 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.482 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.9 t -137.48 125.97 33.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.839 0.352 . . . . 0.0 111.075 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -56.48 119.88 6.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.041 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.583 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -80.74 -149.89 6.58 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.528 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.632 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -177.18 109.3 0.07 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.069 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.793 ' HB2' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -101.53 139.0 37.78 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.295 0.569 . . . . 0.0 109.904 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.671 ' O ' ' HB2' ' A' ' 92' ' ' SER . 91.2 m -75.86 138.99 41.45 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.815 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.473 ' CE1' ' CB ' ' A' ' 42' ' ' GLU . 5.0 m80 -111.64 118.97 37.13 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.745 0.784 . . . . 0.0 112.609 -178.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.698 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -92.05 100.05 12.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.066 -1.424 . . . . 0.0 111.508 -177.365 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.804 ' HB ' HD12 ' A' ' 38' ' ' ILE . 5.0 mp -87.73 141.62 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.79 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.601 ' O ' HD12 ' A' ' 79' ' ' LEU . 5.7 t -98.78 130.26 45.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 0.0 110.753 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.607 HG23 HG22 ' A' ' 85' ' ' THR . 10.6 p -81.42 119.01 30.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.172 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 77' ' ' SER . 5.4 mp -113.21 116.61 30.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.6 m -88.65 94.34 9.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.94 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -87.35 96.72 10.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 42.88 32.06 0.37 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.401 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.39 43.67 2.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.522 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -147.88 107.38 3.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.82 0.343 . . . . 0.0 110.878 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.607 HG22 HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -88.91 119.01 29.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.821 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.31 149.96 44.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -97.25 108.62 21.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.974 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.767 ' O ' HG23 ' A' ' 76' ' ' ILE . 78.0 m -127.5 124.05 37.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 89' ' ' VAL . 9.9 p -55.15 121.82 3.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.865 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.526 HD23 ' HB3' ' A' ' 77' ' ' SER . 0.2 OUTLIER -104.9 -71.24 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.381 -179.523 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.5 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 2.6 t0 -147.06 136.44 22.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.845 0.355 . . . . 0.0 111.576 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.671 ' HB2' ' O ' ' A' ' 73' ' ' THR . 5.8 p -143.56 150.95 39.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.385 0.612 . . . . 0.0 110.938 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.576 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 26.0 mm-40 -113.39 166.93 11.01 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.793 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.6 p -85.27 106.33 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.457 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 71' ' ' GLU . 5.8 p -115.15 81.37 1.56 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.428 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.632 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 157.44 -30.17 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.708 179.159 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 61.73 103.57 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.511 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.629 HG22 ' HB3' ' A' ' 46' ' ' PHE . 7.6 p -71.21 104.26 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.209 0.528 . . . . 0.0 110.081 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.611 ' H ' HD12 ' A' ' 99' ' ' ILE . 5.3 mp -63.68 127.17 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.032 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.435 ' HA ' ' HB2' ' A' ' 46' ' ' PHE . 6.2 m120 -92.36 145.74 24.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.017 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.527 ' HG2' HG23 ' A' ' 48' ' ' VAL . 3.2 tt0 -84.15 101.56 11.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.867 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.85 99.69 7.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.104 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.913 HG12 HD13 ' A' ' 63' ' ' ILE . 24.6 m -125.38 120.84 59.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.139 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -100.64 131.94 46.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 51' ' ' LYS . 6.4 m -110.53 128.37 66.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.147 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.05 137.74 50.17 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.533 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.637 ' HB3' ' HG3' ' A' ' 52' ' ' GLU . . . -173.52 74.92 0.38 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.817 0.342 . . . . 0.0 111.103 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.59 148.5 59.84 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.526 2.15 . . . . 0.0 112.251 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.436 HG23 ' N ' ' A' ' 110' ' ' THR . 7.3 m -149.97 -47.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.133 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 111' ' ' HIS . 0.2 OUTLIER 60.16 -176.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.453 ' H ' HG22 ' A' ' 110' ' ' THR . 4.5 t-80 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.927 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mmt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.854 0.359 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.47 122.31 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.475 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.4 p -175.43 -66.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.867 0.365 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 m 60.41 31.46 20.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.951 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.2 m80 60.35 -179.15 0.1 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -151.66 79.52 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -120.39 -42.61 2.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.45 81.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.861 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -117.09 168.66 10.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.4 p -59.85 161.81 6.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.58 -170.01 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.929 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 161.81 -28.51 0.28 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.531 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.5 tp -98.75 31.56 2.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.922 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t 59.92 87.88 0.13 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.129 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.77 140.36 42.45 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.699 2.266 . . . . 0.0 112.275 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -79.82 -178.55 6.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.05 52.62 0.64 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.481 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.03 -59.61 1.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 0.0 110.911 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.0 t60 68.49 -68.04 0.19 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.04 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 18.2 ttm -67.97 93.1 0.4 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.912 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -130.98 79.95 1.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.27 165.11 31.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.93 -52.84 24.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.926 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -68.43 157.02 36.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.499 ' HB3' ' HB2' ' A' ' 28' ' ' ALA . 28.0 m-20 -133.98 124.7 26.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.928 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.92 -64.2 0.95 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.1 p -110.44 -31.22 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.071 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.499 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . . . 60.1 96.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.124 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.83 126.8 8.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.097 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -131.85 -73.37 0.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.923 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.439 HG12 ' OG1' ' A' ' 33' ' ' THR . 21.5 t 59.89 85.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.152 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -82.72 78.62 9.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.934 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.439 ' OG1' HG12 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -124.35 176.37 6.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 179.972 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -110.79 130.95 22.39 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.39 -167.04 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.494 2.129 . . . . 0.0 112.237 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -94.85 145.21 25.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.757 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mp -93.65 114.07 26.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.195 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.719 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 44.0 pt -101.03 -176.4 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.817 178.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.908 HG22 ' CD1' ' A' ' 75' ' ' TYR . 1.1 p -151.39 147.04 26.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.236 0.541 . . . . 0.0 111.47 -178.564 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.698 ' HG3' HD13 ' A' ' 76' ' ' ILE . 1.4 mtp85 -161.17 104.54 1.3 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.997 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.552 HG21 ' CD ' ' A' ' 71' ' ' GLU . 15.0 t -82.15 131.44 35.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.617 0.722 . . . . 0.0 111.373 -178.526 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.542 ' O ' HD12 ' A' ' 44' ' ' ILE . 2.1 mt-10 -98.39 144.6 27.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.807 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.408 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 28.8 tt0 -66.67 91.68 0.19 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.695 -179.47 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.8 mp -87.72 109.41 26.59 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.978 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.506 ' C ' HG21 ' A' ' 98' ' ' VAL . 69.6 Cg_endo -88.26 158.18 6.88 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.837 2.358 . . . . 0.0 112.853 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.577 ' HB3' HG22 ' A' ' 98' ' ' VAL . 42.3 p90 -87.27 -174.16 4.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.945 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.42 104.43 2.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.733 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.533 HG23 ' HG2' ' A' ' 101' ' ' GLN . 11.9 p -67.42 143.5 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.189 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 49' ' ' ILE . 4.2 mp -111.82 156.07 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.094 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' N ' HG22 ' A' ' 49' ' ' ILE . 9.7 pttp -108.29 100.91 10.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.828 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.4 ttmp? -112.5 161.78 16.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.927 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -117.71 139.97 50.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.931 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -137.76 132.96 17.55 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.69 -20.28 13.77 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.454 2.103 . . . . 0.0 112.554 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.98 -30.5 59.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.155 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.506 HD22 ' NE2' ' A' ' 60' ' ' GLN . 10.5 mt -81.77 162.35 58.03 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.974 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.14 42.15 1.14 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.209 2.606 . . . . 0.0 112.602 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.67 136.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.872 0.368 . . . . 0.0 111.335 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.66 40.54 88.39 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.687 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.506 ' NE2' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -109.47 145.47 36.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 0.0 110.905 -179.993 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -112.05 117.12 31.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.828 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -130.32 126.06 36.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.991 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.688 HD13 HG22 ' A' ' 103' ' ' VAL . 27.3 mm -101.74 96.37 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.044 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.539 HD12 HG12 ' A' ' 102' ' ' VAL . 35.8 mt -66.2 -31.13 52.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.794 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.644 ' CG2' HG23 ' A' ' 102' ' ' VAL . 6.4 t -163.34 119.26 1.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.71 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.07 125.37 27.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.23 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.0 137.75 48.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.319 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.449 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.8 t -138.61 124.16 23.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.814 0.34 . . . . 0.0 111.084 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.86 119.1 4.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.183 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.447 ' CA ' ' O ' ' A' ' 96' ' ' LYS . . . -88.28 -152.25 24.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.044 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.552 ' CD ' HG21 ' A' ' 41' ' ' THR . 0.2 OUTLIER -161.52 145.94 13.13 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.619 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.591 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 31.1 ttm180 -140.36 110.39 6.52 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.139 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.724 ' O ' ' HB3' ' A' ' 92' ' ' SER . 28.0 m -73.77 125.48 28.2 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.014 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.513 ' HD2' ' O ' ' A' ' 72' ' ' ARG . 4.7 m-70 -105.59 117.53 34.25 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 122.098 0.952 . . . . 0.0 113.259 -176.783 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.908 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -89.44 108.26 19.54 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 113.694 -1.594 . . . . 0.0 111.28 -177.912 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.698 HD13 ' HG3' ' A' ' 40' ' ' ARG . 2.4 mp -95.26 160.76 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.814 -179.625 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.731 ' OG ' HD23 ' A' ' 90' ' ' LEU . 55.9 p -104.69 118.76 37.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.711 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.731 HG23 HG23 ' A' ' 85' ' ' THR . 9.9 p -81.45 108.55 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.155 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -113.05 88.68 2.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.6 m -82.16 117.51 22.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -127.8 107.62 10.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.952 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 60.79 31.85 20.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.843 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.75 43.24 7.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.525 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.9 tptp -143.23 107.51 4.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.793 0.33 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.731 HG23 HG23 ' A' ' 78' ' ' VAL . 24.8 m -85.85 120.06 26.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.92 142.8 31.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.925 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -105.85 95.73 6.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.6 m -123.64 125.1 44.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.064 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.9 m -55.11 145.12 5.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.022 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.731 HD23 ' OG ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -130.09 -51.76 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.171 -179.851 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 1.8 t70 -176.62 137.32 0.26 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.274 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.724 ' HB3' ' O ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -143.66 144.87 32.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.352 0.596 . . . . 0.0 111.306 179.005 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.645 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 3.1 mt-30 -103.47 166.75 10.24 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.582 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 94' ' ' VAL . 8.6 p -85.25 107.01 15.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.803 -179.031 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.517 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 19.3 p -110.51 83.2 1.72 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.22 -179.435 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 95' ' ' THR . 0.1 OUTLIER 103.39 44.78 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.746 -179.636 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.46 ' HB2' HG21 ' A' ' 94' ' ' VAL . 6.1 tp10 -31.31 133.32 0.08 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.313 -179.604 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.577 HG22 ' HB3' ' A' ' 46' ' ' PHE . 10.7 p -71.87 118.89 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.002 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.564 ' H ' HD12 ' A' ' 99' ' ' ILE . 5.3 mp -75.49 108.79 7.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.962 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -71.22 130.87 42.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.533 ' HG2' HG23 ' A' ' 48' ' ' VAL . 29.2 tt0 -68.53 148.0 51.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.644 HG23 ' CG2' ' A' ' 65' ' ' THR . 53.4 t -133.11 100.61 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.007 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.688 HG22 HD13 ' A' ' 63' ' ' ILE . 20.1 t -120.47 133.63 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -110.91 154.89 23.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.78 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.88 138.74 52.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.202 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.7 87.81 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.498 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 60.92 155.5 0.11 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.706 0.289 . . . . 0.0 111.171 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.14 -168.14 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.64 2.226 . . . . 0.0 112.336 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.4 m -124.03 31.53 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.113 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.97 -40.28 6.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 7.1 m170 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.935 179.967 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo . . . . . 0 C--O 1.23 0.094 0 CA-C-O 120.739 0.224 . . . . 0.0 112.245 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.68 142.17 51.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.786 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.96 111.3 23.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.191 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.682 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 6.1 pt -101.18 -177.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.966 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.772 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.7 OUTLIER -145.86 162.26 38.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.357 0.598 . . . . 0.0 111.193 -178.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 26.6 ttt180 -174.01 112.96 0.19 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.051 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 11.1 t -82.19 129.57 34.87 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.817 0.817 . . . . 0.0 111.326 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.477 ' O ' HD12 ' A' ' 44' ' ' ILE . 2.1 mt-10 -98.13 147.72 24.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.002 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -67.08 101.48 0.88 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.028 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 1.9 mp -107.67 87.39 3.5 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.56 ' C ' HG21 ' A' ' 98' ' ' VAL . 73.2 Cg_endo -75.86 160.29 37.44 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.66 2.24 . . . . 0.0 112.688 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.593 ' HB3' HG22 ' A' ' 98' ' ' VAL . 33.5 p90 -87.15 -176.92 5.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.985 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.5 ' OE1' HD13 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -158.43 115.13 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.841 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.713 HG22 ' CB ' ' A' ' 101' ' ' GLN . 3.1 t -67.17 143.83 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.132 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.5 HD13 ' OE1' ' A' ' 47' ' ' GLU . 33.4 mm -115.84 156.19 16.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.118 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.449 ' N ' HG22 ' A' ' 49' ' ' ILE . 13.1 ptmt -108.74 109.57 20.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -119.82 153.21 36.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -87.91 129.5 35.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.971 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.436 ' ND2' HD23 ' A' ' 56' ' ' LEU . 5.8 t-20 -122.17 96.5 46.37 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.09 -23.97 45.45 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.392 2.061 . . . . 0.0 112.333 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -59.69 -28.97 67.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.991 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.546 HD12 ' CD ' ' A' ' 60' ' ' GLN . 3.1 mm? -83.18 165.29 41.7 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.742 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -80.84 43.39 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.076 2.518 . . . . 0.0 112.743 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.88 142.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.939 0.399 . . . . 0.0 111.437 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 55.17 25.85 40.93 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.876 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.546 ' CD ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -109.38 136.84 48.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 0.0 110.979 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -101.2 162.57 12.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.59 ' ND2' HD11 ' A' ' 64' ' ' ILE . 46.2 t30 -156.32 111.85 2.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.86 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.815 HD13 HG12 ' A' ' 103' ' ' VAL . 36.7 mm -85.65 86.12 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.138 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.59 HD11 ' ND2' ' A' ' 62' ' ' ASN . 36.9 mm -64.53 -36.07 76.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.953 0.406 . . . . 0.0 110.712 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.661 HG22 ' HB ' ' A' ' 102' ' ' VAL . 9.7 t -166.56 100.35 0.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.554 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.41 135.02 28.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.753 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.467 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -66.0 134.27 34.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.273 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -130.2 132.21 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.907 0.384 . . . . 0.0 111.3 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.458 ' HD3' ' CD2' ' A' ' 46' ' ' PHE . 10.7 mmtt -57.12 125.96 25.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.229 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.453 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -105.49 -159.55 23.0 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.051 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.497 ' HA ' HD12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -162.47 154.62 18.88 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.587 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 14.0 ttt180 -143.67 111.77 6.22 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.576 ' O ' ' HB2' ' A' ' 92' ' ' SER . 64.2 m -72.99 121.46 20.14 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.569 ' O ' ' HA ' ' A' ' 39' ' ' THR . 18.7 m80 -102.26 120.3 40.24 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.772 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -86.02 122.27 29.82 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.679 -1.601 . . . . 0.0 110.767 -178.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.802 HG23 ' C ' ' A' ' 88' ' ' THR . 4.2 mp -116.14 141.78 32.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.282 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.678 ' HB2' HD13 ' A' ' 90' ' ' LEU . 0.2 OUTLIER -105.24 98.06 7.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.829 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 78' ' ' VAL . 12.5 p -81.45 117.9 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.159 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.562 HD13 ' N ' ' A' ' 80' ' ' THR . 2.4 tm? -105.45 124.33 49.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.562 ' N ' HD13 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -84.78 91.24 7.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.549 ' HB2' HD12 ' A' ' 79' ' ' LEU . 5.1 tt0 -123.16 135.96 54.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.2 m120 61.15 30.49 19.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.87 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.54 47.67 81.52 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.597 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.55 142.7 12.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.774 0.321 . . . . 0.0 110.862 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.449 HG22 HG22 ' A' ' 78' ' ' VAL . 0.8 OUTLIER -102.18 120.79 41.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.889 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 t -105.05 125.86 51.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.866 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.37 107.3 19.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.876 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.802 ' C ' HG23 ' A' ' 76' ' ' ILE . 97.3 m -133.71 112.75 11.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.923 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.56 HG12 HG13 ' A' ' 76' ' ' ILE . 22.3 m -56.61 162.37 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.966 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.678 HD13 ' HB2' ' A' ' 77' ' ' SER . 1.2 mp -149.18 -56.72 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.343 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.509 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 1.4 t70 -140.65 134.73 30.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.479 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.576 ' HB2' ' O ' ' A' ' 73' ' ' THR . 17.8 p -143.21 133.33 24.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.308 0.575 . . . . 0.0 111.319 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.562 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 3.4 pt20 -89.52 166.58 13.58 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 94' ' ' VAL . 5.2 m -85.67 107.3 16.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.564 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 20.0 p -114.22 83.01 1.8 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.192 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.564 ' CB ' ' O ' ' A' ' 95' ' ' THR . 20.2 tptm 107.53 48.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.741 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -33.72 122.24 0.44 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.755 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.593 HG22 ' HB3' ' A' ' 46' ' ' PHE . 12.6 p -71.61 109.89 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.212 0.529 . . . . 0.0 111.052 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 34.8 mm -68.72 116.22 8.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.221 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 20.8 m-20 -81.52 129.33 34.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.726 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.713 ' CB ' HG22 ' A' ' 48' ' ' VAL . 12.8 tt0 -62.09 112.36 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.96 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.661 ' HB ' HG22 ' A' ' 65' ' ' THR . 58.1 t -95.4 99.73 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.954 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.815 HG12 HD13 ' A' ' 63' ' ' ILE . 25.5 m -122.85 135.72 61.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.133 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -119.8 108.5 14.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.735 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.0 t -91.41 142.0 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.069 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.81 147.1 37.63 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.552 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.655 0.264 . . . . 0.0 111.135 -179.922 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 CA--C 1.529 0.253 0 N-CA-C 112.594 0.19 . . . . 12.380000000000001 112.594 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.483 ' O ' HG22 ' A' ' 78' ' ' VAL . 11.1 tp10 -147.71 112.03 5.24 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.284 -0.416 . . . . 13.359999999999999 110.467 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 mp -72.74 111.49 7.94 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.181 -0.463 . . . . 10.56 110.764 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.678 HG13 ' HB ' ' A' ' 76' ' ' ILE . 28.6 pt -99.44 121.0 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-O 121.722 0.772 . . . . 11.619999999999999 109.665 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.699 ' HB ' ' CG2' ' A' ' 73' ' ' THR . 6.3 p -87.13 139.39 30.62 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.018 -0.992 . . . . 10.51 111.111 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 7.1 ttt-85 -155.51 117.98 4.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.807 -1.088 . . . . 12.83 108.914 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 68.4 p -79.81 127.49 32.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.503 0.668 . . . . 9.4100000000000001 110.887 -178.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -96.9 139.41 32.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.639 -1.164 . . . . 8.5199999999999996 109.83 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.86 97.82 0.37 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.962 -0.563 . . . . 10.74 110.691 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.739 HD12 ' H ' ' A' ' 72' ' ' ARG . 7.5 mt -99.19 103.01 17.59 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 115.43 -0.805 . . . . 6.29 109.585 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.627 ' C ' HG21 ' A' ' 98' ' ' VAL . 90.5 Cg_endo -78.24 145.63 21.74 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.316 2.677 . . . . 6.46 114.363 -177.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.548 ' HB2' ' HA ' ' A' ' 100' ' ' ASN . 39.1 p90 -86.73 -179.82 6.63 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.278 -0.874 . . . . 7.25 111.175 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.07 117.19 6.83 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.397 -0.365 . . . . 6.0800000000000001 111.678 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.823 HG13 ' HB3' ' A' ' 101' ' ' GLN . 21.9 t -66.11 134.61 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.039 -0.528 . . . . 6.9900000000000002 111.536 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.9 mm -123.48 139.76 49.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.278 -0.419 . . . . 8.7100000000000009 111.49 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -100.19 108.19 20.23 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.881 -0.6 . . . . 10.390000000000001 110.394 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.95 106.18 16.57 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.079 -0.509 . . . . 12.289999999999999 111.155 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -61.64 105.53 0.55 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.822 0.344 . . . . 14.65 110.524 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 0.8 OUTLIER -108.34 119.82 48.46 Favored Pre-proline 0 C--O 1.232 0.173 0 CA-C-N 116.087 -0.506 . . . . 15.73 111.442 -179.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.56 -24.6 18.64 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.785 2.324 . . . . 18.25 112.371 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -61.76 -39.1 90.45 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.421 -0.354 . . . . 19.329999999999998 111.183 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.503 HD21 ' CB ' ' A' ' 62' ' ' ASN . 1.0 OUTLIER -63.58 164.27 16.49 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.495 -0.32 . . . . 17.219999999999999 110.905 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.77 -74.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.769 2.313 . . . . 17.350000000000001 113.301 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -178.76 122.51 0.09 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.098 -0.955 . . . . 15.789999999999999 111.205 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.21 29.1 62.38 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.189 -0.529 . . . . 13.800000000000001 113.025 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.436 ' O ' HD22 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -106.09 136.69 45.33 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.701 0.25 . . . . 15.460000000000001 110.501 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.26 113.4 25.02 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.888 0.375 . . . . 13.220000000000001 111.335 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.503 ' CB ' HD21 ' A' ' 56' ' ' LEU . 1.5 t-20 -106.22 111.99 24.82 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.893 -0.594 . . . . 14.380000000000001 109.948 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.416 HG12 HG13 ' A' ' 103' ' ' VAL . 24.2 mt -85.58 122.51 38.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.095 0.474 . . . . 13.390000000000001 111.851 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.417 HD11 ' OD1' ' A' ' 62' ' ' ASN . 44.4 mm -100.52 -39.7 7.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.374 -0.83 . . . . 13.85 109.841 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.812 HG22 HG23 ' A' ' 99' ' ' ILE . 0.2 OUTLIER -135.54 99.0 4.08 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.682 -0.69 . . . . 11.74 109.815 179.517 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.4 113.72 1.14 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.02 -0.536 . . . . 10.75 112.074 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 99' ' ' ILE . . . -58.7 109.33 1.95 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.871 -0.604 . . . . 8.4700000000000006 112.314 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.5 t -135.1 144.56 34.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.91 0.386 . . . . 10.08 111.251 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -67.48 116.3 8.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.716 -0.675 . . . . 10.15 111.125 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.491 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -81.96 -171.55 46.18 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.154 -0.546 . . . . 7.4500000000000002 112.107 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.562 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -158.72 109.18 2.05 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.461 -0.57 . . . . 10.039999999999999 109.461 179.499 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.739 ' H ' HD12 ' A' ' 44' ' ' ILE . 36.5 ttm180 -98.18 124.8 42.94 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.554 -0.536 . . . . 6.2699999999999996 109.554 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.699 ' CG2' ' HB ' ' A' ' 39' ' ' THR . 95.1 m -74.76 125.37 28.62 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 107.719 -1.215 . . . . 8.5500000000000007 107.719 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.593 ' HD2' HG23 ' A' ' 89' ' ' VAL . 19.8 m80 -105.66 114.88 29.3 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.927 0.87 . . . . 8.0999999999999996 112.647 -177.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.694 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -80.09 92.47 5.64 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 113.67 -1.605 . . . . 8.0800000000000001 109.086 -178.363 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.678 ' HB ' HG13 ' A' ' 38' ' ' ILE . 74.1 mt -88.16 154.86 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 113.411 -1.722 . . . . 10.77 112.474 -177.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.7 t -105.17 121.35 43.63 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.292 -0.413 . . . . 11.99 110.34 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.505 ' CG1' HD13 ' A' ' 38' ' ' ILE . 3.9 m -81.76 98.23 4.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.05 0.452 . . . . 13.470000000000001 111.351 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.0 mt -103.68 106.85 17.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.967 -0.56 . . . . 15.75 110.209 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 p -73.56 93.88 2.08 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.207 -0.451 . . . . 17.620000000000001 111.194 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -90.74 93.99 9.48 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.994 -0.548 . . . . 20.190000000000001 110.26 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 58.5 45.6 16.2 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.098 -0.501 . . . . 22.510000000000002 110.773 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.76 47.71 6.56 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.108 -0.568 . . . . 21.280000000000001 112.713 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -162.13 108.07 1.27 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.657 0.265 . . . . 21.239999999999998 111.114 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.4 p -75.72 97.74 3.92 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.239 -0.437 . . . . 17.93 110.653 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 58.9 m -77.37 110.25 11.96 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.092 -0.504 . . . . 16.48 110.751 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.51 ' HB2' HG21 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -80.79 96.34 6.94 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.112 0.482 . . . . 14.73 110.636 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 45.1 m -108.79 126.15 52.72 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.959 -0.564 . . . . 13.130000000000001 111.4 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.593 HG23 ' HD2' ' A' ' 74' ' ' HIS . 3.1 p -59.16 134.89 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.066 -0.516 . . . . 10.289999999999999 110.134 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 32.2 mt -137.64 -83.94 0.32 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.147 0.425 . . . . 10.300000000000001 112.147 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.81 122.1 44.4 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.563 0.221 . . . . 8.6099999999999994 111.343 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.649 ' HB2' ' O ' ' A' ' 73' ' ' THR . 1.3 p -145.29 148.94 34.0 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.189 0.519 . . . . 6.4699999999999998 111.656 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.636 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 19.0 mm-40 -108.65 164.64 12.19 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.032 -1.47 . . . . 9.3800000000000008 107.032 176.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.68 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 12.3 p -82.22 112.68 20.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.292 -0.563 . . . . 7.9299999999999997 110.544 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 31.9 p -117.61 72.08 0.83 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.671 0.748 . . . . 8.2699999999999996 110.612 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 149.37 -43.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.07 -1.423 . . . . 11.5 108.826 178.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.445 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 9.3 tp10 64.55 115.32 0.02 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.327 -0.851 . . . . 8.7400000000000002 111.571 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.627 HG21 ' C ' ' A' ' 45' ' ' PRO . 11.1 p -71.21 103.24 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.373 0.606 . . . . 6.0700000000000003 110.107 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.812 HG23 HG22 ' A' ' 65' ' ' THR . 4.5 mp -71.68 118.97 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.424 -0.807 . . . . 9.4299999999999997 110.962 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.548 ' HA ' ' HB2' ' A' ' 46' ' ' PHE . 4.1 m120 -82.69 133.1 35.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.846 -0.615 . . . . 7.9000000000000004 110.102 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.823 ' HB3' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -59.64 98.46 0.05 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.422 -0.354 . . . . 8.7799999999999994 111.032 -179.435 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 76.0 t -90.72 99.11 9.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.862 -0.421 . . . . 10.470000000000001 109.862 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.495 HG22 ' NE2' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -115.01 125.39 72.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.949 -0.569 . . . . 10.33 111.177 -179.102 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 53' ' ' ASN . 17.0 mm-40 -96.52 110.29 22.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.822 -0.627 . . . . 13.720000000000001 110.248 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.7 t -85.98 115.55 27.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.226 -0.443 . . . . 12.91 110.992 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.414 ' HA2' ' HB2' ' A' ' 56' ' ' LEU . . . -61.8 132.02 46.48 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.015 -0.612 . . . . 13.960000000000001 112.721 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.361 0.124 . . . . 15.720000000000001 110.933 179.807 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.849 0.27 . . . . 0.0 112.348 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -169.38 128.05 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.88 131.25 35.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.824 HD12 ' HB ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER -101.12 -177.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.698 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.748 HG22 ' CD1' ' A' ' 75' ' ' TYR . 1.0 OUTLIER -163.31 121.08 1.91 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.113 0.482 . . . . 0.0 110.669 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.45 ' HG3' HD13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -142.56 109.72 5.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.774 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.563 HG21 ' OE1' ' A' ' 71' ' ' GLU . 11.3 t -82.52 128.28 34.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.511 0.672 . . . . 0.0 111.407 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.574 ' O ' HD12 ' A' ' 44' ' ' ILE . 1.3 mt-10 -98.31 146.01 26.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.744 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.77 91.67 0.2 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.803 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.577 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.7 mp -89.62 108.23 23.85 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.885 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.455 ' C ' HG21 ' A' ' 98' ' ' VAL . 1.9 Cg_endo -81.95 157.43 18.07 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.941 2.427 . . . . 0.0 112.596 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.449 ' HB3' ' CG2' ' A' ' 98' ' ' VAL . 42.2 p90 -86.57 -174.4 4.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.74 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.99 116.54 3.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.874 HG22 ' CB ' ' A' ' 101' ' ' GLN . 43.2 t -67.29 148.76 11.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.051 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 50' ' ' LYS . 37.9 mm -123.82 156.16 30.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.013 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.446 ' N ' HG22 ' A' ' 49' ' ' ILE . 1.9 pttp -119.42 100.86 7.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.414 ' O ' HG12 ' A' ' 105' ' ' VAL . 8.1 mttm -105.56 141.72 36.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 3.3 pt-20 -104.79 124.89 50.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -128.67 133.29 25.03 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.12 -20.77 12.61 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.468 2.112 . . . . 0.0 112.541 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -55.06 -38.49 68.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.06 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.552 HD22 ' NE2' ' A' ' 60' ' ' GLN . 21.2 mt -62.82 159.64 43.34 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.763 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -80.24 44.98 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.039 2.493 . . . . 0.0 112.724 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.61 125.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.934 0.397 . . . . 0.0 111.424 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.44 53.63 41.92 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.779 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.552 ' NE2' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -109.46 162.91 13.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.746 0.308 . . . . 0.0 110.894 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -145.16 113.92 6.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -143.12 122.54 13.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.2 mt -86.59 131.18 35.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.09 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.5 mm -99.59 -44.24 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.9 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.6 m -144.28 102.25 3.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.659 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.417 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -53.81 153.4 4.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.483 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.59 131.29 10.32 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.19 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -140.62 136.36 35.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.869 0.366 . . . . 0.0 111.132 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -63.12 124.87 22.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 98' ' ' VAL . . . -97.99 -151.98 27.77 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.888 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.563 ' OE1' HG21 ' A' ' 41' ' ' THR . 0.3 OUTLIER -161.03 148.1 15.19 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.577 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 5.2 ttt180 -140.21 111.22 6.98 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.724 ' O ' ' HB2' ' A' ' 92' ' ' SER . 19.1 m -73.58 126.81 31.11 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.461 ' HA ' ' CB ' ' A' ' 92' ' ' SER . 20.3 m80 -107.55 119.72 40.21 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.042 0.925 . . . . 0.0 112.893 -177.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.748 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.1 OUTLIER -91.15 102.72 15.45 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 113.651 -1.613 . . . . 0.0 111.146 -177.529 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.824 ' HB ' HD12 ' A' ' 38' ' ' ILE . 4.8 mp -87.86 160.15 2.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.952 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.771 ' HB2' HD23 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -98.45 126.8 44.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.685 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.501 HG22 HD11 ' A' ' 38' ' ' ILE . 21.6 t -81.43 109.86 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.254 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.4 mt -115.75 103.53 10.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.841 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.33 123.19 34.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.831 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -129.55 93.09 3.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 61.24 36.24 17.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.964 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.82 46.13 5.22 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.442 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.01 114.64 7.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.812 0.339 . . . . 0.0 110.872 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.85 112.09 23.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.856 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.95 150.73 21.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.96 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.421 ' HA ' HG21 ' A' ' 76' ' ' ILE . 18.9 mt-10 -107.77 99.54 9.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 94.1 m -115.37 116.5 28.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.922 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.1 m -50.01 123.67 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.771 HD23 ' HB2' ' A' ' 77' ' ' SER . 0.2 OUTLIER -110.53 -67.87 0.96 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.216 -179.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.51 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -163.13 141.97 8.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.299 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.724 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.6 p -143.56 151.08 39.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.448 0.642 . . . . 0.0 111.394 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.681 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 12.8 mm-40 -110.01 166.96 10.53 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.598 ' O ' HG13 ' A' ' 94' ' ' VAL . 8.3 p -84.95 106.93 15.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.007 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.585 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 15.4 p -111.82 82.61 1.65 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.76 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.585 ' CB ' ' O ' ' A' ' 95' ' ' THR . 21.0 tttt 109.92 48.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.585 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 96' ' ' LYS . 1.2 pm0 -32.43 125.47 0.31 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.819 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.455 HG21 ' C ' ' A' ' 45' ' ' PRO . 4.3 p -71.7 119.14 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.03 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 66' ' ' ALA . 34.8 mm -70.05 115.96 10.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.919 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -90.36 130.9 36.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.874 ' CB ' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -68.57 127.36 32.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.85 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 102' ' ' VAL . 5.5 m -126.5 99.73 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.188 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 103' ' ' VAL . 11.9 p -108.25 116.53 51.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.015 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -87.1 108.55 18.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 51' ' ' LYS . 12.6 p -98.36 137.73 25.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.5 ' CA ' HD12 ' A' ' 56' ' ' LEU . . . -72.66 130.85 15.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.511 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . . . . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 111.063 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo . . . . . 0 C--O 1.231 0.14 0 CA-C-O 120.788 0.245 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.437 ' HG3' HG12 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -98.01 -179.18 4.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.916 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.1 mt -111.36 115.69 29.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.949 0.404 . . . . 0.0 111.132 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.65 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -101.11 -176.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.525 179.273 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.843 HG22 ' CD1' ' A' ' 75' ' ' TYR . 1.4 p -158.03 140.12 14.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.345 0.593 . . . . 0.0 111.079 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.507 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 33.9 ttp180 -161.23 107.07 1.38 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.02 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.599 HG21 ' CD ' ' A' ' 71' ' ' GLU . 14.8 t -81.93 132.43 35.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.709 0.766 . . . . 0.0 111.706 -178.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.579 ' O ' HD12 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -98.56 144.69 27.6 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.574 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -66.77 91.68 0.2 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.854 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.581 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 3.2 mp -85.19 111.04 33.37 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.783 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.528 ' C ' HG21 ' A' ' 98' ' ' VAL . 81.4 Cg_endo -87.46 153.41 7.81 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.667 2.245 . . . . 0.0 112.849 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.604 ' HB3' HG22 ' A' ' 98' ' ' VAL . 49.9 p90 -87.07 -176.83 5.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.782 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -149.57 112.46 4.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.098 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.718 HG22 ' HB3' ' A' ' 101' ' ' GLN . 16.4 t -67.22 149.23 11.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.031 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.441 HG22 ' N ' ' A' ' 50' ' ' LYS . 33.0 mm -125.79 156.06 35.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.184 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.441 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -119.03 100.93 7.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.778 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.89 137.59 38.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -93.81 102.73 14.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.899 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -102.57 96.56 7.59 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.838 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.65 -18.06 48.11 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.461 2.108 . . . . 0.0 112.488 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -58.16 -31.5 67.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.977 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.729 HD22 ' HG2' ' A' ' 60' ' ' GLN . 11.3 mt -76.07 165.4 53.36 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.799 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -83.9 42.34 1.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.13 2.553 . . . . 0.0 112.606 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.06 150.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.843 0.354 . . . . 0.0 111.314 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 55.2 27.15 45.46 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.616 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.729 ' HG2' HD22 ' A' ' 56' ' ' LEU . 51.7 tp60 -95.49 116.14 28.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 110.907 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -110.91 134.88 52.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.798 ' O ' HG23 ' A' ' 103' ' ' VAL . 25.9 p-10 -151.13 161.9 41.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.9 mm -126.49 95.9 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.101 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.7 mm -72.88 -31.79 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.98 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.9 m -163.42 96.2 0.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.708 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.485 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -53.87 151.77 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.483 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.459 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -93.4 120.89 6.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.33 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.39 133.75 57.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.823 0.344 . . . . 0.0 111.152 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.691 ' HA ' HG23 ' A' ' 98' ' ' VAL . 1.2 mtmp? -59.27 125.74 24.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.156 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.415 ' HA2' ' HG3' ' A' ' 96' ' ' LYS . . . -96.05 -141.01 11.46 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.999 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.599 ' CD ' HG21 ' A' ' 41' ' ' THR . 0.3 OUTLIER -166.71 141.94 4.31 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.815 ' NE ' HG12 ' A' ' 94' ' ' VAL . 22.4 ttm180 -136.11 111.11 8.87 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.736 ' O ' ' HB3' ' A' ' 92' ' ' SER . 32.8 m -73.78 124.92 26.98 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.516 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 8.5 m80 -105.08 117.0 32.91 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 122.082 0.944 . . . . 0.0 113.191 -176.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.843 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.1 OUTLIER -89.55 100.72 13.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 113.611 -1.631 . . . . 0.0 110.98 -178.082 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.504 HG22 ' N ' ' A' ' 77' ' ' SER . 4.5 mp -87.56 161.17 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.281 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.725 ' HB3' HD23 ' A' ' 90' ' ' LEU . 5.3 t -107.82 112.85 25.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.721 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.631 HG13 ' O ' ' A' ' 78' ' ' VAL . 8.8 p -81.54 102.19 7.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.017 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 tp -110.1 108.9 19.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.945 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 80' ' ' THR . 9.9 t -86.0 107.55 17.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.814 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -104.85 93.22 4.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.847 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 60.4 31.14 20.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.83 43.16 3.4 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.561 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 11.4 ttpt -149.16 112.66 5.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.792 0.33 . . . . 0.0 110.891 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.486 HG22 ' CG2' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -100.77 110.42 22.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.855 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.86 132.04 50.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.936 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.76 99.63 11.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.951 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.3 t -113.93 125.47 54.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.927 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.3 m -51.04 115.68 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.094 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.725 HD23 ' HB3' ' A' ' 77' ' ' SER . 0.1 OUTLIER -100.84 -63.42 1.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.533 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -166.04 136.58 3.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.009 -179.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.736 ' HB3' ' O ' ' A' ' 73' ' ' THR . 0.8 OUTLIER -143.59 150.1 38.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.547 0.689 . . . . 0.0 111.576 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.617 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -109.46 166.47 10.86 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.815 HG12 ' NE ' ' A' ' 72' ' ' ARG . 30.9 m -85.23 106.79 15.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.06 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.568 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 16.9 p -110.95 82.56 1.61 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.714 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 95' ' ' THR . 2.5 tppt? 132.4 -39.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.631 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 59.09 121.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.556 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.691 HG23 ' HA ' ' A' ' 69' ' ' LYS . 8.2 p -81.71 114.47 22.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.737 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.592 ' H ' HD12 ' A' ' 99' ' ' ILE . 4.6 mp -75.32 132.18 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -93.72 140.49 29.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.962 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.718 ' HB3' HG22 ' A' ' 48' ' ' VAL . 1.6 tp60 -77.12 114.4 15.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.94 99.7 9.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.046 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 62' ' ' ASN . 11.7 p -121.19 119.56 59.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -93.37 133.16 36.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.839 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.3 m -112.27 123.27 67.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.232 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.77 123.79 19.69 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.449 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 120.767 0.318 . . . . 0.0 111.068 -179.999 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 C--O 1.23 0.097 0 CA-C-O 120.768 0.237 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -168.82 113.73 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.814 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mp -76.95 132.49 39.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.045 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.708 HD12 ' HB ' ' A' ' 76' ' ' ILE . 0.5 OUTLIER -101.26 -177.06 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.783 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.792 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.9 OUTLIER -163.67 123.02 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.178 0.513 . . . . 0.0 110.342 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.609 ' HG3' HD13 ' A' ' 76' ' ' ILE . 2.8 mtm180 -149.6 109.36 4.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.29 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.536 HG21 ' OE1' ' A' ' 71' ' ' GLU . 14.9 t -82.41 133.22 35.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.71 0.767 . . . . 0.0 111.872 -178.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.583 ' O ' HD12 ' A' ' 44' ' ' ILE . 3.0 mt-10 -98.35 147.64 24.47 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.453 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.403 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -66.68 98.32 0.51 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.884 -179.355 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.583 HD12 ' O ' ' A' ' 42' ' ' GLU . 2.9 mp -95.9 105.43 21.28 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.576 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.522 ' C ' HG21 ' A' ' 98' ' ' VAL . 87.7 Cg_endo -84.69 150.36 11.37 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.719 2.279 . . . . 0.0 113.171 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.669 ' HB3' HG22 ' A' ' 98' ' ' VAL . 43.0 p90 -86.87 -175.06 5.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.939 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.67 116.53 5.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.239 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.709 HG22 ' CB ' ' A' ' 101' ' ' GLN . 61.6 t -67.23 149.68 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.122 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.748 HD12 ' O ' ' A' ' 101' ' ' GLN . 4.0 mp -115.65 156.2 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.005 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.44 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.9 OUTLIER -122.92 107.76 12.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -115.25 165.82 12.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.905 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -112.81 138.51 49.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.402 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 6.3 m-20 -138.27 96.52 9.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.921 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 53' ' ' ASN . 37.3 Cg_endo -66.02 -20.8 57.15 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.413 2.075 . . . . 0.0 112.438 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -58.3 -29.63 66.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.994 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.473 HD22 ' NE2' ' A' ' 60' ' ' GLN . 3.5 mt -70.97 165.96 42.4 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.878 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.29 46.79 2.2 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.117 2.545 . . . . 0.0 112.796 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.25 126.48 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.832 0.349 . . . . 0.0 111.641 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 51.67 55.88 18.31 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.928 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.473 ' NE2' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -109.4 144.06 38.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.786 0.327 . . . . 0.0 110.951 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -104.4 130.08 52.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.926 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.525 ' ND2' HD11 ' A' ' 64' ' ' ILE . 48.9 t30 -146.58 127.86 14.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.982 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.858 HD13 HG12 ' A' ' 103' ' ' VAL . 25.0 mm -104.99 90.99 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.034 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.525 HD11 ' ND2' ' A' ' 62' ' ' ASN . 36.6 mm -65.47 -32.67 59.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.549 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.688 HG22 ' HB ' ' A' ' 102' ' ' VAL . 5.3 t -161.38 128.3 3.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.398 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.48 135.37 35.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 111.419 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.43 ' HA3' ' CE2' ' A' ' 46' ' ' PHE . . . -81.98 134.95 13.6 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.308 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.641 ' H ' HG23 ' A' ' 99' ' ' ILE . 16.5 t -145.16 142.95 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 111.088 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.69 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -72.56 119.7 17.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.344 -179.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.436 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -89.84 -139.91 7.79 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.639 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.536 ' OE1' HG21 ' A' ' 41' ' ' THR . 0.9 OUTLIER -169.64 146.91 3.4 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 2.5 ttt180 -134.91 111.67 10.04 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.699 ' O ' ' HB3' ' A' ' 92' ' ' SER . 37.4 m -73.84 126.65 30.88 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.527 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 9.1 m80 -105.82 117.37 33.84 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 122.148 0.975 . . . . 0.0 112.753 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.792 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.1 OUTLIER -90.37 100.1 13.0 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 113.57 -1.65 . . . . 0.0 111.075 -177.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.708 ' HB ' HD12 ' A' ' 38' ' ' ILE . 3.1 mp -87.8 159.9 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.726 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.695 ' HB2' HD22 ' A' ' 90' ' ' LEU . 40.0 t -102.83 126.71 50.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.828 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 78' ' ' VAL . 29.1 m -81.51 106.29 12.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.203 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.71 HD13 ' N ' ' A' ' 80' ' ' THR . 1.7 tm? -112.47 130.99 55.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.943 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.71 ' N ' HD13 ' A' ' 79' ' ' LEU . 0.8 OUTLIER -98.6 135.8 39.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.898 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -152.22 115.65 4.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.826 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.8 m120 60.07 34.96 21.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.966 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.98 29.5 66.89 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.509 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -128.3 165.0 21.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.915 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.03 120.32 41.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.97 151.02 22.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.778 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.27 121.97 40.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 98.9 m -144.79 123.07 12.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.967 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 p -58.21 131.99 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.834 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.695 HD22 ' HB2' ' A' ' 77' ' ' SER . 2.2 tp -116.04 -55.54 2.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.296 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 3.6 t0 -169.45 136.91 1.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.482 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.699 ' HB3' ' O ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -143.66 145.23 32.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.387 0.613 . . . . 0.0 111.261 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.605 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 34.5 mm-40 -106.89 165.86 11.02 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 94' ' ' VAL . 9.0 p -85.88 106.93 15.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.4 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.515 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 9.7 p -111.71 82.11 1.56 Allowed 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.656 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 95' ' ' THR . 0.0 OUTLIER 140.96 -36.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.642 178.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 56.44 115.02 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.821 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.69 HG23 ' HA ' ' A' ' 69' ' ' LYS . 14.9 p -81.49 106.29 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.535 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.641 HG23 ' H ' ' A' ' 68' ' ' VAL . 4.1 tt -79.42 133.01 30.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.304 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.428 ' HA ' ' HB2' ' A' ' 46' ' ' PHE . 27.9 m-20 -92.49 161.75 14.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.888 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.772 ' OE1' HG13 ' A' ' 103' ' ' VAL . 0.8 OUTLIER -96.8 140.54 31.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.688 ' HB ' HG22 ' A' ' 65' ' ' THR . 84.2 t -126.1 118.68 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.988 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.858 HG12 HD13 ' A' ' 63' ' ' ILE . 4.4 m -131.25 145.63 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.0 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -116.18 108.38 16.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.26 110.74 20.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.41 133.28 50.3 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.506 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.637 0.256 . . . . 0.0 111.151 179.969 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.813 0.255 . . . . 0.0 112.228 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -93.75 148.89 21.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.657 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.83 117.23 34.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.11 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.705 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 1.1 pp -101.2 -176.72 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.09 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.857 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -149.66 152.58 35.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.257 0.551 . . . . 0.0 111.025 -179.276 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 74' ' ' HIS . 19.5 ttt-85 -170.05 111.62 0.44 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.003 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 14.9 t -82.16 131.78 35.24 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.828 0.823 . . . . 0.0 111.478 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.505 ' O ' HD12 ' A' ' 44' ' ' ILE . 0.7 OUTLIER -98.15 149.72 22.23 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.871 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -66.95 105.53 1.65 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.059 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.576 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.4 mp -107.73 100.41 34.89 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.867 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.539 ' C ' HG21 ' A' ' 98' ' ' VAL . 2.8 Cg_endo -84.99 156.86 11.44 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.038 2.492 . . . . 0.0 112.581 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.623 ' HB3' HG22 ' A' ' 98' ' ' VAL . 46.5 p90 -87.13 -174.25 4.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.013 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -153.35 109.05 3.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.986 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.572 HG23 ' HG2' ' A' ' 101' ' ' GLN . 10.4 p -67.42 154.06 8.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.196 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.6 mp -124.79 156.15 33.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.045 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -107.27 100.81 10.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.8 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -90.43 147.7 23.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.965 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -107.95 102.97 12.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.538 ' HB2' HD12 ' A' ' 56' ' ' LEU . 2.5 m120 -94.16 102.83 9.07 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.61 -26.91 46.06 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.406 2.071 . . . . 0.0 112.271 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -69.41 -31.48 69.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.572 HD22 ' HB3' ' A' ' 60' ' ' GLN . 21.4 mt -63.59 163.23 21.53 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -86.86 31.0 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.818 2.345 . . . . 0.0 112.948 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 56.85 104.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.266 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 118.25 -25.35 8.29 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.634 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.572 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -70.63 134.9 47.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 0.0 110.868 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -137.96 128.44 26.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.533 ' ND2' HD11 ' A' ' 64' ' ' ILE . 24.6 p-10 -128.14 148.61 50.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.771 HD13 HG12 ' A' ' 103' ' ' VAL . 29.0 mm -97.65 86.33 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.147 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.533 HD11 ' ND2' ' A' ' 62' ' ' ASN . 29.2 mm -62.24 -35.82 71.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.812 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.3 m -164.28 90.98 0.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.629 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.401 ' HB2' HG21 ' A' ' 63' ' ' ILE . . . -52.12 150.97 4.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.52 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.429 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -88.86 134.69 12.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.338 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.405 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.4 t -132.41 132.43 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.856 0.36 . . . . 0.0 111.204 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.0 mttp -56.07 126.2 24.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.184 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' A' ' 96' ' ' LYS . . . -99.81 -157.44 28.47 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.129 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.481 ' HA ' HD12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -159.94 151.4 19.79 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.576 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 36.7 ttt180 -141.9 110.91 6.27 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.633 ' O ' ' HB2' ' A' ' 92' ' ' SER . 96.0 m -73.33 121.24 20.11 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.536 ' O ' ' HA ' ' A' ' 39' ' ' THR . 13.7 m80 -102.94 121.55 42.77 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.795 0.807 . . . . 0.0 113.133 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.857 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -89.55 107.78 19.28 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 113.857 -1.52 . . . . 0.0 111.273 -177.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.675 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.5 mp -98.69 159.24 3.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.896 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.634 ' OG ' HD13 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -115.14 113.47 24.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.867 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 78' ' ' VAL . 11.3 p -81.45 113.15 20.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.13 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.33 107.01 15.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.855 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.6 m -76.46 104.05 6.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.992 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -115.3 108.47 16.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.783 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 60.58 35.3 20.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.98 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.84 47.46 25.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.475 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.89 107.41 3.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.785 0.326 . . . . 0.0 110.877 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 p -79.79 125.22 29.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.3 p -123.67 150.98 43.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.95 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -105.59 113.89 27.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.4 t -123.24 123.25 40.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.944 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.3 m -57.66 129.45 19.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.99 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.634 HD13 ' OG ' ' A' ' 77' ' ' SER . 3.1 tp -119.12 -58.15 1.96 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.15 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.521 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 1.9 t70 -166.29 140.78 4.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.273 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.633 ' HB2' ' O ' ' A' ' 73' ' ' THR . 17.2 p -143.15 149.26 37.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.33 0.586 . . . . 0.0 111.12 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.567 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 7.0 pt20 -105.46 166.88 10.12 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.5 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 26.0 t -85.31 106.6 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.122 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 21.8 p -113.07 83.05 1.76 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.13 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 95' ' ' THR . 0.0 OUTLIER 105.55 48.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.853 -179.662 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -33.63 126.2 0.4 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.853 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.623 HG22 ' HB3' ' A' ' 46' ' ' PHE . 10.0 p -71.76 112.5 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.98 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.599 ' H ' HD12 ' A' ' 99' ' ' ILE . 5.2 mp -72.1 126.79 33.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.021 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -87.32 133.44 33.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.814 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.572 ' HG2' HG23 ' A' ' 48' ' ' VAL . 5.3 tt0 -67.33 150.02 49.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.955 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.24 100.51 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.069 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.771 HG12 HD13 ' A' ' 63' ' ' ILE . 4.0 m -119.08 106.76 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.014 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -94.46 109.86 21.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.5 m -105.27 141.0 21.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.138 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.21 147.7 50.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.535 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 120.712 0.291 . . . . 0.0 111.037 -179.964 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 CA--C 1.526 0.113 0 CA-C-O 120.786 0.244 . . . . 0.0 112.287 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -170.52 128.65 0.82 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.861 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.1 mt -84.09 123.34 29.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.986 0.422 . . . . 0.0 111.069 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.763 HD12 ' N ' ' A' ' 39' ' ' THR . 1.1 pp -101.08 -176.37 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.202 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.852 HG22 ' CD1' ' A' ' 75' ' ' TYR . 1.8 p -157.34 142.8 17.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.318 0.58 . . . . 0.0 110.901 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.589 ' HG2' HD13 ' A' ' 76' ' ' ILE . 2.6 ptp85 -162.59 107.33 1.15 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.206 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.455 ' HB ' ' HA ' ' A' ' 73' ' ' THR . 15.4 t -82.28 129.86 34.96 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.768 0.794 . . . . 0.0 111.604 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.596 ' O ' HD12 ' A' ' 44' ' ' ILE . 0.6 OUTLIER -98.29 146.3 25.8 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.678 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -66.81 94.83 0.33 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.952 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.596 HD12 ' O ' ' A' ' 42' ' ' GLU . 3.2 mp -87.07 109.88 28.53 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.949 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.419 ' C ' HG21 ' A' ' 98' ' ' VAL . 6.3 Cg_exo -78.65 152.91 26.18 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.843 2.362 . . . . 0.0 112.563 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.479 ' HB3' ' CG2' ' A' ' 98' ' ' VAL . 52.6 p90 -86.68 -178.58 6.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -138.83 111.67 7.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.961 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.621 HG13 ' CD ' ' A' ' 101' ' ' GLN . 46.2 t -67.45 141.95 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.079 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.438 HG22 ' N ' ' A' ' 50' ' ' LYS . 27.3 mt -130.42 156.07 42.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.103 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.438 ' N ' HG22 ' A' ' 49' ' ' ILE . 1.6 ptpp? -131.98 100.84 5.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -95.02 171.88 8.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -111.56 139.97 46.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.52 ' ND2' HD13 ' A' ' 56' ' ' LEU . 64.1 t-20 -138.48 110.13 8.15 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.85 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.77 -26.15 38.99 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.409 2.072 . . . . 0.0 112.378 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.74 -32.91 71.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.561 HD23 ' HB3' ' A' ' 60' ' ' GLN . 9.1 mp -65.17 165.13 18.17 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.877 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -86.95 32.17 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.914 2.409 . . . . 0.0 112.808 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.86 142.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.874 0.368 . . . . 0.0 111.167 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.42 27.82 61.28 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.561 ' HB3' HD23 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -109.03 141.91 40.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.747 0.308 . . . . 0.0 110.951 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -136.81 124.73 22.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.904 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.818 ' ND2' HD11 ' A' ' 64' ' ' ILE . 15.7 p-10 -130.55 142.08 50.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.585 HD13 HG22 ' A' ' 103' ' ' VAL . 30.9 mm -94.23 94.34 4.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.097 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.818 HD11 ' ND2' ' A' ' 62' ' ' ASN . 21.1 mm -73.63 -32.86 37.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.824 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 m -164.62 84.96 0.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.6 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.476 ' HB2' HG21 ' A' ' 63' ' ' ILE . . . -51.38 132.63 29.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.505 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.45 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -59.68 131.26 50.77 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.327 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 66' ' ' ALA . 21.5 t -130.66 135.52 60.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.389 . . . . 0.0 111.115 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.6 mttp -61.36 116.81 4.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.139 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.468 ' HA3' ' HA ' ' A' ' 98' ' ' VAL . . . -88.46 -149.22 18.44 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.871 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.49 ' CB ' ' HB3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -163.23 146.31 10.45 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.314 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.595 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 19.0 ttp85 -139.67 111.35 7.25 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.737 ' O ' ' HB2' ' A' ' 92' ' ' SER . 91.3 m -73.41 125.16 27.25 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.695 ' HD2' HG21 ' A' ' 89' ' ' VAL . 13.9 m80 -106.14 119.05 38.22 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 122.185 0.993 . . . . 0.0 113.1 -176.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.852 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.1 OUTLIER -90.34 98.85 12.02 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 113.437 -1.71 . . . . 0.0 111.459 -177.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.4 mp -87.56 143.45 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.027 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.813 ' CB ' HD21 ' A' ' 90' ' ' LEU . 25.3 m -89.72 122.26 32.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.708 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.58 HG13 ' CG2' ' A' ' 85' ' ' THR . 21.6 t -81.35 98.35 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.111 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.3 tp -112.21 126.51 55.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.863 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 m -89.06 119.58 29.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.93 95.54 4.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.852 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 60.38 36.41 20.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.851 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.82 28.43 26.32 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.426 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.7 127.11 36.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.795 0.331 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.58 ' CG2' HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -85.15 102.39 13.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -68.63 135.85 52.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.403 ' HA ' HG21 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -115.62 84.9 2.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.548 ' N ' HG23 ' A' ' 76' ' ' ILE . 88.0 m -132.7 130.23 39.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.884 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.695 HG21 ' HD2' ' A' ' 74' ' ' HIS . 12.8 p -85.39 140.37 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.813 HD21 ' CB ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -132.29 2.15 3.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.862 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.464 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.3 OUTLIER 179.96 117.87 0.05 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.9 0.381 . . . . 0.0 111.785 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.737 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.9 p -143.24 134.59 26.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.232 0.539 . . . . 0.0 110.708 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.636 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 5.3 mt-30 -89.72 166.5 13.54 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.43 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 22.9 t -85.5 107.48 16.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.925 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 20.3 p -111.2 82.95 1.68 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.024 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 95' ' ' THR . 7.9 tptm 103.48 41.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.614 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.413 ' CB ' HG11 ' A' ' 94' ' ' VAL . 6.6 tm-20 -29.18 130.54 0.07 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.134 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.479 ' CG2' ' HB3' ' A' ' 46' ' ' PHE . 4.9 p -71.76 126.02 31.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.164 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 29.7 mm -88.33 129.68 39.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.055 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -91.95 146.71 23.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.815 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.621 ' CD ' HG13 ' A' ' 48' ' ' VAL . 0.3 OUTLIER -60.34 139.39 57.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.917 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.4 t -127.67 99.69 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.084 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.796 HG13 ' O ' ' A' ' 62' ' ' ASN . 21.6 t -133.22 137.43 53.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -104.56 132.26 51.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.79 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.48 120.43 53.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.133 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.32 119.34 9.32 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.416 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.724 0.297 . . . . 0.0 111.064 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.783 0.243 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -164.14 123.74 2.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.855 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 71.4 mt -95.5 124.36 39.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 111.126 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.608 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 5.0 pt -101.01 -177.38 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.654 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.759 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.7 OUTLIER -156.9 154.6 30.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.538 0.685 . . . . 0.0 111.809 -179.081 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.75 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 54.8 ttp180 -170.97 120.32 0.53 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 5.6 t -81.78 140.53 34.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.999 0.904 . . . . 0.0 112.68 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.468 ' HG2' ' CD2' ' A' ' 74' ' ' HIS . 6.8 mm-40 -98.66 139.27 34.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.123 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.417 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -66.97 91.59 0.21 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.966 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.844 HD12 ' H ' ' A' ' 72' ' ' ARG . 6.7 mt -96.11 104.7 17.92 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.986 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.546 ' C ' HG21 ' A' ' 98' ' ' VAL . 80.1 Cg_endo -84.78 160.5 12.14 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.785 2.323 . . . . 0.0 113.248 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.598 ' HB3' HG22 ' A' ' 98' ' ' VAL . 54.1 p90 -87.15 -174.13 4.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.081 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -152.78 110.26 3.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.842 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.83 HG22 ' CB ' ' A' ' 101' ' ' GLN . 20.3 t -67.01 148.05 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.17 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 50' ' ' LYS . 5.5 mt -124.02 156.18 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.152 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.44 ' N ' HG22 ' A' ' 49' ' ' ILE . 20.2 tttp -122.96 100.82 7.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.841 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.9 162.97 13.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -94.63 114.51 26.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.906 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.401 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 6.4 t-20 -100.91 96.47 5.66 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 53' ' ' ASN . 37.6 Cg_endo -66.2 -26.75 49.25 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.475 2.117 . . . . 0.0 112.288 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -66.86 -31.22 71.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.92 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 60' ' ' GLN . 18.3 mt -74.64 163.32 69.07 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -86.83 31.47 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.888 2.392 . . . . 0.0 112.923 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.15 122.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.83 0.348 . . . . 0.0 111.26 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.19 -26.69 19.99 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.582 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.455 ' HB3' HD13 ' A' ' 56' ' ' LEU . 1.3 tm0? -66.78 136.4 55.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 0.0 110.871 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -129.34 114.27 16.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.816 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -109.25 130.06 55.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.896 HD13 HG12 ' A' ' 103' ' ' VAL . 31.2 mm -92.2 86.11 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.823 HD13 HG12 ' A' ' 102' ' ' VAL . 3.3 mp -65.3 -44.06 94.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.956 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.429 ' HB ' HG23 ' A' ' 102' ' ' VAL . 25.8 m -151.95 93.79 1.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.599 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -51.18 144.02 10.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.567 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.486 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -77.01 127.6 8.54 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.424 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.46 125.61 37.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.879 0.371 . . . . 0.0 110.985 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.455 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -60.68 113.48 2.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.354 -179.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.492 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -78.8 -146.06 3.17 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.637 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.599 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.1 OUTLIER -177.56 109.88 0.07 Allowed 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.844 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.9 OUTLIER -102.84 138.42 39.75 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.226 -179.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.668 ' O ' ' HB3' ' A' ' 92' ' ' SER . 87.7 m -75.6 140.51 42.68 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.525 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.75 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 2.0 m-70 -118.94 118.42 31.47 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.541 0.686 . . . . 0.0 112.082 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.759 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -91.23 118.82 30.79 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.203 -177.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.691 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.5 mp -108.69 160.3 7.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.962 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.742 ' HB2' HD23 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -101.78 127.37 48.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.895 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.459 HG22 HD13 ' A' ' 38' ' ' ILE . 21.4 t -99.28 98.36 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.3 mt -112.64 111.85 22.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.899 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.62 96.6 6.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -113.72 122.31 46.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.954 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 60.46 34.81 20.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.15 42.34 67.46 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.486 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.87 141.04 17.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.344 . . . . 0.0 110.875 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.37 112.89 25.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.941 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.83 122.98 38.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.839 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -86.66 89.13 7.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.83 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.3 t -103.15 132.75 49.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.934 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.3 m -52.32 124.87 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.121 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.742 HD23 ' HB2' ' A' ' 77' ' ' SER . 0.2 OUTLIER -111.06 -66.83 1.04 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.062 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.515 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -170.87 143.51 2.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.283 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.708 ' HG ' ' CE1' ' A' ' 74' ' ' HIS . 1.0 OUTLIER -143.4 165.29 27.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.407 0.623 . . . . 0.0 110.846 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.603 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 8.1 pt20 -129.31 166.84 18.69 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.096 -0.957 . . . . 0.0 108.661 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.815 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.1 p -85.69 106.84 15.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.599 ' O ' ' O ' ' A' ' 71' ' ' GLU . 7.2 p -117.12 81.0 1.57 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.35 0.595 . . . . 0.0 110.652 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 71' ' ' GLU . 3.1 tptm 149.44 -30.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.273 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 58.35 107.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.818 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.598 HG22 ' HB3' ' A' ' 46' ' ' PHE . 6.8 p -71.48 109.76 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.029 0.442 . . . . 0.0 110.085 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.441 HG22 ' O ' ' A' ' 66' ' ' ALA . 39.3 mm -63.98 123.69 17.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.853 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -91.93 135.62 33.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.886 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.83 ' CB ' HG22 ' A' ' 48' ' ' VAL . 1.8 tt0 -68.5 99.38 0.96 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.823 HG12 HD13 ' A' ' 64' ' ' ILE . 21.8 t -91.68 99.75 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.009 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.896 HG12 HD13 ' A' ' 63' ' ' ILE . 29.4 m -128.48 127.21 66.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.162 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -108.68 108.49 19.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.811 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.38 142.54 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.134 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.52 142.15 43.61 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.522 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.702 0.287 . . . . 0.0 111.057 179.998 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.927 0.303 . . . . 0.0 112.265 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -81.01 -179.07 7.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.771 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mp -104.4 113.92 27.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.058 0.456 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.695 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -101.3 -176.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.815 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.493 HG22 ' CD1' ' A' ' 75' ' ' TYR . 1.2 p -152.57 139.78 19.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.207 0.527 . . . . 0.0 110.892 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 17.5 tpt180 -158.65 102.94 1.72 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.085 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 8.0 t -81.96 129.23 34.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.571 0.701 . . . . 0.0 111.496 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.586 ' O ' HD12 ' A' ' 44' ' ' ILE . 0.6 OUTLIER -98.46 144.18 28.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.941 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.97 91.68 0.21 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.638 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.586 HD12 ' O ' ' A' ' 42' ' ' GLU . 3.0 mp -87.2 110.17 31.28 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.03 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.51 ' C ' HG21 ' A' ' 98' ' ' VAL . 83.8 Cg_endo -86.03 153.68 9.75 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.725 2.283 . . . . 0.0 112.751 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.591 ' HB3' HG22 ' A' ' 98' ' ' VAL . 42.7 p90 -87.17 -174.27 4.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.846 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -159.04 118.42 3.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.936 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.472 HG23 ' NE2' ' A' ' 101' ' ' GLN . 9.0 p -67.49 152.53 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.013 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.1 mp -130.66 156.16 42.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.13 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.44 ' N ' HG22 ' A' ' 49' ' ' ILE . 12.3 mmtm -128.25 100.86 6.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -101.86 170.35 8.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 1.7 mm-40 -109.62 120.34 42.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.954 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.63 HD21 HD22 ' A' ' 56' ' ' LEU . 1.7 p-10 -114.16 96.39 42.08 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.843 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.36 60.42 2.59 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.51 2.14 . . . . 0.0 112.408 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.58 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -160.92 27.23 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.026 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.655 HD23 ' HB3' ' A' ' 60' ' ' GLN . 3.5 mp -130.55 176.53 2.8 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.776 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.27 30.22 0.53 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.176 2.584 . . . . 0.0 112.869 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.2 136.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.91 0.386 . . . . 0.0 111.484 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.9 29.33 67.51 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.734 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.655 ' HB3' HD23 ' A' ' 56' ' ' LEU . 42.9 tp60 -109.39 112.07 23.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.799 0.333 . . . . 0.0 110.762 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.56 143.41 33.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.972 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -135.72 130.05 33.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.0 mm -85.68 86.12 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.164 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.575 HD11 ' HG3' ' A' ' 104' ' ' GLU . 28.6 mt -71.2 -43.46 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.408 ' HB ' HG22 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -149.07 91.93 1.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.613 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.85 154.47 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.522 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.416 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -84.74 129.63 9.33 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.414 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.45 126.96 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.761 0.315 . . . . 0.0 111.075 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.681 ' HA ' HG23 ' A' ' 98' ' ' VAL . 15.0 mtmt -57.37 127.95 34.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.146 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.435 ' HA2' ' HG3' ' A' ' 96' ' ' LYS . . . -101.97 -143.44 13.52 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.079 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.535 ' N ' ' HB3' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -166.97 144.05 4.67 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.593 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 42.1 ttt180 -135.98 111.52 9.25 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.699 ' O ' ' HB2' ' A' ' 92' ' ' SER . 62.0 m -73.84 126.82 31.27 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.524 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 13.3 m80 -107.21 119.87 40.56 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 122.068 0.937 . . . . 0.0 112.921 -176.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.695 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -91.36 99.59 12.52 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 113.541 -1.663 . . . . 0.0 111.391 -177.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.666 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.5 mp -87.58 159.71 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.847 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.755 ' OG ' HD23 ' A' ' 90' ' ' LEU . 77.6 p -108.53 105.38 14.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.775 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.468 ' O ' HG23 ' A' ' 78' ' ' VAL . 8.8 m -81.43 98.33 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.225 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.6 tt -108.08 116.4 31.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 80' ' ' THR . 10.7 t -81.9 112.17 18.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.936 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -116.05 113.27 22.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 60.17 31.83 20.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.894 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.82 44.54 10.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.432 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.77 119.7 4.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.773 0.32 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.84 123.03 32.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.4 150.16 29.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.852 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -97.52 113.8 25.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 94.8 m -133.59 118.05 17.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.931 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 89' ' ' VAL . 10.9 p -54.03 125.37 8.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.978 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.755 HD23 ' OG ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -107.83 -53.46 2.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.267 -179.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.521 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -176.68 141.01 0.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.316 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.699 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.6 p -143.67 150.99 39.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.367 0.603 . . . . 0.0 111.32 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.635 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 23.1 mm-40 -110.74 166.53 10.94 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.522 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 6.2 m -85.26 106.64 15.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.054 -178.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.568 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 15.9 p -110.72 82.6 1.62 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.689 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 95' ' ' THR . 26.2 tptp 131.92 -26.96 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.015 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 96' ' ' LYS . 17.9 pt-20 44.56 111.47 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.681 HG23 ' HA ' ' A' ' 69' ' ' LYS . 8.2 p -71.88 115.77 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.874 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.5 mm -74.04 128.96 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.068 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -95.14 139.41 31.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.978 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.472 ' NE2' HG23 ' A' ' 48' ' ' VAL . 0.6 OUTLIER -77.63 100.34 6.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.817 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.408 HG22 ' HB ' ' A' ' 65' ' ' THR . 5.4 m -100.59 109.28 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 103' ' ' VAL . 11.0 p -123.19 118.38 54.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.575 ' HG3' HD11 ' A' ' 64' ' ' ILE . 2.4 mm-40 -87.16 121.01 29.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.832 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.95 128.51 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.209 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.62 130.64 50.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.503 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 52' ' ' GLU . . . . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.626 0.251 . . . . 0.0 111.008 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo . . . . . 0 N--CA 1.461 -0.409 0 CA-C-O 120.809 0.254 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.57 129.65 36.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.817 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mt -74.21 114.98 13.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.09 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.677 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -101.38 -176.57 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.095 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.517 ' HB ' ' CG2' ' A' ' 73' ' ' THR . 1.4 p -152.19 136.73 16.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.226 0.536 . . . . 0.0 111.223 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.554 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 10.0 mmm-85 -150.1 103.13 3.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.403 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.652 HG23 ' N ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -82.17 124.8 30.21 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.602 0.715 . . . . 0.0 111.163 -178.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.555 ' O ' HD12 ' A' ' 44' ' ' ILE . 3.4 mt-10 -98.29 147.94 24.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.958 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -66.92 101.42 0.84 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.83 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.563 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.4 mp -106.66 91.42 6.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.847 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.687 ' C ' HG21 ' A' ' 98' ' ' VAL . 97.9 Cg_endo -78.49 161.83 28.05 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.74 2.294 . . . . 0.0 112.799 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.546 ' HB3' HG22 ' A' ' 98' ' ' VAL . 49.5 p90 -87.37 176.62 7.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.147 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -147.24 109.38 4.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.971 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.786 HG22 ' CB ' ' A' ' 101' ' ' GLN . 11.6 t -67.13 153.95 8.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.073 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.5 mp -124.94 156.14 33.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.122 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.46 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -125.11 100.81 6.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.831 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.1 mtmt -97.7 171.87 8.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.945 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -109.88 104.77 13.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.578 ' ND2' HD22 ' A' ' 56' ' ' LEU . 2.0 p-10 -110.31 96.51 26.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.78 -18.7 53.26 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.492 2.128 . . . . 0.0 112.593 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.544 ' OD1' HD13 ' A' ' 56' ' ' LEU . 16.1 p30 -54.78 -29.74 54.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.882 0.372 . . . . 0.0 111.008 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.818 HD23 ' HB3' ' A' ' 60' ' ' GLN . 6.2 mp -83.24 175.06 5.12 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.741 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -82.55 28.33 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.094 2.529 . . . . 0.0 112.979 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.1 123.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.883 0.373 . . . . 0.0 111.55 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.18 -23.28 32.28 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.83 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.818 ' HB3' HD23 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -71.47 123.54 22.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.879 0.371 . . . . 0.0 110.956 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.87 ' HG3' HG13 ' A' ' 105' ' ' VAL . 2.5 mp0 -114.44 115.85 27.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.613 ' OD1' HD21 ' A' ' 56' ' ' LEU . 4.8 p-10 -119.04 123.96 45.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.836 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.559 HG23 HG22 ' A' ' 103' ' ' VAL . 22.1 mt -85.76 131.42 34.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.019 0.437 . . . . 0.0 111.115 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.8 mm -94.07 -46.78 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.767 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.772 HG22 ' HB ' ' A' ' 102' ' ' VAL . 15.3 t -149.13 97.85 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.516 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.19 126.64 7.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.815 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.451 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -66.25 132.35 33.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.168 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.421 ' HB ' HD13 ' A' ' 99' ' ' ILE . 22.7 t -131.22 138.83 52.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.954 0.407 . . . . 0.0 111.065 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.612 ' HA ' HG23 ' A' ' 98' ' ' VAL . 8.0 mptt -66.27 130.8 44.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.406 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.403 ' N ' ' HA ' ' A' ' 98' ' ' VAL . . . -109.42 -148.99 12.83 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.47 ' N ' ' CB ' ' A' ' 96' ' ' LYS . 0.6 OUTLIER -166.69 156.71 11.61 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.595 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 4.8 ttt180 -140.14 112.49 7.8 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.693 ' O ' ' HB3' ' A' ' 92' ' ' SER . 86.3 m -73.85 127.32 32.54 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.554 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 20.8 m80 -106.26 117.26 33.59 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.261 1.029 . . . . 0.0 113.055 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.677 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -89.12 102.14 14.8 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 113.433 -1.712 . . . . 0.0 110.921 -177.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.634 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.5 mp -87.66 160.7 2.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.891 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.642 ' OG ' HD22 ' A' ' 90' ' ' LEU . 74.9 m -110.62 127.89 55.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.834 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.38 103.72 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.196 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mt -125.06 88.66 2.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.818 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.22 146.2 39.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.846 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -153.97 126.89 8.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.908 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 60.4 35.9 20.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.956 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.28 48.69 57.17 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.531 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.7 ttpt -159.69 107.5 1.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.837 0.351 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.81 129.9 37.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.5 m -115.39 151.06 35.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.54 112.75 23.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 96.7 m -133.99 126.65 30.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.901 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.0 p -55.61 148.96 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.991 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.642 HD22 ' OG ' ' A' ' 77' ' ' SER . 0.3 OUTLIER -137.86 -50.89 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.26 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.524 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -158.3 126.63 5.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.321 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.693 ' HB3' ' O ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -143.4 144.25 31.97 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.4 0.619 . . . . 0.0 111.417 179.133 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.595 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 5.4 mt-30 -106.25 165.46 11.23 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 94' ' ' VAL . 8.8 p -86.15 106.63 15.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.473 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.476 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 7.2 p -111.71 82.01 1.55 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.568 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' A' ' 95' ' ' THR . 0.0 OUTLIER 148.29 -33.39 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.296 179.087 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.431 ' H ' HG22 ' A' ' 94' ' ' VAL . 1.5 tt0 53.33 109.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.892 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.687 HG21 ' C ' ' A' ' 45' ' ' PRO . 9.4 p -80.7 102.75 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.481 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.576 ' H ' HD12 ' A' ' 99' ' ' ILE . 5.2 mp -64.35 123.92 18.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.056 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.413 ' HA ' ' HB2' ' A' ' 46' ' ' PHE . 3.2 m-20 -89.44 133.85 34.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.673 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.786 ' CB ' HG22 ' A' ' 48' ' ' VAL . 5.4 tt0 -67.05 125.33 25.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.948 0.404 . . . . 0.0 110.98 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.772 ' HB ' HG22 ' A' ' 65' ' ' THR . 60.9 t -113.37 99.71 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.678 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.559 HG22 HG23 ' A' ' 63' ' ' ILE . 21.8 t -125.68 154.71 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.405 ' N ' HG12 ' A' ' 103' ' ' VAL . 2.5 mt-10 -133.22 108.36 8.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.77 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.87 HG13 ' HG3' ' A' ' 61' ' ' GLU . 21.8 t -101.04 136.56 32.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.172 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.03 148.6 35.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.489 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.721 0.296 . . . . 0.0 111.206 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo . . . . . 0 C--O 1.231 0.161 0 CA-C-O 120.783 0.243 . . . . 0.0 112.399 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -170.65 147.18 2.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.79 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.5 mp -104.36 116.59 32.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.95 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.568 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 5.7 pt -101.27 -177.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.363 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.732 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -158.58 154.48 26.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.372 0.606 . . . . 0.0 111.077 -179.209 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.548 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 13.1 ttm180 -169.26 126.08 0.92 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.646 HG22 ' CA ' ' A' ' 73' ' ' THR . 16.1 p -81.89 136.08 35.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 122.006 0.908 . . . . 0.0 112.547 -177.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HG2' ' ND1' ' A' ' 74' ' ' HIS . 9.3 mm-40 -98.23 142.61 29.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.097 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.405 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -66.78 94.21 0.3 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.671 -179.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.91 HD12 ' H ' ' A' ' 72' ' ' ARG . 6.9 mt -101.66 98.02 8.84 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.777 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.484 ' C ' HG21 ' A' ' 98' ' ' VAL . 95.8 Cg_endo -78.51 157.81 28.83 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.772 2.315 . . . . 0.0 113.176 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.682 ' HB3' HG22 ' A' ' 98' ' ' VAL . 45.6 p90 -86.87 -173.93 4.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.105 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.43 102.95 4.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.756 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.71 HG23 ' HG3' ' A' ' 101' ' ' GLN . 8.8 p -66.93 146.47 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.148 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 48' ' ' VAL . 34.2 mm -125.19 156.19 34.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.179 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.445 ' N ' HG22 ' A' ' 49' ' ' ILE . 7.4 mptt -120.42 100.86 7.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.767 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.63 145.13 24.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -114.73 102.61 10.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.781 ' ND2' HD13 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -117.44 140.09 26.95 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.913 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -78.13 -19.88 11.81 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.601 2.201 . . . . 0.0 112.538 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -52.34 -30.26 27.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.116 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.781 HD13 ' ND2' ' A' ' 53' ' ' ASN . 11.2 mp -82.7 169.1 19.09 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.798 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.19 31.23 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.316 2.678 . . . . 0.0 112.874 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 63.18 138.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.899 0.38 . . . . 0.0 111.279 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.02 36.35 80.78 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.603 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.704 ' HB3' HD23 ' A' ' 56' ' ' LEU . 60.1 tp60 -109.51 145.65 35.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.878 0.37 . . . . 0.0 110.935 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.7 113.94 19.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.821 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -118.87 119.12 33.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.928 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.1 mm -85.71 92.76 3.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.722 HD11 ' HG3' ' A' ' 104' ' ' GLU . 21.7 mt -76.55 -44.9 34.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.88 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.54 91.49 1.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.801 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.487 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -46.9 143.18 3.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.791 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.458 ' HA3' ' CE2' ' A' ' 46' ' ' PHE . . . -91.31 129.63 9.9 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.248 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.0 131.11 41.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.966 0.412 . . . . 0.0 111.156 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.522 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -64.12 112.78 3.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.159 -179.647 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.525 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -75.55 -144.29 1.24 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.762 -0.733 . . . . 0.0 111.717 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.68 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 7.7 tt0 -177.55 109.29 0.07 Allowed 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.91 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -98.4 138.43 35.65 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.229 0.538 . . . . 0.0 110.448 -179.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.646 ' CA ' HG22 ' A' ' 41' ' ' THR . 52.0 m -75.55 135.81 40.58 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.729 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.659 ' O ' ' HA ' ' A' ' 39' ' ' THR . 6.5 m80 -116.08 121.83 43.34 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.74 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.732 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -91.93 113.34 25.59 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.772 -178.095 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.695 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.1 mp -97.13 143.56 12.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.02 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.9 t -96.01 105.53 17.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.78 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.764 ' CG1' HG22 ' A' ' 85' ' ' THR . 21.4 t -81.55 105.27 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.9 tp -97.11 88.66 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.844 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.58 123.66 21.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.965 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -143.65 105.92 4.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 65.16 26.88 12.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.094 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.78 41.44 7.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.819 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.591 ' HD2' HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -140.54 122.72 15.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.908 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.764 HG22 ' CG1' ' A' ' 78' ' ' VAL . 1.2 p -101.26 105.5 16.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.591 HG23 ' HD2' ' A' ' 84' ' ' LYS . 27.8 p -87.11 99.88 12.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.476 ' HG3' HG21 ' A' ' 76' ' ' ILE . 2.6 tt0 -74.8 98.75 3.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 76' ' ' ILE . 92.1 m -129.66 125.36 35.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 p -51.18 136.84 10.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.022 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -125.6 -72.66 0.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.343 -179.716 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.493 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 3.6 t0 -137.96 138.2 38.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.349 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.565 ' HB2' ' O ' ' A' ' 73' ' ' THR . 29.0 p -143.24 165.62 26.95 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.66 0.743 . . . . 0.0 111.395 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.665 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 36.0 mm-40 -130.03 166.45 20.1 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.153 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.791 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 17.2 t -86.2 105.75 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.554 ' O ' ' O ' ' A' ' 71' ' ' GLU . 11.6 p -121.43 80.97 1.73 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.551 0.691 . . . . 0.0 110.889 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.68 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 155.3 -31.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.731 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 62.4 101.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.819 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.682 HG22 ' HB3' ' A' ' 46' ' ' PHE . 6.6 p -71.43 103.75 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.144 0.497 . . . . 0.0 110.12 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 66' ' ' ALA . 32.9 mm -63.92 131.05 29.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.222 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 46' ' ' PHE . 3.6 m-20 -98.86 139.67 34.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.002 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.71 ' HG3' HG23 ' A' ' 48' ' ' VAL . 3.0 tp-100 -75.04 103.92 5.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.921 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.29 99.73 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.985 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.1 p -123.12 148.37 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.194 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.722 ' HG3' HD11 ' A' ' 64' ' ' ILE . 22.6 mt-10 -111.17 142.02 43.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.816 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.32 136.56 57.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.141 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -73.87 102.05 1.28 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.468 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.75 0.31 . . . . 0.0 111.141 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.568 ' HD3' HD23 ' A' ' 79' ' ' LEU . 57.6 Cg_endo . . . . . 0 N--CA 1.465 -0.195 0 CA-C-O 120.775 0.24 . . . . 0.0 112.301 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -73.86 168.25 19.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.9 mt -92.52 106.37 18.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.963 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.773 HD12 ' N ' ' A' ' 39' ' ' THR . 1.0 OUTLIER -101.3 -176.49 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.445 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.773 ' N ' HD12 ' A' ' 38' ' ' ILE . 1.0 OUTLIER -152.41 147.85 26.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.281 0.562 . . . . 0.0 110.729 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 74' ' ' HIS . 16.9 ttp180 -164.18 100.62 0.85 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.893 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 15.2 t -81.93 132.19 35.26 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.831 0.824 . . . . 0.0 111.364 -178.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -98.11 145.17 26.83 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.149 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.403 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -66.22 99.11 0.5 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.337 -179.561 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.752 HD12 ' N ' ' A' ' 72' ' ' ARG . 6.4 mt -105.09 92.6 5.56 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.302 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.76 ' C ' HG21 ' A' ' 98' ' ' VAL . 94.1 Cg_endo -78.32 164.37 26.65 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.818 2.345 . . . . 0.0 112.855 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.466 ' CD1' ' HA3' ' A' ' 67' ' ' GLY . 35.2 p90 -87.28 175.04 8.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.102 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -143.04 108.85 5.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.995 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.768 HG22 ' CB ' ' A' ' 101' ' ' GLN . 10.3 t -67.1 154.05 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.22 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.1 mp -140.71 156.09 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.069 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' N ' HG22 ' A' ' 49' ' ' ILE . 23.0 mttt -110.35 108.62 18.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.98 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.92 118.06 35.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.953 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -77.09 104.69 7.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.985 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.444 ' HB2' HD12 ' A' ' 56' ' ' LEU . 30.3 m-20 -106.12 139.79 20.63 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.11 -29.21 6.75 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.58 2.187 . . . . 0.0 112.406 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -57.54 -44.14 84.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.565 HD11 ' O ' ' A' ' 104' ' ' GLU . 5.2 mt -59.76 168.28 2.07 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.93 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -86.31 30.12 0.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.268 2.645 . . . . 0.0 112.69 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 57.73 105.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 0.0 111.315 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.85 -24.18 27.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.784 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.55 144.06 28.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.868 0.366 . . . . 0.0 110.973 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.813 ' HG3' HG23 ' A' ' 105' ' ' VAL . 1.5 mp0 -124.08 173.7 8.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.818 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.723 ' ND2' HD11 ' A' ' 64' ' ' ILE . 49.8 p30 -154.84 147.75 24.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.9 mm -97.76 86.08 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.106 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.723 HD11 ' ND2' ' A' ' 62' ' ' ASN . 24.4 mm -74.36 -32.74 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.964 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.479 ' HB ' HG23 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -161.74 83.83 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.523 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.54 151.64 0.54 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.718 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.466 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -79.43 132.57 11.54 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.192 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.9 t -124.51 131.67 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.844 0.354 . . . . 0.0 111.311 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -64.53 118.88 9.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.347 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.459 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -107.14 -151.9 18.09 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.597 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.497 ' N ' ' CB ' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -174.42 156.75 2.55 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.256 0.55 . . . . 0.0 109.992 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.752 ' N ' HD12 ' A' ' 44' ' ' ILE . 41.4 ttt180 -133.75 113.95 12.88 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.652 ' O ' ' HB2' ' A' ' 92' ' ' SER . 53.0 m -74.06 123.31 24.13 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.463 ' CD2' ' HG ' ' A' ' 92' ' ' SER . 16.6 m80 -104.81 120.82 42.32 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.146 0.975 . . . . 0.0 113.085 -177.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.655 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -89.41 98.14 11.6 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 113.648 -1.615 . . . . 0.0 111.169 -177.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.668 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.5 mp -87.48 158.55 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.89 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.693 ' OG ' HD12 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -101.65 108.3 19.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.727 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.651 HG13 HG21 ' A' ' 38' ' ' ILE . 11.2 m -81.6 98.25 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.146 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.568 HD23 ' HD3' ' A' ' 35' ' ' PRO . 0.9 OUTLIER -117.37 108.9 16.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.975 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.5 m -79.71 124.64 28.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.851 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.21 118.49 21.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 60.36 31.93 20.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.954 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.3 38.96 20.38 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.594 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.62 116.62 4.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.51 119.59 31.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.8 m -101.19 148.4 25.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -109.6 103.44 12.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.852 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 88' ' ' THR . 13.0 t -119.09 116.8 27.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 p -57.19 139.28 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.693 HD12 ' OG ' ' A' ' 77' ' ' SER . 16.2 mt -130.63 -68.4 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.264 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.45 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 1.3 t70 -137.8 134.34 35.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 111.4 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.652 ' HB2' ' O ' ' A' ' 73' ' ' THR . 18.7 p -143.35 160.62 40.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.027 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.608 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 5.8 pt20 -120.97 165.58 15.04 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 94' ' ' VAL . 28.9 m -86.39 106.08 15.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.945 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.483 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 15.4 p -114.84 81.86 1.64 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.684 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.497 ' CB ' ' N ' ' A' ' 71' ' ' GLU . 6.6 mmmt 146.46 -33.16 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.534 178.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 49.96 106.2 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.858 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.76 HG21 ' C ' ' A' ' 45' ' ' PRO . 11.8 p -79.92 102.8 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.075 0.465 . . . . 0.0 110.719 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 27.0 mt -66.55 131.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.185 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -87.7 139.96 30.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.768 ' CB ' HG22 ' A' ' 48' ' ' VAL . 6.1 tt0 -75.55 103.81 5.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.479 HG23 ' HB ' ' A' ' 65' ' ' THR . 21.7 t -85.9 99.75 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.012 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.414 HG23 ' HG2' ' A' ' 101' ' ' GLN . 21.4 t -118.89 110.57 30.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.1 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.565 ' O ' HD11 ' A' ' 56' ' ' LEU . 3.0 mt-10 -96.24 108.55 21.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.813 HG23 ' HG3' ' A' ' 61' ' ' GLU . 11.8 p -100.7 150.65 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.027 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.52 ' N ' HD13 ' A' ' 56' ' ' LEU . . . -76.48 145.53 31.8 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.486 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.505 0.193 . . . . 0.0 111.161 -179.983 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo . . . . . 0 C--O 1.232 0.187 0 CA-C-O 120.753 0.23 . . . . 0.0 112.274 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -83.84 116.37 22.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.71 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.4 mt -71.0 115.61 10.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.971 0.415 . . . . 0.0 111.123 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -101.26 -177.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.858 179.091 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.566 HG22 HG22 ' A' ' 73' ' ' THR . 0.5 OUTLIER -157.02 133.88 10.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.504 0.669 . . . . 0.0 111.58 -179.014 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.706 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 2.8 tpm_? -155.7 115.63 3.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 1.7 t -81.89 136.08 35.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.895 0.855 . . . . 0.0 112.515 -176.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -98.63 138.74 35.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.014 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.408 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 1.8 mp0 -66.73 91.86 0.2 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.445 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.776 HD12 ' H ' ' A' ' 72' ' ' ARG . 6.4 mt -92.68 107.67 25.97 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.907 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.501 ' C ' HG21 ' A' ' 98' ' ' VAL . 72.3 Cg_endo -86.03 153.34 9.73 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.832 2.355 . . . . 0.0 113.309 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.707 ' HB3' HG22 ' A' ' 98' ' ' VAL . 42.7 p90 -86.99 -174.05 4.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.158 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -154.78 116.34 4.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.922 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.732 HG13 ' CG ' ' A' ' 101' ' ' GLN . 4.4 t -67.09 151.45 10.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.134 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.6 mp -129.68 156.15 41.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.086 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.457 ' N ' HG22 ' A' ' 49' ' ' ILE . 2.9 ttpp -109.35 100.78 9.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.774 ' O ' HG22 ' A' ' 105' ' ' VAL . 9.2 mmtm -98.26 154.48 17.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -106.53 132.13 52.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -134.98 111.85 11.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.64 -26.76 39.26 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.368 2.046 . . . . 0.0 112.333 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -59.96 -32.3 70.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.9 mt -65.56 162.77 39.7 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.75 31.33 0.48 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.875 2.384 . . . . 0.0 112.925 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.98 138.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.913 0.387 . . . . 0.0 111.277 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.14 28.73 61.68 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.665 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.45 144.98 36.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.813 0.339 . . . . 0.0 110.933 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -114.32 118.93 35.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.821 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -128.3 118.37 23.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.507 HG23 ' OE1' ' A' ' 101' ' ' GLN . 43.5 mt -90.59 132.06 36.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.125 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.722 HD11 ' HG3' ' A' ' 104' ' ' GLU . 24.5 mt -104.79 -43.63 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.924 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.456 HG22 ' CG2' ' A' ' 99' ' ' ILE . 24.7 m -144.73 92.24 2.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.724 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.4 126.27 5.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.79 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.444 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -70.73 126.12 14.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.449 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.432 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.8 t -138.2 138.07 43.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.904 0.383 . . . . 0.0 110.935 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.542 ' HA ' HG23 ' A' ' 98' ' ' VAL . 3.7 mttp -68.1 116.19 8.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.381 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.522 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -81.11 -147.67 5.61 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.468 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.603 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.4 OUTLIER -177.77 109.27 0.06 Allowed 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.08 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.776 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -104.59 138.08 41.46 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.207 0.527 . . . . 0.0 109.872 -179.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.566 HG22 HG22 ' A' ' 39' ' ' THR . 51.9 m -75.26 136.58 40.93 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.387 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.706 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 2.8 m80 -112.16 116.77 31.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.926 0.869 . . . . 0.0 111.955 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.756 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -91.2 107.93 19.54 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 113.84 -1.527 . . . . 0.0 111.023 -177.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.594 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.4 mp -91.47 156.41 3.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.155 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.41 ' N ' ' CG2' ' A' ' 76' ' ' ILE . 3.8 m -115.85 111.55 20.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.688 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 78' ' ' VAL . 25.4 m -81.27 98.38 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.189 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 tp -109.94 148.75 31.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.833 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.24 106.25 12.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -128.91 126.17 39.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 60.33 31.1 20.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.03 28.39 68.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.368 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -149.03 166.64 28.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.878 0.371 . . . . 0.0 110.857 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.3 p -106.29 89.95 3.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.84 150.9 42.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -104.7 109.53 21.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.5 m -140.05 122.21 15.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.658 HG21 ' CD2' ' A' ' 74' ' ' HIS . 14.9 p -84.48 150.22 4.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.135 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -147.07 -41.39 0.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.582 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.441 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 1.6 t70 -117.64 106.92 13.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.837 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.569 ' HG ' ' CD2' ' A' ' 74' ' ' HIS . 89.3 p -143.14 123.91 14.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.316 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.676 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 5.7 mt-30 -89.38 166.15 13.91 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.727 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 32.1 t -86.1 110.12 19.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.603 ' O ' ' O ' ' A' ' 71' ' ' GLU . 5.9 p -117.69 80.85 1.57 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.361 0.601 . . . . 0.0 110.656 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.529 ' HB3' ' H ' ' A' ' 71' ' ' GLU . 41.0 tptt 148.52 -32.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.447 -1.252 . . . . 0.0 109.218 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 57.44 108.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.38 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.707 HG22 ' HB3' ' A' ' 46' ' ' PHE . 7.4 p -71.64 104.17 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.109 0.48 . . . . 0.0 110.0 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.613 ' H ' HD12 ' A' ' 99' ' ' ILE . 5.1 mp -64.01 129.87 28.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.126 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -99.82 137.7 37.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.013 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.732 ' CG ' HG13 ' A' ' 48' ' ' VAL . 3.6 tp-100 -72.08 107.13 4.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.833 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.679 HG12 HD12 ' A' ' 64' ' ' ILE . 21.7 t -98.29 99.61 9.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.049 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.46 HG12 HG12 ' A' ' 63' ' ' ILE . 5.2 m -116.78 129.61 73.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.091 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.722 ' HG3' HD11 ' A' ' 64' ' ' ILE . 1.4 mm-40 -108.79 117.58 34.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.818 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 51' ' ' LYS . 31.6 m -93.7 142.93 12.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.21 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.88 133.84 14.11 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.527 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.78 0.324 . . . . 0.0 111.094 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.433 ' HG2' HG23 ' A' ' 78' ' ' VAL . 52.6 Cg_endo . . . . . 0 C--O 1.232 0.199 0 CA-C-O 120.844 0.268 . . . . 0.0 112.324 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.96 155.28 20.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.954 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.13 118.76 36.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.152 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 4.0 pt -101.37 -177.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.421 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.754 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -159.88 150.42 18.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.209 0.528 . . . . 0.0 110.792 -179.245 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -162.34 133.18 4.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.183 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 1.7 p -82.44 129.16 34.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.762 0.791 . . . . 0.0 112.123 -178.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.493 ' HG3' HG13 ' A' ' 44' ' ' ILE . 3.4 tp10 -98.55 141.68 31.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.66 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.89 97.29 0.47 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.209 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.895 HD12 ' H ' ' A' ' 72' ' ' ARG . 6.9 mt -106.2 94.02 8.9 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.444 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.478 ' C ' HG21 ' A' ' 98' ' ' VAL . 87.7 Cg_endo -77.51 158.29 32.48 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.714 2.276 . . . . 0.0 113.257 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.688 ' HB3' HG22 ' A' ' 98' ' ' VAL . 40.9 p90 -86.87 -174.04 4.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.841 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -147.17 103.1 3.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.173 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.5 HG23 ' HB3' ' A' ' 101' ' ' GLN . 3.4 p -66.99 132.75 32.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.769 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.442 HG22 ' N ' ' A' ' 50' ' ' LYS . 32.8 mm -109.96 156.1 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.177 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.442 ' N ' HG22 ' A' ' 49' ' ' ILE . 8.7 mtpp -125.83 100.8 6.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.817 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -103.98 171.61 7.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.88 125.63 36.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.868 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.863 ' ND2' HD13 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -100.51 96.52 5.39 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.35 -18.48 44.27 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.465 2.11 . . . . 0.0 112.482 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.36 29.23 3.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.011 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.863 HD13 ' ND2' ' A' ' 53' ' ' ASN . 1.3 mp -124.4 169.43 10.74 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.757 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -87.37 29.09 0.5 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.3 2.667 . . . . 0.0 112.678 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.37 144.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.843 0.354 . . . . 0.0 111.347 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.65 23.22 42.92 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.833 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.608 ' HB3' HD23 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -109.47 156.67 19.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.757 0.313 . . . . 0.0 110.982 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.594 ' HG2' HG22 ' A' ' 105' ' ' VAL . 6.4 mt-10 -140.47 147.26 39.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.913 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.509 ' ND2' HD11 ' A' ' 64' ' ' ILE . 0.7 OUTLIER -145.5 129.77 17.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.927 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.8 mm -87.23 92.8 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.136 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.509 HD11 ' ND2' ' A' ' 62' ' ' ASN . 24.3 mm -72.92 -43.85 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.76 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.83 93.7 1.68 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.544 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -46.62 152.42 0.47 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.82 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.437 ' HA3' ' CE2' ' A' ' 46' ' ' PHE . . . -99.94 132.76 11.05 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.26 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.428 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.6 t -136.93 130.46 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.884 0.374 . . . . 0.0 110.975 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.49 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -62.43 112.72 2.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.28 -179.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.554 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -75.53 -144.91 1.3 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.694 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.672 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 10.3 tt0 -177.58 109.11 0.06 Allowed 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.895 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -98.36 142.79 29.56 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.377 0.608 . . . . 0.0 110.446 -179.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.579 ' O ' ' HB3' ' A' ' 92' ' ' SER . 98.3 m -75.68 143.98 41.86 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.248 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.622 ' O ' ' HA ' ' A' ' 39' ' ' THR . 34.5 m-70 -125.92 116.99 22.36 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.592 0.711 . . . . 0.0 111.485 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.754 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -88.02 111.97 22.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.891 -177.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.501 HG22 ' N ' ' A' ' 77' ' ' SER . 4.3 mp -99.91 160.83 3.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.258 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.63 ' HB2' HD12 ' A' ' 90' ' ' LEU . 9.8 t -107.47 119.34 39.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.7 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 78' ' ' VAL . 8.6 m -81.43 98.36 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.22 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.612 HD13 ' N ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -103.03 129.92 49.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.612 ' N ' HD13 ' A' ' 79' ' ' LEU . 0.5 OUTLIER -96.55 120.17 36.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.832 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -136.03 100.05 4.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 60.13 35.71 21.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.37 47.39 22.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.469 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.27 123.14 15.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.688 0.28 . . . . 0.0 110.871 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.61 112.43 23.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.954 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.45 118.09 35.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.818 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.411 ' CA ' HG21 ' A' ' 76' ' ' ILE . 20.8 mt-10 -94.75 94.81 8.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.918 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.4 m -111.5 113.83 26.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.885 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.6 m -52.94 130.07 14.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.205 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.63 HD12 ' HB2' ' A' ' 77' ' ' SER . 14.3 mt -120.39 -73.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.069 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.478 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -123.98 131.47 53.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.376 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.579 ' HB3' ' O ' ' A' ' 73' ' ' THR . 1.0 OUTLIER -143.14 165.39 27.55 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.459 0.647 . . . . 0.0 111.247 179.441 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.627 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 25.2 mm100 -129.95 166.17 20.59 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.617 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.778 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 46.3 t -86.24 105.92 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.568 ' O ' ' O ' ' A' ' 71' ' ' GLU . 12.5 p -121.12 81.03 1.72 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.501 0.667 . . . . 0.0 110.929 -178.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.672 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 6.6 mmmt 155.37 -30.86 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.751 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 62.82 101.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.8 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.688 HG22 ' HB3' ' A' ' 46' ' ' PHE . 7.6 p -71.45 102.82 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.075 0.465 . . . . 0.0 110.304 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.615 ' H ' HD12 ' A' ' 99' ' ' ILE . 4.4 mp -63.99 133.2 29.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.913 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -102.73 142.79 33.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.018 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.5 ' HB3' HG23 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -76.81 108.3 9.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.927 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.32 109.98 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.055 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 103' ' ' VAL . 10.8 p -138.81 125.74 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.154 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -102.31 108.49 19.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.955 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.594 HG22 ' HG2' ' A' ' 61' ' ' GLU . 27.8 t -92.78 113.75 28.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.129 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.97 142.58 47.42 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.523 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.535 0.207 . . . . 0.0 111.161 -179.912 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.834 0.264 . . . . 0.0 112.228 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -150.44 115.94 5.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.83 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mp -86.18 114.52 23.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.08 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 2.2 pt -101.35 -177.39 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.496 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.768 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -161.52 146.24 13.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.436 0.636 . . . . 0.0 111.103 -179.448 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.726 ' O ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -143.36 -159.54 0.99 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.36 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 3.0 p -145.46 126.83 14.92 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.257 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.534 ' HG3' ' CE1' ' A' ' 74' ' ' HIS . 3.7 mm-40 -98.74 135.57 40.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.751 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.416 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 2.6 mm-40 -67.17 94.87 0.38 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.352 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.841 HD12 ' H ' ' A' ' 72' ' ' ARG . 5.1 mt -102.69 96.43 7.56 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.774 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.516 ' C ' HG21 ' A' ' 98' ' ' VAL . 98.8 Cg_endo -77.87 160.51 30.68 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.803 2.336 . . . . 0.0 113.255 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.629 ' HB3' HG22 ' A' ' 98' ' ' VAL . 49.1 p90 -86.94 -174.15 4.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.234 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.456 ' OE1' HD13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -152.63 113.16 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.847 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.769 HG22 ' CB ' ' A' ' 101' ' ' GLN . 17.6 t -66.74 146.41 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.103 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.456 HD13 ' OE1' ' A' ' 47' ' ' GLU . 36.8 mm -124.7 156.18 32.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.092 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.443 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -105.12 100.88 10.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.771 179.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.567 ' O ' HG12 ' A' ' 105' ' ' VAL . 4.7 tptt -96.75 145.55 25.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.029 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -110.5 123.13 49.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -122.97 128.75 25.23 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.16 -24.79 12.23 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.439 2.093 . . . . 0.0 112.495 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -55.17 -50.94 68.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.039 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.773 HD22 ' OE1' ' A' ' 60' ' ' GLN . 9.4 mt -60.15 167.02 3.22 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.793 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.407 ' HD2' ' CB ' ' A' ' 60' ' ' GLN . 1.2 Cg_endo -83.45 32.36 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.13 2.554 . . . . 0.0 112.697 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.04 119.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.833 0.349 . . . . 0.0 111.398 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.5 -26.27 20.65 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.753 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.773 ' OE1' HD22 ' A' ' 56' ' ' LEU . 2.3 tm0? -70.0 129.92 40.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 110.945 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.404 ' CG ' ' CG1' ' A' ' 103' ' ' VAL . 6.5 tt0 -95.73 158.42 15.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -158.15 118.19 3.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.944 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.6 mt -94.29 132.03 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.186 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.1 mm -105.83 -38.99 4.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.867 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.442 HG22 ' CG2' ' A' ' 99' ' ' ILE . 7.4 m -147.65 96.86 2.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.653 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.33 128.81 17.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.753 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.515 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -67.35 124.42 22.2 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.334 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.45 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.9 t -132.63 130.21 59.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.797 0.332 . . . . 0.0 111.065 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.4 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -62.25 113.38 2.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.387 -179.32 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.524 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -78.1 -146.28 2.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.377 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.694 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 10.7 tt0 -177.52 109.24 0.07 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.841 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -98.47 142.28 30.28 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.457 0.646 . . . . 0.0 110.425 -179.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.726 ' HA ' ' O ' ' A' ' 40' ' ' ARG . 94.7 m -75.62 149.03 38.31 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.92 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.589 ' O ' ' HA ' ' A' ' 39' ' ' THR . 5.2 m80 -128.66 117.9 21.97 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.53 0.681 . . . . 0.0 111.939 -178.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.768 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -90.58 107.27 19.06 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.079 -178.008 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.659 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.4 mp -90.08 158.66 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.798 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.499 ' OG ' HD23 ' A' ' 79' ' ' LEU . 11.7 t -108.15 117.39 34.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.449 HG13 ' HB ' ' A' ' 85' ' ' THR . 21.6 t -84.6 98.51 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.063 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.499 HD23 ' OG ' ' A' ' 77' ' ' SER . 2.8 mm? -103.65 142.3 34.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.5 p -89.96 93.8 9.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -99.12 105.83 17.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.976 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 60.45 33.49 20.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.0 35.78 26.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.516 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.6 147.43 32.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.796 0.331 . . . . 0.0 110.859 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.449 ' HB ' HG13 ' A' ' 78' ' ' VAL . 39.9 p -101.77 120.0 39.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.849 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.0 m -109.35 151.07 27.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -105.17 103.38 12.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.409 ' N ' HG23 ' A' ' 76' ' ' ILE . 94.3 m -122.5 121.05 35.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.78 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.3 t -50.11 116.08 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.124 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.43 ' HA ' HD22 ' A' ' 90' ' ' LEU . 0.2 OUTLIER -105.66 -70.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.189 -179.637 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.5 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 7.2 m-20 -140.25 136.88 33.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.212 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.649 ' HB2' ' O ' ' A' ' 73' ' ' THR . 24.0 p -143.24 165.55 27.15 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.582 0.706 . . . . 0.0 111.275 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.686 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 16.5 mm-40 -129.74 166.27 20.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.64 -1.163 . . . . 0.0 109.346 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.798 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.6 p -85.84 105.94 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.555 ' O ' ' O ' ' A' ' 71' ' ' GLU . 13.3 p -120.39 80.94 1.68 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.498 0.666 . . . . 0.0 110.793 -178.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.694 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.1 OUTLIER 154.7 -29.88 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.616 179.028 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 60.17 102.58 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.708 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.629 HG22 ' HB3' ' A' ' 46' ' ' PHE . 6.2 p -71.34 108.36 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.215 0.531 . . . . 0.0 110.073 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.574 ' H ' HD12 ' A' ' 99' ' ' ILE . 5.3 mp -63.85 126.87 23.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.965 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -96.02 137.12 35.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.993 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.769 ' CB ' HG22 ' A' ' 48' ' ' VAL . 2.5 tp60 -69.47 99.4 1.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.833 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.414 HG23 ' HB ' ' A' ' 65' ' ' THR . 21.5 t -86.1 99.63 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.053 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.404 ' CG1' ' CG ' ' A' ' 61' ' ' GLU . 21.5 t -119.45 125.9 74.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.177 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -114.45 108.55 17.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.834 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 51' ' ' LYS . 10.6 p -96.61 153.39 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.061 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.05 150.69 51.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.442 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.638 0.256 . . . . 0.0 111.145 -179.974 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo . . . . . 0 C--O 1.23 0.088 0 CA-C-O 120.908 0.295 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.53 ' HG3' HG22 ' A' ' 78' ' ' VAL . 5.1 pt-20 -147.6 152.9 38.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.819 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.1 mt -109.6 118.12 35.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.1 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.653 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 10.6 pt -101.23 -177.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.187 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.724 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 0.6 OUTLIER -153.84 160.92 42.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.233 0.54 . . . . 0.0 111.041 -179.471 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.527 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 3.6 tpp85 -172.71 131.61 0.55 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.815 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 2.9 p -81.91 129.93 34.91 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.837 0.827 . . . . 0.0 112.35 -177.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.496 ' HG3' HG13 ' A' ' 44' ' ' ILE . 3.5 tp10 -98.53 141.77 30.97 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.689 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -66.8 97.29 0.46 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.048 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.888 HD12 ' H ' ' A' ' 72' ' ' ARG . 7.0 mt -105.22 92.95 6.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.613 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.463 ' C ' HG21 ' A' ' 98' ' ' VAL . 73.7 Cg_endo -75.0 158.04 42.43 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.743 2.296 . . . . 0.0 113.031 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.658 ' HB3' HG22 ' A' ' 98' ' ' VAL . 41.6 p90 -86.77 -174.01 4.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.024 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -145.74 105.06 3.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.851 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.548 HG23 ' HB3' ' A' ' 101' ' ' GLN . 6.0 p -67.07 138.82 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.001 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.472 HD13 ' O ' ' A' ' 48' ' ' VAL . 27.9 mm -122.69 156.17 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.161 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.444 ' N ' HG22 ' A' ' 49' ' ' ILE . 16.8 mtmt -120.1 100.78 7.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.815 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.709 ' O ' HG22 ' A' ' 105' ' ' VAL . 2.5 tppt? -98.39 154.34 17.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.985 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.654 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 2.3 mm-40 -99.29 129.68 45.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.944 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -124.99 127.22 25.14 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.815 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.4 -27.16 11.48 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.411 2.074 . . . . 0.0 112.442 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -58.6 -35.52 72.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.985 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.453 HD22 ' NE2' ' A' ' 60' ' ' GLN . 8.3 mt -71.03 158.89 87.19 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.825 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -86.33 37.92 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.885 2.39 . . . . 0.0 112.878 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.22 145.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.846 0.355 . . . . 0.0 111.338 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.23 27.74 58.05 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.634 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.453 ' NE2' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -106.01 169.34 8.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.757 0.313 . . . . 0.0 110.963 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -155.32 133.01 11.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.927 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -135.75 125.0 24.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.812 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.791 HD13 ' CG1' ' A' ' 103' ' ' VAL . 26.1 mm -85.75 92.86 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.087 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.408 HD11 ' HG3' ' A' ' 104' ' ' GLU . 19.8 mt -74.26 -31.77 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.992 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.4 m -164.21 93.6 0.7 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.666 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.7 145.03 5.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.537 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.432 ' HA3' ' CE1' ' A' ' 46' ' ' PHE . . . -80.79 136.25 16.09 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.341 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.7 t -141.74 120.86 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 0.0 110.957 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.519 ' HA ' HG23 ' A' ' 98' ' ' VAL . 28.5 mtmt -59.42 112.79 1.89 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.245 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.504 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -76.87 -144.53 1.76 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.758 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.679 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -177.42 109.17 0.07 Allowed 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.219 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.888 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -98.61 139.38 34.42 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.16 0.505 . . . . 0.0 110.47 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.586 ' O ' ' HB2' ' A' ' 92' ' ' SER . 40.5 m -75.39 136.09 40.77 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.451 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.724 ' O ' ' HA ' ' A' ' 39' ' ' THR . 19.8 m-70 -116.17 122.37 44.84 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.416 0.627 . . . . 0.0 111.771 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.74 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -90.69 107.23 19.04 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.054 -177.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 77' ' ' SER . 3.8 mp -96.22 160.42 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.069 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.51 ' HB2' HD23 ' A' ' 90' ' ' LEU . 0.7 OUTLIER -112.76 122.43 47.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.762 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.595 ' O ' HG23 ' A' ' 78' ' ' VAL . 35.8 m -90.11 108.97 20.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.31 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.05 137.96 45.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.796 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.53 123.04 29.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -131.48 109.52 10.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.9 p30 44.08 33.98 0.89 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.416 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.28 45.29 5.64 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.473 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -149.23 156.83 42.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 110.825 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.67 116.22 28.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.943 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.28 151.02 20.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -121.41 83.93 2.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.957 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.6 m -108.29 123.2 48.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.792 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.1 m -50.11 130.07 8.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.221 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.51 HD23 ' HB2' ' A' ' 77' ' ' SER . 0.5 OUTLIER -114.48 -64.56 1.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.233 -179.703 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.488 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -152.82 141.42 20.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.207 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.586 ' HB2' ' O ' ' A' ' 73' ' ' THR . 11.5 p -143.27 165.61 27.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.779 0.8 . . . . 0.0 111.616 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.686 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 41.8 mt-30 -129.18 166.08 20.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.691 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.755 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.5 p -85.96 105.78 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.59 ' O ' ' O ' ' A' ' 71' ' ' GLU . 12.1 p -121.36 80.75 1.7 Allowed 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.579 0.704 . . . . 0.0 110.733 -178.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.679 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 154.46 -31.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.649 178.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 62.94 101.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.777 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.658 HG22 ' HB3' ' A' ' 46' ' ' PHE . 5.8 p -71.48 106.64 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.058 0.456 . . . . 0.0 110.202 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.9 mm -63.87 129.44 27.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.068 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -98.92 134.93 41.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.021 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.548 ' HB3' HG23 ' A' ' 48' ' ' VAL . 1.5 tm0? -68.47 99.45 0.96 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.25 117.28 32.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.073 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.791 ' CG1' HD13 ' A' ' 63' ' ' ILE . 5.1 m -143.09 137.58 26.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.095 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.408 ' HG3' HD11 ' A' ' 64' ' ' ILE . 19.7 mt-10 -118.4 111.85 19.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.882 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 51' ' ' LYS . 29.9 m -88.87 146.94 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.088 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -70.98 146.18 40.97 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.443 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.654 ' HB3' ' HB3' ' A' ' 52' ' ' GLU . . . . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.748 0.308 . . . . 0.0 111.101 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 N--CA 1.465 -0.172 0 CA-C-O 120.833 0.264 . . . . 0.0 112.298 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -163.6 154.49 16.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.775 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 68.4 mt -95.01 122.79 38.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.072 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 76' ' ' ILE . 1.2 tt -101.17 -177.32 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.567 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.852 HG22 ' CD1' ' A' ' 75' ' ' TYR . 1.3 p -162.29 142.22 9.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.331 0.586 . . . . 0.0 111.018 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.688 ' CG ' HD13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -163.64 109.88 1.11 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.147 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 12.5 t -82.3 132.71 35.22 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.685 0.755 . . . . 0.0 111.734 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.469 ' O ' HD12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -98.41 148.24 23.89 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.695 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.407 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 4.8 mt-10 -66.83 100.2 0.69 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.699 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.567 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.0 mp -104.8 91.16 4.01 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.872 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.512 ' C ' HG21 ' A' ' 98' ' ' VAL . 72.0 Cg_endo -76.18 157.38 37.84 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.671 2.247 . . . . 0.0 112.808 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.618 ' HB3' HG22 ' A' ' 98' ' ' VAL . 30.0 p90 -86.73 -177.29 6.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.118 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -157.07 120.25 4.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.96 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.778 HG22 ' CB ' ' A' ' 101' ' ' GLN . 40.0 t -67.26 150.0 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.242 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 50' ' ' LYS . 7.8 mt -129.18 156.15 41.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.079 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' N ' HG22 ' A' ' 49' ' ' ILE . 4.4 mtpp -123.59 100.89 7.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.818 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -110.8 147.37 34.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.901 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.87 140.0 32.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -133.71 98.48 14.79 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.51 84.25 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.484 2.122 . . . . 0.0 112.213 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -175.32 -40.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.924 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.739 HD13 ' HB3' ' A' ' 60' ' ' GLN . 41.7 mt -58.49 167.16 1.87 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.842 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.08 48.84 2.63 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.041 2.494 . . . . 0.0 112.754 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.37 124.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.016 0.436 . . . . 0.0 111.716 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 50.59 55.64 16.39 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.091 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.739 ' HB3' HD13 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -109.47 136.5 48.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.742 0.306 . . . . 0.0 110.802 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.9 117.14 27.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.628 ' O ' HG12 ' A' ' 103' ' ' VAL . 1.1 p30 -127.08 158.02 38.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.799 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.751 HD13 HG12 ' A' ' 103' ' ' VAL . 31.1 mm -113.91 92.52 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.463 HD11 ' HG3' ' A' ' 104' ' ' GLU . 24.3 mt -73.24 -32.25 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.921 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.0 m -161.31 92.74 0.91 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.613 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.49 146.45 5.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.582 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.429 ' HA3' ' CE1' ' A' ' 46' ' ' PHE . . . -76.45 138.72 22.88 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.262 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.8 t -140.95 135.05 32.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.917 0.389 . . . . 0.0 111.349 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.16 134.87 56.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.335 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 96' ' ' LYS . . . -116.25 -159.68 11.91 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.994 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.475 ' HA ' HD12 ' A' ' 44' ' ' ILE . 1.5 tt0 -162.08 153.89 18.84 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 2.6 ttt180 -141.39 112.2 7.17 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.717 ' O ' ' HB2' ' A' ' 92' ' ' SER . 46.5 m -73.92 125.72 28.85 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.526 ' O ' ' HA ' ' A' ' 39' ' ' THR . 13.8 m80 -106.8 119.7 40.05 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 122.083 0.944 . . . . 0.0 113.137 -177.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.852 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -91.14 93.81 9.3 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.103 -177.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.688 HD13 ' CG ' ' A' ' 40' ' ' ARG . 2.0 mp -87.35 142.65 12.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.931 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.724 ' OG ' HD23 ' A' ' 90' ' ' LEU . 2.4 p -77.34 121.42 23.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.762 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.489 ' C ' HD22 ' A' ' 79' ' ' LEU . 21.4 t -81.4 105.56 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.203 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.489 HD22 ' C ' ' A' ' 78' ' ' VAL . 3.9 mm? -125.55 89.27 3.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.891 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.07 131.4 42.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -137.62 117.24 13.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.909 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 60.67 33.35 20.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.28 32.02 49.55 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.438 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -144.32 113.77 7.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.755 0.312 . . . . 0.0 110.86 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.7 p -75.21 127.8 34.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.6 m -100.01 141.28 33.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.899 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -100.29 101.97 13.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.8 m -118.95 121.0 38.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 89' ' ' VAL . 10.8 p -54.26 118.41 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.006 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.724 HD23 ' OG ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -106.0 -59.57 1.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.516 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -177.17 139.95 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.198 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.717 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.8 p -143.64 149.47 37.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.48 0.657 . . . . 0.0 111.362 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.668 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 4.6 mt-30 -107.47 167.11 10.17 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.598 ' O ' HG13 ' A' ' 94' ' ' VAL . 8.3 p -84.75 107.16 15.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 119.854 -0.739 . . . . 0.0 109.872 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.549 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 16.8 p -113.22 82.9 1.74 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.686 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 95' ' ' THR . 11.6 mmmt 113.36 52.93 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.097 -1.41 . . . . 0.0 109.385 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -35.21 117.17 0.39 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.544 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.618 HG22 ' HB3' ' A' ' 46' ' ' PHE . 9.4 p -71.44 106.02 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.206 0.527 . . . . 0.0 110.792 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.0 mm -64.35 121.5 13.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.164 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -98.07 125.95 43.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.931 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.804 ' OE1' HG13 ' A' ' 103' ' ' VAL . 0.5 OUTLIER -62.67 128.91 38.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.788 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.8 m -124.01 101.36 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.195 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.804 HG13 ' OE1' ' A' ' 101' ' ' GLN . 2.4 m -108.96 118.6 56.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.072 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.463 ' HG3' HD11 ' A' ' 64' ' ' ILE . 18.0 mt-10 -87.15 111.58 21.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.783 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.99 143.5 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.225 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.54 109.67 3.03 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.505 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.714 0.292 . . . . 0.0 111.09 179.976 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--O 1.231 0.151 0 CA-C-O 120.796 0.248 . . . . 0.0 112.271 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -78.84 124.84 28.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.641 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 68.4 mt -78.33 116.46 18.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.086 0.469 . . . . 0.0 111.329 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.763 HD11 ' CD1' ' A' ' 76' ' ' ILE . 1.2 pp -100.89 -176.05 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.288 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.67 ' N ' HD12 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -156.35 132.94 10.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.499 0.666 . . . . 0.0 112.486 -178.351 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.653 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 4.7 mmm180 -150.72 115.77 5.32 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -82.13 134.37 35.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.897 0.856 . . . . 0.0 112.34 -177.685 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.417 ' HG2' ' ND1' ' A' ' 74' ' ' HIS . 1.2 mm-40 -98.78 138.81 35.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.24 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.434 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 1.7 pt-20 -66.86 91.45 0.2 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.778 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.866 HD12 ' H ' ' A' ' 72' ' ' ARG . 6.5 mt -94.84 105.04 16.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.651 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.493 ' C ' HG21 ' A' ' 98' ' ' VAL . 80.8 Cg_endo -84.19 157.2 13.02 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.769 2.313 . . . . 0.0 113.296 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.713 ' HB3' HG22 ' A' ' 98' ' ' VAL . 42.6 p90 -86.91 -174.02 4.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.965 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -149.42 103.05 3.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.099 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 101' ' ' GLN . 3.9 p -66.82 145.02 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.931 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.453 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.6 mp -128.97 156.1 41.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.039 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.453 ' N ' HG22 ' A' ' 49' ' ' ILE . 3.4 mptt -109.44 100.89 9.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.754 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.33 164.6 20.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.035 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -116.35 112.56 21.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.826 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.46 ' HB3' HD13 ' A' ' 56' ' ' LEU . 1.4 t-20 -102.23 96.6 7.26 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.67 -13.21 38.98 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.499 2.132 . . . . 0.0 112.512 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -97.81 27.79 4.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.706 0.289 . . . . 0.0 111.047 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.763 HD23 ' HB3' ' A' ' 60' ' ' GLN . 3.5 mp -114.97 175.94 1.68 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.85 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -86.78 29.53 0.5 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.281 2.654 . . . . 0.0 112.781 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.7 130.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.978 0.418 . . . . 0.0 111.225 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.78 54.08 40.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.642 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.763 ' HB3' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -109.44 131.7 54.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.765 0.317 . . . . 0.0 110.823 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -115.18 113.85 24.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.937 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -147.25 119.34 8.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.804 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.418 HG12 HG22 ' A' ' 103' ' ' VAL . 26.1 mt -85.76 130.96 35.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.251 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.752 HD11 ' HG3' ' A' ' 104' ' ' GLU . 2.4 mp -100.24 -46.18 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.636 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.3 m -141.85 102.17 4.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.497 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.68 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -49.43 162.95 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.545 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.436 ' HA3' ' CE2' ' A' ' 46' ' ' PHE . . . -111.07 127.32 8.18 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.243 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.43 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.6 t -139.43 134.7 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.809 0.337 . . . . 0.0 110.97 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.506 ' HA ' HG23 ' A' ' 98' ' ' VAL . 10.0 mttt -65.37 114.55 4.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.075 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.485 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -75.08 -143.06 0.94 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.802 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.608 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -177.33 109.51 0.07 Allowed 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.194 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.866 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -103.35 134.3 46.97 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.251 0.548 . . . . 0.0 110.127 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 92' ' ' SER . 60.6 m -76.15 138.22 40.57 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.532 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.653 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 6.6 m80 -111.79 122.72 48.56 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.687 0.756 . . . . 0.0 112.05 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.726 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -92.99 93.85 8.58 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.241 -177.287 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.763 ' CD1' HD11 ' A' ' 38' ' ' ILE . 4.3 mp -87.66 144.69 8.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.221 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.619 ' HB3' HD22 ' A' ' 90' ' ' LEU . 21.6 p -93.95 115.2 27.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.817 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.452 HG13 HG21 ' A' ' 38' ' ' ILE . 6.8 m -81.44 105.81 11.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' A' ' 79' ' ' LEU . 1.1 tm? -113.98 102.12 9.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.1 m -66.92 91.09 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -62.23 92.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 68.15 -69.86 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.093 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.88 36.99 1.03 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.491 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.88 132.21 6.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.883 0.373 . . . . 0.0 110.859 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.97 130.72 35.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.948 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.61 144.98 43.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -93.84 117.55 30.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.867 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.591 ' C ' HG23 ' A' ' 76' ' ' ILE . 91.3 m -144.62 101.1 3.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.7 t -49.74 133.22 8.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.96 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.619 HD22 ' HB3' ' A' ' 77' ' ' SER . 3.0 tp -110.3 -67.23 1.0 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.271 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.49 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 2.1 m-20 -150.79 141.16 22.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.979 0.419 . . . . 0.0 111.539 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.621 ' HB2' ' O ' ' A' ' 73' ' ' THR . 11.8 p -143.7 160.51 40.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.585 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.66 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 3.7 mt-30 -125.18 167.01 15.42 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.813 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.2 p -85.14 106.34 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 119.557 -0.857 . . . . 0.0 108.964 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.528 ' O ' ' O ' ' A' ' 71' ' ' GLU . 6.1 p -115.78 81.02 1.53 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.613 0.721 . . . . 0.0 110.46 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 156.35 -29.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.721 179.081 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 61.78 100.77 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.532 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.713 HG22 ' HB3' ' A' ' 46' ' ' PHE . 5.9 p -71.24 102.7 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 121.213 0.53 . . . . 0.0 109.998 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.68 HG22 ' O ' ' A' ' 66' ' ' ALA . 3.8 mp -64.28 133.35 29.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.015 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -105.67 141.53 36.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.143 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.531 ' O ' HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -76.4 108.13 9.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.776 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.741 HG12 HD13 ' A' ' 64' ' ' ILE . 21.3 t -95.92 108.7 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.107 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.418 HG22 HG12 ' A' ' 63' ' ' ILE . 22.1 t -129.32 114.96 33.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.019 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.752 ' HG3' HD11 ' A' ' 64' ' ' ILE . 0.7 OUTLIER -89.99 139.94 30.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.763 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.4 109.7 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.082 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.19 128.15 30.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.577 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 120.693 0.282 . . . . 0.0 111.143 179.973 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.464 -0.236 0 CA-C-O 120.876 0.282 . . . . 0.0 112.314 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -139.56 129.13 24.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.5 132.92 42.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.878 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.868 HD12 ' HB ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER -101.25 -176.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.444 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.591 ' H ' HG22 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -163.16 121.93 2.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.03 0.443 . . . . 0.0 109.947 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 74' ' ' HIS . 18.9 ttt180 -145.77 132.49 19.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.328 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.612 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 2.2 p -81.85 130.23 35.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.891 0.853 . . . . 0.0 112.235 -177.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.443 ' HG2' HG13 ' A' ' 44' ' ' ILE . 1.1 tt0 -98.36 143.89 28.34 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.806 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.9 94.26 0.31 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.905 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.897 HD12 ' H ' ' A' ' 72' ' ' ARG . 7.3 mt -103.02 95.3 6.38 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.59 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.473 ' C ' HG21 ' A' ' 98' ' ' VAL . 74.4 Cg_endo -74.16 158.6 45.19 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.73 2.287 . . . . 0.0 113.278 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.644 ' HB3' HG22 ' A' ' 98' ' ' VAL . 53.9 p90 -86.64 -173.97 4.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.111 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -151.64 111.84 4.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.882 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.874 HG22 ' CB ' ' A' ' 101' ' ' GLN . 31.2 t -66.81 151.14 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.249 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.5 mp -126.92 156.25 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.094 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.459 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -121.6 100.75 7.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.807 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -107.88 150.91 26.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.499 ' HG3' ' HB3' ' A' ' 107' ' ' ALA . 0.6 OUTLIER -87.91 123.51 32.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -117.47 96.55 49.53 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.928 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.63 65.71 1.2 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.448 2.099 . . . . 0.0 112.193 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -149.68 -45.87 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.846 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.697 HD23 ' HB3' ' A' ' 60' ' ' GLN . 7.1 mp -55.9 172.93 0.29 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 60' ' ' GLN . 2.0 Cg_endo -82.15 31.72 0.52 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.172 2.582 . . . . 0.0 112.951 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.96 120.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.999 0.428 . . . . 0.0 111.387 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.81 22.17 62.16 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.886 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.697 ' HB3' HD23 ' A' ' 56' ' ' LEU . 69.5 tp60 -109.54 157.68 18.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.826 0.346 . . . . 0.0 110.826 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -136.3 115.17 12.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.48 ' OD1' HD21 ' A' ' 56' ' ' LEU . 7.2 p-10 -117.61 116.68 27.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 26.1 mt -85.81 132.09 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.108 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.444 HD11 ' HG3' ' A' ' 104' ' ' GLU . 12.7 mt -103.46 -44.44 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.984 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.55 92.06 2.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.623 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.501 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -46.83 150.92 0.66 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.768 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.466 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -85.71 129.34 9.27 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.229 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.71 125.95 47.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.915 0.388 . . . . 0.0 110.885 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -60.51 112.71 2.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.281 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.492 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -76.9 -144.15 1.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.509 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.692 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 4.6 tt0 -177.45 109.27 0.07 Allowed 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.897 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -100.39 138.75 37.03 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.24 -179.711 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 92' ' ' SER . 94.6 m -75.22 140.12 43.05 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.68 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.543 ' N ' ' O ' ' A' ' 40' ' ' ARG . 20.4 m-70 -119.78 121.75 39.85 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.047 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.722 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -92.22 106.58 18.55 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.24 -177.256 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.868 ' HB ' HD12 ' A' ' 38' ' ' ILE . 5.0 mp -90.75 160.8 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.874 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.822 ' HB3' HD23 ' A' ' 90' ' ' LEU . 5.6 t -119.28 129.01 54.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.721 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.468 HG23 ' CG2' ' A' ' 85' ' ' THR . 11.4 p -81.41 123.0 37.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.141 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.9 tp -128.91 117.28 20.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.2 p -66.98 98.05 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.818 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.73 92.14 6.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 59.95 31.24 20.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.993 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.24 38.5 7.22 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.541 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -148.12 162.07 40.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.76 0.314 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.468 ' CG2' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -106.97 123.47 48.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.927 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -128.33 110.59 12.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.02 114.66 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 77' ' ' SER . 11.8 t -121.29 121.93 38.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.3 m -52.59 121.15 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.112 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.822 HD23 ' HB3' ' A' ' 77' ' ' SER . 0.2 OUTLIER -110.4 -49.97 3.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.189 -179.736 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.484 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 5.9 t0 -176.62 143.79 0.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.275 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.582 ' HB2' ' O ' ' A' ' 73' ' ' THR . 11.3 p -143.16 165.61 26.95 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.554 0.692 . . . . 0.0 111.496 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.717 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 5.1 mm-40 -131.85 166.3 21.9 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.947 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.798 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 5.5 m -85.97 105.79 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.591 ' O ' ' O ' ' A' ' 71' ' ' GLU . 10.7 p -121.02 80.68 1.67 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.491 0.663 . . . . 0.0 110.76 -178.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.692 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER 154.47 -30.38 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.846 178.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 62.02 101.58 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.624 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.644 HG22 ' HB3' ' A' ' 46' ' ' PHE . 5.0 p -71.36 108.37 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.163 0.506 . . . . 0.0 110.2 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 66' ' ' ALA . 43.2 mm -64.2 128.8 27.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.173 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -100.94 134.83 43.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.874 ' CB ' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -64.55 99.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.749 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.82 99.81 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.182 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.6 p -123.71 141.56 43.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.128 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.444 ' HG3' HD11 ' A' ' 64' ' ' ILE . 2.6 mt-10 -121.53 120.13 33.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.801 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.807 HG22 ' O ' ' A' ' 51' ' ' LYS . 27.8 m -86.99 160.14 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.151 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -98.87 125.84 8.7 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.55 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.499 ' HB3' ' HG3' ' A' ' 52' ' ' GLU . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.762 0.315 . . . . 0.0 111.046 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.774 0.239 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.15 121.22 6.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.944 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.71 135.53 33.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.883 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.804 HD12 ' HB ' ' A' ' 76' ' ' ILE . 0.5 OUTLIER -100.8 -177.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.452 179.381 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.704 ' H ' HG22 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -157.14 121.82 4.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.344 0.592 . . . . 0.0 111.26 -179.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.668 ' O ' ' HA ' ' A' ' 73' ' ' THR . 1.0 OUTLIER -128.06 -151.11 0.46 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 m -144.96 137.87 26.44 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.115 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.473 ' CB ' ' CE1' ' A' ' 74' ' ' HIS . 0.2 OUTLIER -107.94 131.84 54.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.427 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -66.93 92.83 0.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.058 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.775 HD11 ' HG2' ' A' ' 72' ' ' ARG . 4.1 mt -109.1 85.79 3.55 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.152 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.591 ' C ' HG21 ' A' ' 98' ' ' VAL . 86.1 Cg_endo -79.76 163.36 23.72 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.829 2.353 . . . . 0.0 112.93 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.629 ' HB3' HG22 ' A' ' 98' ' ' VAL . 40.1 p90 -87.33 -173.98 4.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.225 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -149.31 107.13 3.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.787 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.527 HG23 ' HG2' ' A' ' 101' ' ' GLN . 9.4 p -66.85 123.61 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.018 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 50' ' ' LYS . 22.8 mm -106.4 156.18 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.228 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.431 ' N ' HG22 ' A' ' 49' ' ' ILE . 8.5 ptmt -108.74 100.84 10.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.808 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.531 ' O ' HG22 ' A' ' 105' ' ' VAL . 32.6 ttmt -87.2 159.16 18.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.985 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.637 ' HG3' ' HB3' ' A' ' 107' ' ' ALA . 0.1 OUTLIER -100.87 120.07 39.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.653 ' HB3' HD13 ' A' ' 56' ' ' LEU . 7.9 t-20 -122.94 96.56 44.86 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.918 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.81 -25.19 53.36 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.453 2.102 . . . . 0.0 112.263 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -62.35 -30.97 71.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.705 HD23 ' HB3' ' A' ' 60' ' ' GLN . 8.5 mp -65.18 171.88 2.87 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.748 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -89.06 29.93 0.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.268 2.646 . . . . 0.0 112.598 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.01 146.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.912 0.387 . . . . 0.0 111.292 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.74 21.49 36.51 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.779 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.705 ' HB3' HD23 ' A' ' 56' ' ' LEU . 1.8 tt0 -109.61 148.02 32.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.882 0.372 . . . . 0.0 110.799 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -137.87 141.63 40.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -137.7 162.47 33.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.81 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.913 HD13 HG12 ' A' ' 103' ' ' VAL . 18.2 mm -117.0 86.28 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.113 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.4 mm -62.97 -49.75 82.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.012 0.434 . . . . 0.0 110.94 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.3 m -143.68 91.12 2.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.576 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.06 139.55 4.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.727 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.445 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -82.67 137.01 16.12 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.211 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.482 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.9 t -137.48 125.97 33.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.839 0.352 . . . . 0.0 111.075 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -56.48 119.88 6.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.041 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.583 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -80.74 -149.89 6.58 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.528 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.632 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -177.18 109.3 0.07 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.069 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.793 ' HB2' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -101.53 139.0 37.78 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.295 0.569 . . . . 0.0 109.904 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.671 ' O ' ' HB2' ' A' ' 92' ' ' SER . 91.2 m -75.86 138.99 41.45 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.815 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.473 ' CE1' ' CB ' ' A' ' 42' ' ' GLU . 5.0 m80 -111.64 118.97 37.13 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.745 0.784 . . . . 0.0 112.609 -178.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.698 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -92.05 100.05 12.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.066 -1.424 . . . . 0.0 111.508 -177.365 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.804 ' HB ' HD12 ' A' ' 38' ' ' ILE . 5.0 mp -87.73 141.62 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.79 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.601 ' O ' HD12 ' A' ' 79' ' ' LEU . 5.7 t -98.78 130.26 45.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 0.0 110.753 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.607 HG23 HG22 ' A' ' 85' ' ' THR . 10.6 p -81.42 119.01 30.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.172 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 77' ' ' SER . 5.4 mp -113.21 116.61 30.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.6 m -88.65 94.34 9.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.94 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -87.35 96.72 10.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 42.88 32.06 0.37 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.401 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.39 43.67 2.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.522 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -147.88 107.38 3.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.82 0.343 . . . . 0.0 110.878 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.607 HG22 HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -88.91 119.01 29.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.821 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.31 149.96 44.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -97.25 108.62 21.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.974 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.767 ' O ' HG23 ' A' ' 76' ' ' ILE . 78.0 m -127.5 124.05 37.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 89' ' ' VAL . 9.9 p -55.15 121.82 3.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.865 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.526 HD23 ' HB3' ' A' ' 77' ' ' SER . 0.2 OUTLIER -104.9 -71.24 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.381 -179.523 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.5 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 2.6 t0 -147.06 136.44 22.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.845 0.355 . . . . 0.0 111.576 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.671 ' HB2' ' O ' ' A' ' 73' ' ' THR . 5.8 p -143.56 150.95 39.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.385 0.612 . . . . 0.0 110.938 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.576 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 26.0 mm-40 -113.39 166.93 11.01 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.793 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.6 p -85.27 106.33 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.457 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 71' ' ' GLU . 5.8 p -115.15 81.37 1.56 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.428 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.632 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 157.44 -30.17 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.708 179.159 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 61.73 103.57 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.511 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.629 HG22 ' HB3' ' A' ' 46' ' ' PHE . 7.6 p -71.21 104.26 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.209 0.528 . . . . 0.0 110.081 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.611 ' H ' HD12 ' A' ' 99' ' ' ILE . 5.3 mp -63.68 127.17 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.032 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.435 ' HA ' ' HB2' ' A' ' 46' ' ' PHE . 6.2 m120 -92.36 145.74 24.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.017 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.527 ' HG2' HG23 ' A' ' 48' ' ' VAL . 3.2 tt0 -84.15 101.56 11.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.867 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.85 99.69 7.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.104 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.913 HG12 HD13 ' A' ' 63' ' ' ILE . 24.6 m -125.38 120.84 59.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.139 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -100.64 131.94 46.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 51' ' ' LYS . 6.4 m -110.53 128.37 66.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.147 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.05 137.74 50.17 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.533 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.637 ' HB3' ' HG3' ' A' ' 52' ' ' GLU . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.817 0.342 . . . . 0.0 111.103 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo . . . . . 0 C--O 1.23 0.119 0 CA-C-O 120.88 0.283 . . . . 0.0 112.237 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -94.85 145.21 25.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.757 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mp -93.65 114.07 26.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.195 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.719 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 44.0 pt -101.03 -176.4 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.817 178.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.908 HG22 ' CD1' ' A' ' 75' ' ' TYR . 1.1 p -151.39 147.04 26.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.236 0.541 . . . . 0.0 111.47 -178.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.698 ' HG3' HD13 ' A' ' 76' ' ' ILE . 1.4 mtp85 -161.17 104.54 1.3 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.997 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.552 HG21 ' CD ' ' A' ' 71' ' ' GLU . 15.0 t -82.15 131.44 35.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.617 0.722 . . . . 0.0 111.373 -178.526 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.542 ' O ' HD12 ' A' ' 44' ' ' ILE . 2.1 mt-10 -98.39 144.6 27.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.807 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.408 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 28.8 tt0 -66.67 91.68 0.19 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.695 -179.47 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.8 mp -87.72 109.41 26.59 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.978 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.506 ' C ' HG21 ' A' ' 98' ' ' VAL . 69.6 Cg_endo -88.26 158.18 6.88 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.837 2.358 . . . . 0.0 112.853 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.577 ' HB3' HG22 ' A' ' 98' ' ' VAL . 42.3 p90 -87.27 -174.16 4.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.945 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.42 104.43 2.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.733 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.533 HG23 ' HG2' ' A' ' 101' ' ' GLN . 11.9 p -67.42 143.5 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.189 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 49' ' ' ILE . 4.2 mp -111.82 156.07 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.094 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.453 ' N ' HG22 ' A' ' 49' ' ' ILE . 9.7 pttp -108.29 100.91 10.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.828 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.4 ttmp? -112.5 161.78 16.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.927 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -117.71 139.97 50.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.931 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -137.76 132.96 17.55 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.69 -20.28 13.77 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.454 2.103 . . . . 0.0 112.554 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.98 -30.5 59.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.155 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.506 HD22 ' NE2' ' A' ' 60' ' ' GLN . 10.5 mt -81.77 162.35 58.03 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.974 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.14 42.15 1.14 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.209 2.606 . . . . 0.0 112.602 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.67 136.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.872 0.368 . . . . 0.0 111.335 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.66 40.54 88.39 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.687 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.506 ' NE2' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -109.47 145.47 36.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 0.0 110.905 -179.993 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -112.05 117.12 31.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.828 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -130.32 126.06 36.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.991 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.688 HD13 HG22 ' A' ' 103' ' ' VAL . 27.3 mm -101.74 96.37 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.044 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.539 HD12 HG12 ' A' ' 102' ' ' VAL . 35.8 mt -66.2 -31.13 52.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.644 ' CG2' HG23 ' A' ' 102' ' ' VAL . 6.4 t -163.34 119.26 1.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.71 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.07 125.37 27.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.23 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.0 137.75 48.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.319 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.449 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.8 t -138.61 124.16 23.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.814 0.34 . . . . 0.0 111.084 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.86 119.1 4.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.183 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.447 ' CA ' ' O ' ' A' ' 96' ' ' LYS . . . -88.28 -152.25 24.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.044 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.552 ' CD ' HG21 ' A' ' 41' ' ' THR . 0.2 OUTLIER -161.52 145.94 13.13 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.619 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.591 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 31.1 ttm180 -140.36 110.39 6.52 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.139 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.724 ' O ' ' HB3' ' A' ' 92' ' ' SER . 28.0 m -73.77 125.48 28.2 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.014 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.506 ' O ' ' HA ' ' A' ' 39' ' ' THR . 10.5 m80 -105.59 117.53 34.25 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 122.098 0.952 . . . . 0.0 113.259 -176.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.908 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -89.44 108.26 19.54 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 113.694 -1.594 . . . . 0.0 111.28 -177.912 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.698 HD13 ' HG3' ' A' ' 40' ' ' ARG . 2.4 mp -95.26 160.76 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.814 -179.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.731 ' OG ' HD23 ' A' ' 90' ' ' LEU . 55.9 p -104.69 118.76 37.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.711 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.731 HG23 HG23 ' A' ' 85' ' ' THR . 9.9 p -81.45 108.55 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.155 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -113.05 88.68 2.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.6 m -82.16 117.51 22.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -127.8 107.62 10.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.952 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 60.79 31.85 20.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.843 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.75 43.24 7.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.525 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.9 tptp -143.23 107.51 4.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.793 0.33 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.731 HG23 HG23 ' A' ' 78' ' ' VAL . 24.8 m -85.85 120.06 26.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.92 142.8 31.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.925 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -105.85 95.73 6.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.6 m -123.64 125.1 44.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.064 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.9 m -55.11 145.12 5.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.022 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.731 HD23 ' OG ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -130.09 -51.76 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.171 -179.851 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 1.8 t70 -176.62 137.32 0.26 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.274 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.724 ' HB3' ' O ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -143.66 144.87 32.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.352 0.596 . . . . 0.0 111.306 179.005 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.645 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 3.1 mt-30 -103.47 166.75 10.24 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.582 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.593 ' O ' HG13 ' A' ' 94' ' ' VAL . 8.6 p -85.25 107.01 15.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.803 -179.031 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.517 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 19.3 p -110.51 83.2 1.72 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.22 -179.435 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 95' ' ' THR . 0.1 OUTLIER 103.39 44.78 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.746 -179.636 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.46 ' HB2' HG21 ' A' ' 94' ' ' VAL . 6.1 tp10 -31.31 133.32 0.08 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.313 -179.604 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.577 HG22 ' HB3' ' A' ' 46' ' ' PHE . 10.7 p -71.87 118.89 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.002 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.564 ' H ' HD12 ' A' ' 99' ' ' ILE . 5.3 mp -75.49 108.79 7.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.962 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -71.22 130.87 42.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.533 ' HG2' HG23 ' A' ' 48' ' ' VAL . 29.2 tt0 -68.53 148.0 51.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.644 HG23 ' CG2' ' A' ' 65' ' ' THR . 53.4 t -133.11 100.61 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.007 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.688 HG22 HD13 ' A' ' 63' ' ' ILE . 20.1 t -120.47 133.63 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -110.91 154.89 23.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.78 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.88 138.74 52.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.202 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.7 87.81 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.498 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.706 0.289 . . . . 0.0 111.171 179.962 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.795 0.331 . . . . 0.0 111.254 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -92.8 -30.32 9.72 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.51 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.69 110.08 3.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.776 0.322 . . . . 0.0 110.887 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.8 p -157.53 135.47 10.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.5 m170 -84.6 -177.57 6.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.945 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.9 34.92 0.83 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.971 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -91.88 80.94 5.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.821 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -160.92 31.53 0.15 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -175.65 37.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.927 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.31 -176.57 4.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -60.18 113.22 2.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.955 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.68 37.69 3.43 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.492 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mt -99.5 -68.94 0.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.648 0.261 . . . . 0.0 110.854 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.0 m 42.18 53.95 8.54 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.705 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.57 -71.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.601 2.2 . . . . 0.0 112.269 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 mtt85 59.76 31.33 20.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.874 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -173.93 70.45 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.512 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.5 p -119.81 31.51 6.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 0.0 110.907 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -147.64 -172.88 4.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.856 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 28.4 mtp -137.55 31.67 2.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.859 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.8 p -130.4 123.2 29.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.967 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.56 129.45 37.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -103.28 34.84 2.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -77.3 144.59 37.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.921 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -145.26 32.49 1.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.89 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -107.07 166.57 10.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.419 HG23 ' N ' ' A' ' 28' ' ' ALA . 31.0 m -59.95 -41.32 85.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.162 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.419 ' N ' HG23 ' A' ' 27' ' ' VAL . . . -130.29 -75.47 0.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.065 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.15 36.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.6 t30 59.93 175.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.48 HG13 ' N ' ' A' ' 32' ' ' GLU . 12.2 p -68.52 -44.8 82.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.025 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.48 ' N ' HG13 ' A' ' 31' ' ' VAL . 4.8 mt-10 -166.42 -76.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.905 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.7 m -164.3 -48.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.2 162.87 42.08 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.55 -165.75 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.587 2.191 . . . . 0.0 112.245 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.68 142.17 51.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.786 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.96 111.3 23.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.191 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.682 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 6.1 pt -101.18 -177.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.966 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.772 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.7 OUTLIER -145.86 162.26 38.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.357 0.598 . . . . 0.0 111.193 -178.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 26.6 ttt180 -174.01 112.96 0.19 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.051 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 11.1 t -82.19 129.57 34.87 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.817 0.817 . . . . 0.0 111.326 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.477 ' O ' HD12 ' A' ' 44' ' ' ILE . 2.1 mt-10 -98.13 147.72 24.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.002 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -67.08 101.48 0.88 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.028 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 1.9 mp -107.67 87.39 3.5 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.56 ' C ' HG21 ' A' ' 98' ' ' VAL . 73.2 Cg_endo -75.86 160.29 37.44 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.66 2.24 . . . . 0.0 112.688 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.593 ' HB3' HG22 ' A' ' 98' ' ' VAL . 33.5 p90 -87.15 -176.92 5.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.985 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.5 ' OE1' HD13 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -158.43 115.13 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.841 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.713 HG22 ' CB ' ' A' ' 101' ' ' GLN . 3.1 t -67.17 143.83 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.132 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.5 HD13 ' OE1' ' A' ' 47' ' ' GLU . 33.4 mm -115.84 156.19 16.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.118 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.449 ' N ' HG22 ' A' ' 49' ' ' ILE . 13.1 ptmt -108.74 109.57 20.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -119.82 153.21 36.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -87.91 129.5 35.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.971 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.436 ' ND2' HD23 ' A' ' 56' ' ' LEU . 5.8 t-20 -122.17 96.5 46.37 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.09 -23.97 45.45 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.392 2.061 . . . . 0.0 112.333 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -59.69 -28.97 67.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.991 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.546 HD12 ' CD ' ' A' ' 60' ' ' GLN . 3.1 mm? -83.18 165.29 41.7 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.742 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -80.84 43.39 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.076 2.518 . . . . 0.0 112.743 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.88 142.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.939 0.399 . . . . 0.0 111.437 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 55.17 25.85 40.93 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.876 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.546 ' CD ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -109.38 136.84 48.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 0.0 110.979 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -101.2 162.57 12.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.59 ' ND2' HD11 ' A' ' 64' ' ' ILE . 46.2 t30 -156.32 111.85 2.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.86 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.815 HD13 HG12 ' A' ' 103' ' ' VAL . 36.7 mm -85.65 86.12 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.138 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.59 HD11 ' ND2' ' A' ' 62' ' ' ASN . 36.9 mm -64.53 -36.07 76.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.953 0.406 . . . . 0.0 110.712 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.661 HG22 ' HB ' ' A' ' 102' ' ' VAL . 9.7 t -166.56 100.35 0.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.554 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.41 135.02 28.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.753 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.467 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -66.0 134.27 34.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.273 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -130.2 132.21 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.907 0.384 . . . . 0.0 111.3 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.458 ' HD3' ' CD2' ' A' ' 46' ' ' PHE . 10.7 mmtt -57.12 125.96 25.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.229 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.453 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -105.49 -159.55 23.0 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.051 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.497 ' HA ' HD12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -162.47 154.62 18.88 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.587 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 14.0 ttt180 -143.67 111.77 6.22 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.576 ' O ' ' HB2' ' A' ' 92' ' ' SER . 64.2 m -72.99 121.46 20.14 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.569 ' O ' ' HA ' ' A' ' 39' ' ' THR . 18.7 m80 -102.26 120.3 40.24 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.772 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -86.02 122.27 29.82 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.679 -1.601 . . . . 0.0 110.767 -178.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.802 HG23 ' C ' ' A' ' 88' ' ' THR . 4.2 mp -116.14 141.78 32.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.282 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.678 ' HB2' HD13 ' A' ' 90' ' ' LEU . 0.2 OUTLIER -105.24 98.06 7.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.829 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 78' ' ' VAL . 12.5 p -81.45 117.9 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.159 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.562 HD13 ' N ' ' A' ' 80' ' ' THR . 2.4 tm? -105.45 124.33 49.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.562 ' N ' HD13 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -84.78 91.24 7.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.549 ' HB2' HD12 ' A' ' 79' ' ' LEU . 5.1 tt0 -123.16 135.96 54.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.2 m120 61.15 30.49 19.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.87 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.54 47.67 81.52 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.597 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.55 142.7 12.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.774 0.321 . . . . 0.0 110.862 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.449 HG22 HG22 ' A' ' 78' ' ' VAL . 0.8 OUTLIER -102.18 120.79 41.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.889 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 t -105.05 125.86 51.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.866 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.37 107.3 19.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.876 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.802 ' C ' HG23 ' A' ' 76' ' ' ILE . 97.3 m -133.71 112.75 11.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.923 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.56 HG12 HG13 ' A' ' 76' ' ' ILE . 22.3 m -56.61 162.37 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.966 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.678 HD13 ' HB2' ' A' ' 77' ' ' SER . 1.2 mp -149.18 -56.72 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.343 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.509 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 1.4 t70 -140.65 134.73 30.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.479 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.576 ' HB2' ' O ' ' A' ' 73' ' ' THR . 17.8 p -143.21 133.33 24.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.308 0.575 . . . . 0.0 111.319 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.562 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 3.4 pt20 -89.52 166.58 13.58 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 94' ' ' VAL . 5.2 m -85.67 107.3 16.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.564 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 20.0 p -114.22 83.01 1.8 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.192 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.564 ' CB ' ' O ' ' A' ' 95' ' ' THR . 20.2 tptm 107.53 48.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.741 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -33.72 122.24 0.44 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.755 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.593 HG22 ' HB3' ' A' ' 46' ' ' PHE . 12.6 p -71.61 109.89 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.212 0.529 . . . . 0.0 111.052 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 34.8 mm -68.72 116.22 8.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.221 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 20.8 m-20 -81.52 129.33 34.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.726 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.713 ' CB ' HG22 ' A' ' 48' ' ' VAL . 12.8 tt0 -62.09 112.36 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.96 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.661 ' HB ' HG22 ' A' ' 65' ' ' THR . 58.1 t -95.4 99.73 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.954 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.815 HG12 HD13 ' A' ' 63' ' ' ILE . 25.5 m -122.85 135.72 61.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.133 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -119.8 108.5 14.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.735 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.0 t -91.41 142.0 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.069 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.81 147.1 37.63 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.552 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.31 144.49 77.49 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.655 0.264 . . . . 0.0 111.135 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.09 -73.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.521 2.147 . . . . 0.0 112.373 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.549 HG13 HG22 ' A' ' 110' ' ' THR . 10.8 p -178.53 -45.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.045 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.549 HG22 HG13 ' A' ' 109' ' ' VAL . 9.9 t -177.83 38.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.912 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.429 ' CE1' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.877 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.741 0.305 . . . . 24.440000000000001 111.246 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.27 50.88 1.15 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.981 -0.628 . . . . 22.379999999999999 112.563 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.3 t -158.58 87.87 0.9 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.825 0.345 . . . . 22.390000000000001 110.895 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.2 m -73.64 -54.22 8.65 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.161 -0.472 . . . . 20.829999999999998 110.616 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -127.03 24.51 6.38 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.178 -0.464 . . . . 19.5 111.173 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.2 m80 63.98 175.36 0.18 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.009 0.433 . . . . 20.52 111.581 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -78.64 -150.24 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.897 -0.592 . . . . 18.210000000000001 110.289 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -46.92 -53.7 11.65 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.628 0.251 . . . . 19.199999999999999 110.81 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 61.56 178.02 0.12 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.079 -0.51 . . . . 18.149999999999999 111.889 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.2 m -119.46 56.44 0.93 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.865 -0.607 . . . . 16.59 110.382 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.546 ' HA ' ' HG3' ' A' ' 15' ' ' PRO . 52.7 m -67.28 -17.12 64.65 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.157 -0.474 . . . . 16.02 112.111 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.39 -1.88 90.26 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.945 -0.645 . . . . 15.34 114.103 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.854 HD22 ' N ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -155.04 -45.0 0.08 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 117.894 0.847 . . . . 16.670000000000002 112.384 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.854 ' N ' HD22 ' A' ' 13' ' ' LEU . 74.5 t -150.19 86.89 5.08 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-O 120.788 0.327 . . . . 14.4 110.908 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.546 ' HG3' ' HA ' ' A' ' 11' ' ' SER . 1.7 Cg_endo -80.47 -64.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.043 2.495 . . . . 14.220000000000001 111.732 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.3 -41.77 2.6 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.023 -0.535 . . . . 15.75 110.532 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -136.3 -78.04 0.08 OUTLIER Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.873 -0.491 . . . . 12.26 111.873 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.38 -157.39 0.33 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.517 0.199 . . . . 12.26 111.306 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -58.01 -31.52 67.05 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.605 -0.27 . . . . 13.960000000000001 111.513 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.466 ' HB2' ' HB3' ' A' ' 23' ' ' ASP . 0.7 OUTLIER 71.34 113.66 0.05 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.587 0.355 . . . . 13.44 111.211 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.1 m -69.51 -23.75 63.65 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.09 -0.504 . . . . 13.720000000000001 111.467 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -91.95 -42.56 9.94 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.715 -0.221 . . . . 13.880000000000001 111.084 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 4.0 t70 -65.3 -31.67 72.93 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.389 -0.369 . . . . 13.08 111.613 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.67 -22.88 64.36 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.942 0.349 . . . . 13.27 111.942 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 0.0 OUTLIER 73.45 157.56 0.19 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.503 0.321 . . . . 12.35 111.249 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 25' ' ' ASN . 26.4 mm-40 70.98 -92.38 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.929 -0.578 . . . . 13.92 110.848 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.468 HG13 ' H ' ' A' ' 28' ' ' ALA . 2.6 p -176.75 -55.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 111.544 0.202 . . . . 13.31 111.544 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.468 ' H ' HG13 ' A' ' 27' ' ' VAL . . . 33.62 -96.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.129 0.572 . . . . 13.44 112.466 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.45 39.3 28.18 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.604 0.24 . . . . 13.289999999999999 111.518 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.8 m120 54.68 34.08 20.77 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.251 -0.431 . . . . 13.27 111.544 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.512 HG12 ' HB3' ' A' ' 35' ' ' PRO . 3.3 t 51.49 53.19 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 121.013 0.435 . . . . 13.59 111.201 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -105.96 -52.89 2.73 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.992 -0.549 . . . . 13.76 110.907 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.0 m -86.0 115.6 23.7 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.557 -0.292 . . . . 13.77 110.356 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.445 ' HD3' ' HB2' ' A' ' 77' ' ' SER . 1.3 mmt180 58.85 59.39 5.52 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.14 -0.482 . . . . 13.109999999999999 110.84 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.512 ' HB3' HG12 ' A' ' 31' ' ' VAL . 56.6 Cg_endo -72.34 -43.2 1.1 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.611 2.207 . . . . 12.380000000000001 112.594 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.483 ' O ' HG22 ' A' ' 78' ' ' VAL . 11.1 tp10 -147.71 112.03 5.24 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.284 -0.416 . . . . 13.359999999999999 110.467 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 mp -72.74 111.49 7.94 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.181 -0.463 . . . . 10.56 110.764 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.678 HG13 ' HB ' ' A' ' 76' ' ' ILE . 28.6 pt -99.44 121.0 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-O 121.722 0.772 . . . . 11.619999999999999 109.665 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.699 ' HB ' ' CG2' ' A' ' 73' ' ' THR . 6.3 p -87.13 139.39 30.62 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.018 -0.992 . . . . 10.51 111.111 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 7.1 ttt-85 -155.51 117.98 4.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.807 -1.088 . . . . 12.83 108.914 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 68.4 p -79.81 127.49 32.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.503 0.668 . . . . 9.4100000000000001 110.887 -178.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -96.9 139.41 32.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.639 -1.164 . . . . 8.5199999999999996 109.83 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.86 97.82 0.37 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.962 -0.563 . . . . 10.74 110.691 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.739 HD12 ' H ' ' A' ' 72' ' ' ARG . 7.5 mt -99.19 103.01 17.59 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 115.43 -0.805 . . . . 6.29 109.585 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.627 ' C ' HG21 ' A' ' 98' ' ' VAL . 90.5 Cg_endo -78.24 145.63 21.74 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.316 2.677 . . . . 6.46 114.363 -177.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.548 ' HB2' ' HA ' ' A' ' 100' ' ' ASN . 39.1 p90 -86.73 -179.82 6.63 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.278 -0.874 . . . . 7.25 111.175 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.07 117.19 6.83 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.397 -0.365 . . . . 6.0800000000000001 111.678 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.823 HG13 ' HB3' ' A' ' 101' ' ' GLN . 21.9 t -66.11 134.61 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.039 -0.528 . . . . 6.9900000000000002 111.536 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.9 mm -123.48 139.76 49.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.278 -0.419 . . . . 8.7100000000000009 111.49 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -100.19 108.19 20.23 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.881 -0.6 . . . . 10.390000000000001 110.394 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.95 106.18 16.57 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.079 -0.509 . . . . 12.289999999999999 111.155 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -61.64 105.53 0.55 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.822 0.344 . . . . 14.65 110.524 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 0.8 OUTLIER -108.34 119.82 48.46 Favored Pre-proline 0 C--O 1.232 0.173 0 CA-C-N 116.087 -0.506 . . . . 15.73 111.442 -179.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.56 -24.6 18.64 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.785 2.324 . . . . 18.25 112.371 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -61.76 -39.1 90.45 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.421 -0.354 . . . . 19.329999999999998 111.183 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.503 HD21 ' CB ' ' A' ' 62' ' ' ASN . 1.0 OUTLIER -63.58 164.27 16.49 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.495 -0.32 . . . . 17.219999999999999 110.905 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.77 -74.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.769 2.313 . . . . 17.350000000000001 113.301 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.514 ' HB1' ' HB3' ' A' ' 108' ' ' PRO . . . -178.76 122.51 0.09 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.098 -0.955 . . . . 15.789999999999999 111.205 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.21 29.1 62.38 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.189 -0.529 . . . . 13.800000000000001 113.025 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.436 ' O ' HD22 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -106.09 136.69 45.33 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.701 0.25 . . . . 15.460000000000001 110.501 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.26 113.4 25.02 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.888 0.375 . . . . 13.220000000000001 111.335 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.503 ' CB ' HD21 ' A' ' 56' ' ' LEU . 1.5 t-20 -106.22 111.99 24.82 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.893 -0.594 . . . . 14.380000000000001 109.948 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.416 HG12 HG13 ' A' ' 103' ' ' VAL . 24.2 mt -85.58 122.51 38.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.095 0.474 . . . . 13.390000000000001 111.851 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.417 HD11 ' OD1' ' A' ' 62' ' ' ASN . 44.4 mm -100.52 -39.7 7.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.374 -0.83 . . . . 13.85 109.841 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.812 HG22 HG23 ' A' ' 99' ' ' ILE . 0.2 OUTLIER -135.54 99.0 4.08 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.682 -0.69 . . . . 11.74 109.815 179.517 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.4 113.72 1.14 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.02 -0.536 . . . . 10.75 112.074 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 99' ' ' ILE . . . -58.7 109.33 1.95 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.871 -0.604 . . . . 8.4700000000000006 112.314 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.5 t -135.1 144.56 34.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.91 0.386 . . . . 10.08 111.251 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -67.48 116.3 8.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.716 -0.675 . . . . 10.15 111.125 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.491 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -81.96 -171.55 46.18 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.154 -0.546 . . . . 7.4500000000000002 112.107 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.562 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -158.72 109.18 2.05 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.461 -0.57 . . . . 10.039999999999999 109.461 179.499 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.739 ' H ' HD12 ' A' ' 44' ' ' ILE . 36.5 ttm180 -98.18 124.8 42.94 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.554 -0.536 . . . . 6.2699999999999996 109.554 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.699 ' CG2' ' HB ' ' A' ' 39' ' ' THR . 95.1 m -74.76 125.37 28.62 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 107.719 -1.215 . . . . 8.5500000000000007 107.719 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.593 ' HD2' HG23 ' A' ' 89' ' ' VAL . 19.8 m80 -105.66 114.88 29.3 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.927 0.87 . . . . 8.0999999999999996 112.647 -177.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.694 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -80.09 92.47 5.64 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 113.67 -1.605 . . . . 8.0800000000000001 109.086 -178.363 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.678 ' HB ' HG13 ' A' ' 38' ' ' ILE . 74.1 mt -88.16 154.86 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 113.411 -1.722 . . . . 10.77 112.474 -177.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.445 ' HB2' ' HD3' ' A' ' 34' ' ' ARG . 32.7 t -105.17 121.35 43.63 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.292 -0.413 . . . . 11.99 110.34 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.505 ' CG1' HD13 ' A' ' 38' ' ' ILE . 3.9 m -81.76 98.23 4.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.05 0.452 . . . . 13.470000000000001 111.351 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.0 mt -103.68 106.85 17.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.967 -0.56 . . . . 15.75 110.209 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 p -73.56 93.88 2.08 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.207 -0.451 . . . . 17.620000000000001 111.194 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -90.74 93.99 9.48 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.994 -0.548 . . . . 20.190000000000001 110.26 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 58.5 45.6 16.2 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.098 -0.501 . . . . 22.510000000000002 110.773 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.76 47.71 6.56 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.108 -0.568 . . . . 21.280000000000001 112.713 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -162.13 108.07 1.27 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.657 0.265 . . . . 21.239999999999998 111.114 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.4 p -75.72 97.74 3.92 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.239 -0.437 . . . . 17.93 110.653 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 58.9 m -77.37 110.25 11.96 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.092 -0.504 . . . . 16.48 110.751 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.51 ' HB2' HG21 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -80.79 96.34 6.94 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.112 0.482 . . . . 14.73 110.636 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 45.1 m -108.79 126.15 52.72 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.959 -0.564 . . . . 13.130000000000001 111.4 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.593 HG23 ' HD2' ' A' ' 74' ' ' HIS . 3.1 p -59.16 134.89 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.066 -0.516 . . . . 10.289999999999999 110.134 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 32.2 mt -137.64 -83.94 0.32 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.147 0.425 . . . . 10.300000000000001 112.147 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.81 122.1 44.4 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.563 0.221 . . . . 8.6099999999999994 111.343 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.649 ' HB2' ' O ' ' A' ' 73' ' ' THR . 1.3 p -145.29 148.94 34.0 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.189 0.519 . . . . 6.4699999999999998 111.656 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.636 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 19.0 mm-40 -108.65 164.64 12.19 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.032 -1.47 . . . . 9.3800000000000008 107.032 176.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.68 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 12.3 p -82.22 112.68 20.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.292 -0.563 . . . . 7.9299999999999997 110.544 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 31.9 p -117.61 72.08 0.83 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.671 0.748 . . . . 8.2699999999999996 110.612 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 149.37 -43.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.07 -1.423 . . . . 11.5 108.826 178.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.445 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 9.3 tp10 64.55 115.32 0.02 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.327 -0.851 . . . . 8.7400000000000002 111.571 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.627 HG21 ' C ' ' A' ' 45' ' ' PRO . 11.1 p -71.21 103.24 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.373 0.606 . . . . 6.0700000000000003 110.107 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.812 HG23 HG22 ' A' ' 65' ' ' THR . 4.5 mp -71.68 118.97 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.424 -0.807 . . . . 9.4299999999999997 110.962 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.548 ' HA ' ' HB2' ' A' ' 46' ' ' PHE . 4.1 m120 -82.69 133.1 35.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.846 -0.615 . . . . 7.9000000000000004 110.102 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.823 ' HB3' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -59.64 98.46 0.05 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.422 -0.354 . . . . 8.7799999999999994 111.032 -179.435 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 76.0 t -90.72 99.11 9.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.862 -0.421 . . . . 10.470000000000001 109.862 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.495 HG22 ' NE2' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -115.01 125.39 72.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.949 -0.569 . . . . 10.33 111.177 -179.102 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 53' ' ' ASN . 17.0 mm-40 -96.52 110.29 22.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.822 -0.627 . . . . 13.720000000000001 110.248 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.7 t -85.98 115.55 27.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.226 -0.443 . . . . 12.91 110.992 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.414 ' HA2' ' HB2' ' A' ' 56' ' ' LEU . . . -61.8 132.02 46.48 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.015 -0.612 . . . . 13.960000000000001 112.721 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . . . -89.41 111.26 44.49 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-O 120.361 0.124 . . . . 15.720000000000001 110.933 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.604 ' O ' HG12 ' A' ' 109' ' ' VAL . 7.2 Cg_exo -73.52 73.08 3.5 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.982 2.454 . . . . 17.07 111.995 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.604 HG12 ' O ' ' A' ' 108' ' ' PRO . 4.1 p 50.68 23.8 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 115.888 -0.596 . . . . 18.699999999999999 112.24 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 108' ' ' PRO . 6.2 t 176.68 123.05 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.439 -0.346 . . . . 19.899999999999999 110.526 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 117.999 -1.0 . . . . 21.09 111.091 -179.998 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttp . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.806 0.336 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.71 59.36 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.474 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.0 m -163.45 36.33 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 m -129.93 -46.83 1.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.991 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.418 ' CE1' ' HB2' ' A' ' 10' ' ' SER . 1.0 OUTLIER -100.85 106.67 18.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -110.63 30.61 6.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.955 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.9 m80 59.32 88.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.91 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -161.74 30.43 0.13 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.95 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 52.9 m80 58.96 82.39 0.14 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.975 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.418 ' HB2' ' CE1' ' A' ' 5' ' ' HIS . 2.1 m -88.79 -75.88 0.42 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.7 t -177.59 171.98 1.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.8 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.9 -158.82 24.06 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.527 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.517 ' O ' HG13 ' A' ' 14' ' ' VAL . 3.6 tp -131.55 -56.96 1.01 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.829 0.347 . . . . 0.0 110.861 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 13' ' ' LEU . 6.4 m -158.29 155.19 25.31 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.123 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.97 -168.22 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.545 2.163 . . . . 0.0 112.33 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.16 -31.4 14.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.987 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -140.6 -79.89 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.367 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.2 m 60.52 35.91 20.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.352 . . . . 0.0 110.904 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -60.27 -176.94 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 18.1 ttm -98.74 -70.72 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.943 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -177.4 -176.17 0.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.01 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.6 mt 60.28 163.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.95 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -176.62 136.1 0.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -60.65 131.43 50.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -123.08 34.73 5.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.902 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 60.55 -175.14 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 28' ' ' ALA . 21.5 t 63.63 158.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.118 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.483 ' N ' HG12 ' A' ' 27' ' ' VAL . . . 60.67 156.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.175 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -164.9 -44.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.3 t30 60.65 158.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.82 HG23 HG23 ' A' ' 33' ' ' THR . 6.1 m -113.15 179.33 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -83.68 -57.6 3.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.82 HG23 HG23 ' A' ' 31' ' ' VAL . 9.5 p 55.79 37.46 28.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.033 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 62.34 149.49 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.48 -45.87 1.08 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.587 2.192 . . . . 0.0 112.348 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -169.38 128.05 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.88 131.25 35.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.824 HD12 ' HB ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER -101.12 -177.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.698 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.748 HG22 ' CD1' ' A' ' 75' ' ' TYR . 1.0 OUTLIER -163.31 121.08 1.91 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.113 0.482 . . . . 0.0 110.669 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.45 ' HG3' HD13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -142.56 109.72 5.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.774 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.563 HG21 ' OE1' ' A' ' 71' ' ' GLU . 11.3 t -82.52 128.28 34.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.511 0.672 . . . . 0.0 111.407 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.574 ' O ' HD12 ' A' ' 44' ' ' ILE . 1.3 mt-10 -98.31 146.01 26.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.744 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.77 91.67 0.2 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.803 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.577 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.7 mp -89.62 108.23 23.85 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.885 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.455 ' C ' HG21 ' A' ' 98' ' ' VAL . 1.9 Cg_endo -81.95 157.43 18.07 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.941 2.427 . . . . 0.0 112.596 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.449 ' HB3' ' CG2' ' A' ' 98' ' ' VAL . 42.2 p90 -86.57 -174.4 4.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.74 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.99 116.54 3.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.874 HG22 ' CB ' ' A' ' 101' ' ' GLN . 43.2 t -67.29 148.76 11.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.051 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 50' ' ' LYS . 37.9 mm -123.82 156.16 30.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.013 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.446 ' N ' HG22 ' A' ' 49' ' ' ILE . 1.9 pttp -119.42 100.86 7.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.414 ' O ' HG12 ' A' ' 105' ' ' VAL . 8.1 mttm -105.56 141.72 36.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 3.3 pt-20 -104.79 124.89 50.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -128.67 133.29 25.03 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.12 -20.77 12.61 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.468 2.112 . . . . 0.0 112.541 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -55.06 -38.49 68.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.06 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.552 HD22 ' NE2' ' A' ' 60' ' ' GLN . 21.2 mt -62.82 159.64 43.34 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.763 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -80.24 44.98 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.039 2.493 . . . . 0.0 112.724 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.61 125.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.934 0.397 . . . . 0.0 111.424 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.44 53.63 41.92 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.779 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.552 ' NE2' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -109.46 162.91 13.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.746 0.308 . . . . 0.0 110.894 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -145.16 113.92 6.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -143.12 122.54 13.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.2 mt -86.59 131.18 35.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.09 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.5 mm -99.59 -44.24 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.9 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.6 m -144.28 102.25 3.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.659 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.417 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -53.81 153.4 4.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.483 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.59 131.29 10.32 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.19 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -140.62 136.36 35.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.869 0.366 . . . . 0.0 111.132 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -63.12 124.87 22.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 98' ' ' VAL . . . -97.99 -151.98 27.77 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.888 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.563 ' OE1' HG21 ' A' ' 41' ' ' THR . 0.3 OUTLIER -161.03 148.1 15.19 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.577 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 5.2 ttt180 -140.21 111.22 6.98 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.724 ' O ' ' HB2' ' A' ' 92' ' ' SER . 19.1 m -73.58 126.81 31.11 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.461 ' HA ' ' CB ' ' A' ' 92' ' ' SER . 20.3 m80 -107.55 119.72 40.21 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.042 0.925 . . . . 0.0 112.893 -177.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.748 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.1 OUTLIER -91.15 102.72 15.45 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 113.651 -1.613 . . . . 0.0 111.146 -177.529 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.824 ' HB ' HD12 ' A' ' 38' ' ' ILE . 4.8 mp -87.86 160.15 2.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.952 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.771 ' HB2' HD23 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -98.45 126.8 44.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.685 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.501 HG22 HD11 ' A' ' 38' ' ' ILE . 21.6 t -81.43 109.86 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.254 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.4 mt -115.75 103.53 10.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.841 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.33 123.19 34.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.831 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -129.55 93.09 3.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 61.24 36.24 17.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.964 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.82 46.13 5.22 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.442 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.01 114.64 7.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.812 0.339 . . . . 0.0 110.872 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.85 112.09 23.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.856 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.95 150.73 21.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.96 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.421 ' HA ' HG21 ' A' ' 76' ' ' ILE . 18.9 mt-10 -107.77 99.54 9.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 94.1 m -115.37 116.5 28.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.922 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.1 m -50.01 123.67 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.771 HD23 ' HB2' ' A' ' 77' ' ' SER . 0.2 OUTLIER -110.53 -67.87 0.96 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.216 -179.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.51 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -163.13 141.97 8.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.299 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.724 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.6 p -143.56 151.08 39.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.448 0.642 . . . . 0.0 111.394 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.681 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 12.8 mm-40 -110.01 166.96 10.53 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.598 ' O ' HG13 ' A' ' 94' ' ' VAL . 8.3 p -84.95 106.93 15.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.007 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.585 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 15.4 p -111.82 82.61 1.65 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.76 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.585 ' CB ' ' O ' ' A' ' 95' ' ' THR . 21.0 tttt 109.92 48.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.585 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 96' ' ' LYS . 1.2 pm0 -32.43 125.47 0.31 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.819 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.455 HG21 ' C ' ' A' ' 45' ' ' PRO . 4.3 p -71.7 119.14 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.03 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 66' ' ' ALA . 34.8 mm -70.05 115.96 10.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.919 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -90.36 130.9 36.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.874 ' CB ' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -68.57 127.36 32.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.85 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 102' ' ' VAL . 5.5 m -126.5 99.73 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.188 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 103' ' ' VAL . 11.9 p -108.25 116.53 51.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.015 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -87.1 108.55 18.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 51' ' ' LYS . 12.6 p -98.36 137.73 25.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.5 ' CA ' HD12 ' A' ' 56' ' ' LEU . . . -72.66 130.85 15.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.511 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . . . -132.32 156.14 80.45 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 111.063 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.24 -168.16 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.572 2.182 . . . . 0.0 112.226 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.5 m -101.92 -37.71 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.124 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.4 m -60.21 -69.15 0.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.401 ' CD2' ' OE2' ' A' ' 52' ' ' GLU . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.917 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.855 0.36 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 105.31 28.47 5.48 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.467 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.3 m 60.34 -169.95 0.15 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.815 0.341 . . . . 0.0 110.885 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.56 159.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.943 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 60.7 80.71 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.886 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -151.59 34.73 0.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -167.73 120.4 0.9 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.828 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -143.44 103.26 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.845 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -169.81 -46.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.3 -171.43 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.48 169.47 8.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.949 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.28 -174.21 44.3 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.5 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mp -95.86 -34.76 11.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.663 0.268 . . . . 0.0 110.832 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 14' ' ' VAL . 9.2 p 42.89 52.03 7.44 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.697 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 14' ' ' VAL . 55.7 Cg_endo -69.94 99.09 0.74 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.581 2.187 . . . . 0.0 112.291 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 60.6 31.62 20.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.99 30.28 10.5 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.436 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.3 t 60.43 109.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.803 0.335 . . . . 0.0 111.006 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -91.77 -31.57 15.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.002 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.1 mtm -100.95 134.22 44.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.941 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.5 m -85.75 -31.39 22.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.8 mt -60.19 167.84 2.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -139.26 -169.97 2.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 61.27 113.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.934 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.96 -178.28 4.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.88 177.82 6.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.923 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 28' ' ' ALA . 21.3 t -78.64 158.74 4.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.111 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.483 ' N ' HG12 ' A' ' 27' ' ' VAL . . . -79.57 -69.11 0.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.203 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.46 -178.89 0.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.156 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -175.65 153.14 1.39 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.1 m -137.09 179.16 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.069 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -131.31 36.42 3.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.2 m -126.37 -52.09 1.5 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -159.88 141.67 9.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.69 -165.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.552 2.168 . . . . 0.0 112.207 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.437 ' HG3' HG12 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -98.01 -179.18 4.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.916 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.1 mt -111.36 115.69 29.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.949 0.404 . . . . 0.0 111.132 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.65 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -101.11 -176.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.525 179.273 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.843 HG22 ' CD1' ' A' ' 75' ' ' TYR . 1.4 p -158.03 140.12 14.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.345 0.593 . . . . 0.0 111.079 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.507 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 33.9 ttp180 -161.23 107.07 1.38 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.02 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.599 HG21 ' CD ' ' A' ' 71' ' ' GLU . 14.8 t -81.93 132.43 35.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.709 0.766 . . . . 0.0 111.706 -178.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.579 ' O ' HD12 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -98.56 144.69 27.6 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.574 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -66.77 91.68 0.2 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.854 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.581 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 3.2 mp -85.19 111.04 33.37 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.783 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.528 ' C ' HG21 ' A' ' 98' ' ' VAL . 81.4 Cg_endo -87.46 153.41 7.81 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.667 2.245 . . . . 0.0 112.849 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.604 ' HB3' HG22 ' A' ' 98' ' ' VAL . 49.9 p90 -87.07 -176.83 5.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.782 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -149.57 112.46 4.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.098 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.718 HG22 ' HB3' ' A' ' 101' ' ' GLN . 16.4 t -67.22 149.23 11.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.031 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.441 HG22 ' N ' ' A' ' 50' ' ' LYS . 33.0 mm -125.79 156.06 35.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.184 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.441 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -119.03 100.93 7.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.778 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.89 137.59 38.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -93.81 102.73 14.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.899 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -102.57 96.56 7.59 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.838 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.65 -18.06 48.11 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.461 2.108 . . . . 0.0 112.488 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -58.16 -31.5 67.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.977 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.729 HD22 ' HG2' ' A' ' 60' ' ' GLN . 11.3 mt -76.07 165.4 53.36 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.799 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -83.9 42.34 1.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.13 2.553 . . . . 0.0 112.606 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.06 150.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.843 0.354 . . . . 0.0 111.314 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 55.2 27.15 45.46 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.616 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.729 ' HG2' HD22 ' A' ' 56' ' ' LEU . 51.7 tp60 -95.49 116.14 28.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 110.907 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -110.91 134.88 52.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.798 ' O ' HG23 ' A' ' 103' ' ' VAL . 25.9 p-10 -151.13 161.9 41.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.9 mm -126.49 95.9 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.101 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.7 mm -72.88 -31.79 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.98 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.9 m -163.42 96.2 0.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.708 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.485 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -53.87 151.77 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.483 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.459 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -93.4 120.89 6.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.33 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.39 133.75 57.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.823 0.344 . . . . 0.0 111.152 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.691 ' HA ' HG23 ' A' ' 98' ' ' VAL . 1.2 mtmp? -59.27 125.74 24.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.156 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.415 ' HA2' ' HG3' ' A' ' 96' ' ' LYS . . . -96.05 -141.01 11.46 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.999 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.599 ' CD ' HG21 ' A' ' 41' ' ' THR . 0.3 OUTLIER -166.71 141.94 4.31 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.815 ' NE ' HG12 ' A' ' 94' ' ' VAL . 22.4 ttm180 -136.11 111.11 8.87 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.736 ' O ' ' HB3' ' A' ' 92' ' ' SER . 32.8 m -73.78 124.92 26.98 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.516 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 8.5 m80 -105.08 117.0 32.91 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 122.082 0.944 . . . . 0.0 113.191 -176.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.843 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.1 OUTLIER -89.55 100.72 13.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 113.611 -1.631 . . . . 0.0 110.98 -178.082 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.504 HG22 ' N ' ' A' ' 77' ' ' SER . 4.5 mp -87.56 161.17 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.281 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.725 ' HB3' HD23 ' A' ' 90' ' ' LEU . 5.3 t -107.82 112.85 25.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.721 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.631 HG13 ' O ' ' A' ' 78' ' ' VAL . 8.8 p -81.54 102.19 7.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.017 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 tp -110.1 108.9 19.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.945 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 80' ' ' THR . 9.9 t -86.0 107.55 17.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.814 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -104.85 93.22 4.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.847 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 60.4 31.14 20.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.83 43.16 3.4 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.561 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 11.4 ttpt -149.16 112.66 5.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.792 0.33 . . . . 0.0 110.891 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.486 HG22 ' CG2' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -100.77 110.42 22.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.855 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.86 132.04 50.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.936 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.76 99.63 11.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.951 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.3 t -113.93 125.47 54.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.927 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.3 m -51.04 115.68 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.094 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.725 HD23 ' HB3' ' A' ' 77' ' ' SER . 0.1 OUTLIER -100.84 -63.42 1.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.533 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -166.04 136.58 3.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.009 -179.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.736 ' HB3' ' O ' ' A' ' 73' ' ' THR . 0.8 OUTLIER -143.59 150.1 38.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.547 0.689 . . . . 0.0 111.576 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.617 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -109.46 166.47 10.86 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.815 HG12 ' NE ' ' A' ' 72' ' ' ARG . 30.9 m -85.23 106.79 15.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.06 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.568 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 16.9 p -110.95 82.56 1.61 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.714 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 95' ' ' THR . 2.5 tppt? 132.4 -39.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.631 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 59.09 121.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.556 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.691 HG23 ' HA ' ' A' ' 69' ' ' LYS . 8.2 p -81.71 114.47 22.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.737 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.592 ' H ' HD12 ' A' ' 99' ' ' ILE . 4.6 mp -75.32 132.18 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -93.72 140.49 29.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.962 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.718 ' HB3' HG22 ' A' ' 48' ' ' VAL . 1.6 tp60 -77.12 114.4 15.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.94 99.7 9.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.046 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 62' ' ' ASN . 11.7 p -121.19 119.56 59.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -93.37 133.16 36.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.839 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.3 m -112.27 123.27 67.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.232 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.77 123.79 19.69 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.449 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -175.24 149.23 1.13 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.767 0.318 . . . . 0.0 111.068 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.85 142.4 43.01 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.585 2.19 . . . . 0.0 112.352 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.2 p -100.6 -32.81 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.062 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.56 -50.76 6.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.822 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 28.9 m170 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.944 179.971 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.82 0.343 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -104.69 -50.23 0.97 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.479 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 t 60.25 82.21 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.868 0.366 . . . . 0.0 110.957 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.1 m -131.17 -46.35 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.837 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -128.57 173.82 9.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -127.92 85.88 2.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.0 m80 64.13 -79.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -171.27 35.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.893 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -176.82 122.33 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.17 93.78 3.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.8 35.91 2.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.944 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.3 163.76 36.08 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.498 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.53 84.13 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.769 0.319 . . . . 0.0 110.861 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.4 m -143.26 154.74 61.25 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.07 -37.52 8.31 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.548 2.165 . . . . 0.0 112.289 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.0 ttp-105 -176.2 90.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -142.7 28.39 2.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.46 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 m -159.41 79.9 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.877 0.37 . . . . 0.0 110.936 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -112.92 -37.59 4.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 tpp -59.71 106.42 0.48 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.86 -31.42 11.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.982 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.3 mt -59.62 -31.48 69.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.017 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -67.29 120.93 14.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -94.81 163.57 13.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.16 -68.08 0.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.952 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.23 170.82 7.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.929 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 27' ' ' VAL . 7.2 p -139.38 93.34 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.074 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 58.87 30.51 20.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.168 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.77 -170.43 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.089 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -162.25 -48.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.859 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.848 HG11 ' NE ' ' A' ' 34' ' ' ARG . 11.2 p -178.13 158.19 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.085 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.466 ' N ' HG22 ' A' ' 31' ' ' VAL . 46.4 mm-40 -119.94 -41.53 2.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 56.0 m -118.26 142.54 47.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.848 ' NE ' HG11 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -118.81 150.88 49.31 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.46 -45.44 1.21 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.624 2.216 . . . . 0.0 112.243 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -168.82 113.73 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.814 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mp -76.95 132.49 39.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.045 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.708 HD12 ' HB ' ' A' ' 76' ' ' ILE . 0.5 OUTLIER -101.26 -177.06 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.783 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.792 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.9 OUTLIER -163.67 123.02 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.178 0.513 . . . . 0.0 110.342 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.609 ' HG3' HD13 ' A' ' 76' ' ' ILE . 2.8 mtm180 -149.6 109.36 4.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.29 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.536 HG21 ' OE1' ' A' ' 71' ' ' GLU . 14.9 t -82.41 133.22 35.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.71 0.767 . . . . 0.0 111.872 -178.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.583 ' O ' HD12 ' A' ' 44' ' ' ILE . 3.0 mt-10 -98.35 147.64 24.47 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.453 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.403 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -66.68 98.32 0.51 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.884 -179.355 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.583 HD12 ' O ' ' A' ' 42' ' ' GLU . 2.9 mp -95.9 105.43 21.28 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.576 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.522 ' C ' HG21 ' A' ' 98' ' ' VAL . 87.7 Cg_endo -84.69 150.36 11.37 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.719 2.279 . . . . 0.0 113.171 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.669 ' HB3' HG22 ' A' ' 98' ' ' VAL . 43.0 p90 -86.87 -175.06 5.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.939 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.67 116.53 5.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.239 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.709 HG22 ' CB ' ' A' ' 101' ' ' GLN . 61.6 t -67.23 149.68 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.122 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.748 HD12 ' O ' ' A' ' 101' ' ' GLN . 4.0 mp -115.65 156.2 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.005 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.44 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.9 OUTLIER -122.92 107.76 12.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -115.25 165.82 12.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.905 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -112.81 138.51 49.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.402 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 6.3 m-20 -138.27 96.52 9.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.921 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 53' ' ' ASN . 37.3 Cg_endo -66.02 -20.8 57.15 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.413 2.075 . . . . 0.0 112.438 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -58.3 -29.63 66.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.994 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.473 HD22 ' NE2' ' A' ' 60' ' ' GLN . 3.5 mt -70.97 165.96 42.4 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.878 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.29 46.79 2.2 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.117 2.545 . . . . 0.0 112.796 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.25 126.48 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.832 0.349 . . . . 0.0 111.641 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 51.67 55.88 18.31 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.928 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.473 ' NE2' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -109.4 144.06 38.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.786 0.327 . . . . 0.0 110.951 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -104.4 130.08 52.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.926 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.525 ' ND2' HD11 ' A' ' 64' ' ' ILE . 48.9 t30 -146.58 127.86 14.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.982 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.858 HD13 HG12 ' A' ' 103' ' ' VAL . 25.0 mm -104.99 90.99 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.034 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.525 HD11 ' ND2' ' A' ' 62' ' ' ASN . 36.6 mm -65.47 -32.67 59.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.549 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.688 HG22 ' HB ' ' A' ' 102' ' ' VAL . 5.3 t -161.38 128.3 3.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.398 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.48 135.37 35.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 111.419 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.43 ' HA3' ' CE2' ' A' ' 46' ' ' PHE . . . -81.98 134.95 13.6 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.308 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.641 ' H ' HG23 ' A' ' 99' ' ' ILE . 16.5 t -145.16 142.95 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 111.088 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.69 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -72.56 119.7 17.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.344 -179.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.436 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -89.84 -139.91 7.79 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.639 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.536 ' OE1' HG21 ' A' ' 41' ' ' THR . 0.9 OUTLIER -169.64 146.91 3.4 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 2.5 ttt180 -134.91 111.67 10.04 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.699 ' O ' ' HB3' ' A' ' 92' ' ' SER . 37.4 m -73.84 126.65 30.88 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.527 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 9.1 m80 -105.82 117.37 33.84 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 122.148 0.975 . . . . 0.0 112.753 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.792 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.1 OUTLIER -90.37 100.1 13.0 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 113.57 -1.65 . . . . 0.0 111.075 -177.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.708 ' HB ' HD12 ' A' ' 38' ' ' ILE . 3.1 mp -87.8 159.9 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.726 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.695 ' HB2' HD22 ' A' ' 90' ' ' LEU . 40.0 t -102.83 126.71 50.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.828 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 78' ' ' VAL . 29.1 m -81.51 106.29 12.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.203 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.71 HD13 ' N ' ' A' ' 80' ' ' THR . 1.7 tm? -112.47 130.99 55.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.943 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.71 ' N ' HD13 ' A' ' 79' ' ' LEU . 0.8 OUTLIER -98.6 135.8 39.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.898 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -152.22 115.65 4.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.826 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.8 m120 60.07 34.96 21.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.966 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.98 29.5 66.89 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.509 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -128.3 165.0 21.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.915 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.03 120.32 41.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.97 151.02 22.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.778 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.27 121.97 40.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 98.9 m -144.79 123.07 12.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.967 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 p -58.21 131.99 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.834 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.695 HD22 ' HB2' ' A' ' 77' ' ' SER . 2.2 tp -116.04 -55.54 2.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.296 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 3.6 t0 -169.45 136.91 1.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.482 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.699 ' HB3' ' O ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -143.66 145.23 32.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.387 0.613 . . . . 0.0 111.261 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.605 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 34.5 mm-40 -106.89 165.86 11.02 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 94' ' ' VAL . 9.0 p -85.88 106.93 15.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.4 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.515 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 9.7 p -111.71 82.11 1.56 Allowed 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.656 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 95' ' ' THR . 0.0 OUTLIER 140.96 -36.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.642 178.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 56.44 115.02 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.821 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.69 HG23 ' HA ' ' A' ' 69' ' ' LYS . 14.9 p -81.49 106.29 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.535 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.641 HG23 ' H ' ' A' ' 68' ' ' VAL . 4.1 tt -79.42 133.01 30.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.304 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.428 ' HA ' ' HB2' ' A' ' 46' ' ' PHE . 27.9 m-20 -92.49 161.75 14.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.888 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.772 ' OE1' HG13 ' A' ' 103' ' ' VAL . 0.8 OUTLIER -96.8 140.54 31.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.688 ' HB ' HG22 ' A' ' 65' ' ' THR . 84.2 t -126.1 118.68 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.988 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.858 HG12 HD13 ' A' ' 63' ' ' ILE . 4.4 m -131.25 145.63 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.0 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -116.18 108.38 16.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.26 110.74 20.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.41 133.28 50.3 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.506 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -101.45 148.23 34.91 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.637 0.256 . . . . 0.0 111.151 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.74 -69.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.613 2.209 . . . . 0.0 112.303 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.429 HG13 ' N ' ' A' ' 110' ' ' THR . 10.8 p -178.06 -41.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.115 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.429 ' N ' HG13 ' A' ' 109' ' ' VAL . 8.3 t -91.94 157.22 16.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.941 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ptm . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.778 0.323 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -148.51 32.07 1.24 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.484 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.438 ' HB3' ' CD2' ' A' ' 6' ' ' HIS . 3.5 t -100.73 -169.98 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.741 0.305 . . . . 0.0 110.945 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.2 t -61.1 -74.56 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -111.0 135.54 51.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.952 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.438 ' CD2' ' HB3' ' A' ' 3' ' ' SER . 2.0 m-70 -141.29 -74.73 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -176.51 100.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.981 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -176.39 84.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -105.28 -69.29 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.899 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.2 m 60.2 79.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.7 p -126.82 -68.48 0.8 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.961 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 158.69 -161.98 32.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.508 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -108.42 -30.81 8.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 0.0 110.961 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.6 t 64.57 77.55 0.29 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.79 -45.91 0.93 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.643 2.229 . . . . 0.0 112.314 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -156.45 -178.55 7.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.25 -24.97 76.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.599 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.2 t -57.94 124.94 20.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.706 0.289 . . . . 0.0 110.943 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -131.6 -168.06 1.96 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 mmt -58.51 155.53 12.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.937 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.525 ' C ' HD12 ' A' ' 22' ' ' LEU . 43.0 m -62.8 -178.09 0.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.952 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 21' ' ' SER . 6.9 mp -132.37 -74.61 0.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.899 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -114.67 81.49 1.57 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -109.57 -31.34 7.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.863 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.9 t30 60.84 157.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.936 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -61.88 142.26 57.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.463 HG12 ' H ' ' A' ' 29' ' ' ALA . 21.4 t -135.49 140.17 45.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.18 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.36 88.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.08 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.463 ' H ' HG12 ' A' ' 27' ' ' VAL . . . -65.14 134.44 53.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.072 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -167.7 145.0 4.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.925 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 m -98.92 31.18 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.184 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 60.85 105.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 62.7 m -123.78 -69.37 0.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -163.61 164.2 15.43 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.02 -166.66 0.17 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.567 2.178 . . . . 0.0 112.228 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -93.75 148.89 21.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.657 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.83 117.23 34.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.11 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.705 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 1.1 pp -101.2 -176.72 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.09 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.857 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -149.66 152.58 35.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.257 0.551 . . . . 0.0 111.025 -179.276 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 74' ' ' HIS . 19.5 ttt-85 -170.05 111.62 0.44 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.003 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 14.9 t -82.16 131.78 35.24 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.828 0.823 . . . . 0.0 111.478 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.505 ' O ' HD12 ' A' ' 44' ' ' ILE . 0.7 OUTLIER -98.15 149.72 22.23 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.871 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -66.95 105.53 1.65 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.059 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.576 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.4 mp -107.73 100.41 34.89 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.867 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.539 ' C ' HG21 ' A' ' 98' ' ' VAL . 2.8 Cg_endo -84.99 156.86 11.44 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.038 2.492 . . . . 0.0 112.581 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.623 ' HB3' HG22 ' A' ' 98' ' ' VAL . 46.5 p90 -87.13 -174.25 4.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.013 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -153.35 109.05 3.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.986 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.572 HG23 ' HG2' ' A' ' 101' ' ' GLN . 10.4 p -67.42 154.06 8.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.196 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.6 mp -124.79 156.15 33.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.045 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -107.27 100.81 10.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.8 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -90.43 147.7 23.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.965 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -107.95 102.97 12.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.538 ' HB2' HD12 ' A' ' 56' ' ' LEU . 2.5 m120 -94.16 102.83 9.07 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.61 -26.91 46.06 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.406 2.071 . . . . 0.0 112.271 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -69.41 -31.48 69.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.572 HD22 ' HB3' ' A' ' 60' ' ' GLN . 21.4 mt -63.59 163.23 21.53 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -86.86 31.0 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.818 2.345 . . . . 0.0 112.948 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 56.85 104.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.266 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 118.25 -25.35 8.29 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.634 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.572 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -70.63 134.9 47.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 0.0 110.868 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -137.96 128.44 26.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.533 ' ND2' HD11 ' A' ' 64' ' ' ILE . 24.6 p-10 -128.14 148.61 50.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.771 HD13 HG12 ' A' ' 103' ' ' VAL . 29.0 mm -97.65 86.33 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.147 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.533 HD11 ' ND2' ' A' ' 62' ' ' ASN . 29.2 mm -62.24 -35.82 71.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.812 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.3 m -164.28 90.98 0.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.629 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.401 ' HB2' HG21 ' A' ' 63' ' ' ILE . . . -52.12 150.97 4.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.52 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.429 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -88.86 134.69 12.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.338 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.405 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.4 t -132.41 132.43 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.856 0.36 . . . . 0.0 111.204 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.0 mttp -56.07 126.2 24.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.184 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' A' ' 96' ' ' LYS . . . -99.81 -157.44 28.47 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.129 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.481 ' HA ' HD12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -159.94 151.4 19.79 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.576 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 36.7 ttt180 -141.9 110.91 6.27 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.633 ' O ' ' HB2' ' A' ' 92' ' ' SER . 96.0 m -73.33 121.24 20.11 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.536 ' O ' ' HA ' ' A' ' 39' ' ' THR . 13.7 m80 -102.94 121.55 42.77 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.795 0.807 . . . . 0.0 113.133 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.857 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -89.55 107.78 19.28 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 113.857 -1.52 . . . . 0.0 111.273 -177.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.675 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.5 mp -98.69 159.24 3.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.896 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.634 ' OG ' HD13 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -115.14 113.47 24.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.867 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 78' ' ' VAL . 11.3 p -81.45 113.15 20.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.13 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.33 107.01 15.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.855 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.6 m -76.46 104.05 6.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.992 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -115.3 108.47 16.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.783 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 60.58 35.3 20.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.98 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.84 47.46 25.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.475 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.89 107.41 3.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.785 0.326 . . . . 0.0 110.877 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 p -79.79 125.22 29.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.3 p -123.67 150.98 43.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.95 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -105.59 113.89 27.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.4 t -123.24 123.25 40.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.944 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.3 m -57.66 129.45 19.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.99 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.634 HD13 ' OG ' ' A' ' 77' ' ' SER . 3.1 tp -119.12 -58.15 1.96 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.15 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.521 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 1.9 t70 -166.29 140.78 4.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.273 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.633 ' HB2' ' O ' ' A' ' 73' ' ' THR . 17.2 p -143.15 149.26 37.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.33 0.586 . . . . 0.0 111.12 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.567 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 7.0 pt20 -105.46 166.88 10.12 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.5 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 26.0 t -85.31 106.6 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.122 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 21.8 p -113.07 83.05 1.76 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.13 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 95' ' ' THR . 0.0 OUTLIER 105.55 48.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.853 -179.662 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -33.63 126.2 0.4 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.853 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.623 HG22 ' HB3' ' A' ' 46' ' ' PHE . 10.0 p -71.76 112.5 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.98 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.599 ' H ' HD12 ' A' ' 99' ' ' ILE . 5.2 mp -72.1 126.79 33.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.021 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -87.32 133.44 33.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.814 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.572 ' HG2' HG23 ' A' ' 48' ' ' VAL . 5.3 tt0 -67.33 150.02 49.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.955 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.24 100.51 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.069 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.771 HG12 HD13 ' A' ' 63' ' ' ILE . 4.0 m -119.08 106.76 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.014 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -94.46 109.86 21.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.5 m -105.27 141.0 21.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.138 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.21 147.7 50.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.535 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -175.23 82.19 0.31 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.712 0.291 . . . . 0.0 111.037 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.1 110.86 2.52 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.557 2.171 . . . . 0.0 112.357 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.728 HG23 HG22 ' A' ' 110' ' ' THR . 14.1 m -128.65 -46.05 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.068 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.728 HG22 HG23 ' A' ' 109' ' ' VAL . 2.6 t -145.7 171.95 13.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.874 179.884 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.8 mtm . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.844 0.354 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.61 41.21 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.426 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 p -68.96 -32.55 72.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.744 0.307 . . . . 0.0 110.899 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 m -104.79 96.85 6.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -103.95 -31.73 9.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.953 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 60.62 158.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -78.59 128.8 34.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.888 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -89.55 99.87 12.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -82.72 -74.32 0.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.947 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.05 136.92 32.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.6 p -89.6 94.9 10.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.958 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 141.69 -136.46 7.39 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.487 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.4 mt -143.71 98.71 3.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.838 0.351 . . . . 0.0 110.922 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.478 HG23 ' HD3' ' A' ' 16' ' ' ARG . 7.0 m -107.31 150.03 39.48 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.195 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.93 130.28 18.86 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.544 2.163 . . . . 0.0 112.267 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.478 ' HD3' HG23 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -176.43 -46.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.839 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.41 -156.61 24.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.411 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.43 89.91 1.3 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.87 0.367 . . . . 0.0 110.88 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -156.83 107.03 2.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.9 mtm -77.37 98.32 5.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.5 p -132.55 -52.52 0.94 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' A' ' 23' ' ' ASP . 3.7 pp -94.29 -38.32 11.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.899 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.463 ' HB2' HD12 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -176.89 -175.0 0.57 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -101.1 -31.13 11.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.865 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 60.76 105.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.882 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -154.08 151.74 29.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 27' ' ' VAL . 6.4 m -134.25 83.59 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.102 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -174.2 36.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.122 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -108.94 32.11 5.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.141 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.8 m120 60.67 99.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.838 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.533 HG12 ' H ' ' A' ' 33' ' ' THR . 28.2 t -71.26 138.85 20.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.102 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -131.51 31.51 4.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.533 ' H ' HG12 ' A' ' 31' ' ' VAL . 7.0 m -163.91 142.75 7.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.78 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 61.22 155.18 0.11 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.974 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.22 -46.07 1.61 Allowed 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.542 2.162 . . . . 0.0 112.287 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -170.52 128.65 0.82 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.861 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.1 mt -84.09 123.34 29.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.986 0.422 . . . . 0.0 111.069 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.763 HD12 ' N ' ' A' ' 39' ' ' THR . 1.1 pp -101.08 -176.37 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.202 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.852 HG22 ' CD1' ' A' ' 75' ' ' TYR . 1.8 p -157.34 142.8 17.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.318 0.58 . . . . 0.0 110.901 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.589 ' HG2' HD13 ' A' ' 76' ' ' ILE . 2.6 ptp85 -162.59 107.33 1.15 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.206 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.455 ' HB ' ' HA ' ' A' ' 73' ' ' THR . 15.4 t -82.28 129.86 34.96 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.768 0.794 . . . . 0.0 111.604 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.596 ' O ' HD12 ' A' ' 44' ' ' ILE . 0.6 OUTLIER -98.29 146.3 25.8 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.678 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -66.81 94.83 0.33 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.952 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.596 HD12 ' O ' ' A' ' 42' ' ' GLU . 3.2 mp -87.07 109.88 28.53 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.949 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.419 ' C ' HG21 ' A' ' 98' ' ' VAL . 6.3 Cg_exo -78.65 152.91 26.18 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.843 2.362 . . . . 0.0 112.563 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.479 ' HB3' ' CG2' ' A' ' 98' ' ' VAL . 52.6 p90 -86.68 -178.58 6.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -138.83 111.67 7.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.961 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.621 HG13 ' CD ' ' A' ' 101' ' ' GLN . 46.2 t -67.45 141.95 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.079 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.438 HG22 ' N ' ' A' ' 50' ' ' LYS . 27.3 mt -130.42 156.07 42.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.103 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.438 ' N ' HG22 ' A' ' 49' ' ' ILE . 1.6 ptpp? -131.98 100.84 5.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -95.02 171.88 8.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -111.56 139.97 46.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.52 ' ND2' HD13 ' A' ' 56' ' ' LEU . 64.1 t-20 -138.48 110.13 8.15 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.85 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.77 -26.15 38.99 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.409 2.072 . . . . 0.0 112.378 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.74 -32.91 71.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.561 HD23 ' HB3' ' A' ' 60' ' ' GLN . 9.1 mp -65.17 165.13 18.17 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.877 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -86.95 32.17 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.914 2.409 . . . . 0.0 112.808 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.86 142.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.874 0.368 . . . . 0.0 111.167 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.42 27.82 61.28 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.561 ' HB3' HD23 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -109.03 141.91 40.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.747 0.308 . . . . 0.0 110.951 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -136.81 124.73 22.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.904 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.818 ' ND2' HD11 ' A' ' 64' ' ' ILE . 15.7 p-10 -130.55 142.08 50.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.585 HD13 HG22 ' A' ' 103' ' ' VAL . 30.9 mm -94.23 94.34 4.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.097 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.818 HD11 ' ND2' ' A' ' 62' ' ' ASN . 21.1 mm -73.63 -32.86 37.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.824 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 m -164.62 84.96 0.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.6 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.476 ' HB2' HG21 ' A' ' 63' ' ' ILE . . . -51.38 132.63 29.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.505 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.45 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -59.68 131.26 50.77 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.327 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 66' ' ' ALA . 21.5 t -130.66 135.52 60.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.389 . . . . 0.0 111.115 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.6 mttp -61.36 116.81 4.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.139 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.468 ' HA3' ' HA ' ' A' ' 98' ' ' VAL . . . -88.46 -149.22 18.44 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.871 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.49 ' CB ' ' HB3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -163.23 146.31 10.45 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.314 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.595 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 19.0 ttp85 -139.67 111.35 7.25 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.737 ' O ' ' HB2' ' A' ' 92' ' ' SER . 91.3 m -73.41 125.16 27.25 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.695 ' HD2' HG21 ' A' ' 89' ' ' VAL . 13.9 m80 -106.14 119.05 38.22 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 122.185 0.993 . . . . 0.0 113.1 -176.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.852 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.1 OUTLIER -90.34 98.85 12.02 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 113.437 -1.71 . . . . 0.0 111.459 -177.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.4 mp -87.56 143.45 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.027 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.813 ' CB ' HD21 ' A' ' 90' ' ' LEU . 25.3 m -89.72 122.26 32.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.708 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.58 HG13 ' CG2' ' A' ' 85' ' ' THR . 21.6 t -81.35 98.35 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.111 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.3 tp -112.21 126.51 55.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.863 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 m -89.06 119.58 29.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.93 95.54 4.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.852 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 60.38 36.41 20.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.851 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.82 28.43 26.32 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.426 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.7 127.11 36.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.795 0.331 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.58 ' CG2' HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -85.15 102.39 13.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -68.63 135.85 52.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.403 ' HA ' HG21 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -115.62 84.9 2.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.548 ' N ' HG23 ' A' ' 76' ' ' ILE . 88.0 m -132.7 130.23 39.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.884 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.695 HG21 ' HD2' ' A' ' 74' ' ' HIS . 12.8 p -85.39 140.37 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.813 HD21 ' CB ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -132.29 2.15 3.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.862 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.464 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.3 OUTLIER 179.96 117.87 0.05 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.9 0.381 . . . . 0.0 111.785 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.737 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.9 p -143.24 134.59 26.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.232 0.539 . . . . 0.0 110.708 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.636 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 5.3 mt-30 -89.72 166.5 13.54 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.43 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 22.9 t -85.5 107.48 16.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.925 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 20.3 p -111.2 82.95 1.68 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.024 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 95' ' ' THR . 7.9 tptm 103.48 41.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.614 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.413 ' CB ' HG11 ' A' ' 94' ' ' VAL . 6.6 tm-20 -29.18 130.54 0.07 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.134 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.479 ' CG2' ' HB3' ' A' ' 46' ' ' PHE . 4.9 p -71.76 126.02 31.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.164 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 29.7 mm -88.33 129.68 39.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.055 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -91.95 146.71 23.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.815 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.621 ' CD ' HG13 ' A' ' 48' ' ' VAL . 0.3 OUTLIER -60.34 139.39 57.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.917 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.4 t -127.67 99.69 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.084 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.796 HG13 ' O ' ' A' ' 62' ' ' ASN . 21.6 t -133.22 137.43 53.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -104.56 132.26 51.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.79 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.48 120.43 53.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.133 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.32 119.34 9.32 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.416 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -126.41 153.63 74.92 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.724 0.297 . . . . 0.0 111.064 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.12 -168.37 0.29 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.547 2.164 . . . . 0.0 112.33 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.0 p -61.57 131.15 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.009 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.2 t -141.98 140.36 32.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.824 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.892 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.1 ttm . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.897 0.379 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -170.44 73.65 0.11 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.52 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 p -132.07 116.21 16.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 0.0 110.857 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.8 t -176.65 -40.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.939 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -121.63 99.14 6.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.405 ' O ' ' CG ' ' A' ' 7' ' ' HIS . 18.8 m-70 -107.46 -75.13 0.64 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.405 ' CG ' ' O ' ' A' ' 6' ' ' HIS . 95.0 m-70 -157.19 30.1 0.29 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.943 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 58.87 31.35 21.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.953 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -69.39 83.49 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.8 t 60.28 166.31 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.3 m -124.9 84.92 2.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.03 64.13 0.36 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.475 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.89 81.48 8.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.829 0.347 . . . . 0.0 110.903 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.453 HG23 ' HD2' ' A' ' 15' ' ' PRO . 10.6 p -59.49 136.35 89.13 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.453 ' HD2' HG23 ' A' ' 14' ' ' VAL . 56.9 Cg_endo -70.54 148.35 59.85 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.446 2.097 . . . . 0.0 112.35 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -31.25 68.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.853 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.64 -138.43 4.93 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.562 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.4 m -106.87 162.9 13.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.797 0.332 . . . . 0.0 110.894 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -70.41 -173.66 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.797 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.7 mtp -128.02 -65.54 0.9 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.842 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 m -82.2 -53.44 6.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.35 -70.38 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.956 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.4 t70 61.52 154.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.72 85.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -105.55 79.86 1.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -106.48 169.53 8.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.527 ' O ' HG13 ' A' ' 27' ' ' VAL . 11.1 p -66.54 116.19 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.169 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.29 109.06 14.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.064 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.19 89.07 2.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.112 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -134.23 31.56 3.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.618 HG23 ' CD ' ' A' ' 32' ' ' GLU . 12.5 m -82.27 -30.76 9.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.187 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.618 ' CD ' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -152.73 175.83 12.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.925 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.8 t -116.98 -39.71 3.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.942 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? -147.62 160.27 39.06 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.24 -42.91 26.03 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.544 2.162 . . . . 0.0 112.42 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -164.14 123.74 2.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.855 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 71.4 mt -95.5 124.36 39.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 111.126 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.608 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 5.0 pt -101.01 -177.38 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.654 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.759 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.7 OUTLIER -156.9 154.6 30.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.538 0.685 . . . . 0.0 111.809 -179.081 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.75 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 54.8 ttp180 -170.97 120.32 0.53 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 5.6 t -81.78 140.53 34.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.999 0.904 . . . . 0.0 112.68 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.468 ' HG2' ' CD2' ' A' ' 74' ' ' HIS . 6.8 mm-40 -98.66 139.27 34.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.123 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.417 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -66.97 91.59 0.21 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.966 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.844 HD12 ' H ' ' A' ' 72' ' ' ARG . 6.7 mt -96.11 104.7 17.92 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.986 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.546 ' C ' HG21 ' A' ' 98' ' ' VAL . 80.1 Cg_endo -84.78 160.5 12.14 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.785 2.323 . . . . 0.0 113.248 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.598 ' HB3' HG22 ' A' ' 98' ' ' VAL . 54.1 p90 -87.15 -174.13 4.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.081 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -152.78 110.26 3.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.842 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.83 HG22 ' CB ' ' A' ' 101' ' ' GLN . 20.3 t -67.01 148.05 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.17 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 50' ' ' LYS . 5.5 mt -124.02 156.18 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.152 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.44 ' N ' HG22 ' A' ' 49' ' ' ILE . 20.2 tttp -122.96 100.82 7.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.841 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.9 162.97 13.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -94.63 114.51 26.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.906 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.401 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 6.4 t-20 -100.91 96.47 5.66 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 53' ' ' ASN . 37.6 Cg_endo -66.2 -26.75 49.25 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.475 2.117 . . . . 0.0 112.288 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -66.86 -31.22 71.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.92 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 60' ' ' GLN . 18.3 mt -74.64 163.32 69.07 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -86.83 31.47 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.888 2.392 . . . . 0.0 112.923 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.15 122.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.83 0.348 . . . . 0.0 111.26 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.19 -26.69 19.99 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.582 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.455 ' HB3' HD13 ' A' ' 56' ' ' LEU . 1.3 tm0? -66.78 136.4 55.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 0.0 110.871 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -129.34 114.27 16.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.816 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -109.25 130.06 55.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.896 HD13 HG12 ' A' ' 103' ' ' VAL . 31.2 mm -92.2 86.11 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.823 HD13 HG12 ' A' ' 102' ' ' VAL . 3.3 mp -65.3 -44.06 94.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.956 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.429 ' HB ' HG23 ' A' ' 102' ' ' VAL . 25.8 m -151.95 93.79 1.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.599 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -51.18 144.02 10.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.567 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.486 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -77.01 127.6 8.54 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.424 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.46 125.61 37.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.879 0.371 . . . . 0.0 110.985 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.455 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -60.68 113.48 2.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.354 -179.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.492 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -78.8 -146.06 3.17 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.637 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.599 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.1 OUTLIER -177.56 109.88 0.07 Allowed 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.844 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.9 OUTLIER -102.84 138.42 39.75 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.226 -179.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.668 ' O ' ' HB3' ' A' ' 92' ' ' SER . 87.7 m -75.6 140.51 42.68 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.525 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.75 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 2.0 m-70 -118.94 118.42 31.47 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.541 0.686 . . . . 0.0 112.082 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.759 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -91.23 118.82 30.79 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.203 -177.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.691 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.5 mp -108.69 160.3 7.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.962 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.742 ' HB2' HD23 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -101.78 127.37 48.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.895 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.459 HG22 HD13 ' A' ' 38' ' ' ILE . 21.4 t -99.28 98.36 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.3 mt -112.64 111.85 22.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.899 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.62 96.6 6.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -113.72 122.31 46.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.954 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 60.46 34.81 20.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.15 42.34 67.46 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.486 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.87 141.04 17.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.344 . . . . 0.0 110.875 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.37 112.89 25.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.941 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.83 122.98 38.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.839 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -86.66 89.13 7.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.83 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.3 t -103.15 132.75 49.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.934 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.3 m -52.32 124.87 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.121 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.742 HD23 ' HB2' ' A' ' 77' ' ' SER . 0.2 OUTLIER -111.06 -66.83 1.04 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.062 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.515 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -170.87 143.51 2.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.283 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.708 ' HG ' ' CE1' ' A' ' 74' ' ' HIS . 1.0 OUTLIER -143.4 165.29 27.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.407 0.623 . . . . 0.0 110.846 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.603 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 8.1 pt20 -129.31 166.84 18.69 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.096 -0.957 . . . . 0.0 108.661 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.815 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.1 p -85.69 106.84 15.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.599 ' O ' ' O ' ' A' ' 71' ' ' GLU . 7.2 p -117.12 81.0 1.57 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.35 0.595 . . . . 0.0 110.652 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 71' ' ' GLU . 3.1 tptm 149.44 -30.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.273 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 58.35 107.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.818 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.598 HG22 ' HB3' ' A' ' 46' ' ' PHE . 6.8 p -71.48 109.76 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.029 0.442 . . . . 0.0 110.085 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.441 HG22 ' O ' ' A' ' 66' ' ' ALA . 39.3 mm -63.98 123.69 17.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.853 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -91.93 135.62 33.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.886 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.83 ' CB ' HG22 ' A' ' 48' ' ' VAL . 1.8 tt0 -68.5 99.38 0.96 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.823 HG12 HD13 ' A' ' 64' ' ' ILE . 21.8 t -91.68 99.75 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.009 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.896 HG12 HD13 ' A' ' 63' ' ' ILE . 29.4 m -128.48 127.21 66.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.162 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -108.68 108.49 19.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.811 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.38 142.54 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.134 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.52 142.15 43.61 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.522 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -175.82 87.83 0.29 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.702 0.287 . . . . 0.0 111.057 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.22 108.69 2.22 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.622 2.215 . . . . 0.0 112.265 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.2 m -80.9 170.01 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.164 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 t -157.86 80.63 0.86 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.918 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.4 p80 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.864 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 mmt . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.795 0.331 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 150.01 45.34 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.521 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.2 m -169.32 137.26 1.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.855 0.359 . . . . 0.0 110.883 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.1 m -93.41 -75.08 0.51 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.93 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 59.95 44.75 13.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.899 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.0 m170 -59.76 -75.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.966 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 59.85 79.17 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -113.16 35.62 3.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.945 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -107.8 144.53 34.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.907 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.88 86.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.8 t -131.41 123.09 27.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.926 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.79 49.14 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.52 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tp -96.15 -34.22 11.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.798 0.333 . . . . 0.0 110.869 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 14' ' ' VAL . 7.3 p -178.68 88.24 0.22 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.055 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.48 141.26 45.89 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.546 2.164 . . . . 0.0 112.302 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 tpp85 68.15 -69.77 0.14 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.993 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 57.84 54.48 37.08 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.542 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.1 m 60.99 41.81 13.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.34 . . . . 0.0 110.835 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.5 t60 61.19 52.42 3.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.0 mpp? 60.73 177.02 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.956 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 p -126.59 151.26 48.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.853 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.534 HD23 ' O ' ' A' ' 22' ' ' LEU . 0.8 OUTLIER 60.57 32.01 20.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.935 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -170.52 126.54 0.76 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.79 151.75 7.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.931 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -62.84 -62.77 1.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -176.55 88.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 28' ' ' ALA . 11.3 p -69.44 -45.15 79.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.056 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.491 ' N ' HG13 ' A' ' 27' ' ' VAL . . . -177.24 -69.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.057 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -171.53 -41.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.122 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.407 ' ND2' HG11 ' A' ' 27' ' ' VAL . 2.9 m-80 60.2 75.73 0.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.452 HG23 ' N ' ' A' ' 32' ' ' GLU . 11.0 m -142.94 -47.17 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.452 ' N ' HG23 ' A' ' 31' ' ' VAL . 1.1 tp10 67.26 -72.78 0.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.0 p -146.18 126.68 14.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.997 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.4 ttt85 -143.43 139.84 16.91 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.97 151.01 78.28 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.456 2.104 . . . . 0.0 112.265 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -81.01 -179.07 7.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.771 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mp -104.4 113.92 27.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.058 0.456 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.695 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -101.3 -176.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.815 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.493 HG22 ' CD1' ' A' ' 75' ' ' TYR . 1.2 p -152.57 139.78 19.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.207 0.527 . . . . 0.0 110.892 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 17.5 tpt180 -158.65 102.94 1.72 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.085 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 8.0 t -81.96 129.23 34.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.571 0.701 . . . . 0.0 111.496 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.586 ' O ' HD12 ' A' ' 44' ' ' ILE . 0.6 OUTLIER -98.46 144.18 28.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.941 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.97 91.68 0.21 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.638 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.586 HD12 ' O ' ' A' ' 42' ' ' GLU . 3.0 mp -87.2 110.17 31.28 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.03 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.51 ' C ' HG21 ' A' ' 98' ' ' VAL . 83.8 Cg_endo -86.03 153.68 9.75 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.725 2.283 . . . . 0.0 112.751 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.591 ' HB3' HG22 ' A' ' 98' ' ' VAL . 42.7 p90 -87.17 -174.27 4.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.846 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -159.04 118.42 3.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.936 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.472 HG23 ' NE2' ' A' ' 101' ' ' GLN . 9.0 p -67.49 152.53 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.013 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.1 mp -130.66 156.16 42.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.13 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.44 ' N ' HG22 ' A' ' 49' ' ' ILE . 12.3 mmtm -128.25 100.86 6.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -101.86 170.35 8.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 1.7 mm-40 -109.62 120.34 42.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.954 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.63 HD21 HD22 ' A' ' 56' ' ' LEU . 1.7 p-10 -114.16 96.39 42.08 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.843 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.36 60.42 2.59 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.51 2.14 . . . . 0.0 112.408 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.58 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -160.92 27.23 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.026 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.655 HD23 ' HB3' ' A' ' 60' ' ' GLN . 3.5 mp -130.55 176.53 2.8 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.776 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.27 30.22 0.53 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.176 2.584 . . . . 0.0 112.869 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.2 136.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.91 0.386 . . . . 0.0 111.484 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.9 29.33 67.51 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.734 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.655 ' HB3' HD23 ' A' ' 56' ' ' LEU . 42.9 tp60 -109.39 112.07 23.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.799 0.333 . . . . 0.0 110.762 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.56 143.41 33.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.972 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -135.72 130.05 33.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.0 mm -85.68 86.12 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.164 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.575 HD11 ' HG3' ' A' ' 104' ' ' GLU . 28.6 mt -71.2 -43.46 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.408 ' HB ' HG22 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -149.07 91.93 1.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.613 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.85 154.47 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.522 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.416 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -84.74 129.63 9.33 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.414 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.45 126.96 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.761 0.315 . . . . 0.0 111.075 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.681 ' HA ' HG23 ' A' ' 98' ' ' VAL . 15.0 mtmt -57.37 127.95 34.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.146 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.435 ' HA2' ' HG3' ' A' ' 96' ' ' LYS . . . -101.97 -143.44 13.52 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.079 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.535 ' N ' ' HB3' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -166.97 144.05 4.67 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.593 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 42.1 ttt180 -135.98 111.52 9.25 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.699 ' O ' ' HB2' ' A' ' 92' ' ' SER . 62.0 m -73.84 126.82 31.27 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.524 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 13.3 m80 -107.21 119.87 40.56 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 122.068 0.937 . . . . 0.0 112.921 -176.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.695 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -91.36 99.59 12.52 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 113.541 -1.663 . . . . 0.0 111.391 -177.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.666 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.5 mp -87.58 159.71 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.847 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.755 ' OG ' HD23 ' A' ' 90' ' ' LEU . 77.6 p -108.53 105.38 14.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.775 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.468 ' O ' HG23 ' A' ' 78' ' ' VAL . 8.8 m -81.43 98.33 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.225 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.6 tt -108.08 116.4 31.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 80' ' ' THR . 10.7 t -81.9 112.17 18.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.936 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -116.05 113.27 22.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 60.17 31.83 20.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.894 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.82 44.54 10.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.432 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.77 119.7 4.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.773 0.32 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.84 123.03 32.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.4 150.16 29.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.852 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -97.52 113.8 25.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 94.8 m -133.59 118.05 17.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.931 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 89' ' ' VAL . 10.9 p -54.03 125.37 8.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.978 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.755 HD23 ' OG ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -107.83 -53.46 2.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.267 -179.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.521 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -176.68 141.01 0.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.316 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.699 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.6 p -143.67 150.99 39.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.367 0.603 . . . . 0.0 111.32 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.635 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 23.1 mm-40 -110.74 166.53 10.94 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.522 ' HA ' ' HG3' ' A' ' 72' ' ' ARG . 6.2 m -85.26 106.64 15.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.054 -178.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.568 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 15.9 p -110.72 82.6 1.62 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.689 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 95' ' ' THR . 26.2 tptp 131.92 -26.96 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.015 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 96' ' ' LYS . 17.9 pt-20 44.56 111.47 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.681 HG23 ' HA ' ' A' ' 69' ' ' LYS . 8.2 p -71.88 115.77 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.874 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.5 mm -74.04 128.96 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.068 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -95.14 139.41 31.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.978 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.472 ' NE2' HG23 ' A' ' 48' ' ' VAL . 0.6 OUTLIER -77.63 100.34 6.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.817 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.408 HG22 ' HB ' ' A' ' 65' ' ' THR . 5.4 m -100.59 109.28 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 103' ' ' VAL . 11.0 p -123.19 118.38 54.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.575 ' HG3' HD11 ' A' ' 64' ' ' ILE . 2.4 mm-40 -87.16 121.01 29.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.832 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.95 128.51 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.209 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.62 130.64 50.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.503 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 52' ' ' GLU . . . -138.99 91.01 11.74 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.626 0.251 . . . . 0.0 111.008 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.49 -167.79 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.473 2.115 . . . . 0.0 112.308 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.49 131.59 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.249 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.445 HG22 ' H ' ' A' ' 111' ' ' HIS . 0.2 OUTLIER -150.96 -172.58 4.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.445 ' H ' HG22 ' A' ' 110' ' ' THR . 13.7 m80 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.888 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 tpp . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.869 0.366 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 106.14 -173.2 19.61 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.479 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 p -138.78 50.64 1.84 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.1 34.25 19.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 60.41 51.67 5.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 60.86 83.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.3 171.83 14.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -126.06 31.28 5.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -176.64 -170.25 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.0 t -129.72 95.67 4.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 p -176.05 165.63 2.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.834 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.95 -73.21 0.85 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.464 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -60.23 -165.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.668 0.271 . . . . 0.0 110.819 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.483 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 42.8 t -56.73 -58.11 19.5 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.635 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 17.9 Cg_endo -58.96 84.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.265 1.976 . . . . 0.0 112.211 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.8 ttt-85 -117.92 135.49 54.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.81 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -165.66 -132.66 1.4 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.44 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 m -130.16 -169.75 2.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.808 0.337 . . . . 0.0 110.885 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -59.93 -31.51 69.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.7 mtm -77.46 -74.4 0.25 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.896 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.3 31.62 20.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.1 mp -74.56 -177.83 3.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -98.38 35.51 1.78 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.869 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -99.1 -33.76 10.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -68.27 121.93 17.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.911 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -68.63 168.48 13.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.941 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.35 -41.37 29.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.193 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.46 124.25 34.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.106 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.15 -75.69 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.108 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -81.83 -74.98 0.31 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.898 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.7 t -151.83 -67.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.051 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 57.39 32.3 21.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.991 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.505 HG22 ' HD2' ' A' ' 35' ' ' PRO . 3.7 m -163.92 104.82 0.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.93 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.643 ' N ' ' CD ' ' A' ' 35' ' ' PRO . 2.7 ptm180 -79.43 -30.48 0.64 Allowed Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.014 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 34' ' ' ARG . 90.8 Cg_endo -85.56 -167.45 0.4 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.087 1.858 . . . . 0.0 112.329 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.57 129.65 36.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.817 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mt -74.21 114.98 13.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.09 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.677 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -101.38 -176.57 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.095 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.517 ' HB ' ' CG2' ' A' ' 73' ' ' THR . 1.4 p -152.19 136.73 16.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.226 0.536 . . . . 0.0 111.223 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.554 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 10.0 mmm-85 -150.1 103.13 3.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.403 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.652 HG23 ' N ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -82.17 124.8 30.21 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.602 0.715 . . . . 0.0 111.163 -178.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.555 ' O ' HD12 ' A' ' 44' ' ' ILE . 3.4 mt-10 -98.29 147.94 24.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.958 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -66.92 101.42 0.84 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.83 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.563 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.4 mp -106.66 91.42 6.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.847 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.687 ' C ' HG21 ' A' ' 98' ' ' VAL . 97.9 Cg_endo -78.49 161.83 28.05 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.74 2.294 . . . . 0.0 112.799 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.546 ' HB3' HG22 ' A' ' 98' ' ' VAL . 49.5 p90 -87.37 176.62 7.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.147 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -147.24 109.38 4.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.971 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.786 HG22 ' CB ' ' A' ' 101' ' ' GLN . 11.6 t -67.13 153.95 8.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.073 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.5 mp -124.94 156.14 33.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.122 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.46 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -125.11 100.81 6.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.831 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.1 mtmt -97.7 171.87 8.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.945 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -109.88 104.77 13.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.578 ' ND2' HD22 ' A' ' 56' ' ' LEU . 2.0 p-10 -110.31 96.51 26.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.78 -18.7 53.26 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.492 2.128 . . . . 0.0 112.593 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.544 ' OD1' HD13 ' A' ' 56' ' ' LEU . 16.1 p30 -54.78 -29.74 54.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.882 0.372 . . . . 0.0 111.008 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.818 HD23 ' HB3' ' A' ' 60' ' ' GLN . 6.2 mp -83.24 175.06 5.12 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.741 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -82.55 28.33 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.094 2.529 . . . . 0.0 112.979 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.1 123.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.883 0.373 . . . . 0.0 111.55 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.18 -23.28 32.28 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.83 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.818 ' HB3' HD23 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -71.47 123.54 22.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.879 0.371 . . . . 0.0 110.956 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.87 ' HG3' HG13 ' A' ' 105' ' ' VAL . 2.5 mp0 -114.44 115.85 27.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.613 ' OD1' HD21 ' A' ' 56' ' ' LEU . 4.8 p-10 -119.04 123.96 45.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.836 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.559 HG23 HG22 ' A' ' 103' ' ' VAL . 22.1 mt -85.76 131.42 34.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.019 0.437 . . . . 0.0 111.115 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.8 mm -94.07 -46.78 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.767 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.772 HG22 ' HB ' ' A' ' 102' ' ' VAL . 15.3 t -149.13 97.85 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.516 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.19 126.64 7.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.815 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.451 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -66.25 132.35 33.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.168 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.421 ' HB ' HD13 ' A' ' 99' ' ' ILE . 22.7 t -131.22 138.83 52.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.954 0.407 . . . . 0.0 111.065 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.612 ' HA ' HG23 ' A' ' 98' ' ' VAL . 8.0 mptt -66.27 130.8 44.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.406 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.403 ' N ' ' HA ' ' A' ' 98' ' ' VAL . . . -109.42 -148.99 12.83 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.47 ' N ' ' CB ' ' A' ' 96' ' ' LYS . 0.6 OUTLIER -166.69 156.71 11.61 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.595 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 4.8 ttt180 -140.14 112.49 7.8 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.693 ' O ' ' HB3' ' A' ' 92' ' ' SER . 86.3 m -73.85 127.32 32.54 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.554 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 20.8 m80 -106.26 117.26 33.59 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.261 1.029 . . . . 0.0 113.055 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.677 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -89.12 102.14 14.8 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 113.433 -1.712 . . . . 0.0 110.921 -177.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.634 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.5 mp -87.66 160.7 2.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.891 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.642 ' OG ' HD22 ' A' ' 90' ' ' LEU . 74.9 m -110.62 127.89 55.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.834 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.38 103.72 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.196 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mt -125.06 88.66 2.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.818 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.22 146.2 39.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.846 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -153.97 126.89 8.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.908 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 60.4 35.9 20.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.956 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.28 48.69 57.17 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.531 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.7 ttpt -159.69 107.5 1.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.837 0.351 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.81 129.9 37.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.5 m -115.39 151.06 35.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.54 112.75 23.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 96.7 m -133.99 126.65 30.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.901 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.0 p -55.61 148.96 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.991 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.642 HD22 ' OG ' ' A' ' 77' ' ' SER . 0.3 OUTLIER -137.86 -50.89 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.26 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.524 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -158.3 126.63 5.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.321 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.693 ' HB3' ' O ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -143.4 144.25 31.97 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.4 0.619 . . . . 0.0 111.417 179.133 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.595 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 5.4 mt-30 -106.25 165.46 11.23 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 94' ' ' VAL . 8.8 p -86.15 106.63 15.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.473 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.476 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 7.2 p -111.71 82.01 1.55 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.568 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' A' ' 95' ' ' THR . 0.0 OUTLIER 148.29 -33.39 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.296 179.087 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.431 ' H ' HG22 ' A' ' 94' ' ' VAL . 1.5 tt0 53.33 109.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.892 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.687 HG21 ' C ' ' A' ' 45' ' ' PRO . 9.4 p -80.7 102.75 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.481 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.576 ' H ' HD12 ' A' ' 99' ' ' ILE . 5.2 mp -64.35 123.92 18.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.056 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.413 ' HA ' ' HB2' ' A' ' 46' ' ' PHE . 3.2 m-20 -89.44 133.85 34.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.673 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.786 ' CB ' HG22 ' A' ' 48' ' ' VAL . 5.4 tt0 -67.05 125.33 25.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.948 0.404 . . . . 0.0 110.98 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.772 ' HB ' HG22 ' A' ' 65' ' ' THR . 60.9 t -113.37 99.71 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.678 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.559 HG22 HG23 ' A' ' 63' ' ' ILE . 21.8 t -125.68 154.71 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.405 ' N ' HG12 ' A' ' 103' ' ' VAL . 2.5 mt-10 -133.22 108.36 8.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.77 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.87 HG13 ' HG3' ' A' ' 61' ' ' GLU . 21.8 t -101.04 136.56 32.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.172 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.03 148.6 35.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.489 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.75 148.47 19.36 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.721 0.296 . . . . 0.0 111.206 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.23 171.46 15.97 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.501 2.134 . . . . 0.0 112.313 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.6 t -112.5 -35.17 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.072 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 111' ' ' HIS . 0.2 OUTLIER -78.78 -175.65 4.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.478 ' H ' HG22 ' A' ' 110' ' ' THR . 8.7 m-70 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.842 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ttm . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.805 0.336 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 143.03 45.26 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.452 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.37 -78.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 110.969 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.24 31.55 20.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.936 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -176.57 115.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.892 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -74.84 176.48 7.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.964 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -64.31 114.24 4.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.921 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -135.29 -176.49 4.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.919 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -60.21 94.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.7 t -126.87 79.45 1.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.914 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.59 165.42 2.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.825 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 146.39 -165.83 28.22 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.447 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tt -83.87 -31.61 25.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.77 0.319 . . . . 0.0 110.87 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 m -130.36 151.0 77.78 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.116 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.19 -39.52 5.61 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.573 2.182 . . . . 0.0 112.297 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 -130.19 174.18 10.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.866 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.55 53.62 4.09 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.499 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.3 p -107.71 33.54 4.01 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.809 0.338 . . . . 0.0 110.945 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 60.19 -168.78 0.16 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.1 mtt -128.92 89.01 2.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.933 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -176.53 -45.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.5 tp -107.98 120.95 43.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.971 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -161.41 -69.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.931 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 63.9 -79.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.966 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -107.13 -62.12 1.45 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 0.0 110.912 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 27' ' ' VAL . 2.6 tm-20 61.02 33.32 19.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.905 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 26' ' ' GLU . 6.6 m -156.9 177.1 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.077 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.86 93.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.102 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.92 -75.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.08 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 t30 60.44 -175.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.586 ' O ' HG12 ' A' ' 31' ' ' VAL . 16.3 t -115.9 32.61 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.074 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -127.92 32.65 4.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.925 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.65 49.08 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.004 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 62.05 151.55 0.1 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.844 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.57 -68.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.496 2.13 . . . . 0.0 112.399 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -170.65 147.18 2.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.79 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.5 mp -104.36 116.59 32.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.95 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.568 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 5.7 pt -101.27 -177.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.363 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.732 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -158.58 154.48 26.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.372 0.606 . . . . 0.0 111.077 -179.209 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.548 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 13.1 ttm180 -169.26 126.08 0.92 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.646 HG22 ' CA ' ' A' ' 73' ' ' THR . 16.1 p -81.89 136.08 35.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 122.006 0.908 . . . . 0.0 112.547 -177.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HG2' ' ND1' ' A' ' 74' ' ' HIS . 9.3 mm-40 -98.23 142.61 29.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.097 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.405 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -66.78 94.21 0.3 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.671 -179.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.91 HD12 ' H ' ' A' ' 72' ' ' ARG . 6.9 mt -101.66 98.02 8.84 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.777 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.484 ' C ' HG21 ' A' ' 98' ' ' VAL . 95.8 Cg_endo -78.51 157.81 28.83 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.772 2.315 . . . . 0.0 113.176 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.682 ' HB3' HG22 ' A' ' 98' ' ' VAL . 45.6 p90 -86.87 -173.93 4.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.105 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.43 102.95 4.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.756 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.71 HG23 ' HG3' ' A' ' 101' ' ' GLN . 8.8 p -66.93 146.47 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.148 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 48' ' ' VAL . 34.2 mm -125.19 156.19 34.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.179 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.445 ' N ' HG22 ' A' ' 49' ' ' ILE . 7.4 mptt -120.42 100.86 7.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.767 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.63 145.13 24.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -114.73 102.61 10.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.781 ' ND2' HD13 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -117.44 140.09 26.95 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.913 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -78.13 -19.88 11.81 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.601 2.201 . . . . 0.0 112.538 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -52.34 -30.26 27.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.116 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.781 HD13 ' ND2' ' A' ' 53' ' ' ASN . 11.2 mp -82.7 169.1 19.09 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.798 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.19 31.23 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.316 2.678 . . . . 0.0 112.874 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 63.18 138.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.899 0.38 . . . . 0.0 111.279 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.02 36.35 80.78 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.603 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.704 ' HB3' HD23 ' A' ' 56' ' ' LEU . 60.1 tp60 -109.51 145.65 35.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.878 0.37 . . . . 0.0 110.935 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.7 113.94 19.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.821 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -118.87 119.12 33.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.928 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.1 mm -85.71 92.76 3.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.722 HD11 ' HG3' ' A' ' 104' ' ' GLU . 21.7 mt -76.55 -44.9 34.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.88 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.54 91.49 1.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.801 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.487 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -46.9 143.18 3.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.791 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.458 ' HA3' ' CE2' ' A' ' 46' ' ' PHE . . . -91.31 129.63 9.9 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.248 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.0 131.11 41.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.966 0.412 . . . . 0.0 111.156 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.522 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -64.12 112.78 3.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.159 -179.647 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.525 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -75.55 -144.29 1.24 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.762 -0.733 . . . . 0.0 111.717 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.68 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 7.7 tt0 -177.55 109.29 0.07 Allowed 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.91 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -98.4 138.43 35.65 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.229 0.538 . . . . 0.0 110.448 -179.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.646 ' CA ' HG22 ' A' ' 41' ' ' THR . 52.0 m -75.55 135.81 40.58 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.729 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.659 ' O ' ' HA ' ' A' ' 39' ' ' THR . 6.5 m80 -116.08 121.83 43.34 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.74 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.732 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -91.93 113.34 25.59 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.772 -178.095 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.695 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.1 mp -97.13 143.56 12.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.02 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.9 t -96.01 105.53 17.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.78 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.764 ' CG1' HG22 ' A' ' 85' ' ' THR . 21.4 t -81.55 105.27 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.9 tp -97.11 88.66 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.844 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.58 123.66 21.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.965 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -143.65 105.92 4.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 65.16 26.88 12.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.094 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.78 41.44 7.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.819 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.591 ' HD2' HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -140.54 122.72 15.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.908 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.764 HG22 ' CG1' ' A' ' 78' ' ' VAL . 1.2 p -101.26 105.5 16.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.591 HG23 ' HD2' ' A' ' 84' ' ' LYS . 27.8 p -87.11 99.88 12.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.476 ' HG3' HG21 ' A' ' 76' ' ' ILE . 2.6 tt0 -74.8 98.75 3.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 76' ' ' ILE . 92.1 m -129.66 125.36 35.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 p -51.18 136.84 10.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.022 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -125.6 -72.66 0.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.343 -179.716 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.493 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 3.6 t0 -137.96 138.2 38.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.349 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.565 ' HB2' ' O ' ' A' ' 73' ' ' THR . 29.0 p -143.24 165.62 26.95 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.66 0.743 . . . . 0.0 111.395 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.665 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 36.0 mm-40 -130.03 166.45 20.1 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.153 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.791 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 17.2 t -86.2 105.75 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.554 ' O ' ' O ' ' A' ' 71' ' ' GLU . 11.6 p -121.43 80.97 1.73 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.551 0.691 . . . . 0.0 110.889 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.68 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 155.3 -31.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.731 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 62.4 101.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.819 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.682 HG22 ' HB3' ' A' ' 46' ' ' PHE . 6.6 p -71.43 103.75 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.144 0.497 . . . . 0.0 110.12 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 66' ' ' ALA . 32.9 mm -63.92 131.05 29.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.222 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 46' ' ' PHE . 3.6 m-20 -98.86 139.67 34.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.002 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.71 ' HG3' HG23 ' A' ' 48' ' ' VAL . 3.0 tp-100 -75.04 103.92 5.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.921 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.29 99.73 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.985 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.1 p -123.12 148.37 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.194 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.722 ' HG3' HD11 ' A' ' 64' ' ' ILE . 22.6 mt-10 -111.17 142.02 43.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.816 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.32 136.56 57.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.141 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -73.87 102.05 1.28 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.468 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 61.77 151.12 0.1 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.75 0.31 . . . . 0.0 111.141 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.09 -168.42 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.639 2.226 . . . . 0.0 112.329 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.53 -30.89 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.122 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.8 t -92.55 -39.34 11.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.927 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 10.8 m80 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.913 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 mtm . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.744 0.306 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.67 -28.89 11.58 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.496 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.1 p -89.15 -169.82 2.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.902 0.382 . . . . 0.0 110.873 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.3 t 61.3 113.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.852 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -59.96 -176.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.924 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -59.76 149.52 30.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.88 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -60.1 172.85 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.976 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -133.71 -176.2 4.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.958 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -98.15 32.51 2.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.0 m -129.82 106.44 8.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.94 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 p -165.4 163.57 19.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.929 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -145.47 -174.69 17.9 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.559 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.9 tp -142.78 -47.37 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.842 0.353 . . . . 0.0 110.862 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.481 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 11.6 t -58.63 -48.69 96.41 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.492 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 72.8 Cg_endo -77.45 -168.33 0.58 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.242 1.962 . . . . 0.0 112.356 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.11 150.83 28.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.855 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.95 48.5 0.94 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.543 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.7 p -129.33 179.54 5.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.807 0.337 . . . . 0.0 110.92 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -151.44 152.53 33.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.849 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.0 ttt -93.08 141.34 28.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.985 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.3 p -78.81 -37.05 41.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.2 tp -81.24 85.05 6.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -153.61 82.49 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.948 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -103.76 90.63 3.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.888 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -76.13 116.2 16.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.88 125.07 25.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.91 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.07 82.64 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 59.64 -173.1 0.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.079 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.11 -75.55 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.119 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 60.07 -176.36 0.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.937 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 31' ' ' VAL . 9.6 m -73.03 79.45 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.123 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.485 ' O ' HG23 ' A' ' 33' ' ' THR . 18.9 mt-10 -106.91 179.16 4.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.845 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 32' ' ' GLU . 23.1 p -158.92 85.78 0.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.974 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.425 ' CG ' ' HD2' ' A' ' 35' ' ' PRO . 2.4 mpt_? -83.81 165.45 39.48 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.717 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.568 ' HD3' HD23 ' A' ' 79' ' ' LEU . 57.6 Cg_endo -71.55 160.53 48.11 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.481 2.12 . . . . 0.0 112.301 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -73.86 168.25 19.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.9 mt -92.52 106.37 18.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.963 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.773 HD12 ' N ' ' A' ' 39' ' ' THR . 1.0 OUTLIER -101.3 -176.49 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.445 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.773 ' N ' HD12 ' A' ' 38' ' ' ILE . 1.0 OUTLIER -152.41 147.85 26.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.281 0.562 . . . . 0.0 110.729 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 74' ' ' HIS . 16.9 ttp180 -164.18 100.62 0.85 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.893 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 15.2 t -81.93 132.19 35.26 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.831 0.824 . . . . 0.0 111.364 -178.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -98.11 145.17 26.83 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.149 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.403 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -66.22 99.11 0.5 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.337 -179.561 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.752 HD12 ' N ' ' A' ' 72' ' ' ARG . 6.4 mt -105.09 92.6 5.56 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.302 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.76 ' C ' HG21 ' A' ' 98' ' ' VAL . 94.1 Cg_endo -78.32 164.37 26.65 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.818 2.345 . . . . 0.0 112.855 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.466 ' CD1' ' HA3' ' A' ' 67' ' ' GLY . 35.2 p90 -87.28 175.04 8.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.102 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -143.04 108.85 5.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.995 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.768 HG22 ' CB ' ' A' ' 101' ' ' GLN . 10.3 t -67.1 154.05 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.22 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.1 mp -140.71 156.09 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.069 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' N ' HG22 ' A' ' 49' ' ' ILE . 23.0 mttt -110.35 108.62 18.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.98 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.92 118.06 35.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.953 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -77.09 104.69 7.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.985 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.444 ' HB2' HD12 ' A' ' 56' ' ' LEU . 30.3 m-20 -106.12 139.79 20.63 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.11 -29.21 6.75 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.58 2.187 . . . . 0.0 112.406 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -57.54 -44.14 84.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.565 HD11 ' O ' ' A' ' 104' ' ' GLU . 5.2 mt -59.76 168.28 2.07 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.93 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -86.31 30.12 0.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.268 2.645 . . . . 0.0 112.69 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 57.73 105.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 0.0 111.315 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.85 -24.18 27.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.784 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.55 144.06 28.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.868 0.366 . . . . 0.0 110.973 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.813 ' HG3' HG23 ' A' ' 105' ' ' VAL . 1.5 mp0 -124.08 173.7 8.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.818 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.723 ' ND2' HD11 ' A' ' 64' ' ' ILE . 49.8 p30 -154.84 147.75 24.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.9 mm -97.76 86.08 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.106 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.723 HD11 ' ND2' ' A' ' 62' ' ' ASN . 24.4 mm -74.36 -32.74 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.964 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.479 ' HB ' HG23 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -161.74 83.83 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.523 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.54 151.64 0.54 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.718 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.466 ' HA3' ' CD1' ' A' ' 46' ' ' PHE . . . -79.43 132.57 11.54 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.192 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.9 t -124.51 131.67 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.844 0.354 . . . . 0.0 111.311 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -64.53 118.88 9.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.347 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.459 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -107.14 -151.9 18.09 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.597 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.497 ' N ' ' CB ' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -174.42 156.75 2.55 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.256 0.55 . . . . 0.0 109.992 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.752 ' N ' HD12 ' A' ' 44' ' ' ILE . 41.4 ttt180 -133.75 113.95 12.88 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.652 ' O ' ' HB2' ' A' ' 92' ' ' SER . 53.0 m -74.06 123.31 24.13 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.463 ' CD2' ' HG ' ' A' ' 92' ' ' SER . 16.6 m80 -104.81 120.82 42.32 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.146 0.975 . . . . 0.0 113.085 -177.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.655 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -89.41 98.14 11.6 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 113.648 -1.615 . . . . 0.0 111.169 -177.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.668 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.5 mp -87.48 158.55 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.89 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.693 ' OG ' HD12 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -101.65 108.3 19.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.727 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.651 HG13 HG21 ' A' ' 38' ' ' ILE . 11.2 m -81.6 98.25 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.146 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.568 HD23 ' HD3' ' A' ' 35' ' ' PRO . 0.9 OUTLIER -117.37 108.9 16.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.975 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.5 m -79.71 124.64 28.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.851 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.21 118.49 21.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 60.36 31.93 20.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.954 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.3 38.96 20.38 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.594 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.62 116.62 4.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.51 119.59 31.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.8 m -101.19 148.4 25.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -109.6 103.44 12.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.852 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 88' ' ' THR . 13.0 t -119.09 116.8 27.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 p -57.19 139.28 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.693 HD12 ' OG ' ' A' ' 77' ' ' SER . 16.2 mt -130.63 -68.4 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.264 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.45 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 1.3 t70 -137.8 134.34 35.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 111.4 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.652 ' HB2' ' O ' ' A' ' 73' ' ' THR . 18.7 p -143.35 160.62 40.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.027 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.608 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 5.8 pt20 -120.97 165.58 15.04 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 94' ' ' VAL . 28.9 m -86.39 106.08 15.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.945 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.483 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 15.4 p -114.84 81.86 1.64 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.684 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.497 ' CB ' ' N ' ' A' ' 71' ' ' GLU . 6.6 mmmt 146.46 -33.16 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.534 178.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 49.96 106.2 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.858 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.76 HG21 ' C ' ' A' ' 45' ' ' PRO . 11.8 p -79.92 102.8 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.075 0.465 . . . . 0.0 110.719 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 27.0 mt -66.55 131.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.185 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -87.7 139.96 30.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.768 ' CB ' HG22 ' A' ' 48' ' ' VAL . 6.1 tt0 -75.55 103.81 5.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.479 HG23 ' HB ' ' A' ' 65' ' ' THR . 21.7 t -85.9 99.75 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.012 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.414 HG23 ' HG2' ' A' ' 101' ' ' GLN . 21.4 t -118.89 110.57 30.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.1 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.565 ' O ' HD11 ' A' ' 56' ' ' LEU . 3.0 mt-10 -96.24 108.55 21.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.813 HG23 ' HG3' ' A' ' 61' ' ' GLU . 11.8 p -100.7 150.65 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.027 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.52 ' N ' HD13 ' A' ' 56' ' ' LEU . . . -76.48 145.53 31.8 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.486 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.53 108.36 1.16 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.505 0.193 . . . . 0.0 111.161 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.495 ' O ' HG13 ' A' ' 109' ' ' VAL . 48.5 Cg_endo -68.68 -46.5 1.76 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.44 2.093 . . . . 0.0 112.365 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 108' ' ' PRO . 9.9 m -158.1 178.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.205 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.69 79.34 0.94 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.835 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.9 t60 . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.851 -179.968 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttm . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.818 0.342 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.13 43.88 2.37 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.558 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.0 t -133.45 -52.88 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.981 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.6 m -64.07 -61.82 2.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.861 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -125.92 79.84 1.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -101.58 132.04 47.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.983 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -167.26 -43.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -130.23 106.13 8.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.845 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -176.38 104.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.7 t 60.6 31.56 20.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.67 -175.47 4.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.857 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.99 47.2 2.69 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.537 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.9 mt 60.26 106.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.745 0.307 . . . . 0.0 110.967 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.9 m 41.69 66.19 4.09 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.77 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.37 116.44 4.52 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.495 2.13 . . . . 0.0 112.262 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.2 155.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -173.94 65.6 0.11 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.48 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 m -161.83 177.95 9.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -78.8 -76.66 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.835 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 82.4 mmm -155.89 30.38 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 m 59.53 98.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.954 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -115.91 36.69 3.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.436 ' OD1' HG21 ' A' ' 27' ' ' VAL . 3.2 t0 -121.14 166.93 13.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -176.9 -173.58 0.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.931 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 62.52 27.01 16.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.05 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 55.69 98.84 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.035 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.436 HG21 ' OD1' ' A' ' 23' ' ' ASP . 29.5 m -156.58 170.58 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.169 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -159.69 77.4 0.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.034 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.61 171.62 13.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.055 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -110.44 -74.62 0.64 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.6 m -147.82 134.45 13.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.457 ' O ' HG22 ' A' ' 33' ' ' THR . 0.0 OUTLIER -59.4 -40.05 85.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 32' ' ' GLU . 14.6 t 44.53 41.41 4.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.42 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.66 136.83 89.77 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.39 -167.23 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.482 2.121 . . . . 0.0 112.274 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -83.84 116.37 22.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.71 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.4 mt -71.0 115.61 10.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.971 0.415 . . . . 0.0 111.123 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -101.26 -177.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.858 179.091 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.566 HG22 HG22 ' A' ' 73' ' ' THR . 0.5 OUTLIER -157.02 133.88 10.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.504 0.669 . . . . 0.0 111.58 -179.014 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.706 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 2.8 tpm_? -155.7 115.63 3.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 1.7 t -81.89 136.08 35.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.895 0.855 . . . . 0.0 112.515 -176.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -98.63 138.74 35.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.014 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.408 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 1.8 mp0 -66.73 91.86 0.2 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.445 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.776 HD12 ' H ' ' A' ' 72' ' ' ARG . 6.4 mt -92.68 107.67 25.97 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.907 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.501 ' C ' HG21 ' A' ' 98' ' ' VAL . 72.3 Cg_endo -86.03 153.34 9.73 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.832 2.355 . . . . 0.0 113.309 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.707 ' HB3' HG22 ' A' ' 98' ' ' VAL . 42.7 p90 -86.99 -174.05 4.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.158 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -154.78 116.34 4.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.922 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.732 HG13 ' CG ' ' A' ' 101' ' ' GLN . 4.4 t -67.09 151.45 10.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.134 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.6 mp -129.68 156.15 41.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.086 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.457 ' N ' HG22 ' A' ' 49' ' ' ILE . 2.9 ttpp -109.35 100.78 9.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.774 ' O ' HG22 ' A' ' 105' ' ' VAL . 9.2 mmtm -98.26 154.48 17.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -106.53 132.13 52.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -134.98 111.85 11.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.64 -26.76 39.26 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.368 2.046 . . . . 0.0 112.333 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -59.96 -32.3 70.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.9 mt -65.56 162.77 39.7 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.75 31.33 0.48 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.875 2.384 . . . . 0.0 112.925 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.98 138.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.913 0.387 . . . . 0.0 111.277 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.14 28.73 61.68 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.665 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.45 144.98 36.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.813 0.339 . . . . 0.0 110.933 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -114.32 118.93 35.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.821 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -128.3 118.37 23.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.507 HG23 ' OE1' ' A' ' 101' ' ' GLN . 43.5 mt -90.59 132.06 36.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.125 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.722 HD11 ' HG3' ' A' ' 104' ' ' GLU . 24.5 mt -104.79 -43.63 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.924 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.456 HG22 ' CG2' ' A' ' 99' ' ' ILE . 24.7 m -144.73 92.24 2.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.724 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.4 126.27 5.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.79 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.444 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -70.73 126.12 14.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.449 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.432 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.8 t -138.2 138.07 43.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.904 0.383 . . . . 0.0 110.935 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.542 ' HA ' HG23 ' A' ' 98' ' ' VAL . 3.7 mttp -68.1 116.19 8.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.381 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.522 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -81.11 -147.67 5.61 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.468 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.603 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.4 OUTLIER -177.77 109.27 0.06 Allowed 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.08 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.776 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -104.59 138.08 41.46 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.207 0.527 . . . . 0.0 109.872 -179.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.566 HG22 HG22 ' A' ' 39' ' ' THR . 51.9 m -75.26 136.58 40.93 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.387 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.706 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 2.8 m80 -112.16 116.77 31.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.926 0.869 . . . . 0.0 111.955 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.756 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -91.2 107.93 19.54 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 113.84 -1.527 . . . . 0.0 111.023 -177.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.594 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.4 mp -91.47 156.41 3.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.155 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.41 ' N ' ' CG2' ' A' ' 76' ' ' ILE . 3.8 m -115.85 111.55 20.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.688 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 78' ' ' VAL . 25.4 m -81.27 98.38 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.189 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 tp -109.94 148.75 31.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.833 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.24 106.25 12.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -128.91 126.17 39.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 60.33 31.1 20.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.03 28.39 68.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.368 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -149.03 166.64 28.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.878 0.371 . . . . 0.0 110.857 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.3 p -106.29 89.95 3.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.84 150.9 42.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -104.7 109.53 21.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.5 m -140.05 122.21 15.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.658 HG21 ' CD2' ' A' ' 74' ' ' HIS . 14.9 p -84.48 150.22 4.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.135 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -147.07 -41.39 0.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.582 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.441 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 1.6 t70 -117.64 106.92 13.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.837 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.569 ' HG ' ' CD2' ' A' ' 74' ' ' HIS . 89.3 p -143.14 123.91 14.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.316 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.676 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 5.7 mt-30 -89.38 166.15 13.91 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.727 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 32.1 t -86.1 110.12 19.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.603 ' O ' ' O ' ' A' ' 71' ' ' GLU . 5.9 p -117.69 80.85 1.57 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.361 0.601 . . . . 0.0 110.656 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.529 ' HB3' ' H ' ' A' ' 71' ' ' GLU . 41.0 tptt 148.52 -32.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.447 -1.252 . . . . 0.0 109.218 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 57.44 108.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.38 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.707 HG22 ' HB3' ' A' ' 46' ' ' PHE . 7.4 p -71.64 104.17 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.109 0.48 . . . . 0.0 110.0 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.613 ' H ' HD12 ' A' ' 99' ' ' ILE . 5.1 mp -64.01 129.87 28.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.126 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -99.82 137.7 37.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.013 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.732 ' CG ' HG13 ' A' ' 48' ' ' VAL . 3.6 tp-100 -72.08 107.13 4.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.833 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.679 HG12 HD12 ' A' ' 64' ' ' ILE . 21.7 t -98.29 99.61 9.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.049 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.46 HG12 HG12 ' A' ' 63' ' ' ILE . 5.2 m -116.78 129.61 73.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.091 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.722 ' HG3' HD11 ' A' ' 64' ' ' ILE . 1.4 mm-40 -108.79 117.58 34.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.818 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 51' ' ' LYS . 31.6 m -93.7 142.93 12.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.21 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.88 133.84 14.11 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.527 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -157.89 55.18 0.87 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.78 0.324 . . . . 0.0 111.094 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.31 63.05 2.11 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.598 2.198 . . . . 0.0 112.287 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 110' ' ' THR . 21.5 t 60.06 158.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.135 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.482 ' N ' HG12 ' A' ' 109' ' ' VAL . 3.0 m -92.33 -63.64 1.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 14.8 p80 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.895 179.988 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 120.73 0.3 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 106.55 51.97 0.78 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.485 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.9 m 60.37 34.71 20.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.749 0.309 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.2 m -104.95 93.93 4.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -106.16 123.14 47.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.896 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 60.7 111.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.961 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -60.13 156.95 14.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.802 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.33 -71.27 0.68 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -172.08 35.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.967 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.47 -169.8 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.869 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.4 p -90.29 -31.19 17.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.49 26.78 4.97 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.565 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 13' ' ' LEU . 3.3 mm? -115.22 131.02 57.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.708 0.29 . . . . 0.0 110.845 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.0 m -58.19 109.33 1.74 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.191 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.53 -46.21 1.41 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.507 2.138 . . . . 0.0 112.27 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -151.92 130.05 11.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.08 75.55 1.57 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.458 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.92 111.47 24.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.757 0.313 . . . . 0.0 110.916 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.6 92.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.921 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.9 mtp -60.35 -178.99 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.842 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 m -113.03 -53.13 2.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.976 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.649 HD13 ' H ' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -164.8 146.11 7.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.932 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.649 ' H ' HD13 ' A' ' 22' ' ' LEU . 1.4 t0 61.2 -169.24 0.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 61.21 35.74 18.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -90.69 -52.67 4.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -87.25 -176.93 5.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.847 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.1 p -81.45 131.14 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.045 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -175.28 92.86 0.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.95 91.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.17 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.518 ' O ' HG13 ' A' ' 31' ' ' VAL . 11.6 p30 -115.06 -50.14 2.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 30' ' ' ASN . 5.4 m -158.25 -48.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.114 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.434 ' N ' HG23 ' A' ' 31' ' ' VAL . 19.5 mt-10 58.75 80.71 0.18 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -177.09 86.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.497 ' CZ ' HD11 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -177.07 58.77 0.15 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.433 ' HG2' HG23 ' A' ' 78' ' ' VAL . 52.6 Cg_endo -69.6 -46.27 1.35 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.596 2.198 . . . . 0.0 112.324 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.96 155.28 20.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.954 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.497 HD11 ' CZ ' ' A' ' 34' ' ' ARG . 5.4 mp -111.13 118.76 36.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.152 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 4.0 pt -101.37 -177.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.421 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.754 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -159.88 150.42 18.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.209 0.528 . . . . 0.0 110.792 -179.245 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -162.34 133.18 4.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.183 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 1.7 p -82.44 129.16 34.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.762 0.791 . . . . 0.0 112.123 -178.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.493 ' HG3' HG13 ' A' ' 44' ' ' ILE . 3.4 tp10 -98.55 141.68 31.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.66 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.89 97.29 0.47 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.209 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.895 HD12 ' H ' ' A' ' 72' ' ' ARG . 6.9 mt -106.2 94.02 8.9 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.444 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.478 ' C ' HG21 ' A' ' 98' ' ' VAL . 87.7 Cg_endo -77.51 158.29 32.48 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.714 2.276 . . . . 0.0 113.257 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.688 ' HB3' HG22 ' A' ' 98' ' ' VAL . 40.9 p90 -86.87 -174.04 4.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.841 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -147.17 103.1 3.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.173 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.5 HG23 ' HB3' ' A' ' 101' ' ' GLN . 3.4 p -66.99 132.75 32.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.769 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.442 HG22 ' N ' ' A' ' 50' ' ' LYS . 32.8 mm -109.96 156.1 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.177 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.442 ' N ' HG22 ' A' ' 49' ' ' ILE . 8.7 mtpp -125.83 100.8 6.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.817 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -103.98 171.61 7.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.88 125.63 36.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.868 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.863 ' ND2' HD13 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -100.51 96.52 5.39 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.35 -18.48 44.27 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.465 2.11 . . . . 0.0 112.482 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.36 29.23 3.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.011 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.863 HD13 ' ND2' ' A' ' 53' ' ' ASN . 1.3 mp -124.4 169.43 10.74 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.757 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -87.37 29.09 0.5 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.3 2.667 . . . . 0.0 112.678 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.449 ' HB1' ' HA ' ' A' ' 108' ' ' PRO . . . 62.37 144.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.843 0.354 . . . . 0.0 111.347 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.65 23.22 42.92 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.833 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.608 ' HB3' HD23 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -109.47 156.67 19.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.757 0.313 . . . . 0.0 110.982 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.594 ' HG2' HG22 ' A' ' 105' ' ' VAL . 6.4 mt-10 -140.47 147.26 39.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.913 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.509 ' ND2' HD11 ' A' ' 64' ' ' ILE . 0.7 OUTLIER -145.5 129.77 17.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.927 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.8 mm -87.23 92.8 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.136 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.509 HD11 ' ND2' ' A' ' 62' ' ' ASN . 24.3 mm -72.92 -43.85 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.76 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.83 93.7 1.68 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.544 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -46.62 152.42 0.47 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.82 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.437 ' HA3' ' CE2' ' A' ' 46' ' ' PHE . . . -99.94 132.76 11.05 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.26 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.428 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.6 t -136.93 130.46 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.884 0.374 . . . . 0.0 110.975 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.49 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -62.43 112.72 2.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.28 -179.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.554 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -75.53 -144.91 1.3 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.694 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.672 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 10.3 tt0 -177.58 109.11 0.06 Allowed 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.895 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -98.36 142.79 29.56 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.377 0.608 . . . . 0.0 110.446 -179.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.579 ' O ' ' HB3' ' A' ' 92' ' ' SER . 98.3 m -75.68 143.98 41.86 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.248 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.622 ' O ' ' HA ' ' A' ' 39' ' ' THR . 34.5 m-70 -125.92 116.99 22.36 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.592 0.711 . . . . 0.0 111.485 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.754 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -88.02 111.97 22.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.891 -177.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.501 HG22 ' N ' ' A' ' 77' ' ' SER . 4.3 mp -99.91 160.83 3.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.258 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.63 ' HB2' HD12 ' A' ' 90' ' ' LEU . 9.8 t -107.47 119.34 39.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.7 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 78' ' ' VAL . 8.6 m -81.43 98.36 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.22 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.612 HD13 ' N ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -103.03 129.92 49.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.612 ' N ' HD13 ' A' ' 79' ' ' LEU . 0.5 OUTLIER -96.55 120.17 36.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.832 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -136.03 100.05 4.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 60.13 35.71 21.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.37 47.39 22.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.469 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.27 123.14 15.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.688 0.28 . . . . 0.0 110.871 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.61 112.43 23.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.954 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.45 118.09 35.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.818 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.411 ' CA ' HG21 ' A' ' 76' ' ' ILE . 20.8 mt-10 -94.75 94.81 8.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.918 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.4 m -111.5 113.83 26.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.885 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.6 m -52.94 130.07 14.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.205 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.63 HD12 ' HB2' ' A' ' 77' ' ' SER . 14.3 mt -120.39 -73.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.069 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.478 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -123.98 131.47 53.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.376 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.579 ' HB3' ' O ' ' A' ' 73' ' ' THR . 1.0 OUTLIER -143.14 165.39 27.55 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.459 0.647 . . . . 0.0 111.247 179.441 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.627 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 25.2 mm100 -129.95 166.17 20.59 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.617 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.778 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 46.3 t -86.24 105.92 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.568 ' O ' ' O ' ' A' ' 71' ' ' GLU . 12.5 p -121.12 81.03 1.72 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.501 0.667 . . . . 0.0 110.929 -178.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.672 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 6.6 mmmt 155.37 -30.86 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.751 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 62.82 101.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.8 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.688 HG22 ' HB3' ' A' ' 46' ' ' PHE . 7.6 p -71.45 102.82 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.075 0.465 . . . . 0.0 110.304 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.615 ' H ' HD12 ' A' ' 99' ' ' ILE . 4.4 mp -63.99 133.2 29.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.913 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -102.73 142.79 33.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.018 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.5 ' HB3' HG23 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -76.81 108.3 9.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.927 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.32 109.98 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.055 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 103' ' ' VAL . 10.8 p -138.81 125.74 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.154 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -102.31 108.49 19.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.955 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.594 HG22 ' HG2' ' A' ' 61' ' ' GLU . 27.8 t -92.78 113.75 28.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.129 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.97 142.58 47.42 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.523 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.31 108.87 1.39 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.535 0.207 . . . . 0.0 111.161 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.449 ' HA ' ' HB1' ' A' ' 58' ' ' ALA . 54.2 Cg_endo -69.32 -168.01 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.343 2.028 . . . . 0.0 112.365 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.3 p -120.99 150.82 23.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.014 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 m -99.03 35.12 1.95 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 8.8 m80 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.902 -179.932 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.4 mmt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.794 0.331 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -97.04 40.58 2.51 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.456 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.95 80.05 1.61 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.319 . . . . 0.0 110.871 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.3 m -96.46 142.46 28.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.82 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -134.8 -47.18 0.74 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.402 ' O ' ' CG ' ' A' ' 7' ' ' HIS . 80.7 m80 -62.85 -75.2 0.08 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.402 ' CG ' ' O ' ' A' ' 6' ' ' HIS . 12.1 m-70 -173.02 -175.52 1.23 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.916 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -131.71 -50.36 0.98 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.94 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -146.77 -67.88 0.27 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.26 31.76 20.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.7 t -106.78 134.98 49.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.949 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 136.22 -76.64 0.37 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.444 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.4 mt -148.98 -177.78 6.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.841 0.353 . . . . 0.0 110.805 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.6 t 61.99 88.23 0.12 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.074 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.26 -46.35 1.47 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.549 2.166 . . . . 0.0 112.279 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.574 ' CD ' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER 59.75 31.15 20.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 19' ' ' HIS . . . 177.03 82.63 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.486 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 p 52.81 -86.62 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.607 0.242 . . . . 0.0 111.319 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.417 ' N ' ' O ' ' A' ' 17' ' ' GLY . 13.3 t-80 68.68 -67.93 0.19 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.821 0.343 . . . . 0.0 111.003 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.33 36.49 2.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.881 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.4 m -142.39 148.4 37.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.952 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.2 -37.89 6.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.946 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -168.62 -176.47 2.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.912 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -135.88 155.54 50.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.964 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -106.41 32.45 4.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.948 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -134.64 153.08 52.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.0 t 69.02 -67.51 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.199 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 59.95 -169.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.13 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.56 106.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.053 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 60.33 167.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.978 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.5 m -142.12 179.32 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -131.57 152.72 50.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.35 -32.17 15.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.775 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 60.57 68.03 1.43 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.42 -45.03 1.35 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.626 2.217 . . . . 0.0 112.228 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -150.44 115.94 5.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.83 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.574 HD13 ' CD ' ' A' ' 16' ' ' ARG . 5.0 mp -86.18 114.52 23.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.08 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 2.2 pt -101.35 -177.39 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.496 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.768 HG22 ' CD1' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -161.52 146.24 13.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.436 0.636 . . . . 0.0 111.103 -179.448 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.726 ' O ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -143.36 -159.54 0.99 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.36 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 3.0 p -145.46 126.83 14.92 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.257 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.534 ' HG3' ' CE1' ' A' ' 74' ' ' HIS . 3.7 mm-40 -98.74 135.57 40.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.751 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.416 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 2.6 mm-40 -67.17 94.87 0.38 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.352 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.841 HD12 ' H ' ' A' ' 72' ' ' ARG . 5.1 mt -102.69 96.43 7.56 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.774 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.516 ' C ' HG21 ' A' ' 98' ' ' VAL . 98.8 Cg_endo -77.87 160.51 30.68 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.803 2.336 . . . . 0.0 113.255 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.629 ' HB3' HG22 ' A' ' 98' ' ' VAL . 49.1 p90 -86.94 -174.15 4.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.234 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.456 ' OE1' HD13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -152.63 113.16 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.847 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.769 HG22 ' CB ' ' A' ' 101' ' ' GLN . 17.6 t -66.74 146.41 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.103 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.456 HD13 ' OE1' ' A' ' 47' ' ' GLU . 36.8 mm -124.7 156.18 32.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.092 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.443 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -105.12 100.88 10.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.771 179.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.567 ' O ' HG12 ' A' ' 105' ' ' VAL . 4.7 tptt -96.75 145.55 25.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.029 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -110.5 123.13 49.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -122.97 128.75 25.23 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.16 -24.79 12.23 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.439 2.093 . . . . 0.0 112.495 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -55.17 -50.94 68.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.039 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.773 HD22 ' OE1' ' A' ' 60' ' ' GLN . 9.4 mt -60.15 167.02 3.22 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.793 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.407 ' HD2' ' CB ' ' A' ' 60' ' ' GLN . 1.2 Cg_endo -83.45 32.36 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.13 2.554 . . . . 0.0 112.697 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.634 ' HB1' ' HD3' ' A' ' 108' ' ' PRO . . . 62.04 119.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.833 0.349 . . . . 0.0 111.398 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.5 -26.27 20.65 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.753 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.773 ' OE1' HD22 ' A' ' 56' ' ' LEU . 2.3 tm0? -70.0 129.92 40.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 110.945 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.404 ' CG ' ' CG1' ' A' ' 103' ' ' VAL . 6.5 tt0 -95.73 158.42 15.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -158.15 118.19 3.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.944 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.6 mt -94.29 132.03 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.186 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.1 mm -105.83 -38.99 4.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.867 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.442 HG22 ' CG2' ' A' ' 99' ' ' ILE . 7.4 m -147.65 96.86 2.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.653 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.33 128.81 17.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.753 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.515 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -67.35 124.42 22.2 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.334 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.45 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.9 t -132.63 130.21 59.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.797 0.332 . . . . 0.0 111.065 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.4 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -62.25 113.38 2.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.387 -179.32 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.524 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -78.1 -146.28 2.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.377 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.694 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 10.7 tt0 -177.52 109.24 0.07 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.841 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -98.47 142.28 30.28 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.457 0.646 . . . . 0.0 110.425 -179.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.726 ' HA ' ' O ' ' A' ' 40' ' ' ARG . 94.7 m -75.62 149.03 38.31 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.92 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.589 ' O ' ' HA ' ' A' ' 39' ' ' THR . 5.2 m80 -128.66 117.9 21.97 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.53 0.681 . . . . 0.0 111.939 -178.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.768 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -90.58 107.27 19.06 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.079 -178.008 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.659 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.4 mp -90.08 158.66 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.798 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.499 ' OG ' HD23 ' A' ' 79' ' ' LEU . 11.7 t -108.15 117.39 34.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.449 HG13 ' HB ' ' A' ' 85' ' ' THR . 21.6 t -84.6 98.51 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.063 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.499 HD23 ' OG ' ' A' ' 77' ' ' SER . 2.8 mm? -103.65 142.3 34.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.5 p -89.96 93.8 9.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -99.12 105.83 17.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.976 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 60.45 33.49 20.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.0 35.78 26.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.516 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.6 147.43 32.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.796 0.331 . . . . 0.0 110.859 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.449 ' HB ' HG13 ' A' ' 78' ' ' VAL . 39.9 p -101.77 120.0 39.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.849 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.0 m -109.35 151.07 27.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -105.17 103.38 12.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.409 ' N ' HG23 ' A' ' 76' ' ' ILE . 94.3 m -122.5 121.05 35.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.78 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.3 t -50.11 116.08 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.124 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.43 ' HA ' HD22 ' A' ' 90' ' ' LEU . 0.2 OUTLIER -105.66 -70.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.189 -179.637 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.5 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 7.2 m-20 -140.25 136.88 33.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.212 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.649 ' HB2' ' O ' ' A' ' 73' ' ' THR . 24.0 p -143.24 165.55 27.15 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.582 0.706 . . . . 0.0 111.275 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.686 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 16.5 mm-40 -129.74 166.27 20.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.64 -1.163 . . . . 0.0 109.346 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.798 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.6 p -85.84 105.94 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.555 ' O ' ' O ' ' A' ' 71' ' ' GLU . 13.3 p -120.39 80.94 1.68 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.498 0.666 . . . . 0.0 110.793 -178.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.694 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.1 OUTLIER 154.7 -29.88 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.616 179.028 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 60.17 102.58 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.708 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.629 HG22 ' HB3' ' A' ' 46' ' ' PHE . 6.2 p -71.34 108.36 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.215 0.531 . . . . 0.0 110.073 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.574 ' H ' HD12 ' A' ' 99' ' ' ILE . 5.3 mp -63.85 126.87 23.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.965 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -96.02 137.12 35.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.993 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.769 ' CB ' HG22 ' A' ' 48' ' ' VAL . 2.5 tp60 -69.47 99.4 1.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.833 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.414 HG23 ' HB ' ' A' ' 65' ' ' THR . 21.5 t -86.1 99.63 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.053 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.404 ' CG1' ' CG ' ' A' ' 61' ' ' GLU . 21.5 t -119.45 125.9 74.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.177 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -114.45 108.55 17.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.834 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 51' ' ' LYS . 10.6 p -96.61 153.39 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.061 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.05 150.69 51.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.442 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.4 99.1 21.62 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.638 0.256 . . . . 0.0 111.145 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.634 ' HD3' ' HB1' ' A' ' 58' ' ' ALA . 54.1 Cg_endo -69.88 -46.14 1.28 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.519 2.146 . . . . 0.0 112.269 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.1 p -177.44 132.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.082 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.27 105.84 1.32 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.855 -179.928 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.407 ' HG2' ' CE1' ' A' ' 8' ' ' HIS . 7.6 mtm . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.799 0.333 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -103.98 -74.45 0.99 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.527 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.1 m -162.67 33.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 0.0 110.923 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.9 m -137.18 31.54 2.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.983 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -176.12 -64.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.891 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -158.87 178.4 10.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -131.79 34.22 3.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.407 ' CE1' ' HG2' ' A' ' 1' ' ' MET . 55.4 p-80 -74.54 126.06 29.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -60.81 -64.33 0.99 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.865 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.4 -78.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.84 120.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.38 . . . . 0.0 110.871 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.39 -56.84 22.86 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.53 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 60.43 -169.39 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.886 0.374 . . . . 0.0 110.85 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.442 HG23 ' HD2' ' A' ' 15' ' ' PRO . 10.3 p -126.45 136.5 28.74 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.006 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 14' ' ' VAL . 55.5 Cg_endo -69.99 149.44 65.43 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.499 2.133 . . . . 0.0 112.25 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -98.34 35.52 1.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.89 -78.98 0.88 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.495 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 67.98 -70.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.802 0.334 . . . . 0.0 110.95 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -121.05 101.74 7.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.892 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.2 mmt -125.44 -57.67 1.46 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.78 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.73 159.59 41.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.939 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.6 tp -160.46 -49.83 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.848 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.1 p30 -84.02 77.55 9.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -90.4 80.1 6.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -106.92 -177.82 3.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.937 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -106.3 -31.68 8.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.947 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.9 p -153.05 146.49 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.026 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.11 -68.96 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.89 -69.24 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.102 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.9 p-10 -167.73 33.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.884 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.5 m -82.41 148.88 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.097 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -150.42 -178.23 6.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.99 HG23 HD21 ' A' ' 79' ' ' LEU . 35.1 m -63.75 -23.63 67.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.087 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.41 ' HD3' HD21 ' A' ' 37' ' ' LEU . 20.3 ttm105 -106.06 79.98 0.61 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.893 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.61 -47.03 1.54 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.595 2.197 . . . . 0.0 112.38 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.53 ' HG3' HG22 ' A' ' 78' ' ' VAL . 5.1 pt-20 -147.6 152.9 38.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.819 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.41 HD21 ' HD3' ' A' ' 34' ' ' ARG . 7.1 mt -109.6 118.12 35.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.1 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.653 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 10.6 pt -101.23 -177.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.187 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.724 ' HA ' ' O ' ' A' ' 74' ' ' HIS . 0.6 OUTLIER -153.84 160.92 42.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.233 0.54 . . . . 0.0 111.041 -179.471 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.527 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 3.6 tpp85 -172.71 131.61 0.55 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.815 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 2.9 p -81.91 129.93 34.91 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.837 0.827 . . . . 0.0 112.35 -177.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.496 ' HG3' HG13 ' A' ' 44' ' ' ILE . 3.5 tp10 -98.53 141.77 30.97 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.689 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -66.8 97.29 0.46 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.048 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.888 HD12 ' H ' ' A' ' 72' ' ' ARG . 7.0 mt -105.22 92.95 6.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.613 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.463 ' C ' HG21 ' A' ' 98' ' ' VAL . 73.7 Cg_endo -75.0 158.04 42.43 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.743 2.296 . . . . 0.0 113.031 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.658 ' HB3' HG22 ' A' ' 98' ' ' VAL . 41.6 p90 -86.77 -174.01 4.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.024 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -145.74 105.06 3.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.851 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.548 HG23 ' HB3' ' A' ' 101' ' ' GLN . 6.0 p -67.07 138.82 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.001 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.472 HD13 ' O ' ' A' ' 48' ' ' VAL . 27.9 mm -122.69 156.17 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.161 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.444 ' N ' HG22 ' A' ' 49' ' ' ILE . 16.8 mtmt -120.1 100.78 7.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.815 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.709 ' O ' HG22 ' A' ' 105' ' ' VAL . 2.5 tppt? -98.39 154.34 17.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.985 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.654 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 2.3 mm-40 -99.29 129.68 45.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.944 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -124.99 127.22 25.14 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.815 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.4 -27.16 11.48 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.411 2.074 . . . . 0.0 112.442 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -58.6 -35.52 72.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.985 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.453 HD22 ' NE2' ' A' ' 60' ' ' GLN . 8.3 mt -71.03 158.89 87.19 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.825 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -86.33 37.92 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.885 2.39 . . . . 0.0 112.878 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.526 ' HB2' ' CD ' ' A' ' 108' ' ' PRO . . . 62.22 145.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.846 0.355 . . . . 0.0 111.338 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.23 27.74 58.05 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.634 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.453 ' NE2' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -106.01 169.34 8.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.757 0.313 . . . . 0.0 110.963 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -155.32 133.01 11.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.927 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -135.75 125.0 24.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.812 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.791 HD13 ' CG1' ' A' ' 103' ' ' VAL . 26.1 mm -85.75 92.86 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.087 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.408 HD11 ' HG3' ' A' ' 104' ' ' GLU . 19.8 mt -74.26 -31.77 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.992 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.4 m -164.21 93.6 0.7 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.666 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.7 145.03 5.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.537 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.432 ' HA3' ' CE1' ' A' ' 46' ' ' PHE . . . -80.79 136.25 16.09 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.341 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.7 t -141.74 120.86 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 0.0 110.957 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.519 ' HA ' HG23 ' A' ' 98' ' ' VAL . 28.5 mtmt -59.42 112.79 1.89 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.245 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.504 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -76.87 -144.53 1.76 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.758 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.679 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -177.42 109.17 0.07 Allowed 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.219 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.888 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -98.61 139.38 34.42 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.16 0.505 . . . . 0.0 110.47 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.586 ' O ' ' HB2' ' A' ' 92' ' ' SER . 40.5 m -75.39 136.09 40.77 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.451 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.724 ' O ' ' HA ' ' A' ' 39' ' ' THR . 19.8 m-70 -116.17 122.37 44.84 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.416 0.627 . . . . 0.0 111.771 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.74 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -90.69 107.23 19.04 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.054 -177.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 77' ' ' SER . 3.8 mp -96.22 160.42 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.069 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.51 ' HB2' HD23 ' A' ' 90' ' ' LEU . 0.7 OUTLIER -112.76 122.43 47.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.762 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.595 ' O ' HG23 ' A' ' 78' ' ' VAL . 35.8 m -90.11 108.97 20.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.31 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.99 HD21 HG23 ' A' ' 33' ' ' THR . 1.0 OUTLIER -108.05 137.96 45.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.796 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.53 123.04 29.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -131.48 109.52 10.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.9 p30 44.08 33.98 0.89 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.416 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.28 45.29 5.64 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.473 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -149.23 156.83 42.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 110.825 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.67 116.22 28.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.943 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.28 151.02 20.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -121.41 83.93 2.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.957 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.6 m -108.29 123.2 48.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.792 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.1 m -50.11 130.07 8.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.221 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.51 HD23 ' HB2' ' A' ' 77' ' ' SER . 0.5 OUTLIER -114.48 -64.56 1.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.233 -179.703 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.488 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -152.82 141.42 20.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.207 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.586 ' HB2' ' O ' ' A' ' 73' ' ' THR . 11.5 p -143.27 165.61 27.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.779 0.8 . . . . 0.0 111.616 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.686 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 41.8 mt-30 -129.18 166.08 20.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.691 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.755 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.5 p -85.96 105.78 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.59 ' O ' ' O ' ' A' ' 71' ' ' GLU . 12.1 p -121.36 80.75 1.7 Allowed 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.579 0.704 . . . . 0.0 110.733 -178.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.679 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 154.46 -31.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.649 178.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 62.94 101.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.777 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.658 HG22 ' HB3' ' A' ' 46' ' ' PHE . 5.8 p -71.48 106.64 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.058 0.456 . . . . 0.0 110.202 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.9 mm -63.87 129.44 27.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.068 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -98.92 134.93 41.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.021 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.548 ' HB3' HG23 ' A' ' 48' ' ' VAL . 1.5 tm0? -68.47 99.45 0.96 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.25 117.28 32.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.073 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.791 ' CG1' HD13 ' A' ' 63' ' ' ILE . 5.1 m -143.09 137.58 26.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.095 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.408 ' HG3' HD11 ' A' ' 64' ' ' ILE . 19.7 mt-10 -118.4 111.85 19.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.882 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 51' ' ' LYS . 29.9 m -88.87 146.94 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.088 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -70.98 146.18 40.97 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.443 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.654 ' HB3' ' HB3' ' A' ' 52' ' ' GLU . . . -167.35 73.85 1.0 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.748 0.308 . . . . 0.0 111.101 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.526 ' CD ' ' HB2' ' A' ' 58' ' ' ALA . 57.8 Cg_endo -71.06 136.32 29.32 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.615 2.21 . . . . 0.0 112.371 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.3 t 68.87 -67.29 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.204 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m 60.96 80.71 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.954 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.926 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.815 0.341 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 147.12 -92.78 0.15 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.54 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m 60.47 32.31 20.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.801 0.334 . . . . 0.0 110.922 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.4 t -106.15 172.71 6.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 7' ' ' HIS . 0.7 OUTLIER -165.52 -178.71 5.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.7 p-80 -92.67 81.84 4.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.816 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.411 ' HB3' ' CE1' ' A' ' 5' ' ' HIS . 9.7 p80 -106.34 -37.75 6.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -60.36 92.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -161.45 -49.58 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.858 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 m -106.12 161.7 14.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.1 t -83.34 -74.66 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.908 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.53 -39.57 1.68 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.533 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 mt -73.08 69.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.829 0.347 . . . . 0.0 110.891 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.64 ' N ' ' CD ' ' A' ' 15' ' ' PRO . 13.4 p -82.2 -28.64 0.46 Allowed Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 14' ' ' VAL . 89.4 Cg_endo -84.75 -26.67 1.52 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.094 1.863 . . . . 0.0 112.585 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -102.42 -31.3 10.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.11 178.01 52.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.498 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.7 p -176.62 169.63 2.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.844 0.354 . . . . 0.0 110.897 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -105.48 89.79 3.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.845 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.34 -38.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.993 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.82 165.01 4.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.909 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.0 -38.25 5.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -176.86 -178.77 0.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -156.17 -74.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -176.78 104.76 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -176.51 106.65 0.07 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.949 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 27' ' ' VAL . 14.9 p -144.61 39.93 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.013 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -175.78 37.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.043 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.34 -74.93 0.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.021 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.514 ' O ' HG22 ' A' ' 31' ' ' VAL . 1.1 t-20 -106.02 -51.58 2.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 30' ' ' ASN . 21.4 m 45.48 -171.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.624 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -144.32 -71.58 0.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.003 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.03 108.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.96 79.86 0.27 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.867 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.69 -35.57 9.7 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.561 2.174 . . . . 0.0 112.298 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -163.6 154.49 16.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.775 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 68.4 mt -95.01 122.79 38.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.072 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 76' ' ' ILE . 1.2 tt -101.17 -177.32 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.567 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.852 HG22 ' CD1' ' A' ' 75' ' ' TYR . 1.3 p -162.29 142.22 9.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.331 0.586 . . . . 0.0 111.018 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.688 ' CG ' HD13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -163.64 109.88 1.11 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.147 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 12.5 t -82.3 132.71 35.22 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.685 0.755 . . . . 0.0 111.734 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.469 ' O ' HD12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -98.41 148.24 23.89 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.695 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.407 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 4.8 mt-10 -66.83 100.2 0.69 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.699 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.567 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.0 mp -104.8 91.16 4.01 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.872 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.512 ' C ' HG21 ' A' ' 98' ' ' VAL . 72.0 Cg_endo -76.18 157.38 37.84 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.671 2.247 . . . . 0.0 112.808 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.618 ' HB3' HG22 ' A' ' 98' ' ' VAL . 30.0 p90 -86.73 -177.29 6.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.118 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -157.07 120.25 4.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.96 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.778 HG22 ' CB ' ' A' ' 101' ' ' GLN . 40.0 t -67.26 150.0 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.242 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 50' ' ' LYS . 7.8 mt -129.18 156.15 41.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.079 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' N ' HG22 ' A' ' 49' ' ' ILE . 4.4 mtpp -123.59 100.89 7.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.818 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -110.8 147.37 34.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.901 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.87 140.0 32.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -133.71 98.48 14.79 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.51 84.25 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.484 2.122 . . . . 0.0 112.213 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -175.32 -40.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.924 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.739 HD13 ' HB3' ' A' ' 60' ' ' GLN . 41.7 mt -58.49 167.16 1.87 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.842 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.08 48.84 2.63 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.041 2.494 . . . . 0.0 112.754 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.37 124.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.016 0.436 . . . . 0.0 111.716 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 50.59 55.64 16.39 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.091 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.739 ' HB3' HD13 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -109.47 136.5 48.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.742 0.306 . . . . 0.0 110.802 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.9 117.14 27.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.628 ' O ' HG12 ' A' ' 103' ' ' VAL . 1.1 p30 -127.08 158.02 38.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.799 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.751 HD13 HG12 ' A' ' 103' ' ' VAL . 31.1 mm -113.91 92.52 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.463 HD11 ' HG3' ' A' ' 104' ' ' GLU . 24.3 mt -73.24 -32.25 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.921 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.0 m -161.31 92.74 0.91 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.613 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.49 146.45 5.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.582 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.429 ' HA3' ' CE1' ' A' ' 46' ' ' PHE . . . -76.45 138.72 22.88 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.262 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.8 t -140.95 135.05 32.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.917 0.389 . . . . 0.0 111.349 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.16 134.87 56.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.335 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 96' ' ' LYS . . . -116.25 -159.68 11.91 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.994 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.475 ' HA ' HD12 ' A' ' 44' ' ' ILE . 1.5 tt0 -162.08 153.89 18.84 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 2.6 ttt180 -141.39 112.2 7.17 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.717 ' O ' ' HB2' ' A' ' 92' ' ' SER . 46.5 m -73.92 125.72 28.85 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.526 ' O ' ' HA ' ' A' ' 39' ' ' THR . 13.8 m80 -106.8 119.7 40.05 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 122.083 0.944 . . . . 0.0 113.137 -177.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.852 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -91.14 93.81 9.3 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.103 -177.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.688 HD13 ' CG ' ' A' ' 40' ' ' ARG . 2.0 mp -87.35 142.65 12.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.931 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.724 ' OG ' HD23 ' A' ' 90' ' ' LEU . 2.4 p -77.34 121.42 23.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.762 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.489 ' C ' HD22 ' A' ' 79' ' ' LEU . 21.4 t -81.4 105.56 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.203 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.489 HD22 ' C ' ' A' ' 78' ' ' VAL . 3.9 mm? -125.55 89.27 3.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.891 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.07 131.4 42.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -137.62 117.24 13.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.909 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 60.67 33.35 20.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.28 32.02 49.55 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.438 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -144.32 113.77 7.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.755 0.312 . . . . 0.0 110.86 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.7 p -75.21 127.8 34.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.6 m -100.01 141.28 33.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.899 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -100.29 101.97 13.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.8 m -118.95 121.0 38.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 89' ' ' VAL . 10.8 p -54.26 118.41 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.006 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.724 HD23 ' OG ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -106.0 -59.57 1.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.516 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -177.17 139.95 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.198 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.717 ' HB2' ' O ' ' A' ' 73' ' ' THR . 4.8 p -143.64 149.47 37.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.48 0.657 . . . . 0.0 111.362 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.668 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 4.6 mt-30 -107.47 167.11 10.17 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.598 ' O ' HG13 ' A' ' 94' ' ' VAL . 8.3 p -84.75 107.16 15.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 119.854 -0.739 . . . . 0.0 109.872 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.549 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 16.8 p -113.22 82.9 1.74 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.686 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 95' ' ' THR . 11.6 mmmt 113.36 52.93 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.097 -1.41 . . . . 0.0 109.385 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -35.21 117.17 0.39 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.544 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.618 HG22 ' HB3' ' A' ' 46' ' ' PHE . 9.4 p -71.44 106.02 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.206 0.527 . . . . 0.0 110.792 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.0 mm -64.35 121.5 13.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.164 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -98.07 125.95 43.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.931 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.804 ' OE1' HG13 ' A' ' 103' ' ' VAL . 0.5 OUTLIER -62.67 128.91 38.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.788 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.8 m -124.01 101.36 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.195 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.804 HG13 ' OE1' ' A' ' 101' ' ' GLN . 2.4 m -108.96 118.6 56.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.072 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.463 ' HG3' HD11 ' A' ' 64' ' ' ILE . 18.0 mt-10 -87.15 111.58 21.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.783 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.99 143.5 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.225 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.54 109.67 3.03 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.505 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 60.84 155.97 0.11 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.714 0.292 . . . . 0.0 111.09 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.493 ' O ' HG13 ' A' ' 109' ' ' VAL . 55.3 Cg_endo -70.19 -45.41 1.37 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.49 2.127 . . . . 0.0 112.285 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 108' ' ' PRO . 6.9 m -157.63 -47.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.15 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.435 ' N ' HG23 ' A' ' 109' ' ' VAL . 33.1 p -65.55 79.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.873 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 72.1 m80 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.936 179.999 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpp? . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.825 0.345 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.74 162.24 28.68 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.528 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.0 t -160.9 -47.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.829 0.347 . . . . 0.0 110.952 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.82 110.84 4.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -129.4 72.87 1.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -177.49 -40.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.47 ' CG ' ' CE1' ' A' ' 8' ' ' HIS . 1.9 t-80 -59.54 -63.86 1.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.47 ' CE1' ' CG ' ' A' ' 7' ' ' HIS . 0.0 OUTLIER -166.37 -83.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.931 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 61.22 155.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.812 0.339 . . . . 0.0 110.896 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.9 m -60.09 -45.33 93.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.965 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.73 -169.97 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.927 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.81 -179.18 28.17 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.527 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 mp -142.82 -170.3 3.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.858 0.361 . . . . 0.0 110.85 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.45 ' O ' HG23 ' A' ' 14' ' ' VAL . 6.7 m -133.28 87.86 37.23 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.15 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.24 -28.15 23.29 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.476 2.118 . . . . 0.0 112.325 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -60.48 124.96 21.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.97 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -170.91 -146.69 5.3 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.56 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.6 m -146.2 32.24 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 110.925 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -131.59 -46.79 0.97 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.957 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.06 79.51 1.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.82 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.9 p -106.6 117.05 33.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 mt -96.93 79.65 2.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -159.38 31.74 0.2 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.853 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -117.92 51.59 1.05 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 60.94 167.5 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.935 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -98.8 31.62 2.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.5 t -109.08 82.47 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.108 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.74 -56.46 2.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.097 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -170.44 137.13 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.129 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -94.67 47.66 1.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.1 m -59.47 178.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.221 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -169.06 -173.1 1.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 34' ' ' ARG . 0.2 OUTLIER 62.1 -172.37 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.936 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.462 ' H ' HG22 ' A' ' 33' ' ' THR . 0.0 OUTLIER -65.21 149.78 96.48 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.02 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.26 -166.16 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.636 2.224 . . . . 0.0 112.271 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -78.84 124.84 28.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.641 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 68.4 mt -78.33 116.46 18.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.086 0.469 . . . . 0.0 111.329 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.763 HD11 ' CD1' ' A' ' 76' ' ' ILE . 1.2 pp -100.89 -176.05 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.288 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.67 ' N ' HD12 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -156.35 132.94 10.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.499 0.666 . . . . 0.0 112.486 -178.351 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.653 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 4.7 mmm180 -150.72 115.77 5.32 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -82.13 134.37 35.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.897 0.856 . . . . 0.0 112.34 -177.685 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.417 ' HG2' ' ND1' ' A' ' 74' ' ' HIS . 1.2 mm-40 -98.78 138.81 35.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.24 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.434 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 1.7 pt-20 -66.86 91.45 0.2 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.778 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.866 HD12 ' H ' ' A' ' 72' ' ' ARG . 6.5 mt -94.84 105.04 16.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.651 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.493 ' C ' HG21 ' A' ' 98' ' ' VAL . 80.8 Cg_endo -84.19 157.2 13.02 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.769 2.313 . . . . 0.0 113.296 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.713 ' HB3' HG22 ' A' ' 98' ' ' VAL . 42.6 p90 -86.91 -174.02 4.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.965 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -149.42 103.05 3.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.099 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 101' ' ' GLN . 3.9 p -66.82 145.02 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.931 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.453 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.6 mp -128.97 156.1 41.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.039 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' N ' HG22 ' A' ' 49' ' ' ILE . 3.4 mptt -109.44 100.89 9.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.754 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.33 164.6 20.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.035 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -116.35 112.56 21.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.826 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.46 ' HB3' HD13 ' A' ' 56' ' ' LEU . 1.4 t-20 -102.23 96.6 7.26 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.67 -13.21 38.98 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.499 2.132 . . . . 0.0 112.512 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -97.81 27.79 4.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.706 0.289 . . . . 0.0 111.047 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.763 HD23 ' HB3' ' A' ' 60' ' ' GLN . 3.5 mp -114.97 175.94 1.68 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.85 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -86.78 29.53 0.5 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.281 2.654 . . . . 0.0 112.781 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.7 130.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.978 0.418 . . . . 0.0 111.225 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.78 54.08 40.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.642 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.763 ' HB3' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -109.44 131.7 54.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.765 0.317 . . . . 0.0 110.823 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -115.18 113.85 24.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.937 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -147.25 119.34 8.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.804 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.418 HG12 HG22 ' A' ' 103' ' ' VAL . 26.1 mt -85.76 130.96 35.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.251 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.752 HD11 ' HG3' ' A' ' 104' ' ' GLU . 2.4 mp -100.24 -46.18 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.636 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.3 m -141.85 102.17 4.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.497 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.68 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -49.43 162.95 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.545 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.436 ' HA3' ' CE2' ' A' ' 46' ' ' PHE . . . -111.07 127.32 8.18 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.243 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.43 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.6 t -139.43 134.7 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.809 0.337 . . . . 0.0 110.97 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.506 ' HA ' HG23 ' A' ' 98' ' ' VAL . 10.0 mttt -65.37 114.55 4.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.075 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.485 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -75.08 -143.06 0.94 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.802 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.608 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -177.33 109.51 0.07 Allowed 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.194 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.866 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -103.35 134.3 46.97 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.251 0.548 . . . . 0.0 110.127 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 92' ' ' SER . 60.6 m -76.15 138.22 40.57 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.532 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.653 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 6.6 m80 -111.79 122.72 48.56 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.687 0.756 . . . . 0.0 112.05 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.726 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -92.99 93.85 8.58 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.241 -177.287 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.763 ' CD1' HD11 ' A' ' 38' ' ' ILE . 4.3 mp -87.66 144.69 8.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.221 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.619 ' HB3' HD22 ' A' ' 90' ' ' LEU . 21.6 p -93.95 115.2 27.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.817 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.452 HG13 HG21 ' A' ' 38' ' ' ILE . 6.8 m -81.44 105.81 11.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' A' ' 79' ' ' LEU . 1.1 tm? -113.98 102.12 9.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.1 m -66.92 91.09 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -62.23 92.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 68.15 -69.86 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.093 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.88 36.99 1.03 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.491 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.88 132.21 6.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.883 0.373 . . . . 0.0 110.859 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.97 130.72 35.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.948 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.61 144.98 43.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -93.84 117.55 30.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.867 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.591 ' C ' HG23 ' A' ' 76' ' ' ILE . 91.3 m -144.62 101.1 3.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.7 t -49.74 133.22 8.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.96 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.619 HD22 ' HB3' ' A' ' 77' ' ' SER . 3.0 tp -110.3 -67.23 1.0 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.271 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.49 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 2.1 m-20 -150.79 141.16 22.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.979 0.419 . . . . 0.0 111.539 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.621 ' HB2' ' O ' ' A' ' 73' ' ' THR . 11.8 p -143.7 160.51 40.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.585 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.66 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 3.7 mt-30 -125.18 167.01 15.42 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.813 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.2 p -85.14 106.34 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 119.557 -0.857 . . . . 0.0 108.964 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.528 ' O ' ' O ' ' A' ' 71' ' ' GLU . 6.1 p -115.78 81.02 1.53 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.613 0.721 . . . . 0.0 110.46 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 156.35 -29.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.721 179.081 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 61.78 100.77 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.532 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.713 HG22 ' HB3' ' A' ' 46' ' ' PHE . 5.9 p -71.24 102.7 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 121.213 0.53 . . . . 0.0 109.998 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.68 HG22 ' O ' ' A' ' 66' ' ' ALA . 3.8 mp -64.28 133.35 29.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.015 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -105.67 141.53 36.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.143 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.531 ' O ' HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -76.4 108.13 9.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.776 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.741 HG12 HD13 ' A' ' 64' ' ' ILE . 21.3 t -95.92 108.7 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.107 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.418 HG22 HG12 ' A' ' 63' ' ' ILE . 22.1 t -129.32 114.96 33.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.019 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.752 ' HG3' HD11 ' A' ' 64' ' ' ILE . 0.7 OUTLIER -89.99 139.94 30.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.763 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.4 109.7 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.082 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.19 128.15 30.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.577 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -84.85 151.83 58.47 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.693 0.282 . . . . 0.0 111.143 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.19 -41.32 3.83 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.612 2.208 . . . . 0.0 112.397 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 31.5 t -63.36 87.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.112 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -176.78 125.93 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.907 -179.973 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.792 0.329 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.59 35.25 88.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.511 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.0 p 58.54 171.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.807 0.337 . . . . 0.0 111.014 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.4 p -87.27 -169.49 2.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.936 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -60.3 -169.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.821 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.48 97.38 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -71.75 -68.05 0.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.002 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.76 -175.22 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.836 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -176.4 37.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.32 164.14 27.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.802 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.3 t -93.08 -170.15 2.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.997 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.18 -133.28 1.85 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.457 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.613 ' O ' HD12 ' A' ' 13' ' ' LEU . 1.7 pp -132.17 133.15 43.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.753 0.311 . . . . 0.0 110.923 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 14' ' ' VAL . 6.1 m -150.46 88.15 4.72 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.136 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -176.02 1.33 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.598 2.199 . . . . 0.0 112.293 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.17 -74.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 59.46 -96.39 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.526 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.08 30.68 20.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.739 0.304 . . . . 0.0 110.91 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -177.23 -68.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 77.5 mmm 59.45 -178.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.961 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 p -113.37 152.37 30.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.001 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.87 86.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.885 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -161.93 -175.97 4.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -82.94 -75.27 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 59.82 31.04 20.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.942 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -170.64 161.22 7.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.5 t -104.38 136.81 36.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.7 40.25 1.14 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.99 78.4 0.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.051 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -60.44 134.94 57.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.859 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.913 HG12 HG23 ' A' ' 33' ' ' THR . 21.7 t -112.73 -67.33 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 62.45 -80.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.959 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.913 HG23 HG12 ' A' ' 31' ' ' VAL . 10.2 p 55.8 33.26 21.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.896 0.379 . . . . 0.0 111.192 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.408 ' N ' ' CD ' ' A' ' 35' ' ' PRO . 8.1 ttm-85 -164.32 52.73 0.31 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.034 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 34' ' ' ARG . 72.1 Cg_endo -76.78 -43.11 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.511 2.141 . . . . 0.0 112.314 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -139.56 129.13 24.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.5 132.92 42.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.878 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.868 HD12 ' HB ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER -101.25 -176.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.444 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.591 ' H ' HG22 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -163.16 121.93 2.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.03 0.443 . . . . 0.0 109.947 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 74' ' ' HIS . 18.9 ttt180 -145.77 132.49 19.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.328 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.612 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 2.2 p -81.85 130.23 35.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.891 0.853 . . . . 0.0 112.235 -177.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.443 ' HG2' HG13 ' A' ' 44' ' ' ILE . 1.1 tt0 -98.36 143.89 28.34 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.806 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.9 94.26 0.31 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.905 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.897 HD12 ' H ' ' A' ' 72' ' ' ARG . 7.3 mt -103.02 95.3 6.38 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.59 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.473 ' C ' HG21 ' A' ' 98' ' ' VAL . 74.4 Cg_endo -74.16 158.6 45.19 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.73 2.287 . . . . 0.0 113.278 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.644 ' HB3' HG22 ' A' ' 98' ' ' VAL . 53.9 p90 -86.64 -173.97 4.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.111 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -151.64 111.84 4.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.882 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.874 HG22 ' CB ' ' A' ' 101' ' ' GLN . 31.2 t -66.81 151.14 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.249 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 50' ' ' LYS . 4.5 mp -126.92 156.25 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.094 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.459 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -121.6 100.75 7.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.807 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -107.88 150.91 26.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.499 ' HG3' ' HB3' ' A' ' 107' ' ' ALA . 0.6 OUTLIER -87.91 123.51 32.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -117.47 96.55 49.53 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.928 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.63 65.71 1.2 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.448 2.099 . . . . 0.0 112.193 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -149.68 -45.87 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.846 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.697 HD23 ' HB3' ' A' ' 60' ' ' GLN . 7.1 mp -55.9 172.93 0.29 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 60' ' ' GLN . 2.0 Cg_endo -82.15 31.72 0.52 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.172 2.582 . . . . 0.0 112.951 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 61.96 120.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.999 0.428 . . . . 0.0 111.387 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.81 22.17 62.16 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.886 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.697 ' HB3' HD23 ' A' ' 56' ' ' LEU . 69.5 tp60 -109.54 157.68 18.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.826 0.346 . . . . 0.0 110.826 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -136.3 115.17 12.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.48 ' OD1' HD21 ' A' ' 56' ' ' LEU . 7.2 p-10 -117.61 116.68 27.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 26.1 mt -85.81 132.09 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.108 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.444 HD11 ' HG3' ' A' ' 104' ' ' GLU . 12.7 mt -103.46 -44.44 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.984 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.55 92.06 2.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.623 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.501 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -46.83 150.92 0.66 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.768 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.466 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -85.71 129.34 9.27 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.229 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.71 125.95 47.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.915 0.388 . . . . 0.0 110.885 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -60.51 112.71 2.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.281 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.492 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -76.9 -144.15 1.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.509 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.692 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 4.6 tt0 -177.45 109.27 0.07 Allowed 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.897 ' H ' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -100.39 138.75 37.03 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.24 -179.711 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 92' ' ' SER . 94.6 m -75.22 140.12 43.05 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.68 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.543 ' N ' ' O ' ' A' ' 40' ' ' ARG . 20.4 m-70 -119.78 121.75 39.85 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.047 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.722 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -92.22 106.58 18.55 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.24 -177.256 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.868 ' HB ' HD12 ' A' ' 38' ' ' ILE . 5.0 mp -90.75 160.8 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.874 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.822 ' HB3' HD23 ' A' ' 90' ' ' LEU . 5.6 t -119.28 129.01 54.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.721 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.468 HG23 ' CG2' ' A' ' 85' ' ' THR . 11.4 p -81.41 123.0 37.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.141 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.9 tp -128.91 117.28 20.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.2 p -66.98 98.05 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.818 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.73 92.14 6.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 59.95 31.24 20.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.993 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.24 38.5 7.22 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.541 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -148.12 162.07 40.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.76 0.314 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.468 ' CG2' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -106.97 123.47 48.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.927 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -128.33 110.59 12.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.02 114.66 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 77' ' ' SER . 11.8 t -121.29 121.93 38.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.3 m -52.59 121.15 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.112 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.822 HD23 ' HB3' ' A' ' 77' ' ' SER . 0.2 OUTLIER -110.4 -49.97 3.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.189 -179.736 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.484 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 5.9 t0 -176.62 143.79 0.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.275 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.582 ' HB2' ' O ' ' A' ' 73' ' ' THR . 11.3 p -143.16 165.61 26.95 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.554 0.692 . . . . 0.0 111.496 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.717 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 5.1 mm-40 -131.85 166.3 21.9 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.947 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.798 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 5.5 m -85.97 105.79 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.591 ' O ' ' O ' ' A' ' 71' ' ' GLU . 10.7 p -121.02 80.68 1.67 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.491 0.663 . . . . 0.0 110.76 -178.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.692 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER 154.47 -30.38 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.846 178.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 62.02 101.58 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.624 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.644 HG22 ' HB3' ' A' ' 46' ' ' PHE . 5.0 p -71.36 108.37 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.163 0.506 . . . . 0.0 110.2 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 66' ' ' ALA . 43.2 mm -64.2 128.8 27.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.173 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -100.94 134.83 43.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.874 ' CB ' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -64.55 99.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.749 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.82 99.81 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.182 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.6 p -123.71 141.56 43.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.128 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.444 ' HG3' HD11 ' A' ' 64' ' ' ILE . 2.6 mt-10 -121.53 120.13 33.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.801 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.807 HG22 ' O ' ' A' ' 51' ' ' LYS . 27.8 m -86.99 160.14 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.151 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -98.87 125.84 8.7 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.55 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.499 ' HB3' ' HG3' ' A' ' 52' ' ' GLU . . . -177.0 148.5 0.76 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.762 0.315 . . . . 0.0 111.046 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.23 131.34 17.71 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.544 2.162 . . . . 0.0 112.363 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.501 HG13 HG22 ' A' ' 110' ' ' THR . 9.9 p -64.54 -45.31 95.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.056 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.501 HG22 HG13 ' A' ' 109' ' ' VAL . 2.3 t -179.73 -38.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.48 ' CD2' HG23 ' A' ' 110' ' ' THR . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.884 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.799 0.333 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -147.43 98.12 0.19 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.427 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.17 -56.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.746 0.307 . . . . 0.0 110.865 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.85 92.98 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.6 m170 -161.76 -72.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.897 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -60.9 179.86 0.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.7 t60 60.65 103.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.851 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -149.1 93.7 2.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.83 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -136.92 145.73 44.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 75.3 m -135.31 -55.38 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.801 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.3 m 60.38 100.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.73 -27.84 45.08 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.582 ' O ' HG23 ' A' ' 14' ' ' VAL . 5.7 mp 60.14 31.56 20.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.714 0.292 . . . . 0.0 110.9 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 13' ' ' LEU . 20.7 t -158.87 -64.6 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.052 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.501 ' CD ' ' HB ' ' A' ' 14' ' ' VAL . 30.9 Cg_endo -63.21 -48.29 6.52 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.271 1.981 . . . . 0.0 112.193 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.19 -40.48 9.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.867 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.89 84.13 1.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.445 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 m -131.52 -65.43 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.865 0.365 . . . . 0.0 110.923 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -105.79 87.94 2.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.9 mtp -61.16 -31.66 71.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.5 p -130.07 177.28 7.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 22' ' ' LEU . 3.6 mp -92.77 -31.49 15.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.944 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -171.96 -43.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.528 ' O ' HG13 ' A' ' 27' ' ' VAL . 9.9 mt-10 63.88 -79.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.998 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 59.87 62.07 1.76 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 60.08 82.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.785 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 24' ' ' GLU . 12.7 m -129.27 164.68 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.134 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -175.16 43.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.054 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.57 -74.54 0.07 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.111 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -146.96 95.21 2.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.932 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.4 m -67.47 -36.89 77.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.086 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -136.43 -177.83 4.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.24 39.69 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.981 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.95 144.62 33.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.864 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.62 -44.64 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.498 2.132 . . . . 0.0 112.366 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.15 121.22 6.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.944 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.71 135.53 33.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.883 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.804 HD12 ' HB ' ' A' ' 76' ' ' ILE . 0.5 OUTLIER -100.8 -177.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.452 179.381 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.704 ' H ' HG22 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -157.14 121.82 4.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.344 0.592 . . . . 0.0 111.26 -179.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.668 ' O ' ' HA ' ' A' ' 73' ' ' THR . 1.0 OUTLIER -128.06 -151.11 0.46 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 m -144.96 137.87 26.44 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.115 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.473 ' CB ' ' CE1' ' A' ' 74' ' ' HIS . 0.2 OUTLIER -107.94 131.84 54.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.427 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -66.93 92.83 0.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.058 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.775 HD11 ' HG2' ' A' ' 72' ' ' ARG . 4.1 mt -109.1 85.79 3.55 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.152 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.591 ' C ' HG21 ' A' ' 98' ' ' VAL . 86.1 Cg_endo -79.76 163.36 23.72 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.829 2.353 . . . . 0.0 112.93 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.629 ' HB3' HG22 ' A' ' 98' ' ' VAL . 40.1 p90 -87.33 -173.98 4.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.225 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -149.31 107.13 3.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.787 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.527 HG23 ' HG2' ' A' ' 101' ' ' GLN . 9.4 p -66.85 123.61 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.018 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 50' ' ' LYS . 22.8 mm -106.4 156.18 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.228 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.431 ' N ' HG22 ' A' ' 49' ' ' ILE . 8.5 ptmt -108.74 100.84 10.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.808 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.531 ' O ' HG22 ' A' ' 105' ' ' VAL . 32.6 ttmt -87.2 159.16 18.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.985 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.637 ' HG3' ' HB3' ' A' ' 107' ' ' ALA . 0.1 OUTLIER -100.87 120.07 39.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.653 ' HB3' HD13 ' A' ' 56' ' ' LEU . 7.9 t-20 -122.94 96.56 44.86 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.918 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.81 -25.19 53.36 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.453 2.102 . . . . 0.0 112.263 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -62.35 -30.97 71.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.705 HD23 ' HB3' ' A' ' 60' ' ' GLN . 8.5 mp -65.18 171.88 2.87 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.748 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -89.06 29.93 0.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.268 2.646 . . . . 0.0 112.598 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.01 146.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.912 0.387 . . . . 0.0 111.292 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.74 21.49 36.51 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.779 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.705 ' HB3' HD23 ' A' ' 56' ' ' LEU . 1.8 tt0 -109.61 148.02 32.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.882 0.372 . . . . 0.0 110.799 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -137.87 141.63 40.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -137.7 162.47 33.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.81 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.913 HD13 HG12 ' A' ' 103' ' ' VAL . 18.2 mm -117.0 86.28 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.113 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.4 mm -62.97 -49.75 82.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.012 0.434 . . . . 0.0 110.94 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.3 m -143.68 91.12 2.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.576 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.06 139.55 4.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.727 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.445 ' HA3' ' CD2' ' A' ' 46' ' ' PHE . . . -82.67 137.01 16.12 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.211 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.482 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.9 t -137.48 125.97 33.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.839 0.352 . . . . 0.0 111.075 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -56.48 119.88 6.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.041 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.583 ' H ' HG23 ' A' ' 98' ' ' VAL . . . -80.74 -149.89 6.58 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.528 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.632 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -177.18 109.3 0.07 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.069 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.793 ' HB2' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -101.53 139.0 37.78 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.295 0.569 . . . . 0.0 109.904 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.671 ' O ' ' HB2' ' A' ' 92' ' ' SER . 91.2 m -75.86 138.99 41.45 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.815 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.473 ' CE1' ' CB ' ' A' ' 42' ' ' GLU . 5.0 m80 -111.64 118.97 37.13 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.745 0.784 . . . . 0.0 112.609 -178.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.698 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -92.05 100.05 12.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.066 -1.424 . . . . 0.0 111.508 -177.365 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.804 ' HB ' HD12 ' A' ' 38' ' ' ILE . 5.0 mp -87.73 141.62 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.79 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.601 ' O ' HD12 ' A' ' 79' ' ' LEU . 5.7 t -98.78 130.26 45.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 0.0 110.753 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.607 HG23 HG22 ' A' ' 85' ' ' THR . 10.6 p -81.42 119.01 30.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.172 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 77' ' ' SER . 5.4 mp -113.21 116.61 30.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.6 m -88.65 94.34 9.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.94 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -87.35 96.72 10.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 42.88 32.06 0.37 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.401 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.39 43.67 2.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.522 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -147.88 107.38 3.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.82 0.343 . . . . 0.0 110.878 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.607 HG22 HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -88.91 119.01 29.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.821 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.31 149.96 44.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -97.25 108.62 21.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.974 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.767 ' O ' HG23 ' A' ' 76' ' ' ILE . 78.0 m -127.5 124.05 37.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 89' ' ' VAL . 9.9 p -55.15 121.82 3.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.865 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.526 HD23 ' HB3' ' A' ' 77' ' ' SER . 0.2 OUTLIER -104.9 -71.24 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.381 -179.523 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.5 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 2.6 t0 -147.06 136.44 22.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.845 0.355 . . . . 0.0 111.576 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.671 ' HB2' ' O ' ' A' ' 73' ' ' THR . 5.8 p -143.56 150.95 39.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.385 0.612 . . . . 0.0 110.938 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.576 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 26.0 mm-40 -113.39 166.93 11.01 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.793 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 7.6 p -85.27 106.33 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.457 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 71' ' ' GLU . 5.8 p -115.15 81.37 1.56 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.428 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.632 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 157.44 -30.17 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.708 179.159 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 61.73 103.57 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.511 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.629 HG22 ' HB3' ' A' ' 46' ' ' PHE . 7.6 p -71.21 104.26 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.209 0.528 . . . . 0.0 110.081 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.611 ' H ' HD12 ' A' ' 99' ' ' ILE . 5.3 mp -63.68 127.17 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.032 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.435 ' HA ' ' HB2' ' A' ' 46' ' ' PHE . 6.2 m120 -92.36 145.74 24.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.017 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.527 ' HG2' HG23 ' A' ' 48' ' ' VAL . 3.2 tt0 -84.15 101.56 11.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.867 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.85 99.69 7.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.104 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.913 HG12 HD13 ' A' ' 63' ' ' ILE . 24.6 m -125.38 120.84 59.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.139 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -100.64 131.94 46.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 51' ' ' LYS . 6.4 m -110.53 128.37 66.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.147 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.05 137.74 50.17 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.533 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.637 ' HB3' ' HG3' ' A' ' 52' ' ' GLU . . . -173.52 74.92 0.38 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.817 0.342 . . . . 0.0 111.103 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.59 148.5 59.84 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.526 2.15 . . . . 0.0 112.251 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.436 HG23 ' N ' ' A' ' 110' ' ' THR . 7.3 m -149.97 -47.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.133 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 111' ' ' HIS . 0.2 OUTLIER 60.16 -176.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.453 ' H ' HG22 ' A' ' 110' ' ' THR . 4.5 t-80 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.927 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mmt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.854 0.359 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.47 122.31 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.475 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.4 p -175.43 -66.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.867 0.365 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 m 60.41 31.46 20.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.951 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.2 m80 60.35 -179.15 0.1 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -151.66 79.52 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -120.39 -42.61 2.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.45 81.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.861 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -117.09 168.66 10.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.4 p -59.85 161.81 6.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.58 -170.01 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.929 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 161.81 -28.51 0.28 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.531 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.5 tp -98.75 31.56 2.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.922 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t 59.92 87.88 0.13 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.129 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.77 140.36 42.45 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.699 2.266 . . . . 0.0 112.275 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -79.82 -178.55 6.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.05 52.62 0.64 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.481 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.03 -59.61 1.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 0.0 110.911 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.0 t60 68.49 -68.04 0.19 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.04 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 18.2 ttm -67.97 93.1 0.4 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.912 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -130.98 79.95 1.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.27 165.11 31.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.93 -52.84 24.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.926 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -68.43 157.02 36.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.499 ' HB3' ' HB2' ' A' ' 28' ' ' ALA . 28.0 m-20 -133.98 124.7 26.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.928 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.92 -64.2 0.95 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.1 p -110.44 -31.22 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.071 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.499 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . . . 60.1 96.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.124 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.83 126.8 8.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.097 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -131.85 -73.37 0.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.923 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.439 HG12 ' OG1' ' A' ' 33' ' ' THR . 21.5 t 59.89 85.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.152 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -82.72 78.62 9.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.934 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.439 ' OG1' HG12 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -124.35 176.37 6.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 179.972 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -110.79 130.95 22.39 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.39 -167.04 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.494 2.129 . . . . 0.0 112.237 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -94.85 145.21 25.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.757 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mp -93.65 114.07 26.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.195 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.719 ' O ' ' HA ' ' A' ' 75' ' ' TYR . 44.0 pt -101.03 -176.4 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.817 178.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.908 HG22 ' CD1' ' A' ' 75' ' ' TYR . 1.1 p -151.39 147.04 26.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.236 0.541 . . . . 0.0 111.47 -178.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.698 ' HG3' HD13 ' A' ' 76' ' ' ILE . 1.4 mtp85 -161.17 104.54 1.3 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.997 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.552 HG21 ' CD ' ' A' ' 71' ' ' GLU . 15.0 t -82.15 131.44 35.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.617 0.722 . . . . 0.0 111.373 -178.526 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.542 ' O ' HD12 ' A' ' 44' ' ' ILE . 2.1 mt-10 -98.39 144.6 27.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.807 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.408 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 28.8 tt0 -66.67 91.68 0.19 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.695 -179.47 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 72' ' ' ARG . 2.8 mp -87.72 109.41 26.59 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.978 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.506 ' C ' HG21 ' A' ' 98' ' ' VAL . 69.6 Cg_endo -88.26 158.18 6.88 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.837 2.358 . . . . 0.0 112.853 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.577 ' HB3' HG22 ' A' ' 98' ' ' VAL . 42.3 p90 -87.27 -174.16 4.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.945 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.42 104.43 2.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.733 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.533 HG23 ' HG2' ' A' ' 101' ' ' GLN . 11.9 p -67.42 143.5 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.189 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 49' ' ' ILE . 4.2 mp -111.82 156.07 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.094 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' N ' HG22 ' A' ' 49' ' ' ILE . 9.7 pttp -108.29 100.91 10.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.828 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.4 ttmp? -112.5 161.78 16.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.927 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -117.71 139.97 50.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.931 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -137.76 132.96 17.55 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.69 -20.28 13.77 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.454 2.103 . . . . 0.0 112.554 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.98 -30.5 59.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.155 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.506 HD22 ' NE2' ' A' ' 60' ' ' GLN . 10.5 mt -81.77 162.35 58.03 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.974 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.14 42.15 1.14 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.209 2.606 . . . . 0.0 112.602 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.67 136.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.872 0.368 . . . . 0.0 111.335 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.66 40.54 88.39 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.687 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.506 ' NE2' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -109.47 145.47 36.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 0.0 110.905 -179.993 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -112.05 117.12 31.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.828 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -130.32 126.06 36.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.991 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.688 HD13 HG22 ' A' ' 103' ' ' VAL . 27.3 mm -101.74 96.37 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.044 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.539 HD12 HG12 ' A' ' 102' ' ' VAL . 35.8 mt -66.2 -31.13 52.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.644 ' CG2' HG23 ' A' ' 102' ' ' VAL . 6.4 t -163.34 119.26 1.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.71 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.07 125.37 27.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.23 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.0 137.75 48.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.319 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.449 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.8 t -138.61 124.16 23.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.814 0.34 . . . . 0.0 111.084 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.86 119.1 4.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.183 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.447 ' CA ' ' O ' ' A' ' 96' ' ' LYS . . . -88.28 -152.25 24.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.044 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.552 ' CD ' HG21 ' A' ' 41' ' ' THR . 0.2 OUTLIER -161.52 145.94 13.13 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.619 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.591 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 31.1 ttm180 -140.36 110.39 6.52 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.139 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.724 ' O ' ' HB3' ' A' ' 92' ' ' SER . 28.0 m -73.77 125.48 28.2 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.014 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.506 ' O ' ' HA ' ' A' ' 39' ' ' THR . 10.5 m80 -105.59 117.53 34.25 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 122.098 0.952 . . . . 0.0 113.259 -176.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.908 ' CD1' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -89.44 108.26 19.54 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 113.694 -1.594 . . . . 0.0 111.28 -177.912 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.698 HD13 ' HG3' ' A' ' 40' ' ' ARG . 2.4 mp -95.26 160.76 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.814 -179.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.731 ' OG ' HD23 ' A' ' 90' ' ' LEU . 55.9 p -104.69 118.76 37.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.711 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.731 HG23 HG23 ' A' ' 85' ' ' THR . 9.9 p -81.45 108.55 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.155 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -113.05 88.68 2.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.6 m -82.16 117.51 22.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -127.8 107.62 10.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.952 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 60.79 31.85 20.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.843 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.75 43.24 7.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.525 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.9 tptp -143.23 107.51 4.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.793 0.33 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.731 HG23 HG23 ' A' ' 78' ' ' VAL . 24.8 m -85.85 120.06 26.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.92 142.8 31.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.925 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -105.85 95.73 6.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.6 m -123.64 125.1 44.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.064 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.9 m -55.11 145.12 5.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.022 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.731 HD23 ' OG ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -130.09 -51.76 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.171 -179.851 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 1.8 t70 -176.62 137.32 0.26 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.274 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.724 ' HB3' ' O ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -143.66 144.87 32.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.352 0.596 . . . . 0.0 111.306 179.005 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.645 ' HB2' ' OH ' ' A' ' 75' ' ' TYR . 3.1 mt-30 -103.47 166.75 10.24 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.582 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.593 ' O ' HG13 ' A' ' 94' ' ' VAL . 8.6 p -85.25 107.01 15.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.803 -179.031 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.517 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 19.3 p -110.51 83.2 1.72 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.22 -179.435 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 95' ' ' THR . 0.1 OUTLIER 103.39 44.78 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.746 -179.636 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.46 ' HB2' HG21 ' A' ' 94' ' ' VAL . 6.1 tp10 -31.31 133.32 0.08 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.313 -179.604 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.577 HG22 ' HB3' ' A' ' 46' ' ' PHE . 10.7 p -71.87 118.89 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.002 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.564 ' H ' HD12 ' A' ' 99' ' ' ILE . 5.3 mp -75.49 108.79 7.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.962 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -71.22 130.87 42.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.533 ' HG2' HG23 ' A' ' 48' ' ' VAL . 29.2 tt0 -68.53 148.0 51.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.644 HG23 ' CG2' ' A' ' 65' ' ' THR . 53.4 t -133.11 100.61 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.007 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.688 HG22 HD13 ' A' ' 63' ' ' ILE . 20.1 t -120.47 133.63 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -110.91 154.89 23.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.78 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.88 138.74 52.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.202 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.7 87.81 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.498 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 60.92 155.5 0.11 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.706 0.289 . . . . 0.0 111.171 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.14 -168.14 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.64 2.226 . . . . 0.0 112.336 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.4 m -124.03 31.53 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.113 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.97 -40.28 6.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 7.1 m170 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.935 179.967 . . . . . . . . 0 0 . 1 stop_ save_